Journal Menu
► ▼ Journal Menu-
- JCM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
27 November 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 in the Section “Sports Medicine”
We are delighted to share some highly cited papers from the Section “Sports Medicine” that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023.
The following is a list of articles that we believe will interest you:
1. “The Effect of High-Intensity Interval Training Type on Body Fat Percentage, Fat and Fat-Free Mass: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”
by Fatemeh Khodadadi, Reza Bagheri, Raoof Negaresh, Sajjad Moradi, Michael Nordvall, Donny M. Camera, Alexei Wong and Katsuhiko Suzuki
J. Clin. Med. 2023, 12(6), 2291; https://doi.org/10.3390/jcm12062291
Available online: https://www.mdpi.com/2077-0383/12/6/2291
2. “Effectiveness and Consequences of Direct Access in Physiotherapy: A Systematic Review”
by Marco Gallotti, Benedetta Campagnola, Antonello Cocchieri, Firas Mourad, John D. Heick and Filippo Maselli
J. Clin. Med. 2023, 12(18), 5832; https://doi.org/10.3390/jcm12185832
Available online: https://www.mdpi.com/2077-0383/12/18/5832
3. “Time-Restricted Eating and Its Metabolic Benefits”
by Sneha Mishra, Patress A. Persons, Andrea M. Lorenzo, Swarna S. Chaliki and Sophie Bersoux
J. Clin. Med. 2023, 12(22), 7007; https://doi.org/10.3390/jcm12227007
Available online: https://www.mdpi.com/2077-0383/12/22/7007
4. “Effect of Localized Vibration Massage on Popliteal Blood Flow”
by Devin Needs, Jonathan Blotter, Madison Cowan, Gilbert Fellingham, A. Wayne Johnson and Jeffrey Brent Feland
J. Clin. Med. 2023, 12(5), 2047; https://doi.org/10.3390/jcm12052047
Available online: https://www.mdpi.com/2077-0383/12/5/2047
5. “Impacts of Whole-Body Vibration on Muscle Strength, Power, and Endurance in Older Adults: A Systematic Review and Meta-Analysis”
by Raphael Gonçalves de Oliveira, Heloísa Maria Elaine Licha Coutinho, Maiara Naldi Mansano Martins, Mario Bernardo-Filho, Danúbia da Cunha de Sá-Caputo, Laís Campos de Oliveira and Redha Taiar
J. Clin. Med. 2023, 12(13), 4467; https://doi.org/10.3390/jcm12134467
Available online: https://www.mdpi.com/2077-0383/12/13/4467
6. “The Evaluation of Asymmetry in Isokinetic and Electromyographic Activity (sEMG) of the Knee Flexor and Extensor Muscles in Football Players after ACL Rupture Reconstruction and in the Athletes following Mild Lower-Limb Injuries”
by Łukasz Oleksy, Anna Mika, Iwona Sulowska-Daszyk, Renata Kielnar, Zofia Dzięcioł-Anikiej, Joanna Zyznawska, Olga Adamska and Artur Stolarczyk
J. Clin. Med. 2023, 12(3), 1144; https://doi.org/10.3390/jcm12031144
Available online: https://www.mdpi.com/2077-0383/12/3/1144
7. “Clinical Research Progress of Internal Brace Ligament Augmentation Technique in Knee Ligament Injury Repair and Reconstruction: A Narrative Review”
by Wenhao Lu, Zhenhan Deng, Anko Elijah Essien, Djandan Tadum Arthur Vithran, Michael Opoku, Yusheng Li and Wenfeng Xiao
J. Clin. Med. 2023, 12(5), 1999; https://doi.org/10.3390/jcm12051999
Available online: https://www.mdpi.com/2077-0383/12/5/1999
8. “Epidemiology of Injuries in Men’s Professional and Amateur Football (Part I)”
by Tudor Vladimir Gurau, Gabriela Gurau, Doina Carina Voinescu, Lucretia Anghel, Gelu Onose, Daniel Andrei Iordan, Constantin Munteanu, Ilie Onu and Carmina Liana Musat
J. Clin. Med. 2023, 12(17), 5569; https://doi.org/10.3390/jcm12175569
Available online: https://www.mdpi.com/2077-0383/12/17/5569
9. “The Influence of Conventional and Innovative Rehabilitation Methods on Brain Plasticity Induction in Patients with Multiple Sclerosis”
by Marta Milewska-Jędrzejczak and Andrzej Głąbiński
J. Clin. Med. 2023, 12(5), 1880; https://doi.org/10.3390/jcm12051880
Available online: https://www.mdpi.com/2077-0383/12/5/1880
10. “Home-Based Preoperative Exercise Training for Lung Cancer Patients Undergoing Surgery: A Feasibility Trial”
by Pedro Machado, Sara Pimenta, Ana Luís Garcia, Tiago Nogueira, Sónia Silva, Bárbara Oliveiros, Raul A. Martins and Joana Cruz
J. Clin. Med. 2023, 12(8), 2971; https://doi.org/10.3390/jcm12082971
Available online: https://www.mdpi.com/2077-0383/12/8/2971
11. “The Prevalence of Responders and Non-Responders for Body Composition, Resting Blood Pressure, Musculoskeletal, and Cardiorespiratory Fitness after Ten Weeks of School-Based High-Intensity Interval Training in Adolescents”
by Jarosław Domaradzki, Dawid Koźlenia and Marek Popowczak
J. Clin. Med. 2023, 12(13), 4204; https://doi.org/10.3390/jcm12134204
Available online: https://www.mdpi.com/2077-0383/12/13/4204
12. “A Randomized, Double-Blind Placebo Control Study on the Effect of a Blood Flow Restriction by an Inflatable Cuff Worn around the Arm on the Wrist Joint Position Sense in Healthy Recreational Athletes”
by Aleksandra Królikowska, Klaudia Kusienicka, Ewa Lazarek, Łukasz Oleksy, Robert Prill, Anna Kołcz, Maciej Daszkiewicz, Dariusz Janczak and Paweł Reichert
J. Clin. Med. 2023, 12(6), 2262; https://doi.org/10.3390/jcm12062262
Available online: https://www.mdpi.com/2077-0383/12/6/2262
13. “Effects of a Single Session of Systemic Vibratory Therapy on Flexibility, Perception of Exertion and Handgrip Strength in Chronic Obstructive Pulmonary Disease Individuals: A Quasi-Experimental Clinical Trial”
by Eliane de Oliveira Guedes-Aguiar, Redha Taiar, Laisa Liane Paineiras-Domingos, Bruno Bessa Monteiro-Oliveira, Danúbia da Cunha de Sá-Caputo and Mario Bernardo-Filho
J. Clin. Med. 2023, 12(9), 3241; https://doi.org/10.3390/jcm12093241
Available online: https://www.mdpi.com/2077-0383/12/9/3241
14. “Comparing Post-Exercise Hypotension after Different Sprint Interval Training Protocols in a Matched Sample of Younger and Older Adults”
by Sascha Ketelhut, Martin Möhle, Tina Gürlich, Laura Hottenrott and Kuno Hottenrott
J. Clin. Med. 2023, 12(2), 640; https://doi.org/10.3390/jcm12020640
Available online: https://www.mdpi.com/2077-0383/12/2/640
15. “Scapular Kinematics and Patterns of Scapular Dyskinesis in Rotator Cuff Tears: A Prospective Cohort Study”
by Umile Giuseppe Longo, Laura Risi Ambrogioni, Vincenzo Candela, Alessandra Berton, Daniela Lo Presti and Vincenzo Denaro
J. Clin. Med. 2023, 12(12), 3841;https://doi.org/10.3390/jcm12113841
Available online: https://www.mdpi.com/2077-0383/12/11/3841
16. “The Moderating Effects of Physical Activity on the Relationships between Child Maltreatment and Health Outcomes among Korean Adolescents: A Secondary Analysis of the 2020 Korean Children and Youth Rights Survey”
by Suryeon Ryu and Zan Gao
J. Clin. Med. 2023, 12(14), 4574; https://doi.org/10.3390/jcm12144574
Available online: https://www.mdpi.com/2077-0383/12/14/4574
17. “Effects of Vibrotherapy with Different Characteristics and Body Position on Post-Exercise Recovery after Anaerobic Exercise”
by Tomasz Pałka, Marcin Maciejczyk, Olga Czerwińska-Ledwig, Łukasz Tota, Marek Bawelski, Alejandro Leiva-Arcas, Rafał Stabrawa, Przemysław Bujas, Dawid Mucha, Andrzej Wiśniewski et al.
J. Clin. Med. 2023, 12(14), 4629; https://doi.org/10.3390/jcm12144629
Available online: https://www.mdpi.com/2077-0383/12/14/4629
18. “Key Considerations When Addressing Physical Inactivity and Sedentary Behaviour in People with Asthma”
by Paola D. Urroz Guerrero, Joice M. Oliveira, Hayley Lewthwaite, Peter G. Gibson and Vanessa M. McDonald
J. Clin. Med. 2023, 12(18), 5998; https://doi.org/10.3390/jcm12185998
Available online: https://www.mdpi.com/2077-0383/12/18/5998
19. “The Relationship between Body Composition and Physical Activity Level in Students of Medical Faculties”
by Aleksandra Jaremków, Iwona Markiewicz-Górka, Wojciech Hajdusianek, Karolina Czerwińska and Paweł Gać
J. Clin. Med. 2023, 12(13), 4521; https://doi.org/10.3390/jcm12134521
Available online: https://www.mdpi.com/2077-0383/12/13/4521
by Marco Corsi, Edoardo Falconi, Roberto Palazzo, Vittorio Bini, Gabriele Mascherini, Sabrina Mancini, Marco Maglione and Laura Stefani
J. Clin. Med. 2023, 12(13), 4521; https://doi.org/10.3390/jcm12134521
Available online: https://www.mdpi.com/2077-0383/12/13/4521
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
26 November 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Intensive Care” Held on 8 April 2024
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board meeting for the Section “Intensive Care” on 8 April 2024. We appreciate the Section Editor-in-Chief, Prof. Dr. Karim Bendjelid, for hosting this meeting; five Editorial Board Members were in attendance. We would like to invite everyone to jointly review the content of this meeting. We are extremely grateful for the strong support from our Editorial Board Members. Meanwhile, we sincerely hope that more Editorial Board Members will be able to participate in future meetings.
The meeting started with a presentation about the development of the journal, as well as the Section “Intensive Care” in particular, and the following topics were discussed:
- Journal history, open access policy, and author benefits;
- Journal publication statistics and authors’ group analysis (2018–2023);
- Journal awards, conference sponsorship, and journal social media management;
- Section EBM overview, decision-making statistics, and Section development statistics.
At this Editorial Board meeting, the following areas were covered in the discussion:
- Strategies for Improving the Impact Factor: The impact factors of the current 35 Sections (including the “Intensive Care” Section) need to be analyzed and accurate plans for development were made, including focusing on high-quality manuscripts, writing a year-in-review article, strengthening the preliminary examination process, and paying attention to the quality of peer review.
- Development Plans for the “Intensive Care” Section: Our desire to actively participate in significant academic conferences and establish connections with relevant societies was expressed. In addition, consideration was given to diversifying the types of papers, attaching great importance to basic scientific research. In the ICU field, cardiovascular and respiratory systems, liver function, nutrition, and metabolism are very important; we should organize online expert conferences where authoritative experts in the industry are invited to discuss clinical issues, form consensus expert opinions, and compile them into high-quality papers.
- Promotion and Other Suggestions: Editorial Board Members exchanged different promotion ideas, and some members agreed to promote the journal during academic conferences. It was suggested that we control the rationality of the number and composition of Editorial Board Members, which should be small and precise, covering various professional fields and regions.
We sincerely thank the Editorial Board Members for their active participation. Thanks to your participation, we could exchange views face-to-face and get timely feedback. Here, we sincerely thank every member for their hard work and academic support. We hope that more members will join us in the future, and we look forward to your valuable suggestions, as they push us to work together, continue to move towards a higher level of development, and make greater progress.
Attendee list (in no particular order):
- Prof. Dr. Karim Bendjelid (Section Editor-in-Chief), CardioVascular Unit, Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland;
- Prof. Dr. Davide Alberto Chiumello, 1Department of Anesthesia and Intensive Care, ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy; 2Department of Health Sciences, University of Milan, Milan, Italy; 3Coordinated Research Center on Respiratory Failure, University of Milan, Milan, Italy;
- Dr. Banwari Agarwal, 1Intensive Care Unit, Royal Free Hospital, London, UK; 2Institute for Liver & Digestive Health, University College London, London, UK; 3Liver Failure Group, Institute for Liver and Digestive Health, University College London, London, UK;
- Prof. Dr. Luca Brazzi, Department of Surgical Science, University of Turin, Torino, Italy;
- Prof. Dr. Peter Markus Spieth, Department of Anesthesiology and Critical Care Medicine, University Hospital Carl Gustav Carus, Dresden, Germany;
- Dr. Francesco Corradi, Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current impact factor of JCM is 3.0 (2023), ranking 58/325 (Q1) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Intensive_Care.
JCM Editorial Office
25 November 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Endocrinology & Metabolism
We are delighted to share some highly cited papers on endocrinology and metabolism that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues in the Section “Endocrinology & Metabolism” are currently open for submission. The following is a list of articles and Special Issues that we believe will interest you.
1. “Association between the Prognostic Nutritional Index and Chronic Microvascular Complications in Patients with Type 2 Diabetes Mellitus”
by Gulali Aktas
J. Clin. Med. 2023, 12(18), 5952; https://doi.org/10.3390/jcm12185952
Available online: https://www.mdpi.com/2077-0383/12/18/5952
2. “Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux”
by Alejandro Gugliucci
J. Clin. Med. 2023, 12(13), 4399; https://doi.org/10.3390/jcm12134399
Available online: https://www.mdpi.com/2077-0383/12/13/4399
3. “Sexual and Reproductive Outcomes in Obese Fertile Men with Functional Hypogonadism after Treatment with Liraglutide: Preliminary Results”
by Sandro La Vignera, Rosita A. Condorelli, Aldo E. Calogero, Rossella Cannarella and Antonio Aversa
J. Clin. Med. 2023, 12(2), 672; https://doi.org/10.3390/jcm12020672
Available online: https://www.mdpi.com/2077-0383/12/2/672
4. “A Comprehensive Summary of the Current Understanding of the Relationship between Severe Obesity, Metabolic Syndrome, and Inflammatory Status”
by Razvan-Marius Ion, Melania Sibianu, Adina Hutanu, Felicia Gabriela Beresescu, Daniela Tatiana Sala, Mocian Flavius, Ancuta Rosca, Calin Constantin, Alexandra Scurtu, Renata Moriczi et al.
J. Clin. Med. 2023, 12(11), 3818; https://doi.org/10.3390/jcm12113818
Available online: https://www.mdpi.com/2077-0383/12/11/3818
5. “From Innate Immunity to Metabolic Disorder: A Review of the NLRP3 Inflammasome in Diabetes Mellitus”
by Iris Maria Nițulescu, George Ciulei, Angela Cozma, Lucia Maria Procopciuc and Olga Hilda Orășan
J. Clin. Med. 2023, 12(18), 6022; https://doi.org/10.3390/jcm12186022
Available online: https://www.mdpi.com/2077-0383/12/18/6022
6. “Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes”
by Riccardo Candido, Sara Gaiotti, Fabiola Giudici, Barbara Toffoli, Federica De Luca, Valerio Velardi, Alessandra Petrucco, Chiara Gottardi, Elena Manca, Iris Buda et al.
J. Clin. Med. 2023, 12(18), 6052; https://doi.org/10.3390/jcm12186052
Available online: https://www.mdpi.com/2077-0383/12/18/6052
7. “The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study”
by Aikaterini Giannouli, Vasiliki Efthymiou, Marianna Konidari, Iliana Mani, Leon Aravantinos, Spyridon P. Dourakis, Aristeidis Antoniou, Efthymios Deligeoroglou and Flora Bacopoulou
J. Clin. Med. 2023, 12(2), 557; https://doi.org/10.3390/jcm12020557
Available online: https://www.mdpi.com/2077-0383/12/2/557
8. “Diagnosis and Non-Invasive Treatment of Obesity in Adults with Type 2 Diabetes Mellitus: A Review of Guidelines”
by Michał Łuniewski, Beata Matyjaszek-Matuszek and Monika Lenart-Lipińska
J. Clin. Med. 2023, 12(13), 4431; https://doi.org/10.3390/jcm12134431
Available online: https://www.mdpi.com/2077-0383/12/13/4431
9. “Exercise and Weight Management: The Role of Leptin—A Systematic Review and Update of Clinical Data from 2000–2022”
by Gilmara Gomes de Assis and Eugenia Murawska-Ciałowicz
J. Clin. Med. 2023, 12(13), 4490; https://doi.org/10.3390/jcm12134490
Available online: https://www.mdpi.com/2077-0383/12/13/4490
10. “Mirabegron, a Selective β3-Adrenergic Receptor Agonist, as a Potential Anti-Obesity Drug”
by Anna Maria Dąbrowska and Jarosław Dudka
J. Clin. Med. 2023, 12(21), 6897; https://doi.org/10.3390/jcm12216897
Available online: https://www.mdpi.com/2077-0383/12/21/6897
11. “Associations between Systemic Immune-Inflammation Index and Diabetes Mellitus Secondary to Pancreatic Ductal Adenocarcinoma”
by Guanhua Chen, Chunlu Tan, Xubao Liu, Xing Wang, Qingquan Tan and Yonghua Chen
J. Clin. Med. 2023, 12(3), 756; https://doi.org/10.3390/jcm12030756
Available online: https://www.mdpi.com/2077-0383/12/3/756
12. “Type 2 Diabetes Prevention Programs—From Proof-of-Concept Trials to National Intervention and Beyond”
by Jaakko Tuomilehto, Matti Uusitupa, Edward W. Gregg and Jaana Lindström
J. Clin. Med. 2023, 12(5), 1876; https://doi.org/10.3390/jcm12051876
Available online: https://www.mdpi.com/2077-0383/12/5/1876
13. “Evaluation of Adjuvant Antibiotic Loaded Injectable Bio-Composite Material in Diabetic Foot Osteomyelitis and Charcot Foot Reconstruction”
by Catalina Solano, Marie Chicaud, Stessy Kutchukian, Luigi Candela, Mariela Corrales, Frédéric Panthier, Steeve Doizi and Olivier Traxer
J. Clin. Med. 2023, 12(9), 3239; https://doi.org/10.3390/jcm12093239
Available online: https://www.mdpi.com/2077-0383/12/9/3239
14. “Significance of Umbilical Cord Leptin Profile during Pregnancy in Gestational Diabetes Mellitus—A Systematic Review and Meta-Analysis”
by María del Mar Roca-Rodríguez, Pablo Ramos-García, Cristina López-Tinoco and Manuel Aguilar-Diosdado
J. Clin. Med. 2023, 12(14), 4756; https://doi.org/10.3390/jcm12144756
Available online: https://www.mdpi.com/2077-0383/12/14/4756
15. “Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States”
by Tomasz Stompór, Marcin Adamczak, Ilona Kurnatowska, Beata Naumnik, Michał Nowicki, Leszek Tylicki, Agata Winiarska and Magdalena Krajewska
J. Clin. Med. 2023, 12(14), 4783; https://doi.org/10.3390/jcm12144783
Available online: https://www.mdpi.com/2077-0383/12/14/4783
Special Issues: | |
“Type 2 Diabetes and Complications: From Diagnosis to Treatment” Guest Editor: Dr. Matteo Monami Submission deadline: 15 February 2025 |
“Endocrine Tumors: Diagnosis, Treatment, and Management” Guest Editors: Dr. Jules T. Zhang-Yin, Dr. Francesco Dondi and Dr. Emmanouil Panagiotidis Submission deadline: 31 March 2025 |
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
21 November 2024
Journal of Clinical Medicine | 2024 Editorial Board Meeting of the Section “Sports Medicine” Held on 27 March 2024
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board meeting for the Section “Sports Medicine” on 27 March 2024. We appreciate the Section Editor-in-Chief, Prof. Dr. Naama W. Constantini, for hosting this meeting, with two Editorial Board Members in attendance. We would like to invite everyone to jointly review the content of the meeting at that time. We are extremely grateful for the strong support from the Editorial Board Members. We are actively promoting the construction of the Section and expanding the number of Editorial Board Members.
The meeting started with a presentation on the development of the journal, as well as the Section “Sports Medicine” in particular, and the following information was presented:
- The journal’s history, open access policy, and author benefits;
- Journal publication statistics and authors group analysis (2019–2023);
- Journal awards, conference sponsorships, and journal social media management;
- Section EBM overview, decision-making statistics, and section development statistics.
At this Editorial Board meeting, the following details were covered in the discussion:
- Regarding reviewers: we have reached a consensus to keep inviting outstanding and highly proficient professionals as reviewers; they are capable of providing valuable suggestions, which can effectively improve the quality of the papers;
- Upgrading the peer review interface: the Editorial Board Members proposed some possible ideas for the improvement of the editorial process, enabling reviewers and Academic Editors to convey their suggestions with enhanced flexibility;
- Section topics and organization: the Editorial Board Members pointed out that mental health in sports medicine is a hot topic that could be suitable for a new Special Issue; we will actively organize and create a relevant Special Issue and welcome submissions on related topics; they are satisfied with the current departmental organization and are willing to assist in identifying new EBM candidates when needed; EBMs also agreed and supported holding an exchange meeting every six months.
We sincerely express our gratitude to all the Editorial Board Members who participated in this meeting. They provided positive suggestions regarding our reviewer and peer review system and recommended popular topics. Looking ahead, we anticipate attracting outstanding senior reviewers and authors and publishing high-quality articles with our manuscript-handling services. We look forward to having more Editorial Board Members attend future meetings and offer their valuable advice to the journal in the future. We are convinced that our collective efforts will enable the “Sports Medicine” Section to thrive.
Attendee list (in no particular order):
- Prof. Dr. Naama W. Constantini (Section Editor-in-Chief), Heidi Rothberg Sports Medicine Center, Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University, Jerusalem, Israel;
- Dr. Anna Maria Malagoni, Vascular Diseases Center, University Hospital of Ferrara, Ferrara, Italy;
- Dr. Andrea Ermolao, Sport and Exercise Medicine Division, Department of Medicine, University of Padova, Padova, Italy.
The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.0 (2023), ranking 58/325 (Q1) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Sports_Medicine.
JCM Editorial Office
18 November 2024
JCM Webinar | Stress, Rhythms Dysregulation and Bipolar Spectrum: Virtual Reality-Based Interventions to Improve Related Conditions, 20 November 2024
MDPI would like to invite all experts recognized in their fields to attend the webinar organized by the Journal of Clinical Medicine (JCM, ISSN: 2077-0383), entitled “Stress, Rhythms Dysregulation and Bipolar Spectrum: Virtual Reality-Based Interventions to Improve Related Conditions”. The webinar aims to explore new perspectives regarding stress, rhythm dysregulation, and the bipolar spectrum, with a focus on novel treatments, such as virtual reality-based interventions to improve cognitive functions and related psychosocial conditions.
We look forward to seeing you at the webinar “Stress, Rhythms Dysregulation and Bipolar Spectrum: Virtual Reality-Based Interventions to Improve Related Conditions”.
Title: Stress, Rhythms Dysregulation and Bipolar Spectrum: Virtual Reality-Based Interventions to Improve Related Conditions
Date: 20 November 2024
Time: 15:00 CET
More information: https://sciforum.net/event/JCM-11
This is a free webinar. Following registration, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available for viewing.
Register for free:
Program
Speaker/Presentation |
Time in CET |
Dr. Giulia Cossu and Dr. Alessandra Perra |
3:00 p.m.–3:10 p.m. |
Dr. Diego Primavera |
3:10 p.m.–3:30 p.m. |
Dr. Goce Kalcev |
3:30 p.m.–3:50 p.m. |
Dr. Cesar Avilez Gonzales |
3:50 p.m.–4:10 p.m. |
Dr. Federica Sancassiani |
4:10 p.m.–4:30 p.m. |
Q&A Session |
4:30 p.m.–4:45 p.m. |
Dr. Giulia Cossu and Dr. Alessandra Perra |
4:50 p.m.–5:00 p.m. |
Relevant Special Issue:
“Stress, Rhythms Dysregulation and Bipolar Spectrum”
Guest Editors: Prof. Dr. Mauro Giovanni Carta and Dr. Giulia Cossu
Deadline for manuscript submissions: 20 January 2025
15 November 2024
Prof. Dr. A. Douglas Kinghorn Appointed Chair of the 2024 Tu Youyou Award Committee
We are honored to announce that Prof. Dr. A. Douglas Kinghorn will serve as the Chair of the 2024 Tu Youyou Award Committee.
Name: Prof. Dr. A. Douglas Kinghorn
Affiliation: College of Pharmacy, The Ohio State University, USA
Prof. Dr. Kinghorn is a leading expert in pharmacognosy and natural products research. He is recognized for his key contributions to discovering bioactive compounds from plants, especially in anticancer, cancer chemopreventive, and substances with a sweet taste and taste-modifying agents. His prolific contributions include over 590 peer-reviewed works and edited or co-edited 40 scientific volumes.
The 2024 Tu Youyou Award Committee, under Prof. Dr. Kinghorn's guidance, will focus on identifying innovative research in the fields of natural products chemistry and medicinal chemistry. The committee will aim to identify groundbreaking work with the potential to lead to significant advancements in these areas.
We are confident that, with Prof. Dr. Kinghorn at the helm, the 2024 Tu Youyou Award will continue to inspire excellence and innovation in the related fields.
About the Tu Youyou Award
Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal.
The 2024 Tu Youyou Award remains open for nominations until 31 December 2024. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.
If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.
7 November 2024
Journal of Clinical Medicine | 2024 Editorial Board Meeting of the Section “Clinical Rehabilitation” Held on 16 April 2024
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board meeting for the Section “Clinical Rehabilitation” on 16 April 2024. We appreciate the Section Editor-in-Chief, Prof. Dr. Masahiro Kohzuki, for hosting this meeting; three Editorial Board Members were in attendance. We would like to invite everyone to jointly review the content of the meeting at that time. We are extremely grateful for the strong support from the Editorial Board Members. Meanwhile, we sincerely hope that more Editorial Board Members will be able to participate in future meetings.
The meeting started with a presentation about the development of the journal, as well as the Section “Clinical Rehabilitation”in particular, and the following information was presented:
- Journal history, open access policy, and benefits;
- Publication statistics and authors roup analysis (2018–2023);
- Journal awards, conference sponsorship, and journal social media management;
- Section EBM overview, decision-making statistics, and Section development statistics.
At this Editorial Board meeting, the Editorial Board Members participated in a productive discussion encompassing various aspects including the impact factor, rapid publication process, and the potential for enhanced submissions. Recommended topics such as burns, early intervention, and rehabilitation were proposed. The quality of life after burn injury, particularly the bone injury of lowland bone patients, was considered as a potential area for establishing Special Issues. Moreover, the types of articles and potential authors were also discussed.
We are very grateful to our Editorial Board Members for actively promoting the journal at relevant conferences. We would like to thank every Editorial Board Member and contributing academic for their support, and we look forward to receiving more suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Prof. Dr. Masahiro Kohzuki (Section Editor-in-Chief), Yamagata Prefectural University of Health Sciences, Yamagata, Japan. Tohoku University Graduate School of Medicine, Sendai, Japan;
- Prof. Dr. Stefano Negrini, University La Statale and Research Hospital Galeazzi Sant'Ambrogio, Milan, Italy;
- Dr. Dale Edgar, The University of Notre Dame Australia, Fremantle, Australia and Armadale Hospital, Mount Nasura, Australia;
- Dr. Indre Bileviciute-Ljungar, Karolinska Institutet, Sweden. St Göran Hospital, Stockholm, Sweden.
The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.0 (2023), ranking 58/325 (Q1) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Clinical_Rehabilitation.
JCM Editorial Office
5 November 2024
MDPI INSIGHTS: The CEO's Letter #17 - OA Week, Basel Open Day, Beijing Graphene Forum
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access Week: Forging the Future of Open Access through Global Reach and Collaboration
From 21 to 27 October, we celebrated International Open Access Week (OAW), highlighting the importance of making research accessible to everyone. This campaign reinforced our commitment to advancing open access (OA) and showcased how we are helping research communities worldwide adopt OA as their standard.
“OA publishing is now a cornerstone of global research”
Throughout the week, we featured MDPI’s efforts to support quality open research through blog posts on topics such as how Research Integrity Promotes OA Practices, our Preprints.org platform, and supporting societies with different OA models. These initiatives capture our commitment to making research more inclusive and accessible to all.
OA publishing is now a cornerstone of global research, with more researchers choosing OA over traditional paywalled models, and embracing new, community-driven models.
Benefits of Open Access and Open Research
- Accelerated Discoveries: OA speeds up scientific progress by allowing immediate access to findings, enabling researchers to build on each other’s work faster.
- Community-Led Innovation: Open research empowers communities to manage their own platforms, creating collaboration and shared knowledge.
- Increased Visibility: OA broadens the reach of your research, leading to greater recognition, collaboration, and impact.
- Cross-Disciplinary Connections: By removing financial and geographical barriers, OA unites diverse fields, sparking innovation across disciplines.
MDPI Singapore Celebrates Open Access Week
MDPI Singapore also hosted its first-ever OAW event at the Marina Bay Sands Convention Centre, bringing together academics, researchers, and students to discuss the future of open scholarship. Conversations focused on the potential of new publishing models, alternative funding strategies, and the importance of communicating research to wider audiences.
As OA evolves, MDPI remains a committed partner in advancing open science and creating a transparent, inclusive research environment. For a full recap of the week’s highlights and resources, visit our campaign page.
Impactful Research
MDPI Connection to Nobel-Winning Protein Research
David Baker, an American biochemist, and Demis Hassabis and John M. Jumper, two scientists from Google DeepMind, have been awarded the 2024 Nobel Prize in Chemistry for their groundbreaking advancements in better understanding the structure of proteins, the molecular engines of life’s processes.
One half of the prize was awarded to Professor David Baker from the University of Washington for his development of revolutionary protein design software enabling the creation of novel proteins for vaccines, nanomaterials, and sensors. Prof. Baker co-authored a 2016 paper in MDPI’s Toxins journal on protein-based therapeutics.
Meanwhile, DeepMind’s Demis Hassabis and John M. Jumper received recognition for AlphaFold, the AI model that predicts protein structures from amino acid sequences, fulfilling a long-held scientific dream.
“We congratulate this year’s Nobel laureates for their groundbreaking contributions to the study of life”
Nobel Prize Laureates Entrust MDPI with Their Research
As at October 2024, 45 Nobel laureates had contributed to more than 115 articles across
35 MDPI journals. The privilege of hosting the research of such contributors, who significantly influence the open access movement, resonates deeply with our editorial teams.
We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath, Tomas Lindahl, Thomas C. Südhof, Stanley B. Prusiner, Roger Kornberg, Robert F. Engle, Richard J. Roberts, Ōmura Satoshi, Kenneth J. Arrow, John B. Goodenough, Jennifer Doudna, Hamilton Othanel Smith, Eric R. Kandel, Carlo Rubbia, Bernard Feringa, Barry J. Marshall, Anthony J. Leggett, Andrew Victor Schally, and David Baker.
Notable MRNA Published in Cells
On 7 October 2024, the 2024 Nobel Prize in Physiology or Medicine was jointly awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
MicroRNAs are proving to be fundamentally important for how organisms develop and function. Some interesting papers about microRNA research are published in the MDPI journal Cells. I invite you browse through the notable papers related to microRNA research in Cells.
Inside MDPI
Basel Open Day
On 21 October, we held the Basel Open Day at our headquarters, welcoming a group of journal Editors-in-Chief (EiC) and Editorial Board Members (EBMs) for a full-day workshop. The event featured presentations and discussions on MDPI’s latest editorial updates, data integrity policies, society collaborations, and local market insights.
The following MDPI journals were represented during the visit: Physics, Journal of Personalized Medicine (JPM), Sci, Remote Sensing, Animals, Cells, Buildings, Histories, Sensors, and International Journal of Environmental Research and Public Health (IJERPH).
This was a great opportunity to showcase our new office space while gathering feedback from leading journal stakeholders. To get everyone on the same page, we took 60 minutes for round-table introductions, which helped set a collaborative tone and ground us in MDPI’s mission of disseminating open science.
“This was a great opportunity to gather feedback from leading journal stakeholders”
The general feedback from the day highlighted positive developments around our editorial and ethics policies, as well as areas for improvement, including flexibility regarding reviewer deadlines. There was a genuine appreciation and push for our ongoing efforts to share more about MDPI, including company updates and promoting high-quality research through our blog, announcements, and social media channels, which we have been growing and expanding.
Our Basel Open Day was a positive experience, bringing together key journal stakeholders and gathering insights to guide MDPI’s continued engagement with the academic community. We look forward to hosting future events of this kind and welcoming more scholars to our headquarters in Basel, Switzerland.
Coming Together for Science
ncRNA 2024 Conference in Basel
I am pleased to share that we held Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines (ICM 2024) in Basel, Switzerland this past 7–9 October.
The three-day event attracted just over 100 attendees, including two Chairs, 10 invited speakers and two keynotes from Prof. Mauro Giacca and Prof. Ling-Ling Chen. Of the presentations on site, there were 35 posters and 44 oral presentations.
The overall feedback was positive, with people enjoying the intimate event and the unique activities offered, including a guided tour around Basel’s Old Town (a must-see for anyone visiting the city) and a memorable conference dinner.
It was cool to see the winners of the 2024 Nobel Prize in Physiology or Medicine announced during the conference days. This was exciting for attendees, as the winners discovered a new class of RNA molecules (miRNAs). As one invited speaker put it, “It's exciting to be among fellows when something that important for the field is announced.”
“It's exciting to be among fellows when something that important for the field is announced”
Every attendee receives a conference survey, and I’m always pleased to see a high percentage of ‘Very Satisfied’ responses when asked about ‘treatment from conference personnel’. Kudos to our conference team for meeting our attendees’ needs. These events are a great opportunity for us to reach new audiences, as 92% of the respondents had never been to an MDPI conference, so I am thrilled to see us connecting with a new demographic of your researchers in the RNA field.
A special thank-you to our partnering societies The Epigenetics Society, The French Society of Genetics, LS2 / USGEB (Union of Swiss Societies for Experimental Biology), and The RNA Biology Group, as well as to our sponsors New England Biolabs and Arraystar for their support of the ncRNA 2024 conference. I am also pleased to report that we presented two awards, including the Best Presentation Award and two Best Poster Award, recognizing the contributions of our participants.
Upcoming In-Person Event
27–29 November 2024
Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life
Location: Barcelona, Spain
The discovery of new molecules, their properties, and actions to enhance human health and quality of life.
Find more upcoming MDPI events here.
Closing Thoughts
Beijing Graphene Forum 2024
I am pleased to share that we had a successful time at the Beijing Graphene Forum 2024, which drew around 1,000 attendees, including Konstantin Novoselov (2015 Nobel Prize in Physics) and other high-profile scholars in materials science and chemistry. It was a great opportunity to present MDPI on the big stage, with university presidents from institutions such as Peking University also in attendance.
I had the honour of awarding Prof. Zhongfan Liu, Chairman of the Chemical Science Committee, with a medal and presenting certificates to the members of the Chemical Science Committee; this is an important initiative to help expand MDPI’s journals and influence in China. These are highly respected scholars, and we enjoyed connecting with them over lunch as well.
“This is an important initiative to help expand MDPI’s journals and influence in China”
I also had the chance to speak about MDPI and open access, giving a five-minute speech during the opening ceremony and a 20-minute presentation at the close. MDPI hosted a sub-forum where both academic scholars and MDPI members shared insights, and we engaged with attendees at our MDPI booth.
This was a great opportunity to spotlight MDPI as the main publishing partner for the event, and I was proud to represent us on stage. We also met with scholars to discuss topics such as their publishing needs and institutional policies, open access, impact journals, and IOAP.
Chief Executive Officer
MDPI AG
4 November 2024
Journal of Clinical Medicine | Notable Papers in Q3 of 2024
We are pleased to present the notable papers published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in Q3 of 2024. These papers received good Altmetric scores. We would like to take this opportunity to acknowledge the exceptional individuals and teams who worked on these papers. These articles are from multiple fields within the scope of JCM, and we hope they can provide insights and references for scholars in related fields. Learn more about the latest research below.
1. “Pulmonary Function Tests: Easy Interpretation in Three Steps”
by Josuel Ora, Federica Maria Giorgino, Federica Roberta Bettin, Mariachiara Gabriele and Paola Rogliani
J. Clin. Med. 2024, 13(13), 3655;https://doi.org/10.3390/jcm13133655
Full text available online: https://www.mdpi.com/2077-0383/13/13/3655
2. “Albuminuria, Forgotten No More: Underlining the Emerging Role in CardioRenal Crosstalk”
by Berit Hackenberg, Julia Döge, Karoline O’Brien, Andrea Bohnert, Karl J. Lackner, Manfred E. Beutel, Matthias Michal, Thomas Münzel, Philipp S. Wild, Norbert Pfeiffer et al.
J. Clin. Med. 2023, 12(3), 1169; https://doi.org/10.3390/jcm12031169
Full text available online: https://www.mdpi.com/2077-0383/12/3/1169
3. “Is Central Sensitisation the Missing Link of Persisting Symptoms after COVID-19 Infection?”
by Lisa Goudman, Ann De Smedt, Marc Noppen and Maarten Moens
J. Clin. Med. 2021, 10(23), 5594; https://doi.org/10.3390/jcm10235594
Full text available online: https://www.mdpi.com/2077-0383/10/23/5594
4. “Inferior Vena Cava Ultrasonography for Volume Status Evaluation: An Intriguing Promise Never Fulfilled”
by Pierpaolo Di Nicolò, Guido Tavazzi, Luca Nannoni and Francesco Corradi
J. Clin. Med. 2023, 12(6), 2217; https://doi.org/10.3390/jcm12062217
Full text available online: https://www.mdpi.com/2077-0383/12/6/2217
5. “A Systematic Review and Meta-Analysis of Nature Walk as an Intervention for Anxiety and Depression”
by Simone Grassini
J. Clin. Med. 2022, 11(6), 1731; https://doi.org/10.3390/jcm11061731
Full text available online: https://www.mdpi.com/2077-0383/11/6/1731
6. “CNS Ageing in Health and Neurodegenerative Disorders”
by Evangelia Kesidou, Paschalis Theotokis, Olympia Damianidou, Marina Boziki, Natalia Konstantinidou, Charilaos Taloumtzis, Styliani-Aggeliki Sintila, Panagiotis Grigoriadis, Maria Eleptheria Evangelopoulos, Christos Bakirtzis et al.
J. Clin. Med. 2023, 12(6), 2255; https://doi.org/10.3390/jcm12062255
Full text available online: https://www.mdpi.com/2077-0383/12/6/2255
7. “Larval Wound Therapy: Possibilities and Potential Limitations—A Literature Review”
by Dariusz Bazaliński, Joanna Przybek-Mita, Kamila Pytlak, Daria Kardyś, Adrian Bazaliński, Marek Kucharzewski and Paweł Więch
J. Clin. Med. 2023, 12(21), 6862; https://doi.org/10.3390/jcm12216862
Full text available online: https://www.mdpi.com/2077-0383/12/21/6862
8. “Physiology-Guided Resuscitation: Monitoring and Augmenting Perfusion during Cardiopulmonary Arrest”
by Nicole Natarelli, Nimrit Gahoonia and Raja K. Sivamani
J. Clin. Med. 2024, 13(12), 3527; https://doi.org/10.3390/jcm13123527
Full text available online: https://www.mdpi.com/2077-0383/13/12/3527
9. “The Brain–Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review”
by Eugenio Caradonna, Raffaello Nemni, Angelo Bifone, Patrizia Gandolfo, Lucy Costantino, Luca Giordano, Elisabetta Mormone, Anna Macula, Mariarosa Cuomo, Rossana Difruscolo et al.
J. Clin. Med. 2024, 13(14), 4130; https://doi.org/10.3390/jcm13144130
Full text available online: https://www.mdpi.com/2077-0383/13/14/4130
10. “Pregnancy Arrhythmias: Management in the Emergency Department and Critical Care”
by Elena Conti, Nunzio Dario Cascio, Patrizia Paluan, Giulia Racca, Yaroslava Longhitano, Gabriele Savioli, Manfredi Tesauro, Roberto Leo, Fabrizio Racca and Christian Zanza
J. Clin. Med. 2024, 13(15), 4569; https://doi.org/10.3390/jcm13154569
Full text available online: https://www.mdpi.com/2077-0383/13/15/4569
11. “Mpox: An Overview of Pathogenesis, Diagnosis, and Public Health Implications”
by Francesco Branda, Chiara Romano, Massimo Ciccozzi, Marta Giovanetti, Fabio Scarpa, Alessandra Ciccozzi and Antonello Maruotti
J. Clin. Med. 2024, 13(8), 2234; https://doi.org/10.3390/jcm13082234
Full text available online: https://www.mdpi.com/2077-0383/13/8/2234
12. “Skin Manifestation of Human Monkeypox”
by Xue Wang and Wenhui Lun
J. Clin. Med. 2023, 12(3), 914; https://doi.org/10.3390/jcm12030914
Full text available online: https://www.mdpi.com/2077-0383/12/3/914
13. “Delirium in Medically Hospitalized Patients: Prevalence, Recognition and Risk Factors: A Prospective Cohort Study”
by Rajaa Saleh Al Farsi, Abdullah M. Al Alawi, Aisha Ramadhan Al Huraizi, Taif Al-Saadi, Noof Al-Hamadani, Khalfan Al Zeedy and Juhaina Salim Al-Maqbali
J. Clin. Med. 2023, 12(12), 3897; https://doi.org/10.3390/jcm12123897
Full text available online: https://www.mdpi.com/2077-0383/12/12/3897
14. “Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations”
by Laura Dresser, Richard Wlodarski, Kourosh Rezania and Betty Soliven
J. Clin. Med. 2021, 10(11), 2235; https://doi.org/10.3390/jcm10112235
Full text available online: https://www.mdpi.com/2077-0383/10/11/2235
15. “Mental Stress and Cardiovascular Health—Part I”
by Federico Vancheri, Giovanni Longo, Edoardo Vancheri and Michael Y. Henein
J. Clin. Med. 2022, 11(12), 3353; https://doi.org/10.3390/jcm11123353
Full text available online: https://www.mdpi.com/2077-0383/11/12/3353
To access more journal information, please click the following link: https://www.mdpi.com/journal/jcm.
To access more details about Altmetric, please click here.
JCM Editorial Office
1 November 2024
Meet Us at the 63rd Annual Meeting of Japanese Retina and Vitreous Society, 6–8 December 2024, Osaka, Japan
MDPI will be attending the 63rd Annual Meeting of Japanese Retina and Vitreous Society, which will be held from 6 to 8 December 2024 in Osaka, Japan.
The 63rd Annual Meeting of Japanese Retina and Vitreous Society will be held at the Osaka international convention center from 5 to 8 December 2024 (set-up booth on 5 December; technical session on 6–8 December.) This meeting aims to exchange cutting-edge knowledge in the vitreous retina field among young doctors, health professions and researchers. The vitreous retina field is the hottest specialty in ophthalmology, due to the large number of patients in the vitreous retina field, as well as the existence of many new treatments and technological innovations, such as advances in imaging technology such as OCT, OCT angiography, and ultra-wide-angle fundus cameras, the practical application of AI-based testing equipment, the practical application of gene therapy, and the development of vitreous surgery devices and instruments that allow safer and more stable surgery.
The following MDPI journals will be represented at the conference:
If you are planning to attend the above conference, please feel free to stop by our booth and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://convention.jtbcom.co.jp/63moumaku/index.html.
28 October 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Clinical Pediatrics
We are delighted to share some highly cited papers on clinical pediatrics that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues in the Section “Clinical Pediatrics” are currently open for submission. The following is a list of articles and Special Issues that we believe will interest you.
1. “PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment”
by Blazej Meczekalski, Olga Niwczyk, Anna Kostrzak, Marzena Maciejewska-Jeske, Gregory Bala and Anna Szeliga
J. Clin. Med. 2023, 12(3), 1221; https://doi.org/10.3390/jcm12031221
Available online: https://www.mdpi.com/2077-0383/12/3/1221
2. “Remimazolam as an Adjunct to General Anesthesia in Children: Adverse Events and Outcomes in a Large Cohort of 418 Cases”
by Yoshitaka Kimoto, Tatsuya Hirano, Norifumi Kuratani, David Cavanaugh and Keira P. Mason
J. Clin. Med. 2023, 12(12), 3930; https://doi.org/10.3390/jcm12123930
Available online: https://www.mdpi.com/2077-0383/12/12/3930
3. “Remimazolam for Pediatric Procedural Sedation: Results of an Institutional Pilot Program”
by Tatsuya Hirano, Yoshitaka Kimoto, Norifumi Kuratani, David Cavanaugh and Keira P. Mason
J. Clin. Med. 2023, 12(18), 5937; https://doi.org/10.3390/jcm12185937
Available online: https://www.mdpi.com/2077-0383/12/18/5937
4. “Necrotizing Pneumonia in Children: Early Recognition and Management”
by Yuanyuan Chen, Lanxin Li, Chenlu Wang, Yuanyuan Zhang and Yunlian Zhou
J. Clin. Med. 2023, 12(6), 2256; https://doi.org/10.3390/jcm12062256
Available online: https://www.mdpi.com/2077-0383/12/6/2256
5. “Diagnostic Utility of Serum Leucine-Rich α-2-Glycoprotein 1 for Acute Appendicitis in Children”
by Goran Tintor, Miro Jukić, Daniela Šupe-Domić, Ana Jerončić and Zenon Pogorelić
J. Clin. Med. 2023, 12(7), 2455; https://doi.org/10.3390/jcm12072455
Available online: https://www.mdpi.com/2077-0383/12/7/2455
6. “Cough Hypersensitivity Syndrome: Why Its Use Is Inappropriate in Children”
by Anne B. Chang, Richard S. Irwin, Hannah E. O’Farrell, Peter V. Dicpinigaitis, Suhani Goel, Ahmad Kantar and Julie M. Marchant
J. Clin. Med. 2023, 12(15), 4879; https://doi.org/10.3390/jcm12154879
Available online: https://www.mdpi.com/2077-0383/12/15/4879
7. “The Advanced Diabetes Technologies for Reduction of the Frequency of Hypoglycemia and Minimizing the Occurrence of Severe Hypoglycemia in Children and Adolescents with Type 1 Diabetes”
by Tatsuhiko Urakami
J. Clin. Med. 2023, 12(3), 781; https://doi.org/10.3390/jcm12030781
Available online: https://www.mdpi.com/2077-0383/12/3/781
8. “Mental Health and Health-Related Quality of Life in Austrian Adolescents with Chronic Physical Health Conditions: Results from the MHAT Study”
by Gudrun Wagner, Andreas Karwautz, Julia Philipp, Stefanie Truttmann, Wolfgang Dür, Karin Waldherr, Gabriele Berger and Michael Zeiler
J. Clin. Med. 2023, 12(5), 1927; https://doi.org/10.3390/jcm12051927
Available online: https://www.mdpi.com/2077-0383/12/5/1927
9. “Preclinical Application of Augmented Reality in Pediatric Craniofacial Surgery: An Accuracy Study”
by Federica Ruggiero, Laura Cercenelli, Nicolas Emiliani, Giovanni Badiali, Mirko Bevini, Mino Zucchelli, Emanuela Marcelli and Achille Tarsitano
J. Clin. Med. 2023, 12(7), 2693; https://doi.org/10.3390/jcm12072693
Available online: https://www.mdpi.com/2077-0383/12/7/2693
10. “Predictive Power of Oxygen Desaturation Index (ODI) and Apnea-Hypopnea Index (AHI) in Detecting Long-Term Neurocognitive and Psychosocial Outcomes of Sleep-Disordered Breathing in Children: A Questionnaire-Based Study”
by Marco Zaffanello, Giuliana Ferrante, Leonardo Zoccante, Marco Luigi Ciceri, Luana Nosetti, Laura Tenero, Michele Piazza and Giorgio Piacentini
J. Clin. Med. 2023, 12(9), 3060; https://doi.org/10.3390/jcm12093060
Available online: https://https://www.mdpi.com/2077-0383/12/9/3060
11. “CAR T-Cell Therapy in Children with Solid Tumors”
by Marika Kulczycka, Kamila Derlatka, Justyna Tasior, Monika Lejman and Joanna Zawitkowska
J. Clin. Med. 2023, 12(6), 2326; https://doi.org/10.3390/jcm12062326
Available online: https://www.mdpi.com/2077-0383/12/6/2326
12. “Protein Biomarkers in Chronic Kidney Disease in Children—What Do We Know So Far?”
by Agnieszka Rybi Szumińska, Anna Wasilewska and Monika Kamianowska
J. Clin. Med. 2023, 12(12), 3934; https://doi.org/10.3390/jcm12123934
Available online: https://www.mdpi.com/2077-0383/12/12/3934
13. “Elevated Neutrophil-to-Lymphocyte Ratio Is Associated with Severe Asthma Exacerbation in Children”
by Noga Arwas, Sharon Uzan Shvartzman, Aviv Goldbart, Romi Bari, Itai Hazan, Amir Horev and Inbal Golan Tripto
J. Clin. Med. 2023, 12(9), 3312; https://doi.org/10.3390/jcm12093312
Available online: https://www.mdpi.com/2077-0383/12/9/3312
14. “Finite Element Analysis of the Mechanical Performance of Non-Restorable Crownless Primary Molars Restored with Intracoronal Core-Supported Crowns: A Proposed Treatment Alternative to Extraction for Severe Early Childhood Caries”
by Kunyawan Thaungwilai, Yanee Tantilertanant, Weerachai Singhatanadgit and Pairod Singhatanadgid
J. Clin. Med. 2023, 12(5), 1872; https://doi.org/10.3390/jcm12051872
Available online: https://www.mdpi.com/2077-0383/12/5/1872
15. “Depression in Children and Adolescents with Chronic Kidney Disease—Review of Available Literature”
by Natalia Dryjańska and Katarzyna Kiliś-Pstrusińska
J. Clin. Med. 2023, 12(10), 3554; https://doi.org/10.3390/jcm12103554
Available online: https://www.mdpi.com/2077-0383/12/10/3554
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
Special Issues |
|
“Endocrine Disorders in Children” Guest Editor: Dr. Juan Pedro López-Siguero Submission deadline: 25 December 2024 |
“Pediatric Palliative Care and Surgery” Guest Editors: Dr. Danielle B. Cameron and Dr. Amy Porter Submission deadline: 15 May 2025 |
Special Issue Reprint: |
“New Insights into Pediatric Pulmonology”
“Clinical Research Advances in Congenital Heart Disease”
Access more Special Issue books here.
JCM Editorial Office
16 October 2024
MDPI's Newly Launched Journals in September 2024
Five new journals covering a diverse range of subjects launched their inaugural issue in September 2024. Like other journals in MDPI’s portfolio, these journals are dedicated to sharing the latest research through open access, reflecting our commitment to making knowledge accessible to all.
We extend our sincere gratitude to the Editorial Board Members for their dedication to the launch and development of our new journals. Each journal will ensure its high-quality output via excellent editorial and rigorous peer-review processes so that the published articles achieve significant impact and broad visibility.
We invite you to explore and learn more about these new journals below.
Journal | Founding Editor-in-Chief | Journal Topics (Selected) |
Prof. Dr. Nejat Düzgüneş, University of the Pacific, USA | Editorial | view inaugural issue | biological therapy and stem-cell therapy; drug therapy; chemotherapy; radiation and other nonsurgical therapeutic strategies | view journal scope | submit an article | |
Prof. Dr. Magda Tsolaki, Greek Federation of Alzheimer’s Disease, Greece; Aristotle University of Thessaloniki, Greece | Editorial | view inaugural issue | surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article | |
Prof. Dr. Steven R. Fassnacht, Colorado State University, USA; Cooperative Institute for Research in the Atmosphere, USA | Editorial | view inaugural issue | ice as a mineral; atmospheric ice; sea ice; freshwater ice; ice sheets; ice caps and ice shelves | view journal scope | submit an article | |
Dr. Francisco Epelde, Hospital Universitari Parc Tauli, Spain; University Autonoma of Barcelona, Spain | Editorial | view inaugural issue | hospital management; hospital facilities; hospital services; hospital risk management; health law | view journal scope | submit an article | |
Prof. Dr. Nicola Ferri, University of Padova, Italy | Editorial | view inaugural issue | lipids in cells and whole organisms; lipid structure and function; lipid products and processes; dietary lipids and nutrition | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here or contact the New Journal Committee ([email protected]) if you would like to create more new journals.
9 October 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Mental Health” Held on 24 September 2024
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board meeting for the Section “Mental Health” on 24 September 2024. We appreciate the Section Editor-in-Chief, Prof. Dr. Icro Maremmani, for hosting this meeting; four Editorial Board Members were in attendance.
The meeting started with a presentation about the development of the journal, as well as the Section “Mental Health” in particular, and the following information was presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), the benefits of open access, journal awards, conference sponsorship, society collaborations, and promotion on social media;
- Section highly cited papers, geographical distribution of the Section’s Editorial Board Members, decision-making statistics, and Section statistics.
At this Editorial Board meeting, the EBMs had a positive discussion about the Section name, scope (medical psychiatry, medical psychology, and behavioral medicine), popular topics (such as hyperactive disorder and autism), article type, paper rejection rate, submissions’ diversity of country types, recruitment of Editorial Board Members, Section promotion at relevant conferences, etc. The meeting ended with a suggestion from Prof. Dr. Maremmani for the development of Special Issues.
We would like to thank every Editorial Board Member and contributing academic for their support, and we look forward to receiving more suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Prof. Dr. Icro Maremmani (Section Editor-in-Chief), Institute of Behavioural Sciences, Pisa, Italy;
- Prof. Dr. Napoleon Waszkiewicz, Medical University of Bialystok, Bialystok, Poland;
- Prof. Dr. Jerzy Samochowiec, Pomeranian Medical University in Szczecin, Szczecin, Poland;
- Dr. Camilla Gesi, ASST Fatebenefratelli-Sacco, Milan, Italy;
- Prof. Dr. Yori Gidron, University of Haifa, Haifa, Israel.
The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.0 (2023), ranking 58/325 (Q1) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Mental_Health.
JCM Editorial Office
4 October 2024
MDPI INSIGHTS: The CEO's Letter #16 - UNGA79 Science Summit, OASPA, Peer Review Week
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Joins the Science Summit at UNGA79 (23–27 September 2024, New York)
On Friday 27 September, I had the privilege of giving the opening talk at the “Youth at the Science Summit” panel during the Science Summit conference, held in New York at the 79th session of the United Nations General Assembly (UNGA). Together, we discussed the future of science, publishing, innovation, and sustainable development.
It was a great opportunity to learn from our young leaders, whose voices must be included in the conversation as science shapes the future of artificial intelligence, climate mitigation, healthcare, technology, and more. This was also a powerful reminder of how essential global collaboration is in solving the major challenges we face. I left inspired by the dedication of these young researchers to making the world a better place!
Today’s youth are not just the leaders of tomorrow – they are already leading the change today.
Stefan Tochev (second from left) at the UNGA Science Summit 2024: “A great opportunity to learn from our young leaders.”
MDPI Supports the Future Generation of Scientists
This aligns with MDPI’s mission to support the next generation of scientists and early-career researchers by recognizing their achievements through our various MDPI awards, including the Young Investigator Awards, Best PhD Thesis Awards, Travel Awards, and more.
Our presence at this global event showed our commitment to advancing Open Science as a key driver for sustainable development. As a leading Open Access (OA) publisher, MDPI’s role at the summit was to emphasize the critical importance of democratizing scientific knowledge, making it accessible to all, and promoting global collaboration.
Through OA publishing, we aim to address pressing global challenges such as climate change, public health, and inequality, in line with the United Nations Sustainable Development Goals (SDGs).
“We aim to address pressing global challenges”
MDPI and the SDGs
In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs.
During the summit, we highlighted the connection between Open Science and the SDG Publishers Compact, supporting the core objective to “Leave No One Behind” (LNOB). The transformative promise of the SDGs relies heavily on the Open Access model, which serves as a fundamental enabler of Open Science. We advocate for the wider adoption of Open Science practices in order to achieve the SDGs by 2030.
Impactful Research
Presenting at the 1st International Conference of Environmental Medicine
In September, MDPI and our journals IJERPH and Diseases sponsored and participated in the 1st International Conference of Environmental Medicine: Environmental Threats to Human Health: From Genetics to Epigenetics, held in Chieti, Italy.
The conference was organized in collaboration with various societies, including the Italian Society of Environmental Medicine (SIMA), one of more than 160 societies partnering MDPI journals.
The conference brought together influential figures from the Italian scholarly community, such as Antonio Felice Uricchio (President of the National Agency for University Research Assessment [ANVUR]), Alessandro Miani (President of SIMA), and Liborio Stuppia (Director of ‘Gabriele d’Annunzio’ University of Chieti-Pescara), among others.
MDPI was the sole publishing sponsor of the conference, at which I had the opportunity to present on behalf of the company. I provided an overview of MDPI, covering key facts and figures, the peer-review process, our strong collaboration with the Italian market, and insights into Nobel Prize winners who have published with MDPI, ahead of Sir Richard Roberts’ Nobel lecture.
“As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals”
The keynote speaker at the event was Sir Richard Roberts, Nobel Laureate and 1993 Nobel Prize winner in Medicine, recognized for his discovery of split genes.
Nobel Laureates’ Contributions to MDPI
As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals. I’ll share more details on this in the October newsletter.
Hosting such prominent figures in their respective fields, who play a significant role in advancing the OA movement, of which we are leaders in, resonates deeply with our editorial teams.
Sponsoring and supporting academic conferences is something we do on a large scale, and it continues to grow. Attending and speaking about MDPI shows our commitment by taking the time to connect with the scholarly community in person.
MDPI’s Presence in Italy
Italy ranks third globally in total MDPI publications, with nearly 130,000 contributions. We collaborate with about 12,000 Editorial Board Members in Italy, over 6,100 of whom have an H-index of more than 25.
We have 83 Editors-in-Chief and 209 Section Editors-in-Chief from Italy. We also support 20 Italian universities through our Institutional Open Access Program (IOAP) agreements with major institutions such as Sapienza University of Rome, the University of Milan, and the University of Pisa, among others.
Inside MDPI
Celebrating Peer Review Week, 23–27 September 2024
As we conclude another productive month at MDPI, I am pleased to highlight our participation in this year’s Peer Review Week (PRW), which took place from 23–27 September 2024. This global, community-driven celebration underscores the vital importance of peer review in maintaining the integrity and reliability of academic work. PRW provide a platform for institutions, publishers, and scholars to come together and reflect on the processes that uphold the quality of scholarly communication.
“We remain committed to enhancing the peer review process”
The theme for PRW 2024 was ‘Innovation and Technology in Peer Review.’ At MDPI, we were proud to contribute through various online and in-person events, including webinars from Europe, Asia-Pacific, and a roundtable discussion on innovation and technology in peer review. These events offer an opportunity to explore new tools and technologies that are shaping the future of peer review, particularly the integration of AI. As a company, we remain committed to enhancing the peer review process with innovative solutions while preserving the essential human expertise that makes it effective.
Peer Review Innovation and Technology at MDPI
Our efforts to improve peer review extend beyond the activities of this week. We also released a blog article discussing New Tools for Advancing Research Integrity and Peer Review, where we highlight two tools that MDPI has developed to support research integrity: Eureka – Reviewer Recommender and Online Proofreader. We are continually refining SuSy, our in-house submission system, to provide a seamless experience for authors and reviewers alike.
Listening to MDPI’s Authors and Reviewers
We highly value the time of our reviewers, and so do the authors who contribute to our journals. Our editorial process is bolstered by a network of dedicated reviewers, a team of over 6,000 diligent, well-trained staff members, and an in-house article submission platform designed to ensure efficient processes.
We make it a point to continually improve the experiences of both our authors and our reviewers throughout the entire editorial process, from submission to publication. This is why we regularly ask for feedback by conducting surveys. Here is what some of our respondents recently had to say about working with MDPI:
Coming Together for Science
ICM 2024 – Advances in Material Innovation
I am pleased to share that we held The 5th International Conference on Materials: Advances in Material Innovation (ICM 2024) in Basel, Switzerland this past 25–27 September.
This intimate event brought together leading scientists, researchers, and industry experts to exchange insights on recent advancements in materials characterization, processing, and manufacturing. Key focus areas included nanotechnology in material sciences and engineering, optical, electrical, and magnetic materials, soft, biological, and biomaterials, fibres, membranes, thin films, sensing materials, as well as materials and devices for energy and solar fuels. In addition, discussions featured the integration of AI and machine learning in materials research.
We received 90 abstract submissions. Over the course of the three-day event, 18 posters were displayed, and 34 talks were delivered, including three plenary speeches, seven invited talks, and 24 selected oral presentations.
A special thank-you to our partnering societies The Polish Membrane Society and The North American Thermal Analysis Society, as well as our sponsor, Nanomegas, for their support of the ICM conference. I am also pleased to share that we presented three awards, including the Best Presentation Award and two Best Poster Awards, recognizing the outstanding contributions of our participants.
Upcoming In-Person Event
7–9 October 2024
Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines
Location: Basel, Switzerland
ncRNA 2024 will explore the latest advances in the field, covering topics from basic biology to medical and technological applications.
Find more upcoming MDPI events here.
Closing Thoughts
Reflections from OASPA 2024 Conference in Lisbon (16–18 September)
Amidst my September travels, I also had pleasure of attending the OASPA 2024 Conference in Lisbon from 16–18 September. It’s the first in-person Open Access Scholarly Publishing Association (OASPA) event in five years, and being in the sunny city of Lisbon made it even better! MDPI has long been a member of OASPA, and attending this conference gave us an opportunity to connect with other key members of the organization to see the latest developments in the OA movement.
“I believe that publishers have a lot to offer in terms of data and insights”
Main Themes from OASPA 2024
The main themes covered were equity and inclusivity, diamond OA, AI and openness, OA books, research integrity, and how OA can address broader societal challenges such as climate change. While it was great to see the latest developments in these areas, it was also clear that certain voices were missing, particularly those of major publishers. Although it’s not easy to incorporate every perspective, I believe that publishers, including MDPI, have a lot to offer in terms of data and insights. During the membership meeting, a few of us raised the point that large-scale publisher input could add value to these discussions.
It’s important to participate in industry conferences such as OASPA in order to be part of the discussions and remain at the forefront of the OA movement.
It’s an opportunity to build meaningful relationships with organizations that share our commitment to OA.
While sponsorship is one way to show our support, it’s clear that being part of the conversation through participating in the OASPA groups and committee is what really makes a difference.
It took the last 20 years for more than 50% of the world's research to be published via open access. This provides a sobering reminder that flipping the remaining 50% will be a big challenge.
An important takeaway for me was that there is no "one-size-fits-all" solution for OA challenges: different regions and different stakeholders need different forms of support, whether it is infrastructure, funding, education, or policy, for example. I also enjoyed Rebecca Ross' presentation on how OA can drive action on climate. A few panellists shared the need for transparency in the peer-review process, advocating for open review reports, which is something we have been offering since 2014.
Speaking of openness, we are excited to celebrate Open Access Week 2024 with the scholarly community from 21–27 October. I look forward to sharing a recap of our activities in the next newsletter.
Chief Executive Officer
MDPI AG
3 October 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Clinical Pediatrics” Held on 15 April 2024
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board meeting for the Section “Clinical Pediatrics” on 15 April 2024. Prof. Dr. Luis Garcia-Marcos, the Section Editor-in-Chief, had an engaging conversation with the Editorial Board Members Prof. Dr. Jean-Michel Hascoët and Dr. Meir Mei-Zahav.
The meeting started with a 15-minute self-introduction of the SEiC and Editorial Board Members who attended the meeting. After that, a presentation on the development of both the journal and the “Clinical Pediatrics” Section was given. Information on the following topics was presented:
- Journal history, publication statistics, the distribution of scholars (2018–2023), the benefits of open access, journal awards, conference sponsorship, webinars, society collaborations, and social media promotion;
- Highly cited papers of the Section, article types, graphical abstracts/video abstracts, the geographical distribution of the Section’s Editorial Board Members, Special Issues, and Section statistics.
At this Editorial Board meeting, the EBMs had a positive discussion about Section visibility, Section advertisement in pediatric societies, the discovery of potential contributors, journal and Section promotion at relevant conferences, and the recruitment of Editorial Board Members. The meeting ended with some suggestions from our Editorial Board Members regarding the organization of a webinar involving young scholars and pediatricians from all over the world.
We would like to thank every Editorial Board Member and all contributing academics for their support. We look forward to receiving more suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Dr. Luis Garcia-Marcos (Section Editor-in-Chief), Arrixaca Children’s University Hospital, University of Murcia, Murcia, Spain;
- Dr. Jean-Michel Hascoët, Maternité Régionale Universitaire, Université de Lorraine, Nancy, France;
- Meir Mei-Zahav, Schneider Children’s Medical Center of Israel, Tel Aviv University, Pulmonary Institute, Tel Aviv, Israel.
The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current impact factor of JCM is 3.0 (2023), ranking 58/325 (Q1) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Clinical_Pediatrics.
JCM Editorial Office
1 October 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Dermatology” Held on 30 May 2024
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board meeting for the Section “Dermatology” on 30 May 2024. We appreciate the Section Editor-in-Chief, Dr. Alan Fleischer, for hosting this meeting; five Editorial Board Members were in attendance.
The meeting started with a presentation about the development of the journal, as well as the Section “Dermatology”in particular and the following information was presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), the benefits of open access, journal awards, conference sponsorship, webinars, society collaborations, and promotion on social media;
- Section highly cited papers, article types, graphical abstract/video abstract, geographical distribution of the Section’s Editorial Board Members, Special Issues, and Section statistics.
At this Editorial Board meeting, the EBMs had a positive discussion about submissions’ diversity of country types, Section visibility, journal and Section promotion at relevant conferences, popular topics (such as alopecia, drug development in the field, and the personalized treatment of melanoma), recruitment of Editorial Board Members, etc. The meeting ended with some suggestions from our Editorial Board Members regarding the improvement of our editorial process and suggestions for marketing activities.
We would like to thank every Editorial Board Member and contributing academic for their support and we look forward to receiving more suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Alan Fleischer (Section Editor-in-Chief), University of Cincinnati, Cincinnati, OH, USA;
- Guy Orchard, St. Thomas’ Hospital, London, UK;
- Dr. Carlo Pincelli, University of Modena and Reggio Emilia, Modena, Italy;
- Dr. Marcus Schmitt-Egenolf, Umeå University, Umeå, Sweden;
- Dr. Reinhart M. Speeckaert, Ghent University Hospital, Ghent, Belgium;
- Yolanda Gilaberte, University Hospital Miguel Servet, Zaragoza, Spain.
The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.0 (2023), ranking 58/325 (Q1) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Dermatology.
JCM Editorial Office
29 September 2024
MDPI New Journal Proposal—Invitation to Shape the Future of Open Science Together
As a leader in open access publishing, MDPI is eager to explore new collaboration opportunities, including the launch of new journals and the transfer of existing ones. At present, MDPI publishes over 400 journals, more than 160 of which have established partnerships with academic organizations. Additionally, we publish 19 association journals.
In order to enhance exchange and cooperation with scientific researchers and share the results of open science, MDPI invites experts and scholars from various fields to submit proposals for new journal collaboration opportunities. If your proposal is approved, you could take on the role of Editor-in-Chief, Deputy Editor-in-Chief, or Editorial Board Member of the journal. This position allows you to manage the manuscript review process alongside our editorial department, participate in calls for papers, strengthen your network with scholars in the field, expand scientific research cooperation, enhance your personal and academic influence internationally, and play a leading role in academia.
Once the new journal is online, MDPI will provide a variety of promotional channels to market the journal internationally.
MDPI will offer various promotional channels to enhance its visibility and promote it internationally.
How can you determine the theme of a new journal?
- Assess research hotspots/academic frontiers;
- Assess pioneers in the field/key research directions of universities;
- Determine whether MDPI has already established a journal in the field.
You can browse MDPI’s existing journals at the following link: https://www.mdpi.com/about/journals.
Advantages of collaborating with MDPI:
- MDPI is a global leader in open-access publishing with extensive academic resources.
- MDPI offers a professional publishing team that provides comprehensive support throughout the publishing process.
- MDPI’s diverse promotional platforms and channels help journals quickly increase their international visibility and influence.
We invite you to submit new journal proposal here, and contribute to academic development! In addition, if your institution (university, institute, college, national key laboratory, society, etc.) intends to establish a journal, you can also submit a draft to MDPI on its behalf.
29 September 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Obstetrics and Gynecology
We are delighted to share some highly cited papers on obstetrics and gynecology that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues in the Section “Obstetrics & Gynecology” are currently open for submission.
The following is a list of articles and Special Issues that we believe will interest you:
1. “Evaluating the Efficacy of Pervistop®, a New Combination Based on EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on Patients with Human Papilloma Virus (HPV) Persistent Infections and Cervical Lesions: A Pilot Study”
by Cesare Aragona, Maria Salomè Bezerra Espinola, Gabriele Bilotta, Giuseppina Porcaro and Marco Calcagno
J. Clin. Med. 2023, 12(6), 2171; https://doi.org/10.3390/jcm12062171
Available online: https://www.mdpi.com/2077-0383/12/6/2171
2. “Non-Pharmacological Pain Management in Labor: A Systematic Review”
by Wassan Nori, Mustafa Ali Kassim Kassim, Zeena Raad Helmi, Alexandru Cosmin Pantazi, Dragos Brezeanu, Ana Maria Brezeanu, Roxana Cleopatra Penciu and Lucian Serbanescu
J. Clin. Med. 2023, 12(23), 7203; https://doi.org/10.3390/jcm12237203
Available online: https://www.mdpi.com/2077-0383/12/23/7203
3. “Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies”
by Aleksandra Szczesnowicz, Anna Szeliga, Olga Niwczyk, Gregory Bala and Blazej Meczekalski
J. Clin. Med. 2023, 12(18), 5915; https://doi.org/10.3390/jcm12185915
Available online: https://www.mdpi.com/2077-0383/12/18/5915
4. “Understanding Psychological Symptoms of Endometriosis from a Research Domain Criteria Perspective”
by Katharina van Stein, Kathrin Schubert, Beate Ditzen and Cornelia Weise
J. Clin. Med. 2023, 12(12), 4056; https://doi.org/10.3390/jcm12124056
Available online: https://www.mdpi.com/2077-0383/12/12/4056
5. “Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System”
by Toobah Farooqi, Deep Jyoti Bhuyan, Mitchell Low, Justin Sinclair, Mathew Leonardi and Mike Armour
J. Clin. Med. 2023, 12(22), 7071; https://doi.org/10.3390/jcm12227071
Available online: https://www.mdpi.com/2077-0383/12/22/7071
6. “Recurrent Pregnancy Loss Etiology, Risk Factors, Diagnosis, and Management. Fresh Look into a Full Box”
by Akbayan Turesheva, Gulzhanat Aimagambetova, Talshyn Ukybassova, Aizada Marat, Perizat Kanabekova, Lyazzat Kaldygulova, Ainur Amanzholkyzy, Svetlana Ryzhkova, Anastassiya Nogay, Zaituna Khamidullina et al.
J. Clin. Med. 2023, 12(12), 4074; https://doi.org/10.3390/jcm12124074
Available online: https://www.mdpi.com/2077-0383/12/12/4074
7. “Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment?”
by Anna Maria Rzewuska, Monika Żybowska, Ilona Sajkiewicz, Izabela Spiechowicz, Klaudia Żak, Monika Abramiuk, Krzysztof Kułak and Rafał Tarkowski
J. Clin. Med. 2023, 12(3), 1008; https://doi.org/10.3390/jcm12031008
Available online: https://www.mdpi.com/2077-0383/12/3/1008
8. “Recent Advances in the Prevention and Screening of Preeclampsia”
by Balázs Mészáros, Zoltán Kukor and Sándor Valent
J. Clin. Med. 2023, 12(18), 6020; https://doi.org/10.3390/jcm12186020
Available online: https://www.mdpi.com/2077-0383/12/18/6020
9. “Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review”
by Jaume Alijotas-Reig, Enrique Esteve-Valverde, Ariadna Anunciación-Llunell, Joana Marques-Soares, Josep Pardos-Gea and Francesc Miró-Mur
J. Clin. Med. 2022, 11(3), 675; https://doi.org/10.3390/jcm11030675
Available online: https://www.mdpi.com/2077-0383/11/3/675
10. “PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment”
by Blazej Meczekalski, Olga Niwczyk, Anna Kostrzak, Marzena Maciejewska-Jeske, Gregory Bala and Anna Szeliga
J. Clin. Med. 2023, 12(3), 1221; https://doi.org/10.3390/jcm12031221
Available online: https://www.mdpi.com/2077-0383/12/3/1221
11. “Diaphragmatic Endometriosis—A Single-Center Retrospective Analysis of the Patients’ Demographics, Symptomatology, and Long-Term Treatment Outcomes”
by Antoine Naem, Argyrios Andrikos, Alin Stefan Constantin, Michael Khamou, Dimitrios Andrikos, Antonio Simone Laganà, Rudy Leon De Wilde and Harald Krentel
J. Clin. Med. 2023, 12(20), 6455; https://doi.org/10.3390/jcm12206455
Available online: https://www.mdpi.com/2077-0383/12/20/6455
12. “Surgical Management of Ovarian Endometrioma: Impact on Ovarian Reserve Parameters and Reproductive Outcomes”
by Angelos Daniilidis, Georgios Grigoriadis, Dimitrios Rafail Kalaitzopoulos, Stefano Angioni, Üzeyir Kalkan, Adrien Crestani, Benjamin Merlot and Horace Roman
J. Clin. Med. 2023, 12(16), 5324; https://doi.org/10.3390/jcm12165324
Available online: https://www.mdpi.com/2077-0383/12/16/5324
13. “Three Types of Endometriosis: Pathogenesis, Diagnosis and Treatment. State of the Art”
by Ludovica Imperiale, Michelle Nisolle, Jean-Christophe Noël and Maxime Fastrez
J. Clin. Med. 2023, 12(3), 994; https://doi.org/10.3390/jcm12030994
Available online: https://www.mdpi.com/2077-0383/12/3/994
14. “Radiofrequency Ablation for Adenomyosis”
by Ioannis Dedes, Georgios Kolovos, Arrigo Fruscalzo, David Toub, Cloé Vaineau, Susanne Lanz, Sara Imboden, Anis Feki and Michael D. Mueller
J. Clin. Med. 2023, 12(9), 3069; https://doi.org/10.3390/jcm12093069
Available online: https://www.mdpi.com/2077-0383/12/9/3069
15. “Concomitant Autoimmunity in Endometriosis Impairs Endometrium–Embryo Crosstalk at the Implantation Site: A Multicenter Case-Control Study”
by Noemi Salmeri, Gianluca Gennarelli, Valeria Stella Vanni, Stefano Ferrari, Alessandro Ruffa, Patrizia Rovere-Querini, Luca Pagliardini, Massimo Candiani and Enrico Papaleo
J. Clin. Med. 2023, 12(10), 3557; https://doi.org/10.3390/jcm12103557
Available online: https://www.mdpi.com/2077-0383/12/10/3557
Special Issues | |
“New Advances in Prenatal Diagnosis and Newborn Screening” |
“Clinical Risks and Perinatal Outcomes in Pregnancy and Childbirth” |
“Prevention and Treatment for Pelvic and Relative Diseases” |
“Clinical Updates on Maternal Fetal Medicine” |
“New Challenges and Perspectives in Polycystic Ovary Syndrome” |
“Advances in Gynecological Diseases” |
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
27 September 2024
MDPI’s 2023 Travel Awards—Winners Announced
MDPI journals frequently grant travel awards to empower junior researchers to showcase their latest research at academic conferences, thereby amplifying their impact within their research fields.
We extend our heartfelt congratulations to the 103 recipients of MDPI's 2023 Travel Awards from different countries and territories for their exceptional presentations. These outstanding individuals were selected by the journal editors based on the strength of their research proposals and the anticipated impact of their presentations at academic conferences. We commend their exceptional contributions and wish them continued success in their academic endeavors.
MDPI will continue to provide support and recognition to the academic community. To learn more about the list of awardees, please visit the following pages:
- Biology and Life Sciences;
- Chemistry and Materials Sciences;
- Engineering;
- Environmental and Earth Sciences;
- Medicine and Pharmacology;
- Public Health and Healthcare;
- Others.
About MDPI Awards:
To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.
To explore more MDPI awards, please click here.
27 September 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Nephrology and Urology
We are delighted to share some highly cited papers on nephrology and urology that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues in the Section “Nephrology & Urology” are currently open for submission.
The following is a list of articles and Special Issues that we believe will interest you:
1. “Management of Hypertension in Diabetic Kidney Disease”
by Gates B. Colbert, Mohamed E. Elrggal, Anna Gaddy, Hector M. Madariaga and Edgar V. Lerma
J. Clin. Med. 2023, 12(21), 6868; https://doi.org/10.3390/jcm12216868
Available online: https://www.mdpi.com/2077-0383/12/21/6868
2. “Urethral Injuries: Diagnostic and Management Strategies for Critical Care and Trauma Clinicians”
by Anish B. Patel, E. Charles Osterberg, Praveen N. Satarasinghe, Jessica L. Wenzel, Sabah T. Akbani, Saad L. Sahi, Brent J. Emigh, J. Stuart Wolf, Jr. and Carlos V. R. Brown
J. Clin. Med. 2023, 12(4), 1495; https://doi.org/10.3390/jcm12041495
Available online: https://www.mdpi.com/2077-0383/12/4/1495
3. “A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence”
by Mohit Mathur, Tak Mao Chan, Kook-Hwan Oh, Laura Kooienga, Min Zhuo, Cibele S. Pinto and Bobby Chacko
J. Clin. Med. 2023, 12(21), 6927; https://doi.org/10.3390/jcm12216927
Available online: https://www.mdpi.com/2077-0383/12/21/6927
4. “Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety”
by Peter Schnuelle
J. Clin. Med. 2023, 12(19), 6424; https://doi.org/10.3390/jcm12196424
Available online: https://www.mdpi.com/2077-0383/12/19/6424
5. “Pseudohyponatremia: Mechanism, Diagnosis, Clinical Associations and Management”
by Fahad Aziz, Ramin Sam, Susie Q. Lew, Larry Massie, Madhukar Misra, Maria-Eleni Roumelioti, Christos P. Argyropoulos, Todd S. Ing and Antonios H. Tzamaloukas
J. Clin. Med. 2023, 12(12), 4076; https://doi.org/10.3390/jcm12124076
Available online: https://www.mdpi.com/2077-0383/12/12/4076
6. “Adaptation of the Brain to Hyponatremia and Its Clinical Implications”
by Fabrice Gankam Kengne
J. Clin. Med. 2023, 12(5), 1714; https://doi.org/10.3390/jcm12051714
Available online: https://www.mdpi.com/2077-0383/12/5/1714
7. “Shockwave Lithotripsy for De-Novo Urolithiasis after Kidney Transplantation: A Systematic Review of the Literature”
by Clara Cerrato, Victoria Jahrreiss, Carlotta Nedbal, Francesco Ripa, Vincenzo De Marco, Manoj Monga, Amelia Pietropaolo and Bhaskar Somani
J. Clin. Med. 2023, 12(13), 4389; https://doi.org/10.3390/jcm12134389
Available online: https://www.mdpi.com/2077-0383/12/13/4389
8. “Pathomechanisms of Diabetic Kidney Disease”
by Satyesh K. Sinha and Susanne B. Nicholas
J. Clin. Med. 2023, 12(23), 7349; https://doi.org/10.3390/jcm12237349
Available online: https://www.mdpi.com/2077-0383/12/23/7349
9. “A Meta-Analysis of Proton Pump Inhibitor Use and the Risk of Acute Kidney Injury: Geographical Differences and Associated Factors”
by Cheng Ta Han, Md. Mohaimenul Islam, Tahmina Nasrin Poly, Yu-Chun Lu and Ming-Chin Lin
J. Clin. Med. 2023, 12(7), 2467; https://doi.org/10.3390/jcm12072467
Available online: https://www.mdpi.com/2077-0383/12/7/2467
10. “Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?”
by Giovanni Bertoldi, Ilaria Caputo, Giulia Driussi, Lucia Federica Stefanelli, Valentina Di Vico, Gianni Carraro, Federico Nalesso and Lorenzo A. Calò
J. Clin. Med. 2023, 12(5), 2063; https://doi.org/10.3390/jcm12052063
Available online: https://www.mdpi.com/2077-0383/12/5/2063
11. “Nephroprotective Properties of Antidiabetic Drugs”
by Christian Gerdes, Nicolle Müller, Gunter Wolf and Martin Busch
J. Clin. Med. 2023, 12(10), 3377; https://doi.org/10.3390/jcm12103377
Available online: https://www.mdpi.com/2077-0383/12/10/3377
12. “Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies”
by Chieh-Chen Wu, Mao-Hung Liao, Woon-Man Kung and Yao-Chin Wang
J. Clin. Med. 2023, 12(6), 2262; https://doi.org/10.3390/jcm12062262
Available online: https://www.mdpi.com/2077-0383/12/6/2262
13. “Optimizing Outcomes in Flexible Ureteroscopy: A Narrative Review of Suction Techniques”
by Catalina Solano, Marie Chicaud, Stessy Kutchukian, Luigi Candela, Mariela Corrales, Frédéric Panthier, Steeve Doizi and Olivier Traxer
J. Clin. Med. 2023, 12(8), 2815; https://doi.org/10.3390/jcm12082815
Available online: https://www.mdpi.com/2077-0383/12/8/2815
14. “Acute Kidney Injury and Sepsis after Cardiac Surgery: The Roles of Tissue Inhibitor Metalloproteinase-2, Insulin-like Growth Factor Binding Protein-7, and Mid-Regional Pro-Adrenomedullin”
by Antonio Lacquaniti, Fabrizio Ceresa, Susanna Campo, Giovanna Barbera, Daniele Caruso, Elenia Palazzo, Francesco Patanè and Paolo Monardo
J. Clin. Med. 2023, 12(16), 5193; https://doi.org/10.3390/jcm12165193
Available online: https://www.mdpi.com/2077-0383/12/16/5193
15. “Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease—Clinical Practice Position Statement of the Polish Society of Nephrology”
by Tomasz Stompór, Marcin Adamczak, Ilona Kurnatowska, Beata Naumnik, Michał Nowicki, Leszek Tylicki, Agata Winiarska and Magdalena Krajewska
J. Clin. Med. 2023, 12(16), 5184; https://doi.org/10.3390/jcm12165184
Available online: https://www.mdpi.com/2077-0383/12/16/5184
Special Issues | |
“Chronic Kidney Disease: Clinical Updates and Perspectives, Opportunities and Challenges” |
“New Insights into Peritoneal Dialysis and Hemodialysis” |
“Renal Failure: Treatment Advances and Future Directions” |
“Clinical Perspectives in Reconstructive Urethral Surgery” |
“Innovations in Minimally Invasive Surgery (MIS) in Urology” |
“Current Advances and Challenges in Urological Surgery Using Laser Technologies” |
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
11 September 2024
MDPI’s 2023 Best PhD Thesis Awards—Winners Announced
MDPI’s Best PhD Thesis Awards are granted to promising young scholars whose PhD theses are deemed exceptional within their respective research fields. These awards aim to encourage young scholars to continue their outstanding accomplishments and further contribute to their field.
We extend our heartfelt congratulations to the 54 winners of the 2023 Best PhD Thesis Awards and wish them success with their future research endeavors.
MDPI will continue to provide support and recognition to the academic community. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:
About MDPI Awards:
To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.
To explore more MDPI awards, please click here.
10 September 2024
Journal of Clinical Medicine | Special Issue Mentor Program
We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program.
This program will enable early career researchers (required to hold a Ph.D. in a related field) to gain experience editing a Special Issue in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) under the mentorship of our experienced Editorial Board Members or other experienced scientists. The program will provide an excellent opportunity for early career scientists to cultivate their ability to edit and process scientific research.
The mentee’s responsibilities include:
- Proposing a Special Issue title and, with the assistance of the mentor, preparing a summary (around 200 words) and 5–10 keywords describing the background, importance, and goal of the Issue;
- Writing a brief promotion plan for the Special Issue;
- Preparing a list of scholars who may be interested in the Issue and personally e-mailing the invitations on behalf of Guest Editors;
- Writing an editorial for the online Special Issue together with the mentor.
The mentor’s responsibilities include:
- Conducting a final check before the Special Issue is published online;
- Performing editorial control of the Special issue and quality control of the publications in a timely manner;
- Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
- Organizing video calls with young scholars and the Editorial office regularly to discuss problems and improvement suggestions for the Special Issue;
- Making and submitting decisions for submissions under the assistance of mentees.
Certificates and Awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and mentees.
If you are interested in this opportunity, please send your Special Issue proposal to the Journal of Clinical Medicine Editorial Office, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.
In addition to the new Special Issue Mentor Program, the Journal of Clinical Medicine will continue to welcome all Special Issue proposals focusing on hot research topics.
JCM Editorial Office
10 September 2024
Meet Us at the GSA 2024 Annual Scientific Meeting (GSA 2024), 13–16 November 2024, Seattle, USA
MDPI will be attending the GSA 2024 Annual Scientific Meeting (GSA 2024), which will be held from 13 to 16 of November 2024, in Seattle, USA.
The Gerontological Society of America (GSA) Annual Scientific Meeting draws professionals in the field of aging on a global scale, representing specialties including geriatrics, biological sciences, nursing, nutrition, medicine, social work, economics, policy, and psychology. The GSA is the largest and most established international, interdisciplinary scientific organization devoted to the advancement of gerontological research.
GSA 2024 offers numerous opportunities for career development and networking. Nearly 4,000 researchers, clinicians, educators, and other professionals will gather in Seattle to learn about and discuss the latest trends, research, and key issues in aging.
The following MDPI journals will be represented at the conference:
- Healthcare;
- Geriatrics;
- Nursing Report;
- Epidemiologia;
- Journal of Clinical Medicine (JCM);
- International Journal of Environmental Research and Public Health (IJERPH);
- European Journal of Investigation in Health, Psychology and Education (EJIHPE);
- Journal of Personalized Medicine (JPM);
- Nutrients;
- Journal of Ageing and Longevity (JAL);
- International Journal of Molecular Sciences (IJMS);
- Societies;
- Behavioral Sciences.
If you are planning to attend the conference, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries you may have. For more information about the conference, please visit the official website at https://www.gsa2024.org/.
4 September 2024
Meet Us at the 30th Annual Meeting of Japanese Society for Hemodiafiltration, 2–3 November 2024, Nagasaki, Japan
Conference: The 30th Annual Meeting of Japanese Society for Hemodiafiltration
Date: 2–3 November 2024
Location: Nagasaki, Japan
MDPI will be attending the 30th Annual Meeting of Japanese Society for Hemodiafiltration as an exhibitor, and we are welcoming researchers from different backgrounds to visit and share their latest ideas with us.
This conference has been organized by the Japanese Society for Hemodiafiltration. The Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry (JRDR) was established in 1968. The society has a long history and more than 1000 members. The event being organized in Nagasaki in 2024 is estimated to have around 1000 attendees.
The following MDPI journals will be represented:
If you are planning on attending this conference, please do not hesitate to contact us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.congre.co.jp/hdf2024/index.html.
3 September 2024
MDPI INSIGHTS: The CEO's Letter #15 - CHORUS, Best Paper Award, August Events
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
I am pleased to share that MDPI is now an Affiliate Member of CHORUS, a not-for-profit organization dedicated to ensuring public access to articles reporting on U.S. government-funded research. This partnership highlights our long-standing commitment to advancing Open Access (OA) publishing and meeting funders’ open research requirements.
Read the full announcement here.
With the White House Office of Science and Technology Policy (OSTP) 2022 memorandum calling for immediate public access to all federally funded research by 2026, this partnership positions MDPI to further support academic institutions in adhering to national mandates while providing authors with fully compliant (CC-BY) OA journals.
The CHORUS platform went live in July 2014 and includes NASA, the U.S. Department of Energy, the U.S. Department of Defense, the U.S. Geological Survey, and the National Science Foundation.
“This partnership positions MDPI to further support academic institutions in adhering to national mandates”
Joining CHORUS perfectly aligns our mission as the leading OA publisher, which is to drive transparency and innovation in scholarly publishing, with that of CHORUS itself, which is to advance Open Access research. It will also support MDPI publications from organizations such as NASA, with 1,200 research papers published by NASA-affiliated authors as at 31 August 2024.
Impactful Research
MDPI’s Best Paper Awards—Award-Winning Papers in 2023 Announced
MDPI is committed to supporting and recognizing the academic community and is proud to announce the recipients of the 2023 Best Paper Awards, which recognize high-quality papers of significant scientific merit and impact. Each year, the editors of our journals carefully select papers that showcase outstanding scientific achievement.
This year, 115 Best Paper Awards were presented, chosen from 346 exceptional papers in a highly competitive selection process. Congratulations to the authors for their remarkable contributions!
To learn more about all the awardees and their research projects, visit the following pages:
- Biology and Life Sciences
- Business and Economics
- Chemistry and Materials Sciences
- Computer Sciences and Mathematics
- Engineering
- Environmental and Earth Sciences
- Medicine and Pharmacology
- Public Health and Healthcare
- Social Sciences, Arts and Humanities
- Physical Sciences
About MDPI Awards
MDPI regularly offers various awards to recognize researchers, particularly young scientists, and to promote communication within the scientific community. These awards exist to inspire and acknowledge talented scientists who have made significant contributions to advancing their fields.
To find out more MDPI awards, please click here.
“Our awards exist to inspire and acknowledge talented scientists”
Inside MDPI
MDPI AI Team Presented at EuroSciPy 2024 in Poland
As part of the CEO Letter, I hold dear this ‘Inside MDPI’ section, where I have an opportunity to highlight various projects, teams and updates within our organization. As such, I’m happy to showcase the following presentations from members of MDPI’s Artificial Intelligence (AI) team, which were recently presented at the EuroSciPy 2024 (16th European Conference on Python in Science). This conference took place in Szczecin, Poland from 26–30 August.
“This event was a great opportunity to reinforce our commitment to innovation and excellence in publishing”
MDPI colleagues Frank Sauerburger (AI Tech Leader) and Daniele Raimondi (Senior Data Scientist) both presented at the conference. Frank discussed MDPI’s AI infrastructure, while Daniele showcased a new methodological approach we have been developing to track the journey of rejected academic manuscripts. This approach combines AI, data science and analytics to improve the identification of manuscripts and authors, enhancing our understanding of publishing dynamics.
This event was a great opportunity to reinforce our commitment to innovation and excellence in publishing. It also allowed us to contribute to the academic discussion on integrating AI and data science into scholarly communication.
From data analysis in Jupyter Notebooks to production applications: AI infrastructure at reasonable scale – Frank Sauerburger
Frank’s presentation on MDPI’s AI infrastructure provided a chance to showcase the advanced technological frameworks that power our operations. Given the technical and academic focus of EuroSciPy, this talk demonstrated how MDPI’s AI capabilities are not only cutting-edge but also central to driving efficiency and innovation in scholarly publishing. Engaging with the EuroSciPy community helps position MDPI as a leader in applying AI within the publishing industry, fostering potential collaborations and attracting interest from top researchers.
A Qdrant and Specter2 framework for tracking resubmissions of rejected manuscripts in academia – Daniele Raimondi
Daniele’s talk on the novel methodological approach that combines AI, Data Science, and Analytics was crucial in highlighting how MDPI is advancing the precision and effectiveness of manuscript and author identification. This approach is pivotal in enhancing our understanding of publishing dynamics and ensuring the quality and integrity of the academic content we manage. By presenting at EuroSciPy, we had the opportunity to engage with an audience deeply involved in scientific computing, gaining feedback and insights that could further refine our methodologies.
Thank you, Frank and Daniele, for representing MDPI so well!
I will share more about MDPI’s AI team and projects in upcoming CEO Letters, as we have a well-rounded AI and Data Team working on an exciting suite of AI products for MDPI and the scholarly community at large.
Coming Together for Science
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
I am pleased to share the success of our MDPI conference The 1st International Conference on Artificial Intelligence (AI) Sensors and the 10th International Symposium on Sensor Science in Singapore this past 1–4 August.
With nearly 400 attendees, the event brought together researchers and industry experts from China, Singapore, Japan, Korea, Taiwan, India and other countries to share their findings on the latest developments in sensors, sensing technology, artificial intelligence for sensing applications and AI-enhanced sensing systems.
We accepted a total of 355 abstracts, featuring 772 authors from 28 countries. Over the course of the four-day event, 66 posters were displayed and 296 talks were delivered, including 4 plenary talks, 46 keynote speeches, 122 invited talks, and 124 selected oral presentations. View the event gallery here.
I am pleased to announce the winners of the four awards, including Best Presentation and Best Poster, recognizing the contributions of our participants during the conference.
Looking ahead, the 2nd International Conference on AI Sensors and Transducers is scheduled to take place from 29 July to 5 August, 2025, in Bangkok, Thailand.
Thank you to our Conference team, including Ionut Spatar, Teodora Nicoleta Cremene, Ang Kai Lin, Benjamin Tay, Leong Jin Yue Esther, Wong Jolin, Judith Wu, Alethea Liu and Flora Li, who were involved in making this event a success. A big thank-you also goes to our local MDPI colleagues for their support: Yu Nwe Soe, Hen Chu Yang, Kwah Zhi En Watcharapong, Zephan Yang, Daphne Neo, Huimin Cheng, Nathan Li and Ting Yin.
Upcoming In-Person Event
25–27 September, 2024
The 5th International Conference on Materials: Advances in Material Innovation
Location: Basel, Switzerland
ICM 2024 will unite experts to share insights on recent advancements in Materials Characterization, Processing and Manufacturing.
7–9 October, 2024
Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines
Location: Basel, Switzerland
ncRNA 2024 will explore the latest advances in the field, covering topics from basic biology to medical and technological applications.
Find more upcoming MDPI events here.
Closing Thoughts
The 2nd Sustainable Publishing Forum
In 2022, the International Association of Scientific, Technical and Medical Publishers (STM) outlined three goals to reflect the academic community’s shared aspirations: promoting Open Science, maintaining research integrity and fulfilling social responsibility. Open Science has evolved from the Open Access movement of the early 2000s to become a preferred model in academic publishing. Publishers and academic journals play a crucial role in ensuring research integrity, with efforts to prevent misconduct markedly on the increase now.
As the world faces sustainability challenges, the academic publishing industry is increasingly committed to contributing the achievement of the United Nations Sustainable Development Goals (SDGs). Many publishers are implementing strategies to support these objectives, including ours, which you can view here.
The 2nd MDPI Sustainable Publishing Forum provided a platform for global editors and publishers to discuss these themes, aiming to strengthen collaboration and advance the contributions that scientific publishing can make to academia and society.
“Open Science has evolved to become a preferred model in academic publishing”
The 2nd Sustainable Publishing Forum
We hosted MDPI’s 2nd Sustainable Publishing Forum in Beijing, China, on 15–16 August, attracting nearly 120 attendees from local and international publishers, university presses, scientific and technical journal associations, libraries and the Chinese Academy of Sciences. The event focused on promoting Open Science, maintaining research integrity, and fulfilling social responsibility.
This was an excellent opportunity for us to share more with conference attendees about the approach of our research integrity team. Our Head of Publishing, Peter Roth, also participated, speaking on how to identify and avoid predatory publishers and about the principles that underpin ethical academic publishing.
I extend my thanks to all of our conference speakers, including Hylke Koers (STM Solutions), who presented on STM Trends 2028 and shared insights on the STM Integrity Hub, of which MDPI is a member.
Chief Executive Officer
MDPI AG
30 August 2024
Meet Us at the 37th Annual Congress of the European Association of Nuclear Medicine, 19–23 October 2024, Hamburg, Germany
The 37th Annual Congress of the European Association of Nuclear Medicine, organized by the European Association of Nuclear Medicine, will be held from 19 to 23 October 2024, in Hamburg, Germany.
This conference will offer a platform to exchange and discuss the latest theranostic advances, alongside the most impactful clinical evidence, recently developed radiopharmaceuticals, and novel imaging and detection technologies. Several topics will be discussed during the “Technologists’ Track”, including, among many others, whole-body multimodality imaging principles, PET-CT in oncologic disease-staging applications, radio-guided surgery, brain PET studies, and recent advancements regarding artificial intelligence and radiomics, as well as one of the most relevant aspects of healthcare—patient advocacy.
The following MDPI journals will be represented at the conference:
- Diagnostics;
- Neurology International;
- Journal of Clinical Medicine;
- Medicina;
- Cancers;
- Children;
- Imaging;
- Tomography;
- Sci;
- Current Oncology.
If you are attending this conference, please feel free to start a conversation by contacting us online. Our delegates look forward to meeting you in person at our booth and answering any questions that you may have. For more information about the conference, please visit the following link: https://eanm24.eanm.org/.
30 August 2024
Journal of Clinical Medicine | Hot Papers in 2024
We are delighted to present a list of hot papers published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) over the past two years. These articles cover a wide range of topics, including cardiovascular mortality, polycystic ovary syndrome, spine medicine, sepsis, colorectal cancer, post-COVID-19 syndrome, and diabetic nephropathy, to name a few. We hope that you will find something of interest.
1. “Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults”
by Yiyuan Xia, Chunlei Xia, Lida Wu, Zheng Li, Hui Li and Junxia Zhang
J. Clin. Med. 2023, 12(3), 1128; https://doi.org/10.3390/jcm12031128
Full text available online: https://www.mdpi.com/2077-0383/12/3/1128
2. “Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics”
by Samradhi Singh, Namrata Pal, Swasti Shubham, Devojit Kumar Sarma, Vinod Verma, Francesco Marotta and Manoj Kumar
J. Clin. Med. 2023, 12(4), 1454; https://doi.org/10.3390/jcm12041454
Full text available online: https://www.mdpi.com/2077-0383/12/4/1454
3. “XR (Extended Reality: Virtual Reality, Augmented Reality, Mixed Reality) Technology in Spine Medicine: Status Quo and Quo Vadis”
by Tadatsugu Morimoto, Takaomi Kobayashi, Hirohito Hirata, Koji Otani, Maki Sugimoto, Masatsugu Tsukamoto, Tomohito Yoshihara, Masaya Ueno and Masaaki Mawatari
J. Clin. Med. 2022, 11(2), 470; https://doi.org/10.3390/jcm11020470
Full text available online: https://www.mdpi.com/2077-0383/11/2/470
4. “2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department”
by Matteo Guarino, Benedetta Perna, Alice Eleonora Cesaro, Martina Maritati, Michele Domenico Spampinato, Carlo Contini and Roberto De Giorgio
J. Clin. Med. 2023, 12(9), 3188; https://doi.org/10.3390/jcm12093188
Full text available online: https://www.mdpi.com/2077-0383/12/9/3188
5. “Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis”
by Kin Israel Notarte, Maria Helena Santos de Oliveira, Princess Juneire Peligro, Jacqueline Veronica Velasco, Imee Macaranas, Abbygail Therese Ver, Flos Carmeli Pangilinan, Adriel Pastrana, Nathaniel Goldrich, David Kavteladze et al.
J. Clin. Med. 2022, 11(24), 7314; https://doi.org/10.3390/jcm11247314
Full text available online: https://www.mdpi.com/2077-0383/11/24/7314
6. “Noise-Induced Hearing Loss”
by Nirvikalpa Natarajan, Shelley Batts and Konstantina M. Stankovic
J. Clin. Med. 2023, 12(6), 2347; https://doi.org/10.3390/jcm12062347
Full text available online: https://www.mdpi.com/2077-0383/12/6/2347
7. “The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis”
by Aleksandra Kałużna, Paweł Olczyk and Katarzyna Komosińska-Vassev
J. Clin. Med. 2022, 11(2), 400; https://doi.org/10.3390/jcm11020400
Full text available online: https://www.mdpi.com/2077-0383/11/2/400
8. “Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients”
by Matteo Regolo, Mauro Vaccaro, Alessandra Sorce, Benedetta Stancanelli, Michele Colaci, Giuseppe Natoli, Mario Russo, Innocenza Alessandria, Massimo Motta, Nicola Santangelo et al.
J. Clin. Med. 2022, 11(8), 2235; https://doi.org/10.3390/jcm11082235
Full text available online: https://www.mdpi.com/2077-0383/11/8/2235
9. “Stage IV Colorectal Cancer Management and Treatment”
by Oscar Hernandez Dominguez, Sumeyye Yilmaz and Scott R. Steele
J. Clin. Med. 2023, 12(5), 2072; https://doi.org/10.3390/jcm12052072
Full text available online: https://www.mdpi.com/2077-0383/12/5/2072
10. “Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy”
by Gian Marco Leone, Katia Mangano, Maria Cristina Petralia, Ferdinando Nicoletti and Paolo Fagone
J. Clin. Med. 2023, 12(4), 1630; https://doi.org/10.3390/jcm12041630
Full text available online: https://www.mdpi.com/2077-0383/12/4/1630
11. “Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems”
by Valeria Visco, Carolina Vitale, Antonella Rispoli, Carmine Izzo, Nicola Virtuoso, Germano Junior Ferruzzi, Mario Santopietro, Americo Melfi, Maria Rosaria Rusciano, Angelantonio Maglio et al.
J. Clin. Med. 2022, 11(3), 524; https://doi.org/10.3390/jcm11030524
Full text available online: https://www.mdpi.com/2077-0383/11/3/524
12. “Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis”
by Giuseppe Maglietta, Francesca Diodati, Matteo Puntoni, Silvia Lazzarelli, Barbara Marcomini, Laura Patrizi and Caterina Caminiti
J. Clin. Med. 2022, 11(6), 1541; https://doi.org/10.3390/jcm11061541
Full text available online: https://www.mdpi.com/2077-0383/11/6/1541
13. “Therapeutic Advances in Diabetic Nephropathy”
by Hanny Sawaf, George Thomas, Jonathan J. Taliercio, Georges Nakhoul, Tushar J. Vachharajani and Ali Mehdi
J. Clin. Med. 2022, 11(2), 378; https://doi.org/10.3390/jcm11020378
Full text available online: https://www.mdpi.com/2077-0383/11/2/378
14. “Correlation between Inflammatory Systemic Biomarkers and Surgical Trauma in Elderly Patients with Hip Fractures”
by Flaviu Moldovan, Adrian Dumitru Ivanescu, Pal Fodor, Liviu Moldovan and Tiberiu Bataga
J. Clin. Med. 2023, 12(15), 5147; https://doi.org/10.3390/jcm12155147
Full text available online: https://www.mdpi.com/2077-0383/12/15/5147
15. “Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study”
by Matteo Megna, Angelo Ruggiero, Teresa Battista, Laura Marano, Sara Cacciapuoti and Luca Potestio
J. Clin. Med. 2023, 12(9), 3233; https://doi.org/10.3390/jcm12093233
Full text available online: https://www.mdpi.com/2077-0383/12/9/3233
To access more journal information, please click the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
29 August 2024
Journal of Clinical Medicine | Selected Feature Papers in 2023
We are pleased to present the a list of selected feature papers in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. We would like to take this opportunity to acknowledge the exceptional individuals and teams who worked on these papers. These articles are from multiple fields within the scope of JCM, and we hope they can provide insights and references for scholars in related fields. Learn more about the latest research below.
1. “Management of Coronary Artery Disease in Older Adults: Recent Advances and Gaps in Evidence”
by Stefano Cacciatore, Luigi Spadafora, Marco Bernardi, Mattia Galli, Matteo Betti, Francesco Perone, Giulia Nicolaio, Emanuele Marzetti, Anna Maria Martone, Francesco Landi et al.
J. Clin. Med. 2023, 12(16), 5233; https://doi.org/10.3390/jcm12165233
Available online: https://www.mdpi.com/2077-0383/12/16/5233
2. “Marginal Ulcers after Roux-en-Y Gastric Bypass: Etiology, Diagnosis, and Management”
by Marita Salame, Noura Jawhar, Amanda Belluzzi, Mohammad Al-Kordi, Andrew C. Storm, Barham K. Abu Dayyeh and Omar M. Ghanem
J. Clin. Med. 2023, 12(13), 4336; https://doi.org/10.3390/jcm12134336
Available online: https://www.mdpi.com/2077-0383/12/13/4336
3. “Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux”
by Alejandro Gugliucci
J. Clin. Med. 2023, 12(13), 4399; https://doi.org/10.3390/jcm12134399
Available online: https://www.mdpi.com/2077-0383/12/13/4399
4. “Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease”
by Shu Xian Loh, Yasemin Ekinci, Luke Spray, Visvesh Jeyalan, Thomas Olin, Gavin Richardson, David Austin, Mohammad Alkhalil and Ioakim Spyridopoulos
J. Clin. Med. 2023, 12(14), 4821; https://doi.org/10.3390/jcm12144821
Available online: https://www.mdpi.com/2077-0383/12/14/4821
5. “Cold Plasma Therapy in Chronic Wounds—A Multicenter, Randomized Controlled Clinical Trial (Plasma on Chronic Wounds for Epidermal Regeneration Study): Preliminary Results”
by Nessr Abu Rached, Susanne Kley, Martin Storck, Thomas Meyer and Markus Stücker
J. Clin. Med. 2023, 12(15), 5121; https://doi.org/10.3390/jcm12155121
Available online: https://www.mdpi.com/2077-0383/12/15/5121
6. “Limb–Girdle Muscular Dystrophies Classification and Therapies”
by Camille Bouchard and Jacques P. Tremblay
J. Clin. Med. 2023, 12(14), 4769; https://doi.org/10.3390/jcm12144769
Available online: https://www.mdpi.com/2077-0383/12/14/4769
7. “Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes”
by Riccardo Candido, Sara Gaiotti, Fabiola Giudici, Barbara Toffoli, Federica De Luca, Valerio Velardi, Alessandra Petrucco, Chiara Gottardi, Elena Manca, Iris Buda et al.
J. Clin. Med. 2023, 12(18), 6052; https://doi.org/10.3390/jcm12186052
Available online: https://www.mdpi.com/2077-0383/12/18/6052
8. “Adjunctive Hemoadsorption Therapy with CytoSorb in Patients with Septic/Vasoplegic Shock: A Best Practice Consensus Statement”
by Steffen Mitzner, Klaus Kogelmann, Can Ince, Zsolt Molnár, Ricard Ferrer and Axel Nierhaus
J. Clin. Med. 2023, 12(23), 7199; https://doi.org/10.3390/jcm12237199
Available online: https://www.mdpi.com/2077-0383/12/23/7199
9. “Advances in Targeted Therapy for the Treatment of Cervical Cancer”
by Dean E. Watkins, Daniel J. Craig, Shahnaz D. Vellani, Ahmad Hegazi, Kaylee J. Fredrickson, Adam Walter, Laura Stanbery and John Nemunaitis
J. Clin. Med. 2023, 12(18), 5992; https://doi.org/10.3390/jcm12185992
Available online: https://www.mdpi.com/2077-0383/12/18/5992
10. “The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial”
by Barbara Skrzydło-Radomańska, Beata Prozorow-Król, Anetta Kurzeja-Mirosław, Halina Cichoż-Lach, Katarzyna Laskowska, Emilia Majsiak, Joanna B. Bierła, Sowińska Agnieszka and Bożena Cukrowska
J. Clin. Med. 2023, 12(14), 4838; https://doi.org/10.3390/jcm12144838
Available online: https://www.mdpi.com/2077-0383/12/14/4838
11. “Anatomical and Functional Connectivity of Critical Deep Brain Structures and Their Potential Clinical Application in Brain Stimulation”
by Qiao Kong, Valeria Sacca, Meixuan Zhu, Amy Katherine Ursitti and Jian Kong
J. Clin. Med. 2023, 12(13), 4426; https://doi.org/10.3390/jcm12134426
Available online: https://www.mdpi.com/2077-0383/12/13/4426
12. “Development of Bleeding Artificial Intelligence Detector (BLAIR) System for Robotic Radical Prostatectomy”
by Enrico Checcucci, Pietro Piazzolla, Giorgia Marullo, Chiara Innocente, Federico Salerno, Luca Ulrich, Sandro Moos, Alberto Quarà, Gabriele Volpi, Daniele Amparore et al.
J. Clin. Med. 2023, 12(23), 7355; https://doi.org/10.3390/jcm12237355
Available online: https://www.mdpi.com/2077-0383/12/23/7355
13. “In Vitro Gametogenesis in Oncofertility: A Review of Its Potential Use and Present-Day Challenges in Moving toward Fertility Preservation and Restoration”
by Victoria G. Wesevich, Christopher Arkfeld and David B. Seifer
J. Clin. Med. 2023, 12(9), 3305; https://doi.org/10.3390/jcm12093305
Available online: https://www.mdpi.com/2077-0383/12/9/3305
14. “Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review”
by David de la Rosa-Carrillo, Guillermo Suárez-Cuartín, Oriol Sibila, Rafael Golpe, Rosa-María Girón and Miguel-Ángel Martínez-García
J. Clin. Med. 2023, 12(10), 3577; https://doi.org/10.3390/jcm12103577
Available online: https://www.mdpi.com/2077-0383/12/10/3577
15. “Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies”
by Ahsanullah Unar, Lorenzo Bertolino, Fabian Patauner, Raffaella Gallo and Emanuele Durante-Mangoni
J. Clin. Med. 2023, 12(19), 6128; https://doi.org/10.3390/jcm12196128
Available online: https://www.mdpi.com/2077-0383/12/19/6128
To access more journal information, please click the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
29 August 2024
Journal of Clinical Medicine | Title Story Articles for the First Half of 2024
We are delighted to present a list of title story articles selected for display at the top of the homepage of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) for the first half of 2024. These articles cover a wide range of topics, including pulmonary embolism, lung disease, keratitis, and prostate cancer liver metastasis, to name a few. We hope you will find something of interest.
1. “Pulmonary Embolism in Pregnancy: A Review for Clinical Practitioners”
by Agata Makowska, Thomas Treumann, Stefan Venturini and Michael Christ
J. Clin. Med. 2024, 13(10), 2863; https://doi.org/10.3390/jcm13102863
Full text available online: https://www.mdpi.com/2077-0383/13/10/2863
2. “Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”
by Anna Paffrath, Laura Kim, Claudia Kedor, Elisa Stein, Rebekka Rust, Helma Freitag, Uta Hoppmann, Leif G. Hanitsch, Judith Bellmann-Strobl, Kirsten Wittke et al.
J. Clin. Med. 2024, 13(7), 2153; https://doi.org/10.3390/jcm13072153
Full text available online: https://www.mdpi.com/2077-0383/13/7/2153
3. “Acute Lung Injury after Cardiopulmonary Resuscitation: A Narrative Review”
by Giuseppe Marchese, Elisabetta Bungaro, Aurora Magliocca, Francesca Fumagalli, Giulia Merigo, Federico Semeraro, Elisa Mereto, Giovanni Babini, Erik Roman-Pognuz, Giuseppe Stirparo et al.
J. Clin. Med. 2024, 13(9), 2498; https://doi.org/10.3390/jcm13092498
Full text available online: https://www.mdpi.com/2077-0383/13/9/2498
4. “Antiplatelet Therapy and Anticoagulation before, during, and after Acute Coronary Syndrome”
by Christoph C. Kaufmann, Marie Muthspiel, Laura Lunzer, Edita Pogran, David Zweiker, Achim Leo Burger, Johann Wojta and Kurt Huber
J. Clin. Med. 2024, 13(8), 2313; https://doi.org/10.3390/jcm13082313
Full text available online: https://www.mdpi.com/2077-0383/13/8/2313
5. “Effectiveness of a Dual-Task Intervention Involving Exercise and Vocalized Cognitive Tasks”
by Masahiro Abo and Toyohiro Hamaguchi
J. Clin. Med. 2024, 13(10), 2962; https://doi.org/10.3390/jcm13102962
Full text available online: https://www.mdpi.com/2077-0383/13/10/2962
6. “Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases”
by Zack Biskupiak, Victor Vinh Ha, Aarushi Rohaj and Grzegorz Bulaj
J. Clin. Med. 2024, 13(2), 403; https://doi.org/10.3390/jcm13020403
Full text available online: https://www.mdpi.com/2077-0383/13/2/403
7. “Chronic Obstructive Lung Disease: Treatment Guidelines and Recommendations for Referral and Multidisciplinary Continuity of Care”
by Javier De Miguel-Díez, Alberto Fernández-Villar, Esperanza Doña Díaz, Marta Padilla Bernáldez, Eva Trillo-Calvo, Jesús Molina París, Miriam Barrecheguren, José Miguel Valero Pérez and María Teresa Ramírez Prieto
J. Clin. Med. 2024, 13(2), 303; https://doi.org/10.3390/jcm13020303
Full text available online: https://www.mdpi.com/2077-0383/13/2/303
8. “Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense?”
by Federica Fogacci, Valentina Di Micoli, Pierre Sabouret, Marina Giovannini and Arrigo F. G. Cicero
J. Clin. Med. 2024, 13(3), 751; https://doi.org/10.3390/jcm13030751
Full text available online: https://www.mdpi.com/2077-0383/13/3/751
9. “From Clinical Suspicion to Diagnosis: A Review of Diagnostic Approaches and Challenges in Fungal Keratitis”
by Panagiotis Toumasis, Andreas G. Tsantes, Anastasia Tsiogka, George Samonis and Georgia Vrioni
J. Clin. Med. 2024, 13(1), 286; https://doi.org/10.3390/jcm13010286
Full text available online: https://www.mdpi.com/2077-0383/13/1/286
10. “Prostate Cancer Liver Metastasis: An Ominous Metastatic Site in Need of Distinct Management Strategies”
by Audrey Shiner, Rubens Copia Sperandio, Mahdi Naimi and Urban Emmenegger
J. Clin. Med. 2024, 13(3), 734; https://doi.org/10.3390/jcm13030734
Full text available online: https://www.mdpi.com/2077-0383/13/3/734
To access more journal information, please click the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
19 August 2024
MDPI’s 2023 Young Investigator Awards—Winners Announced
MDPI’s Young Investigator Awards recognize promising early career scientists, acknowledge their contributions, and foster collaboration within the scientific community. We are proud to announce the recipients for 2023, who were carefully selected by the journals’ esteemed Award Evaluation Committee.
We extend our heartfelt congratulations to the 79 winners of MDPI’s 2023 Young Investigator Awards for their excellent contributions in their research field. We look forward to seeing these rising stars continue to contribute to the advancement of science.
MDPI will continue to support and recognize the academic community. To explore details about the awardees by field, please visit the individual pages listed below:
Congratulations to all the winners for their exceptional contributions and dedication to advancing scientific research.
About MDPI Awards:
To support the academic community, particularly young researchers, and to enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help to elevate the profiles of talented individuals who have made outstanding achievements and are making significant contributions to advancements in their respective fields.
To find out more about MDPI awards, please click here.
9 August 2024
Journal of Clinical Medicine | Google Scholar Metrics Released
We are pleased to announce that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) ranked 13th under the subcategory “Health & Medical Sciences (general)” in the latest released 2024 Google Scholar Metrics on 9 July 2024. The ranking increased from 17th in the 2023 metrics. The latest release covers articles published from 2019 to 2023 and includes citations from all articles that were indexed in Google Scholar as of July 2024 (source: 2024 Google Scholar Metrics).
The h5-index of the Journal of Clinical Medicine is 146, and the h5-median is 193. We express our gratitude to all of the editors, reviewers, authors, and readers of the Journal of Clinical Medicine. Thank you for all your support for the journal.
You are welcome to browse the most-cited publications over the last 5 years here.
Please feel free to contact us at [email protected] if you have any questions or suggestions for the Journal of Clinical Medicine.
Supplementary Explanations:
- Scholar Metrics provide an easy way for authors to quickly gauge the visibility and influence of recent articles in scholarly publications;
- h5-index: The h5-index is the h-index for articles published in the last 5 complete years. H articles published in 2019–2023 have at least h citations each;
- h5-median: The h5-median for a publication is the median number of citations for the articles that make up its h5-index.
JCM Editorial Office
8 August 2024
Journal of Clinical Medicine | Highly Cited Papers and Hot Topic Special Issues on Artificial Intelligence
We are delighted to share some highly cited papers on artificial intelligence that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) between 2022 and 2024. In addition, some Special Issues on this topic are currently open for submission.
The following is a list of articles and Special Issues that we believe will interest you.
1. “Machine Learning and Deep Learning in Spinal Injury: A Narrative Review of Algorithms in Diagnosis and Prognosis”
by Satoshi Maki, Takeo Furuya, Masahiro Inoue, Yasuhiro Shiga, Kazuhide Inage, Yawara Eguchi, Sumihisa Orita and Seiji Ohtori
J. Clin. Med. 2024, 13(3), 705; https://doi.org/10.3390/jcm13030705
Available online: https://www.mdpi.com/2077-0383/13/3/705
2. “Exploring the Impact of Glycemic Control on Diabetic Retinopathy: Emerging Models and Prognostic Implications”
by Nicola Tecce, Gilda Cennamo, Michele Rinaldi, Ciro Costagliola and Annamaria Colao
J. Clin. Med. 2024, 13(3), 831; https://doi.org/10.3390/jcm13030831
Available online: https://www.mdpi.com/2077-0383/13/3/831
3. “Periapical Lesions in Panoramic Radiography and CBCT Imaging—Assessment of AI’s Diagnostic Accuracy”
by Wojciech Kazimierczak, Róża Wajer, Adrian Wajer, Veronica Kiian, Anna Kloska, Natalia Kazimierczak, Joanna Janiszewska-Olszowska and Zbigniew Serafin
J. Clin. Med. 2024, 13(9), 2709; https://doi.org/10.3390/jcm13092709
Available online: https://www.mdpi.com/2077-0383/13/9/2709
4. “How Radiomics Can Improve Breast Cancer Diagnosis and Treatment”
by Filippo Pesapane, Paolo De Marco, Anna Rapino, Eleonora Lombardo, Luca Nicosia, Priyan Tantrige, Anna Rotili, Anna Carla Bozzini, Silvia Penco, Valeria Dominelli et al.
J. Clin. Med. 2023, 12(4), 1372; https://doi.org/10.3390/jcm12041372
Available online: https://www.mdpi.com/2077-0383/12/4/1372
5. “Overview of Artificial Intelligence in Breast Cancer Medical Imaging”
by Dan Zheng, Xiujing He and Jing Jing
J. Clin. Med. 2023, 12(2), 419; https://doi.org/10.3390/jcm12020419
Available online: https://www.mdpi.com/2077-0383/12/2/419
6. “Towards Automation in IVF: Pre-Clinical Validation of a Deep Learning-Based Embryo Grading System during PGT-A Cycles”
by Danilo Cimadomo, Viviana Chiappetta, Federica Innocenti, Gaia Saturno, Marilena Taggi, Anabella Marconetto, Valentina Casciani, Laura Albricci, Roberta Maggiulli, Giovanni Coticchio et al.
J. Clin. Med. 2023, 12(5), 1806; https://doi.org/10.3390/jcm12051806
Available online: https://www.mdpi.com/2077-0383/12/5/1806
7. “Validation of an Automated Artificial Intelligence Algorithm for the Quantification of Major OCT Parameters in Diabetic Macular Edema”
by Edoardo Midena, Lisa Toto, Luisa Frizziero, Giuseppe Covello, Tommaso Torresin, Giulia Midena, Luca Danieli, Elisabetta Pilotto, Michele Figus, Cesare Mariotti et al.
J. Clin. Med. 2023, 12(6), 2134; https://doi.org/10.3390/jcm12062134
Available online: https://www.mdpi.com/2077-0383/12/6/2134
8. “Diagnostic Image Quality of a Low-Field (0.55T) Knee MRI Protocol Using Deep Learning Image Reconstruction Compared with a Standard (1.5T) Knee MRI Protocol”
by Ingo Lopez Schmidt, Nina Haag, Iram Shahzadi, Lynn Johann Frohwein, Claus Schneider, Julius Henning Niehoff, Jan Robert Kroeger, Jan Borggrefe and Christoph Moenninghoff
J. Clin. Med. 2023, 12(5), 1916; https://doi.org/10.3390/jcm12051916
Available online: https://www.mdpi.com/2077-0383/12/5/1916
9. “Artificial Intelligence (AI) versus POCUS Expert: A Validation Study of Three Automatic AI-Based, Real-Time, Hemodynamic Echocardiographic Assessment Tools”
by Eyal Gohar, Amit Herling, Mor Mazuz, Gal Tsaban, Tomer Gat, Sergio Kobal and Lior Fuchs
J. Clin. Med. 2023, 12(4), 1352; https://doi.org/10.3390/jcm12041352
Available online: https://www.mdpi.com/2077-0383/12/4/1352
10. “Application and Progress of Artificial Intelligence in Fetal Ultrasound”
by Sushan Xiao, Junmin Zhang, Ye Zhu, Zisang Zhang, Haiyan Cao, Mingxing Xie and Li Zhang
J. Clin. Med. 2023, 12(9), 3298; https://doi.org/10.3390/jcm12093298
Available online: https://www.mdpi.com/2077-0383/12/9/3298
11. “XR (Extended Reality: Virtual Reality, Augmented Reality, Mixed Reality) Technology in Spine Medicine: Status Quo and Quo Vadis”
by Tadatsugu Morimoto, Takaomi Kobayashi, Hirohito Hirata, Koji Otani, Maki Sugimoto, Masatsugu Tsukamoto, Tomohito Yoshihara, Masaya Ueno and Masaaki Mawatari
J. Clin. Med. 2022, 11(2), 470; https://doi.org/10.3390/jcm11020470
Available online: https://www.mdpi.com/2077-0383/11/2/470
12. “Clinical Applications of Artificial Intelligence—An Updated Overview”
by Ștefan Busnatu, Adelina-Gabriela Niculescu, Alexandra Bolocan, George E. D. Petrescu, Dan Nicolae Păduraru, Iulian Năstasă, Mircea Lupușoru, Marius Geantă, Octavian Andronic, Alexandru Mihai Grumezescu et al.
J. Clin. Med. 2022, 11(8), 2265; https://doi.org/10.3390/jcm11082265
Available online: https://www.mdpi.com/2077-0383/11/8/2265
13. “Artificial Intelligence in Dermatology Image Analysis: Current Developments and Future Trends”
by Zhouxiao Li, Konstantin Christoph Koban, Thilo Ludwig Schenck, Riccardo Enzo Giunta, Qingfeng Li and Yangbai Sun
J. Clin. Med. 2022, 11(22), 6826; https://doi.org/10.3390/jcm11226826
Available online: https://www.mdpi.com/2077-0383/11/22/6826
14. “Artificial Intelligence-Based Approaches to Reflectance Confocal Microscopy Image Analysis in Dermatology”
by Ana Maria Malciu, Mihai Lupu and Vlad Mihai Voiculescu
J. Clin. Med. 2022, 11(2), 429; https://doi.org/10.3390/jcm11020429
Available online: https://www.mdpi.com/2077-0383/11/2/429
15. “A Machine-Learning-Based Risk-Prediction Tool for HIV and Sexually Transmitted Infections Acquisition over the Next 12 Months”
by Xianglong Xu, Zongyuan Ge, Eric P. F. Chow, Zhen Yu, David Lee, Jinrong Wu, Jason J. Ong, Christopher K. Fairley and Lei Zhang
J. Clin. Med. 2022, 11(7), 1818; https://doi.org/10.3390/jcm11071818
Available online: https://www.mdpi.com/2077-0383/11/7/1818
Special Issues |
|
“Technological Advancements and Clinical Innovations in Diagnostic and Interventional Radiology” |
“Corneal Transplantation: Recent Advances and Current Perspectives” |
“Clinical Advancements in Infertility Treatments and Assisted Reproductive Technology (ART)” |
“PET/CT Imaging in Oncology: Innovations, Challenges, and Opportunities” |
“Clinical Advances in Artificial Intelligence in Urology” |
“Non-Small-Cell Lung Cancer: Screening, Diagnosis and Treatment Options in the AI and Omics Era” |
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
7 August 2024
MDPI Insights: The CEO's Letter #14 - New Headquarters, Marketing, Poland
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Moves to New Headquarters in Basel, Switzerland
I am excited to share that MDPI has moved to a new state-of-the-art office space in Basel, Switzerland. This move consolidates our operations by bringing together our two previously separated Basel offices into one central location.
We are always growing our talent pool and encourage you to view our Careers Page for the positions available in Basel and across our offices.
New Address: Grosspeteranlage 5, CH-4052 Basel, Switzerland
Effective Date: 1 July 2024
This new chapter in our company’s journey is designed to continue our mission of positioning MDPI as a leader in Open Access (OA) publishing, highlighting our commitment to making scholarly research accessible to everyone.
Boasting modern amenities, improved meeting and event spaces designed to support our growing needs, the new location provides a more collaborative and efficient working environment for our employees. The location offers convenient accessibility to public transportation and is situated near the Basel SBB railway station, with a variety of nearby services and amenities.
In fact, I can see the trains right outside of my window as I write these lines!
This move marks an exciting milestone in MDPI’s development, and I am confident that the new headquarters will serve as an inspiring and productive space for everyone. We also very much look forward to welcoming visitors here. You can read more about MDPI's history here.
“This new chapter continues our mission of positioning MDPI as a leader in OA publishing”
For Those New to MDPI
A pioneer in scholarly, Open Access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to Open Science by making a greater proportion of the research conducted worldwide free and accessible to everyone. To date, over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6,000 professional, well-trained staff members, and an in-house article submission platform designed to ensure efficient processes within its 440 fully Open Access titles. MDPI supports more than 800 academic institutions worldwide, helping them adhere to national mandates while facilitating authors’ publication in fully compliant (CC BY) Open Access journals.
Impactful Research
New and Emerging MDPI Journals Making an Immediate Impact
Unpacking some of the Impact Factor updates from the June CEO Letter, I wanted to dive a little deeper into the 137 MDPI journals which received Impact Factor for the first time.
Academic authors highly value efficient publishing processes, robust editorial support, and the opportunity to publish in high-impact journals. We are proud that our newly launched journals typically achieve coverage in the Emerging Sources Citation Index (ESCI) of the Web of Science within just a few years, with a median time of only three years from release to inclusion.
As part of our commitment to advancing academic research and providing high-quality OA publishing, we actively seek new research areas to expand our portfolio of journals. We have a proven track record of successfully establishing new journals.
Our dedicated teams excel in fostering dynamic editorial boards and working closely with Editors-in-Chief (EiC) to define the precise scope and focus of each new journal. Our expertise extends to collaborating with indexing services, ensuring that our journals comply with best practices and are indexed promptly in all relevant databases.
Emerging Titles Ranked for the First Time
Our commitment to excellence is reflected in the annual impact metrics released this past June. The latest edition of the Journal Citation Reports (JCR) showcases the integration of journals from the ESCI in the new unified category rankings, providing a simplified and more complete view of all journals within each subject category, including newly established titles.
Out of 137 new and developing MDPI journals ranked in the 2024 release, 79 are in the top half (Q1 or Q2) of their categories. Here is a breakdown of the number of MDPI’s ESCI-indexed journals by quartile in the JCR:
Quartile | No. of journals |
Q1 | 17 (12.4%) |
Q2 | 62 (45.3%) |
Q3 | 43 (31.4%) |
Q4 | 15 (10.9%) |
Not ranked (humanities-related journals) | 2 |
These rankings highlight our success in rapidly establishing high-impact new journals. Among those that made it directly into the top 25% of their category are the International Journal of Neonatal Screening, Journal of Xenobiotics, Polysaccharides, Smart Cities, and thirteen other journals.
You can browse MDPI journals by Indexing. Simply visit our Journals page and select from the list of Indexing bodies in the top left-hand corner.
Inside MDPI
MDPI Corporate Marketing Strategy and Team Meeting 2024
In July, I hosted the annual Corporate Marketing strategy and team-building activity with 15 of our team members.
The aim was to align the Corporate Marketing strategy with MDPI's goal of becoming the world's most trusted OA publisher. While we provide a high-level publishing experience for our authors, as seen from our surveys, we need to keep building on our transparent and open communication to foster trust within the scholarly community and continue enhancing our reputation.
The Corporate Marketing team plays an important role as the mouthpiece for all our major activities within MDPI, especially those that model what it means to be a trusted partner. The purpose of the strategy meeting was to develop a feeling of trust in one another and an understanding of how to inspire trust in the stakeholders with whom we interact.
“We need to keep building on our transparent and open communication to foster trust within the scholarly community”
We conducted a set of activities to facilitate that sense of mutual trust and trustworthiness. Examples of some activities we worked on during this strategy-building event include:
- Exploring what trust means
- ‘Letter to self’
- ‘The brand I most trust’
- Most Trusted Academic Publisher
- ‘The brand I would like MDPI to become’
- ‘The 2029 MDPI Annual Report’
- Voice of Customer and Share of Voice – survey/data update on MDPI Brand Experience and Brand Perception
- Integrate Trust-Based Objective into Marketing Plan
- ‘Becoming the MDPI experience’
- ‘Trusting the next steps’
While two days is not enough to finalize a marketing strategy, it is sufficient to get everyone who attended into the mindset of the direction in which we are working. From here, we will develop a program with next steps on main projects, update communications, and collaborate with team leads to incorporate this approach into our work going forward.
As a marketing team, we can communicate our messages, but trust has to be built at every touchpoint in the stakeholder journey. Just talking about it isn’t enough. We need to be about it. That’s a role each of us plays, from editorial to IT, from marketing to HR. We must build trust from the inside out. It starts with each manager and resonates out via every team member.
As a company, our goal is to give all stakeholders with whom we interact – whether internal or external – the experience of working with an organization it can trust.
Coming Together for Science
MDPI in Poland: Krakow Office
In July, I had the pleasure of visiting our Krakow office, following my recent trip to Warsaw to meet with the Polish Ministry of Science and Higher Education.
During these visits, I prioritized meeting with our Office Manager, Editorial Director, Group Leads, and members from various teams, including editorial, production, marketing, and journal relationship specialists, to understand their roles and current challenges. Instead of a formal presentation, I opted for an open discussion, sharing updates from headquarters to engage with colleagues in a more personal way.
Our Krakow office has many things to be proud of, including a large number of PhD colleagues (over a third of its staff holds a PhD degree). Krakow provides an opportunity for expanding beyond the 100 colleagues we currently have, by adding new hires in departments including editorial, production and marketing, among others.
About our Krakow office
- Opened in 2020
- 99 staff members as at 1 August 2024
- Main Departments include Editorial, Production, English Department, JRS, PR
Our Krakow office participates in international conferences, conducts author trainings and scholar visits, and engages in local market outreach. The office is also a member of the Polish Chamber of Commerce for High Technology (IZTECH) and is working on expanding its local engagement.
Krakow is the second-largest city in Poland, with a population of about 800,000. It also has a large student population of around 128,000, with seven universities. This means that roughly one in every eight residents is a student.
Poland and MDPI
Poland is a crucial market for MDPI. From 2020 to June 2024, Poland ranked 7th in submissions and 5th in publications for MDPI research articles. As at 31 July 2024, Poland ranks 7th in total MDPI publications, with approximately 70,000 research papers.
Between 2020 and June 2024, 61,500 authors from Poland published with MDPI. As at 30 June 2024, there are 1,205 active Editorial Board Members (EBMs) from Poland, with 661 EBMs (55% of the total) having an H-index over 25.
We also have four Editors-in-Chief (EiC) from Poland leading our journals: Coatings, Venereology, Advances in Respiratory Medicine, and Limnological Review, along with six Section EiC.
In 2023, we received approximately 21,000 submissions from Polish-affiliated authors, of which 12,032 were published.
“Poland is a crucial market for MDPI”
Meeting with Ministry of Education
On 22 July, we visited Warsaw to meet with the Polish Ministry of Science and Higher Education.
We were pleased to learn that they are strong supporters of the OA publishing model and value MDPI’s approach to the peer-review process, including our high ethical standards for quality control.
In 2023 Polish authors predominantly published their papers in OA, with MDPI holding the largest market share in OA publications within the country.
Our commitment to collaborating with Polish institutions is evident through our 33 Institutional Open Access Program (IOAP) agreements with prestigious institutions such as the University of Warsaw, the University of Wroclaw, the Jagiellonian University, and Gdańsk University of Technology. Through IOAP discounts, a healthy waiver rate, and our peer-review voucher system, we provide the Polish scholarly community with significant savings in OA publishing. The Minister greatly appreciated these efforts and our commitment to offsetting some of the APC costs.
We discussed industry concerns about the threat of papermills and presented the preventive measures MDPI has in place to mitigate this risk and uphold high ethical standards. We informed them of our commitment to combating papermills, including our involvement with United2Act and the STM Research Integrity Hub, as well as our efforts to expand our research integrity team and explore proactive measures.
Closing Thoughts
MDPI Thought Leadership Op-ed on Open Access is Now Live on Politico
I am pleased to share that our thought leadership Op-ed piece on Open Access (OA) is now live on Politico. This is a nice push for continued influence and support of OA among policymakers and industry leaders.
Why Politico?
Politico's reputation as a highly credible and influential news platform makes it an important venue to reach key opinion leaders (KOL) from academia, policymakers, and thought leaders from many industries. This visibility helps promote the OA philosophy.
Open Access: A Moral Imperative for Progress
In this piece, I discuss the necessity of making scientific research freely available to all. I argue that publicly funded research should be publicly accessible, highlighting how OA democratizes scientific knowledge, accelerates research availability, and fosters collaboration.
“Open Access is a fundamental right for all citizens”
Democratizing scientific communication
The impulse to democratize scientific communication is nothing new. OA may seem like a recent innovation, but its principles have historical roots traceable to Europe in the 15th century. Just as the printing revolution accelerated the dissemination of new ideas, OA publishing unlocks new scientific insights that would otherwise only be accessible to a few.
Benefits for scholars: amplifying impact through Open Access
Authors publishing in an OA journal can expect more citations of their work, increasing its potential impact. Research findings that are freely available are more likely to be cited than those hidden behind a paywall. Freedom of access greatly increases the potential audience for each paper, fostering a sense of community among researchers worldwide. Heightened visibility can attract prospective collaborators and employers for young scientists. At MDPI, we believe that all these factors can only accelerate the advance of science. Additionally, authors retain copyright in their work instead of signing it away, permitting broader dissemination under Creative Commons licenses and increasing its capacity for impact.
The moral imperative
OA is not just a matter of scientific policy; it is a fundamental right for all citizens and a prerequisite for a brighter, more informed future. Publicly funded research should be a top priority, and I am pleased to see policy moving in this direction. Our capacity to generate transformative scientific insights has to be democratized. The question today is no longer whether we can afford to embrace OA; rather, it is whether we can afford not to.
Chief Executive Officer
MDPI AG
2 August 2024
MDPI Romania Author Training Sessions in May
In May, MDPI Romania held three author training sessions – one endorsing an external event and two stand-alone sessions.
The National Session of Scientific Student Communications took place at Technical University Cluj on 17 and 18 May 2024. MDPI Romania sponsored this event and contributed an author training session on the production of research papers and case study analyses. JRS Norbert Kiss gave a presentation called The World of Open Access to explain different open access publishing models and the benefits of open access publishing. His presentation highlighted the impact of open access publishing on scientific progress and innovation.
On 29 May 2024, MDPI Romania hosted an author training session for Ph.D. students, early career researchers, and professors at the Carol Davila University of Medicine and Pharmacy. In collaboration with Prof. Andreea Arsene, JRS Ioana Paunescu prepared two presentations: The Steps of the Publishing Process and Elaboration of a Peer Review Report. In her first presentation, she delved into MDPI’s history and mission, MDPI’s editorial process, and MDPI journals of various scopes that are accepting submissions. Her second presentation outlined the types of peer review, the contents of a peer review report by an MDPI reviewer, and the responsibilities of an MDPI reviewer.
MDPI Romania also hosted an author training session at the Iasi University of Life Sciences on 29 May 2024. JRSs Laurentiu Preda and Cosmin Artan gave four presentations: Efficient Writing of an ISI-Indexed Scientific Article, Benefits of Publishing in the Open Access Model, Various Methods of Open Access Publishing, and MDPI Guide for the Article Review Process. The first three presentations offered guidance on how to improve academic writing, the fourth focused on how to write peer review reports. A highly interactive discussion followed the presentations, during which the JRSs provided extensive answers to attendees’ questions.
MDPI is grateful for all the attendees, speakers, and organizers involved in these events. Through their enthusiasm and dedication, these events were great successes.
31 July 2024
Journal of Clinical Medicine | Notable Papers in Q2 of 2024
We are pleased to present the notable papers published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in Q2 of 2024. These papers received good Altmetric scores. We would like to take this opportunity to acknowledge the exceptional individuals and teams who worked on these papers. These articles are from multiple fields within the scope of JCM, and we hope they can provide insights and references for scholars in related fields. Learn more about the latest research below.
1. “Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives”
by Katharine A. Seton, José A. Espejo-Oltra, Karen Giménez-Orenga, Rik Haagmans, Donia J. Ramadan and Jesper Mehlsen on behalf of the European ME Research Group for Early Career Researchers (Young EMERG)
J. Clin. Med. 2024, 13(2), 325; https://doi.org/10.3390/jcm13020325
Full text available online: https://www.mdpi.com/2077-0383/13/2/325
2. “Albuminuria, Forgotten No More: Underlining the Emerging Role in CardioRenal Crosstalk”
by Gregorio Romero-González, Néstor Rodríguez-Chitiva, Carles Cañameras, Javier Paúl-Martínez, Marina Urrutia-Jou, Maribel Troya, Jordi Soler-Majoral, Fredzzia Graterol Torres, Maya Sánchez-Bayá, Jordi Calabia et al.
J. Clin. Med. 2024, 13(3), 777; https://doi.org/10.3390/jcm13030777
Full text available online: https://www.mdpi.com/2077-0383/13/3/777
3. “Challenges in ARDS Definition, Management, and Identification of Effective Personalized Therapies”
by Denise Battaglini, Brigitta Fazzini, Pedro Leme Silva, Fernanda Ferreira Cruz, Lorenzo Ball, Chiara Robba, Patricia R. M. Rocco and Paolo Pelosi
J. Clin. Med. 2023, 12(4), 1381; https://doi.org/10.3390/jcm12041381
Full text available online: https://www.mdpi.com/2077-0383/12/4/1381
4. “Choice and Duration of Anticoagulation for Venous Thromboembolism”
by Aroosa Malik, Nghi B. Ha and Geoffrey D. Barnes
J. Clin. Med. 2024, 13(1), 301; https://doi.org/10.3390/jcm13010301
Full text available online: https://www.mdpi.com/2077-0383/13/1/301
5. “Heterogeneity in Measures of Illness among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Not Explained by Clinical Practice: A Study in Seven U.S. Specialty Clinics”
by Elizabeth R. Unger, Jin-Mann S. Lin, Yang Chen, Monica E. Cornelius, Britany Helton, Anindita N. Issa, Jeanne Bertolli, Nancy G. Klimas, Elizabeth G. Balbin, Lucinda Bateman et al.
J. Clin. Med. 2024, 13(5), 1369; https://doi.org/10.3390/jcm13051369
Full text available online: https://www.mdpi.com/2077-0383/13/5/1369
6. “Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”
by Johanna Rohrhofer, Lisa Hauser, Lisa Lettenmaier, Lena Lutz, Larissa Koidl, Salvatore Alessio Gentile, Davide Ret, Michael Stingl and Eva Untersmayr
J. Clin. Med. 2024, 13(1), 275; https://doi.org/10.3390/jcm13010275
Full text available online: https://www.mdpi.com/2077-0383/13/1/275
7. “Immunomodulatory Effect of Withania somnifera (Ashwagandha) Extract—A Randomized, Double-Blind, Placebo Controlled Trial with an Open Label Extension on Healthy Participants”
by Ajit Tharakan, Himanshu Shukla, Irin Rosanna Benny, Matthan Tharakan, Lekha George and Santhosh Koshy
J. Clin. Med. 2021, 10(16), 3644; https://doi.org/10.3390/jcm10163644
Full text available online: https://www.mdpi.com/2077-0383/10/16/3644
8. “Integrative and Mechanistic Approach to the Hair Growth Cycle and Hair Loss”
by Nicole Natarelli, Nimrit Gahoonia and Raja K. Sivamani
J. Clin. Med. 2023, 12(3), 893; https://doi.org/10.3390/jcm12030893
Full text available online: https://www.mdpi.com/2077-0383/12/3/893
9. “Long-COVID Prevalence and Its Association with Health Outcomes in the Post-Vaccine and Antiviral-Availability Era”
by Ramida Jangnin, Worraya Ritruangroj, Sirada Kittisupkajorn, Pattarapa Sukeiam, Juthamas Inchai, Benchalak Maneeton, Narong Maneetorn, Jindarat Chaiard and Theerakorn Theerakittikul
J. Clin. Med. 2024, 13(5), 1208; https://doi.org/10.3390/jcm13051208
Full text available online: https://www.mdpi.com/2077-0383/13/5/1208
10. “Pregnancy Arrhythmias: Management in the Emergency Department and Critical Care”
by Elena Conti, Nunzio Dario Cascio, Patrizia Paluan, Giulia Racca, Yaroslava Longhitano, Gabriele Savioli, Manfredi Tesauro, Roberto Leo, Fabrizio Racca and Christian Zanza
J. Clin. Med. 2024, 13(4), 1095; https://doi.org/10.3390/jcm13041095
Full text available online: https://www.mdpi.com/2077-0383/13/4/1095
11. “Recent Advances and Future Directions in Syncope Management: A Comprehensive Narrative Review”
by Anna Maria Martone, Iris Parrini, Francesca Ciciarello, Vincenzo Galluzzo, Stefano Cacciatore, Claudia Massaro, Rossella Giordano, Tommaso Giani, Giovanni Landi, Michele Massimo Gulizia et al.
J. Clin. Med. 2024, 13(3), 727; https://doi.org/10.3390/jcm13030727
Full text available online: https://www.mdpi.com/2077-0383/13/3/727
12. “Risk Stratification and Management of Intermediate-Risk Acute Pulmonary Embolism”
by Nichole Brunton, Robert McBane, Ana I. Casanegra, Damon E. Houghton, Dinu V. Balanescu, Sumera Ahmad, Sean Caples, Arashk Motiei and Stanislav Henkin
J. Clin. Med. 2024, 13(1), 257; https://doi.org/10.3390/jcm13010257
Full text available online: https://www.mdpi.com/2077-0383/13/1/257
13. “The Management of Hepatic Encephalopathy from Ward to Domiciliary Care: Current Evidence and Gray Areas”
by Daniele Bellafante, Stefania Gioia, Jessica Faccioli, Oliviero Riggio, Lorenzo Ridola and Silvia Nardelli
J. Clin. Med. 2024, 13(1), 166; https://doi.org/10.3390/jcm13010166
Full text available online: https://www.mdpi.com/2077-0383/13/1/166
14. “The Management of Hypertensive Emergencies—Is There a “Magical” Prescription for All?”
by Ana-Maria Balahura, Ștefan-Ionuț Moroi, Alexandru Scafa-Udrişte, Emma Weiss, Cristina Japie, Daniela Bartoş and Elisabeta Bădilă
J. Clin. Med. 2022, 11(11), 3138; https://doi.org/10.3390/jcm11113138
Full text available online: https://www.mdpi.com/2077-0383/11/11/3138
15. “Mitochondrial Metabolism in Major Depressive Disorder: From Early Diagnosis to Emerging Treatment Options”
by Ane Larrea, Laura Sánchez-Sánchez, Eguzkiñe Diez-Martin, Ane Elexpe, María Torrecilla, Egoitz Astigarraga and Gabriel Barreda-Gómez
J. Clin. Med. 2024, 13(6), 1727; https://doi.org/10.3390/jcm13061727
Full text available online: https://www.mdpi.com/2077-0383/13/6/1727
To access more journal information, please click the following link: https://www.mdpi.com/journal/jcm.
To access more details about Altmetric, please click here.
JCM Editorial Office
31 July 2024
Journal of Clinical Medicine | Notable Papers in Q1 of 2024
We are pleased to present the notable papers published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in Q1 of 2024. These papers received good Altmetric scores. We would like to take this opportunity to acknowledge the exceptional individuals and teams who worked on these papers. These articles are from multiple fields within the scope of JCM, and we hope they can provide insights and references for scholars in related fields. Learn more about the latest research below.
1. “New Developments and Challenges in Liver Transplantation”
by Amjad Khalil, Alberto Quaglia, Pierre Gélat, Nader Saffari, Hassan Rashidi and Brian Davidson
J. Clin. Med. 2023, 12(17), 5586; https://doi.org/10.3390/jcm12175586
Full text available online: https://www.mdpi.com/2077-0383/12/17/5586
2. “The Auto-Brewery Syndrome: A Perfect Metabolic “Storm” with Clinical and Forensic Implications”
by Ricardo Jorge Dinis-Oliveira
J. Clin. Med. 2021, 10(20), 4637; https://doi.org/10.3390/jcm10204637
Full text available online: https://www.mdpi.com/2077-0383/10/20/4637
3. “Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”
by Anna Paffrath, Laura Kim, Claudia Kedor, Elisa Stein, Rebekka Rust, Helma Freitag, Uta Hoppmann, Leif G. Hanitsch, Judith Bellmann-Strobl, Kirsten Wittke et al.
J. Clin. Med. 2024, 13(7), 2153; https://doi.org/10.3390/jcm13072153
Full text available online: https://www.mdpi.com/2077-0383/13/7/2153
4. “The German Multicenter Registry for ME/CFS (MECFS-R)”
by Hannah Hieber, Rafael Pricoco, Katrin Gerrer, Cornelia Heindrich, Katharina Wiehler, Lorenz L. Mihatsch, Matthias Haegele, Daniela Schindler, Quirin Donath, Catharina Christa et al.
J. Clin. Med. 2024, 13(11), 3168; https://doi.org/10.3390/jcm13113168
Full text available online: https://www.mdpi.com/2077-0383/13/11/3168
5. “Treatment of Acute Kidney Injury: A Review of Current Approaches and Emerging Innovations”
by Christina Tamargo, Mohamad Hanouneh and C. Elena Cervantes
J. Clin. Med. 2024, 13(9), 2455; https://doi.org/10.3390/jcm13092455
Full text available online: https://www.mdpi.com/2077-0383/13/9/2455
6. “Assessing Functional Capacity in Myalgic Encephalopathy/Chronic Fatigue Syndrome: A Patient-Informed Questionnaire”
by Kristian Sommerfelt, Trude Schei, Katharine A. Seton and Simon R. Carding
J. Clin. Med. 2024, 13(12), 3486; https://doi.org/10.3390/jcm13123486
Full text available online: https://www.mdpi.com/2077-0383/13/12/3486
7. “Sexual Dysfunction in Postural Orthostatic Tachycardia Syndrome (POTS): A Cross-Sectional, Case-Control Study”
by Svetlana Blitshteyn, Anna Lange, Chelsea Corinaldi, Paige Guy and Jill Brook
J. Clin. Med. 2024, 13(8), 2274; https://doi.org/10.3390/jcm13082274
Full text available online: https://www.mdpi.com/2077-0383/13/8/2274
8. “Menopause Predisposes Women to Increased Risk of Cardiovascular Disease”
by Magdalena Sylwia Kamińska, Daria Schneider-Matyka, Kamila Rachubińska, Mariusz Panczyk, Elżbieta Grochans and Anna Maria Cybulska
J. Clin. Med. 2023, 12(22), 7058; https://doi.org/10.3390/jcm12227058
Full text available online: https://www.mdpi.com/2077-0383/12/22/7058
9. “Acute Lung Injury after Cardiopulmonary Resuscitation: A Narrative Review”
by Giuseppe Marchese, Elisabetta Bungaro, Aurora Magliocca, Francesca Fumagalli, Giulia Merigo, Federico Semeraro, Elisa Mereto, Giovanni Babini, Erik Roman-Pognuz, Giuseppe Stirparo et al.
J. Clin. Med. 2024, 13(9), 2498; https://doi.org/10.3390/jcm13092498
Full text available online: https://www.mdpi.com/2077-0383/13/9/2498
10. “Finerenone: Questions and Answers—The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist”
by Luca Di Lullo, Carlo Lavalle, Alessia Scatena, Marco Valerio Mariani, Claudio Ronco and Antonio Bellasi
J. Clin. Med. 2023, 12(12), 3992; https://doi.org/10.3390/jcm12123992
Full text available online: https://www.mdpi.com/2077-0383/12/12/3992
11. “Effectiveness of Therapeutic Exercise and Patient Education on Cancer-Related Fatigue in Breast Cancer Survivors: A Randomised, Single-Blind, Controlled Trial with a 6-Month Follow-Up”
by Virginia Prieto-Gómez, María José Yuste-Sánchez, Javier Bailón-Cerezo, Helena Romay-Barrero, Irene de la Rosa-Díaz, Cristina Lirio-Romero and María Torres-Lacomba
J. Clin. Med. 2022, 11(1), 269; https://doi.org/10.3390/jcm11010269
Full text available online: https://www.mdpi.com/2077-0383/11/1/269
12. “Pulmonary Embolism in Pregnancy: A Review for Clinical Practitioners”
by Agata Makowska, Thomas Treumann, Stefan Venturini and Michael Christ
J. Clin. Med. 2024, 13(10), 2863; https://doi.org/10.3390/jcm13102863
Full text available online: https://www.mdpi.com/2077-0383/13/10/2863
13. “Once-Weekly Semaglutide Use in Patients with Type 2 Diabetes: Results from the SURE Spain Multicentre, Prospective, Observational Study”
by Virginia Bellido, Cristina Abreu Padín, Andrei-Mircea Catarig, Alice Clark, Sofía Barreto Pittol and Elias Delgado
J. Clin. Med. 2022, 11(17), 4938; https://doi.org/10.3390/jcm11174938
Full text available online: https://www.mdpi.com/2077-0383/11/17/4938
14. “Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment”
by Maria Pompea Antonia Baldassarre, Giulia Di Dalmazi, Sara Coluzzi, Federica Carrieri, Fabrizio Febo, Giorgia Centorame, Piergiuseppe Cassino, Luigi Piacentino, Marco Giorgio Baroni, Agostino Consoli et al.
J. Clin. Med. 2024, 13(11), 3054; https://doi.org/10.3390/jcm13113054
Full text available online: https://www.mdpi.com/2077-0383/13/11/3054
15. “Time-Restricted Eating and Its Metabolic Benefits”
by Sneha Mishra, Patress A. Persons, Andrea M. Lorenzo, Swarna S. Chaliki and Sophie Bersoux
J. Clin. Med. 2023, 12(22), 7007; https://doi.org/10.3390/jcm12227007
Full text available online: https://www.mdpi.com/2077-0383/12/22/7007
To access more journal information, please click the following link: https://www.mdpi.com/journal/jcm.
To access more details about Altmetric, please click here.
JCM Editorial Office
30 July 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Clinical Neurology
We are delighted to share some highly cited papers on clinical neurology that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues in the Section “Clinical Neurology” are currently open for submission.
The following is a list of articles and Special Issues that we believe will interest you.
1. “Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges”
by Zuber Khan, Ghanshyam Das Gupta and Sidharth Mehan
J. Clin. Med. 2023, 12(13), 4274; https://doi.org/10.3390/jcm12134274
Available online: https://www.mdpi.com/2077-0383/12/13/4274
2. “The Impact of Microbiota on the Gut–Brain Axis: Examining the Complex Interplay and Implications”
by Tuba Shahid Chaudhry, Sidhartha Gautam Senapati, Srikanth Gadam, Hari Priya Sri Sai Mannam, Hima Varsha Voruganti, Zainab Abbasi, Tushar Abhinav, Apurva Bhavana Challa, Namratha Pallipamu, Niharika Bheemisetty et al.
J. Clin. Med. 2023, 12(16), 5231; https://doi.org/10.3390/jcm12165231
Available online: https://www.mdpi.com/2077-0383/12/16/5231
3. “Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance”
by Prabhakar Tiwari, Rekha Dwivedi, Manisha Bansal, Manjari Tripathi and Rima Dada
J. Clin. Med. 2023, 12(4), 1650; https://doi.org/10.3390/jcm12041650
Available online: https://www.mdpi.com/2077-0383/12/4/1650
4. “Advances in Therapies to Treat Neonatal Hypoxic-Ischemic Encephalopathy”
by Amaresh K. Ranjan and Anil Gulati
J. Clin. Med. 2023, 12(20), 6653; https://doi.org/10.3390/jcm12206653
Available online: https://www.mdpi.com/2077-0383/12/20/6653
5. “Levodopa-Induced Dyskinesias in Parkinson’s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions”
by Lazzaro di Biase, Pasquale Maria Pecoraro, Simona Paola Carbone, Maria Letizia Caminiti and Vincenzo Di Lazzaro
J. Clin. Med. 2023, 12(13), 4427; https://doi.org/10.3390/jcm12134427
Available online: https://www.mdpi.com/2077-0383/12/13/4427
6. “The Biology of Stress Intolerance in Patients with Chronic Pain—State of the Art and Future Directions”
by Arne Wyns, Jolien Hendrix, Astrid Lahousse, Elke De Bruyne, Jo Nijs, Lode Godderis and Andrea Polli
J. Clin. Med. 2023, 12(6), 2245; https://doi.org/10.3390/jcm12062245
Available online: https://www.mdpi.com/2077-0383/12/6/2245
7. “The Prevalence of Diabetes Mellitus Type II (DMII) in the Multiple Sclerosis Population: A Systematic Review and Meta-Analysis”
by Vasileios Giannopapas, Lina Palaiodimou, Dimitrios Kitsos, Georgia Papagiannopoulou, Konstantina Stavrogianni, Athanasios Chasiotis, Maria Kosmidou, John S. Tzartos, George P. Paraskevas, Daphne Bakalidou et al.
J. Clin. Med. 2023, 12(15), 4948; https://doi.org/10.3390/jcm12154948
Available online: https://www.mdpi.com/2077-0383/12/15/4948
8. “The Putative Role of Neuroinflammation in the Interaction between Traumatic Brain Injuries, Sleep, Pain and Other Neuropsychiatric Outcomes: A State-of-the-Art Review”
by Alberto Herrero Babiloni, Andrée-Ann Baril, Camille Charlebois-Plante, Marianne Jodoin, Erlan Sanchez, Liesbet De Baets, Caroline Arbour, Gilles J. Lavigne, Nadia Gosselin and Louis De Beaumont
J. Clin. Med. 2023, 12(5), 1793; https://doi.org/10.3390/jcm12051793
Available online: https://www.mdpi.com/2077-0383/12/5/1793
9. “The Biology of Chronic Pain and Its Implications for Pain Neuroscience Education: State of the Art”
by Kory Zimney, Wouter Van Bogaert and Adriaan Louw
J. Clin. Med. 2023, 12(13), 4199; https://doi.org/10.3390/jcm12134199
Available online: https://www.mdpi.com/2077-0383/12/13/4199
10. “Peri-Operative Risk Factors Associated with Post-Operative Cognitive Dysfunction (POCD): An Umbrella Review of Meta-Analyses of Observational Studies”
by Nikolaj Travica, Mojtaba Lotfaliany, Andrew Marriott, Seyed A. Safavynia, Melissa M. Lane, Laura Gray, Nicola Veronese, Michael Berk, David Skvarc, Hajara Aslam et al.
J. Clin. Med. 2023, 12(4), 1610; https://doi.org/10.3390/jcm12041610
Available online: https://www.mdpi.com/2077-0383/12/4/1610
11. “Non-Invasive Intracranial Pressure Monitoring”
by Sebastian Johannes Müller, Elina Henkes, Matthew J. Gounis, Stephan Felber, Oliver Ganslandt and Hans Henkes
J. Clin. Med. 2023, 12(6), 2209; https://doi.org/10.3390/jcm12062209
Available online: https://www.mdpi.com/2077-0383/12/6/2209
12. “CNS Ageing in Health and Neurodegenerative Disorders”
by Evangelia Kesidou, Paschalis Theotokis, Olympia Damianidou, Marina Boziki, Natalia Konstantinidou, Charilaos Taloumtzis, Styliani-Aggeliki Sintila, Panagiotis Grigoriadis, Maria Eleptheria Evangelopoulos, Christos Bakirtzis et al.
J. Clin. Med. 2023, 12(6), 2255; https://doi.org/10.3390/jcm12062255
Available online: https://www.mdpi.com/2077-0383/12/6/2255
13. “Pathophysiology of Early Brain Injury and Its Association with Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage: A Review of Current Literature”
by Diana L. Alsbrook, Mario Di Napoli, Kunal Bhatia, Masoom Desai, Archana Hinduja, Clio A. Rubinos, Gelsomina Mansueto, Puneetpal Singh, Gustavo G. Domeniconi, Asad Ikram et al.
J. Clin. Med. 2023, 12(3), 1015; https://doi.org/10.3390/jcm12031015
Available online: https://www.mdpi.com/2077-0383/12/3/1015
14. “Skull-Base Surgery—A Narrative Review on Current Approaches and Future Developments in Surgical Navigation”
by Sharon Tzelnick, Vittorio Rampinelli, Axel Sahovaler, Leonardo Franz, Harley H. L. Chan, Michael J. Daly and Jonathan C. Irish
J. Clin. Med. 2023, 12(7), 2706; https://doi.org/10.3390/jcm12072706
Available online: https://www.mdpi.com/2077-0383/12/7/2706
15. “Hip Surveillance and Management of Hip Displacement in Children with Cerebral Palsy: Clinical and Ethical Dilemmas”
by Jason J. Howard, Kate Willoughby, Pam Thomason, Benjamin J. Shore, Kerr Graham and Erich Rutz
J. Clin. Med. 2023, 12(4), 1651; https://doi.org/10.3390/jcm12041651
Available online: https://www.mdpi.com/2077-0383/12/4/1651
Special Issues |
|
“Review Special Issue Series: Current Advances in Clinical Neurology” |
“Epilepsy: Causes, Symptoms, Diagnosis, and Treatment” |
“Subarachnoid Hemorrhage: Clinical Advances and Challenges” |
“Neurocritical Care: New Insights and Challenges” |
“Clinical Advances in Traumatic Brain Injury” |
“Clinical Advances in Spinal Cord Injury” |
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
30 July 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Gastroenterology & Hepatopancreatobiliary Medicine
We are delighted to share some highly cited papers on gastroenterology and hepatopancreatobiliary medicine that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues in the Section “Gastroenterology & Hepatopancreatobiliary Medicine” are currently open for submission.
The following is a list of articles and Special Issues that we believe will interest you.
1. “Early Management of Severe Biliary Infection in the Era of the Tokyo Guidelines”
by Esther Nve, Josep M. Badia, Mireia Amillo-Zaragüeta, Montserrat Juvany, Mónica Mourelo-Fariña and Rosa Jorba
J. Clin. Med. 2023, 12(14), 4711; https://doi.org/10.3390/jcm12144711
Available online: https://www.mdpi.com/2077-0383/12/14/4711
2. “Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective”
by Wayne Eskridge, Donna R. Cryer, Jörn M. Schattenberg, Amalia Gastaldelli, Harmeet Malhi, Alina M. Allen, Mazen Noureddin and Arun J. Sanyal
J. Clin. Med. 2023, 12(19), 6216; https://doi.org/10.3390/jcm12196216
Available online: https://www.mdpi.com/2077-0383/12/19/6216
3. “Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment”
by Stefano Ciardullo, Michela Vergani and Gianluca Perseghin
J. Clin. Med. 2023, 12(17), 5597; https://doi.org/10.3390/jcm12175597
Available online: https://www.mdpi.com/2077-0383/12/17/5597
4. “Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis”
by Sarah Bencardino, Ferdinando D’Amico, Ilaria Faggiani, Francesca Bernardi, Mariangela Allocca, Federica Furfaro, Tommaso Lorenzo Parigi, Alessandra Zilli, Gionata Fiorino, Laurent Peyrin-Biroulet et al.
J. Clin. Med. 2023, 12(15), 5014; https://doi.org/10.3390/jcm12155014
Available online: https://www.mdpi.com/2077-0383/12/15/5014
5. “Risk for Esophageal Cancer Based on Lifestyle Factors–Smoking, Alcohol Consumption, and Body Mass Index: Insight from a South Korean Population Study in a Low-Incidence Area”
by Mi Jung Kwon, Ho Suk Kang, Hyo Geun Choi, Joo-Hee Kim, Ji Hee Kim, Woo Jin Bang, Sung Kwang Hong, Nan Young Kim, Sangkyoon Hong and Hong Kyu Lee
J. Clin. Med. 2023, 12(22), 7086; https://doi.org/10.3390/jcm12227086
Available online: https://www.mdpi.com/2077-0383/12/22/7086
6. “The Latest Advancements in Diagnostic Role of Endosonography of Pancreatic Lesions”
by Jagoda Oliwia Rogowska, Łukasz Durko and Ewa Malecka-Wojciesko
J. Clin. Med. 2023, 12(14), 4630; https://doi.org/10.3390/jcm12144630
Available online: https://www.mdpi.com/2077-0383/12/14/4630
7. “Personalized Risk Assessment of Hepatic Fibrosis after Cholecystectomy in Metabolic-Associated Steatotic Liver Disease: A Machine Learning Approach”
by Miguel Suárez, Raquel Martínez, Ana María Torres, Antonio Ramón, Pilar Blasco and Jorge Mateo
J. Clin. Med. 2023, 12(20), 6489; https://doi.org/10.3390/jcm12206489
Available online: https://www.mdpi.com/2077-0383/12/20/6489
8. “Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights”
by Giusi Desirè Sciumè, Ginevra Berti, Christian Lambiase, Italia Paglianiti, Vincenzo Villanacci, Francesco Rettura, Antonio Grosso, Angelo Ricchiuti, Nicola de Bortoli, Paolo Usai Satta et al.
J. Clin. Med. 2023, 12(18), 5787; https://doi.org/10.3390/jcm12185787
Available online: https://www.mdpi.com/2077-0383/12/18/5787
9. “Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP”
by Cristina Rubín de Célix, Javier Martín-de-Carpi, Gemma Pujol-Muncunill, Laura María Palomino, Marta Velasco Rodríguez-Belvís, Rafael Martín-Masot, Víctor Manuel Navas-López, Elena Ricart, María José Casanova, Alejandro Rodríguez-Martínez et al.
J. Clin. Med. 2023, 12(14), 4813; https://doi.org/10.3390/jcm12144813
Available online: https://www.mdpi.com/2077-0383/12/14/4813
10. “Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review”
by Sofia D. Shaikh, Natalie Sun, Andrew Canakis, William Y. Park and Horst Christian Weber
J. Clin. Med. 2023, 12(7), 2558; https://doi.org/10.3390/jcm12072558
Available online: https://www.mdpi.com/2077-0383/12/7/2558
11. “Non-Alcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression”
by Ramiro Manzano-Nunez, Marta Santana-Dominguez, Jesus Rivera-Esteban, Clara Sabiote, Elena Sena, Juan Bañares, Frank Tacke and Juan M. Pericàs
J. Clin. Med. 2023, 12(3), 856; https://doi.org/10.3390/jcm12030856
Available online: https://www.mdpi.com/2077-0383/12/3/856
12. “What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)”
by Marcin Kosmalski, Rafał Frankowski, Sylwia Ziółkowska, Monika Różycka-Kosmalska and Tadeusz Pietras
J. Clin. Med. 2023, 12(5), 1852; https://doi.org/10.3390/jcm12051852
Available online: https://www.mdpi.com/2077-0383/12/5/1852
13. “Introducing Machine Perfusion into Routine Clinical Practice for Liver Transplantation in the United States: The Moment Has Finally Come”
by Kristopher P. Croome
J. Clin. Med. 2023, 12(3), 909; https://doi.org/10.3390/jcm12030909
Available online: https://www.mdpi.com/2077-0383/12/3/909
14. “The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis”
by Ming-Cheng Guan, Shi-Yu Zhang, Qian Ding, Na Li, Ting-Ting Fu, Gui-Xia Zhang, Qian-Qian He, Feng Shen, Tian Yang and Hong Zhu
J. Clin. Med. 2023, 12(3), 949; https://doi.org/10.3390/jcm12030949
Available online: https://www.mdpi.com/2077-0383/12/3/949
15. “Overview of Chemotherapy for Gastric Cancer”
by Yasushi Sato, Koichi Okamoto, Yoshifumi Kida, Yasuhiro Mitsui, Yutaka Kawano, Masahiro Sogabe, Hiroshi Miyamoto and Tetsuji Takayama
J. Clin. Med. 2023, 12(4), 1336; https://doi.org/10.3390/jcm12041336
Available online: https://www.mdpi.com/2077-0383/12/4/1336
Special Issues |
|
“Gastric Cancer: Diagnosis, Treatment and Prevention” |
“Updates in Liver Cirrhosis” |
“Diagnosis, Treatment, and Management of Gastrointestinal Oncology” |
“Editorial Board Members’ Collection Series: Inflammatory Bowel Disease” |
“Ulcers after Bariatric Surgery” |
“Advances in Diagnosis and Management of Pancreatobiliary Disorders” |
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
29 July 2024
Meet Us at the ESC Congress 2024, 30 August–2 September 2024, London, UK
MDPI will attend the ESC Congress 2024, held in London, UK, from 30 August to 2 September 2024, at booth #G 160. We invite researchers from different backgrounds to visit and share their latest ideas with us.
The Spotlight of the ESC Congress 2024 will be “Personalising Cardiovascular Care”, a topic devoted to empowering patients through tailored treatments to improve outcomes, reduce risk, and redefine the standard of care.
The following MDPI journals will be represented:
- Medicina;
- JCM;
- Healthcare;
- IJTM;
- Diseases;
- IJERPH;
- Genes;
- Clinics and Practice;
- Medicines;
- EJIHPE;
- Cardiogenetics.
If you are participating in this conference, please feel free to contact us online prior to attendance. Our delegates look forward to meeting you in person at booth #G 160 and answering any questions you may have. For more information regarding the conference, please visit the following link: https://www.escardio.org/Congresses-Events/ESC-Congress.
29 July 2024
Interview with Dr. Ferdinando D'Amico—Winner of the Journal of Clinical Medicine 2024 Travel Award
Dr. Ferdinando D'Amico is a gastroenterologist in the Gastroenterology and Digestive Endoscopy Department of the IRCCS San Raffaele Hospital (Milan, Italy) directed by Prof. Silvio Danese. After graduating in medicine from the Catholic University of Rome in 2015, he obtained a specialization in gastroenterology at the Humanitas University of Milan in 2020. In 2024, he obtained his Ph.D. in “Histology in inflammatory bowel diseases” at the Humanitas University of Milan. He is mainly interested in chronic inflammatory bowel diseases (Crohn’s disease and ulcerative colitis). He is the author and co-author of more than 150 scientific articles published in international journals and book chapters. He consistently participates as a speaker at international congresses and conferences.
The following is a short interview with Dr. Ferdinando D'Amico:
1. As the winner of this award, is there anything you would like to express?
Yes, I want to thank JCM for this opportunity, which allowed me to disseminate my research data at an international conference and interface with experts from all over the world.
2. Did you promote the journal at the conference? In addition, how do you prefer to share the journal with your community?
Yes, I promoted the journal at the conference by clearly specifying in my poster that “Travel expenses were partially covered by the Travel Award sponsored by the open access Journal of Clinical Medicine published by MDPI”.
.
3. Where do you obtain journal award participation information? In your previous cooperation with JCM and MDPI, what impressed you most?
I received information about the journal award through an email from the journal. Regarding JCM, I appreciate two things in particular: the articles are reviewed very quickly and the time between submission and publication is very short.
4. Could you briefly introduce your current research to our readers?
I am a gastroenterologist at the IRCCS San Raffaele Hospital in Milan (Italy). I mainly deal with clinical research. My main research topics are the role of histology in IBD, new endpoints for IBD, the role of fecal calprotectin in patient management, and the efficacy and safety of new drugs.
5. Which research topics do you think will be of particular interest to the research community in the coming years?
In the coming years, I believe there will be increasingly greater attention toward achieving composite endpoints that can allow greater disease control. To achieve this objective, there will be increasingly greater attention to tight control through the use of non-invasive tools such as intestinal ultrasound and combination strategies of multiple advanced drugs (dual therapy) will be increasingly frequent and will be used increasingly earlier in the therapeutic algorithm of patients with IBD.
6. Which qualities do you think young researchers need?
I believe that a young researcher must first and foremost be in love with what they do. Passion is the key element that drives research. They must have patience as the search does not provide results in a short time and they must have great willpower.
7. JCM is an open access (OA) journal. What is your opinion of the open access model of publishing?
Open access is a method that allows for the simple and rapid dissemination of scientific articles. In fact, everyone has access to published works.
More information about journal awards can be found at the following link: https://www.mdpi.com/journal/jcm/awards.
26 July 2024
Meet Us at the 22nd Congress of the International Society for Burn Injuries (ISBI) and the 55th Annual Meeting of the British Burn Association (BBA), 18–22 August 2024, Birmingham, UK
MDPI will be attending the 22nd Congress of the International Society for Burn Injuries (ISBI) and the 55th Annual Meeting of the British Burn Association (BBA) in Birmingham, UK, from 18 to 22 August 2024. The 2024 ISBI/BBA Congress is organized to continue to promote the concept of “one world and one standard of burn care” for people suffering as a result of a thermal injury.
The following MDPI journals will be represented:
If you are planning to attend the conference, please do visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://worldburn.org/events/7/2024_isbibba_congress.
22 July 2024
Journal of Clinical Medicine 2024 Editor of Distinction Award—Open for Applications
The success and esteemed reputation of Journal of Clinical Medicine (JCM, ISSN: 2077-0383) owe much to the dedication of the Editorial Board Members. The Editorial Office deeply appreciates the hard work and commitment of our editors. We hereby launch the JCM 2024 Editor of Distinction Award. An evaluation committee, led by the journal’s Editors-in-Chief, Prof. Dr. Emmanuel Andrès and Prof. Dr. Kent Doi, will be responsible for selecting the winners based on their activities and contributions to the successful development and maintenance of high-quality standards throughout 2024.
Prizes:
- One first prize: CHF 1500 and a certificate;
- Two second prizes: CHF 1000 and a certificate each;
- Three third prizes: CHF 500 and a certificate each.
Eligibility for the Award:
All Editorial Board Members, excluding Editors-in-Chief and Section Editors-in-Chief.
Contributions in 2024 qualify Editorial Board Members for the award.
Schedule:
Application deadline: 31 January 2025.
Winner announcement: 30 June 2025.
How to Submit Applications?
Please download the application form HERE to briefly describe your contributions as a journal editor and in journal promotion, then send it to the JCM Editorial Office ([email protected], and copy in [email protected]).
You can access more awards information here: https://www.mdpi.com/journal/jcm/awards.
JCM Editorial Office
10 July 2024
MDPI's Newly Launched Journals in June 2024
Five new journals covering multiple subjects have launched their inaugural issue in June 2024. We are excited to be able to share with you the newest research rooted in the value of open access.
We would like to express our deepest appreciation to all the Editorial Board Members and each journal will ensure its high-quality output using excellent editorial and rigorous peer review processes, to ensure that the articles achieve high impact and visibility.
Please feel free to browse and discover more about the new journals below.
Journal |
Founding Editor-in-Chief |
Journal Topics (Selected) |
Prof. Dr. Marco Ranucci, IRCCS Policlinico San Donato, Italy |
anaesthetic medications; blood and fluid management; pain management; critical care; critical illness | view journal scope | submit an article |
|
Dr. Giovanni E. Cacciamani, University of Southern California, USA |
surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article |
|
Prof. Dr. Gassan Hodaifa, Universidad Pablo de Olavide, Spain |
laboratory management; laboratory safety; protective equipment; laboratory problems and challenges; laboratory Innovation | view journal scope | submit an article |
|
Prof. Dr. Jan S. Suchodolski, Texas A&M University, USA |
companion animals health and disease; veterinary care and nutrition; genetics and genomics; behavior and welfare; human-animal relations | view journal scope | submit an article |
|
Prof. Dr. Pierfrancesco De Paola, University of Naples Federico II, Italy |
real estate appraisal; economic and financial valuation of real estate projects; sustainable real estate; housing and urban economics | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee ([email protected]) if you would like to create more new journals.
2 July 2024
Journal of Clinical Medicine Receives an Updated Impact Factor of 3.0
We are pleased to share that Journal of Clinical Medicine (JCM, ISSN: 2077-0383,) was awarded an updated Impact Factor of 3.0 in the 2023 Journal Citation Reports™ released by Clarivate in June 2024. JCM ranks Q1 (58 among 325 titles) in the “Medicine, General & Internal” category.
3.02023 Impact Factor |
58/325 (Q1)Medicine, General & Internal |
75,455Citations in 2023 |
For further statistics, please visit: https://www.mdpi.com/journal/jcm/stats. For more information about MDPI flagship journals’ citation metrics, please see here.
The support and dedication of all editors, reviewers, authors, and readers are an integral part of the journal’s performance. We would like to take this opportunity to thank everyone who has contributed to the journal.
Our journals have received over 13 million citations in the Web of Science, making us the most cited open access publisher. With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services.
JCM Editorial Office
2 July 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Cardiovascular Medicine
We are delighted to share some highly cited papers on cardiovascular medicine that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues on this topic are currently open for submission.
The following is a list of articles and Special Issues that we believe will interest you.
1. “Management of Coronary Artery Disease in Older Adults: Recent Advances and Gaps in Evidence”
by Stefano Cacciatore, Luigi Spadafora, Marco Bernardi, Mattia Galli, Matteo Betti, Francesco Perone, Giulia Nicolaio, Emanuele Marzetti, Anna Maria Martone, Francesco Landi et al.
J. Clin. Med. 2023, 12(16), 5233; https://doi.org/10.3390/jcm12165233
Available online: https://www.mdpi.com/2077-0383/12/16/5233
2. “The Impact of Physical Activity and Inactivity on Cardiovascular Risk across Women’s Lifespan: An Updated Review”
by Valentina Bucciarelli, Anna Vittoria Mattioli, Susanna Sciomer, Federica Moscucci, Giulia Renda and Sabina Gallina
J. Clin. Med. 2023, 12(13), 4347; https://doi.org/10.3390/jcm12134347
Available online: https://www.mdpi.com/2077-0383/12/13/4347
3. “Blood Count-Derived Inflammatory Markers and Acute Complications of Ischemic Heart Disease in Elderly Women”
by Ewelina A. Dziedzic, Jakub S. Gąsior, Agnieszka Tuzimek and Wacław Kochman
J. Clin. Med. 2023, 12(4), 1369; https://doi.org/10.3390/jcm12041369
Available online: https://www.mdpi.com/2077-0383/12/4/1369
4. “Desmoplakin Cardiomyopathy: Comprehensive Review of an Increasingly Recognized Entity”
by Mariana Brandão, Riccardo Bariani, Ilaria Rigato and Barbara Bauce
J. Clin. Med. 2023, 12(7), 2660; https://doi.org/10.3390/jcm12072660
Available online: https://www.mdpi.com/2077-0383/12/7/2660
5. “Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence”
by Athina Dimosiari, Dimitrios Patoulias, George D. Kitas and Theodoros Dimitroulas
J. Clin. Med. 2023, 12(4), 1302; https://doi.org/10.3390/jcm12041302
Available online: https://www.mdpi.com/2077-0383/12/4/1302
6. “Finerenone: Questions and Answers—The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist”
by Luca Di Lullo, Carlo Lavalle, Alessia Scatena, Marco Valerio Mariani, Claudio Ronco and Antonio Bellasi
J. Clin. Med. 2023, 12(12), 3992; https://doi.org/10.3390/jcm12123992
Available online: https://www.mdpi.com/2077-0383/12/12/3992
7. “Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice”
by Giosiana Bosco, Francesco Di Giacomo Barbagallo, Salvatore Spampinato, Lorena Lanzafame, Antonino Di Pino, Salvatore Piro, Francesco Purrello and Roberto Scicali
J. Clin. Med. 2023, 12(6), 2444; https://doi.org/10.3390/jcm12062444
Available online: https://www.mdpi.com/2077-0383/12/6/2444
8. “Left Bundle Branch Area Pacing and Atrioventricular Node Ablation in a Single-Procedure Approach for Elderly Patients with Symptomatic Atrial Fibrillation”
by Jesse H. J. Rijks, Theo Lankveld, Randolph Manusama, Bernard Broers, Antonius M. W. van Stipdonk, Sevasti Maria Chaldoupi, Rachel M. A. ter Bekke, Ulrich Schotten, Dominik Linz, Justin G. L. M. Luermans et al.
J. Clin. Med. 2023, 12(12), 4028; https://doi.org/10.3390/jcm12124028
Available online: https://www.mdpi.com/2077-0383/12/12/4028
9. “Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios”
by Fabiana Lucà, Fabrizio Oliva, Maurizio Giuseppe Abrignani, Stefania Angela Di Fusco, Iris Parrini, Maria Laura Canale, Simona Giubilato, Stefano Cornara, Martina Nesti, Carmelo Massimiliano Rao et al.
J. Clin. Med. 2023, 12(18), 5955; https://doi.org/10.3390/jcm12185955
Available online: https://www.mdpi.com/2077-0383/12/18/5955
10. “Predicting Six-Month Re-Admission Risk in Heart Failure Patients Using Multiple Machine Learning Methods: A Study Based on the Chinese Heart Failure Population Database”
by Shiyu Chen, Weiwei Hu, Yuhui Yang, Jiaxin Cai, Yaqi Luo, Lingmin Gong, Yemian Li, Aima Si, Yuxiang Zhang, Sitong Liu et al.
J. Clin. Med. 2023, 12(3), 870; https://doi.org/10.3390/jcm12030870
Available online: https://www.mdpi.com/2077-0383/12/3/870
11. “The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis”
by Cormac Kennedy, Peter Hayes, Sulafa Salama, Martina Hennessy and Federica Fogacci
J. Clin. Med. 2023, 12(3), 772; https://doi.org/10.3390/jcm12030772
Available online: https://www.mdpi.com/2077-0383/12/3/772
12. “Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets”
by Angelo Silverio, Francesco Paolo Cancro, Luca Esposito, Michele Bellino, Debora D’Elia, Monica Verdoia, Maria Giovanna Vassallo, Michele Ciccarelli, Carmine Vecchione, Gennaro Galasso et al.
J. Clin. Med. 2023, 12(6), 2161; https://doi.org/10.3390/jcm12062161
Available online: https://www.mdpi.com/2077-0383/12/6/2161
13. “Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling”
by Jason Stencel, Hamid R. Alai, Aneesh Dhore-patil, Daniela Urina-Jassir and Thierry H. Le Jemtel
J. Clin. Med. 2023, 12(9), 3341; https://doi.org/10.3390/jcm12093341
Available online: https://www.mdpi.com/2077-0383/12/9/3341
14. “Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)”
by Ivan J. Núñez-Gil, Gisela Feltes, María C. Viana-Llamas, Sergio Raposeiras-Roubin, Rodolfo Romero, Emilio Alfonso-Rodríguez, Aitor Uribarri, Francesco Santoro, Víctor Becerra-Muñoz, Martino Pepe et al.
J. Clin. Med. 2023, 12(2), 706; https://doi.org/10.3390/jcm12020706
Available online: https://www.mdpi.com/2077-0383/12/2/706
15. “Effectiveness of Telemedicine for Reducing Cardiovascular Risk: A Systematic Review and Meta-Analysis”
by Jesús Jaén-Extremera, Diego Fernando Afanador-Restrepo, Yulieth Rivas-Campo, Alejandro Gómez-Rodas, Agustín Aibar-Almazán, Fidel Hita-Contreras, María del Carmen Carcelén-Fraile, Yolanda Castellote-Caballero and Raúl Ortiz-Quesada
J. Clin. Med. 2023, 12(3), 841; https://doi.org/10.3390/jcm12030841
Available online: https://www.mdpi.com/2077-0383/12/3/841
Special Issues |
|
“Prevalence and Risk Factors of Obesity and Hypertension” |
“Primary and Secondary Cardiovascular Disease Risk Factors, Prevention and Therapy” |
“New Perspectives in Cardiothoracic Surgery” |
“Diagnosis, Monitoring, and Treatment of Myocardial Infarction” |
“Advances in Clinical Cardiovascular Magnetic Resonance Imaging” |
“Clinical Updates on the Aortic Aneurysm and Aortic Dissection” |
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
2 July 2024
Prof. Kent Doi Appointed Co-Editor-in-Chief of Journal of Clinical Medicine
We are delighted to announce that Prof. Kent Doi has accepted our invitation to assume the role of Co-Editor-in-Chief of Journal of Clinical Medicine (JCM, ISSN: 2077-0383). With his extensive background in scientific research and publishing and his unwavering commitment to clinical excellence, Prof. Doi brings a wealth of knowledge and expertise to this prestigious position. JCM is one of the world’s leading medical journals. Prof. Doi will work closely with his fellow Co-Editor-in-Chief, Prof. Dr. Emmanuel Andrès, to build on its legacy and take the journal to new levels of insight and influence.
Prof. Kent Doi is a professor at the University of Tokyo Hospital in Tokyo, Japan, and Chairman of the hospital’s Department of Emergency and Critical Care Medicine. He received his M.D., Ph.D. and residency training at the University of Tokyo Hospital. This was followed by research work in nephrology at Japan’s National Institutes of Health / the National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) from 2005 to 2007. Between 2008 and 2021, Prof. Doi occupied the positions of Assistant Professor, Lecturer, and Associate Professor at the University of Tokyo Hospital.
At the University of Tokyo today, Prof. Doi is a clinical and basic research investigator. His research interests include sepsis, multiple organ failure, acute kidney injury, and blood purification. Prof. Doi is a Fellow of the Japanese Society of Internal Medicine (FJSIM) as well as a Councilor and Board-Certified Nephrologist of the Japanese Society of Nephrology (JSN) and of the Japanese Society of Intensive Care Medicine (JSICM). Known for his strict focus on patient well-being, he is very active internationally, maintaining regular contact with an extensive network of clinical specialists around the world.
We are very much looking forward to working with Prof. Doi. He can rely on the best support from our editorial team, and we wish him every success in his new position. For more information on Prof. Doi’s vision for JCM, please see the editorial “In Pursuit of Transformational Clinical Solutions”.
JCM Editorial Office
20 June 2024
2023 Impact Factors for MDPI Journals Released
MDPI is pleased to announce the inclusion of 237 journals in the 2024 release of the Journal Citation Reports (JCR) and share the key results (see above).
This year, journals covered in the Emerging Sources Citation Index (ESCI) received category ranks together with journals in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI). Overall, 139 MDPI journals indexed in ESCI are included in the new unified rankings for the first time.
Enhanced Comparability of Data
According to Clarivate, "the creation of unified category rankings [provides] a simpler and more complete category view for the evaluation of journal performance. [...] The category-first approach simplifies journal performance assessment with a holistic view of all journals in each subject category."
We are thrilled to announce that 72% of our ranked MDPI journals (171 of 237) are above average, in Q1 or Q2. Twenty-nine of our journals received their first Impact Factor this year, accounting for more than 5% of the journals accepted into the Web of Science last year.
MDPI Journals Ranked in JCR
The following data includes all MDPI journals indexed in SCIE, SSCI, ESCI and AHCI.
Journal |
Impact Factor |
Rank Quartile |
Category |
Q3 |
Acoustics |
||
Q2 |
Engineering, Mechanical |
||
Q2 |
Instruments & Instrumentation |
||
Q2 |
Management |
||
Q3 |
Respiratory System |
||
Q2 |
Engineering, Aerospace |
||
Q1 |
Agronomy |
||
Q2 |
Agricultural Engineering |
||
Q1 |
Agronomy |
||
Q1 |
Plant Sciences |
||
Q2 |
Computer Science, Artificial Intelligence |
||
Q2 |
Computer Science, Interdisciplinary Applications |
||
Q3 |
Computer Science, Artificial Intelligence |
||
Q2 |
Computer Science, Theory & Methods |
||
Q1 |
Agriculture, Dairy & Animal Science |
||
Q1 |
Veterinary Sciences |
||
Q1 |
Infectious Diseases |
||
Q1 |
Pharmacology & Pharmacy |
||
Q3 |
Immunology |
||
Q1 |
Biochemistry & Molecular Biology |
||
Q1 |
Chemistry, Medicinal |
||
Q1 |
Food Science & Technology |
||
Q2 |
Chemistry, Multidisciplinary |
||
Q1 |
Engineering, Multidisciplinary |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q2 |
Physics, Applied |
||
Q2 |
Computer Science, Information Systems |
||
Q2 |
Engineering, Electrical & Electronic |
||
Q2 |
Telecommunications |
||
N/A |
Humanities, Multidisciplinary |
||
Q3 |
Environmental Sciences |
||
Q3 |
Meteorology & Atmospheric Sciences |
||
Q3 |
Physics, Atomic, Molecular & Chemical |
||
Q1 |
Audiology & Speech-language Pathology |
||
Q1 |
Mathematics, Applied |
||
Q2 |
Electrochemistry |
||
Q2 |
Energy & Fuels |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q2 |
Psychology, Multidisciplinary |
||
Q2 |
Food Science & Technology |
||
Q2 |
Computer Science, Artificial Intelligence |
||
Q2 |
Computer Science, Information Systems |
||
Q1 |
Computer Science, Theory & Methods |
||
Q2 |
Engineering, Biomedical |
||
Q1 |
Biology |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q2 |
Medicine, Research & Experimental |
||
Q1 |
Pharmacology & Pharmacy |
||
Q1 |
Engineering, Multidisciplinary |
||
Q3 |
Materials Science, Biomaterials |
||
Q1 |
Biochemistry & Molecular Biology |
||
Q1 |
Chemistry, Analytical |
||
Q1 |
Instruments & Instrumentation |
||
Q2 |
Nanoscience & Nanotechnology |
||
Q3 |
Biotechnology & Applied Microbiology |
||
Q1 |
Ornithology |
||
Q3 |
Neurosciences |
||
Q2 |
Construction & Building Technology |
||
Q2 |
Engineering, Civil |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q1 |
Oncology |
||
Q4 |
Cardiac & Cardiovascular Systems |
||
Q2 |
Chemistry, Physical |
||
Q2 |
Cell Biology |
||
Q1 |
Materials Science, Ceramics |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q2 |
Engineering, Chemical |
||
Q3 |
Chemistry, Multidisciplinary |
||
Q2 |
Chemistry, Analytical |
||
Q2 |
Electrochemistry |
||
Q1 |
Instruments & Instrumentation |
||
Q2 |
Pediatrics |
||
Q2 |
Engineering, Environmental |
||
Q2 |
Environmental Sciences |
||
Q3 |
Green & Sustainable Science & Technology |
||
Q2 |
Meteorology & Atmospheric Sciences |
||
Q2 |
Medicine, General & Internal |
||
Q3 |
Clinical Neurology |
||
Q3 |
Neurosciences |
||
Q2 |
Materials Science, Coatings & Films |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q2 |
Physics, Applied |
||
Q3 |
Chemistry, Physical |
||
Q2 |
Mathematics, Interdisciplinary Applications |
||
Q2 |
Computer Science, Interdisciplinary Applications |
||
Q3 |
Physics, Condensed Matter |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q2 |
Dermatology |
||
Q3 |
Computer Science, Information Systems |
||
Q2 |
Computer Science, Theory & Methods |
||
Q2 |
Crystallography |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q3 |
Biochemistry & Molecular Biology |
||
Q2 |
Oncology |
||
Q3 |
Computer Science, Information Systems |
||
Q2 |
Multidisciplinary Sciences |
||
Q2 |
Dentistry, Oral Surgery & Medicine |
||
Q3 |
Dermatology |
||
Q3 |
Endocrinology & Metabolism |
||
Q1 |
Medicine, General & Internal |
||
Q2 |
Medicine, Research & Experimental |
||
Q2 |
Biodiversity Conservation |
||
Q3 |
Ecology |
||
Q1 |
Remote Sensing |
||
Q3 |
Environmental Sciences |
||
Q3 |
Geosciences, Multidisciplinary |
||
Q3 |
Ecology |
||
Q3 |
Economics |
||
Q2 |
Economics |
||
Q1 |
Education & Educational Research |
||
Q2 |
Computer Science, Information Systems |
||
Q2 |
Engineering, Electrical & Electronic |
||
Q2 |
Physics, Applied |
||
Q3 |
Energy & Fuels |
||
Q2 |
Physics, Multidisciplinary |
||
Q2 |
Environmental Sciences |
||
Q3 |
Genetics & Heredity |
||
Q4 |
Critical Care Medicine |
||
Q4 |
Dermatology |
||
European Journal of Investigation in Health Psychology and Education |
Q1 |
Psychology, Clinical |
|
Q2 |
Biotechnology & Applied Microbiology |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q2 |
Ecology |
||
Q1 |
Forestry |
||
Q2 |
Fisheries |
||
Q2 |
Marine & Freshwater Biology |
||
Q3 |
Mechanics |
||
Q3 |
Physics, Fluids & Plasmas |
||
Q1 |
Food Science & Technology |
||
Q2 |
Multidisciplinary Sciences |
||
Q1 |
Forestry |
||
Q1 |
Mathematics, Interdisciplinary Applications |
||
Q3 |
Energy & Fuels |
||
Q3 |
Engineering, Chemical |
||
Q2 |
Computer Science, Information Systems |
||
Q2 |
Astronomy & Astrophysics |
||
Q4 |
Economics |
||
Q4 |
Mathematics, Interdisciplinary Applications |
||
Q4 |
Social Sciences, Mathematical Methods |
||
Q3 |
Gastroenterology & Hepatology |
||
Q4 |
Gastroenterology & Hepatology |
||
Q1 |
Polymer Science |
||
Q3 |
Ethnic Studies |
||
Q4 |
Family Studies |
||
Q3 |
Sociology |
||
Q2 |
Genetics & Heredity |
||
Q2 |
Geosciences, Multidisciplinary |
||
Q3 |
Geriatrics & Gerontology |
||
Q2 |
Health Care Sciences & Services |
||
Q2 |
Health Policy & Services |
||
Q4 |
Hematology |
||
Q4 |
Hematology |
||
N/A |
Humanities, Multidisciplinary |
||
Q2 |
Multidisciplinary Sciences |
||
Q1 |
Horticulture |
||
N/A |
Humanities, Multidisciplinary |
||
Q2 |
Water Resources |
||
Q4 |
Immunology |
||
Q2 |
Infectious Diseases |
||
Q2 |
Computer Science, Interdisciplinary Applications |
||
Q3 |
Computer Science, Information Systems |
||
Q2 |
Construction & Building Technology |
||
Q2 |
Engineering, Civil |
||
Q2 |
Transportation Science & Technology |
||
Q2 |
Chemistry, Inorganic & Nuclear |
||
Q1 |
Entomology |
||
Q2 |
Business, Finance |
||
Q1 |
Biochemistry & Molecular Biology |
||
Q2 |
Chemistry, Multidisciplinary |
||
Q1 |
Genetics & Heredity |
||
Q1 |
Pediatrics |
||
International Journal of Turbomachinery Propulsion and Power |
Q2 |
Engineering, Aerospace |
|
Q3 |
Engineering, Mechanical |
||
Q2 |
Engineering, Multidisciplinary |
||
Q2 |
Computer Science, Information Systems |
||
Q2 |
Geography, Physical |
||
Q2 |
Remote Sensing |
||
Q2 |
Cardiac & Cardiovascular Systems |
||
Q1 |
Medicine, General & Internal |
||
Q2 |
Materials Science, Composites |
||
Q3 |
Developmental Biology |
||
Q1 |
Engineering, Biomedical |
||
Q2 |
Materials Science, Biomaterials |
||
Q1 |
Sport Sciences |
||
Q2 |
Microbiology |
||
Q1 |
Mycology |
||
Q3 |
Imaging Science & Photographic Technology |
||
Q1 |
Psychology, Multidisciplinary |
||
Q3 |
Engineering, Electrical & Electronic |
||
Q2 |
Engineering, Manufacturing |
||
Q1 |
Engineering, Mechanical |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q1 |
Engineering, Marine |
||
Q2 |
Engineering, Ocean |
||
Q2 |
Oceanography |
||
Q2 |
Health Care Sciences & Services |
||
Q1 |
Medicine, General & Internal |
||
Q2 |
Computer Science, Information Systems |
||
Q2 |
Telecommunications |
||
Journal of Theoretical and Applied Electronic Commerce Research |
Q1 |
Business |
|
Q1 |
Toxicology |
||
Q2 |
Biodiversity Conservation |
||
Q2 |
Communication |
||
Q2 |
Environmental Studies |
||
N/A |
Language & Linguistics |
||
Q2 |
Linguistics |
||
Q1 |
Law |
||
Q1 |
Biology |
||
Q2 |
Management |
||
Q2 |
Operations Research & Management Science |
||
Q2 |
Engineering, Mechanical |
||
Q2 |
Computer Science, Artificial Intelligence |
||
Q2 |
Computer Science, Interdisciplinary Applications |
||
Q2 |
Engineering, Electrical & Electronic |
||
Q3 |
Engineering, Electrical & Electronic |
||
Q2 |
Engineering, Mechanical |
||
Q2 |
Chemistry, Inorganic & Nuclear |
||
Q3 |
Chemistry, Physical |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q1 |
Chemistry, Medicinal |
||
Q1 |
Pharmacology & Pharmacy |
||
Q3 |
Chemistry, Physical |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q1 |
Metallurgy & Metallurgical Engineering |
||
Q2 |
Physics, Applied |
||
Q2 |
Physics, Condensed Matter |
||
Q2 |
Mathematics, Interdisciplinary Applications |
||
Q1 |
Mathematics |
||
Q1 |
Medicine, General & Internal |
||
Q2 |
Chemistry, Physical |
||
Q2 |
Engineering, Chemical |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q2 |
Polymer Science |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q2 |
Metallurgy & Metallurgical Engineering |
||
Q3 |
Biochemical Research Methods |
||
Q3 |
Microbiology |
||
Q2 |
Chemistry, Analytical |
||
Q2 |
Instruments & Instrumentation |
||
Q3 |
Nanoscience & Nanotechnology |
||
Q2 |
Physics, Applied |
||
Q2 |
Microbiology |
||
Q2 |
Geochemistry & Geophysics |
||
Q2 |
Mineralogy |
||
Q2 |
Mining & Mineral Processing |
||
Q3 |
Engineering, Multidisciplinary |
||
Q4 |
Chemistry, Organic |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q2 |
Chemistry, Multidisciplinary |
||
Q3 |
Computer Science, Artificial Intelligence |
||
Q2 |
Computer Science, Cybernetics |
||
Q3 |
Computer Science, Information Systems |
||
Q2 |
Chemistry, Multidisciplinary |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q2 |
Nanoscience & Nanotechnology |
||
Q2 |
Physics, Applied |
||
Q2 |
Clinical Neurology |
||
Q3 |
Clinical Neurology |
||
Q4 |
Neurosciences |
||
Q4 |
Environmental Sciences |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q2 |
Genetics & Heredity |
||
Q1 |
Nursing |
||
Q1 |
Nutrition & Dietetics |
||
Q3 |
Marine & Freshwater Biology |
||
Q3 |
Oceanography |
||
Q4 |
Optics |
||
Q3 |
Chemistry, Organic |
||
Q3 |
Astronomy & Astrophysics |
||
Q2 |
Physics, Nuclear |
||
Q3 |
Physics, Particles & Fields |
||
Q2 |
Microbiology |
||
Q2 |
Pathology |
||
Q3 |
Pediatrics |
||
Q2 |
Chemistry, Medicinal |
||
Q1 |
Pharmacology & Pharmacy |
||
Q1 |
Pharmacology & Pharmacy |
||
Q3 |
Pharmacology & Pharmacy |
||
Q2 |
History & Philosophy of Science |
||
N/A |
Philosophy |
||
Q2 |
Optics |
||
Q2 |
Physics, Multidisciplinary |
||
Q1 |
Plant Sciences |
||
Q3 |
Physics, Fluids & Plasmas |
||
Q1 |
Polymer Science |
||
Q1 |
Polymer Science |
||
Q2 |
Engineering, Chemical |
||
Q4 |
Materials Science, Biomaterials |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q4 |
Psychiatry |
||
Q1 |
Information Science & Library Science |
||
Q3 |
Instruments & Instrumentation |
||
Q3 |
Materials Science, Characterization & Testing |
||
Q4 |
Quantum Science & Technology |
||
Q2 |
Geosciences, Multidisciplinary |
||
Q3 |
Chemistry, Multidisciplinary |
||
Q2 |
Green & Sustainable Science & Technology |
||
N/A |
Religion |
||
Q2 |
Environmental Sciences |
||
Q1 |
Geosciences, Multidisciplinary |
||
Q2 |
Imaging Science & Photographic Technology |
||
Q2 |
Remote Sensing |
||
Q3 |
Medicine, General & Internal |
||
Q4 |
Obstetrics & Gynecology |
||
Q4 |
Reproductive Biology |
||
Q2 |
Environmental Sciences |
||
Q3 |
Green & Sustainable Science & Technology |
||
Q2 |
Business, Finance |
||
Q2 |
Robotics |
||
Q3 |
Public, Environmental & Occupational Health |
||
Q3 |
Pharmacology & Pharmacy |
||
Q2 |
Chemistry, Analytical |
||
Q2 |
Engineering, Electrical & Electronic |
||
Q2 |
Instruments & Instrumentation |
||
Q3 |
Chemistry, Analytical |
||
Q2 |
Medicine, General & Internal |
||
Q3 |
Psychology, Multidisciplinary |
||
Q2 |
Social Sciences, Interdisciplinary |
||
Q2 |
Womens Studies |
||
Q1 |
Engineering, Electrical & Electronic |
||
Q1 |
Urban Studies |
||
Q2 |
Social Sciences, Interdisciplinary |
||
Q2 |
Sociology |
||
Q2 |
Soil Science |
||
Q3 |
Chemistry, Physical |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q2 |
Sport Sciences |
||
Q4 |
Mathematics, Interdisciplinary Applications |
||
Q3 |
Statistics & Probability |
||
Q3 |
Chemistry, Physical |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q4 |
Surgery |
||
Q2 |
Environmental Sciences |
||
Q2 |
Environmental Studies |
||
Q3 |
Green & Sustainable Science & Technology |
||
Q2 |
Multidisciplinary Sciences |
||
Q1 |
Social Sciences, Interdisciplinary |
||
Q1 |
Engineering, Multidisciplinary |
||
Q3 |
Telecommunications |
||
Q4 |
Hematology |
||
Q2 |
Radiology, Nuclear Medicine & Medical Imaging |
||
Q2 |
Environmental Sciences |
||
Q1 |
Toxicology |
||
Q2 |
Food Science & Technology |
||
Q1 |
Toxicology |
||
Q2 |
Infectious Diseases |
||
Q2 |
Parasitology |
||
Q1 |
Tropical Medicine |
||
Q2 |
Astronomy & Astrophysics |
||
Q2 |
Physics, Particles & Fields |
||
Q3 |
Environmental Sciences |
||
Q3 |
Environmental Studies |
||
Q2 |
Geography |
||
Q3 |
Regional & Urban Planning |
||
Q2 |
Urban Studies |
||
Q1 |
Immunology |
||
Q1 |
Medicine, Research & Experimental |
||
Q2 |
Engineering, Mechanical |
||
Q2 |
Transportation Science & Technology |
||
Q2 |
Veterinary Sciences |
||
Q3 |
Engineering, Mechanical |
||
Q3 |
Mechanics |
||
Q2 |
Virology |
||
Q2 |
Environmental Sciences |
||
Q2 |
Water Resources |
||
Q2 |
Economics |
||
Q2 |
Political Science |
||
Q1 |
Social Sciences, Interdisciplinary |
||
Q2 |
Engineering, Electrical & Electronic |
||
Q2 |
Transportation Science & Technology |
Source: 2023 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2024)
About MDPI
A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 440 fully open access titles.
11 June 2024
Journal of Clinical Medicine Receives an Increased CiteScore of 5.7
We are pleased to inform you that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has received an increased CiteScore of 5.7, which is an increase of 5.6% compared with the 2022 metric. The 2023 CiteScore™ was recently released, and it assesses the scientific influence of journals in the 2020 to 2023 period. JCM’s CiteScore ranks Q1 (80 out of 636) in the “General Medicine” category.
To learn more about journal statistics, please visit https://www.mdpi.com/journal/jcm/stats.
Excellent performance is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We would like to take this opportunity to thank all of you who have contributed to the journal.
JCM Editorial Office
7 June 2024
MDPI Calls for Greater Open Access to Science for Ocean Protection
On UNESCO’s 2024 Oceans Day, MDPI encourages the scientific community to increase the accessibility of ocean research to accelerate ocean conservation.
Basel, Switzerland, June 7, 2024: MDPI, a leading open access (OA) publisher, is proud to announce its active support for World Oceans Day 2024, celebrated under UNESCO’s Ocean Decade framework. MDPI’s CEO, Stefan Tochev hopes that “the latest ocean research can be made freely accessible to help empower scientists and communities at large to save our oceans,” under UNESCO’s Ocean Decade until 2030.
Open Access: A Catalyst for Ocean Action
MDPI’s presence at the UNESCO Ocean Decade Conference 2024 highlights our unwavering commitment to using OA to advance ocean science, support research communities, and promote sustainable ocean management.
"Our involvement in the UNESCO Ocean Decade Conference underscores MDPI's commitment to the underfunded Ocean SDG. By promoting OA to scientific articles and books on SDGs, we aim to inspire critical actions," said Tochev. "Our initiatives, like the World Sustainability Award and Emerging Sustainability Award, further demonstrate our dedication to advancing sustainability.”
Showcasing MDPI’s Contributions to Ocean Research
Over the past three years, MDPI has published 30,000 papers focused on ocean research and related topics. Key MDPI journals contributing to this body of work include:
- Journal of Marine Science and Engineering (4.9k papers)
- Remote Sensing (2.6k papers)
- Sustainability (2k papers)
- International Journal of Molecular Sciences (IJMS) (1.7k papers)
- Marine Drugs (1.5k papers)
- Water (1.5k papers)
These publications highlight MDPI’s contributions to ocean science, reinforcing our role in the broader sustainability agenda by promoting blue innovation and economy.
Additionally, MDPI has launched Oceans, an international, peer-reviewed forum specifically aimed at publishing studies related to all branches of oceanography with an emphasis on the functioning of the ocean and the sustainable use of its resources and ecosystem services.
Affirming MDPI’s Commitment to Ocean Science
MDPI’s commitment to OA is pivotal in addressing critical global challenges, from climate change to ocean sustainability. Our efforts resonate with Outcome 4 of the UNESCO Ocean Decade action roadmap: an accessible ocean with open and equitable access to data, information, technology, and innovation. By aligning with UNESCO’s goals, MDPI continues to contribute to shaping a sustainable future for our oceans, reinforcing our position as a forward-thinking publisher dedicated to environmental stewardship and scientific excellence.
For more information, contact Rui Duarte at [email protected] or +41764313242.
About MDPI
A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of over 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully open access titles.
5 June 2024
MDPI Sets a New Benchmark for Publishing Excellence
95% of authors rate MDPI’s publication process as excellent or good, setting a new benchmark in scientific publishing – reveals 2023 Annual Report.
Basel, Switzerland, June 4, 2024: MDPI, the leading open access (OA) publisher, proudly announces the release of its 2023 Annual Report, detailing remarkable achievements and reaffirming its leadership in advancing OA publishing. In 2023, MDPI received 655,065 submissions, of which 285,244 articles were published. The company now commands a 17% market share in gold open access articles, with a median publication time of six weeks.
Stefan Tochev, MDPI's CEO, stated, "As a pioneer in open access publishing, MDPI has long been a game-changer in the scholarly community, serving millions of authors around the world to ensure the latest research is freely available. Reflecting on our incredible journey at MDPI, 2023 has been marked by growth in paper submissions, ambitious projects and initiatives aimed at improving our internal processes and delivering top-notch services to our scientists."
MDPI's 2023 Annual Report highlights several key achievements:
- 17% market share in gold open access articles across all disciplines.
- Record satisfaction rates: 95% of authors, 82% of reviewers, and 85% of guest editors.
- Enhanced editorial standards and feedback processes.
- Increased reach and impact with 54 new MDPI journal inclusions in Scopus, 29 in Web of Science, and 77 in DOAJ.
MDPI’s unwavering commitment to advancing OA has transformed the landscape of scholarly publishing, making high-quality research freely accessible to the global scientific community. The continuous improvement in our editorial standards and feedback processes underscores MDPI’s dedication to ensuring academic integrity and excellence.
Global Reach and Collaboration
MDPI’s global footprint continues to expand, with authors from diverse regions: 37% from Asia/Pacific, 36% from Europe, 15% from the Americas, and 12% from other parts of the world. The company’s fully OA platform attracted nearly 14 million monthly visitors in 2023, reflecting its widespread influence in the scientific community.
Commitment to Partnerships
With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services. The introduction of a transparent flat-fee model highlights MDPI's ongoing efforts to enhance affordability and support to the academic community. For more details read our 2023 Annual Report.
For more information, contact Rui Duarte at [email protected] or +41764313242.
About MDPI
A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of over 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully open access titles.
5 June 2024
Meet Us at the ESMO Congress 2024, 13–17 September 2024, Barcelona, Spain
The ESMO Congress is a globally influential oncology platform that unites clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2024 will disseminate the latest cutting-edge data, providing high-quality education and excellent networking opportunities for oncologists and other stakeholders on an international level.
The following MDPI journals will be represented:
- Cancers;
- JCM;
- Healthcare;
- Pharmaceutics;
- Applied Biosciences;
- Dermatopathology;
- Onco;
- Biomedicines;
- Cells;
- Diagnostics;
- Current Oncology;
- Immuno;
- Hemato;
- Gastrointestinal Disorders;
- Biologics;
- Biomolecules;
- Clinics and Practice;
- Medical Sciences.
If you are participating in this conference, please feel free to engage with us online prior to attendance. Our delegates look forward to meeting you in person at booth #P627 and answering any questions you may have. For more information regarding the conference, please visit the following link: https://www.esmo.org/meeting-calendar/esmo-congress-2024.
4 June 2024
MDPI Insights: The CEO's Letter #12 - First Term as CEO, Tu Youyou Award, Books Report
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Renewed Term as CEO of MDPI
I released the first CEO Letter at the end of June 2023, reflecting on my first month as CEO. Looking back at the first release, I’m pleased to see a marked consistency of content – from talking about open access (OA) and highlighting the great work being done at MDPI, to bringing together the science community with our conferences and building relations with our editorial board members and our industry as a whole.
For example, in the first letter, I highlighted our meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief (EiC) of our journal Viruses. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal.
On 21 May, 2024 we met with EiC Prof. Dr. Antonino Carbone, and Section EiC Prof. Dr. Alberto Signore (pictured on the left), of our journal Hemato (tracked for Impact Factor, and indexed in Scopus), showing our continued and active collaboration with our chief editors to develop the visions for the journal. Over the course of the day, we gathered feedback and gained an understanding of the journal's expectations and focus on strategic growth.
Reflections on my first year as CEO: achievements and initiatives
During my first year as CEO, there have been many remarkable moments, including a strong focus on bringing people together, focusing on company communications and performance.
According to a recent study of 3,400 people across 10 countries, “Managers impact employees’ mental health (69%) more than doctors (51%) or therapists (41%) — and even the same as a partner (69%).” This is an important topic for me, and perhaps that’s why I place a high value on management culture due to its tangible impact on people’s lives.
When I joined MDPI, I created a weekly meet-up for the Corporate Marketing department and their team leads. On the final Thursday of every month, we hold a Global Marketing meet-up to present projects, share knowledge, and conduct training. For years, I’ve maintained the tradition of ending each of our monthly global calls with a group photo to boost morale, motivation, and productivity, and to finish on a positive note.
In keeping with this, when I stepped into the role of CEO, I launched a bi-weekly management meeting, chairing over 20 MDPI Management Team meetings in my first year. These sessions provide an opportunity for managers to present their team’s work, focusing on their achievements and the challenges they face, while at the same time creating space for sharing knowledge.
“I firmly believe that OA is the future of publishing”
I co-organized and co-led the 2023 MDPI Strategy Management meeting this past October, from which we established an Executive Task Force that meets monthly to prioritize projects aimed at building MDPI into the world’s most trusted publisher. To achieve our goals, we as managers need to maintain collaborative communication and connect to the bigger picture.
As CEO, I focused on leadership communication by publishing 12 CEO Letters, one for each month of my tenure, to share more about MDPI news and achievements. I also produced ten videos to help further communicate our message.
I was happy to attend eight publishing and conference events, including STM in Frankfurt and Washington, APE, and R2R, and facilitate critical company meetings with Elsevier, Web of Science, ResearchGate, DOAJ, and others. It was a pleasure to meet and have discussions with key organizations and governing bodies such as CAS in China and ANVUR in Italy.
The best part was the opportunity to visit seven MDPI offices across Europe and Asia-Pacific, meeting with local managers and colleagues and supporting them in person. As part of this, I conducted training sessions while continuing to lead the Corporate Marketing department.
Looking ahead
My goal for my second year as CEO is to continue building on the initiatives from the past, including leadership communications, public relations, educational marketing, and company culture, while representing MDPI to the best of my ability. Additionally, I have a few new projects I hope to launch that I believe will be valuable to MDPI and the industry at large.
I firmly believe that OA is the future of publishing, and I am grateful to be in a position to advocate for this belief as part of MDPI, the world's leading open access publisher.
Thank you to our staff and industry friends for your genuine support in this role.
Impactful Research
Nominations Open for the Prestigious Tu Youyou Award 2024
I am pleased to share that MDPI has opened nominations for the 2024 Tu Youyou Award, a prestigious recognition established in honour of Professor Tu Youyou, Nobel Laureate, whose work has significantly transformed the global fight against malaria.
The Tu Youyou Award offers CHF 100,000
In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine for her discovery of artemisinin, significantly reducing mortality rates from malaria and shaping global health policies. Artemisinin-based combination therapies (ACTs) are now the standard treatment endorsed by the World Health Organization (WHO), saving countless lives, especially in regions heavily burdened by malaria.
MDPI Special Issue
To mark Professor Tu’s 80th birthday in 2009, MDPI’s journal Molecules issued a Special Issue focusing on her contributions to medical research. Recognizing her continuous contribution, MDPI created the Tu Youyou Award in 2016 to honour outstanding achievements in natural products and medicinal chemistry.
The deadline for nominations is 31 December 2024
Nominations are open to scientists excelling in natural products and medicinal chemistry. Eligible nominators include academic institutes, universities, and societies. The deadline for nominations is 31 December 2024, with the winners to be announced on 30 April 2025. The Tu Youyou Award offers CHF 100,000, split equally among the winners.
MDPI encourages the academic community to nominate individuals who have demonstrated excellence and innovation in line with Professor Tu’s legacy. This award not only honours individual achievement but also encourages further scientific exploration and discovery in critical areas of medicine.
This award embodies our deep commitment to groundbreaking research that drives societal progress and celebrates the legacy of one of the greatest medical innovators of our time.
Inside MDPI
2023 MDPI Books Report
In past CEO letters, I have highlighted our publishing process and the impactful peer-reviewed articles that represent the core output of scholarly publishing. However, scholarly books are another pillar of publishing that MDPI also services, which our core audience may not be fully aware of. In this section, I highlight the 2023 MDPI Books report, released by our MDPI Books team in May 2024.
Download the 2023 MDPI Books Report
In the report, you will find a summary of MDPI Books’ 10th anniversary, the books indexed in the Web of Science Book Citation Index, our market outreach, and our outlook for 2024.
MDPI Books celebrated its 10th anniversary in 2023
MDPI Books published its first OA Reprint, “From the Renaissance to the Modern World,” in 2013. Over the past ten years, MDPI Books has seen a significant increase in both the volume and nature of published Reprints. As of December 2023, our catalogue includes a total of 7,369 Reprints, with 1,811 of them added in 2023 alone. MDPI Books includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.
We’re also celebrating the 10-year MDPI anniversary of Laura Wagner, Head of MDPI Books.
Laura Wagner (Head of Books Division)
Laura holds a Bachelor’s degree in Art History and History from the University of Basel. After her studies, she started her career at an art gallery in Basel.
Since joining MDPI in 2014, Laura has held several roles within the company. This included editorial work, development of reprint and book services, and the temporary management of the journal Arts.
Currently Laura holds the role of Head of Books Division and is in charge of the development and strategic direction of MDPI Books.
MDPI Books indexed in Web of Science Book Citation Index
Another milestone in 2023 was the indexing of four book titles in the Web of Science Book Citation Index. The indexing of our open access books is crucial for their reach and accessibility, ensuring higher visibility within the open science community.
- Self-Representation in an Expanded Field: From Self-Portraiture to Selfie, Contemporary Art in the Social Media Age by editor Ace Lehner
- Towards Socially Integrative Cities: Perspectives on Urban Sustainability in Europe and China by editors Bernhard Müller, Jian Liu, Jianming Cai, Paulina Schiappacasse, Hans-Martin Neumann, and Baojun Yang
- Transitioning to Gender Equality by editors Christa Binswanger and Andrea Zimmermann
- Under Construction: Performing Critical Identity by editor Marie-Anne Kohl
If you would like to learn more about MDPI Books, please visit: www.mdpi.com/books
If you are thinking of writing or editing a book, you can submit your proposal at www.mdpi.com/books/publish-with-us, or email us at [email protected].
Coming Together for Science
Polymers 2024 – Polymers for a Safe and Sustainable Future
Our conference team successfully managed the Polymers 2024 – Polymers for a Safe and Sustainable Future international conference which took place from 28–31 May 2024 in Athens, Greece. The conference was chaired by Prof. Dr. Dimitrios Bikiaris and Prof. Dr. Konstantinos Triantafyllidis from the Aristotle University of Thessaloniki, Greece, and Dr. Ioanna Deligkiozi from AXIA Innovation, Germany. In total, the conference had 259 accepted abstracts and over 300 attendees from 22 different countries.
The conference featured three keynote speakers and 12 invited speakers, including esteemed scholars from Europe, Asia, Africa, and Canada. It included 60 selected talks and 189 posters, chosen by the 24 members of the Scientific Committee along with the three Conference Chairs. The event explored the latest scientific advancements and innovations in polymer science, focusing on creating safe, sustainable, and environmentally friendly materials. Emphasizing green polymer chemistry and the use of bioresources, the conference promoted the synthesis of biobased and biodegradable polymers.
The conference featured esteemed scholars from Europe, Asia, Africa, and Canada
Conference awards
The conference also presented three awards: two sponsored by the journal Polymers – The Best Poster Award (€500) and the Best Oral Presentation Award (€600) – and one sponsored by Ossila, the Best Student Poster Award (€500).
Thank you to our 16 sponsors, three partnering societies (Hellenic Polymer Society, European Polymer Federation, and North American Thermal Analysis Society [NATAS]) and eight media partners.
Upcoming in-person event
1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Find more upcoming MDPI events here.
Closing Thoughts
3rd World Forum Principles of Scientific Publications
I’m pleased to share that MDPI sponsored and attended the 3rd World Forum on Principles of Scientific Publications, which took place from 22–24 May in Malaga, Spain. The event brought together academic professionals and leading researchers to discuss critical topics in the realm of publishing and research. Presentation topics included Open Science, AI in Publishing, Predatory Journals, Fake Publications, Challenges for Non-native English Speakers, and more.
“It was great to see strong support from MDPI authors in the audience”
MDPI presentations
Stefan Tochev (CEO, MDPI) presenting at the 3rd World Forum Principles of Scientific Publications
I had the privilege of attending and presenting at the event, along with my colleague Dr. Enric Sayas (Business Analyst, MDPI) from our Barcelona office, who explored the ethical concerns and opportunities brought by AI in publishing.
I took the opportunity to present on Open Science, the benefits of Open Access, and MDPI’s performance, operations, and investment in ethics. Special thanks to Evan Escamilla (Project Manager, MDPI Books) and Facundo Santomé (Sr. Marketing Manager, MDPI) who also joined the conference.
It was great to see strong support from MDPI authors in the audience who shared their positive experiences publishing with us. Their story reflects the experience of the vast majority of authors who choose to work with MDPI.
We also encountered some conservative views on OA, which created an opportunity for open discussion aimed at addressing concerns about OA and MDPI. Engaging in such discussions is important, as scepticism sometimes arises from misinformation or from a misunderstanding of who we are and how we operate. When we engage in open and honest discussion, we tend to see people getting a better understanding of MDPI, which helps address any misconceptions they may have had.
Left to right: Dr. Enric Sayas (Business Analyst, MDPI), Stefan Tochev (CEO, MDPI), Facundo Santomé (Sr. Marketing Manager, MDPI), and Evan Escamilla (Project Manager, MDPI Books) at 3rd World Forum Principles of Scientific Publications
Chief Executive Officer
MDPI AG
3 June 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Pulmonology” Held on 28 February 2024
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board Meeting for the Section “Pulmonology” on 28 February 2024. We appreciate the Section Editor-in-Chief, Dr. Sukhwinder Singh Sohal, for hosting this meeting; there were seven Editorial Board Members in attendance.
The meeting started with a presentation about the development of the journal, as well as the Section “Pulmonology”, with the following information being presented:
- The journal’s history, publication statistics, distribution of scholars (2018–2023), the benefits of open access, journal awards, conference sponsorship, and promotion on social media;
- The geographical distribution of the Section’s Editorial Board Members, decision-making statistics, and Section statistics.
The meeting chaired by Dr. Sukhwinder Singh Sohal mainly addressed the following points:
- To set up targets that would bring the journal into the Q1 category;
- Authors: balancing the scholar distribution from all over the world, consideration of various views on one topic from scholars from different disciplines, and suggestions on Author Contribution Form;
- Manuscript processing: Academic Editors' decisions, paper lengths, the reviewer quality and checking database, reviewer vouchers, and acceptance/rejection rate;
- Article type: in addition to original articles, comprehensive review papers and guidelines will be encouraged;
- Hot topics: emerging topics in pulmonology (e.g., the minimally invasive application of AI), lung cancer screening, rare pulmonary diseases, cystic fibrosis, biomarkers, treatable traits, COPD, the pathogenesis of pulmonary fibrosis, fibrosis in general, etc.;
- Section Editorial Board: invitation of board members from different skills or fields in pulmonology and deeper EBM communications via online meetings/emails/offline meetings;
- Conferences/meetings: the proposal of an offline board meeting for board members during the ERS conference and suggestions on a COPD convention in November.
We would like to thank every Editorial Board Member and contributing academics for their support. We look forward to receiving more suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Dr. Sukhwinder Singh Sohal (Section Editor-in-Chief), University of Tasmania, Launceston, Australia;
- Prof. Dr. Ildiko Horvath, National Koranyi Institute for Pulmonology, Budapest, Hungary; University of Debrecen, Debrecen, Hungary;
- Dr. Silvano Dragonieri, University of Bari, Bari, Italy;
- Prof. Dr. Enrico M. Clini, University of Modena and Reggio Emilia, Modena, Italy;
- Dr. Eugenio Pompeo, Policlinico Tor Vergata University, Rome, Italy;
- Dr. Josuel Ora, University of Rome Tor Vergata, Rome, Italy;
- Prof. Dr. Francisco Dasí, University of Valencia, Valencia, Spain;
- Prof. Dr. Yüksel Peker, Koc University School of Medicine, Istanbul, Turkey; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; University of Gothenburg, Gothenburg, Sweden; Lund University, Lund, Sweden.
The latest official CiteScore (2022 Scopus data) for the Journal of Clinical Medicine is 5.4, ranking 137/830 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To find out more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Pulmonology.
3 June 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Otolaryngology” Held on 28 February 2024
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board Meeting for the Section “Otolaryngology” on 28 February 2024. Dr. Eng Ooi, the Section Editor-in-Chief, had an engaging conversation with the Editorial Board Members Dr. Giulio Cesare Passali, Dr. Alfonso Del Cuvillo, Prof. Adrien Eshraghi, and the journal relations team.
The meeting started with a presentation about the development of the journal and the Section “Otolaryngology”, with the following information being presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), the benefits of open access publication, journal awards, conference sponsorship, and promotion on social media;
- The geographical distribution of the Section’s Editorial Board Members, decision-making statistics, and Section statistics.
The meeting chaired by Dr. Eng Ooi mainly addressed the following points:
- The Impact Factor, citations, and indexing databases of the Section and the journal;
- Journal Sections setup;
- Section hot topics: long post-COVID symptoms in the areas of smell, the new biological agents for head and neck cancer, and emerging treatments for obstructive sleep apnea;
- Manuscript processing: review reports, Academic Editors' decisions, and acceptance/rejection rates;
- Conferences/journal promotion: Citation and mention in the presentations of conference participants, and providing the president/organizer with the opportunity to publish original articles/consensus articles in JCM.
We would like to thank every Editorial Board Member and the academics for their support. We look forward to receiving more suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Dr. Eng Ooi (Section Editor-in-Chief), Flinders University, Adelaide, Australia;
- Dr. Giulio Cesare Passali, Catholic University of the Sacred Heart, Agostino Gemelli Polyclinic, Rome, Italy;
- Dr. Alfonso Del Cuvillo, Jerez University Hospital, Jerez, Spain;
- Prof. Adrien Eshraghi, University of Miami, Miami, FL, USA.
The latest official CiteScore (2022 Scopus data) for the Journal of Clinical Medicine is 5.4, ranking 137/830 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Otolaryngology.
31 May 2024
Meet Us at the 10th Congress of the European Academy of Neurology, 29 June–2 July 2024, Helsinki, Finland
MDPI will attend the 10th Congress of the European Academy of Neurology, held in Helsinki, Finland, from 29 June to 2 July 2024, at booth #E28. We invite researchers from different backgrounds to visit and share their latest ideas with us.
The EAN Congress covers “big diseases” such as multiple sclerosis, movement disorders, headache, muscle disorders, epilepsy, dementia, and stroke, as well as breakthrough research on rare diseases. This edition will celebrate 10 years of the EAN with over 8000 professionals. The 10th EAN Congress's overarching theme is “Neuromodulation: Advances and Opportunities in Neurological Diseases”. Leading specialists will tackle hot topics in invasive and non-invasive neuromodulation in movement and cognitive disorders, chronic pain, and refractory epilepsy. The current state and future directions of neuromodulation will be addressed with relevant questions regarding which techniques are available as diagnostic tools or therapeutic interventions; how to precisely target specific cortical regions, deep brain structures, and head nerves for therapeutic purposes; and how to advance neuromodulation in new areas of neurology such as chronic minimally conscious state or limb prosthesis.
The following MDPI journals will be represented at the conference:
- Biomedicines;
- Clinical and Translational Neuroscience;
- Brain Sciences;
- Biomolecules;
- Cells;
- Current Issues in Molecular Biology;
- Diagnostics;
- Genes;
- Healthcare;
- International Journal of Translational Medicine;
- Journal of Clinical Medicine;
- Life;
- Muscles;
- Methods and Protocols;
- Neuroglia;
- Neurology International;
- Vaccines.
If you are planning to attend the conference, please feel free to start a conversation with us at our booth #E28. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.ean.org/congress2024.
31 May 2024
Meet Us at the FENS Forum 2024, 25–29 June 2024, Vienna, Austria
Conference: FENS Forum 2024
Date: 25–29 June 2024
Location: Vienna, Austria
MDPI will be attending FENS Forum 2024 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference has been organized by the Federation of European Neuroscience Societies (FENS), the Austrian Neuroscience Association (ANA) and and the Hungarian Neuroscience Society. The FENS Forum is Europe’s largest neuroscience congress, covering all areas of neuroscience from basic to translational research.
The following MDPI journals will be represented:
- Brain Sciences;
- Journal of Clinical Medicine (JCM);
- Cells;
- NeuroSci;
- Neuroglia;
- Biomedicines;
- Neurology International;
- Behavioral Sciences;
- Psychoactives.
If you are planning on attending this conference, please do not hesitate to contact us. Our delegates look forward to meeting you in person at booth #1003, and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.fens.org/meetings/fens-forum/upcoming-fens-forums.
31 May 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Ophthalmology
We are delighted to share some highly cited papers on ophthalmology that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues on this topic are currently open for submission.
The following is a list of articles and Special Issues that we believe will interest you:
1. “iERM: An Interpretable Deep Learning System to Classify Epiretinal Membrane for Different Optical Coherence Tomography Devices: A Multi-Center Analysis“
by Kai Jin, Yan Yan, Shuai Wang, Ce Yang, Menglu Chen, Xindi Liu, Hiroto Terasaki, Tun-Hang Yeo, Neha Gulab Singh, Yao Wang et al.
J. Clin. Med. 2023, 12(2), 400; https://doi.org/10.3390/jcm12020400
Available online: https://www.mdpi.com/2077-0383/12/2/400
2. “A No-History Multi-Formula Approach to Improve the IOL Power Calculation after Laser Refractive Surgery: Preliminary Results”
by Ferdinando Cione, Maddalena De Bernardo, Marco Gioia, Marianunzia Oliviero, Andrea Giuseppe Santoro, Alessandro Caputo, Luigi Capasso, Sergio Pagliarulo and Nicola Rosa
J. Clin. Med. 2023, 12(8), 2890; https://doi.org/10.3390/jcm12082890
Available online: https://www.mdpi.com/2077-0383/12/8/2890
3. “Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration”
by Sarah Hammadi, Nikolaos Tzoumas, Mariantonia Ferrara, Ingrid Porpino Meschede, Katharina Lo, Claire Harris, Majlinda Lako and David H. Steel
J. Clin. Med. 2023, 12(8), 2870; https://doi.org/10.3390/jcm12082870
Available online: https://www.mdpi.com/2077-0383/12/8/2870
4. “Segmentation-Assisted Fully Convolutional Neural Network Enhances Deep Learning Performance to Identify Proliferative Diabetic Retinopathy”
by Minhaj Alam, Emma J. Zhao, Carson K. Lam and Daniel L. Rubin
J. Clin. Med. 2023, 12(1), 385; https://doi.org/10.3390/jcm12010385
Available online: https://www.mdpi.com/2077-0383/12/1/385
5. “Detecting Macular Disease Based on Optical Coherence Tomography Using a Deep Convolutional Network“
by Jinyoung Han, Seong Choi, Ji In Park, Joon Seo Hwang, Jeong Mo Han, Junseo Ko, Jeewoo Yoon and Daniel Duck-Jin Hwang
J. Clin. Med. 2023, 12(3), 1005; https://doi.org/10.3390/jcm12031005
Available online: https://www.mdpi.com/2077-0383/12/3/1005
6. “Three-Month Safety and Efficacy Outcomes for the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT™)”
by Mario Damiano Toro, Faustino Vidal-Aroca, Marina Montemagni, Claudio Xompero, Gaetano Fioretto and Ciro Costagliola
J. Clin. Med. 2023, 12(2), 518; https://doi.org/10.3390/jcm12020518
Available online: https://www.mdpi.com/2077-0383/12/2/518
7. “Complement Inhibitors for Advanced Dry Age-Related Macular Degeneration (Geographic Atrophy): Some Light at the End of the Tunnel?”
by Miguel Cruz-Pimentel and Lihteh Wu
J. Clin. Med. 2023, 12(15), 5131; https://doi.org/10.3390/jcm12155131
Available online: https://www.mdpi.com/2077-0383/12/15/5131
8. “Exploring the Relationship between Anti-VEGF Therapy and Glaucoma: Implications for Management Strategies”
by Qëndresë Daka, Nina Špegel, Makedonka Atanasovska Velkovska, Tjaša Steblovnik, Miriam Kolko, Burim Neziri and Barbara Cvenkel
J. Clin. Med. 2023, 12(14), 4674; https://doi.org/10.3390/jcm12144674
Available online: https://www.mdpi.com/2077-0383/12/14/4674
9. “Comparison of Five Presbyopia-Correcting Intraocular Lenses: Optical-Bench Assessment with Visual-Quality Simulation”
by Grzegorz Łabuz, Weijia Yan, Isabella D. Baur, Ramin Khoramnia and Gerd U. Auffarth
J. Clin. Med. 2023, 12(7), 2523; https://doi.org/10.3390/jcm12072523
Available online: https://www.mdpi.com/2077-0383/12/7/2523
10. “Objective Classification of Glistening in Implanted Intraocular Lenses Using Optical Coherence Tomography: Proposal for a New Classification and Grading System”
by José Ignacio Fernández-Vigo, Bárbara Burgos-Blasco, Lucía De-Pablo-Gómez-de-Liaño, Inés Sánchez-Guillén, Virginia Albitre-Barca, Susana Fernández-Aragón, José Ángel Fernández-Vigo and Ana Macarro-Merino
J. Clin. Med. 2023, 12(6), 2351; https://doi.org/10.3390/jcm12062351
Available online: https://www.mdpi.com/2077-0383/12/6/2351
11. “The Global Burden of Glaucoma: Findings from the Global Burden of Disease 2019 Study and Predictions by Bayesian Age–Period–Cohort Analysis”
by Yi Lin, Bingcai Jiang, Yuanqing Cai, Wangdu Luo, Xiaomin Zhu, Qianyi Lin, Min Tang, Xiangji Li and Lin Xie
J. Clin. Med. 2023, 12(5), 1828; https://doi.org/10.3390/jcm12051828
Available online: https://www.mdpi.com/2077-0383/12/5/1828
12. “Efficacy Evaluation of Tissue Plasminogen Activator with Anti-Vascular Endothelial Growth Factor Drugs for Submacular Hemorrhage Treatment: A Meta-Analysis”
by Xuejun He, Wenye Cao, Zhiyi Wang, Ningzhi Zhang, Kexin Xu, Lu Yu, Yiqiao Xing and Ning Yang
J. Clin. Med. 2023, 12(3), 1035; https://doi.org/10.3390/jcm12031035
Available online: https://www.mdpi.com/2077-0383/12/3/1035
13. “Association between Optic Nerve Sheath Diameter and Lamina Cribrosa Morphology in Normal-Tension Glaucoma”
by Seung Hyen Lee, Tae-Woo Kim, Eun Ji Lee and Hyunkyung Kil
J. Clin. Med. 2023, 12(1), 360; https://doi.org/10.3390/jcm12010360
Available online: https://www.mdpi.com/2077-0383/12/1/360
14. “Effectiveness and Safety of Xen Gel Stent in Glaucoma Surgery: A Systematic Review of the Literature”
by Carlo Enrico Traverso, Roberto G. Carassa, Antonio Maria Fea, Michele Figus, Carlo Astarita, Benedetta Piergentili, Vanessa Vera and Stefano Gandolfi
J. Clin. Med. 2023, 12(16), 5339; https://doi.org/10.3390/jcm12165339
Available online: https://www.mdpi.com/2077-0383/12/16/5339
15. “Long-Term Outcomes of the PRESERFLO MicroShunt Implant in a Heterogeneous Glaucoma Cohort”
by Jens Julian Storp, Friederike Elisabeth Vietmeier, Ralph-Laurent Merté, Raphael Koch, Julian Alexander Zimmermann, Nicole Eter and Viktoria Constanze Brücher
J. Clin. Med. 2023, 12(13), 4474; https://doi.org/10.3390/jcm12134474
Available online: https://www.mdpi.com/2077-0383/12/13/4474
Special Issues |
|
“Refractive Surgery—Where Are We Now?” |
“Multifactorial Causation and Therapies of Myopia” |
“Advances in Glaucoma Management and Intraocular Pressure Physiology” |
“Advances in the Diagnosis and Management of Age-Related Macular Degeneration” |
“Diabetic Retinopathy: Current Concepts and Future Directions” |
“Ocular Manifestations of Systemic Diseases” |
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
29 May 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Cardiology
We are delighted to share some highly cited papers on cardiology that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues on this topic are currently open for submission.
The following is a list of articles and Special Issues that we believe will interest you:
1. “Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence”
by Francesco Condello, Carmen Spaccarotella, Sabato Sorrentino, Ciro Indolfi, Giulio G. Stefanini and Alberto Polimeni
J. Clin. Med. 2023, 12(3), 1238; https://doi.org/10.3390/jcm12031238
Available online: https://www.mdpi.com/2077-0383/12/3/1238
2. “Left Atrial Posterior Wall Isolation with Pulsed Field Ablation in Persistent Atrial Fibrillation”
by Melanie A. Gunawardene, Gerrit Frommeyer, Christian Ellermann, Mario Jularic, Patrick Leitz, Jens Hartmann, Philipp Sebastian Lange, Omar Anwar, Benjamin Rath, Rahin Wahedi et al.
J. Clin. Med. 2023, 12(19), 6304; https://doi.org/10.3390/jcm12196304
Available online: https://www.mdpi.com/2077-0383/12/19/6304
3. “The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management”
by Gloria Santangelo, Francesca Bursi, Andrea Faggiano, Silvia Moscardelli, Pasquale Simone Simeoli, Marco Guazzi, Roberto Lorusso, Stefano Carugo and Pompilio Faggiano
J. Clin. Med. 2023, 12(6), 2178; https://doi.org/10.3390/jcm12062178
Available online: https://www.mdpi.com/2077-0383/12/6/2178
4. “TAVI after More Than 20 Years”
by Adriana Postolache, Simona Sperlongano and Patrizio Lancellotti
J. Clin. Med. 2023, 12(17), 5645; https://doi.org/10.3390/jcm12175645
Available online: https://www.mdpi.com/2077-0383/12/17/5645
5. “Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Focus on Coronary Microvascular Dysfunction and Genetic Susceptibility”
by Paolo Severino, Andrea D’Amato, Silvia Prosperi, Vincenzo Myftari, Lorenzo Colombo, Elisa Tomarelli, Alice Piccialuti, Gianluca Di Pietro, Lucia Ilaria Birtolo, Viviana Maestrini et al.
J. Clin. Med. 2023, 12(10), 3586; https://doi.org/10.3390/jcm12103586
Available online: https://www.mdpi.com/2077-0383/12/10/3586
6. “The Triglyceride–Glucose Index Might Be a Better Indicator for Predicting Poor Cardiovascular Outcomes in Chronic Coronary Syndrome”
by Aslan Erdoğan, Duygu İnan, Ömer Genç, Ufuk Yıldız, Ayşe İrem Demirtola, İlyas Çetin, Yeliz Güler, Ali Fuat Tekin, Süleyman Barutçu, Ahmet Güler et al.
J. Clin. Med. 2023, 12(19), 6201; https://doi.org/10.3390/jcm12196201
Available online: https://www.mdpi.com/2077-0383/12/19/6201
7. “Catheter Ablation for Tachyarrhythmias in Left Ventricular Assist Device Recipients: Clinical Significance and Technical Tips”
by Naoya Kataoka and Teruhiko Imamura
J. Clin. Med. 2023, 12(22), 7111; https://doi.org/10.3390/jcm12227111
Available online: https://www.mdpi.com/2077-0383/12/22/7111
8. “Artificial Intelligence (AI) versus POCUS Expert: A Validation Study of Three Automatic AI-Based, Real-Time, Hemodynamic Echocardiographic Assessment Tools”
by Eyal Gohar, Amit Herling, Mor Mazuz, Gal Tsaban, Tomer Gat, Sergio Kobal and Lior Fuchs
J. Clin. Med. 2023, 12(4), 1352; https://doi.org/10.3390/jcm12041352
Available online: https://www.mdpi.com/2077-0383/12/4/1352
9. “Clinical Usefulness of Right Ventricle–Pulmonary Artery Coupling in Cardiovascular Disease”
by Qing He, Yixia Lin, Ye Zhu, Lang Gao, Mengmeng Ji, Li Zhang, Mingxing Xie and Yuman Li
J. Clin. Med. 2023, 12(7), 2526; https://doi.org/10.3390/jcm12072526
Available online: https://www.mdpi.com/2077-0383/12/7/2526
10. “Heart Failure Pharmacological Management: Gaps and Current Perspectives”
by Paolo Severino, Andrea D'Amato, Silvia Prosperi, Vincenzo Myftari, Elena Sofia Canuti, Aurora Labbro Francia, Claudia Cestiè, Viviana Maestrini, Carlo Lavalle, Roberto Badagliacca et al.
J. Clin. Med. 2023, 12(3), 1020; https://doi.org/10.3390/jcm12031020
Available online: https://www.mdpi.com/2077-0383/12/3/1020
11. “Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective”
by Felice Gragnano, Francesco Pelliccia, Natale Guarnaccia, Giampaolo Niccoli, Salvatore De Rosa, Raffaele Piccolo, Elisabetta Moscarella, Enrico Fabris, Rocco Antonio Montone, Arturo Cesaro et al.
J. Clin. Med. 2023, 12(8), 2810; https://doi.org/10.3390/jcm12082810
Available online: https://www.mdpi.com/2077-0383/12/8/2810
12. “Neuroimaging Studies of the Neural Correlates of Heart Rate Variability: A Systematic Review”
by Patrycja S. Matusik, Chuwen Zhong, Paweł T. Matusik, Omar Alomar and Phyllis K. Stein
J. Clin. Med. 2023, 12(3), 1016; https://doi.org/10.3390/jcm12031016
Available online: https://www.mdpi.com/2077-0383/12/3/1016
13. “Arrhythmic Manifestations of Cardiac Amyloidosis: Challenges in Risk Stratification and Clinical Management”
by Natallia Laptseva, Valentina A. Rossi, Isabella Sudano, Rahel Schwotzer, Frank Ruschitzka, Andreas J. Flammer and Firat Duru
J. Clin. Med. 2023, 12(7), 2581; https://doi.org/10.3390/jcm12072581
Available online: https://www.mdpi.com/2077-0383/12/7/2581
14. “The Feasibility, Effectiveness and Acceptance of Virtual Visits as Compared to In-Person Visits among Clinical Electrophysiology Patients during the COVID-19 Pandemic”
by Marco Valerio Mariani, Nicola Pierucci, Giovanni Battista Forleo, Marco Schiavone, Alessia Bernardini, Alessio Gasperetti, Gianfranco Mitacchione, Mariachiara Mei, Giuseppe Giunta, Agostino Piro et al.
J. Clin. Med. 2023, 12(2), 620; https://doi.org/10.3390/jcm12020620
Available online: https://www.mdpi.com/2077-0383/12/2/620
15. “Hypertensive Heart Failure”
by Filippos Triposkiadis, Pantelis Sarafidis, Alexandros Briasoulis, Dimitrios E. Magouliotis, Thanos Athanasiou, John Skoularigis and Andrew Xanthopoulos
J. Clin. Med. 2023, 12(15), 5090; https://doi.org/10.3390/jcm12155090
Available online: https://www.mdpi.com/2077-0383/12/15/5090
Special Issues |
|
“Interventional Cardiology: Current Challenges in Clinical Practice” |
“Exercise and Sports Cardiology” |
“Adult Congenital Heart Disease: An Increasing and Ageing Population: Part II” |
“Clinical Updates in Cardiac Electrophysiology” |
“Better Management of Heart Failure: Contemporary Strategy and Future Perspective” |
“Clinical Advances in the Diagnosis and Treatment of Atrial Fibrillation” |
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
23 May 2024
Transfer Service in MDPI
We are pleased to announce MDPI’s Transfer Service.
This service provides a convenient method of transferring your manuscript file, along with any reviewer comments, to another journal within our publishing portfolio.
We are committed to helping authors find the right home for their research, and we will provide authors with guidance and technical support through all stages of the transfer process. Authors will be able to choose to transfer in the following two situations:
1. Select alternative journals on submission.
2. Authors are encouraged to transfer manuscripts to other MDPI journals.
More details about the Transfer Service can be found at the following link:
17 May 2024
Tu Youyou Award—Open for Nominations
In acknowledgment of the groundbreaking achievements of Professor Tu Youyou, the Nobel laureate credited with the discovery of artemisinin, MDPI is proud to announce the Tu Youyou Award. This award, inaugurated in 2016, seeks to honor scholars who excel in the fields of natural products chemistry and medicinal chemistry.
Prize:
- CHF 100,000 in total (If there is more than one winner, the prize will be divided equally amongst the winners);
- An award medal for each winner.
Who should be nominated?
- Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.
Who can submit a nomination?
- Academic research institutes
- Universities
- Academic societies
Any personal nominations are not accepted.
How do I submit a nomination?
Candidates’ institutional affiliations need to submit their nominations for final candidates to the Tu Youyou Award Team directly by email after internal screening, and each institution can only nominate a maximum of two candidates for each edition of the Tu Youyou Award. Please note that the nominations cannot be modified once they are submitted and confirmed by the Tu Youyou Award Team.
Required nomination materials:
Nomination Form (Download)
Schedule:
Nomination deadline: 31 December 2024;
Winner announcement: 30 April 2025.
Contact:
Tu Youyou Award Team ([email protected])
More information can be found on the Tu Youyou Award official website. For any inquiries, do not hesitate to contact the Tu Youyou Award Team.
16 May 2024
MDPI Romania Author Training Academic Events in April
MDPI Romania sponsored four events over the month of April, contributing author training sessions to each event.
The NutriSciLabs 2024 conference was held at the Carol Davila University of Medicine and Pharmacy on 12 April 2024. Organized by the Association of Students from the Faculty of Pharmacy Studies, the conference aimed to enhance students’ academic writing and research skills, and bolster their confidence in participating in the academic world. Ioana Paunescu, journal relations specialist for MDPI Romania, led the training session. Paunescu first outlined MDPI’s history and core values, then explained academic writing techniques, ethics, and similarity percentages. The presentation covered the entire editorial process, highlighting the amount of attention paid to details throughout manuscript processing. Paunescu also discussed common errors that authors make while writing, and how to avoid such errors.
On 13 April 2024, the NextGEN 2.0 Student Conference took place at the Babes-Bolyai University of Cluj-Napoca. NextGen Healthcare organized this event with the university’s European Students’ Society to discuss European and international current affairs. MDPI Romania contributed an author training session called Steps of the Publication Process. Irina Codruta Zaharia, journal relations specialist, began the session with a general introduction of MDPI before diving into different article types, different layout formats, possible journals to submit to, the MDPI submission checklist, and the MDPI editorial process. By explaining the fundamentals of writing and publishing academic papers, Zaharia imparted valuable industry knowledge to the curious minds present. Participants were eager to engage with Zaharia in the subsequent Q&A session.
Celebrating its 20th anniversary this year, the International Conference “Students for Students” has long been a gathering place for undergraduate and postgraduate students of all nationalities to present their work and exchange ideas with each other. This year’s conference was held on 18 April 2024, with MDPI Romania contributing an author training session called The World of Open Access. Key speakers included Dr. Norbert Kiss from MDPI Romania and Prof. Dragos Horvath from Strasbourg University. Dr. Kiss discussed the history of open access, differences between open access publishing and traditional publishing, and implications for open access in the future. Attendees expressed keen interest in the subject, approaching Dr. Kiss with questions about academic publishing as well as his career trajectory.
Most recently, on 26 April 2024, MDPI Romania sponsored the National Symposium of Students from Geology and Geophysics Faculties. The AAPG Students Chapter at the Babes-Bolyai University organized this event as an opportunity for geology students from all Romanian universities to present their work and confer with other researchers. Dr. Kiss gave his lecture The World of Open Access at this event as well.
MDPI is thankful to all the participants, speakers, and organizers who attended these events. Through their enthusiasm and dedication, these events were great successes.
8 May 2024
Meet Us at the 61st ERA Congress, 23–26 May 2024, Stockholm, Sweden
MDPI will be attending the 61st ERA Congress, which will be held from 23 to 26 May 2024 in Stockholm, Sweden.
The ERA Annual Congress remains committed to advancing the understanding and treatment of kidney disease to improve the well-being of patients. Our aim is to disseminate knowledge with a focus on clinical assessment and treatment, with the overarching theme for this year being “Rethinking Kidney Health and Transforming Kidney Care”. The ERA 2024 will also mark the 60th anniversary of the ERA Registry. Four special sessions (Creative Labs), organized by the ERA Registry group, will provide insight into their expertise and knowledge.
The following MDPI journals will be represented:
If you plan on attending this conference, feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please visit the following link: https://era-shop.interplan.de/.
2 May 2024
MDPI Insights: The CEO's Letter #11 - 2023 Annual Report, MDPI Awards, STM
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
2023 Annual Report
This is an exciting time of year at MDPI, as we have just released our annual report 2023, recapping the past year and sharing the progress and changes that took place during it.
Stefan Tochev (CEO, MDPI)
Reflecting on 2023, I can't help but think of the changes that have occurred not only at MDPI but also within our industry as a whole. In light of this, I’m reminded that change is the only constant, and that for a publishing enterprise that has experienced rapid growth, adapting to change becomes not only a necessity but also a catalyst for sustained success.
Looking back on the significant ground we covered in 2023, I am pleased to report that the year was marked by a rise in paper submissions, along with a range of initiatives aimed at improving our internal processes and delivering top services to our scientists.
2023 Top-line MDPI Numbers
An important priority for 2023 was to strengthen our editorial policies. Despite a notable increase in the number of papers submitted from 603,000 to 655,000 (+8.6%), there was a decrease in the number of papers published from 303,000 to 285,000 (-5.9%), consistent with the overall trend in the scholarly publishing market. MDPI’s market share in gold open access articles published reached 17% in 2023 (according to Dimensions data).
2023 Open Access Numbers
For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment to, and vision for, an open future. This momentum continued in 2023, with 39% of the 4.16 million articles and reviews published as gold full-OA, 15% as gold hybrid-OA, 8% as bronze-OA, and 3% as green-OA, relative to 35% behind a paywall. In terms of gold OA (full or hybrid) articles and reviews published, MDPI leads the way in terms of total articles published in 2023.
MDPI is the trusted and preferred OA publisher for the scholarly community
However, in 2023, we saw a downward trend in publication numbers compared to 2022. This trend was also seen in total OA publications. While the number of submissions increased, the decline in MDPI publications can be attributed to several factors, such as improved scrutiny in our peer-review process, including the evaluation of content scope and higher rejection rates, and a post-pandemic decrease in research related to COVID-19 papers.
Download 2023 MDPI Annual Report.
Access 2023 Digital Report.
Impactful Research
Recognizing Scholars – MDPI Awards
MDPI is committed to empowering young researchers as they embark on their careers. In 2023, our journals hosted a total of 400 awards, receiving 8,839 applications and nominations. The evaluation committees selected 959 winners, with the total budget for these awards amounting to CHF 546,500.
For more information about MDPI awards, applications, and winners, please click here
The following awards recognize scholars and the impact of their research, including Young Investigator Awards, Best PhD Thesis Awards, and Travel Awards for junior researchers.
MDPI Awards – The following awards require an application or a nomination.
Young Investigator Award (CHF 1000–2000 for each winner)
This award acknowledges the achievements of young investigators in research areas relevant to the journal’s scope. Candidates must have received their PhD no more than 10 years prior to the award announcement date and must be nominated.
Best PhD Thesis Award (CHF 500–800 for each winner)
This award recognizes young scholars who have completed outstanding PhD theses in research areas relevant to the journal’s scope. It aims to encourage them to continue their excellent work and make further contributions to their field.
Travel Award (CHF 500–800 for each winner)
This award encourages junior scientists to present their latest research at academic conferences relevant to the journal’s scope, thereby increasing their impact.
Distinguished Scholars
Additionally, 220 awards were granted to the most distinguished authors and reviewers in our journals through Best Paper Awards and Outstanding Reviewer Awards. The following awards are selected by the editorial staff of the journal and do not require an application or a nomination. They exemplify the excellent contributions made by our authors, reviewers, and editors.
These awards exemplify the excellent contributions made by our authors, reviewers, and editors
Best Paper Award (CHF 200–500 for each winner)
This award is granted annually to highlight publications of high quality, scientific significance, and extensive influence.
Outstanding Reviewer Award (CHF 500 for partial winners)
This award is given annually to recognize reviewers who generously contribute their time to reviewing papers and demonstrate thoroughness, professionalism, and timeliness in their reviews.
MDPI also offers awards for specific topics in various research fields:
Carbon Neutrality Award (CHF 500–800 for each winner)
Sponsored by MDPI journal Sustainability, this award recognizes applicants who have made exceptional academic or societal contributions to carbon neutrality, either in general or in relation to a specific carbon-neutrality-related issue.
Intelligent Manufacturing Award (CHF 500–800 for each winner)
Administered by MDPI journal Machines, this award is presented to an individual who has made outstanding academic or societal contributions to the field of intelligent manufacturing.
Granted: World Sustainability Awards
Inside MDPI
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager
As CEO of the world’s leading OA publisher, I am pleased to announce the official opening of our Korean branch office. With this addition, MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher. This expansion represents more than just an increase in our physical footprint; it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible across the globe.
MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher
Claude Seo (MDPI Korea Office Manager, Seoul)
Claude Seo, who has over 15 years of experience in the academic publishing industry, has been appointed as the Office Manager of the Seoul office. The launch of our Seoul office allows us to better support the Korean scientific community and to further promote the publication of OA journals in the region.
Reflecting on his role, Claude shared that he is:
“Delighted to have been entrusted with this position within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating ourselves into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”
Sungkyunkwan University Joins MDPI’s Institutional Open Access Program
Additionally, I am pleased to share that Sungkyunkwan University has joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDP’s online submission system for institutions and provides APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyunghee University, Chung-Ang University, and the Catholic University of Korea, have adopted IOAP in Korea.
Learn more about MDPI’s collaboration in Korea in my previous CEO Letter, in which I recap our visit to Seoul, South Korea.
Coming Together for Science
4th MMCS: Harnessing the Power of New Drug Modalities
Our conference team successfully managed the 4th Molecules Medicinal Chemistry Symposium, held from 24–26 April in Barcelona, Spain. It was chaired by Prof. Dr. Diego Muñoz-Torrero from the Institute of Biomedicine (IBUB), University of Barcelona, Spain, and Prof. Dr. Simona Collina from the University of Pavia, Italy. In total, there were 84 accepted abstracts and 102 conference attendees from 22 different countries.
From left to right: Prof. Dr. Rino Ragno (Scientific Committee), Dr. Maria Emilia Sousa (Scientific Committee), Prof. Dr. Claudio Viegas Jr. (Scientific Committee), Prof. Dr. Simona Collina (Chair), Prof. Dr. Diego Muñoz-Torrero (Chair), Alvina Wu (Managing Editor, MDPI), Prof. Dr. Roman Dembinski (Scientific Committee), Prof. Dr. Mariana Spetea (Scientific Committee).
The event comprised 12 Invited Speakers, 35 Selected Talks, 10 Flash Poster Presentations, and 39 Posters. The overarching topic of the conference was the impact of the emergence of new drug modalities on drug discovery, with thematic sessions covering topics such as photoactivatable drugs, candidates targeting RNA and epigenetic targets, covalent modifiers, and the development of new anti-cancer agents, among other medicinal chemistry projects.
We are pleased to have received feedback from attendees highlighting the professional approach of the conference chairs and participants, the high quality of the talks, and the overall outstanding organization on the part of the MDPI conference team.
Thank you to the conference sponsors, Fluorochem and IBUB, and to our partnering societies, The Spanish Society for Biochemistry and Molecular Biology (SEBBM), and the Spanish Society of Medicinal Chemistry (SEQT).
Upcoming In-Person Event
28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location: Athens, Greece
Conference Chairs: Prof. Dr. Dimitrios Bikiaris, Prof. Dr. Konstantinos Triantafyllidis, Dr. Ioanna Deligkiozi
We look forward to welcoming experts Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Find more upcoming MDPI events here.
Organize Your Event with MDPI’s Sciforum
Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.
Closing Thoughts
A Report from the Future – STM US Annual Conference 2024
Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board.
MDPI has for a long time been a sponsor of the STM Annual Conferences, held yearly in the US and Frankfurt, and is a trusted partner and supporter of the STM organization. While I have attended the Frankfurt conference for the past three years, this was my first time visiting the Washington, DC session, and I am glad I did.
Although it was a brief trip, I greatly appreciated the opportunity to attend in the company of my colleagues Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board. They always help map some of the new industry trends against MDPI’s operational framework and guidelines. It’s a great group for kicking ideas back and forth on what we can apply at MDPI.
In my experience, STM never fails to deliver. It’s always a great conference for reconnecting with fellow publishers, industry friends, and vendors. As usual, STM this year curated a diverse range of speakers and panels, who proferred valuable knowledge and insights from outside our industry, delivering thought-provoking insights into our field. An example of this was the ‘Trust Panel’ session, which included Alan Schiffres (Managing Director, InfoLinx), who shared a number of the learnings about fraud and risk management from his 40 years in financial services, to help address some of the challenges we are currently facing in the area of publishing integrity.
Launch of STM Trends 2028 Panel
I particularly enjoyed the ‘Launch of STM Trends 2028 Panel’, which presented a report focused on the integration of humans and machines in scholarly publishing. The session highlighted themes such as AI, digitization, and the evolving research ecosystem. The report envisions a future where technology blurs the lines between human and machine involvement in research processes, with significant implications for trust, reputation, and equity. While this presents opportunities for connectivity and knowledge dissemination, it also poses challenges such as disinformation, fragmentation, and geopolitical tensions. We must rely on a wise combination of technology and human agency to navigate this complex landscape and will have to carefully examine its potential impacts on communication and scholarly publishing.
MDPI has joined the STM Integrity Hub. Click here to learn more.
While every presenter brought their own knowledge and personal touch, I was particularly pleased to encounter new speakers such as Heather Whitney (Research Assistant Professor, Radiology, University of Chicago) and Igor Grossmann (Professor of Psychology, University of Waterloo, Canada). Having studied Sociology at the University of Guelph, I have a soft spot for fellow social scientists from Canada, and I was very impressed by Igor’s presentation on ‘The Social Scientist: A View from the Future’ and his participation in the panel session ‘The Future Beyond the Article,’ which was one of my favourites from the conference, given the diversity of perspectives from the panel speakers.
Memorial Park in Washington, DC
On a personal note, this was my first-time visiting Washington, DC, and I’m glad we took an afternoon to visit the Memorial Park, with its incredible monuments to figures ranging from Martin Luther King, Jr. to Abraham Lincoln. The magnitude of the monuments is deeply impressive. I particularly appreciated the Thomas Jefferson memorial and the following quote, which I think speaks to the importance of change and adaptation. It’s something we can apply not only in our industry but also in our personal lives.
"I am not an advocate for frequent changes in laws and constitutions, but laws and institutions must go hand in hand with the progress of the human mind. As that becomes more developed, more enlightened, as new discoveries are made, new truths discovered and manners and opinions change, with the change of circumstances, institutions must advance also to keep pace with the times. We might as well require a man to wear still the coat which fitted him when a boy as a civilized society to remain ever under the regimen of their barbarous ancestors."
– Excerpted from a letter to Samuel Kercheval, July 12, 1816.
Chief Executive Officer
MDPI AG
30 April 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Epidemiology & Public Health” Held on 6 March 2024
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board meeting for the Section “Epidemiology & Public Health” on 6 March 2024. We appreciate the Section Editor-in-Chief, Prof. Dr. Francisco Guillen-Grima, for hosting this meeting; four Editorial Board Members were in attendance.
The meeting started with a presentation about the development of the journal as well as the Section “Epidemiology & Public Health”, with the following information being presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), the benefits of open access, journal awards, conference sponsorship, and promotion on social media;
- Geographical distribution of the Section’s Editorial Board Members, decision-making statistics, and Section statistics.
The meeting mainly discussed the Section scope, popular topics (such as AI and machine learning in medicine), feature paper contributions and invitations by the Editorial Board Members, the direction of article types, social media promotion, and conference suggestions.
Based on the discussion, the journal plans to update the Section webpage (in progress), fortify feature paper contributions from the Editorial Board Members, keep an eye on popular topics and research fronts, be more present at conferences (such as the European Public Health Association Conference, etc.), and try different social media platforms (YouTube, etc.) to strengthen journal promotion.
We thank every Editorial Board Member and the academics for their support. We look forward to receiving more suggestions to continue our progress together.
Attendee list (in no particular order):
- Prof. Dr. Francisco Guillen-Grima (Section Editor-in-Chief), University of Navarra, Pamplona, Spain;
- Dr. Giampiero Mazzaglia, University of Milan-Bicocca, 20900 Monza, Italy;
- Prof. Dr. Gabriel Chodick, Tel-Aviv University, Tel-Aviv, Israel;
- Prof. Dr. Frank Klawonn, Ostfalia University of Applied Sciences, Wolfenbuettel, Germany;
- Prof. Dr. Eleni Jelastopulu, University of Patras, University Campus, Rio, Greece.
The latest official CiteScore (2022 Scopus data) for the Journal of Clinical Medicine is 5.4, ranking 137/830 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Epidemiology_Public_Health.
30 April 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Gastroenterology & Hepatopancreatobiliary Medicine” Held on 1 March 2024
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board Meeting for the Section “Gastroenterology & Hepatopancreatobiliary Medicine” on 1 March 2024. Professor Doctor Hidekazu Suzuki, the Section Editor-in-Chief, had an engaging conversation with the Editorial Board Members Professor Doctor Pieter Hindryckx, Professor Doctor Stephen Riordan, and the journal relations team.
The meeting started with a presentation about the development of the journal, as well as the Section “Gastroenterology & Hepatopancreatobiliary Medicine”, with the following information being presented:
- The journal’s history, publication statistics, distribution of scholars (2018–2023), the benefits of open access, journal awards, conference sponsorship, and promotion on social media;
- The geographical distribution of the Section’s Editorial Board Members, decision-making statistics, and Section statistics.
The meeting chaired by Professor Doctor Suzuki mainly addressed the following points:
- The Impact Factor and citations of the Section and the journal;
- Article type: in addition to original articles, comprehensive review papers and guidelines will be encouraged. Excellent case reports on rare diseases and papers with videos or high-quality tables/figures will also be considered for submission;
- Hot topics: recommendations by Editorial Board Members within the Section, such as AI and its application in inflammatory bowel disease (IBD), endoscopy, etc.;
- Manuscript processing: papers’ topic distribution, paper lengths, the reviewer database, reviewer vouchers, acceptance/rejection rates;
- Journal promotion: we discussed enhancing the journal’s advertising and describing author benefits in social media posts;
- Conferences/meetings: enriching of the geographical distribution of our conferences, the proposal of an offline board meeting, and suggestions for the board’s meeting frequency (quarterly or half yearly).
We would like to thank every Editorial Board Member and contributing academics for their support. We look forward to receiving more suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Prof. Dr. Hidekazu Suzuki (Section Editor-in-Chief), Tokai University School of Medicine, Kanagawa, Japan;
- Prof. Dr. Pieter Hindryckx, Ghent University, Ghent, Belgium;
- Prof. Dr. Stephen Riordan, University of New South Wales, Sydney, Australia.
Due to time-zone differences, some Editorial Board Members were unable to attend this meeting.
The latest official CiteScore (2022 Scopus data) for the Journal of Clinical Medicine is 5.4, ranking 137/830 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To find out more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Gastroenterology_Hepatology.
30 April 2024
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager
MDPI, the leading Open Access (OA) publisher, announced on Monday that it opened its Korean branch office on 29th April 2024. With this addition, MDPI now operates 21 offices in 12 countries worldwide. Claude Seo, with over 20 years of experience in the academic journal publishing industry, including Nature Publishing Group (NPG), has been appointed as the Office Manager of the Seoul office.
With the establishment of a Seoul office, MDPI aims to actively support Korea scientific communities to further promote the publication of OA journals in the region. As of the end of 2023, Korea ranked sixth worldwide in both submissions and publications of MDPI research papers. MDPI is the number one OA publisher in Korea.
Sungkyunkwan University Joins MDPI’s Institutional Open Access Program
In addition, MDPI announced that Sungkyunkwan University joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDPI online submission system for the institutions and APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyung Hee University, Chung-Ang University and Catholic University of Korea, have adopted IOAP in Korea.
OA aims to break down barriers that have traditionally restricted access to science, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Authors, academia, and scientific communities are rapidly moving toward OA. MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020.
MDPI CEO Visits Seoul, Korea
In March, Stefan Tochev, Chief Executive Officer (CEO) of MDPI, visited Korea and met with various stakeholders including government agencies, research and academic institutions, universities. During his visit, Stefan highlighted that MDPI continues to pave the way for a world where science is accessible to all, supporting a global community of inclusive innovation and collaborative solutions.
Stefan expressed excitement about the new venture, stating, "Today marks a significant milestone for MDPI as we celebrate the opening of our new office in Seoul, Korea. This expansion is more than just an increase in our physical footprint, it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible, participatory, and inclusive across the globe."
Claude Seo, reflecting on his new role, commented, "I am delighted to have been offered this position of trust within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”
For further inquiries, please contact our Seoul office directly.
About MDPI
A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.3 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 diligent, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully OA titles.
30 April 2024
Journal of Clinical Medicine Exceptional Reviewers List 2024
We are thrilled to share the updated Exceptional Reviewers List 2024. This program was designed to recognize and honor scholars who have delivered consistently exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) recognizes the significant role our reviewers play in maintaining the quality and integrity of the articles we publish. According to recent surveys conducted in 2023, 91% of our authors rate the peer review as good or excellent, thanks to our pool of excellent reviewers.
We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in the Journal of Clinical Medicine’s peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable.
The Exceptional Reviewers List was introduced in 2024. Each quarter, we will be selecting a group of outstanding reviewers and introduce them here.
Q2:
Name: Dr. Yuri P. Matusov
Affiliation: Division of Pulmonary & Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Interests: pulmonary hypertension; pulmonary vascular disease; pulmonary embolism; shock resuscitation; ARDS
Name: Dr. Yuko Ono
Affiliation: Department of Disaster and Emergency Medicine, Graduate School of Medicine, Kobe University, Kobe, Japan
Interests: trauma; airway management; sepsis
Name: Dr. Adam Buckholz
Affiliation: Division of Gastroenterology and Hepatology, Presbyterian-Weill Cornell Medical College, New York, NY, USA
Interests: autoimmune hepatitis; cirrhosis; fatty liver disease; general hepatology; hepatitis B; hepatitis C
Name: Dr. Baptiste Demey
Affiliation: Department of Virology, CHU Amiens-Picardie, Amiens, France
Interests: virology; infectious disease; polyomavirus
Q1:
Name: Dr. Carlos Rodríguez-López
Affiliation: Teaching and Research in Neurorrehabilitation, Lecturer University Schools Gimbernat, University of Cantabria, La Coruña, Spain
Interests: peripheral nerve disorders and neuropathic behaviour; pain in neurological patients; therapeutic exercise in neurorehabilitation; - perceptual disorders after a central lesion; robotics and technology in neurorehabilitation
Interview: “As a lecturer and clinician my main interest when reviewing papers is to be updated in the neurorehabilitation field, and help through my contribution to set the standards concerning solutions for people who had suffered a lesion to their nervous system. Also, I´m very much interested in papers offering different ways to understand common signs and symptoms in the field, such as spasticity or neuropathic behaviour in such conditions, as I strongly believe that understanding peripheral nerve adaptations after a neurological disorder onset can shine a light on perceptual and motor alterations we see in the clinical setting. The review process allows me, also, to have a broader look on my field and to get in touch with researchers worldwide, with different points of view, opening my clinical reasoning to new perspectives in neurorrehabilitation.”
Name: Dr. Shiqi Ling
Affiliation: Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
Interests: Treatment and surgery of children's eye diseases; treatment and surgery of strabismus, amblyopia, and myopia; diagnosis and treatment of ocular surface diseases; corneal transplantation; amniotic membrane transplantation; limbal stem cells transplantation
Name: Prof. Dr. Gianluca Manni
Affiliation: Dipartimento di Scienze Cliniche e Medicina Traslazionale, Università degli Studi di Roma, Tor Vergata, Roma, Lazio, Italy
Interests: glaucoma; clinical ophthalmology; OCT; optical coherence tomography; visual field tests; optic disk; clinical pharmacology
Name: Dr. Eftihia Polyzogopoulou
Affiliation: Emergency Medicine Department, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece
Interests: heart failure; acute heart failure; acute myocardial infarction; cardiac imaging
18 April 2024
Journal of Clinical Medicine 2025 Travel Award—Open for Applications
We are pleased to announce that Journal of Clinical Medicine (JCM, ISSN: 2077-0383) will be granting the Travel Award to junior scientists. The applications will be assessed by an Evaluation Committee consisting of senior scholars from the JCM Editorial Board.
This award provides financial support for the winners to attend an international conference in the field of clinical medicine to be held in 2025, in order to hold a presentation, present a poster, or both.
Candidate requirements:
- Postdoctoral fellows or Ph.D. students;
- Plans to attend an international conference in 2025 (oral presentation or poster).
Required application documents:
- Information of the conference the applicant is planning to attend and the abstract that will be submitted;
- curriculum vitae and list of publications;
- Justification letter describing the focus of the research (max. 800 words);
- Letter of recommendation from the supervisor, research director, or department head, which also confirms the applicant’s status as a postdoctoral fellow/Ph.D. student.
The winners will each be awarded CHF 800 and an electronic certificate.
Please submit your applications for the JCM 2025 Travel Award online by 31 October 2024. You can find more information about this award and how to nominate here. To request further information, please contact the JCM Editorial Office.
Journal of Clinical Medicine Editorial Office
18 April 2024
Journal of Clinical Medicine 2024 Young Investigator Award—Open for Nominations
We are pleased to announce that Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is now inviting nominations for the JCM 2024 Young Investigator Award. This prize will be given to one young investigator in recognition of their excellence in the field of clinical medicine. All the nominations will be assessed by an Award Evaluation Committee led by the Editor-in-Chief, Dr. Emmanuel Andrès.
The prize includes:
- CHF 2000;
- The option to publish one paper free of charge in JCM after peer review before the end of 2025;
- An electronic certificate.
Eligibility and requirements:
- The candidate must have received their Ph.D. no more than 10 years prior to 31 December 2024;
- The candidate must have produced ground-breaking research and made a significant contribution to the advancement of clinical medicine;
- The candidate must be nominated by senior scientists.
List of documents for nomination:
- Detailed curriculum vitae, including an updated publication list and a list of the researcher’s own research grants;
- Scanned copy of their doctorate certificate;
- Signed nomination letters from two established senior scientists.
Nomination deadline: 31 December 2024.
You can find more information about this award and how to nominate here. To request further information, please contact the JCM Editorial Office.
Journal of Clinical Medicine Editorial Office
8 April 2024
Meet Us at the 2024 ASCO Annual Meeting, 31 May–4 June 2024, Chicago, IL, USA
The 2024 ASCO Annual Meeting will take you to discover state-of-the-art research, groundbreaking treatments, and visionary insights, igniting your passion for oncology. This year's program will feature over 200 sessions, complementing Dr. Lynn Schuchter’s Presidential theme “The Art and Science of Cancer Care: From Comfort to Cure”.
The following MDPI journals will be represented:
- Cancers;
- JPM;
- Pharmaceutics;
- Healthcare;
- JCM;
- CIMB;
- Medical Sciences;
- Clinics and Practice;
- Onco;
- Current Oncology;
- Dermato;
- Pharmacy;
- Biomedicines;
- Diseases;
- Immuno;
- Biologics;
- Vaccines;
- Diagnostics;
- Hemato;
- Venereology.
If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth at the conference and answering any questions you may have. For more information regarding the conference, please visit the following link: https://conferences.asco.org/am/attend.
2 April 2024
Join Us for the 2024 Annual Congress of the European Association for Cancer Research (EACR 2024), 10–13 June 2024, Rotterdam, the Netherlands
The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) is a four-day congress engaged in basic, preclinical and translational cancer research across a myriad of topics that is aiming to spotlight, inspire and unite the cancer research community to innovate, build knowledge, and create collaborations.
The following MDPI journals will be represented:
- Cancers;
- Cells;
- IJMS;
- Healthcare;
- JCM;
- CIMB;
- Medical Sciences;
- Clinics and Practice;
- Onco;
- JMP;
- Current Oncology.
If you are attending this conference, please feel free to contact us online. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following link: https://2024.eacr.org/.
2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.
Visit to Seoul, South Korea
During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).
As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.
MDPI and South Korea by Numbers
As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.
“South Korea is the sixth-largest contributor to our total publications”
Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.
Institutional Partnerships with South Korea
I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.
Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.
Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.
MDPI Hosts Seminar for Academia and Media
As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.
“MDPI is actively democratizing science”
MDPI in the News
Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.
Media coverage generated by our visit to Seoul included the following stories:
“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”
I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.
Impactful Research
Featured Articles on Women’s Leadership and Healthcare
In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.
Women’s Leadership
- Women Entrepreneurship and Sustainable Development: Bibliometric Analysis and Emerging Research Trends
Sustainability 2022, 14, 9160. https://doi.org/10.3390/su14159160 - Refugee Women Business Mentors: New Evidence for Women’s Empowerment
Sustainability 2022, 14, 9154. https://doi.org/10.3390/su14159154 - Women and Leadership in Higher Education: A Systematic Review
Soc. Sci. 2023, 12, 555. https://doi.org/10.3390/socsci12100555 - Understanding Needs and Potentials for Gender-Balanced Empowerment and Leadership in Climate Change Adaptation and Mitigation in Africa
Sustainability 2022, 14, 9410. https://doi.org/10.3390/su14159410 - Challenges Women Experience in Leadership Careers: An Integrative Review
Merits 2023, 3, 366-389. https://doi.org/10.3390/merits3020021
Women’s Reproductive Health
- Recreational Female Athletes’ Understanding of and Perceived Impact of the Menstrual Cycle on Physical Performance, Mood, and Sleeping Behaviour
Women 2023, 3, 445-456. https://doi.org/10.3390/women3030034 - Difficulties in Adaptation of the Mother and Newborn via Cesarean Section versus Natural Birth—A Narrative Review
Life 2023, 13, 300. https://doi.org/10.3390/life13020300 - The Main Theories on the Pathogenesis of Endometriosis
Int. J. Mol. Sci. 2023, 24, 4254. https://doi.org/10.3390/ijms24054254
Women’s Preventive Healthcare
- Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Int. J. Mol. Sci. 2023, 24, 3140. https://doi.org/10.3390/ijms24043140 - Assessing Barriers Encountered by Women in Cervical Cancer Screening and Follow-Up Care in Urban Bolivia, Cochabamba
Healthcare 2022, 10, 1604. https://doi.org/10.3390/healthcare10091604 - Updates on HPV Vaccination
Diagnostics 2023, 13, 243. https://doi.org/10.3390/diagnostics13020243
Featured Articles in MDPI Journal Women
Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.
- Premenstrual Syndrome and Exercise: A Narrative Review
Women 2023, 3, 348-364. https://doi.org/10.3390/women3020026 - Increasing Awareness of the Human Papillomavirus (HPV) Vaccine for Women 18–45 Years of Age
Women 2023, 3, 365-373. https://doi.org/10.3390/women3030027 - Addressing Women’s Needs with Human Immunodeficiency Virus (HIV) and Enhancing the Visibility of Pharmacists in the Public Health Arena
Women 2022, 2, 346-352. https://doi.org/10.3390/women2040032
Inside MDPI
Championing Women’s Healthcare and Access to Healthcare Information
MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:
- Empowering women to assume leadership and decision-making roles in both business and science.
- Helping women and girls make informed decisions about their health.
- Recruiting and developing female talent and fostering inclusive workplace environments.
“We are thrilled to recognize the accomplishments of women scientists”
I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.
We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.
“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’
“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’
Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.
Coming Together for Science
MDPI Joins United2Act in Collective Fight to Stop Paper Mills
In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.
The text below is taken from our official announcement:
United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.
Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.
MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.
United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:
- Education and awareness
- Improve post-publication corrections
- Facilitate and organise research on paper mills
- Enable the development of trust markers
- Facilitate dialogue between stakeholders
MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.
Closing Thoughts
Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.
Visit to Tokyo and Kyoto, Japan
In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.
We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.
Japan’s Open Access statistics
Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:
- 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
- 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
- 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.
To learn more about the history of OA in Japan as well as about future trends, please read this blog post.
“Japan is the ninth-largest contributor to our total publications”
Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.
MDPI and Japan by Numbers
As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.
In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.
General Feedback – a side note
A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.
That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.
Chief Executive Officer
MDPI AG
2 April 2024
Journal of Clinical Medicine | Ten Selected Papers in 2023
We are pleased to invite you to read the ten selected papers in 2023 in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). The list of relevant papers can be seen below.
1. “Do Insomnia Treatments Improve Daytime Function?”
by Nathaniel F. Watson, Suzanne M. Bertisch, Charles M. Morin, Rafael Pelayo, John W. Winkelman, Phyllis C. Zee and Andrew D. Krystal
J. Clin. Med. 2023, 12(9), 3089; https://doi.org/10.3390/jcm12093089
Available online: https://www.mdpi.com/2077-0383/12/9/3089
2. “What Should Be the Focus of Treatment When Insomnia Disorder Is Comorbid with Depression or Anxiety Disorder?”
by Charles M. Morin, Suzanne M. Bertisch, Rafael Pelayo, Nathaniel F. Watson, John W. Winkelman, Phyllis C. Zee and Andrew D. Krystal
J. Clin. Med. 2023, 12(5), 1975; https://doi.org/10.3390/jcm12051975
Available online: https://www.mdpi.com/2077-0383/12/5/1975
3. “Management and Prognosis of Acute Stroke in Atrial Fibrillation”
by Mette F. Hindsholm, Dorte Damgaard, M. Edip Gurol, David Gaist and Claus Z. Simonsen
J. Clin. Med. 2023, 12(17), 5752; https://doi.org/10.3390/jcm12175752
Available online: https://www.mdpi.com/2077-0383/12/17/5752
4. “Introducing Machine Perfusion into Routine Clinical Practice for Liver Transplantation in the United States: The Moment Has Finally Come”
by Kristopher P. Croome
J. Clin. Med. 2023, 12(3), 909; https://doi.org/10.3390/jcm12030909
Available online: https://www.mdpi.com/2077-0383/12/3/909
5. “Diagnosis, Classification, and Assessment of the Underlying Etiology of Uveitis by Artificial Intelligence: A Systematic Review”
by Robin Jacquot, Pascal Sève, Timothy L. Jackson, Tao Wang, Antoine Duclos and Dinu Stanescu-Segall
J. Clin. Med. 2023, 12(11), 3746; https://doi.org/10.3390/jcm12113746
Available online: https://www.mdpi.com/2077-0383/12/11/3746
6. “Evidence-Based Approach of Biologic Therapy in Bronchial Asthma”
by Adnan Liaqat, Mathew Mason, Brian Foster, Grant Gregory, Avani Patel, Aisha Barlas, Sagar Kulkarni, Rafaela Basso, Pooja Patak, Hamza Liaqat et al.
J. Clin. Med. 2023, 12(13), 4321; https://doi.org/10.3390/jcm12134321
Available online: https://www.mdpi.com/2077-0383/12/13/4321
7. “Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease”
by Anjay Rastogi and James L. Januzzi, Jr.
J. Clin. Med. 2023, 12(8), 2824; https://doi.org/10.3390/jcm12082824
Available online: https://www.mdpi.com/2077-0383/12/8/2824
8. “Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia”
by Reed Mszar, Sarah Bart, Alexander Sakers, Daniel Soffer and Dean G. Karalis
J. Clin. Med. 2023, 12(4), 1382; https://doi.org/10.3390/jcm12041382
Available online: https://www.mdpi.com/2077-0383/12/4/1382
9. “Aerobic and Muscle-Strengthening Physical Activity, Television Viewing, and Nonalcoholic Fatty Liver Disease: The CARDIA Study”
by Daniel J. McDonough, Mahesh Mathew, Zachary C. Pope, Pamela J. Schreiner, David R. Jacobs, Jr., Lisa B. VanWagner, John Jeffrey Carr, James G. Terry, Kelley Pettee Gabriel, Jared P. Reis et al.
J. Clin. Med. 2023, 12(17), 5603; https://doi.org/10.3390/jcm12175603
Available online: https://www.mdpi.com/2077-0383/12/17/5603
10. “Neuroworsening in the Emergency Department Is a Predictor of Traumatic Brain Injury Intervention and Outcome: A TRACK-TBI Pilot Study”
by John K. Yue, Nishanth Krishnan, John H. Kanter, Hansen Deng, David O. Okonkwo, Ava M. Puccio, Debbie Y. Madhok, Patrick J. Belton, Britta E. Lindquist, Gabriela G. Satris et al.
J. Clin. Med. 2023, 12(5), 2024; https://doi.org/10.3390/jcm12052024
Available online: https://www.mdpi.com/2077-0383/12/5/2024
You are invited to view and submit clinical papers to the journal at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
1 April 2024
Meet Us at the American Thoracic Society International Conference 2024, 17–22 May 2024, San Diego, USA
MDPI will be attending the American Thoracic Society International Conference 2024, which will be held on from 17 to 22 May 2024 in San Diego, USA.
The ATS International Conference brings together pulmonary, critical care, and sleep professionals at all career stages, fostering collaboration and knowledge exchange. With nearly 14,000 attendees annually, the event serves as a platform for the latest research, global networking, and interdisciplinary discussions. Healthcare professionals from various fields, including nurses, therapists, and hospitalists, converge to share insights and advancements in pulmonary health, critical care, and sleep disorders. Furthermore, the conference's global reach is highlighted by 40 percent of participants representing healthcare facilities from around the world.
The following MDPI journals will be represented at the conference:
- Children;
- Medicina;
- Journal of Clinical Medicine;
- International Journal of Environmental Research and Public Health;
- Tomography;
- European Journal of Investigation in Health, Psychology and Education.
If you are considering attending this conference, we warmly welcome you to visit our booth and interact with our representatives. We are eager to meet you in person and assist you with any queries you may have. For more information about the conference, please visit the official website at https://conference.thoracic.org/.
1 April 2024
Journal of Clinical Medicine 2023 Best Paper Award—Winners Announced
We are pleased to announce the winners of the JCM 2023 Best Paper Award, who were chosen by a selection committee chaired by the Editor-in-Chief of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383), Prof. Dr. Emmanuel Andrès. Following a review process conducted by the Award Evaluation Committee, five winners were selected.
Each winner will receive CHF 500 and the chance to publish a paper in JCM in 2024, following peer review.
Articles:
“Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge”
by Modesto M. Maestre-Muñiz, Ángel Arias, Emilia Mata-Vázquez, María Martín-Toledano, Germán López-Larramona, Ana María Ruiz-Chicote, Bárbara Nieto-Sandoval and Alfredo J. Lucendo
J. Clin. Med. 2021, 10(13), 2945; https://doi.org/10.3390/jcm10132945
“Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection”
by Rosa Bellmann-Weiler, Lukas Lanser, Robert Barket, Lukas Rangger, Anna Schapfl, Marc Schaber, Gernot Fritsche, Ewald Wöll and Günter Weiss
J. Clin. Med. 2020, 9(8), 2429; https://doi.org/10.3390/jcm9082429
Reviews:
“Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”
by Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella and Gaetano Santulli
J. Clin. Med. 2020, 9(5), 1417; https://doi.org/10.3390/jcm9051417
“Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations”
by Laura Dresser, Richard Wlodarski, Kourosh Rezania and Betty Soliven
J. Clin. Med. 2021, 10(11), 2235; https://doi.org/10.3390/jcm10112235
“Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US”
by Donald J. Alcendor
J. Clin. Med. 2020, 9(8), 2442; https://doi.org/10.3390/jcm9082442
Please join us in congratulating the winners of the JCM 2023 Best Paper Award. We would also like to thank all our authors for their continued support of JCM. You can access more awards information via the following link: https://www.mdpi.com/journal/jcm/awards.
JCM Editorial Office
1 April 2024
Journal of Clinical Medicine 2024 Travel Award—Winners Announced
We are pleased to announce the winners of the JCM 2024 Travel Award. This award has been granted to Dr. Nurulamin Noor, a post-doctoral fellow at the University of Cambridge, UK, and to Mr. Ferdinando D'Amico, a Ph.D. student at IRCCS San Raffaele Hospital, Gastroenterology and Endoscopy, Milan, Italy. They will be awarded CHF 800 to attend the Digestive Disease Week (18–21 May 2024) which is to be held in Washington, USA.
As the awardees, they will each receive an additional honorarium of CHF 800, a chance to publish a paper free of charge in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) before 31 December 2024, after peer review, and an electronic certificate.
With so many high-quality applicants, the evaluation process and final decision were challenging. We would like to thank all the applicants for submitting their diverse and fascinating range of research topics. On behalf of the assessment committee, we congratulate the winners on their accomplishments.
You can access more awards information via the following link: https://www.mdpi.com/journal/jcm/awards.
JCM Editorial Office
1 April 2024
Journal of Clinical Medicine 2023 Young Investigator Award—Winner Announced
We are pleased to announce that the winner of the JCM 2023 Young Investigator Award is Dr. Jasper Iske.
Dr. Jasper Iske has been working in the field of heart transplantation at the department of Cardiothoracic and Vascular Surgery, German Heart Center of Charité Berlin, Germany. Dr. Iske has an outstanding publication record and has made significant scientific contributions to transplant-related topics including the age-specific effects on ischemia reperfusion injury, alloimmune responses as they relate to organ age, and age-adapted immunosuppression. His publication record is remarkable, with 16 (co-)first authorships to his name, an exceptional output for his age. This is an outstanding achievement in today’s competitive academic environment. Please join us in congratulating Dr. Iske on his outstanding achievements.
As the awardee, Dr. Jasper Iske will receive an honorarium of CHF 2000, a chance to publish a paper free of charge in Journal of Clinical Medicine (JCM, ISSN: 2077-0383) before 31 December 2024, after peer review, and an electronic certificate.
We would like to thank all the nominators for their participation and all the Award Committee Members for their evaluation of the many excellent nominees.
You can access more awards information via the following link: https://www.mdpi.com/journal/jcm/awards.
JCM Editorial Office
29 March 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Plastic, Reconstructive and Aesthetic Surgery/Aesthetic Medicine” Held on 29 January 2024
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board Meeting for the Section “Plastic, Reconstructive and Aesthetic Surgery/Aesthetic Medicine” on 29 January 2024. We appreciate the Section Editor-in-Chief, Prof. Dr. Roberto Cuomo, for hosting this meeting; there were three Editorial Board Members in attendance.
The meeting started with a presentation about the development of the journal as well as the Section “Plastic, Reconstructive and Aesthetic Surgery/Aesthetic Medicine”, with the following information being presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), the benefits of open access, journal awards, conference sponsorship, and promotion on social media;
- Geographical distribution of the Section’s Editorial Board Members, decision-making statistics, and Section statistics.
The meeting mainly discussed hot topics within the Section, quality control of manuscripts, English editing, tools for detecting plagiarism and AI generation, indexing categories, conference promotions of the Section, etc.
Based on the discussion, the journal intends to keep an eye on trending topics within the Section, investigate new themes, and conduct Special Issues on specific aspects, among other things.
We would like to thank every Editorial Board Member and the academics for their support. We look forward to receiving more suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Prof. Dr. Roberto Cuomo (Section Editor-in-Chief), University of Siena, Siena, Italy;
- Dr. Franco Bassetto, University of Padua, Padua, Italy;
- Prof. Dr. Yves Harder, Ente Ospedaliero Cantonale (EOC), Università della Svizzera Italiana (USI), Lugano, Switzerland.
The latest official CiteScore (2022 Scopus data) for the Journal of Clinical Medicine is 5.4, ranking 137/830 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To access more information about the Section, please visit the following link:
https://www.mdpi.com/journal/jcm/sections/Reconstructive_Aesthetic_Surgery_Aesthetic_Medicine.
22 March 2024
Meet Us at the SCA 2024 Annual Meeting and Workshops, 27–30 April 2024, Toronto, Canada
MDPI will be attending the SCA 2024 Annual Meeting and Workshops in Toronto, Canada, which will take place from 27 to 30 April 2024. All sessions are multidisciplinary with panels discussing heart failure, transcatheter heart procedures, adult congenital heart disease, transplantation, aortic surgery, mitral valve surgery, mechanical circulatory support, and coagulation/transfusion strategies. The workshops are state-of-the-art, hands-on opportunities to learn cutting edge technology from masters in the field.
The following MDPI journals will be represented:
- Journal of Cardiovascular Development and Disease;
- Journal of Clinical Medicine;
- Clinics and Practice;
- Complications;
- Diseases;
- Hearts;
- Life;
- Medical Sciences;
- Medicina;
- Surgeries;
- Surgical Techniques Development.
If you are attending the conference, please visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://scahq.org/education/meetings-and-events/annual-meetings-workshops/.
20 March 2024
Journal of Clinical Medicine | World Oral Health Day 2024—“A Happy Mouth is a Happy Body”
World Oral Health Day (WOHD) is a global awareness day held annually on 20 March. This year's theme is “A Happy Mouth is a Happy Body”; it aims to empower people with the knowledge, tools and confidence to maintain good oral health.
To explore this topic on World Oral Health Day 2024, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has collected open access academic research on oral diseases and dentistry. Thus, we shall share engaging, up-to-date scientific knowledge in this field.
Article Collection:
1. “Prevalence of Clinical Signs and Symptoms of Temporomandibular Joint Disorders Registered in the EUROTMJ Database: A Prospective Study in a Portuguese Center”
by David Faustino Ângelo, Beatriz Mota, Ricardo São João, David Sanz and Henrique José Cardoso
J. Clin. Med. 2023, 12(10), 3553; https://doi.org/10.3390/jcm12103553
Available online: https://www.mdpi.com/2077-0383/12/10/3553
2. “Superior Dislocation of the Mandibular Condyle into the Middle Cranial Fossa: A Comprehensive Review of the Literature”
by Kazuya Yoshida
Clin. Med. 2023, 12(11), 3781; https://doi.org/10.3390/jcm12113781
Available online: https://www.mdpi.com/2077-0383/12/11/3781
3. “Machine Learning to Predict Apical Lesions: A Cross-Sectional and Model Development Study”
by Sascha Rudolf Herbst, Vinay Pitchika, Joachim Krois, Aleksander Krasowski and Falk Schwendicke
J. Clin. Med. 2023, 12(17), 5464; https://doi.org/10.3390/jcm12175464
Available online: https://www.mdpi.com/2077-0383/12/17/5464
4. “Salivary Complaints in Burning Mouth Syndrome: A Cross Sectional Study on 500 Patients”
by Federica Canfora, Elena Calabria, Gianrico Spagnuolo, Noemi Coppola, Niccolò Giuseppe Armogida, Cristina Mazzaccara, Domenico Solari, Luca D’Aniello, Massimo Aria, Giuseppe Pecoraro et al.
J. Clin. Med. 2023, 12(17), 5561; https://doi.org/10.3390/jcm12175561
Available online: https://www.mdpi.com/2077-0383/12/17/5561
5. “The Slavcleft: A Three-Center Study of the Outcome of Treatment of Cleft Lip and Palate Considering Palatal Shape”
by Tereza Petrova, Andrzej Brudnicki, Magdalena Kotova, Wanda Urbanova, Ivana Dubovska, Petra Polackova, Iva Voborna and Piotr S. Fudalej
J. Clin. Med. 2023, 12(18), 5985; https://doi.org/10.3390/jcm12185985
Available online: https://www.mdpi.com/2077-0383/12/18/5985
6. “3D Printing and Virtual Surgical Planning in Oral and Maxillofacial Surgery”
by Adeeb Zoabi, Idan Redenski, Daniel Oren, Adi Kasem, Asaf Zigron, Shadi Daoud, Liad Moskovich, Fares Kablan and Samer Srouji
J. Clin. Med. 2022, 11(9), 2385; https://doi.org/10.3390/jcm11092385
Available online: https://www.mdpi.com/2077-0383/11/9/2385
7. “Prevalence and Methods for Assessment of Oropharyngeal Dysphagia in Older Adults: A Systematic Review and Meta-Analysis”
by Thanh-Nhan Doan, Wen-Chao Ho, Liang-Hui Wang, Fei-Chun Chang, Nguyen Thanh Nhu and Li-Wei Chou
J. Clin. Med. 2022, 11(9), 2605; https://doi.org/10.3390/jcm11092605
Available online: https://www.mdpi.com/2077-0383/11/9/2605
8. “Comparison of the Clinical Outcomes of Titanium and Zirconia Implant Abutments: A Systematic Review of Systematic Reviews”
by Felita Clarissa Halim, Paolo Pesce, Nicola De Angelis, Stefano Benedicenti and Maria Menini
J. Clin. Med. 2022, 11(17), 5052; https://doi.org/10.3390/jcm11175052
Available online: https://www.mdpi.com/2077-0383/11/17/5052
9. “Caries Management—The Role of Surface Interactions in De- and Remineralization-Processes”
by Jasmin Flemming, Christian Hannig and Matthias Hannig
J. Clin. Med. 2022, 11(23), 7044; https://doi.org/10.3390/jcm11237044
Available online: https://www.mdpi.com/2077-0383/11/23/7044
10. “A Retrospective Digital Analysis of Contour Changing after Tooth Extraction with or without Using Less Traumatic Surgical Procedures”
by Giovanni Battista Menchini-Fabris, Paolo Toti, Roberto Crespi, Giovanni Crespi, Saverio Cosola and Ugo Covani
J. Clin. Med. 2022, 11(4), 922; https://doi.org/10.3390/jcm11040922
Available online: https://www.mdpi.com/2077-0383/11/4/922
Call for Papers:
“Experimental Dental Research—New Concepts for Future Patient Needs: Part II”
Guest Editor: Prof. Dr. Matthias Karl
Submission Deadline: 25 April 2024
“Current Topics in Endodontics”
Guest Editor: Prof. Dr. Federico Foschi
Submission Deadline: 25 July 2024
You can access more Special Issues here.
Special Issue Reprints:
“Current Trends and Future Directions in Prosthetic and Implant Dentistry in the Digital Era”
“The State of the Art in Endodontics”
Access more Special Issue books here.
4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.
MDPI’s Impact on Romania
In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.
Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.
With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.
Romania ranks as a top 20 contributing country.
The Numbers: 2019–2023
MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.
With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).
Institutional Open Access Programs
Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.
Our growth and presence in Romania are a true testament.
We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.
Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.
Impactful Research
MDPI Joins the STM Integrity Hub
MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.
“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”
Joris van Rossum, Director of Research Integrity, STM
MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.
I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.
Inside MDPI
MDPI Expands Research Integrity and Publication Ethics Team (RIPE)
In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.
We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.
The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.
Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”
Introducing our Research Integrity and Publication Ethics Team
Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).
Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.
With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.
Quality Updates to Special Issues Oversight
At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.
The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.
PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.
Read more:
Coming Together for Science
Viruses 2024 – A World of Viruses
I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.
Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.
Recap on the #Viruses2024 Conference
Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!
Below are calls to action from the keynote speakers encouraging collaboration and communication:
“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA
“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain
Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.
Upcoming In-Person Event
24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain
Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Find more upcoming MDPI events here.
Organize Your Event with MDPI’s Sciforum
Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.
Closing Thoughts
Researcher to Reader (R2R) Conference
From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.
We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.
R2R Peer Review Innovations Workshop
I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.
Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.
The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.
At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.
Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!
Chief Executive Officer
MDPI AG
28 February 2024
Meet Us Online at the 2nd International Electronic Conference on Clinical Medicine (ECCM 2024), 13–15 November 2024
We are pleased to announce that the 2nd International Electronic Conference on Clinical Medicine (ECCM 2024) is back. The conference is organized by MDPI’s Journal of Clinical Medicine (JCM, ISSN: 2077-0383, Impact Factor: 3.9) and will take place virtually from 13 to 15 November 2024, Central European Time (CET).
ECCM 2024 will present the latest studies in various fields of clinical medicine. The goal of the conference is to show the current state, challenges, opportunities, and future trends in the field. All clinical medicine-related scientists, researchers, and individuals are welcome to take part in the event and share their clinical findings.
The sessions of this conference include:
S1. Cardiology;
S2. Gastroenterology and Hepatopancreatobiliary Medicine;
S3. Epidemiology and Public Health;
S4. AI and Telemedicine;
S5. Immunology;
S6. Mental Health;
S7. Oncology and Hematology;
S8. Dermatology.
Conference Chair:
Prof. Dr. Emmanuel Andrès, Internal Medicine Department, University Hospital Strasbourg, France
Important Deadlines:
Deadline for abstract submission: 16 July 2024
Abstract acceptance notification: 6 September 2024
Registration deadline: 8 November 2024
Guide for Authors:
To submit your abstract, please click here.
To register for the event, please click here.
Note: We are only accepting abstracts for this conference. To publish a conference proceedings paper for free and submit a full manuscript to JCM, please refer to the “Publication Opportunities” section of the “Instructions for Authors” at the following link: https://sciforum.net/event/iecd2024?subscribe§ion=#instructions.
Best Oral Presentation Award and Best Poster Award:
There will be six winners selected for these awards. Each winner will receive a certificate and 200 CHF.
For any inquiries regarding the event, please contact [email protected].
We look forward to seeing you at the 2nd International Electronic Conference on Clinical Medicine.
26 February 2024
Journal of Clinical Medicine | Collaboration Established with the Hellenic Society of Pediatric and Adolescent Gynecology (HSPAG)
In January 2024, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) established a cooperation with the Hellenic Society of Pediatric and Adolescent Gynecology (HSPAG). As part of this collaboration, all members of HSPAG will enjoy a discount on the Article Processing Charge (APC) when submitting articles to JCM. The collaboration goes beyond the discount benefit offered to members and includes other services and cross-promotions.
Pediatric and Adolescent Gynaecology (PAG) is an emerging specialty. It addresses a wide spectrum of diseases from the newborn period to adolescence. PAG evaluates and treats patients from infancy through adolescence and young adulthood, giving special consideration to young women's physical and emotional needs and supporting their transition from pediatric care to gynecologic care.
As the official journal of HSPAG, JCM presents a Topical Collection, “Pediatric and Adolescent Gynecology”, to contribute to the advancement of knowledge and understanding in the field of pediatric and adolescent gynecology and promote networking among practitioners.
For more information about societies cooperating with JCM, please visit https://www.mdpi.com/journal/jcm/societies.
22 February 2024
Journal of Clinical Medicine | Notable Papers in Q4 of 2023
We are pleased to present the notable papers published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in Q4 of 2023. We would like to take this opportunity to acknowledge the exceptional individuals and teams who worked on these papers. These articles are from multiple fields within the scope of JCM, and we hope they can provide insights and references for scholars in related fields. Learn more about the latest research below.
1. “Hypertensive Heart Failure”
by Filippos Triposkiadis, Pantelis Sarafidis, Alexandros Briasoulis, Dimitrios E. Magouliotis, Thanos Athanasiou, John Skoularigis and Andrew Xanthopoulos
J. Clin. Med. 2023, 12(15), 5090; https://doi.org/10.3390/jcm12155090
Full text available online: https://www.mdpi.com/2077-0383/12/15/5090
2. “Outcomes of Social Egg Freezing: A Cohort Study and a Comprehensive Literature Review”
by Pragati Kakkar, Joanna Geary, Tania Stockburger, Aida Kaffel, Julia Kopeika and Tarek El-Toukhy
J. Clin. Med. 2023, 12(13), 4182; https://doi.org/10.3390/jcm12134182
Full text available online: https://www.mdpi.com/2077-0383/12/13/4182
3. “Is It All about Surface Topography? An Intra-Individual Clinical Outcome Analysis of Two Different Implant Surfaces in Breast Reconstruction”
by Ines Schoberleitner, Angela Augustin, Daniel Egle, Christine Brunner, Birgit Amort, Bettina Zelger, Andrea Brunner and Dolores Wolfram
J. Clin. Med. 2023, 12(4), 1315; https://doi.org/10.3390/jcm12041315
Full text available online: https://www.mdpi.com/2077-0383/12/4/1315
4. “Long-Term Adverse Effects of Mild COVID-19 Disease on Arterial Stiffness, and Systemic and Central Hemodynamics: A Pre-Post Study”
by Mario Podrug, Pjero Koren, Edita Dražić Maras, Josip Podrug, Viktor Čulić, Maria Perissiou, Rosa Maria Bruno, Ivana Mudnić, Mladen Boban and Ana Jerončić
J. Clin. Med. 2023, 12(6), 2123; https://doi.org/10.3390/jcm12062123
Full text available online: https://www.mdpi.com/2077-0383/12/6/2123
5. “Perioperative Outcomes, Comorbidities, and Complications following Total Shoulder Arthroplasty in Wheelchair Users: A Retrospective Cohort Analysis of a Nationwide Database”
by Kevin Prabhu, Andrew J. Nasr, Donald Kasitinon, Alison Cabrera and Yen-Sheng Lin
J. Clin. Med. 2023, 12(18), 5799; https://doi.org/10.3390/jcm12185799
Full text available online: https://www.mdpi.com/2077-0383/12/18/5799
6. “The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients—A Large Population-Based Study”
by Ortal Tuvali, Sagi Tshori, Estela Derazne, Rebecca Regina Hannuna, Arnon Afek, Dan Haberman, Gal Sella and Jacob George
J. Clin. Med. 2022, 11(8), 2219; https://doi.org/10.3390/jcm11082219
Full text available online: https://www.mdpi.com/2077-0383/11/8/2219
7. “Characteristics of Long COVID: Cases from the First to the Fifth Wave in Greater Tokyo, Japan”
by Kouichi Hirahata, Nobutoshi Nawa and Takeo Fujiwara
J. Clin. Med. 2022, 11(21), 6457; https://doi.org/10.3390/jcm11216457
Full text available online: https://www.mdpi.com/2077-0383/11/21/6457
8. “Clinical Characteristics of Youth with Autism or Developmental Disability during Inpatient Psychiatric Admission”
by Emily Neuhaus, Anthony Osuna, Daina M Tagavi, Sina Shah-Hosseini, Shannon Simmons, Jennifer Gerdts and Alysha D Thompson
J. Clin. Med. 2022, 11(21), 6328; https://doi.org/10.3390/jcm11216328
Full text available online: https://www.mdpi.com/2077-0383/11/21/6328
9. “Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition”
by Pierre-Grégoire Guinot, Audrey Martin, Vivien Berthoud, Pierre Voizeux, Loic Bartamian, Erminio Santangelo, Belaid Bouhemad and Maxime Nguyen
J. Clin. Med. 2021, 10(14), 3164; https://doi.org/10.3390/jcm10143164
Full text available online: https://www.mdpi.com/2077-0383/10/14/3164
10. “Gastrointestinal Transit Times in Health as Determined Using Ingestible Capsule Systems: A Systematic Review”
by Gursharan Kaur Nandhra, Phakanant Chaichanavichkij, Malcolm Birch and S. Mark Scott
J. Clin. Med. 2023, 12(16), 5272; https://doi.org/10.3390/jcm12165272
Full text available online: https://www.mdpi.com/2077-0383/12/16/5272
To access more journal information, please visit the following link: https://www.mdpi.com/journal/jcm.
6 February 2024
Meet Us at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024), 27–30 April 2024, Barcelona, Spain
MDPI will attend the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) as an exhibitor. This conference will be held in Barcelona, Spain, from 27 to 30 April 2024.
The following MDPI journals will be represented:
- JCM;
- JPM;
- Pathogens;
- Antibiotics;
- Diagnostics;
- Biomolecules;
- Life;
- Venereology;
- IJMS;
- Microorganisms;
- TropicalMed;
- Medical Sciences;
- CIMB.
If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://www.eccmid.org/.
31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI and Digital Science Meeting
At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.
As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.
Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.
During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.
What is Altmetric?
You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.
Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.
“Almetric provides visual insights into where research is being discussed”
Sources Tracked by Altmetric
Altmetric badge showing the Altmetric score and colour-coded mention sources.
Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.
The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.
Read more:
Impactful Research
Ten High-Altmetric Articles Published by MDPI
As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.
So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.
Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.
“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort” J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003 Altmetric page: https://mdpi.altmetric.com/details/20477344 Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News. |
|
“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis” J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404 Altmetric page: https://mdpi.altmetric.com/details/57654628 Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times. |
|
“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia” Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024 Altmetric page: https://mdpi.altmetric.com/details/111086701 Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic. |
|
“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability” Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007 Altmetric page: https://mdpi.altmetric.com/details/83796184 Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian. |
|
“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study” Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933 Altmetric page: https://mdpi.altmetric.com/details/133463915 Altmetric shows that this article appeared in 192 news stories from 186 outlets. |
How do I use altmetrics?
Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.
Sharing Research Online
For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.
“An Update on Eukaryotic Viruses Revived from Ancient Permafrost” Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564 Altmetric page: https://mdpi.altmetric.com/details/142929875 Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN. |
|
“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications” Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001 Altmetric page: https://mdpi.altmetric.com/details/53406248 Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes. |
|
“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health” Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212 Altmetric page: https://mdpi.altmetric.com/details/86529137 Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum. |
|
“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health” Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431 Altmetric page: https://mdpi.altmetric.com/details/34714141 Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review. |
|
“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens” Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590 Altmetric page: https://mdpi.altmetric.com/details/142934305 Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC. |
Inside MDPI
MDPI Annual Meeting Celebrations in China
On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.
The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.
“It is essential that we stay connected and share best practices”
I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.
Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.
Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.
The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.
I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!
Coming Together for Science
MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership
We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.
“This initiative reflects our dedication to transparent and inclusive publishing”
TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.
For further details on our Institutional Open Access Program (IOAP), please contact us.
Benefits to MDPI’s IOAP
At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.
For further information, see our IOAP FAQ.
Closing Thoughts
Reflections on the 2024 APE Conference
MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.
The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.
“It's fascinating to see how other publishers are leveraging AI”
Highlights
Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.
In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.
“We can share best practices and lessons learned”
Incorporating MDPI’s Insights into Conferences
I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.
Chief Executive Officer
MDPI AG
31 January 2024
Acknowledgment of the Reviewers of Journal of Clinical Medicine(JCM) in 2023
In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of JCM. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.
In 2023, JCM received 27524 review reports, from 17004 reviewers. This past year, we worked with reviewers from 124 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the JCM family throughout 2023, and we look forward to their continued support in 2024.
The following are the reviewers who have consented to show their names:
Aadil Javed | Kourosh Hooshmand |
Aalap Chokshi | Kourosh Sheibani |
Aaron Blandino Ortiz | Kousalya Prabahar |
Aarti Nagayach | Koustav Sarkar |
Abayomi Baruwa | Koyeli Girigoswami |
Abbas F. Almulla | Kozo Tanno |
Abbas Malandish | Krasimira Krasimira |
Abdallah Allam | Krishna Rao Maddipati |
Abdellatif Bouazzaoui | Krista Wartchow |
Abdelmotagaly Elgalad | Krzysztof Dowgierd |
Abdelrahman Elsayid | Krzysztof Gomułka |
Abdolhassan Kazemi | Krzysztof Myrda |
Abdolrasoul Rangrazi | Krzysztof Pawlaczyk |
Abdolreza Jamilian | Ksenia Babina |
Abdul Rasheed Mohammed | Kuan Yu Chi |
Abdullah Assiri | Kuang-Ting Yeh |
Abdurrahman Sahin | Kuanjung Chen |
Abeir Osman Dabbous | Kubilay Gürünlüoğlu |
Abel Lerma | Kui Zhang |
Abhijit Mondal | Kukiat Tudpor |
Abhijit Nair | Kun Lyu |
Abhilash Vemulapalli | Kunal Bhatia |
Abhiram Kanneganti | Kunhua Qin |
Abhishek Kumar | Kunihiro Tsuchida |
Abid Hussain | Kwon-Duk Seo |
Abiola Adepoju | Kyohei Kin |
Abouzar Najafi | Laetitia Chauviere |
Abraham Pouliakis | Lai Wei |
Abraham Rudnick | Laith Thamer Al-Ameri |
Abuzer Coskun | Lajos Gergely |
Ach Taieb | Lakshmi Menon |
Achille Aveta | Lampros Lakkas |
Achilleas Boutsiadis | Lan Lin |
Adam Abu Abeid | Lana El Osta |
Adam Halinski | Lance Young |
Adam Kern | Lanuza Faccioli |
Adam Reich | Larisa Ryskalin |
Adam Zawada | Lars Heggelund |
Adelaida Avino | László Oláh |
Adelina Vlad | Laura Bozomitu |
Adina Armencia | Laura Burattini |
Adina Braha | Laura C. Berumen |
Adina Marza | Laura Cardelli |
Adina Stoian | Laura Eadie |
Adina Thomaidis | Laura Gilbertson |
Aditya Sarode | Laura Pittari |
Adli Ali | Laura Răducu |
Adrián Alegre | Laura Sánchez-Muñoz |
Adrian Costache | Laura Scaramuzzo |
Adrian Muresan | Laura Stătescu |
Adrian Vaduva | Laura Zlibinaite |
Adriana Angarita-Fonseca | Laurence Lagneaux |
Adriana Caldo-Silva | Laurence Rozen |
Adriana Objelean | Laurentiu Simion |
Adriano Murrone | Lavinia La Grasta Sabolić |
Adyb - Adrian Khal | Lavinia Rech |
Afshan Masood | Leda Guzmán |
Agata Poniewierska-Baran | Lei Huang |
Agata Stanek | Leila Allahqoli |
Agnieszka Ćwirlej Sozańska | Lenko Šarić |
Agnieszka Jankowicz-Szymańska | Lenycia De Cassya Lopes Neri |
Agnieszka Jeleń | Leonardo Fazio |
Agnieszka Kuczaj | Leopoldo Ardiles |
Agnieszka Lasota | Lervasen Pillay |
Agnishwar Girigoswami | Lesley Storey |
Agostino Ognibene | Letícia Oba Sakae |
Agostino Roasio | Levent Ceylan |
Ah Young Kim | Liang Hu |
Ahila Singaravel | Liang She |
Ahmad Jalili | Liaqat Hussain |
Ahmad Khusairi Azemi | Lidija Poposka |
Ahmed Abdelghany | Lidija Savić |
Ahmed Abdelrahman | Lijing Gong |
Ahmed Abu-Awwad | Liliana Dain |
Ahmed Abu-Zaid | Liliana Torres-López |
Ahmed Afify | Lilly-Ann Mohlkert |
Ahmed Ahmed | Lily Chu |
Ahmed Arafa | Liming Zhang |
Ahmed Bakillah | Linlin Guo |
Ahmed Elamragy | Lino Polese |
Ahmed Elbarbary | Lisa Di Blas |
Ahmed Elfana | Lisa Mcmahon |
Ahmed Elmasry | Lisbeth Eischer |
Ahmed Elshaer | Livia Bobu |
Ahmed Elshahat | Livio Vitiello |
Ahmed Hamdan | Liviu Macovei |
Ahmed Hamed Arisha | Li-Wei Chou |
Ahmed Jamleh | Lize Van Vulpen |
Ahmed Kamel | Ljubica Djukanović |
Ahmed Mahmoud | Ljubica Harhaji-Trajkovic |
Ahmed Mohsen | Lokman Kehribar |
Ahmed Mousa | Loredan Niculescu |
Ahmed S. Zakaria | Lorena Duca |
Ahmet Can Topcu | Lorena Elena Melit |
Ahsanullah Unar | Lorena Torroni |
Aida Petca | Lorenzo Brognara |
Aikaterini Konstantinidi | Lorenzo Caruso |
Aikaterini Theodorou | Lorenzo Menicanti |
Aiken Dao | Lorenzo Monfardini |
Aiwei Wang | Lorenzo Onorato |
Ajay Pal | Lorenzo Schiavoni |
Ajinkya Pawar | Lorina Badger-Emeka |
Ajith Polopnowita | Loris Marin |
Aki Uutela | Louis Morisson |
Akihiko Yamamoto | Loukas Chatzis |
Akihiro Yamashita | Luan Ferreira |
Akil Sherif | Luana Macovei |
Akio Oishi | Luca Bedetti |
Akira Obana | Luca Bergamaschi |
Akito Nakagawa | Luca Bertolaccini |
Ákos Pethő | Luca Coppeta |
Akshaya Bhagavathula | Luca Costanzo |
Akshyaya Pradhan | Luca Donazzan |
Alanderson Ramalho | Luca Filippi |
Alarico Ariani | Luca Flesia |
Alba Grayston | Luca Giovanni Locatello |
Alba Panarese | Luca Ielasi |
Alban Fouasson-Chailloux | Luca Mezzetto |
Alberto Alperi | Luca Potestio |
Alberto Arnedo-Pena | Luca Raccampo |
Alberto Brolese | Luca Toti |
Alberto D’Amico | Lucas Fornari Laurindo |
Alberto Dal Molin | Lucas Magalhães |
Alberto Donzelli | Lucía Ortiz-Comino |
Alberto Fantin | Lucia Stanciakova |
Alberto Fogagnolo | Lucia Tricarico |
Alberto Martino | Lucian Evdochim |
Alberto Palazzuoli | Luciano Colangelo |
Alberto Piana | Luciano Frassanito |
Alberto Zamora | Ludovica Anna Cimini |
Aldo Ferreira-Hermosillo | Ludovico Carbone |
Aleix Cases | Luigi Cappannoli |
Alejandro Botero Carvajal | Luigi Gargiulo |
Alejandro Candia | Luigi Irace |
Alejandro De-La-Sierra | Luigi La Via |
Alejandro Pérez Milena | Luigi Matera |
Alejandro Rubio Zarapuz | Luigi Ruggiero |
Alejandro Silva Palacios | Luigi Schiavo |
Alejandro Suarez De La Rica | Luigi Tritapepe |
Alejandro Tello | Luis Augusto Palma Dallan |
Aleksandar Miladinovic | Luis Bracero |
Aleksandar Rakic | Luis Cabral |
Aleksander Zwierz | Luis Carrasco |
Aleksandra Asaturova | Luis Cobos Puc |
Aleksandra Bondžić | Luis Eduardo Almeida |
Aleksandra Klisic | Luis Fernandez |
Aleksandra Kuzan | Luis Fonte |
Aleksandra Stachoń | Luis Gales |
Aleksandra Szylińska | Luis García-Marcos |
Aleksandra Zeljkovic | Luis Jacinto-Alemán |
Aleksandras Vilionskis | Luis Junquera |
Alena Buková | Luis Larrea |
Ales Blinc | Luis Leitão |
Aleš Dolenec | Luis Ochoa-Ramirez |
Ales Rozman | Luís Puga |
Alessandra Borchiellini | Luis Puig |
Alessandra Di Maria | Luis Ramirez-Gonzalez |
Alessandra Micera | Luis Ribeiro |
Alessandra Verzelloni Sef | Luís Roberto Gonçalves |
Alessandro Genazzani | Luis Sánchez Vargas |
Alessandro Gonfiotti | Luis Servia Goixart |
Alessandro Guida | Luis Tallón-Aguilar |
Alessandro Pasculli | Luisa Masciullo |
Alessandro Pedicelli | Luiz Vinicius De Sousa |
Alessandro Ramieri | Luka Crnošija |
Alessandro Strumia | Luka Matak |
Alessandro Zucchi | Lukas Fiedler |
Alessio Conti | Lukas Holzer |
Alessio Mylonas | Lukas Müller-Wirtz |
Alessio Paladini | Lukas Schroeder |
Alessio Rizzo | Lukasz Antkowiak |
Alex Crisp | Lukasz Dobrek |
Alexa Klettner | Łukasz Lewandowski |
Alexander Christ | Lukasz Nawacki |
Alexander Dullenkopf | Łukasz Pulik |
Alexander Edo Tondas | Luke Chong |
Alexander H. Maass | Lusi Zhang |
Alexander Nikolaev | Lut Tamam |
Alexander Otahal | Luz Angela Torres-De La Roche |
Alexander Pugovkin | Luz Gonzalez |
Alexander Shinkov | Lydia Gaba |
Alexander Zemchenkov | Lysandro Borges |
Alexander Zimmermann | Lyudmila Bel'Skaya |
Alexandr Ceasovschih | M Idoia Ugarte-Gurrutxaga |
Alexandra Filippopoulou | M. Luz Sanchez-Sanchez |
Alexandra Lappas | Mabel Noemí Brunotto |
Alexandra Roman | Mabliny Thuany |
Alexandra Vornicu | Macarena Lozano |
Alexandre Hudon | Maciej Dyrbuś |
Alexandrina Nikova | Maciej Kochman |
Alexandros Rovas | Maciej Socha |
Alexandros Sykaras | Maciej Walędziak |
Alexandru Mester | Madankumar Ghatge |
Alexandru Vlasa | Madhup Rastogi |
Alexey Mazurov | Madhuradhar Chegondi |
Alexey Sumin | Magdalena Cyma-Wejchenig |
Alexi Kiss | Magdalena Emilia Grzybowska |
Alexis Murillo Carrasco | Magdalena Hurkacz |
Alexsandra Christianne Malaquias | Magdalena Mackiewicz-Milewska |
Alfredo Abad-Gurumeta | Magdalena Mroczek |
Alfredo Bellon | Magdalena Wujak |
Alfredo Caturano | Magdalena Zemelka-Wiacek |
Alfredo G. Casanova | Magdalena Żychowska |
Alfredo J. Lucendo | Magdy Abdelhamid |
Alhadi Jahan | Magdy Algowhary |
Ali Azhar Dawasaz | Maged Elghannam |
Ali Kashkooe | Maha Emad Ibrahim |
Ali Kerim Yılmaz | Maha Nasr |
Ali Montazeri | Mahdi Mahdipour |
Ali Ulas | Mahdi Majlesi |
Aliaksandr Varabei | Mahdi Shahmoradi |
Alice Grossi | Mahesh Gupta |
Alicia Rodriguez-Pla | Mahmoud Abdallah |
Alicia Romero-Lorca | Mahmoud Balbaa |
Alicia Ruiz-Pomeda | Mahmoud Elbattah |
Alida Caforio | Mahmoud Elzanaty |
Alin Laurentiu Tatu | Mahmoud Farzat |
Alin Nedelcu | Mahmoud Singer |
Alina Dima | Mai Albaik |
Alina Zorina Stuparu Stroe | Maite Antonio Rebollo |
Alin-Constantin Pînzariu | Maite Rivera Gorrin |
Alireza Baratloo | Maja Socan |
Alise Balcere | Maja Tomicic |
Alisha Akya | Majed Alamri |
Alister Du Rose | Makoto Endo |
Alkistis Adramerina | Makoto Inoue |
Allegra Ferrari | Makoto Nakamura |
Allen Titus | Makoto Takei |
Alma Nurtazina | Malcolm Miller |
Almerinda Agrelli | Malene Pedersen |
Almudena De Laiglesia | Małgorzata Blatkiewicz |
Alper Bilgic | Małgorzata Buksińska-Lisik |
Alper Öztürk | Małgorzata Chojak |
Alperen Degirmenci | Małgorzata Gietka-Czernel |
Alpesh Goyal | Małgorzata Kołodziej |
Altijana Hromic-Jahjefendic | Małgorzata Mrowicka |
Álvaro Astasio-Picado | Malgorzata Sawicka-Żukowska |
Alvaro Macias | Małgorzata Szczuko |
Alvaro Manuel Rodriguez-Rodriguez | Małgorzata Znyk |
Amalia Cornea | Malika Kengsakul |
Amanda Kvist-Hansen | Man Ki Ju |
Amanda Radulescu | Manan Shah |
Amanda Trout | Manarshhjot Singh |
Amany Abdel-Rahman | Manazir Athar |
Amany Sholkamy | Mandeep Singh Rahi |
Amaranta De Miguel-Rubio | Manfred Schmidt |
Amato Santoro | Manish Dhawan |
Amely Hartmann | Manish Gupta |
America Vanoye-Carlo | Manish Manrai |
Ami Mehta-Doshi | Manoel Rios |
Amin Nakhostin-Ansari | Manoj Neog |
Amine Khaldi | Manoj Saxena |
Amir Faisal | Manoj Tembhre |
Amir Kashi | Manon Pigeolet |
Amir Mahdjoubi | Manpreet Semwal |
Amirhesam Babajani | Mansoor-Ali Vaali-Mohammed |
Amirhossein Ahmadi | Mansour Alghamdi |
Amirmohammad Khalaji | Mansur Sandhu |
Amit Chougule | Manuel Coheña-Jimenez |
Amit Gaikwad | Manuel Delgado-Vélez |
Amit Goel | Manuel Díez-Alonso |
Amita Attlee | Manuel Florian Struck |
Ammad Ahmad Farooqi | Manuel López-Baamonde |
Amnah Algarni | Manuel Luís Capelas |
Amr Ahmed El-Arabey | Manuel Muro |
Amr Arafat | Manuel Obermaier |
Amr Mohamed | Manuel Rebollo Salas |
Amrin Kharawala | Manuel Vilela |
Amritlal Mandal | Manuela Andrea Hoffmann |
Amro Amara | Manuela Mastronardi |
Amutha Ramadas | Maochun Wang |
Ana Andabak Rogulj | Mara Carsote |
Ana Cristina Ribeiro | Marc Hendrikx |
Ana Dascalu | Marcel Adler |
Ana Gascón-Catalán | Marcel Kunrath |
Ana Leticia Fornari Caprara | Marcel Niemann |
Ana Lúcia Ramos | Marceli Lukaszewski |
Ana Messias | Marcello Ambrogi |
Ana Moreno Alvarez | Marcello Benevento |
Ana Paula Rodrigues | Marcello Della Corte |
Ana S. Pejčić | Marcello Di Martino |
Ana Sofia Pais | Marcelo Alarcón |
Ana Sofia Vallés | Marcelo Coertjens |
Ana Vinhas | Marcelo Ferreira |
Anabela Correia | Marcelo Nascimento |
Anamaria Cozma-Petruț | Marchel Vetrile |
Anamaria Savu | Marcia Bastos Convento |
Anamarija Šestak | Márcia Teixeira |
Anand Paramasivam | Marcin Jozwik |
Anand Singh | Marcin Kozuch |
Anand Sundaralingam | Marcin Włodarczyk |
Anastasia Papaporfyriou | Márcio Formiga |
Anastasia Raymer | Marco Bongiovanni |
Anastasios Apostolos | Marco Ferrari |
Anastasios Potiris | Marco Fogante |
Anastasios Serbis | Marco Germanotta |
Anastasiya Kazantseva | Marco Invernizzi |
Anca Bobirca | Marco Manfredi |
Anca Huniadi | Marco Manzetti |
Ancuta Mihai | Marco Materazzo |
Anders Gottsater | Marco Meyer |
Anders Gram-Hanssen | Marco Mouanness |
Andleeb Khan | Marco Sapienza |
Andor Molnár | Marco Thomas |
András Molnár | Marco Zedda |
André Antonio Pelegrine | Marc-Olivier Deguise |
Andre Luiz Costa | Marcos Brioschi |
André Pereira | Marcos Herkenhoff |
André Ramalho | Marcy Martin |
Andrea Ambrosini-Spaltro | Marek Bolanowski |
Andrea Buono | Marek Kiliszek |
Andrea Buonsenso | Marek Koziński |
Andrea Capucciati | Marek Nahajowski |
Andrea Carai | Margarita Ivanova |
Andrea Carugno | Margherita Pallocci |
Andrea Cimini | Margit Serban |
Andrea Ciricugno | Margriet Fleur Charlotte De Jong |
Andrea Corda | Mari Leppänen |
Andrea Cozzolino | Mari Sakamoto |
Andrea Emanuele Guerini | Maria Millan |
Andrea Fabbri | Maria A. Baturova |
Andrea Frosolini | Maria A. Bonifacio |
Andrea Grillo | Maria A. Poca |
Andrea Mari | Maria Antonio Castro |
Andrea Michelerio | Maria Barsan |
Andrea Molnár | Maria Begoña Criado |
Andrea Pantalone | Maria Blanco-Diaz |
Andrea Piasentin | Maria Boboshko |
Andrea Teufelberger | Maria Carmela Pera |
Andrea Tigrini | Maria Chiara Maccarone |
Andrea Vianello | María Coronada Fernández Calderón |
Andrea Vukic Dugac | Maria Cristina De Martino |
Andrea Weinzierl | María Del Mar Fernández Álvarez |
Andreas Brodehl | Maria Di Pace |
Andreas Enz | Maria Florence |
Andreas G. Tsantes | Maria Gabriela Anitei |
Andreas Kalogeropoulos | Maria Ida Maiorino |
Andreas Koulouris | Maria Jesus Vinolo-Gil |
Andreas Lipphaus | Maria José De Santos |
Andreas Mitsis | Maria Kapritsou |
Andreas Toepfer | Maria Kercheva |
Andreea Kui | Maria Lorenza Muiesan |
Andreea Moga | Maria Ludovica Ruggeri |
Andrei Adrian Tica | María Luna Luna |
Andrei Marian Feier | Maria Malvina Tsamouri |
Andrej Belančić | Maria Miletta |
Andrej Cokan | Maria Mondardini |
Andreja Sinkovic | Maria Naufel |
Andres Tittarelli | Maria P Ntalouka |
Andreu Comas-Garcia | Maria Paola Bertuccio |
Andrew A. Gumbs | Maria Papasavva |
Andrew Bentley | Maria Rita Bianco |
Andrew Gladden | Maria Salbini |
Andrew Huang | Maria Salomé Ferreira |
Andrew J. | Maria Simonenko |
Andrew Kolarik | Maria Szubert |
Andrew Leask | Maria Teresa Barreiros Tomás |
Andrey Dubovoy | Maria Teresa Bruno |
Andrey Glotov | María Teresa Hernández-Huerta |
Andrey Petrov | Maria Teresa Villarreal Molina |
Andrija Matetic | Maria Totan |
Andrius Pranskunas | Maria Vega Pittao |
Andrzej Konieczny | María Velásquez |
Aneta Aleksova | Maria Zavala-Cerna |
Aneta Klotzka | María-Arántzazu Ruescas-Nicolau |
Aneta Ostróżka-Cieślik | Maria-Carmen Silva-Viguera |
Aneta Otocka-Kmiecik | Mariaconsiglia Ferriero |
Angel Augusto Perez-Calatayud | Maria-Elissavet (Mariliza) Nikolaidou |
Ángel Becerra-Bolaños | Maria-Jimena Mucino-Bermejo |
Ángel Chimenea | Marialucia Gallorini |
Ángel Luis García-Otín | Marialuisa Zedde |
Angel Vértiz-Hernández | Marian Mihai |
Angela Comanducci | Marian Simka |
Angela De Palma | Mariana Câmara-Souza |
Angela M. Malek | Mariana Floria |
Angela Madalina Lazar | Mariana Melo |
Angela Papa | Mariangela Mancini |
Ângela Yamamoto | Marianna Berton |
Ángeles Rovirosa | Marianna Kapsetaki |
Angelika Buczynska | Marianna Török |
Angeliki Angelidi | Mariarosaria Campise |
Angeliki Papageorgiou | Mariateresa Rossi |
Angelo Castello | Maribel Acién |
Angelo Fumia | Mariella D'Angiò |
Angelo Hooker | Marie-Luise Klietz |
Angelo Michele Inchingolo | Marija Vukoja |
Angelo Mottaran | Marika Comegna |
Angelo Naselli | Marilena Mangiardi |
Angelo Roberto Raccagni | Marilia Carabotti |
Angelo Scuteri | Mariluz Latorre-Moratalla |
Angelo Torrente | Marin Lozić |
Angelo Troedhan | Marin Ogorevc |
Angelos Karelis | Marina Holyavka |
Angelos Papadopoulos | Marina Khodanovich |
Angus Oli | Marina Letica Crepulja |
Anichavezhi Devendran | Marina Mat Baki |
Anil Rajendra | Marino Paroli |
Anirejuoritse Bafor | Mario Diaz |
Anjali Geethadevi | Mario Diplomatico |
Ankit Tomar | Mario Fruschelli |
Ankush Kawali | Mario Ganau |
Anna Caretto | Mario Nava-Villalba |
Anna Cybulska | Mario Pacilli |
Anna Dückelmann | Mario Simirgiotis |
Anna Furlan | Mario Šokac |
Anna Hadamus | Marios Papasotiriou |
Anna Jamroz-Wis̈Niewska | Marisa Varrenti |
Anna Kasielska-Trojan | Marish Oerlemans |
Anna Kitta | Marius Baranauskas |
Anna La Salvia | Marius Craina |
Anna Lipert | Marius Keller |
Anna Paradowska-Stolarz | Mariusz Niemczyk |
Anna Piotrowska | Mariusz Siemiński |
Anna Podlasek | Mariusz Stasiolek |
Anna Rozaliyani | Mariya Smetanina |
Anna Shcheglova | Marjan Mirsalehi |
Anna Staniszewska | Márk Antal |
Anna Stochel-Gaudyn | Mark Barakat |
Anna Woźniak-Biel | Mark Cronshaw |
Anna Zalewska | Mark Fox |
Annalisa Barbieri | Mark I. Johnson |
Annalisa Grandi | Mark J. Roef |
Anna-Maria Barciszewska | Mark Timmions |
Anne Demulder | Marko Baralić |
Annibale Antonioni | Marko Bašković |
Annina Vischer | Marko Tarle |
Ann-Kathrin Kahle | Markus Gesslein |
Anoop Rawat | Markus Kipp |
Antoine Naem | Markus Kuster |
Anton Kiselev | Markus Oertel |
Antón L. Martínez | Markus Puchinger |
Anton Tyurin | Markus Wilhelmi |
Antonella Loperfido | Marlon Mencia |
Antonella Olivero | Marouan Zoghbi |
Antonella Santonicola | Marousa Kouvela |
Antoni Stadnicki | Marshall Williams |
Antonia Marciano' | Marta Grabowska |
Antonietta G Gravina | Marta Greco |
Antonino S. Rubino | Márta Hock |
Antonio Álvarez-Kindelán | Marta Krasny |
Antonio Artigas | Marta Nardini |
Antonio Aversa | Marta Regina Cezar-Vaz |
Antonio Borzelli | Marta Rogalska |
Antonio Córdoba-Fernández | Marta Rojas Gimenez |
Antonio De Vita | Marta Rusek |
Antonio Fortunato | Marta Woldanska-Okonska |
Antonio Francesco Maria Giuliano | Marta Wysocka-Mincewicz |
Antonio Franco | Marta-C. García-Romera |
Antonio Gidaro | Martha Alejandra Morales-Sánchez |
Antonio Guaita | Martha Sierra-Vargas |
Antonio J. Amor | Martin Bedolla-Barajas |
Antonio Klasan | Martin Hartrumpf |
Antonio M. Picó | Martin Michel |
Antonio Marzola | Martin Sigl |
Antonio Mazzotti | Martin Teraa |
António Miguel Morgado | Martina Baiardo Redaelli |
Antonio Oliveira | Martina Kleber |
Antonio Pinna | Martina Ozbič |
Antonio Portoles | Martina Schmiedhofer |
Antonio Quintero Rincón | Martina Zigante |
Antonio Romanelli | Márton Berczeli |
Antonio Rosales-Castillo | Márton Kivovics |
Antonio Salsano | Marwa Zalat |
Antonio Santagostini | Marwan El Ghoch |
Antonio Tufano | Maryam Naghibolhosseini |
Antonio Yaghy | Maryam Poursadeghfard |
Antonios Koutras | Maryam Ranjbar |
Anupam Mukherjee | Marzia Baldereschi |
Anupama Gupta | Marzia Segù |
Anupama Rani | Marzieh Nojomi |
Anurag Satpathy | Marzieh Saei Ghare Naz |
Anusha Shanbhag | Masaaki Minami |
Anwar Sayed | Masahiko Ayaki |
Apichat Kaewdech | Masaru Tanaka |
Apostolos Agrafiotis | Masaru Yamaguchi |
Apostolos Mamopoulos | Masateru Kawakubo |
Apostolos Tsolakis | Masoud Golakani |
Aram Boada | Masoud Keikha |
Aravind Thavamani | Masoud Mohammadnezhad |
Arboix Adrià | Masoud Sadeghi |
Archana Rajagopalan | Massimiliano Piatti |
Arda Güler | Massimo Bonacchi |
Arda Isik | Massimo Ganassi |
Argyro Pachi | Massimo Mapelli |
Arindam Ghosh Mazumder | Massimo Serra |
Aris Kaltsas | Massimo Torreggiani |
Aristeidis Stavroulopoulos | Mate Vamos |
Arkadeep Dhali | Matei Bratu |
Arkadiusz Lubas | Mateusz Szudzik |
Arman Rahimmi | Matheus Bertanha |
Armando Patrizio | Matheus Sewastjanow-Silva |
Armin Kraus | Mathias Reichert |
Arnaldo Santos | Mathieu Delorme |
Arne Mehrkens | Matias Ferrán Escobedo |
Arnulfo Alanis | Mats C. Ranebo |
Aron Tendler | Mats Eriksson |
Arshiya Sultana | Mats Remberger |
Arthur Melkumyants | Matteo Armillotta |
Arthur Yee | Matteo Bianco |
Artur Owczarek | Matteo Bradicich |
Artur Słomka | Matteo Della Zoppa |
Arun Pandian J | Matteo Mario Carlà |
Arun Shah | Matteo Martinato |
Arunava Ghosh | Matteo Neri |
Arunee Promsri | Matteo Riccò |
Arun-Kumar Kaliya-Perumal | Matteo Ripa |
Arup Acharjee | Matteo Sangiorgi |
Aryvelto Miranda Silva | Matthew Benesch |
Asaad Babker | Matthew Hiskens |
Asaf Honig | Matthew Hoptman |
Asha Tyagi | Matthew Strub |
Ashish Runthala | Matthias Fröhlich |
Ashok Kumar | Matthias Kapischke |
Ashok Kumar Srinivasan | Matthias Renker |
Ashokkumar Manickam | Matthias Unterhuber |
Ashraf Kariminik | Matthieu Lalevée |
Ashraf Roshdy | Mattia Paratore |
Ashraf S. Gorgey | Mattia Russel Pantalone |
Ashril Yusof | Mau-Ern Poh |
Ashwani Sharma | Maurits K. A. Van Selms |
Asker Khapchaev | Maurizio Leone |
Asra Al Fauzi | Maurizio Marchesini |
Assunta Pozzuoli | Maurizio Romagnuolo |
Atefeh Najafi | Maurizio Stella |
Atefeh Vaezi | Mauro Biffi |
Athanasia Proklou | Mauro Jurno |
Athanasios Konstantinidis | Max Tischfield |
Athanasios Pantelis | Maximilian Deußing |
Athanasios Papadopoulos | Maximilian Hammer |
Athanasios Vergados | Maximilian Scheer |
Athanasios-Dimitrios Bakasis | Maximilian Zaussinger |
Athikhun Suwannakhan | Maya N. Hatch |
Athina Samara | Mayank Gautam |
Atsuko Nakayama | Mayrel Palestino Dominguez |
Atsumi Tsuji-Hosokawa | Mayu Fujikawa |
Atsushi Kawahara | Md Belal Bin Heyat |
Atsuto Katano | Md Sayeed Akhtar |
Attila Frigy | Mederle Ovidiu Alexandru |
Attila Roka | Meenakshi Maurya |
Attilio Cavezzi | Megan Crumbaker |
Atukuri Dorababu | Megan L. Falsetta |
Audrius Dulskas | Mehmet Baysal |
Aung Kyaw | Mehran Falahchai |
Aurelio Olmedilla-Zafra | Mehran Ghasemzadeh |
Avram Manea | Mehran Shayganfard |
Ayaz Ahmed | Mehrnaz Shoushtarian |
Aybars Kıvrak | Mehul Adhaduk |
Ayman Elsamanoudy | Meihui Wu |
Aynur Özge | Meiji Soe Aung |
Ayodele Akinremi | Meir Barak |
Ayokanmi Ore | Meitsz Su |
Ayse Gunes-Bayir | Melanie Walker |
Aysegul Sari | Melis Palamar |
Ayush Dogra | Melissa Grigorescu |
Azamossadat Hosseini | Mengxi Shen |
B. V. Swapna | Mercedes Bermúdez |
Babak Chehroudi | Mercedes Bueno-Campaña |
Babita Kumari Verma | Mercedes Gimeno |
Balazs Horvath | Mercedes Mitjavila Casanovas |
Baptiste Demey | Meredith Yeung |
Barani Kumar Rajendran | Metaxia Bareka |
Barbara Gawda | Mi Bai |
Barbara Giordani | Micael Gerardo Bravo-Sánchez |
Barbara Jasiewicz | Michael Diamantidis |
Barbara Kirnbauer | Michael Dworzak |
Barbara Lapinska | Michael Eichinger |
Barbara Mognetti | Michael Fadel |
Barbara Ruaro | Michael Fritz |
Barbara Sándor | Michael Garnet Irwin |
Bart Laan | Michael Gembicki |
Bart Van Hoek | Michael Gruber |
Bartłomiej Barczyński | Michaël Hardy |
Bartłomiej Górski | Michael Joachim |
Bartłomiej Henryk Noszczyk | Michael Kelly |
Bartosz Małkiewicz | Michael Oeverhaus |
Basant Puri | Michael Osseis |
Basavaraj Balapal | Michael Owusu |
Basem Battah | Michael Schirmer |
Batuhan Gencer | Michael Sticherling |
Bayode Romeo Adegbite | Michael Wester |
Beata Łabuz-Roszak | Michael Zeiler |
Beata Mrozikiewicz-Rakowska | Michaela Cellina |
Beatrice Gallo | Michail Diakosavvas |
Beatrice Paradiso | Michail Papafaklis |
Belen Alonso Ortiz | Michał Ciurzyński |
Belgin Akın | Michal Czapla |
Ben Beaglehole | Michał Ginszt |
Bence András Lázár | Michał Gontarz |
Benedetto Morelli | Michał Kulus |
Benedict Francis | Michał Łobacz |
Benjamin Rolles | Michal Nowak |
Benjamin Valente-Acosta | Michal Ordak |
Benjamin Voellger | Michal Pruc |
Bergin Shan | Michał Tomaszewski |
Bernard Speculand | Michel Noutsias |
Bernardo Cacho-Díaz | Michel Roethlisberger |
Bernardo Pereira | Michela Rossi |
Bernat Soria | Michela Saracco |
Bernice Gulek | Michela Terlizzi |
Beth Cadugan | Michelangelo La Placa |
Beth Schrope | Michele Boffano |
Bethany Keenan | Michele Campigotto |
Betul Karademir | Michele Correale |
Beyza Goncu | Michele Costanzo |
Beyza Ünalan Değirmenci | Michele Coviello |
Bhakti Basu | Michele Finotti |
Bhim Rai | Michele Lioncino |
Bhupendra Prajapati | Michele Malaguarnera |
Bidisha Mitra | Michele Schiano Di Visconte |
Bi-He Cai | Michelle Zappas |
Bilal Haj Najeeb | Michihiro Hide |
Bilal Kirmani | Mieszko Wieckiewicz |
Biljana Kurtović | Miguel Á. Castro Villamor |
Biljana Popeska | Miguel A. Ortega |
Bin Wang | Miguel Ângelo Cardoso |
Binaya Sapkota | Miguel Armengot |
Bipradas Roy | Miguel Castelo-Branco Sousa |
Birgit Markus | Miguel Gonzalez-Gay |
Birgit Schramm | Miguel Mayol Del Valle |
Birol Topçu | Miguel Nobre Menezes |
Bjarte Tidemann Andersen | Miguel Pino |
Björn Nashan | Miguel Urina-Triana |
Blanca Bazán-Perkins | Miha Mrak |
Blanca Gonzalez Sanchez | Mihael Tsalta-Mladenov |
Blažen Marijić | Mihaela Avram |
Bogdan Chis | Mihaela Balas |
Bogdan Geavlete | Mihaela Hostiuc |
Bogdan Gherman | Mihaela Moscalu |
Bogdan Iliescu | Mihaela Niculae |
Bogdan Socea | Mihaela Pertea |
Bogdan Stancu | Mihaela Spataru |
Bogna Grygiel-Górniak | Mihaela Vlad |
Bogomir Milojevic | Mihai Capilna |
Bojan Masanovic | Mihai Craiu |
Bojan Stojanovic | Mihai Cristian Dumitrascu |
Bojan Vujkovac | Mihai Dumitru |
Bolin Li | Mihai Georgescu |
Boon Seng Liew | Mihai Popescu |
Boris Kozlov | Mikael Forsman |
Božena Ćurko-Cofek | Mikhail Efanov |
Branimir Anić | Mikhail Golman |
Branislava Milenkovic | Mikhail Kostik |
Bratko Filipic | Mikołaj Maga |
Breno Fernando Martins De Almeida | Milad Shirvaliloo |
Brent Siesky | Milaine Sanfins |
Brian Howe | Milan D. Perovic |
Brian J Piper | Milen Dimitrov |
Bruce Duncan | Milena Tomanic |
Bruno Fionda | Miles Weinberger |
Bruno Imbimbo | Milica Jeremić Knežević |
Bruno Macedo De Sousa | Milica Lukic |
Bruno Rego | Milica Markelic |
Bugra Karasu | Miljan Krstić |
Buong-O Chun | Milos Matkovic |
Burcin Celik | Miloš Štulić |
C. Andrew Combs | Miłosz Caban |
Caio Sampaio | Milton Santos |
Calero Morales Santiago | Min Gyu Kyung |
Calin Homorodean | Min Wook Joo |
Cameron Kneib | Minenori Ishido |
Camil Mirestean | Minerva Codruta Badescu |
Camillo Fulchignoni | Ming Xu |
Camino De Juan Romero | Ming Yang |
Caner Günaydın | Ming-Chi Lu |
Carina Balcoş | Mingjian Shi |
Carina Ladeira | Mingming Zhao |
Carla Di Stefano | Minjeong Nam |
Carla Faria | Mio Ebato |
Carla Masala | Miquéias Lopes-Pacheco |
Carlo Bellucci | Mircea Lițescu |
Carlo Bieńkowski | Mircea Vasile Milaciu |
Carlo Contini | Mireia Puig-Campmany |
Carlo Finelli | Miriam F. Scelza |
Carlo Gandi | Mirjana Ždraljević |
Carlo Lavalle | Mirko Manetti |
Carlo Lucchesi | Mirta Kadivnik |
Carlo Maria Rossi | Mirto Foletto |
Carlos Aroso | Miruna A. Popa |
Carlos Cerdán Santacruz | Mirza Baig |
Carlos Delgado-Miguel | Mislav Mikuš |
Carlos Escobar | Mithun Rudrapal |
Carlos Filipe Portela | Mithun Santra |
Carlos Franco-Paredes | Mititelu Magdalena |
Carlos Guijarro | Mitsuhiro Nito |
Carlos Hernando Gómez Quintero | Mi-Yeon Eun |
Carlos Lam | Mladen Kocica |
Carlos López-De-Celis | Modupe Tunde-Byass |
Carlos Martín Ardila | Mohamed Abdelnaim |
Carlos O'Connor-Reina | Mohamed Abuzaid |
Carlos Ortiz Mendoza | Mohamed Ahmed Said |
Carlos Pérez López | Mohamed Boussarsar |
Carlos Rocha-De-Lossada | Mohamed G. Shiha |
Carlotta Cocchetti | Mohamed Gaballa |
Carly Filgueira | Mohamed Ibrahim |
Carmelina Zirafa | Mohamed Jaber |
Carmelo Caldarella | Mohamed Lounis |
Carmen Pavelescu | Mohamed Rahouma |
Carmen Ramírez | Mohamed Soltan |
Carmen Soria-Segarra | Mohammad Alkhatib |
Carmen Tyler | Mohammad Alwahsh |
Carmine Izzo | Mohammad Al-Wardat |
Carolina Donà | Mohammad Etoom |
Carolina Rodríguez-Llorente | Mohammad Hossein Khosravi |
Caroline Speksnijder | Mohammad Javanbakht |
Carrie Howell | Mohammad Kassar |
Carsten Tjell | Mohammad Khan |
Cassandra Hua | Mohammad Mofatteh |
Cássia Maria Fischer Rubira | Mohammad Mohammadianpanah |
Catalin Bulai | Mohammad Qneibi |
Catalin Herghelegiu | Mohammad Rafiee |
Catalina Mihai | Mohammad Reza Jamalpour |
Catalina Mourgues | Mohammad Zamani |
Catana Cristina | Mohammad Zulkifli |
Catarina Gregório Martins | Mohammadreza Shalbafan |
Catarina Tomás | Mohammad-Salar Hosseini |
Caterina Fede | Mohammed Ramadan |
Cecilia Jimeno | Mohammed Sayed |
Cecilia Lazea | Mohammed Shahait |
Cecilia Muglia | Mohammed Talle |
Cecilia Pegelow Halvorsen | Mohan Kalaiah |
Cees A. Swenne | Mohankumar Palaniswamy |
Celia Strunz | Mohanraj Thangamuthu |
Cenyi Wang | Mohd Kausar |
Cesar Martín Bozzola | Mohd Khairi Md Daud |
Cesare Danesino | Mohit Joshi |
Cesare Tosetti | Mohsen Korani |
Cevat Erisken | Mohsen Norouzinia |
Chaemoon Lim | Mohsin Shah |
Chaitanya Gadepalli | Moises Betancort |
Chaiyaboot Ariyachet | Moisés Franco Molina |
Chakradhara Rao S Uppugunduri | Moisés Silva |
Chamara Senaratna | Mojca Bizjak |
Chandima Tilakaratne | Mojtaba Bayani |
Chang Xu | Mojtaba Mokari |
Chang-Hee Suh | Mojtaba Moradi |
Chang-Tong Yang | Mona Alinejad-Naeini |
Changyu Huang | Mona Alshahawey |
Changzheng Chen | Mona El Zarif |
Charalampos Konstantinidis | Mona Sadat Larijani |
Charis Theodoridis | Mona Tan |
Charlene Kahler | Monica Cattaneo |
Charles C. Coddington | Monica Palermo |
Charles D. Ponte | Monica Rusticeanu |
Charles Norton | Monica Stufano |
Charles Reisman | Monica Zigman Suchsland |
Charmaine Van Eeden | Monika Franczuk |
Che-Hung Tsai | Monika Łopuszańska-Dawid |
Chen Xie | Monika Martiniaková |
Chen Zhao | Monika Mielus |
Chen-Cheng Yang | Monika Peshevska-Sekulovska |
Cheng Yang | Monika Ruszala |
Cheng-Chieh Yen | Monika Zawadka-Kunikowska |
Chengfeng Zhang | Monika. Szturmowicz |
Chengquan Ma | Moon Fai Chan |
Chengwei Huang | Mordechai Pollak |
Chen-Hua Liu | Morgan Michalet |
Chethan Kn | Morteza Taheri |
Chia-Hung Yu | Mostafa Hegazy |
Chiara Cinquini | Moto Fukai |
Chiara Comisi | Motohiro Munakata |
Chiara Panicucci | Mounir M. Salem Bekhit |
Chiara Pavanello | Mrinmoy Das |
Chiara Suffritti | Mudassar Iqbal Arain |
Chidozie Anyaegbu | Mufarriq Shah |
Chien-Chia Huang | Muhammad Anshory |
Chien-Hao Huang | Muhammad Jameel Mughal |
Chienhsiu Huang | Muhammad Mahmood |
Chien-Liang Chen | Muhammad N Zahid |
Chih-Wei Zeng | Muhammad Nadeem |
Chika Ezeana | Muhammad Sardaraz |
Chin Wen Tan | Muhammad Sarfaraz Iqbal |
Ching-Fu Wang | Muhammed Altinisik |
Chloe Fletcher | Muharrem Özkaya |
Chon In Kuok | Muna Barakat |
Chong Chen | Muneaki Matsuo |
Choo Hock Tan | Murad Abualhasan |
Choon Oh | Muralidharan Arumugam Ramachandran |
Chris Devera | Murat Akand |
Christian Bailly | Musheer A. Aljaberi |
Christian Berger | Mushriq Abid |
Christian Carulli | Mustafa Al-Zamil |
Christian Colcuc | Mustafa Cemali |
Christian Dalton-Locke | Mustafa Kursat Sahin |
Christian Gabriel Toledo Lozano | Mustafa Sevindik |
Christian Gernhardt | Mustapha Imam |
Christian Hagemann | Myriam Hadjouni |
Christian Saleh | Myriam Rubio |
Christian Selinger | Myung Seo Kim |
Christian Smolle | Nabi Jomehzadeh |
Christian Stoess | Nadeem Ullah |
Christian Volberg | Nader Bakheet |
Christian Wunder | Nader Tanideh |
Christina Oetzmann Von Sochaczewski | Nadezhda Fursova |
Christine Curcio | Nadhir Hammami |
Christine Steiert | Nadia Najafi |
Christof Roosli | Nadia Nasreddin |
Christoph Biehl | Nadine Darwiche |
Christoph Dietrich | Nadira Yuldasheva |
Christoph Faschinger | Nagendraprabhu Ponnuraj |
Christoph Mitsch | Nahid Ramazani |
Christoph Sinning | Nahla Gomaa |
Christoph Wölfl | Nahum Rosenberg |
Christophe Masset | Nalu Navarro-Alvarez |
Christopher Bagley | Nam Tran |
Christopher Carcia | Naman Vatsa |
Christopher Donnell | Nan Jiang |
Christopher Kobierzycki | Nan Miao |
Christopher Lenz | Nan Yang |
Christopher Roche | Nancy Kassem |
Christopher Sjöwall | Nancy Saad |
Christopher Wilcox | Naohiro Shioji |
Christoph-Ludwig Hennig | Naomichi Okamoto |
Christos A. Gogos | Naotake Funamizu |
Christos Katsouras | Naoto Iwai |
Christos Kontovounisios | Narendar Dudhipala |
Christos Kourek | Narendra Jha |
Christos Koutserimpas | Naresh Koju |
Christos Rizos | Naresh Kumar |
Christos Savopoulos | Naresh Kumar Ravichandran |
Chuan Hun Ding | Naresh Poondla |
Chuanming Xu | Naseer Ahmed |
Chuanwu Zhu | Naser Alsharairi |
Chun Woo Choi | Nasser Alsaleh |
Chun-Jen Huang | Nastaran Ghotbi |
Chunyue Wang | Natale Calomino |
Cihad Dundar | Natale Musso |
Cila Umat | Natalia A. Bezdenezhnykh |
Cinzia Giacometti | Natália Araújo |
Cinzia Trumello | Natalia Maciejewska |
Ciprian Danielescu | Natalia Motas |
Ciprian Rosca | Natalia Oliveira |
Ciprian Tanasescu | Natalia Piekuś-Słomka |
Ciro Romano | Natalia Shnayder |
Claes Frostell | Natalia Stepanova |
Claire Stocker | Natalia Torlińska-Walkowiak |
Clara Hjalmarsson | Natalya Glushkova |
Claude Arnal | Natascha Platz Batista Da Silva |
Claudia Bardoni | Natércia Conceição |
Cláudia Cristina Biguetti | Nathachit Limjunyawong |
Claudia Ferraris | Nathalie Jeanne Bravo-Valenzuela |
Claudia Kedor | Nathalie Vermeulen |
Claudia Todaro | Nathan Brown |
Claudio De Lazzari | Nathan T Zwagerman |
Claudio Sorino | Naveen Sendhilnathan |
Claudio Tirelli | Navid Abedpoor |
Claudio Zimatore | Nazario Foschi |
Claudiu Morgovan | Nazia Saiyed |
Claudiu N. Lungu | Nebojsa Prijovic |
Claudiu Popescu | Neda Baghban |
Claus Schildberg | Neda Stefanovic |
Clemens Schopper | Neelamadhab Padhy |
Clément Marcelin | Negrut Nicoleta |
Clemente Iodice | Nehal Hassib |
Collette Bromhead | Neil Bodagh |
Constantin Hintschich | Neil Nadkarni |
Corina Vasile | Nejc Umek |
Corinna Bruckmann | Neluwa-Liyanage Indika |
Corinna Culler | Nessr Abu Rached |
Cornelie Nienaber-Rousseau | Nestor Cabrera-Munoz |
Cornelis H. Pameijer | Néstor J. Martínez-Hernández |
Corrado Ciatti | Nevena Todorović Vukotić |
Corrado Pelaia | Nianqiao Gong |
Corrado Zengarini | Nicklas Staunstrup |
Cosima Prahm | Nico Van Bakelen |
Cosimo Bruni | Nicola Alberto Valente |
Cosimo Galletti | Nicola Marziliano |
Cosimo Nardi | Nicola Mondanelli |
Costas Chryssanthopoulos | Nicola Tambasco |
Crenguta Serboiu | Nicolae Gica |
Crescenzio Scioscia | Nicolás Rocchetti |
Cristian Baicus | Nicolas Segal |
Cristian George Tieranu | Nicole De Mello Fiallos |
Cristian Indino | Nicoleta Anton |
Cristian Mirvald | Nicoletta Mancianti |
Cristian Mornos | Nicolò Brandi |
Cristian Olteanu | Nicolò Girolimetto |
Cristian Persu | Nidhi Puranik |
Cristiana Soldani | Niels Qvist |
Cristiane Lamas | Niklas Schenker |
Cristian-Mihail Niculae | Nikola Štoković |
Cristiano Amarelli | Nikola Žaja |
Cristina Anghele | Nikolai Paul Pace |
Cristina Blebea | Nikolaos Gkantidis |
Cristina Capatina | Nikolaos Kakaletsis |
Cristina Galvan | Nikolaos Laliotis |
Cristina García-Bravo | Nikolaos Schizas |
Cristina Gavrilovici | Nikolaos Sideris |
Cristina Gluhovschi | Nikolaos Stavropoulos |
Cristina Grippaudo | Nikolaos Zaras |
Cristina Mambet | Nikolaos-Andreas Anastasopoulos |
Cristina Meniz Garcia | Nikolay Bugaev |
Cristina Monteiro | Nima Farshidfar |
Cristina Oprean | Nima Firouzeh |
Cristina Ramírez-Fernández | Nina Novozhilova |
Cristoforo Pomara | Nina Tikunova |
Cruciat Gheorghe | Nina Tyutyusheva |
Cuma Mertoglu | Nino Cocco |
Dafna Sussman | Nir Bar |
Daisuke Akagi | Nir Erdinest |
Damiano Patrono | Nirmal Mohakud |
Damir Fabijanić | Nirmala Parajuli |
Damir Franic | Nirmaljot Kaur |
Dan Alexe | Niroj Sahoo |
Dan Boitor-Borza | Nisarat Phithakwatchara |
Dan Granberg | Nishant Kumar |
Dan Tesloianu | Nitesh Kumar Poddar |
Dana Lawrence | Nitika Kumari |
Dana Otzel | Nitin Amdare |
Dana Sabir | Niya Mileva |
Daniel Alsoof | Nobuaki Miyahara |
Daniel Antwi-Amoabeng | Noemi Salmeri |
Daniel Barbosa | Noha Hammad |
Daniel Böger | Noor Al-Khathlan |
Daniel Costache | Noor Almandil |
Daniel Eiger | Nor Rafeah Tumian |
Daniel Gonzalez | Nora Hosny |
Daniel Gonzalez-Nieto | Norafiza Zainuddin |
Daniel Hier | Norhafiza Mat Lazim |
Daniel Lindegger | Norio Imai |
Daniel Meier | Noriyuki Ishihara |
Daniel Mønsted Shabanzadeh | Norma Ab Rahman |
Daniel O’Toole | Nouran Salah |
Daniel Ortega | Nuno Morais |
Daniel Piskorz | Nunzio Montelione |
Daniel Potaczek | Nur Sabrina Idrose |
Daniel Pozza | Nuria Novoa |
Daniel Reyes-Molina | Nur-Vaizura Mohamad |
Daniel San Juan Orta | Oana Almasan |
Daniel Ślęzak | Oana Sirbu |
Daniel Torres-Lagares | Octavian Andercou |
Daniel Zamora-Valdés | Octavian Neagoe |
Daniela Anistoroaei | Octavian Vasiliu |
Daniela Branzan | Ohsawa Suguru |
Daniela Buchaim | Oleh Berezsky |
Daniela Dobru | Oleksii Skorokhod |
Daniela Elena Serban | Olga Anatskaya |
Daniela Goncalves | Olga Burenina |
Daniela Nosch | Olga Di Fede |
Daniela Opriş-Belinski | Olga Lilia Garibay-Cerdenares |
Daniela-Roxana Matasariu | Olga Maria Nardone |
Daniele Garcovich | Olga Redina |
Daniele Maria-Ferreira | Olga S. Chumakova |
Daniele Panetta | Olgica Mihaljevic |
Daniele Sola | Olguța Orzan |
Danieli Andrade | Olimpia Pino |
Danijela Miljanovic | Oliver Kimberger |
Danijela Ristic-Medic | Oliver Sommerfeld |
Danijela Trifunovic-Zamaklar | Oliver Zeitz |
Danny Epsteina | Olubunmi Oladunjoye |
Daria Shishkova | Omar Almohammed |
Dario Calafiore | Omar Hamdy |
Dario Giorgio | Omar Janeh |
Dario Monzani | Ombretta Repetto |
Dario Pellegrini | Omid Mirmosayyeb |
Dário Sobral-Filho | Onan Perez-Hernandez |
Dariush Irani | Ondřej Jor |
Dariusz Bazaliński | Ondrej Kalita |
Dariusz Krok | Ondrej Kostov |
Dariusz Rydz | Oralia Alejandra Guillén |
Darlene Mitrano | Orestis Ioannidis |
Daryoush Babazadeh | Orhan Selcuk Guven |
Daša Stupica | Orhan Tansel Korkmaz |
David Bar-Or | Orietta Calcinoni |
David Bennett | Oriol Cantó Navés |
David Beversdorf | Orlando Guntinas-Lichius |
David Burmeister | Ornella Cominetti |
David Chambers | Osama Gheith |
David Champion | Osamu Samura |
David Daguet | Óscar Rapado-González |
David Jaramillo | Oskars Kalejs |
David Lawrence | Osman Akdemir |
David Meier | Osman Faruk Bayramlar |
David P Lin | Ouafa Sijilmassi |
David Parada | Ovidiu Pop |
David Ribas Pérez | Ovidiu Samoila |
David Santer | Oyuna Kozhevnikova |
David Žižek | Oyuntugs Byambasukh |
Davide Bizzoca | Pablo Avanzas |
Davide Borroni | Pablo Demelo‐Rodríguez |
Davide Brotto | Pablo Martinez-Camblor |
Davide Di Lazzaro | Pablo Thomas |
Davide Giuseppe Ribaldone | Pacholczak-Madej Renata |
Davide Romano | Pai Feng Hsu |
Davide Tosi | Pajaree Krisanapan |
Davor Kuiš | Palmieri Michelle |
Dawei Song | Paloma Malagón |
Dawid Ciechanowicz | Pan Huang |
Deborah Novelli | Panagiota Anyfanti |
Deepa Madathil | Panagiota Mitrou |
Deepa Patil | Panagiotis Gkrilias |
Deepak Ahire | Panagiotis Katrakazas |
Deepali Mathur | Panagiotis Mourmouris |
Deepika Yadav | Panagiotis Savvoulidis |
Dejan Raković | Panayiota Petrou |
Delcea Cristian | Pankaj Bhatia |
Demetrios J. Halazonetis | Pankaj Maheshwari |
Denis Dupoiron | Pantelis Zebekakis |
Denis Losik | Pao-Chu Chen |
Denise M.D. Özdemir-Van Brunschot | Paolo Albino Ferrari |
Deokjong Lee | Paolo Aluffi Valletti |
Derar H. Abdel-Qader | Paolo Brusini |
Despoina Tzanakaki | Paolo Castiglioni |
Devendra Kumar | Paolo Cavoretto |
Devendra Paudel | Paolo Orsaria |
Dharmendra Choudhary | Paolo Pelliccioni |
Dhaval Pau | Paolo Santini |
Dhiraj Bhatia | Paolo Savadori |
Di Li | Paolo Spath |
Diana Abo El Ola | Paolo Spinnato |
Diana Mackay | Paramita Basu |
Diana Popa-Andrei | Paraschiva Chereches-Panta |
Diana Rodríguez-Hurtado | Parham Habibzadeh |
Diana Zaliaduonyte | Parichehr Zarean |
Diego De Ortueta | Paris Binos |
Dillon Mintoff | Parisa Ziarati |
Dimitrios A. Liakopoulos | Partha Narayan Dey |
Dimitrios Balalis | Parvaneh Karimzadeh |
Dimitrios Flevas | Parveen Rewri |
Dimitrios Panagopoulos | Parwis Massoudy |
Dimitrios Papageorgiou | Pasquale Paolisso |
Dimitris Dimzas | Pasquale Sessa |
Dimitris Miliopoulos | Pasquale Viggiano |
Dimitris Tatsis | Pasqualino Sirignano |
Dimitris Tsakogiannis | Patrícia Monteiro Seraphim |
Dimosthenis Lykouras | Patricia Wadowski |
Dinesh Verma | Patrick Dällenbach |
Ding Zou | Patrick G. Arndt |
Dion Enari | Patrik Šimják |
Dionisio Carvalho | Patrycja Matusik |
Dionysios Tafiadis | Pattharawin Pattharanitima |
Divya Radhakrishnan | Paul Corris |
Diwakar Guragain | Paul Henderson |
Djayanti Sari | Paul Oakley |
Dmitri Panfilov | Paul Ramirez |
Dmitriy Viderman | Paul Vanderlaan |
Dmitry Verbenko | Paul Viscuse |
Doina Andrada Mihai | Paula Parás-Bravo |
Doina Carstea | Paulina Adamska |
Doina Todea | Paulina Cegla |
Domagoj Vidosavljevic | Paulina Dumnicka |
Domen Vozel | Paulo Schwingel |
Domenico Baldini | Paulo Tambasco De Oliveira |
Domenico Di Raimondo | Paulo Victor Sgobbi Souza |
Domenico Diacono | Pavan Kripashankar Patel |
Domenico Ferro | Pavel Calda |
Dominic Augustine | Pavel Onofrei |
Dominic Iliescu | Pavel Solopov |
Dominicus Husada | Paweł Borkowski |
Dominik Dłuski | Pawel Grabala |
Dominique Israël-Biet | Paweł Rynio |
Dong Ha Lee | Paweł Wałek |
Dong Hyun Kim | Paweł Wańkowicz |
Dong Keon Yon | Payal Ganguly |
Dong Luo | Payam Safavi‐Naeini |
Dongheon Kang | Payton Yau |
Dongrong Xu | Pedro Arce |
Dongying Zhang | Pedro Infante-Cossio |
Dor Golomb | Pedro Serralheiro |
Dora Visnjic | Pekka Puska |
Dorin Novacescu | Pembe Oltulu |
Dorota Tichaczek-Goska | Peng Chen |
Douglas Lightstone | Peng Zheng |
Do-Youn Lee | Pengfei Dong |
Dr Jaya Shanker Tedla | Pengyu Zong |
Dragana Gabric | Per Nordin |
Dragana Krstic | Pere Torán-Monserrat |
Dragana Lazarević | Petar Brlek |
Dragana M. Stanojevic | Peter Choate |
Dragos Apostu | Peter Hadden |
Dragos Predescu | Peter Hauser |
Dragos Scarlet | Peter Keogh |
Dragos Serban | Péter Kupó |
Dražen Čular | Peter Kvarda |
Drew Braet | Peter Mitro |
Duilio Divisi | Peter Piko |
Duilio Pagano | Peter Pilot |
Durga Prasanna Misra | Peter Reinach |
Durgadevi Ravillah | Peter Schnuelle |
Dusan Popovic | Peter Seah Keng Tok |
Dusanka Obradovic | Peter Szatmary |
Dushad Ram | Petras Navickas |
Duska Martinovic Kaliterna | Petros Ioannou |
Dustin Hillerson | Petroula Nana |
Dzintra Kazoka | Philip Houck |
Ebenezer Esenogho | Philipp Kriechling |
Ebrahim Asadi | Philippe Gorce |
Ebrahim Kouhsari | Philippe Lewalle |
Ebtesam Al-Suhaimi | Philippe Tscholl |
Eckart Haneke | Philippos Klonizakis |
Edda Tschernko | Pierfrancesco Visaggi |
Edel Noriega Álvarez | Piergiusto Vitulli |
Edgar F. Manrique-Hernández | Pierluigi Fracasso |
Edgar G. Ordóñez-Rubiano | Piero Antonio Zecca |
Edgar García-Torres | Pietro Alfano |
Edgar Ramos Martínez | Pietro Cacialli |
Edgar Vieira | Pietro Geri |
Edit Hermesz | Pietro Mazzeo |
Edit Xhajanka | Pietro Orlando |
Edith Claros | Pietro Spennato |
Edmund Cheung So | Pilar Font-Ugalde |
Edoardo Bianchini | Pilar Paredes |
Edoardo Maria Muttillo | Pinar Cevik |
Edoardo Pasqui | Pınar Cihan |
Edoardo Pirera | Pinelopi Arvaniti |
Edoardo Porto | Piotr Futyma |
Edoardo Sciatti | Piotr Gabryel |
Eduardo Couchonnal | Piotr Krajewski |
Eduardo Vieira Neto | Piotr Rutkowski |
Edwards Emily S.J. | Piotr Szkodziak |
Edwin Bechir | Piotr Szwed |
Edyta Pasicka | Piyush Baindara |
Edyta Tulewicz-Marti | Plamen Todorov |
Edyta Urbanska | Poay Sian Sabrina Lee |
Edyta Zbroch | Poletti Enrico |
Efthymia Papadopoulou | Pornchai Sathirapanya |
Eftychia Demerouti | Pragya Lodha |
Egidio Candela | Pranav Kidambi |
Ehab S. El Desoky | Pranav Prabhakar |
Eirini Grapsa | Pranothi Mulinti |
Eitaro Kodani | Prapaporn Suprasert |
Ejvind Hansen | Prasath Manogaran |
Ekaterina A. Narodova | Prashant Damke |
Ekaterina Diachkova | Prathyusha Bagam |
Elamara Vieira | Pratibha Gopalkrishna |
Eleftherios Anastasopoulos | Pratikkumar Desai |
Eleftherios Gkioulekas | Praveen Kumar Kandakurti |
Eleftherios Paraskevopoulos | Pravin Sehgal |
Elena Amaricai | Prawej Ansari |
Elena Bernad | Prem Menon |
Elena Dantes | Priyanka Dogra |
Elena Dinte | Przemysław Chmielewski |
Elena Donetti | Przemyslaw Kosinski |
Elena Fico | Puneet Saxena |
Elena Grakova | Pushpa Rao |
Elena Koroleva | Qi Dai |
Elena Navarro | Qian Chen |
Elena Porumb- Andrese | Qian Ma |
Elena Rezus | Qianrong Qi |
Elena Sacco | Qida Zhang |
Elena Shipitsyna | Qin Xiang Ng |
Elena Svirshchevskaya | Qingsen Shang |
Elena Tomba | Qing-Wei Chen |
Elena Vorobyeva | Qingxiang Guo |
Elena Zakharova | Qiwen Deng |
Elena Zharkikh | Quanyou Zhang |
Elena-Lia Spoiala | Rachid Ait Addi |
Elena-Raluca Baciu | Rada Kazakova |
Eleni Gkrinia | Rada Miskovic |
Eleni-Myrto Trifylli | Rade M. Babić |
Elenko Popov | Radha Ramadevi |
Eleonora Bielawska-Batorowicz | Radmila Jankovic |
Eleonóra Spekker | Radoslaw Gocol |
Eleuterio A. Sánchez Romero | Radoslaw Kiedrowicz |
Elham Asgari | Radu Andrei Moga |
Eli Mansour | Radu Chicea |
Elias De França | Radu Chifor |
Elias Tsakos | Radu Crișan-Dabija |
Elisa Belluzzi | Radu Miftode |
Elisa Camela | Radu Pirlog |
Elisa Diral | Rafael Coveñas Rodríguez |
Elisa Russo | Rafael De La Camara |
Elisabeth Pinart | Rafael Fernandez Castillo |
Elisabetta Xue | Rafael Moreno-Gómez-Toledano |
Elisavet Grouzi | Rafael Vila Candel |
Elise Margaretha Adriana Slob | Rafael Zaragoza |
Elizabeta A. Rojas | Rafał Dankowski |
Elizabeth Thomas | Rafał Jaeschke |
Elizabeth Unger | Rafal Moszynski |
Ellina Velichko | Rafal Surmacz |
Elnaz Ayati | Rafał Watrowski |
Elrashdy Redwan | Raffaele Campisi |
Elsa Fonseca | Raffaele Nappo |
Elsa Labrune | Raffaele Natella |
Elsayed Mehana | Raffaele Pellegrino |
Elvira Orduna-Hospital | Rahat Ullah |
Elvis Hysa | Raid Al-Ani |
Elżbieta Jarocka-Cyrta | Raimundas Lunevicius |
Elżbieta Petriczko | Rais Ansari |
Eman Mehanna | Rajesh Kar |
Eman Toraih | Rajiv Singla |
Emanuela Locati | Rajkishor Pandey |
Emanuela Mari | Rajkumar Chinnadurai |
Emanuele Bernardinelli | Rajkumar Vutukuri |
Emanuele Bertaglia | Rajmohan Dharmaraj |
Emanuele Gallinoro | Rakshit Shah |
Emanuele Panza | Ralph Wendt |
Emeline Laurent | Raluca Roman |
Emeline Maisonneuve | Ram Sagar |
Emil Dąbrowski | Rama Krishna Alla |
Emil Stoicescu | Rama Rao Tata |
Emile J.M. Rijcken | Ramcés Falfán-Valencia |
Emília Alves | Ramendra Pandey |
Emilio Cataldo | Rameswari Chilamakuri |
Emilio Piccione | Ramgopal Kashyap |
Emma Rheel | Rami Elshazli |
Emmanouil Dermitzakis | Ramit Maoz Segal |
Emmanouil Karampinis | Ramón Fuentes |
Emmanouil Panagiotou | Ramona Meanti |
Emmanouil-Georgios Tzanakakis | Ramses Santacruz-Marquez |
Emmanuel E. Zervos | Ramy Abdelnaby |
Emre Bilgin | Ramy Samargandi |
Endre Nemeth | Ranjith Kamity |
Enes Erul | Rany Vorn |
Engy Mogahed | Raoul-Vasile Lupuşoru |
Enita Nakas | Rares Mircea Birlutiu |
Enrico Apa | Rasa Mladenovic |
Enrico Checcucci | Rasa Sabaliauskaite |
Enrico Pessina | Rasha Ashmawy |
Enrique Gea-Izquierdo | Rasheda Chowdhury |
Enrique Morales Villegas | Rashmi Bhandari |
Enwu Liu | Rashmi Kumari |
Epaminondas Zakynthinos | Rashmin Savani |
Ercole Mazzeo | Rasmus Gantzel |
Erdogan Bulut | Raul Díaz |
Erdoǧan Sökmen | Raúl González-Domínguez |
Erhan Okuyan | Ravindra A. Prabhu |
Eric Franssen | Ravish Patel |
Eric Rytkin | Rayid Abdulqawi |
Eric Van Breda | Raymond Sayegh |
Eric Wisotzky | Raywat Noiphithak |
Erica Valencic | Razeghian-Jahromi Iman |
Erita Filipek | Razvan - Cosmin Petca |
Erkin Mirrakhimov | Razvan Rahota |
Ernest Adeghate | Razvan-Vladimir Socolov |
Ernesto Cesar Leal-Junior | Rebecca Aicheler |
Ernst Oberlechner | Rebekka Heitmar |
Ersin Gumus | Recai Ergun |
Ertuğrul Şahin | Regina Ruiz De Viñaspre-Hernández. |
Erum Whyne | Reinhold Fuegger |
Esma Inan Yuksel | Rejean Couture |
Esra Demir | Remigiusz Kazimierczyk |
Estefania Nuñez | Remington L. Nevin |
Estela Sanguesa | Renan Dal-Fabbro |
Eszter Ducza | Renars Erts |
Étienne Labyt | Renata Beck |
Eugene Statnik | Renata Curić Radivojević |
Eugenia Irene Davidescu | Renata D'Incà |
Eui-Jae Lee | Renata Rutkauskaite |
Eun Ji Lee | Renata Vrsalovic |
Eun-Jee Oh | Renato Galzio |
Eusebiu Vlad Gorduza | Renato Melo |
Eva Lieto | René Hartensuer |
Eva Venegas | Renold Elsen |
Evangelia Koukaki | Renqiang Yu |
Evangelia Maria Tsapakis | Reyad Dada |
Evangelos Sdogkos | Reza Mazaheri |
Evans Asamoah Adu | Reza Nedaeinia |
Evelyn Pereira | Reza Shirazi |
Evgenia Efthymiou | Reza Zamani |
Evgeny Bojko | Rhalena Thomas |
Evgeny Ermakov | Ricardo Cartes |
Evgeny Ovcharenko | Ricardo Castro Alves |
Evi Fleischhacker | Ricardo Dias |
Ewa Grudzińska | Ricardo Gomes |
Ewa Skarżyńska | Ricardo Ortega‐Santiago |
Eylem Kulkoyluoglu Cotul | Ricardo Ribeiro |
F M Javed Mehedi Shamrat | Ricardo Ruiz-Villaverde |
F. W. S. Lima | Riccardo Beltrami |
Fabian Bartsch | Riccardo Mastroianni |
Fabiana Pani | Richard N. Merchant |
Fabio Costa | Richard Trohman |
Fabio Dell’Olio | Rie Aoyama |
Fabio Fabbian | Rigas Kalaitzidis |
Fabio Fiorino | Rinat Gabbay-Benziv |
Fabio Melandro | Rini Arianti |
Fabio Sambataro | Rishi Man Chugh |
Fabio Santacaterina | Rita Catalina Aquino Caregnato |
Fabio Vitagliani | Rita El Feghali |
Fabrizio Bambini | Rita Indirli |
Fabrizio Ceresa | Rita Pavasini |
Fabrizio Martora | Ritesh Chimoriya |
Fabrizio Stasolla | Ritthideach Yorsaeng |
Fahad Aldakheel | Ritu Gupta |
Fahd Alsalleeh | Ritu Raval |
Faheem Shehjar | Rob Mccorkle |
Fahrul Nurkolis | Robert Bransfield |
Faisal Ahmed | Robert Emmett Kelly |
Faiza Amin | Robert Flisiak |
Fang Tong | Robert Hoerr |
Fang Wang | Robert Nastasa |
Fangfang Sun | Robert Ossendorff |
Farah Hamandi | Robert Prill |
Fareeha Saadi | Robert Sharp |
Farhad Seif | Roberta Ambrosini |
Farid El-Askary | Roberta Antonia Diotti |
Farzad Taghizadeh-Hesary | Roberta Costanzo |
Fatemeh Mirzayeh Fashami | Roberta Gasparro |
Fatih Hatipoglu | Roberta Gualtierotti |
Fausto Fiori | Roberta Mancuso |
Fedele Lembo | Roberta Milone |
Federica Fogacci | Roberta Monzani |
Federica Rigo | Roberta Scrimieri |
Federica Veronese | Roberta Tutino |
Federico B. Roesch-Dietlen | Roberto Cascone |
Federico Biscetti | Roberto Cemin |
Federico Castro-Munozledo | Roberto De La Plaza Llamas |
Federico Giorgi | Roberto Lazzarini |
Federico Landra | Roberto Menè |
Federico Marchesi | Roberto Scarpioni |
Federico Solla | Robiatul Adawiyah |
Fedor Moiseenko | Rocco Simone Flammia |
Felipe Contreras-Briceño | Rocío Llamas-Ramos |
Felipe Freitas | Rodolfo Mauceri |
Felipe Machado | Rodolfo Reda |
Felipe Soto-Pérez | Rodolfo Valtuille |
Felipe Vadillo-Ortega | Rodrigo Okubo |
Feng Ma | Rodrigo Serafim |
Feng Tian | Rodrigo Torres |
Fengyuan Zhao | Rogerio Buchaim |
Ferdinando Antonio Gulino | Rogério Gonçalves |
Ferdinando Cione | Rohan Singh |
Fernanda Gentil | Rohit Malhotra |
Fernando De La Guía-Galipienso | Rok Civljak |
Fernando Gomollón | Rok Gaspersic |
Fernando Monroy | Romil Parikh |
Fernando Montenegro Sá | Romina Fucà |
Fernando Muñoz-Hernández | Ronan Tanguy |
Fernando Rueda | Rongfei Zhu |
Fernando Vazquez-Alaniz | Roop Kalia |
Fésüs Adina | Rosa Alessia Battista |
Feten Zar Kalai | Rosa Di Crescenzo |
Filip Jaskiewicz | Rosa Direito |
Filippo Confalonieri | Rosa María Tapia-Haro |
Filippo Manelli | Rosa Suades |
Filippo Maria Polli | Rosalie Steinberg |
Filippo Mariano | Rosalinda Sanchez |
Filippo Tatti | Rosa-María Rodríguez-Jiménez |
Filippos Triposkiadis | Rosario Sarabia |
Fiorenzo Moscatelli | Rosendo Berengüí |
Firoz Ahmed | Roshan Mahat |
Flavio De Alcantara Camejo | Rossella Sgarzani |
Flavio Milana | Rossen Rousseff |
Flaviu Moldovan | Roxana Maria Nemeș |
Flor H. Pujol | Rozeta Sokou |
Flora N. Balieva | Ruben Antonio Vazquez-Roque |
Flora Tzifi | Rubén Arroyo Fernández |
Florian Beck | Rubén Cámara-Calmaestra |
Florian Eyer | Rubén Cuesta-Barriuso |
Florian Kipfmueller | Ruchire Eranga Wijesinghe |
Florian Recker, Mme | Rui Han |
Florica Sandru | Rui Milton Da Silva-Jr |
Florica Voita-Mekeres | Ru-Lan Hsieh |
Florin Achim | Rulin Zhuang |
Florina Iliescu | Rummenigge Dantas |
Floris Van Den Brink | Runze Li |
Forogh Soltaninejad | Ruoliang Tang |
Foroud Shahbazi | Ruperto González-Pérez |
Fortunato Iacovelli | Ruta Vaiciuniene |
Fortunato Lonardo | Rute Brites |
Fotios Barkas | Rute J. Macedo-De-Araújo |
Fouad Sakr | Ruxandra Diana Sinescu |
Fragkiski Anthouli-Anagnostopoulou | Ruziana Masiran |
Francesc Graus | Ryan Marquardt |
Francesca Bursi | Ryan Maves |
Francesca Cattoni | Ryo Wakita |
Francesca Coppi | Ryuichi Furuya |
Francesca Felicia Operto | Saba Ahmed Beigh |
Francesca Gaino | Saba Nikanfar |
Francesca Pacifici | Saber Saedmocheshi |
Francesca Pisano | Sabina Antonela Antoniu |
Francesca Zotti | Sabine Brandt |
Francesco Antonio Salzano | Sabrina Birsan |
Francesco Bianco | Sabrina Bossio |
Francesco Bosco | Sabrina Hupp |
Francesco Cei | Sabrina Scroggins |
Francesco Claps | Saburo Matsubara |
Francesco Di Bello | Sachin Chaugule |
Francesco D'Oria | Sachit Anand |
Francesco Grecchi | Sadaf Dabeer |
Francesco Maffìa | Saeed Mohammadi |
Francesco Maruccia | Safa Faraj |
Francesco Mattace-Raso | Safaa Elkholi |
Francesco Meroi | Safaa Elmeneza |
Francesco Panzuto | Safwan Omran |
Francesco Perone | Sagar Salave |
Francesco Puleio | Sahar Hassanein |
Francesco Saverio Ludovichetti | Sahiti Chukkapalli |
Francesco Stringa | Sai Shilpa Kommaraju |
Francesco Tiralongo | Sajal De |
Francesco Valente | Sakti Chakrabarti |
Francisco Bandeira | Salim Gallouj |
Francisco Calvo Iglesias | Saloni Sinha |
Francisco De Asís Bartol-Puyal | Salvatore Allosso |
Francisco Guillen-Grima | Salvatore Iacono |
Francisco J Medrano | Sam Mckay |
Francisco Javier Cano-García | Samantha Miner |
Francisco Javier Cantero Sánchez | Samantha Pasca |
Francisco Javier Fernández Carrasco | Samantha Redman |
Francisco M Nadal-Nicolas | Samar Tharwat |
Francisco Miguel Martínez-Arnau | Sameh Attia |
Francisco Nieto Escámez | Samit Ghosh |
Francisco Paulo Magalhães Simões | Samo Fokter |
Francisco Pilar-Orive | Samuel Álvarez-Almazán |
Francisco Sandro Menezes-Rodrigues | Samuel Frimpong |
Franco Alchiede Simonato | Samuel Menahem |
Franco Musio | Samuele Sutera |
François Jamar | Samuele Vaccari |
François Regoli | Sana Boudabbous |
Françoise Valentini | Sandeep Dhallu |
Frank A. Schildberg | Sandeep Kaushik |
Frank Halfwerk | Sandeep Vijayan |
Frank Hassel | Sandor Bernad |
Frank Martin Haecker | Sandra Nischwitz |
Frank Münch | Sandra Rute-Pérez |
Frank Nelson | Sandrine Basaglia-Pappas |
Frederic Carsten Schmeel | Sandrita Simonyte |
Frederic Panthier | Sandro Glumac |
Frederik Berrevoet | Sang Tae Choi |
Frédérique Servin | Sang-Won Lee |
Fredrik Nylén | Sanjana Nagraj |
Freek Hollman | Sanjin Kovacevic |
Friedhelm Beyersdorf | Sankha Bhattacharya |
Fritz Parl | Sante Pierdomenico |
Fuat Demirkíran | Santhosh Kumar Rajamani |
Gábor Nagy-Grócz | Santi Mandal |
Gabriel Anesetti | Santosh Paudel |
Gabriel Gutiérrez-Ospina | Santosh S. Jeevannavar |
Gabriel Magrin | Saqlain Raza |
Gabriela Iancu | Sara Abdel Gaber |
Gabriele Di Giammarco | Sara Conti |
Gabriele Grunig | Sara Da Silva Ramos |
Gabriele Melegari | Sara Lönn |
Gabriele Roccuzzo | Sara Manti |
Gaetana Costanza | Sara Momtazmanesh |
Gaetano Antonio Lanza | Sara Morón-López |
Gaetano Aurilio | Sarawut Lapmanee |
Gaetano La Rocca | Sarhang Gul |
Gaetano Paone | Sarika Gupta |
Gaetano Rea | Sarita Prabhakaran |
Gaetano Santulli | Sarmad Al-Marsoummi |
Galina Shepelkova | Saroj Panigrahy |
Gallot Denis | Sashi Debnath |
Galvin Sim Siang Lin | Sasho Stoleski |
Gamal El-Hiti | Sasi Viktor |
Gamal Mohamed El-Sherbiny | Satish Sagar |
Gangaram Akangire | Satish Vishwanathaiah |
Gary Garcia Molina | Satoru Munakata |
Gary Smerdon | Satoru Watanabe |
Gaurav Kumar | Satu Turunen-Taheri |
Gauri Mankekar | Satyendra Tiwary |
Gavin Connolly | Satyesh K. Sinha |
Geetha Kandasamy | Saumya Shah |
Gema Esquiva | Saurabh Chaturvedi |
Gemma Caro | Saurabh Jain |
Gemma Marcucci | Saveria Capria |
Gengo Sunagawa | Saverio Muscoli |
Gennaro Perrone | Savvas Lampridis |
Geno Marcovici | Scarlette Hernández-Vigueras |
Gensheng Zhang | Schäfer Frank-Mattias |
Georg Gelbenegger | Se Hun Kang |
Georg Schlachtenberger | Sebastián Castillo-Galán |
George Doumat | Sebastian Cozma |
George Imataka | Sebastian Knitter |
George K. Psillas | Sebastian Manzanares |
George Koumantakis | Sebastian Sahli |
George Paraskevas | Sebastian Schnaubelt |
George Thompson | Sebastian Theurich |
Georgi Panov | Sebastian Valverde-Martinez |
Georgia Zara | Sebastian Waechter |
Georgiana Bianca Constantin | Sebastian Yu |
Georgiana Nemeti | Sebastiano Cicco |
Georgiana-Emmanuela Gilca-Blanariu | Sedigheh Sadat Naimi |
Georgios Evangelou | Seema Kumari |
Georgios Leventopoulos | Seenaiah Byreddy |
Georgios Markantes | Seicean Radu |
Georgios Matis | Seiichiro Inoue |
Georgios Panos | Selim Ayhan |
Georgios Papathanakos | Sema Belli |
Georgios Tampakoudis | Semih Başcı |
Georgios Tzikos | Sena Turkdogan |
Geovani Lopez-Ortiz | Senem Güner |
Gerald R. Marx | Senija Eminović |
Gerald Wozasek | Sentaro Kusuhara |
Gerasimos Grivas | Seok Kyeong Oh |
Gerd Göstemeyer | Seongmin Kim |
Gerdi Tuli | Serap Özer Yaman |
Gerhard Situmorang | Sergej Nadalin |
Gerhild Euler | Sergey Arutyunov |
Germán Domínguez-Vías | Sergey Kolesnikov |
Germina Cosma | Sergey Morozov |
Gerson Aparecido Foratori-Junior | Serghei Covantsev |
Ghasem Farahmand | Sergio Conti |
Ghassan Ghssein | Sergio Crespo-Garcia |
Gheorghe-Emilian Olteanu | Sergio Facchini |
Ghulam Jilany Khan | Sergio Ruiz-Santana |
Giacomo Casalini | Sergio Sanchez-Cordero |
Giacomo Papotto | Sergiu Cazacu |
Giacomo Pucci | Serhat Akcaalan |
Giacomo Tondo | Sethupathi Velmurugan |
Giancarlo Micheletto | Seungyup Lee |
Giandomenico Bisaccia | Seyed Ahmad Naseri Alavi |
Gianfilippo Caggiari | Seyed Ali Mirshahvalad |
Gianluca Lucchese | Seyed Jamaleddin Mostafavi Yazdi |
Gianluca Rompianesi | Shabnam Bakhshalizadeh |
Gianluca Scalia | Shaher Hamaideh |
Gianmarco Arabia | Shahid Ud Din Wani |
Gianni Lazzarin | Shahnawaz Anwer |
Gianpaolo Zerbini | Shahnawaz Khijmatgar |
Gianpiero D'Amico | Shahriar Faghani |
Gianpietro Sechi | Shahrokh Hatefi |
Gilbert Sterling Octavius | Shahrzad Alimohammadi |
Gilles Lesieur | Shai Factor |
Gionata Fragomeni | Shamaila Zafar |
Giorgio Fiore | Shambaditya Das |
Giorgio Prouse | Shangkun Ou |
Giorgio Treglia | Shangrong Fan |
Giorgos Dritsakis | Shaobin Wang |
Giosuè Giordano Incognito | Shaun Sabico |
Giou-Teng Yiang | Shaymaa Bahnassy |
Giovanni Battista Di Pierro | Shaza Bishti |
Giovanni Buzzaccarini | Sheikh Nizamuddin |
Giovanni Casini | Sheila Butler |
Giovanni Colpi | Shekhar Saha |
Giovanni Corrado | Sheng Zhang |
Giovanni Guglielmo Laracca | Shengshuai Shan |
Giovanni Mario Pes | Shervin Hashemi |
Giovanni Pennisi | Shi Wei |
Giovanni Viroli | Shibo Yu |
Giovanni Vitale | Shida Chen |
Girish Srivastava | Shiek Ahmed |
Giulia Cossu | Shigao Huang |
Giulia Gibiino | Shigemitsu Sakuma |
Giulia Wiggers | Shigeo Iijima |
Giuliano Tocci | Shigeo Takebayashi |
Giulio Cabrelle | Shih-Chi Ku |
Giulio Gabrieli | Shilin Liu |
Giuseppe Barile | Shilpa Gopinath |
Giuseppe Basile | Shilpa Sonti |
Giuseppe Bruno | Shimbo Keisuke |
Giuseppe Caminiti | Shingo Tsujinaka |
Giuseppe Camporese | Shinichi Okazumi |
Giuseppe Casalino | Shinsuke Mizutani |
Giuseppe Cerullo | Shinya Suzuki |
Giuseppe Colella | Shipra Agarwal |
Giuseppe Consorti | Shir Lynn Lim |
Giuseppe Cucinella | Shivalee Duduskar |
Giuseppe Francesco Papalia | Shivani Bansal |
Giuseppe Guida | Shlomo Elbahary |
Giuseppe Lanzarone | Shobana Navaneethabalakrishnan |
Giuseppe Liberatore | Shooka Mohammadi |
Giuseppe Maccagnano | Shoushui Wei |
Giuseppe Migliaretti | Shraddha Vyas |
Giuseppe Nasso | Shruti Chandra |
Giuseppe Pignataro | Shu Wang |
Giuseppe Reimondo | Shuai Guo |
Giuseppe Seghieri | Shuang Niu |
Giuseppe Varone | Shuhei Yoshida |
Giuseppe Verolino | Shujie Deng |
Giuseppe Vitale | Shyam Bihari Bansal |
Gjin Ndrepepa | Shyh-Ming Chen |
Gladiol Zenunaj | Sibylle Scholtz |
Glauco Chisci | Sid Gaikwad |
Gokhan Ceylan | Siddharth Sunilkumar |
Gokhan Gorgisen | Sigit Prastowo |
Gongwei Long | Sigmar Schnutenhaus |
Gontse Mokwatsi | Signe Tomsone |
Gonzalo Varela | Silvano Dragonieri |
Goohyeon Hong | Silvia Dossena |
Gopinath M. Sundaram | Silvia Grazietta Foddai |
Goran Augustin | Silvia Kalantari |
Goran Vrgoč | Silvia Lai |
Gorazd Poje | Silvia Linari |
Gordana Kenđel Jovanović | Silvia Palma |
Gordana Pavliša | Silvio Maringhini |
Gotam Das | Silviu Daniel Preda |
Gowtham Subramanian | Sima Romina-Marina |
Gözde Şengül Ayçiçek | Simon Allen |
Grazia D'Onofrio | Simon Fandler-Höfler |
Grazyna Puto | Simon Fox |
Greger Lindberg | Simon Horslen |
Gregor Jezernik | Simona Ascanelli |
Gregory Jackson | Simona Bolamperti |
Grigol Keshelava | Simona Ferraro |
Grigorios Dimas | Simona Laurino |
Grzegorz Cieślar | Simona-Delia Nicoara |
Grzegorz Grześk | Simona-Roxana Georgescu |
Grzegorz Jakubiak | Simone Ciaccioni |
Grzegorz Kowalewski | Simone Cilio |
Grzegorz Trybek | Simone Morselli |
Guan Yang | Simone Redaelli |
Guankui Du | Simonetta Baraldo |
Guanying Xu | Simons Svirskis |
Guglielmo Stefanelli | Sinziana Ionescu |
Guido Gembillo | Sirijan Santajit |
Guilherme Cançado | Sirvan Najafi |
Guillaume Drevin | Siva Gandhapudi |
Guillaume Ducarme | Sivashanmugam Raju |
Guillaume E Courtoy | Sladjan Pavlovic |
Guillaume Lefebvre | Slava Rom |
Guillem Pintos-Morell | Slavica Kvolik |
Guillermo Ceballos | Slavisa Djuricic |
Guillermo Til-Perez | Snježana Kaštelan |
Guisen Li | Soedarsono Soedarsono |
Gulali Aktas | Sofia Karachrysafi |
Gülay Taşcı | Sofia Lopes |
Gule Cinar | Sofia Perazzo |
Guna Semjonova | Sofia Soares |
Gundula Schulze-Tanzil | Sofoklis Mitsos |
Gündüz Yümün | Sofya Kulikova |
Güneş Şenol | Sofya Morozova |
Gunta Krumina | Soha Albeitawi |
Guotao Li | Sohaib Shujaat |
Guowei Kim | Sohail Mushtaq |
Gurkan Bayar | Soichiro Saeki |
Gustavo Christofoletti | Soma Jyothula |
Gustavo Fernandes | Somchai Amornyotin |
Gustavo Zubieta-Calleja | Somdutt Mujwar |
Gyanesh Kumar Tiwari | Somnath Pandey |
Gyehyun Jung | Sonay Aydin |
H. Volkan Kara | Song Wang |
Habib Karim | Sonia D'Arrigo |
Hadeel Halaweh | Sonia Gaur |
Hafdís Skúladóttir | Sonia Ronchey |
Hafizur Rahman | Sonu Acharya |
Hagen Frickmann | Soo Jin Kim |
Hahn Jin Jung | Soon Kyu Lee |
Hailong Hu | Soon-Hyo Kwon |
Haiyan Chen | Soonil Kwon |
Haiyan Yang | Sophelia Hoi Shan Chan |
Hajar Mehdizadeh | Sorana-Maria Bucur |
Hajnalka Lőrincz | Sorin Brull |
Halil Kose | Sorin Radu Fleaca |
Hallie Thomas | Sotiria Vrouva |
Hamed Nosrati | Sotirios Sotiriou |
Hamid Moghaddasi | Spela Stunf Pukl |
Hamid Pakmanesh | Spyros Mentzelopoulos |
Hammad Ganatra | Sravya Palavalasa |
Han Hou | Srdjan Aleksandric |
Han Naung Tun | Sreekanth Gopinathan Pillai |
Hanaa Shafiek | Sreekumar Othumpangat |
Hani Chanbour | Sri Ram Pentakota |
Hanifi Yildiz | Sridhar Mangalesh |
Hanlin Zhang | Srijit Das |
Hanna Hübner | Stacey Schutte |
Hanna Moczulska | Stanislav Pekarskiy |
Hans Degens | Stavros Pitoglou |
Hantai Kim | Stavroula Ilia |
Hanying Chen | Stefan Acosta |
Hao Du | Stefan Chiriac |
Hao Wu | Stefan Förch |
Haolin Sun | Stefan Krause |
Haoming Zhang | Stefan Naydenov |
Haoyu Chen | Stefan Oswald |
Haralampos Tzoupis | Stefan Zachow |
Harald Krentel | Stefana Bilha |
Harald Schulze | Stefana Moisa |
Haralds Plaudis | Stefani Parmentier |
Hardik Dineshbhai Desai | Stefania Spina |
Harriet Corbett | Stefania Teodora Duca |
Harshraj Leuva | Stefania Troise |
Haruhito A. Uchida | Stefanie Amend |
Haruka Abe | Stefano Bacci |
Haruto Nishida | Stefano Carugo |
Hasan Alghetaa | Stefano Catarci |
Hasan Güney Yılmaz | Stefano Cirillo |
Hasan Özdoğan | Stefano Elia |
Hassan Ishqi | Stefano Fusco |
Hassan Kassassir | Stefano Ghirardelli |
Hassan Maleki | Stefano Giannubilo |
Hassan Ranjbar | Stefano Priola |
Hatem El-Shanti | Stefano Saran |
Hayley Letson | Steffen Grautoff |
Haytham Wali | Stelios Loukides |
Hazem El Beyrouti | Stella Gabeta |
Heang Lim | Stephan Listabarth |
Heba Abdelal | Stéphane Carlier |
Heba Sahyon | Stephanie Deluca |
Heber Arbildo Vega | Stephanie Navarro |
Hector Caballero-Flores | Stephen Gerfer |
Héctor González-De La Torre | Stephen Inns |
Hector Rangel | Stephen Pan |
Hee Sue Park | Stephen Strum |
Hee-Geun Jo | Stephen Tomlin |
Hei Yeung Kelvin Chiu | Stephen Wirya |
Helen Sun | Stergios Boussios |
Helioswilton Sales-Campos | Steve Glass |
Hemant Kumar Srivastava | Steve Mann |
Hendrik Berth | Steven Baumrucker |
Heng-Chang Chen | Steven Bernstein |
Henk Jan Schuijt | Steven Esworthy |
Henk Maria Koning | Stuart F. Quan |
Henk Van Hamersvelt | Stylianos Daios |
Henry Atkinson | Subbarao Madhunapantula |
Henry Sutanto | Subbulakshmi Chidambaram |
Hequn Zou | Subodh Dubey |
Herjan Coelingh Bennink | Sudarshan Bhattacharjee |
Herko Grubitzsch | Sudi Patel |
Hermínia Dias | Sueli Carneiro |
Hernan Polo Friz | Sufyan Ibrahim |
Hicham Elmsellem | Suhwan Lee |
Hidehiko Nakanishi | Suisui Hao |
Hidehito Maeda | Sujeong Han |
Hideki Ishii | Suk Kyun Hong |
Hideo Kato | Sulea Daniela |
Hideo Wada | Süleyman Cemil Oğlak |
Hidetatsu Tanaka | Suman Baral |
Hideto Yamada | Sumeet Patiyal |
Himanshi Tanwar | Sumi Hidaka |
Himanshu Deshwal | Sumit Sohal |
Himanshu Khajuria | Sumru Savas |
Hind Alsharhan | Suncanica Ljubin‐Sternak |
Hiroaki Neki | Sundar Ramalingam |
Hirofumi Kogure | Sung Cheol Park |
Hirofumi Sasajima | Sung Oh Hwang |
Hirokazu Toyoshima | Sung-Woon On |
Hiroki Hashida | Sunil Rai |
Hiroki Teragawa | Sunilgowda Sunnagatta Nagaraja |
Hiromichi.Ito Ito | Suparerk Janjarasjitt |
Hiroshi Yoshida | Supriyo Ray |
Hirotaka Suto | Surabhi Gautam |
Hiroyuki Kataoka | Suraj Mali |
Hiroyuki Katoh | Surbhi Sharma |
Hiroyuki Nojima | Suresh Anand Sadananthan |
Hiroyuki Yamaguchi | Suresh Kalathil |
Hitesh Singhavi | Surya Nirmal |
Hoda Shirafkan | Susan Motch Perrine |
Holger Herff | Susana Cerritelli |
Hong Jin | Sushruth Edla |
Hong Jin Kim | Suzan Çinar |
Hong Qi | Sven Hungerer |
Hongbing Chen | Sven Niklander |
Hongliang Sun | Svetlana Chibisova |
Hongwei Cheng | Svetlana Rachina |
Hongyang Ma | Svjetlana Raus |
Hooman Shafaee | Swanand Koli |
Horea Benea | Syed Adeel Hasan |
Horea Feier | Syed Ali Raza Naqvi |
Horia Mocanu | Syed Furqan Qadri |
Horia Stanca | Syed Husain Mustafa Rizvi |
Hossam El-Sherbiny | Syed Mohd Faisal |
Hossein Moeini | Syed Nasir Abbas Bukhari |
Hossein Zarrinfar | Syed Rashid Habib |
Howard Schneider | Sylvain Blanchon |
Hridaya Shrestha | Sylvère Störmann |
Hrvoje Budincevic | Sylvester Lokpo |
Hsiang-Ning Luk | Sylwester Ciećwież |
Huang-Pin Wu | Sylwia Dziegielewska-Gesiak |
Hubert Marotte | Szczepan Piszczatowski |
Hue-Yu Wang | Székely Andrea |
Hugo Pena-Verdeal | Szymon Sieciński |
Hugo Yoo | T Diemen |
Huitzilihuitl Saucedo-Orozco | Tadahisa Sugiura |
Hülya Özsahin | Tae Il Kim |
Humberto Hernandez | Taha Anbara |
Huseyin Arikan | Tahir Yagdi |
Huseyin Ede | Tahira Sultan |
Hussam Ali | Taiwo Aremu |
Hussein Hamade | Takaaki Tomofuji |
Hwa-Yen Chiu | Takahiro Homma |
Hyonmin Choe | Takahito Katano |
Hyun Kwon | Takanori Kikumoto |
Hyun-Joong Kim | Takaomi Kobayashi |
Hyun-Min Seo | Takaomi Kurioka |
Iacopo Cappellini | Takashi Ishino |
Iakovos Armenis | Takashi Ono |
Ian Burgess | Takayuki Masaki |
Ibrahim Ahmed Shaikh | Takayuki Nakagawa |
Ibrahim Bello | Takayuki Nitta |
Ibrahim Moustafa Amer | Takemichi Fukasawa |
Ibsen Coimbra | Takeshi Kawasaki |
Ighli Di Bari | Takeshi Kezuka |
Ignacio Miranda | Takeshi Okamoto |
Ignazio Gaspare Vetrano | Takuji Yokoe |
Igor Frangež | Takuma Hayashi |
Igor Iskusnykh | Takwa Gabr |
I-Ju Yeh | Tally Naveh-Many |
Ikbal Ok Bozkaya | Tamara Basishvili |
Iker Alegría Lertxundi | Tamas Alexy |
Ikkei Tamada | Tamer Basha |
Ilan Merdler | Tamer Ghazy |
Ilaria Giambuzzi | Tamer Hamdy |
Ilaria Grassi | Tamerah Hunt |
Ilaria Marcantoni | Tamra Ranasinghe |
Ilaria Mormile | Tan Ken-Soon |
Ilaria Stura | Tanja M. Luković |
Ileana Mardare | Tanja Miličić |
Ilektra Antonia Mavroeidi | Tao Li |
Ilias Iliopoulos | Tao Qin |
Ilias Tsiflikas | Tao Wang |
Ilias Tsochantaridis | Tarek Abdelghany |
Ilknur Kıvanç Altunay | Tarek M.A. Abdel-Fatah |
Ilya Klabukov | Tarik Kivrak |
Iman Karimzadeh | Tariq Malik |
Imran Gani | Tarr Tünde |
Imtiaz Hussain | Tarun Keswani |
Ina Sevic | Tasneem Arsiwala |
Inés Aguinaga-Ontoso | Tatiana Arefieva |
Inés Llamas-Ramos | Tatiana Berezina |
Ingrid Raponi | Tatiana Kuznetsova |
Inzamam Mashood Nasir | Tatsuo Kanda |
Ioan Hutu | Tatsuya Igawa |
Ioana Damian | Tatsuya Kin |
Ioana Grigoras | Tatyana Baltina |
Ioana Pavaleanu | Taweegrit Siripongboonsitti |
Ioana Suciu | Tengbin Shi |
Ioanna Stergiou | Teodor Salmen |
Ioannis Halkiadakis | Teodora Dominteanu |
Ioannis Ilias | Terenzio Cosio |
Ioannis Kougioumtzis | Teresa Perra |
Ioannis Kyriakoulis | Teru Kamogashira |
Ioannis Lyros | Teruya Komatsu |
Ioannis Maroulis | Thach Nguyen |
Ioannis Mitselos | Thais Heinke |
Ioannis Petrakis | Thanavel Rajangam |
Ioannis Sanidas | Theng Choon Ooi |
Ioannis Stavropoulos | Theodorakys Marín Fermín |
Ion Cosmin Puia | Theodore Warkentin |
Ionela-Larisa Miftode | Theodoros Androutsakos |
Ionut Donoiu | Theodoros Dimitroulas |
Ionuț Jeican | Theodoros Kalampokas |
Iqram Hussain | Theodoros Mavridis |
Irakli Kopaliani | Theodoros Tokas |
Iram Murtaza | Theofilos Kolettis |
Irena Jekova | Thiago P Fernandes |
Irena Milaniak | Thilla Sekar Vinothkumar |
Irena Wojsyk – Banaszak | Thitipramote Natthawut |
Irene Karampela | Thomas Fraccalini |
Irene Ottaviani | Thomas Greither |
Irene Paraboschi | Thomas Henry Tranah |
Irene Pinucci | Thomas Mayer |
Irene Scalera | Thomas Mayers |
Irina Andrievskaya | Thomas Muders |
Irina Girleanu | Thomas Tschoellitsch |
Irina Kologrivova | Tianyuan Wang |
Irina Mandel | Tiberiu Augustin Georgescu |
Irina Murakhovskaya | Tihana Regović Džombeta |
Irina Novikova | Tijana Išić Denčić |
Irina Ogneva | Tijl Vermassen |
Irini Patsaki | Timothy G. Campbell |
Irma Gabriela Anaya Saavedra | Timothy Hardcastle |
Irshad Ahmad | Timothy Hasenoehrl |
Isabel Carmona | Timothy Ness |
Isabel Céspedes | Tina Didari |
Isabel Escobio Prieto | Tiong Peng Yap |
Isabel Fort | Tippawan Siritientong |
Isabel Moscoso | Tito Brambullo |
Isabel Soto-Cruz | Tizian Heinz |
Isabelle Dehaene | Tjasse Bruintjes |
Isac Sebastian | Tobias Ballhause |
Isamu Hokuto | Tobias Mett |
Isehaq Al-Huseini | Tobias Zeus |
Islam Sayed | Todd Girard |
Ismaheel Lawal | Tolga Olmez |
Ismail Ben Abdallah | Tomas Fait |
Ismet Hortu | Tomas Koller |
Israel Amirav | Tomasz Gębarowski |
Israel Casado-Hernández | Tomasz Michalski |
Israel Safiriyu | Tomasz Pawłowski |
Ita Hadžisejdić | Tomasz Zieliński |
Iulia-Ioana Stanescu-Spinu | Tomislav Kokic |
Iuliana Magdalena Starcea | Tomislav Pribanic |
Iuliu Gabriel Cocuz | Tommaso Bacci |
Iva Sklempe Kokic | Tommaso Greco |
Ivan Alić | Tommaso Sconocchia |
Ivan Budnik | Tommaso Torresin |
Iván Ferraz-Amaro | Tomohiro Chiba |
Ivan Giovannini | Tomokazu Shimizu |
Ivan Pavić | Tomoya Tateishi |
Ivan Potapenko | Tomoyuki Asada |
Ivan Sabol | Torbjörn Ledin |
Ivan Valdivia-Gandur | Torsten Malm |
Ivana Babovic | Toru Horinouchi |
Ivana Banic | Toshiaki Iba |
Ivana Medvedec Mikic | Toshikazu Kimura |
Ivana Šimić | Toshiyuki Oshitari |
Ivana Skrinjar | Toso Elisabetta |
Ivo Bozovic | Tossaporn Seeherunvong |
Iwahashi Noriaki | Toyonori Tsuzuki |
I-Wei Chang | Tran Nguyen |
Iwona Szydłowska | Trevor Gerson |
Iwona Wertel | Tri Pudy Asmarawati |
Izabela Chudzicka-Strugala | Tsunahiko Hirano |
Izabela Zakrocka | Tsung-Jung Liang |
Izabella Petre | Tuba Taslamacioglu Duman |
J. S. Hill Gaston | Tudor Pop |
Jacek Piątek | Tudoran Cristina |
Jacek Szepietowski | Tulassigeri M. Totiger |
Jacek Sznurkowski | Tunc Eren |
Jackline Ayres-Silva | Tung Nguyen-Thanh |
Jacob Genizi | Tursi Antonio |
Jacob Teitelbaum | Tushar Ganjawala |
Jacobo Trebol | Tze-Kiong Er |
Jacopo Davide Giamello | Uberto Bortolotti |
Jacopo Lisoni | Ufuk Erginoglu |
Jacques-Olivier Fortrat | Ufuk Okkay |
Jad Adrian Washif | Ulf Jensen-Kondering |
Jad El Masri | Ulia Zinchenko |
Jaesik Park | Ulrich Frey |
Jaeyun Wang | Ulrich Zissler |
Jagdish Joshi | Uma Langkulsen |
Jairo León-Quismondo | Undral Munkhsaikhan |
Jakir Hossain Bhuiyan Masud | Uri Farkash |
Jakub Bargiel | Uros Bumbasirevic |
Jakub Klekowski | Usman Ghafoor |
Jakub Smiechowicz | Ute Hidding |
Jakub Staniczek | Utthapon Issara |
Jameel Rizwana Hussaindeen | Uwe Bieri |
James A. Tolley | Uzma Khan |
James D. West | Vadim Elagin |
James Hunter | Vadim Genkel |
James Leigh | Vahid Eslami |
James Russell | Valentin Bartha |
Jan Duedal Rölfing | Valentino Natoli |
Jan Henzel | Valentinos Sofokleous |
Jan Hugo | Valeria Coviltir |
Jan Zabrzyński | Valeria Dionisi |
Jan Žatecký | Valeria Pergola |
Janet M. Gray | Valeria Saccà |
Janey Prodoehl | Valeria Visconte |
Jani Tikkanen | Valery V. Likhvantsev |
Janice Chew-Harris | Valter Travagli |
Janice Garcia-Quiroz | Van Du Nguyen |
Janice Wang | Vanessa Meier-Stephenson |
Janitschke Daniel | Vanessa Paredes-Gallardo |
Janja Zupan | Vanessa Ramírez-Mayorga |
Janko Jankovic | Vanja Kopilaš |
Janos Filep | Vanja Martinovic Jovicevic |
Jaroslaw Chmielewski | Vanya Rangelova |
Jaroslaw Kasprzak | Vartika Sharma |
Jasemin Todri | Varvara Valotassiou |
Jasminka Peršec | Vasile Bintintan |
Jason Tasoulas | Vasile Valeriu Lupu |
Jason Wilson | Vasile-Bogdan Halatiu |
Jassin Rashidi | Vasileios Nikolaou |
Javier Arredondo Montero | Vasileios P. Papadopoulos |
Javier Ros | Vasileios P. Vassilikos |
Jayakanthan Kabeerdoss | Vasileios Papavasileiou |
Jayson Stoffman | Vassiliki Michou |
Jazmin Calyeca | Vedat Eljezi |
Jean Amiral | Vedran Kovacic |
Jean De La Rosette | Veenesh Selvaratnam |
Jean-Baptiste Armengaud | Veli Ozalp |
Jefferson Russo Victor | Velia Cassano |
Jeffrey Velotta | Velmarini Vasquez |
Jelena Jadzic | Venkata Nagaraj Kakaraparthi |
Jelena Marković Filipović | Venkata Rajesh Yella |
Jelena Nesovic Ostojic | Vera Larina |
Jelena Roganovic | Verena Lieb |
Jelena Vekic | Verena Tretter |
Jelle Himmelreich | Veronica Baioccato |
Jeng-Wen Chen | Vesna Mandic-Markovic |
Jennifer Lira Mandujano | Vicente Bertomeu-González |
Jennifer Pursley | Vicente León-Muñoz |
Jennifer Van Wyk | Victor Díaz-Flores García |
Jeong Yeon Kim | Víctor Hernández-Beltrán |
Jeremías Bayón | Victor Martin |
Jérémie Rouger-Gaudichon | Victor Palarie |
Jeremy Lavine | Víctor Segura-Jiménez |
Jeremy W. Chopek | Victoria Bunik |
Jer-Ming Chang | Victoria Díaz Tomé |
Jerome Dinga | Victorița Șorodoc |
Jesper Dahlgaard | Vidhu Aeri |
Jesus Aibar | Vidya Rattan |
Jesus Pelaez | Viet Tran |
Jesús Rivera-Esteban | Vijaya Anand Arumugam |
Jesús Torres | Vikas Jhawat |
Jesús Zepeda-Cervantes | Vikas Kundra |
Jeyasakthy Saniasiaya | Vikash Jaiswal |
Jhonatan Betancourt-Peña | Vikash Mishra |
Ji Zhang | Vilma Dudoniene |
Jia Li | Vincent Castelain |
Jiamei Hou | Vincent Peter C. Magboo |
Jian Ge | Vincenza Gragnaniello |
Jiangang Chen | Vincenzo Capriotti |
Jianjiu Chen | Vincenzo Castiglione |
Jiawen Yong | Vincenzo Giordano |
Jiaxi Yao | Vincenzo Menditto |
Jia-Yuh Chen | Vincenzo Savarino |
Jie Qian | Vincenzo Verzeletti |
Jie Wen | Vincenzo Zanon |
Jieping Lei | Vinicius Cavalheri |
Jihane Soueid | Vinko Vidjak |
Jimin Han | Virginia Solitano |
Jin Hyuck Lee | Viseslav Popadic |
Jing Han | Vishal Tewari |
Jing Hongwu | Vishwanath Prabhu |
Jingan Li | Vito Di Lernia |
Jing-Jie Wang | Vitor Panhóca |
Jing-Jing Fang | Vivek Krishnan |
Jingrui Huang | Vivian Paraskevi Douglas |
Jinjun Xia | Vlad David |
Jinlong Liu | Vlad Dima |
Jinluan Chen | Vladimir M. Cvetković |
Jinming Han | Vladimir Milosavljevic |
Jiří Suchý | Vladimir Pisarev |
Jitender Dabas | Vladimir Poroch |
Jitendra Kumar Sinha | Vladimir Shvartz |
Joana Barbosa | Vladimir Tesar |
Joana Ferreira | Vladimira Boyadzhieva |
Joana Pereira Sousa | Vlasios Karageorgos |
Joanna Bierła | Vlasta Vukovic Cvetkovic |
Joanna Czerwińska | Vojko Kanic |
Joanna Fox | Volkan Arısan |
Joanna Gołębiewska | Volkan Karataşlı |
Joanna Pogorzelska-Dyrbuś | Volkan Ulker |
Joanna Roskal-Wałek | Wachira Wongtanasarasin |
Joanna Sekulska-Nalewajko | Wael Mansy |
Joanna Solich | Wael Mohamed |
Joanna Wojtasik-Bakalarz | Wael Saade |
Joanna Zawitkowska | Wajdy Al-Awaida |
João Gama Marques | Walter Flapper |
João Lima | Wan-Chun Chang |
João Marcelo Teixeira | Wanjiku Mathenge |
Joao Rocha-Neves | Wan-Ju Annabelle Lee |
João Scarini | Wan-Tai Au-Yeung |
Joaquim Bustorff-Silva | Wantana Siritaratiwat |
Joaquim Soares Do Brito | Warawut Chaiwong |
Jochen Maurer | Warren Bakay |
Joel Ellwanger | Wasim Ahmad |
Joel Locher | Wassim Abou-Kheir |
Johannes Duvekot | Weerasak Tapanya |
Johannes Mair | Wei Cheong Ngeow |
Johannes Ott | Wei Feng |
Johannes Wach | Wei Huang |
John A. Albert St. Cyr | Wei Shi |
John Bernat | Weibing Ye |
John Cunha | Wei-Chieh Lee |
John M. Perry | Wei-Chih Chen |
John Oas | Wei-Chih Kan |
John Shelley-Tremblay | Wei-Fan Hsu |
John Triantafillidis | Weihua Ding |
John W. Berkenbosch | Weihua Yang |
John-David Aubert | Wei-Min Chen |
Johnny Ionut Efanov | Weiqian Chen |
Jolanta E. Loster | Weita Chen |
Jon Wietholter | Weiting Wang |
Jon Zabaleta | Weiwei Xu |
Jonas Schmid | Wen Chen |
Jonatan García-Campos | Wencai Liu |
Jonathan Saenger | Wen-Chih Liu |
Jonathan Soldera | Wenlong Zhao |
Jonghyuk Lee | Wenming Yang |
Joonhong Park | Wen-Sheng Liu |
Jordi Bover | Wenyi Wang |
Jordi Ripoll | Werner Lang |
Jorge Gutiérrez-Cuevas | Werner Zechner |
Jorge Perez-Gonzalez | Wesam Ahmed |
José A. Carrión | Wesam Gouda |
Jose Adams | Wey-Ran Lin |
José Arturo Prada-Oliveira | Wiktor Paskal |
José Brito | Wilhelm Mistiaen |
José C. De La Flor | Willem De Hertogh |
Jose Carlos Vilches Jimenez | William Berg |
Jose E. Naranjo | Winda Ariyani |
Jose Felipe Varona Arche | Winkins Santosh |
José Fougo | Wladimir Beck |
José Francisco López-Gil | Wladimir Bocca Vieira De Rezende Pinto |
Jose Guilherme Chaui-Berlinck | Wojciech Kiebzak |
Jose Guirola | Wojciech Konarski |
José López Castro | Wojciech Rozek |
Jose Luis Gorriz | Wolfgang Boettcher |
Jose Luis Perez-Lasierra | Wolfgang Kreisel |
Jose Manuel Cancio-Trujillo | Woo-Jong Kim |
Jose Manuel Morales | Xavier Santander |
José Maria Lasso | Xenophon Sinopidis |
José Reyes-Lagos | Xiang Ma |
José Reyes-Ruiz | Xiangjiu Ding |
José Teixeira | Xiangxiang Hu |
Jose Urbano | Xiangyu Liu |
Jose Velázquez-Aragón | Xianxiu Chen |
Josef Köhrle | Xiaobo Wu |
José-María Sánchez-González | Xiaochun Peng |
Josep Clua-Espuny | Xiaodong Wang |
Joseph G. Pressey | Xiaohua Li |
Joseph Westrich | Xiaokang Wu |
Joshua Keller | Xiaoshu Pan |
Josip A. Borovac | Xiaotang Ma |
Josko Markic | Xiaowei Zhang |
Josko Mitrovic | Xiaoyan Liu |
Jothi Varghese | Xiaoyi Zhao |
Jousel Ora | Xiaoyong Wang |
Jovana Cvetkovic | Xiaoyu Liao |
Jovana Joksimovic Jovic | Xi-Ming Yuan |
Joydeep Chakraborty | Xin Wang |
Jozef Simenko | Xing Wei |
József Furák | Xingfeng Li |
Juan A. Galán-Llopis | Xinghua Qin |
Juan Carlos Amor-Dorado | Xingkang Wu |
Juan Carlos Sánchez Delgado | Xinglin Yang |
Juan Carlos Sánchez-García | Xingshun Qi |
Juan Fidel Osuna-Ramos | Xinli Li |
Juan Francisco B. Blanco | Xinrong Zhang |
Juan Grignola | Xinru Qiu |
Juan Guzman-Flores | Xinyuan Lei |
Juan Jose Criado-Alvarez | Xiruo Li |
Juan Luis Chávez Pacheco | Xóchitl Ortiz-Jiménez |
Juan Manuel Velázquez-Enríquez | Xuan Li |
Juan Maza-Solano | Xuchang Zhou |
Juan Pablo Hervás Pérez | Xueju Wang |
Juan Rodríguez Mansilla | Xuelin Zhou |
Juandy Jo | Xueqing Wu |
Jue Ling | Yadollah Abolfathi Momtaz |
Juergen Taxis | Yair Binyamin |
Jules Zhang-Yin | Yale Tung-Chen |
Julia Kalmar | Yamini Krishnan |
Julia Mwangi | Yan Li |
Julian Rozenberg | Yan Sun |
Juliana Faria | Yan Zhan |
Juliana Fernandes | Yang Zhang |
Julie St-Pierre | Yang Zhao |
Julien Issa | Yang-Ding Lin |
Julio Ochoa | Yanhui Ma |
Julio Ortega-Usobiaga | Yaniv Mayer |
Julio Plaza Diaz | Yaniv Steinfeld |
Julius Moratin | Yanming Li |
Jung Sunwoo | Yan-Ming Xu |
Junhel Dalanon | Yanning Zuo |
Junichi Iwata | Yannis Dimitroglou |
Junichiro Hamada | Yanpeng Li |
Junxiang Chen | Yanping Xu |
Junya Kuroda | Yanshuo Han |
Jure Urbančič | Yansong Qi |
Jürg Kesselring | Yao Hung Tsai |
Justyna Gołębiewska | Yari Longobucco |
Justyna Janocha-Litwin | Yaser Kharakh |
Juzer Saifee | Yasin Hamarat |
Jyoti Das | Yasin Tülüce |
Kacper Nijakowski | Yasmin Ghantous |
Kah Suan Lim | Yasser Mohamed |
Kah Teik Chew | Yasser Mostafa Kamel |
Kai Liang Teh | Yasuhiko Ebina |
Kaida Atsushi | Yasuhisa Ohata |
Kaili Ma | Yavuz Ayar |
Kajo Bucan | Yavuz Samanci |
Kallay Eva | Yen-Chun Peng |
Kalliopi Megari | Ygal Plakht |
Kamal Karkonasasi | Yi Liu |
Kamal Sharma | Yi Lu |
Kamalakannan Radhakrishnan | Yi Shen |
Kamil Nelke | Yifan Zhang |
Kamini Singh | Yigit Ozpeynirci |
Kamyar Khoshnevisan | Yihan Cao |
Kanon Jatuworapruk | Yi-Lang Chen |
Kao Yao | Ying Wang |
Karel Kostev | Ying-Bin Yan |
Karel Mena Ulecia | Yingyun Gong |
Karen Bohmwald | Yi-Teng Hung |
Karen Villar Zarra | Yiwen Zhao |
Karina Gómez | Yoav Arnson |
Karl Andriessen | Yogeswaran Lokanathan |
Karl Bechter | Yolanda Alcaraz-Contreras |
Karmen Stankov | Yong Chen |
Karol Kaziród-Wolski | Yong Hai |
Karolina Czarnecka-Chrebelska | Yong Liu |
Karolina Hoffmann | Yong Teng |
Karolina Nowak | Yonggang Pei |
Karolina Pieniawska-Śmiech | Yongji Liu |
Karolina Stepien | Yongtao Sun |
Karolina Turżańska | Yoshiaki Zaizen |
Karpal Sohal | Yoshinori Moriyama |
Kasi Vegesana | Youakim Saliba |
Kasra Cheraqpour | Young A Kim |
Katalin Pető | Young Choi |
Katarina Savic Vujovic | Young Zoon Kim |
Katarzyna Antosik | Yousef Fouad |
Katarzyna Grocholewicz | Yu Gu |
Katarzyna Jalowiec | Yuan Liu |
Katarzyna Komosinska-Vassev | Yuan-Yang Cheng |
Katarzyna Lisowska | Yuanyuan Zhao |
Katarzyna Neubauer | Yubao Wang |
Katarzyna Ogrodzka-Ciechanowicz | Yubing Liu |
Katarzyna Pogoda | Yu-Chin Lien |
Katarzyna Samelska | Yue Luo |
Kate Eglseder | Yu-Feng Jiang |
Kate Kloot | Yuh-Yih Lin |
Katerina Kambouri | Yuichi Yoshii |
Katerina Naka | Yuji Nagatomo |
Katharina Rump | Yuka Kotozaki |
Katherine Theken | Yuki Hirata |
Kathleen Nicholls | Yuki Shinya |
Katia Pagnano | Yuko Harada |
Katsuyuki Tanabe | Yuko Nakagawa |
Kautilya Jena | Yuko Ono |
Kaveh Nasiri | Yulia Argunova |
Kayvan Zainabadi | Yun Wang |
Kazuhiko Nakadate | Yunan Wu |
Kazuhiro Tsuchiya | Yung-Taek Ouh |
Kazuhisa Asai | Yu-Ning Hu |
Kazuki Ide | Yuriy Vasil'Ev |
Kazuki Tokumasu | Yu-Shan Hsieh |
Kazumoto Murata | Yusuke Katayama |
Kee-Lung Chang | Yuta Norimatsu |
Keigi Fujiwara | Yutaka Endo |
Keisuke Seki | Yutang Wang |
Keith Gaynor | Yutao Liu |
Keith Siau | Yutian Zou |
Kenichi Iwasaki | Yuya Takakubo |
Kenji Yamagata | Yuzhou Zhang |
Kenneth Chua | Yves Borbély |
Kenneth Friedman | Yves Piette |
Kenneth J. Taubenslag | Zacharias Papadakis |
Kenneth Kok | Zachary Winkelmann |
Kenny Kwan | Zaher Alwafai |
Kentaro Okamoto | Zahid Asghar |
Kevin Couloures | Zahra Ashena |
Kevin Forton | Zahra Heidari |
Kevin Zarrabi | Zaida Abad-Jiménez |
Kezhou Zhu | Zainub Jooma |
Khaled El Matri | Zbigniew Heleniak |
Khaled Saad | Zefferino Palamà |
Khaled Soliman | Zeinab Akbarnejad |
Khalid Raza | Zeliha Selamoglu |
Khamin Chinsakchai | Željko Jeleč |
Khodabakhsh Javanshir | Zen-Kong Dai |
Kichang Lee | Zenon Pogorelić |
Kikuo Isoda | Zhanqi Zhao |
Kim Faulkner-Hogg | Zhaohua Cai |
Kim-Seng Law | Zhaoqing Cong |
Kinga Lis | Zhemeng Wu |
Kipras Pribuišis | Zhengwei Huang |
Kirk Stephenson | Zhenyu Wei |
Klemen Steblovnik | Zhidong Hu |
Koen Reyntjens | Zhila Semnani-Azad |
Kok Hian Tan | Zhiyuan Xu |
Komsun Suwannarurk | Zhuang Wang |
Komwit Surachat | Zhuhuang Zhou |
Konosuke Nakaji | Živka Dika |
Konrad Mendrala | Ziyad S. Haidar |
Konrad Stępień | Zlatko Kljajic |
Konstantin Scholz | Zoltan Herold |
Konstantinos Kostopanagiotou | Zoltan Kozinszky |
Konstantinos Perivoliotis | Zoltán Kukor |
Konstantinos Petsios | Zong Jie Cui |
Konstantinos Sidiropoulos | Zoran Gluvic |
Konstantinos Spanos | Zorana Dobrijević |
Konstantinos Tigkiropoulos | Zsolt Piróth |
Konstantinos Triantafyllou | Zulfan Zazuli |
Koos Jaap Van Zwieten | Zunyi Zhang |
Koray Durmaz | Zuohui Zhang |
Korhan Kilic | Zurabi Lominadze |
Kornanong Yuenyongchaiwat | Zygmunt Warzecha |
Kornelia Zaręba | Κωνσταντινος Papadopoulos |
Kouichi Hirayama |
30 January 2024
Journal of Clinical Medicine 2023 Editorial Board Meeting of the Section “Cardiovascular Medicine” Held on 12 December 2023
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board Meeting for the Section “Cardiovascular Medicine” on 12 December 2023. We greatly appreciate the Section Editor-in-Chief, Prof. Dr. Nathan Wong, for hosting this meeting and there were 12 Editorial Board Members in attendance.
The meeting started with a presentation about the development of the journal and the Section “Cardiovascular Medicine”, with the following information being presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), open access benefits, journal awards, 2024 ECCM Conference, promotion on social media;
- Geographical distribution of the Section’s Editorial Board Members, decision-making statistics, and Section statistics.
The meeting mainly discussed hot topics and emerging themes within the Section, the geographical distribution of our authors, Feature Paper invitations, quality control for both reviewers and review reports, tools for detecting plagiarism and AI generation, society collaborations, social media promotion, etc.
Based on the discussion, the journal intends to keep an eye on trending topics within the Section, investigate new themes, promote publications more widely, conduct meetings on specific cardiovascular topics, fortify its collaboration with the societies that our Editorial Board Members are part of, and improve publicity for the 2024 ECCM Conference, among other things.
We would like to thank every Editorial Board Member and the academics for their great support. We look forward to receiving more support and suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Nathan Wong (Section Editor-in-Chief), Division of Cardiology, University of California, Irvine, CA, USA;
- Theofilos M. Kolettis, 1st Cardiology Department, University Hospital of Ioannina, Ioannina, Greece;
- Roberto De Ponti, Department of Heart and Vessels, Ospedale di Circolo-University of Insubria, Varese, Italy;
- Piero Pollesello, Critical Care, Orion Pharma, Espoo, Finland;
- Alejandro De la Sierra, Hypertension Unit, Hospital Mutua Terrassa, University of Barcelona, Barcelona, Spain;
- Ronald J. Krone, Division of Cardiovascular, Washington University in St. Louis, St. Louis, MI, USA;
- Karol Kaminski, Department of Population Medicine and Lifestyle Disease Prevention, Medical University of Bialystok, Bialystok, Poland;
- Roberto Pedrinelli, Istituto Nazionale di Ricerche Cardiovasolari (INRC), Via Irnerio, Bologna, Italy;
- Rita Pavasini, Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy;
- Alexander H. Maass, Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands;
- Jeffrey L. Anderson, Intermountain Medical Center Heart Institute, Murray, UT, USA;
- Ioannis Vogiatzis, Department of Cardiology, General Hospital of Veroia, Veroia, Greece.
The latest official CiteScore (2022 Scopus data) for the Journal of Clinical Medicine is 5.4, ranking 137/830 (Q1) in the area of “General Medicine”. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the category “Medicine, General & Internal”.
To access more journal statistics, please click here.
To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Cardiovascular_Medicine.
23 January 2024
Journal of Clinical Medicine | Issue Cover Articles in 2023 (II)
The articles below have been selected as the second half of 2023 Issue Cover Articles by the Editorial Office of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). These articles are from multiple fields within the scope of the Journal of Clinical Medicine, and we hope they can provide insights and references for scholars in related fields. To access more journal volume information, please click on the following link: https://www.mdpi.com/2077-0383/12.
1. “Personalized Respiratory Support in ARDS: A Physiology-to-Bedside Review” by Salvatore Lucio Cutuli, Domenico Luca Grieco, Teresa Michi, Melania Cesarano, Tommaso Rosà, Gabriele Pintaudi, Luca Salvatore Menga, Ersilia Ruggiero, Valentina Giammatteo, Giuseppe Bello et al. J. Clin. Med. 2023, 12(13), 4176; https://doi.org/10.3390/jcm12134176 Available online: https://www.mdpi.com/2077-0383/12/13/4176 |
|
2. “The Limitations of Periapical X-ray Assessment in Endodontic Diagnosis—A Systematic Review” by Alexandru Gliga, Marina Imre, Simone Grandini, Crystal Marruganti, Carlo Gaeta, Dana Bodnar, Bogdan Alexandru Dimitriu and Federico Foschi J. Clin. Med. 2023, 12(14), 4647; https://doi.org/10.3390/jcm12144647 Available online: https://www.mdpi.com/2077-0383/12/14/4647 |
|
3. “Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches” by Christian Baumeier, Dominik Harms, Ganna Aleshcheva, Ulrich Gross, Felicitas Escher and Heinz-Peter Schultheiss J. Clin. Med. 2023, 12(15), 5050; https://doi.org/10.3390/jcm12155050 Available online: https://www.mdpi.com/2077-0383/12/15/5050 |
|
4. “Right Atrial Phasic Function in Heart Failure with Preserved Ejection Fraction: Cardiac Magnetic Resonance Feature Tracking and Outcomes” by Robert Schönbauer, Fiona Hana, Franz Duca, Matthias Koschutnik, Carolina Donà, Christian Nitsche, Michael Sponder, Max Lenz, Jonghui Lee, Christian Loewe et al. J. Clin. Med. 2023, 12(16), 5179; https://doi.org/10.3390/jcm12165179 Available online: https://www.mdpi.com/2077-0383/12/16/5179 |
|
5. “Maintenance Therapy for Children and Adolescents with Asthma: Guidelines and Recommendations from the Emilia-Romagna Asthma (ERA) Study Group” by Valentina Fainardi, Carlo Caffarelli, Michela Deolmi, Giulia Zambelli, Elisabetta Palazzolo, Sara Scavone, Barbara Maria Bergamini, Luca Bertelli, Loretta Biserna, Paolo Bottau et al. J. Clin. Med. 2023, 12(17), 5467; https://doi.org/10.3390/jcm12175467 Available online: https://www.mdpi.com/2077-0383/12/17/5467 |
|
6. “Long-Term Performance of Epicardial versus Transvenous Left Ventricular Leads for Cardiac Resynchronization Therapy” by Gijs E. de Maat, Bart A. Mulder, Martijn E. Van de Lande, Rajiv S. Rama, Michiel Rienstra, Massimo A. Mariani, Alexander H. Maass and Theo J. Klinkenberg J. Clin. Med. 2023, 12(18), 5766; https://doi.org/10.3390/jcm12185766 Available online: https://www.mdpi.com/2077-0383/12/18/5766 |
|
7. “Positron Emission Computed Tomography Spectrum of Large Vessel Vasculitis in a Tertiary Center: Differences in 18F-fluorodeoxyglucose Uptake between Large Vessel Vasculitis with Predominant Cranial and Extracranial Giant Cell Arteritis Phenotypes” by Elena Heras-Recuero, Laura Cristina Landaeta-Kancev, Marta Martínez de Bourio-Allona, Arantxa Torres-Rosello, Teresa Blázquez-Sánchez, Iván Ferraz-Amaro, Santos Castañeda, Juan Antonio Martínez-López, Luis Martínez-Dhier, Raquel Largo et al. J. Clin. Med. 2023, 12(19), 6164; https://doi.org/10.3390/jcm12196164 Available online: https://www.mdpi.com/2077-0383/12/19/6164 |
|
8. “Increasing Soluble P-Selectin Levels Predict Higher Peripheral Atherosclerotic Plaque Progression” by Philip Sommer, Michael Schreinlechner, Maria Noflatscher, Daniela Lener, Fabian Mair, Markus Theurl, Rudolf Kirchmair and Peter Marschang J. Clin. Med. 2023, 12(20), 6430; https://doi.org/10.3390/jcm12206430 Available online: https://www.mdpi.com/2077-0383/12/20/6430 |
|
9. “Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents” by Pierre Brami, Quentin Fischer, Vincent Pham, Gabriel Seret, Olivier Varenne and Fabien Picard J. Clin. Med. 2023, 12(21), 6711; https://doi.org/10.3390/jcm12216711 Available online: https://www.mdpi.com/2077-0383/12/21/6711 |
|
10. “Reasons for Discontinuing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes in Real-World Settings: The KAMOGAWA-A Study” by Yuto Saijo, Hiroshi Okada, Shinnosuke Hata, Hanako Nakajima, Nobuko Kitagawa, Takuro Okamura, Takafumi Osaka, Noriyuki Kitagawa, Saori Majima, Takafumi Senmaru et al. J. Clin. Med. 2023, 12(22), 6993; https://doi.org/10.3390/jcm12226993 Available online: https://www.mdpi.com/2077-0383/12/22/6993 |
|
11. “Evaluation of Femoropopliteal In-Stent Restenosis Characteristics Stratified by Stent Design” by Elias Noory, Tanja Böhme, Jonas Salm, Ulrich Beschorner, Larissa Endress, Roaa Bollenbacher, Dirk Westermann, and Thomas Zeller J. Clin. Med. 2023, 12(23), 7225; https://doi.org/10.3390/jcm12237225 Available online: https://www.mdpi.com/2077-0383/12/23/7225 |
|
12. “Myocardial Work Assessment in Patients after Coronary Artery Bypass Grafting during Cardiac Rehabilitation” by Francesco Perone, Roberta Ancona, Fausto di Stasio, Vito La Gambina and Salvatore Comenale Pinto J. Clin. Med. 2023, 12(24), 7540; https://doi.org/10.3390/jcm12247540 Available online: https://www.mdpi.com/2077-0383/12/24/7540 |
23 January 2024
Journal of Clinical Medicine | Issue Cover Articles in 2023 (I)
The articles below have been selected as the first half of 2023 Issue Cover Articles by the Editorial Office of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). These articles are from multiple fields within the scope of the Journal of Clinical Medicine, and we hope they can provide insights and references for scholars in related fields. To access more journal volume information, please click on the following link: https://www.mdpi.com/2077-0383/12.
1. “Selective Decontamination of the Digestive Tract in Pancreatic Head Resections—A Propensity Score-Matched Analysis” by Olga Radulova-Mauersberger, Florian Oehme, Alexandra Doerell, Laura Frohneberg, Sebastian Hempel, Jürgen Weitz, Thilo Welsch, Marius Distler and Christian Teske J. Clin. Med. 2023, 12(1), 250; https://doi.org/10.3390/jcm12010250 Available online: https://www.mdpi.com/2077-0383/12/1/250 |
|
2. “Anatomical Variations of the Human Cochlea Using an Image Analysis Tool” by Raabid Hussain, Attila Frater, Roger Calixto, Chadlia Karoui, Jan Margeta, Zihao Wang, Michel Hoen, Herve Delingette, François Patou, Charles Raffaelli et al. J. Clin. Med. 2023, 12(2), 509; https://doi.org/10.3390/jcm12020509 Available online: https://www.mdpi.com/2077-0383/12/2/509 |
|
3. “Effect of Left Atrial Pulmonary Vein Angiography on Safety and Efficacy for High-Power, Short-Duration Pulmonary Vein Isolation in Patients with Atrial Fibrillation” by Sebastian Weyand, Viola Adam, Matthias Beuter, Simon Hanger, David Heinzmann, Willibald Schrezenmeier and Peter Seizer J. Clin. Med. 2023, 12(3), 1094; https://doi.org/10.3390/jcm12031094 Available online: https://www.mdpi.com/2077-0383/12/3/1094 |
|
4. “Long-Term Results of Endoscopic Metal Stenting for Biliary Anastomotic Stricture after Liver Transplantation” by Aymeric Becq, Alexis Laurent, Quentin De Roux, Cristiano Cremone, Hugo Rotkopf, Yann Le Baleur, Farida Mesli, Christophe Duvoux, Aurélien Amiot, Charlotte Gagniere et al. J. Clin. Med. 2023, 12(4), 1453; https://doi.org/10.3390/jcm12041453 Available online: https://www.mdpi.com/2077-0383/12/4/1453 |
|
5. “A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine” by Martin Sattler, Isa Mambetsariev, Jeremy Fricke, Tingting Tan, Sariah Liu, Nagarajan Vaidehi, Evan Pisick, Tamara Mirzapoiazova, Adam G. Rock, Amartej Merla et al. J. Clin. Med. 2023, 12(5), 1936; https://doi.org/10.3390/jcm12051936 Available online: https://www.mdpi.com/2077-0383/12/5/1936 |
|
6. “Postoperative Radiological Improvement after Staged Surgery Using Lateral Lumbar Interbody Fusion for Preoperative Coronal Malalignment in Patients with Adult Spinal Deformity” by Akihiko Hiyama, Daisuke Sakai, Hiroyuki Katoh, Masato Sato and Masahiko Watanabe J. Clin. Med. 2023, 12(6), 2389; https://doi.org/10.3390/jcm12062389 Available online: https://www.mdpi.com/2077-0383/12/6/2389 |
|
7. “Cognitive Stress Regulation in Schizophrenia Patients and Healthy Individuals: Brain and Behavior” by Lydia Kogler, Christina Regenbogen, Veronika I. Müller, Nils Kohn, Frank Schneider, Ruben C. Gur and Birgit Derntl J. Clin. Med. 2023, 12(7), 2749; https://doi.org/10.3390/jcm12072749 Available online: https://www.mdpi.com/2077-0383/12/7/2749 |
|
8. “Revascularization and Medical Therapy for Chronic Coronary Syndromes: Lessons Learnt from Recent Trials, a Literature Review” by Vincent Pham, Alice Moroni, Emmanuel Gall, Alice Benedetti, Carlo Zivelonghi and Fabien Picard J. Clin. Med. 2023, 12(8), 2833; https://doi.org/10.3390/jcm12082833 Available online: https://www.mdpi.com/2077-0383/12/8/2833 |
|
9. “Oral Cavity Squamous Cell Carcinoma Risk Factors: State of the Art” by Lara Nokovitch, Charles Maquet, Frédéric Crampon, Ihsène Taihi, Lise-Marie Roussel, Rais Obongo, François Virard, Béatrice Fervers and Sophie Deneuve J. Clin. Med. 2023, 12(9), 3264; https://doi.org/10.3390/jcm12093264 Available online: https://www.mdpi.com/2077-0383/12/9/3264 |
|
10. “Advances in Imaging for Tricuspid Transcatheter Edge-to-Edge Repair: Lessons Learned and Future Perspectives” by Francesca Romana Prandi, Stamatios Lerakis, Martina Belli, Federica Illuminato, Davide Margonato, Lucy Barone, Saverio Muscoli, Marcello Chiocchi, Mario Laudazi, Massimo Marchei et al. J. Clin. Med. 2023, 12(10), 3384; https://doi.org/10.3390/jcm12103384 Available online: https://www.mdpi.com/2077-0383/12/10/3384 |
|
11. “Nagor Impleo Round Silicone Gel Breast Implants: Early Outcome Analysis after 340 Primary Breast Augmentations” by Maximilian Zaussinger, Dominik Duscher and Georg M. Huemer J. Clin. Med. 2023, 12(11), 3708; https://doi.org/10.3390/jcm12113708 Available online: https://www.mdpi.com/2077-0383/12/11/3708 |
|
12. “Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes” by Almudena Castro Conde, Domingo Marzal Martín, Raquel Campuzano Ruiz, Maria Rosa Fernández Olmo, Carlos Morillas Ariño, Juan José Gómez Doblas, Jose Luis Gorriz Teruel, Pilar Mazón Ramos, Xavier García-Moll Marimon, Maria Jose Soler Romeo et al. J. Clin. Med. 2023, 12(12), 3925; https://doi.org/10.3390/jcm12123925 Available online: https://www.mdpi.com/2077-0383/12/12/3925 |
10 January 2024
Meet Us at the 53rd Annual Meeting of the Japanese Society for Spine Surgery and Related Research, 18–20 April 2024, Yokohama, Japan
MDPI will attend the 53rd Annual Meeting of the Japanese Society for Spine Surgery and Related Research as an exhibitor. This conference will be held in Yokohama, Japan, from 18 to 20 April 2024.
The following MDPI journals will be represented:
- JCM;
- JPM;
- JFMK;
- Osteology;
- Surgeries;
- Clinics and Practice;
- Surgical Techniques Development (STD);
- Biomechanics;
- Pathophysiology;
- Reports.
If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://site2.convention.co.jp/jssr2024/index_en.html.
9 January 2024
Meet Us at the 7th Symposium on Primary Breast Cancer in Older Women, 1 March 2024, Nottingham, UK
MDPI will attend the 7th Symposium on Primary Breast Cancer in Older Women as an exhibitor. This conference will be held in Nottingham, UK, on 1 March 2024.
The 7th Symposium on Primary Breast Cancer in Older Women aims to develop an in-depth understanding around the biology and treatment options, explore the specific physical and psychosocial needs and consideration including the patient perspective, and gain insight into the development of a holistic and multidisciplinary management approach and the importance of supporting research in the field of breast cancer.
The following MDPI journals will be represented:
If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://www.nottingham.ac.uk/conference/fac-mhs/medicine/symposia-on-primary-breast-cancer-in-older-women/index.aspx
2 January 2024
MDPI Insights: The CEO's Letter #7 - Nobel Laureates Entrust MDPI with Their Research
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Nobel Prize Laureates Entrust MDPI with Their Research
The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.
Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, Pharmaceutics, Photonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.
The best of the best trust us with their work.
Nobel Prize Laureates Who Have Published with MDPI
We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.
The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.
2023 Nobel Prize Winners Published by MDPI
Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)
Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.
In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.
Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".
We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.
Read more:
Impactful Research
MDPI Journals Newly Indexed in 2023
The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.
Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.
In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.
The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.
MDPI’s journals are indexed in all major global databases.
Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.
Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)
Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.
Read more:
Inside MDPI
MDPI Appoints New Chief Operating Officer (COO)
Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.
Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.
As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.
Coming Together for Science
MDPI’s 2024 In-Person Academic Events Schedule
MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.
Here's a glimpse of the notable events we currently have scheduled for 2024:
14–16 February, 2024 |
|
24–26 April, 2024 |
|
28–31 May, 2024 |
|
1–4 August, 2024 |
Upcoming events with details to be announced:
- September 2024, Materials 2024 – Basel, Switzerland
- 19–21 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
- October 2024, ncRNA 2024 – Basel, Switzerland
- November 2024, Pharmaceuticals 2024 – Barcelona, Spain
- 22–26 November 2024, International Conference on Science of Electronics – Wuhan, China
- Stay tuned for more details on the Sustainable Publishing Forum 2024.
Click here for all upcoming MDPI events.
Organize Your Event with MDPI’s Sciforum
Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.
Closing Thoughts
Reflecting on 2023 and Looking Ahead to 2024
As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.
Becoming a stronger organisation
While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.
I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.
“I am committed to taking MDPI to a new level of excellence.”
Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.
Accountability and communication
As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.
Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.
Here’s to a joyous and prosperous 2024!
Chief Executive Officer
MDPI AG
26 December 2023
Editorial Board Members from the Journal of Clinical Medicine Featured in the 2023 Highly Cited Researchers List Published by Clarivate
Recently, ClarivateTM revealed its 2023 list of Highly Cited ResearchersTM—individuals at universities, research institutes, and commercial organizations.
The scientists who were selected for this year’s list of Highly Cited Researchers published highly cited papers in the 11-year period from January 2012 to December 2022, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. This year, 7125 Highly Cited Researcher 2023 designations were issued to 6849 individuals, representing just 1 in 1000 researchers worldwide. This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. The list is truly global, spanning 67 countries or regions and spread across a diverse range of research sciences and social sciences.
According to our statistics, 8 members of the Editorial Board of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) were selected for the list of Highly Cited Researchers by ClarivateTM in 2023. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields. The JCM Editorial Office sincerely congratulates all elected editorial members and hopes that they continue to have an academically productive relationship with the journal.
Researcher |
|
Category |
Affiliation |
Lancellotti, Patrizio |
Clinical Medicine |
University of Liege, Belgium |
|
Timsit, Jean-Francois |
Cross-Field |
Université Paris Cité, France |
|
Young, Allan H. |
Cross-Field |
King's College London, United Kingdom |
|
Graus, Francesc |
Neuroscience and Behavior |
University of Barcelona, Spain |
|
Vita, Antonio |
Psychiatry and Psychology |
University of Brescia, Italy |
|
Landi, Francesco |
Cross-Field |
Catholic University of the Sacred Heart, Italy |
|
Rocca, Maria A. |
Neuroscience and Behavior |
Vita-Salute San Raffaele University, Italy |
|
Carvalho, Andre F. |
Psychiatry and Psychology |
Deakin University, Australia |
To access more information about the JCM Editorial Board, please visit the following link: https://www.mdpi.com/journal/jcm/editors.
26 December 2023
2023 Journal of Clinical Medicine Editorial Board Meeting of the Section “Cardiology” Held on 21 November 2023
It is our great pleasure to share the news that the 2023 Journal of Clinical Medicine (JCM, ISSN: 2077-0383) Editorial Board Meeting of the Section “Cardiology” was held on 21 November 2023, conducted by the Section Editor-in-Chiefs, Prof. Dr. Maciej Banach and Prof. Dr. Gregory Y. H. Lip.
The meeting started with a presentation about the development of the journal and the Section “Cardiology”, with the following information presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), open access benefits, journal awards, conference sponsorship, and promotion on social media;
- Section Editorial Board Member distribution, decision-making statistics, and Section statistics.
The meeting mainly discussed the quality control of manuscripts, feature paper invitations, reviewer awards, the direction of article types, Special Issue collaboration, conference suggestions, and social media promotion. Based on the discussion, the journal plans to enrich reviewer award applications, be more present at conferences in the field, keep an eye on hot topics and research fronts, and have social media ambassadors to improve promotion.
We would like to thank every Editorial Board Member and the academics for their great support. We look forward to receiving more support and suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Prof. Dr. Maciej Banach, Chair of Nephrology and Hypertension, Medical University of Lodz, Lodz, Poland; Johns Hopkins University School of Medicine, Baltimore, MD, USA;
- Prof. Dr. Gregory Y. H. Lip, University of Liverpool, Liverpool, UK; Aalborg University, Aalborg, Denmark;
- Prof. Dr. Massimiliano Ruscica, Università degli Studi di Milano, Milan, Italy;
- Prof. Dr. Filippos Triposkiadis, University of Thessaly, Larissa University General Hospital, Larissa, PO, Greece;
- Prof. Dr. Manuel Martínez-Sellés, Hospital General Universitario Gregorio Marañón, Calle Doctor Esquerdo, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain;
- Prof. Dr. Sheldon Goldberg, University of Pennsylvania Health System, Philadelphia, PA, USA;
- Prof. Dr. Gani Bajraktari, Umeå University and Heart Centre, Umeå, Sweden; University Clinical Centre of Kosova, Prishtina, Kosovo;
- Prof. Dr. Laurent Fauchier, Centre Hospitalier Universitaire Trousseau, Faculté de Médecine, Université de Tours, Avenue de la-République, Tours, France;
- Prof. Dr. Manuel Martínez-Sellés, Hospital General Universitario Gregorio Marañón, Calle Doctor Esquerdo, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain;
- Dr. Chirag Bavishi, University of Missouri, Columbia, MO, USA;
- Dr. Karl-Philipp Rommel, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
The latest official CiteScore (2022 Scopus data) of the Journal of Clinical Medicine is 5.4, ranking 137/830 (Q1) in the area of “General Medicine”. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the category “Medicine, General & Internal”.
To access more journal statistics, please click here.
To access more Section information, please visit the following link: https://www.mdpi.com/journal/jcm/sections/JCM_Cardiology.
20 December 2023
Interview with Dr. Víctor Marcos Garcés—Winner of the JCM 2022 Ph.D. Thesis Award
We had the pleasure of speaking with Dr. Víctor Marcos Garcés, winner of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) 2022 Ph.D. Thesis Award.
Name: Dr. Víctor Marcos Garcés Affiliation: 1.Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain; |
Dr. Víctor Marcos Garcés is a cardiologist and gained his Doctor in Medicine degree from the University of Valencia, Spain. He has shown special interest in clinical and preventive cardiology, cardiac rehabilitation, and cardiac imaging techniques, pursuing postgraduate university training in these areas. In January 2022, he initiated the Post-Myocardial Infarction Cardiac Rehabilitation Program at the University Clinical Hospital of Valencia, Spain. Dr. Víctor Marcos Garcés also has extensive research experience, emphasizing various aspects of cardiac imaging techniques (especially cardiac magnetic resonance), basic and translational research, and, in recent years, preventive cardiology and cardiac rehabilitation. He has published 47 articles in scientific journals (with half of them being published in first decile or quartile journals), participated in 8 competitive research projects, and presented more than 150 abstracts at scientific congresses, with more than 50 of them being international congresses. He has received several awards throughout his career, such as the Extraordinary Ph.D. Award from the University of Valencia, the Final Residency Award, and the García Blanco Medal-Award in its 42nd edition.
We hope you enjoy the interview.
We wish Dr. Víctor Marcos Garcés every success in his current work, and we look forward to his future contributions to the journal.
For more information about the awards presented by JCM, please visit the following link: https://www.mdpi.com/journal/jcm/awards.
We wish Dr. Víctor Marcos Garcés every success in his current work, and we look forward to his future contributions to the journal.
For more information about the awards presented by JCM, please visit the following link: https://www.mdpi.com/journal/jcm/awards.
1 December 2023
Journal of Clinical Medicine | Collaboration Established with the Italian Society of Thoracic Endoscopy (SIET)
In September 2023, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has established a cooperation with the Italian Society of Thoracic Endoscopy (SIET). As part of this collaboration, all members of SIET will enjoy a discount on the Article Processing Charge (APC) when submitting articles to JCM. The collaboration goes beyond the discount benefit offered to members and includes other services as well as cross-promotions. Italian Society of Thoracic Endoscopy was founded as an Italian organization in 1980. However, it now has members from all over the European continent. SIET is a dynamic and young scientific society that plays a leading role in endoscopy and minimally invasive thoracic surgery. |
SIET is a professional organization whose functions are highly relevant to the scope of JCM. We look forward to collaborating with SIET and publishing state-of-the-art research from its members in this field.
For more information about societies cooperated with JCM, please visit: https://www.mdpi.com/journal/jcm/societies.
30 November 2023
MDPI Insights: The CEO's Letter #6 - MDPI Spain Summit and ResearchGate
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Spain Summit
Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.
On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.
With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.
The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.
The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.
Connecting with Editorial Board Members
Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."
Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.
From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.
As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.
Open Access in Spain
In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.
For further details of Spain's OA policy and the history of government mandates, click here.
Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus.
A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!
MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.
I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.
Impactful Research
769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023
Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.
Click here to view the full list of 769 Editorial Board Members.
Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.
This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.
These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.
Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!
Inside MDPI
Corporate Marketing and Communications Strategy Session
Members of MDPI’s Corporate Marketing & Communications team.
For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.
This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.
We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.
The strategy session also serves as a team-building activity, during which the team voted on bowling!
Strategy Session
In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.
To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.
I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.
Coming Together for Science
ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home
Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.
When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.
In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.
While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.
The press release below provides further details.
Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023
ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.
This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.
Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.
Closing Thoughts
November is Men’s Health Awareness Month
Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.
November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.
I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.
Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.
Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.
Healthy men help build healthy families and a healthy society
Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.
From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.
Mindfulness
Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:
Chief Executive Officer
MDPI AG
28 November 2023
Journal of Clinical Medicine | Highly Cited Papers in the Section “Gastroenterology & Hepatopancreatobiliary Medicine”
Journal of Clinical Medicine (JCM, ISSN: 2077-0383) publishes high-quality original research, reviews, and systematic reviews that contribute to advancing clinical health and medicine. As JCM is of open access format, you have free and unlimited access to the full text of all the articles published in it.
We welcome you to read the highly cited papers published in 2022 in the Section “Gastroenterology & Hepatopancreatobiliary Medicine”.
1. “Extra-Intestinal Manifestations of Celiac Disease: What Should We Know in 2022?”
by Marilena Durazzo, Arianna Ferro, Isabella Brascugli, Simone Mattivi, Sharmila Fagoonee and Rinaldo Pellicano
J. Clin. Med. 2022, 11(1), 258; https://doi.org/10.3390/jcm11010258
Available online: https://www.mdpi.com/2077-0383/11/1/258
2. “The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus”
by Marcin Kosmalski, Sylwia Ziółkowska, Piotr Czarny, Janusz Szemraj and Tadeusz Pietras
J. Clin. Med. 2022, 11(5), 1375; https://doi.org/10.3390/jcm11051375
Available online: https://www.mdpi.com/2077-0383/11/5/1375
3. “The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?”
by Matteo Renzulli, Anna Pecorelli, Nicolò Brandi, Stefano Brocchi, Francesco Tovoli, Alessandro Granito, Gianpaolo Carrafiello, Anna Maria Ierardi and Rita Golfieri
J. Clin. Med. 2022, 11(15), 4399; https://doi.org/10.3390/jcm11154399
Available online: https://www.mdpi.com/2077-0383/11/15/4399
4. “Current Status and Future Perspectives of Artificial Intelligence in Colonoscopy”
by Yu Kamitani, Kouichi Nonaka and Hajime Isomoto
J. Clin. Med. 2022, 11(10), 2923; https://doi.org/10.3390/jcm11102923
Available online: https://www.mdpi.com/2077-0383/11/10/2923
5. “Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn’s Disease: Systematic Review and Meta-Analysis of Observational Studies”
by Cristina Rubín de Célix, María Chaparro and Javier P. Gisbert
J. Clin. Med. 2022, 11(14), 4202; https://doi.org/10.3390/jcm11144202
Available online: https://www.mdpi.com/2077-0383/11/14/4202
6. “Ulva pertusa, a Marine Green Alga, Attenuates DNBS-Induced Colitis Damage via NF-κB/Nrf2/SIRT1 Signaling Pathways”
by Alessio Ardizzone, Alessia Filippone, Deborah Mannino, Sarah Adriana Scuderi, Giovanna Casili, Marika Lanza, Laura Cucinotta, Michela Campolo and Emanuela Esposito
J. Clin. Med. 2022, 11(15), 4301; https://doi.org/10.3390/jcm11154301
Available online: https://www.mdpi.com/2077-0383/11/15/4301
7. “COVID-19 Pneumonia and Gut Inflammation: The Role of a Mix of Three Probiotic Strains in Reducing Inflammatory Markers and Need for Oxygen Support”
by Angela Saviano, Annalisa Potenza, Valentina Siciliano, Carmine Petruzziello, Claudia Tarli, Alessio Migneco, Flavia Nasella, Francesco Franceschi and Veronica Ojetti
J. Clin. Med. 2022, 11(13), 3758; https://doi.org/10.3390/jcm11133758
Available online: https://www.mdpi.com/2077-0383/11/13/3758
8. “Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways”
by Laure-Alix Clerbaux, Julija Filipovska, Amalia Muñoz, Mauro Petrillo, Sandra Coecke, Maria-Joao Amorim and Lucia Grenga
J. Clin. Med. 2022, 11(18), 5400; https://doi.org/10.3390/jcm11185400
Available online: https://www.mdpi.com/2077-0383/11/18/5400
9. “Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)”
by Olga P. Nyssen, Dino Vaira, Ilaria Maria Saracino, Giulia Fiorini, María Caldas, Luis Bujanda, Rinaldo Pellicano, Alma Keco-Huerga, Manuel Pabón-Carrasco, Elida Oblitas Susanibar et al.
J. Clin. Med. 2022, 11(6), 1658; https://doi.org/10.3390/jcm11061658
Available online: https://www.mdpi.com/2077-0383/11/6/1658
10. “Suppurative Thrombosis of the Portal Vein (Pylephlebits): A Systematic Review of Literature”
by Dorde Jevtic, Tatjana Gavrancic, Ivana Pantic, Terri Nordin, Charles W. Nordstrom, Marina Antic, Nikola Pantic, Marija Kaljevic, Bojan Joksimovic, Milan Jovanovic et al.
J. Clin. Med. 2022, 11(17), 4992; https://doi.org/10.3390/jcm11174992
Available online: https://www.mdpi.com/2077-0383/11/17/4992
Access more Section information here.
21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023
We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.
Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.
This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.
This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.
Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!
Abate, Antonio |
Jaiswal, Amit K. |
Shen, Zexiang |
15 November 2023
2023 Journal of Clinical Medicine Editorial Board Meeting of Section “Endocrinology & Metabolism” Held on 5 and 18 September 2023
It is our great pleasure to share the news that the 2023 Journal of Clinical Medicine (JCM) Editorial Board Meeting of Section “Endocrinology & Metabolism” was held on 5 and 18 September 2023, conducted by the Section Editor-in-Chief, Prof. Dr. Didac Mauricio.
The meeting started with a presentation about the journal and Section “Endocrinology & Metabolism” development with the following information presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), open access benefits, journal awards, conference sponsorship, promotion on social media;
- Section aims and scope, Editorial Board Member distribution and decision-making statistics, Section statistics, highly cited papers.
The meeting mainly discussed keyword expansion and revision of the Section website, as well as other topics such as Academic Editor decisions, Section title, Section competitiveness, manuscript processing flow, Special Issue series, and feature paper invitations. Based on the discussion, some keywords may be added to the Section website, such as therapy of obesity, diabetes, metabolic bone diseases/disorders, prevention of endocrine diseases, pediatric endocrinology, etc. We will keep an eye out for more proposals and maintain regular communication with the Editorial Board Members to further the Section's growth.
This Section Editorial Board online meeting aims to increase support for the Section's and the journal's next development. We would like to thank every Editorial Board Member and the academics for their support again. We look forward to receiving more support and suggestions and making common progress.
Attendee list (in no particular order):
Part I (5 September 2023):
- Prof. Dr. Didac Mauricio, Hospital de la Sant Creu i Sant Pau, Barcelona, Spain; University of Vic & Central University of Catalonia, Barcelona, Spain; Instituto de Salud Carlos III, Barcelona, Spain;
- Prof. Dr. Luigi Uccioli, University of Rome Tor Vergata, Rome, Italy;
- Prof. Dr. Brian Tomlinson, Macau University of Science and Technology, Macau; The Chinese University of Hong Kong, Hong Kong;
- Dr. Sheyu Li, West China Hospital of Sichuan University, Chengdu, China.
Part II (18 September 2023):
- Prof. Dr. Didac Mauricio, Hospital de la Sant Creu i Sant Pau, Barcelona, Spain; University of Vic & Central University of Catalonia, Barcelona, Spain; Instituto de Salud Carlos III, Barcelona, Spain;
- Dr. John Griffith Jones, University of Coimbra, Coimbra, Portugal;
- Prof. Dr. Gyanendra Tripathi, University of Derby, Derby, UK;
- Prof. Dr. Alejandro Gugliucci, Touro University California, Vallejo, CA, USA;
- Prof. Dr. Neveen Agnes Therese Hamdy, Leiden University Medical Center, University of Leiden, Leiden, the Netherlands;
- Prof. Dr. Cees Noordam, Centre for Paediatric Endocrinology Zurich (PEZZ), Zurich, Switzerland; Radboud University Medical Centre, Nijmegen, the Netherlands;
- Dr. Ishwarlal Jialal, UCDAVIS School of Medicine, Sacramento, CA, USA.
The latest official CiteScore (2022 Scopus data) of the Journal of Clinical Medicine (ISSN: 2077-0383) is 5.4, ranking 137/830 (Q1) in the area of “General Medicine”. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the category “Medicine, General & Internal”.
To access more journal statistics please click here.
To access more Section information, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Endocrinology_Metabolism.
9 November 2023
Interview with Dr. Francesco Restelli—Winner of the JCM 2023 Travel Award
Name: Dr. Francesco Restelli
Affiliation: 1. Neurovascular Unit and Revascularization Unit, the Foundation IRCCS Neurological Institute “C. Besta,” Milan, Italy;
2. Italian Society of Neurosurgery and the European Association of Neurosurgical Societies.
We wish to congratulate Dr. Francesco Restelli on winning the JCM 2023 Travel Award. Dr. Francesco Restelli, MD., is an attending neurosurgeon of the Neurovascular Unit and the Revascularization Unit at the Foundation IRCCS Neurological Institute “C. Besta” in Milano. Dr. Restelli’s expertise includes cerebrovascular disorders (aneurysm, AVM, cavernomas, and moyamoya disease and stroke), brain, skull base, and intramedullary tumors.
He is a member of the Italian Society of Neurosurgery and the European Association of Neurosurgical Societies. Dr. Restelli received his medical degree and neurosurgery residency at the University of Milano. He completed a neurosurgical fellowship at the Arkansas Neuroscience Institute in Little Rock, Arkansas.
Dr. Restelli's research activities include the development of new visualization techniques during surgical approaches for oncological and vascular disease, particularly involving intraoperative fluorescence, developing new surgical techniques for cerebral revascularization, and anatomical studies of neurosurgical approaches. In the last five years, he has won five international awards related to neurosurgical research, and he is the author and co-author of over 40 peer-reviewed articles and four book chapters.
The following is an interview with Dr. Francesco Restelli:
1. How does it feel to receive this recognition for your work?
It was an honor; I feel very good because, for a researcher, having your work recognized that it is good enough to win a prize, is wonderful.
2. Where do you obtain journal award participation information?
My mentor, Prof. Dr. Francesco Acerbi, here at our neurological institute, suggested I apply for this recognition. Our group recently published many papers in your journal, and he probably received some emails about it. So, he was the one who suggested I apply.
3. Have you promoted it at a conference? In addition to promoting at the conference, how do you prefer to share the journal with your community?
In 2023, emails and notes on social media are the mainstream way for scientific diffusion. So I think that these ways would be my preferred ones.
4. How did winning this award impact your career, and what do you hope to do?
This kind of award is fundamental to my professional career and future. We are now working on the future steps of our project and trying to push it to the next clinical level.
5. Could you please briefly introduce your research direction for those who may not be familiar with it?
Confocal microscopy is a new technique that obtains images intraoperatively at the microscopic level during surgeries without needing standings or fixations using classical histological techniques. So basically, with this machine, the operator can obtain intraoperatively virtual histological images during the surgery an infinite number of times. So you can check inside and outside the tumor area, at the tumor bed, etc. Of course, in neurological surgery, as in my case, this aspect could have a significant role in the near future, as the microscopic vision of tumor tissue, particularly at the margins of resection of the intra-axial or glial tumor, could increase the extent of resection, leading to an increase in postoperative survival, hopefully.
6. What inspired you to follow this line of research?
Our group at Besta Institute, headed by Dr. Ferroli and Dr. Acerbi, has been very active in intraoperative imaging surgery in the last 20–25 years. So, following this path was a natural, consecutive step.
7. What do you think sets your research apart from others?
I think that our study was the first available in the literature where a machine's ability, named CONVIVO, was studied prospectively and blindly. For instance, similar works have been performed in recent years by different groups, but almost every study was characterized by not completely controlled designs or a low number of patients. For instance, only gliomas were often included in the surgical cohorts. Furthermore, in similar works, the analysis at the margins of the tumors has always been uncontrolled, with consecutively poor results in accuracy, sensitivity, sensitivity, and specificity.
8. How do you see your research findings impacting the field of clinical medicine and other related research areas?
Confocal microscopy has been widely used in medical clinical fields in recent years, such as gastroenterology, dermatology, gynecology, and neurosurgery. It is a wonderful technology because it permits physicians, clinicians, and surgeons to have live histological images during a procedure, an exam, an endoscopy, or surgery. I think this aspect may have very relevant insights in all the fields of clinical medicine, but especially for neurosurgery, where we all need to check the difference between a normal brain and a pathologic brain, and this difference during surgery is not always easy to find. Hence, having a machine that permits the physician to check whether tissue is pathologic is very interesting.
9. What are the next steps for this research?
We just concluded a 75-patient prospective study and presented the results at several international meetings. I think the two consecutive steps would be creating a common and worldwide shared database to increase the amount of collected data regarding rarer pathologies, not just metastasis and gliomas because for pathologies that are encountered less frequently, the data are still suboptimal. The other aspect is that we still need to study the real effectiveness of this kind of technology regarding the extent of resection, especially in intra-axial tumors. This aspect is just hypothesized for now, but we need to keep going and create a clinical protocol to check the difference in the extent of resection and overall survival in patients, considering if they are operated on with the aid of CONVIVO.
10. Do you have any advice for aspiring researchers in the field?
I have some advice. First, this is a very interesting field, but it requires physicians and surgeons to increase their skill in visualizing histological images. In Italy, for example, a neurosurgical resident's ability to analyze histological images is not commonly requested (and tested) in the residency program. So, regarding this aspect, I suggest that other researchers keep their minds open. I think the more a professional figure can analyze different aspects of his proper research, from the histological image analysis to the statistical analysis, the more comprehensive and interesting ideas could become because the researcher has the instruments to talk with everyone and share ideas.
A second piece of advice that I would give everyone is not to hesitate to contact colleagues worldwide to take a tour and look at their work. In scientific papers, it very often is impossible to present all those clinical, blurred, and accessory aspects that represent ingredients necessary for good clinical results, regardless of the main theme of the research. Once again, keep your mind open and travel.
11. What is your opinion of the open access model of publishing?
Science is based on information sharing, which is the only way to improve research. Therefore, every option that permits authors to increase the diffusion of their thinking and work should always be welcomed.
You can find more information about JCM Awards at the following link: https://www.mdpi.com/journal/jcm/awards. To request further information, please contact the JCM Editorial Office ([email protected]).
Journal of Clinical Medicine Editorial Office
1 November 2023
MDPI Insights: The CEO's Letter #5 - OA Week, UK, and Strategy
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access Week 2023 – the Global Drive to Open Continues
As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.
International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.
Core principles of OA publishing
Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.
One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.
OA holds the potential to democratize knowledge, advance science, and drive positive societal change.
Policy driving change
Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the US, EU and China.
OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.
Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.
For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.
MDPI is proud to lead the transition to open access.
Read more:
Impactful Research
Spotlight on Smart Cities
Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.
As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.
Highly cited papers in Smart Cities
Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.
1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities”
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.
2. “A Review on Electric Vehicles: Technologies and Challenges”
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.
3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges”
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.
4. “Artificial Intelligence Techniques in Smart Grid: A Survey”
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.
5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures”
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.
Testimonial
“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators.” – Dr. Luís Rosa, University of Minho
Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility
Inside MDPI
MDPI Manchester office, UK Visit
Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.
In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.
Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.
I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.
The UK by numbers
The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.
As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.
According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.
We are currently hiring EEs in various locations worldwide.
English Editing at MDPI
Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.
While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.
Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.
Testimonials
“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam
“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño
Read more:
Coming Together for Science
STM and Frankfurt Book Fair
Attending STM
MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.
Meeting with Web of Science
On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.
“We discussed ways to improve our communication and collaboration.”
I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.
75th Frankfurt Book Fair
Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.
For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.
MDPI Books
Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?
The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.
If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.
Closing Thoughts
MDPI Strategy Meeting
As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.
Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.
“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”
As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!
Chief Executive Officer
MDPI AG
24 October 2023
JCM 2023 Best Ph.D. Thesis Award—Open for Applications
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is inviting applications for the JCM 2023 Ph.D. Thesis Award. This prize will be awarded to a Ph.D. student or recently qualified Ph.D. fellow who has produced a highly anticipated thesis with great academic potential. The applications will be assessed by an evaluation committee led by the Editors-in-Chief, Dr. Emmanuel Andrès and Prof. Dr. Michael G. Hennerici.
Eligibility and requirements:
- The candidate must be a Ph.D. student or recently qualified Ph.D. fellow who has produced a highly anticipated thesis with great academic potential;
- The Ph.D. thesis must be their original work;
- The Ph.D. thesis must be defended in 2023.
Required application documents:
- An executive summary of the Ph.D. thesis in English of around 3000 words;
- A letter from the Ph.D. supervisor recommending the candidate for consideration for this award;
- The candidate’s CV, including a list of publications connected with the thesis;
- An electronic copy of the Ph.D. thesis;
- A scanned copy of the Ph.D. diploma (or certificate of studying at a school or research institute as a Ph.D. student going to graduate or participate in graduation thesis defenses).
Selection criteria:
- Quality of resume and publications;
- Relevance of the candidate and research description;
- Novelty of the candidate’s Ph.D. thesis;
- Strength of the recommendation letter;
- Anticipated academic potential;
- Originality and impact of the research.
Prizes:
- CHF 800;
- Certificate;
- Offer to publish one paper free of charge in JCM after peer review before the end of 2024.
The application deadline is 30 April 2024. The winner will be announced on the JCM website by the end of June 2024.
JCM Editorial Office
19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues
MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.
In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!
Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.
The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.
Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.
Promoting the values of accessibility, transparency, and collaboration
Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations.
Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways.
One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges.
Funders' policies are getting aligned with open science
Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the US, EU and China.
Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication.
Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.
For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.
MDPI is proud to be a leader in the transition to open access.
18 October 2023
Meet Us at Neuroscience 2023, 11–15 November 2023, Washington, DC, USA
Neuroscience 2023 will be held from 11 to 15 November 2023 in Washington, DC, USA. The conference is organized by the Society for Neuroscience.
The conference will gather scientists, clinicians, and decision makers from around the world, creating a platform for the communication of knowledge and the sharing of groundbreaking research on the brain as well as nervous system. As stated in the introduction to the conference, you can “Present new research. Exchange ideas. Expand collaborations. Strengthen your career.”
As one of the exhibitors of Neuroscience 2022 last year, MDPI will be a part of Neuroscience 2023 this year, and looks forward to meeting our scholars as well as new friends, hoping to impress you with our open access publishing model face-to-face.
The following MDPI journals will be represented:
- Brain Sciences.
- JCM.
- Cells.
- NeuroSci.
- J. Intell.
- Neuroglia.
- JPM.
- Biomedicines.
- Clinics and Practice.
- Diagnostics.
- Neurology International.
- Pathophysiology.
- Psych.
If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.sfn.org/meetings/neuroscience-2023.
17 October 2023
JCM 2024 Travel Award—Open for Applications
We are pleased to announce that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) will grant a Travel Award to two junior scientists. The applications will be assessed by an Evaluation Committee consisting of senior scholars from the JCM Editorial Board.
This award provides financial support for the winners to hold a presentation, present a poster, or both, at an international conference in the field of clinical medicine in 2024.
Candidate requirements:
- Postdoctoral fellows or Ph.D. students;
- Plans to attend an international conference in 2024 (oral presentation or poster).
Required application documents:
- Information of the conference the applicant is planning to attend and the abstract that will be submitted;
- CV and list of publications;
- Justification letter describing the focus of the research (max. 800 words);
- Letter of recommendation from the supervisor, research director, or department head, which also confirms the applicant’s status as a postdoctoral fellow/Ph.D. student.
The winners (two awardees) will each be awarded CHF 800 and a certificate.
Please submit your applications for the JCM 2024 Travel Award online by 31 December 2023.
JCM Editorial Office
16 October 2023
Journal of Clinical Medicine | Global Day against Pain 2023
The Global Day against Pain, celebrated every year on the third Monday of October, is supported by the World Health Organization (WHO), which considers that the “treatment of pain and palliative care form an integral part of the right to enjoy good health”.
To further explore the related research on the 2023 Global Day against Pain, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has gathered open access academic articles on the topic of pain. We hope to share new scientific knowledge in this field with the world on this special day.
Article Collection:
1. “New Generation Gepants: Migraine Acute and Preventive Medications”
by David Moreno-Ajona, María Dolores Villar-Martínez and Peter J. Goadsby
J. Clin. Med. 2022, 11(6), 1656; https://doi.org/10.3390/jcm11061656
Available online: https://www.mdpi.com/2077-0383/11/6/1656
2. “Endometriosis, an Ongoing Pain—Step-by-Step Treatment”
by Sylvia Mechsner
J. Clin. Med. 2022, 11(2), 467; https://doi.org/10.3390/jcm11020467
Available online: https://www.mdpi.com/2077-0383/11/2/467
3. “Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls”
by Pottathil Shinu, Mohamed A. Morsy, Anroop B. Nair, Abdulaziz K. Al Mouslem, Katharigatta N. Venugopala, Manoj Goyal, Monika Bansal, Shery Jacob and Pran Kishore Deb
J. Clin. Med. 2022, 11(11), 3002; https://doi.org/10.3390/jcm11113002
Available online: https://www.mdpi.com/2077-0383/11/11/3002
4. “Effect of Preoperative Anxiety on Postoperative Pain after Craniotomy”
by Lucía Valencia, Ángel Becerra, Nazario Ojeda, Ancor Domínguez, Marcos Prados, Jesús María González-Martín and Aurelio Rodríguez-Pérez
J. Clin. Med. 2022, 11(3), 556; https://doi.org/10.3390/jcm11030556
Available online: https://www.mdpi.com/2077-0383/11/3/556
5. “Platelet-Rich Plasma Releasate versus Corticosteroid for the Treatment of Discogenic Low Back Pain: A Double-Blind Randomized Controlled Trial”
by Koji Akeda, Kohshi Ohishi, Norihiko Takegami, Takao Sudo, Junichi Yamada, Tatsuhiko Fujiwara, Rui Niimi, Takeshi Matsumoto, Yuki Nishimura, Toru Ogura et al.
J. Clin. Med. 2022, 11(2), 304; https://doi.org/10.3390/jcm11020304
Available online: https://www.mdpi.com/2077-0383/11/2/304
6. “Knee Pain from Osteoarthritis: Pathogenesis, Risk Factors, and Recent Evidence on Physical Therapy Interventions”
by Jean-Philippe Berteau
J. Clin. Med. 2022, 11(12), 3252; https://doi.org/10.3390/jcm11123252
Available online: https://www.mdpi.com/2077-0383/11/12/3252
7. “State-of-the-Art Review on Immersive Virtual Reality Interventions for Colonoscopy-Induced Anxiety and Pain”
by Marcel-Alexandru Găină, Andreea Silvana Szalontay, Gabriela Ștefănescu, Gheorghe Gh Bălan, Cristina Mihaela Ghiciuc, Alexandra Boloș, Alexandra-Maria Găină and Cristinel Ștefănescu
J. Clin. Med. 2022, 11(6), 1670; https://doi.org/10.3390/jcm11061670
Available online: https://www.mdpi.com/2077-0383/11/6/1670
8. “Different Machine Learning Approaches for Implementing Telehealth-Based Cancer Pain Management Strategies”
by Marco Cascella, Sergio Coluccia, Federica Monaco, Daniela Schiavo, Davide Nocerino, Mariacinzia Grizzuti, Maria Cristina Romano and Arturo Cuomo
J. Clin. Med. 2022, 11(18), 5484; https://doi.org/10.3390/jcm11185484
Available online: https://www.mdpi.com/2077-0383/11/18/5484
9. “Effect of a Craniosacral Therapy Protocol in People with Migraine: A Randomized Controlled Trial”
by Elena Muñoz-Gómez, Marta Inglés, Marta Aguilar-Rodríguez, Sara Mollà-Casanova, Núria Sempere-Rubio, Pilar Serra-Añó and Gemma V. Espí-López
J. Clin. Med. 2022, 11(3), 759; https://doi.org/10.3390/jcm11030759
Available online: https://www.mdpi.com/2077-0383/11/3/759
10. “Factors Influencing Pain Management of Patients with Osteoarthritis: A Cross-Sectional Study”
by Gyöngyi Anna Mezey, Zsuzsanna Máté and Edit Paulik
J. Clin. Med. 2022, 11(5), 1352; https://doi.org/10.3390/jcm11051352
Available online: https://www.mdpi.com/2077-0383/11/5/1352
11. “Association between Metformin Use and Risk of Total Knee Arthroplasty and Degree of Knee Pain in Knee Osteoarthritis Patients with Diabetes and/or Obesity: A Retrospective Study”
by Shibo Chen, Guangfeng Ruan, Muhui Zeng, Tianyu Chen, Peihua Cao, Yan Zhang, Jia Li, Xiaoshuai Wang, Shengfa Li, Su’an Tang et al.
J. Clin. Med. 2022, 11(16), 4796; https://doi.org/10.3390/jcm11164796
Available online: https://www.mdpi.com/2077-0383/11/16/4796
12. “The Importance of Nutrition as a Lifestyle Factor in Chronic Pain Management: A Narrative Review”
by Ömer Elma, Katherine Brain and Huan-Ji Dong
J. Clin. Med. 2022, 11(19), 5950; https://doi.org/10.3390/jcm11195950
Available online: https://www.mdpi.com/2077-0383/11/19/5950
13. “Chronic Pain and Emotional Stroop: A Systematic Review”
by Lidia Amaro-Díaz, Casandra I. Montoro, Laura R. Fischer-Jbali and Carmen M. Galvez-Sánchez
J. Clin. Med. 2022, 11(12), 3259; https://doi.org/10.3390/jcm11123259
Available online: https://www.mdpi.com/2077-0383/11/12/3259
14. “Reduction of Thoracic Hyper-Kyphosis Improves Short and Long Term Outcomes in Patients with Chronic Nonspecific Neck Pain: A Randomized Controlled Trial”
by Ibrahim Moustafa Moustafa, Tamer Mohamed Shousha, Lori M. Walton, Veena Raigangar and Deed E. Harrison
J. Clin. Med. 2022, 11(20), 6028; https://doi.org/10.3390/jcm11206028
Available online: https://www.mdpi.com/2077-0383/11/20/6028
15. “Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of 2007–2018 National Hospital Ambulatory Medical Care Survey Data”
by Seonkyeong Yang, Yulia Orlova, Abigale Lipe, Macy Boren, Juan M. Hincapie-Castillo, Haesuk Park, Ching-Yuan Chang, Debbie L. Wilson, Lauren Adkins and Wei-Hsuan Lo-Ciganic
J. Clin. Med. 2022, 11(5), 1401; https://doi.org/10.3390/jcm11051401
Available online: https://www.mdpi.com/2077-0383/11/5/1401
Access more articles here.
Call for Papers:
1. Special Issue “Low Back Pain Management: Clinical Advances and Perspectives”
Guest Editor: Dr. Maryse Fortin
Submission Deadline: 20 December 2023
2. Special Issue “Neuropathic Pain Management and Deep Brain Stimulation in Clinical Practice”
Guest Editor: Dr. Sylvie Raoul
Submission Deadline: 20 December 2023
3. Special Issue “Pain and Rheumatology”
Guest Editors: Prof. Dr. Giustino Varrassi, Prof. Dr. Piercarlo Sarzi-Puttini and Prof. Dr. Stefano Coaccioli
Submission Deadline: 31 December 2023
Access more Special Issues here.
Special Issue Books:
1. “Chronic Pain: Clinical Updates and Perspectives”
2. “Lifestyle and Chronic Pain”
Access more Special Issue books here.
13 October 2023
Meet Us at the 34th Annual Meeting of the Japanese Society of Clinical Sports Medicine, 11–12 November 2023, Tokyo, Japan
MDPI will be attending the 34th Annual Meeting of the Japanese Society of Clinical Sports Medicine, which will be held from 11 to 12 November in Tokyo, Japan.
The theme of this academic conference is "Cooperation and Evolution". As many academic conferences have been held online due to the coronavirus pandemic, we are now realizing that one of the most important aspects of academic conferences is the face-to-face exchange of information inside and outside the academic venue. This academic conference will aim to promote the future progress of sports medicine by disseminating the research results of each person who has made progress during the coronavirus pandemic and by bringing together many participants for full discussions.
The following MDPI journals will be represented:
- Sports;
- Medicina;
- JPM;
- Nutrients;
- JCM;
- IJERPH;
- STD;
- Geriatrics.
If you are planning to attend this conference, please feel free to stop by our booth and chat with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.34rinspo.jp/index.html.
12 October 2023
Journal of Clinical Medicine | World Sight Day 2023—“Love Your Eyes at Work”
World Sight Day, held annually on the second Thursday of October, is a global event meant to draw attention to blindness and vision impairment. This year’s theme is “Love your eyes at work”.
To further explore related research on World Sight Day 2023, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has brought together open access academic articles from the Section “Ophthalmology”. We hope to share new scientific knowledge in the field of eye health with the world on this special day.
Article Collection:
1. “Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression”
by Daniele Veritti, Valentina Sarao, Valentina Soppelsa, Carla Danese, Jay Chhablani and Paolo Lanzetta
J. Clin. Med. 2022, 11(2), 325; https://doi.org/10.3390/jcm11020325
Available online: https://www.mdpi.com/2077-0383/11/2/325
2. “Vision-Threatening Ocular Adverse Events after Vaccination against Coronavirus Disease 2019”
by Mihyun Choi, Min-Hwan Seo, Kwang-Eon Choi, Sukyeon Lee, Boyoon Choi, Cheolmin Yun, Seong-Woo Kim and Yong Yeon Kim
J. Clin. Med. 2022, 11(12), 3318; https://doi.org/10.3390/jcm11123318
Available online: https://www.mdpi.com/2077-0383/11/12/3318
3. “Scleral Buckling: A Review of Clinical Aspects and Current Concepts”
by Matteo Fallico, Pietro Alosi, Michele Reibaldi, Antonio Longo, Vincenza Bonfiglio, Teresio Avitabile and Andrea Russo
J. Clin. Med. 2022, 11(2), 314; https://doi.org/10.3390/jcm11020314
Available online: https://www.mdpi.com/2077-0383/11/2/314
4. “The Dual Effect of Rho-Kinase Inhibition on Trabecular Meshwork Cells Cytoskeleton and Extracellular Matrix in an In Vitro Model of Glaucoma”
by Juliette Buffault, Françoise Brignole-Baudouin, Élodie Reboussin, Karima Kessal, Antoine Labbé, Stéphane Mélik Parsadaniantz and Christophe Baudouin
J. Clin. Med. 2022, 11(4), 1001; https://doi.org/10.3390/jcm11041001
Available online: https://www.mdpi.com/2077-0383/11/4/1001
5. “Meibomian Gland Density: An Effective Evaluation Index of Meibomian Gland Dysfunction Based on Deep Learning and Transfer Learning”
by Zuhui Zhang, Xiaolei Lin, Xinxin Yu, Yana Fu, Xiaoyu Chen, Weihua Yang and Qi Dai
J. Clin. Med. 2022, 11(9), 2396; https://doi.org/10.3390/jcm11092396
Available online: https://www.mdpi.com/2077-0383/11/9/2396
6. “Subretinal Injection Techniques for Retinal Disease: A Review”
by Cristina Irigoyen, Asier Amenabar Alonso, Jorge Sanchez-Molina, María Rodríguez-Hidalgo, Araceli Lara-López and Javier Ruiz-Ederra
J. Clin. Med. 2022, 11(16), 4717; https://doi.org/10.3390/jcm11164717
Available online: https://www.mdpi.com/2077-0383/11/16/4717
7. “Post Penetrating Keratoplasty Ectasia: Incidence, Risk Factors, Clinical Features, and Treatment Options”
by Antonio Moramarco, Lorenzo Gardini, Danilo Iannetta, Piera Versura and Luigi Fontana
J. Clin. Med. 2022, 11(10), 2678; https://doi.org/10.3390/jcm11102678
Available online: https://www.mdpi.com/2077-0383/11/10/2678
8. “Choroidal Thickness in Different Patterns of Diabetic Macular Edema”
by Rida Amjad, Cheong-Ah Lee, Hafiz Muhammad Umer Farooqi, Hina Khan and Dong-Guk Paeng
J. Clin. Med. 2022, 11(20), 6169; https://doi.org/10.3390/jcm11206169
Available online: https://www.mdpi.com/2077-0383/11/20/6169
9. “360° Ab-Interno Schlemm’s Canal Viscodilation with OMNI Viscosurgical Systems for Open-Angle Glaucoma—Midterm Results”
by Giacomo Toneatto, Marco Zeppieri, Veronica Papa, Laura Rizzi, Carlo Salati, Andrea Gabai and Paolo Brusini
J. Clin. Med. 2022, 11(1), 259; https://doi.org/10.3390/jcm11010259
Available online: https://www.mdpi.com/2077-0383/11/1/259
10. “A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments”
by Aniruddha Agarwal, Anne Rübsam, Lynn zur Bonsen, Francesco Pichi, Piergiorgio Neri and Uwe Pleyer
J. Clin. Med. 2022, 11(9), 2525; https://doi.org/10.3390/jcm11092525
Available online: https://www.mdpi.com/2077-0383/11/9/2525
11. “In Vitro Chromatic Performance of Three Presbyopia-Correcting Intraocular Lenses with Different Optical Designs”
by Diego Montagud-Martínez, Vicente Ferrando, Anabel Martínez-Espert, Salvador Garcia-Delpech, Juan A. Monsoriu and Walter D. Furlan
J. Clin. Med. 2022, 11(5), 1212; https://doi.org/10.3390/jcm11051212
Available online: https://www.mdpi.com/2077-0383/11/5/1212
12. “Long-Term Outcomes of a Kahook Dual Blade Procedure Combined with Phacoemulsification in Japanese Patients with Open-Angle Glaucoma”
by Kentaro Iwasaki, Hiroshi Kakimoto, Yusuke Orii, Shogo Arimura, Yoshihiro Takamura and Masaru Inatani
J. Clin. Med. 2022, 11(5), 1354; https://doi.org/10.3390/jcm11051354
Available online: https://www.mdpi.com/2077-0383/11/5/1354
13. “Myopia Control Effect Is Influenced by Baseline Relative Peripheral Refraction in Children Wearing Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses”
by Hanyu Zhang, Carly S. Y. Lam, Wing-Chun Tang, Myra Leung, Hua Qi, Paul H. Lee and Chi-Ho To
J. Clin. Med. 2022, 11(9), 2294; https://doi.org/10.3390/jcm11092294
Available online: https://www.mdpi.com/2077-0383/11/9/2294
14. “Dry Eye Parameters and Lid Geometry in Adults Born Extremely, Very, and Moderately Preterm with and without ROP: Results from the Gutenberg Prematurity Eye Study”
by Achim Fieß, Clara Hufschmidt-Merizian, Sandra Gißler, Ulrike Hampel, Eva Mildenberger, Michael S. Urschitz, Fred Zepp, Bernhard Stoffelns, Norbert Pfeiffer and Alexander K. Schuster
J. Clin. Med. 2022, 11(10), 2702; https://doi.org/10.3390/jcm11102702
Available online: https://www.mdpi.com/2077-0383/11/10/2702
15. “Pharmacological Treatment in Presbyopia”
by Andrzej Grzybowski and Varis Ruamviboonsuk
J. Clin. Med. 2022, 11(5), 1385; https://doi.org/10.3390/jcm11051385
Available online: https://www.mdpi.com/2077-0383/11/5/1385
Access more articles here.
Call for Papers:
1. “Latest Advances in the Diagnosis and Management of Vitreo-Retinal Disorders”
Guest Editor: Prof. Dr. Takeshi Iwase
Submission Deadline: 15 November 2023
2. “Current Update and Perspectives in Corneal Disorders”
Guest Editors: Dr. Domenico Schiano-Lomoriello and Dr. Anna Maria Roszkowska
Submission Deadline: 25 November 2023
3. “Clinical Presentation and Management of Eye Infections”
Guest Editor: Dr. Reza Razaghi
Submission Deadline: 18 December 2023
Access more Special Issues here.
Special Issue Books:
1. “Advances in Glaucoma Surgery”
2. “Current Challenges and Advances in Cataract Surgery”
3. “Intraocular Pressure and Ocular Hypertension”
Access more Special Issue books here.
12 October 2023
Journal of Clinical Medicine | World Arthritis Day 2023
World Arthritis Day (WAD) is a global awareness day held annually on 12 October. It aims to increase the knowledge of all audiences of the existence as well as impact of rheumatic and musculoskeletal diseases (RMDs). RMDs comprise over 200 diseases and syndromes, which are usually progressive and associated with pain.
To further explore the related research on World Arthritis Day 2023, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has gathered open access academic research on rheumatic and musculoskeletal diseases. We hope to share interesting and up-to-date scientific knowledge in this field.
Article Collection:
1. “Secondary Osteoporosis and Metabolic Bone Diseases”
by Mahmoud M. Sobh, Mohamed Abdalbary, Sherouk Elnagar, Eman Nagy, Nehal Elshabrawy, Mostafa Abdelsalam, Kamyar Asadipooya and Amr El-Husseini
J. Clin. Med. 2022, 11(9), 2382; https://doi.org/10.3390/jcm11092382
Available online: https://www.mdpi.com/2077-0383/11/9/2382
2. “Autologous Microfragmented Adipose Tissue for the Treatment of Knee Osteoarthritis: Real-World Data at Two Years Follow-Up”
by Daniele Screpis, Simone Natali, Luca Farinelli, Gianluca Piovan, Venanzio Iacono, Laura de Girolamo, Marco Viganò and Claudio Zorzi
J. Clin. Med. 2022, 11(5), 1268; https://doi.org/10.3390/jcm11051268
Available online: https://www.mdpi.com/2077-0383/11/5/1268
3. “Induction and Maintenance Treatment of Lupus Nephritis: A Comprehensive Review of Meta-Analyses”
by Jae Il Shin, Han Li, Seoyeon Park, Jae Won Yang, Keum Hwa Lee, Yongsuk Jo, Seongeun Park, Jungmin Oh, Hansol Kim, Hyo Jin An et al.
J. Clin. Med. 2022, 11(2), 343; https://doi.org/10.3390/jcm11020343
Available online: https://www.mdpi.com/2077-0383/11/2/448
4. “Lifestyle Factors and Their Influence on Rheumatoid Arthritis: A Narrative Review”
by Christoph Schäfer and Gernot Keyßer
J. Clin. Med. 2022, 11(23), 7179; https://doi.org/10.3390/jcm11237179
Available online: https://www.mdpi.com/2077-0383/11/23/7179
5. “Systemic Scleroderma—Definition, Clinical Picture and Laboratory Diagnostics”
by Piotr Gałecki, Jerzy Samochowiec, Magdalena Mikułowska and Agata Szulc
J. Clin. Med. 2022, 11(9), 2299; https://doi.org/10.3390/jcm11092299
Available online: https://www.mdpi.com/2077-0383/11/9/2299
6. “Systemic Lupus Erythematosus and Lung Involvement: A Comprehensive Review”
by Jae Il Shin, Keum Hwa Lee, Seoyeon Park, Jae Won Yang, Hyung Ju Kim, Kwanhyuk Song, Seungyeon Lee, Hyeyoung Na, Yong Jun Jang, Ju Yun Nam et al.
J. Clin. Med. 2022, 11(22), 6714; https://doi.org/10.3390/jcm11226714
Available online: https://www.mdpi.com/2077-0383/11/22/6714
7. “Osteoarthritis: Pathogenesis, Animal Models, and New Regenerative Therapies”
by Tomasz Szponder, Michał Latalski, Anna Danielewicz, Katarzyna Krać, Aleksandra Kozera, Beata Drzewiecka, Dominika Nguyen Ngoc, Dominika Dobko and Joanna Wessely-Szponder
J. Clin. Med. 2023, 12(1), 5; https://doi.org/10.3390/jcm12010005
Available online: https://www.mdpi.com/2077-0383/12/1/5
8. “Unraveling the Signaling Secretome of Platelet-Rich Plasma: Towards a Better Understanding of Its Therapeutic Potential in Knee Osteoarthritis”
by Cristina Del Amo, Arantza Perez-Valle, Leire Atilano and Isabel Andia
J. Clin. Med. 2022, 11(3), 473; https://doi.org/10.3390/jcm11030473
Available online: https://www.mdpi.com/2077-0383/11/3/473
9. “Knee Pain from Osteoarthritis: Pathogenesis, Risk Factors, and Recent Evidence on Physical Therapy Interventions”
by Jean-Philippe Berteau
J. Clin. Med. 2022, 11(12), 3252; https://doi.org/10.3390/jcm11123252
Available online: https://www.mdpi.com/2077-0383/11/12/3252
10. “Short- and Long-Term Effectiveness of Low-Level Laser Therapy Combined with Strength Training in Knee Osteoarthritis: A Randomized Placebo-Controlled Trial”
by Martin Bjørn Stausholm, Ingvill Fjell Naterstad, Patricia Pereira Alfredo, Christian Couppé, Kjartan Vibe Fersum, Ernesto Cesar Pinto Leal-Junior, Rodrigo Álvaro Brandão Lopes-Martins, Jon Joensen and Jan Magnus Bjordal
J. Clin. Med. 2022, 11(12), 3446; https://doi.org/10.3390/jcm11123446
Available online: https://www.mdpi.com/2077-0383/11/12/3446
11. “Curcumin: Useful add-on for Rheumatic Diseases?”
by Stylianos Tomaras, Gernot Keyßer and Eugen Feist
J. Clin. Med. 2022, 11(10), 2908; https://doi.org/10.3390/jcm11102908
Available online: https://www.mdpi.com/2077-0383/11/10/2908
12. “Factors Influencing Pain Management of Patients with Osteoarthritis: A Cross-Sectional Study”
by Gyöngyi Anna Mezey, Zsuzsanna Máté and Edit Paulik
J. Clin. Med. 2022, 11(5), 1352; https://doi.org/10.3390/jcm11051352
Available online: https://www.mdpi.com/2077-0383/11/5/1352
13. “Effect of Combined Intraosseous and Intraarticular Infiltrations of Autologous Platelet-Rich Plasma on Subchondral Bone Marrow Mesenchymal Stromal Cells from Patients with Hip Osteoarthritis”
by Payal Ganguly, Nicolás Fiz, Maider Beitia, Heather E. Owston, Diego Delgado, Elena Jones and Mikel Sánchez
J. Clin. Med. 2022, 11(13), 3891; https://doi.org/10.3390/jcm11133891
Available online: https://www.mdpi.com/2077-0383/11/13/3891
14. “Associations of IL-18 with Altered Cardiovascular Risk Profile in Psoriatic Arthritis and Ankylosing Spondylitis”
by Krzysztof Bonek, Ewa Kuca-Warnawin, Anna Kornatka, Agnieszka Zielińska, Małgorzata Wisłowska, Ewa Kontny and Piotr Głuszko
J. Clin. Med. 2022, 11(3), 766; https://doi.org/10.3390/jcm11030766
Available online: https://www.mdpi.com/2077-0383/11/3/766
15. “The Impacts of the Clinical and Genetic Factors on Chronic Damage in Caucasian Systemic Lupus Erythematosus Patients”
by Fulvia Ceccarelli, Giulio Olivieri, Carmelo Pirone, Cinzia Ciccacci, Licia Picciariello, Francesco Natalucci, Carlo Perricone, Francesca Romana Spinelli, Cristiano Alessandri, Paola Borgiani et al.
J. Clin. Med. 2022, 11(12), 3368; https://doi.org/10.3390/jcm11123368
Available online: https://www.mdpi.com/2077-0383/11/12/3368
Call for Papers:
“Inflammatory Arthritis and Autoimmune Inflammatory Systemic Diseases: From Bench to Bedside and Back”
Guest Editors: Dr. Marco Sebastiani and Prof. Dr. Giovanni Lapadula
Submission Deadline: 25 November 2023
“Clinical Updates on Rheumatoid Arthritis”
Guest Editor: Dr. Francesca Bandinelli
Submission Deadline: 15 February 2024
Access more Special Issues here.
Special Issue Books:
“Diagnostic Imaging of Arthritis”
“Clinical Features and Long-Term Outcomes of Systemic Lupus Erythematosus”
Access more Special Issue books here.
10 October 2023
Journal of Clinical Medicine | World Mental Health Day 2023—“A Universal Human Right”
World Mental Health Day is an annual event held on October 10th to raise awareness of mental health issues worldwide and to mobilize efforts to support mental health. This year's theme is “Mental health is a universal human right”. It provides us with an opportunity to ensure that the human rights and well-being of people with mental illness are respected in all parts of the world.
To further explore the related research on Mental Health Day 2023, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has gathered open access academic research on mental health. We hope to share interesting and up-to-date scientific knowledge in this field.
Article Collection:
1. “Intestinal Permeability and Depression in Patients with Inflammatory Bowel Disease”
by Miorita Melina Iordache, Cristina Tocia, Mariana Aschie, Andrei Dumitru, Mihaela Manea, Georgeta Camelia Cozaru, Lucian Petcu, Sabina E. Vlad, Eugen Dumitru and Anca Chisoi
J. Clin. Med. 2022, 11(17), 5121; https://doi.org/10.3390/jcm11175121
Available online: https://www.mdpi.com/2077-0383/11/17/5121
2. “Higher-Level Executive Functions in Healthy Elderly and Mild Cognitive Impairment: A Systematic Review”
by Ilaria Corbo and Maria Casagrande
J. Clin. Med. 2022, 11(5), 1204; https://doi.org/10.3390/jcm11051204
Available online: https://www.mdpi.com/2077-0383/11/5/1204
3. “Multi-Level Processes and Retina–Brain Pathways of Photic Regulation of Mood”
by Julia Maruani and Pierre A. Geoffroy
J. Clin. Med. 2022, 11(2), 448; https://doi.org/10.3390/jcm11020448
Available online: https://www.mdpi.com/2077-0383/11/2/448
4. “Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases”
by Ewa Szczepanska-Sadowska, Agnieszka Wsol, Agnieszka Cudnoch-Jedrzejewska, Katarzyna Czarzasta and Tymoteusz Żera
J. Clin. Med. 2022, 11(4), 908; https://doi.org/10.3390/jcm11040908
Available online: https://www.mdpi.com/2077-0383/11/4/908
5. “Treatment-Resistant Depression in Poland—Epidemiology and Treatment”
by Piotr Gałecki, Jerzy Samochowiec, Magdalena Mikułowska and Agata Szulc
J. Clin. Med. 2022, 11(3), 480; https://doi.org/10.3390/jcm11030480
Available online: https://www.mdpi.com/2077-0383/11/3/480
6. “A Systematic Review and Meta-Analysis of Nature Walk as an Intervention for Anxiety and Depression”
by Simone Grassini
J. Clin. Med. 2022, 11(6), 1731; https://doi.org/10.3390/jcm11061731
Available online: https://www.mdpi.com/2077-0383/11/6/1731
7. “Diagnosis and Management of Functional Tic-Like Phenomena”
by Irene A. Malaty, Seonaid Anderson, Shannon M. Bennett, Cathy L. Budman, Barbara J. Coffey, Keith A. Coffman, Erica Greenberg, Joseph F. McGuire, Kirsten R. Müller-Vahl, Michael S. Okun et al.
J. Clin. Med. 2022, 11(21), 6470; https://doi.org/10.3390/jcm11216470
Available online: https://www.mdpi.com/2077-0383/11/21/6470
8. “Pathways Linking the Big Five to Psychological Distress: Exploring the Mediating Roles of Stress Mindset and Coping Flexibility”
by Luxi Chen, Li Qu and Ryan Y. Hong
J. Clin. Med. 2022, 11(9), 2272; https://doi.org/10.3390/jcm11092272
Available online: https://www.mdpi.com/2077-0383/11/9/2272
9. “Repetitive Transcranial Magnetic Stimulation (rTMS) as a Promising Treatment for Craving in Stimulant Drugs and Behavioral Addiction: A Meta-Analysis”
by Aurélia Gay, Julien Cabe, Ingrid De Chazeron, Céline Lambert, Maxime Defour, Vikesh Bhoowabul, Thomas Charpeaud, Aurore Tremey, Pierre-Michel Llorca, Bruno Pereira et al.
J. Clin. Med. 2022, 11(3), 624; https://doi.org/10.3390/jcm11030624
Available online: https://www.mdpi.com/2077-0383/11/3/624
10. “rTMS Reduces Craving and Alcohol Use in Patients with Alcohol Use Disorder: Results of a Randomized, Sham-Controlled Clinical Trial”
by Maarten Belgers, Philip Van Eijndhoven, Wiebren Markus, Aart H. Schene and Arnt Schellekens
J. Clin. Med. 2022, 11(4), 951; https://doi.org/10.3390/jcm11040951
Available online: https://www.mdpi.com/2077-0383/11/4/951
11. “The Deficit Schizophrenia Subtype Is Associated with Low Adherence to the Mediterranean Diet: Findings from a Case–Control Study”
by Krzysztof Kowalski, Bogna Bogudzińska, Bartłomiej Stańczykiewicz, Patryk Piotrowski, Tomasz Bielawski, Jerzy Samochowiec, Krzysztof Szczygieł, Piotr Plichta and Błażej Misiak
J. Clin. Med. 2022, 11(3), 568; https://doi.org/10.3390/jcm11030568
Available online: https://www.mdpi.com/2077-0383/11/3/568
12. “State-of-the-Art Review on Immersive Virtual Reality Interventions for Colonoscopy-Induced Anxiety and Pain”
by Marcel-Alexandru Găină, Andreea Silvana Szalontay, Gabriela Ștefănescu, Gheorghe Gh Bălan, Cristina Mihaela Ghiciuc, Alexandra Boloș, Alexandra-Maria Găină and Cristinel Ștefănescu
J. Clin. Med. 2022, 11(6), 1670; https://doi.org/10.3390/jcm11061670
Available online: https://www.mdpi.com/2077-0383/11/6/1670
13. “The Impact of Group Emotion Regulation Interventions on Emotion Regulation Ability: A Systematic Review”
by Rebekah Moore, David Gillanders and Simon Stuart
J. Clin. Med. 2022, 11(9), 2519; https://doi.org/10.3390/jcm11092519
Available online: https://www.mdpi.com/2077-0383/11/9/2519
14. “Second-Generation Antipsychotics’ Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders”
by Michele Fabrazzo, Salvatore Cipolla, Alessio Camerlengo, Francesco Perris and Francesco Catapano
J. Clin. Med. 2022, 11(15), 4530; https://doi.org/10.3390/jcm11154530
Available online: https://www.mdpi.com/2077-0383/11/15/4530
15. “Insomnia Symptoms, Sleep Hygiene, Mental Health, and Academic Performance in Spanish University Students: A Cross-Sectional Study”
by Sara Carrión-Pantoja, Germán Prados, Florian Chouchou, Martha Holguín, Ángela Mendoza-Vinces, Manuela Expósito-Ruiz and Laura Fernández-Puerta
J. Clin. Med. 2022, 11(7), 1989; https://doi.org/10.3390/jcm11071989
Available online: https://www.mdpi.com/2077-0383/11/7/1989
Call for Papers:
“Bipolar Disorder: Clinical Advances and Challenges”
Guest Editors: Dr. Laura Fusar-Poli and Prof. Dr. Andrea Aguglia
Submission Deadline: 31 October 2023
“Clinical Updates on Psychology in Children and Adolescents”
Guest Editor: Dr. Oswald D. Kothgassner
Submission Deadline: 31 December 2023
Access more Special Issues here.
Special Issue Book:
“Recent Advances in Dual Disorders (Addiction and Other Mental Disorders)”
Access more Special Issue books here.
2 October 2023
MDPI Insights: The CEO's Letter #4 - MDPI Presence in China
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access in China
It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.
Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!
Open Access Policy in China
As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.
Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.
In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.
In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.
MDPI Offices in China
While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.
Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.
In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:
- 2008: Beijing (Tongzhou, Haidian)
- 2013: Wuhan (Hankou, Guanggu)
- 2019: Tianjin
- 2021: Dalian
- 2021: Nanjing
Our Strength is in Our People
With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.
In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.
Impactful Research
MDPI Awards
To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.
In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.
Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.
To learn more about MDPI Awards and to find out which are currently available, please click here.
MDPI Awards to Scholars from China
Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.
MDPI’s Tu Youyou Award
Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).
In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.
The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.
2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu
Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.
Highly Cited Articles by Chinese Scholars Published in MDPI
Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.
Read more:
- Tu Youyou Award
- World Sustainability Awards
- Available Awards
Inside MDPI
Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.
Marketing Department in China
During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.
I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.
Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.
Coming Together for Science
Collaborations, Scholarships and Meetings
MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.
Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.
Scholarships in China
Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).
Meeting with the Society of Chinese University Journals (CUJS)
Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.
I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.
We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.
MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.
Meeting with National Science Library, Chinese Academy of Sciences (NSLC)
Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.
We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.
In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.
The Numbers
As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.
At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.
Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.
Closing Thoughts
Final Reflections on our MDPI Offices in Beijing and Wuhan
Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.
I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.
Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.
95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).
91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.
Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.
Hospitality and Service
Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.
I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.
Chief Executive Officer
MDPI AG
28 September 2023
Journal of Clinical Medicine | Highly Cited Papers in 2022 in the Section “Stomatology”
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. The Section “Stomatology” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
The Section “Stomatology” follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2022 below:
1. “3D Printing and Virtual Surgical Planning in Oral and Maxillofacial Surgery”
by Adeeb Zoabi, Idan Redenski, Daniel Oren, Adi Kasem, Asaf Zigron, Shadi Daoud, Liad Moskovich, Fares Kablan and Samer Srouji
J. Clin. Med. 2022, 11(9), 2385; https://doi.org/10.3390/jcm11092385
Available online: https://www.mdpi.com/2077-0383/11/9/2385
2. “Prevalence and Methods for Assessment of Oropharyngeal Dysphagia in Older Adults: A Systematic Review and Meta-Analysis”
by Thanh-Nhan Doan, Wen-Chao Ho, Liang-Hui Wang, Fei-Chun Chang, Nguyen Thanh Nhu and Li-Wei Chou
J. Clin. Med. 2022, 11(9), 2605; https://doi.org/10.3390/jcm11092605
Available online: https://www.mdpi.com/2077-0383/11/9/2605
3. “The Administration of Hyaluronic Acid into the Temporomandibular Joints’ Cavities Increases the Mandible’s Mobility: A Systematic Review and Meta-Analysis”
by Maciej Chęciński, Maciej Sikora, Kamila Chęcińska, Zuzanna Nowak and Dariusz Chlubek
J. Clin. Med. 2022, 11(7), 1901; https://doi.org/10.3390/jcm11071901
Available online: https://www.mdpi.com/2077-0383/11/7/1901
4. “Lipid Peroxidation Levels in Saliva and Plasma of Patients Suffering from Periodontitis”
by Tanja Veljovic, Milanko Djuric, Jelena Mirnic, Ivana Gusic, Aleksandra Maletin, Bojana Ramic, Isidora Neskovic, Karolina Vukoje and Snezana Brkic
J. Clin. Med. 2022, 11(13), 3617; https://doi.org/10.3390/jcm11133617
Available online: https://www.mdpi.com/2077-0383/11/13/3617
5. “Nonsurgical Periodontal Treatment Options and Their Impact on Subgingival Microbiota”
by Susanne Schulz, Jamal M. Stein, Anne Schumacher, David Kupietz, Sareh S. Yekta-Michael, Florian Schittenhelm, Georg Conrads, Hans-Günter Schaller and Stefan Reichert
J. Clin. Med. 2022, 11(5), 1187; https://doi.org/10.3390/jcm11051187
Available online: https://www.mdpi.com/2077-0383/11/5/1187
6. “Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis”
by Vignesh Murthy, Petros Mylonas, Barbara Carey, Sangeetha Yogarajah, Damian Farnell, Owen Addison, Richard Cook, Michael Escudier, Marcio Diniz-Freitas and Jacobo Limeres et al.
J. Clin. Med. 2022, 11(7), 1793; https://doi.org/10.3390/jcm11071793
Available online: https://www.mdpi.com/2077-0383/11/7/1793
7. “Clinical Outcome and Comparison of Regenerative and Apexification Intervention in Young Immature Necrotic Teeth—A Systematic Review and Meta-Analysis”
by Pratima Panda, Lora Mishra, Shashirekha Govind, Saurav Panda and Barbara Lapinska
J. Clin. Med. 2022, 11(13), 3909; https://doi.org/10.3390/jcm11133909
Available online: https://www.mdpi.com/2077-0383/11/13/3909
8. “Home Oral Care Domiciliary Protocol for the Management of Dental Erosion in Rugby Players: A Randomized Clinical Trial”
by Andrea Butera, Simone Gallo, Maurizio Pascadopoli, Giuseppe Alessandro Scardina, Sofia Pezzullo and Andrea Scribante
J. Clin. Med. 2022, 11(16), 4893; https://doi.org/10.3390/jcm11164893
Available online: https://www.mdpi.com/2077-0383/11/16/4893
9. “Comparison between Ecological Momentary Assessment and Questionnaire for Assessing the Frequency of Waking-Time Non-Functional Oral Behaviours”
by Rosaria Bucci, Daniele Manfredini, Francesca Lenci, Vittorio Simeon, Alessandro Bracci and Ambrosina Michelotti
J. Clin. Med. 2022, 11(19), 5880; https://doi.org/10.3390/jcm11195880
Available online: https://www.mdpi.com/2077-0383/11/19/5880
10. “Autonomous Robotic Surgery for Immediately Loaded Implant-Supported Maxillary Full-Arch Prosthesis: A Case Report”
by Shuo Yang, Jiahao Chen, An Li, Ping Li and Shulan Xu
J. Clin. Med. 2022, 11(21), 6594; https://doi.org/10.3390/jcm11216594
Available online: https://www.mdpi.com/2077-0383/11/21/6594
11. “Effects of the Dental Caries Preventive Procedure on the White Spot Lesions during Orthodontic Treatment—An Open Label Randomized Controlled Trial”
by Yudai Shimpo, Yoshiaki Nomura, Toshiko Sekiya, Chihiro Arai, Ayako Okada, Kaoru Sogabe, Nobuhiro Hanada and Hiroshi Tomonari
J. Clin. Med. 2022, 11(3), 854; https://doi.org/10.3390/jcm11030854
Available online: https://www.mdpi.com/2077-0383/11/3/854
12. “Chewing Patterns and Muscular Activation in Deep Bite Malocclusion”
by Maria Grazia Piancino, Alessandro Tortarolo, Laura Di Benedetto, Vito Crincoli and Deborah Falla
J. Clin. Med. 2022, 11(6), 1702; https://doi.org/10.3390/jcm11061702
Available online: https://www.mdpi.com/2077-0383/11/6/1702
13. “Primary Orbital Reconstruction with Selective Laser Melting (SLM) of Patient-Specific Implants (PSIs): An Overview of 96 Surgically Treated Patients”
by Majeed Rana, Henriette L. Moellmann, Lara Schorn, Julian Lommen, Madiha Rana, Max Wilkat and Karsten Hufendiek
J. Clin. Med. 2022, 11(12), 3361; https://doi.org/10.3390/jcm11123361
Available online: https://www.mdpi.com/2077-0383/11/12/3361
14. “One Third of Patients before Endoprosthesis Implantation Show an Oral Focus as Potential Source of Infectious Complication—The Value of Pre-Operative Dental Risk Stratification in a German Cohort”
by Gerhard Schmalz, Florentine Reuschel, Markus Bartl, Laura Schmidt, Janine Runge, Rainer Haak, Szymon Goralskiandreas Roth and Dirk Ziebolz
J. Clin. Med. 2022, 11(13), 3686; https://doi.org/10.3390/jcm11133686
Available online: https://www.mdpi.com/2077-0383/11/13/3686
15. “Update on the Accuracy of Conventional and Digital Full-Arch Impressions of Partially Edentulous and Fully Dentate Jaws in Young and Elderly Subjects: A Clinical Trial”
by Maximiliane Amelie Schlenz, Julian Maximilian Stillersfeld, Bernd Wöstmann and Alexander Schmidt
J. Clin. Med. 2022, 11(13), 3723; https://doi.org/10.3390/jcm11133723
Available online: https://www.mdpi.com/2077-0383/11/13/3723
16. “Clinical, Microbiologicaland Biochemical Impact of the Surgical Treatment of Peri-Implantitis—A Prospective Case Series”
by Fernando Luengo, Myroslav Solonko, Javier Sanz-Esporrín, Ignacio Sanz-Sánchez, David Herrera and Mariano Sanz
J. Clin. Med. 2022, 11(16), 4699; https://doi.org/10.3390/jcm11164699
Available online: https://www.mdpi.com/2077-0383/11/16/4699
17. “In Vitro Accuracy of Digital and Conventional Impressions for Full-Arch Implant-Supported Prostheses”
by Rani D’haese, Tom Vrombaut, Herman Roeykens and Stefan Vandeweghe
J. Clin. Med. 2022, 11(3), 594; https://doi.org/10.3390/jcm11030594
Available online: https://www.mdpi.com/2077-0383/11/3/594
18. “Non-Interventional Prospective Observational Study of Platelet Rich Fibrin as a Therapy Adjunctive in Patients with Medication-Related Osteonecrosis of the Jaw”
by Sebastian Blatt, Maximilian Krüger, Peer W. Kämmerer, Daniel G. E. Thiem, Philipp Matheis, Anne-Katrin Eisenbeiß, Jörg Wiltfang, Bilal Al-Nawas and Hendrik Naujokat
J. Clin. Med. 2022, 11(3), 682; https://doi.org/10.3390/jcm11030682
Available online: https://www.mdpi.com/2077-0383/11/3/682
19. “Quality of Life in Patients with End-Stage Renal Disease Undergoing Hemodialysis”
by Elżbieta Dembowska, Aleksandra Jaroń, Ewa Gabrysz-Trybek, Joanna Bladowska, Szymon Gacek and Grzegorz Trybek
J. Clin. Med. 2022, 11(6), 1584; https://doi.org/10.3390/jcm11061584
Available online: https://www.mdpi.com/2077-0383/11/6/1584
20. “What Does Bone Corticalization around Dental Implants Mean in Light of Ten Years of Follow-Up?”
by Marcin Kozakiewicz, Małgorzata Skorupska and Tomasz Wach
J. Clin. Med. 2022, 11(12), 3545; https://doi.org/10.3390/jcm11123545
Available online: https://www.mdpi.com/2077-0383/11/12/3545
26 September 2023
Journal of Clinical Medicine | Issue Cover Articles in 2021
The articles below have been selected as 2021 Issue Cover Articles by the Editorial Office of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). These articles are from multiple fields within the scope of the Journal of Clinical Medicine, and we hope they can provide insights and references for scholars in related fields.
1. “Retinal Microcirculation and Cytokines as Predictors for Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Branch Retinal Vein Occlusion” by Hidetaka Noma, Kanako Yasuda, Tatsuya Mimura, Noboru Suganuma and Masahiko Shimura J. Clin. Med. 2021, 10(1), 58; https://doi.org/10.3390/jcm10010058 Available online: https://www.mdpi.com/2077-0383/10/1/58 |
|
2. “Pravastatin Promotes Endothelial Colony-Forming Cell Function, Angiogenic Signaling and Protein Expression In Vitro” by Nadia Meyer, Lars Brodowski, Katja Richter, Constantin S. von Kaisenberg, Bianca Schröder-Heurich and Frauke von Versen-Höynck. J. Clin. Med. 2021, 10(2), 183; https://doi.org/10.3390/jcm10020183 Available online: https://www.mdpi.com/2077-0383/10/2/183 |
|
3. “Ventricular Assist Device-Specific Infections” by Yue Qu, Anton Y. Peleg and David McGiffin. J. Clin. Med. 2021, 10(3), 453; https://doi.org/10.3390/jcm10030453 Available online: https://www.mdpi.com/2077-0383/10/3/453 |
|
4. “Functional and Structural Characterization of Nucleic Acid Ligands That Bind to Activated Coagulation Factor XIII” by Nasim Shahidi Hamedani, Arijit Biswas, Oliver Rudan, Rosa Tönges, Carlotta Meyring, Fabian Tolle, Günter Mayer, Johannes Oldenburg, Jens Müller and Bernd Pötzsch. J. Clin. Med. 2021, 10(4), 677; https://doi.org/10.3390/jcm10040677 Available online: https://www.mdpi.com/2077-0383/10/4/677 |
|
5. “Emerging Therapies in Immune Thrombocytopenia” by Sylvain Audia and Bernard Bonnotte. J. Clin. Med. 2021, 10(5), 1004; https://doi.org/10.3390/jcm10051004 Available online: https://www.mdpi.com/2077-0383/10/5/1004 |
|
6. “Degenerative Cervical Myelopathy: Insights into Its Pathobiology and Molecular Mechanisms” by Ji Tu, Jose Vargas Castillo, Abhirup Das and Ashish D. Diwan. J. Clin. Med. 2021, 10(6), 1214; https://doi.org/10.3390/jcm10061214 Available online: https://www.mdpi.com/2077-0383/10/6/1214 |
|
7. “Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies” by Elisa Stellaria Grassi, Viola Ghiandai and Luca Persani. J. Clin. Med. 2021, 10(7), 1455; https://doi.org/10.3390/jcm10071455 Available online: https://www.mdpi.com/2077-0383/10/7/1455 |
|
8. “Cardiovascular and Renal Disease in Chronic Critical Illness” by Tyler J. Loftus, Amanda C. Filiberto, Tezcan Ozrazgat-Baslanti, Saraswathi Gopal and Azra Bihorac. J. Clin. Med. 2021, 10(8), 1601; https://doi.org/10.3390/jcm10081601 Available online: https://www.mdpi.com/2077-0383/10/8/1601 |
|
9. “Advanced Microscopy for Liver and Gut Ultrastructural Pathology in Patients with MVID and PFIC Caused by MYO5B Mutations” by Michael W. Hess, Iris M. Krainer, Przemyslaw A. Filipek, Barbara Witting, Karin Gutleben, Ilja Vietor, Heinz Zoller, Denise Aldrian, Ekkehard Sturm and James R. Goldenring et al. J. Clin. Med. 2021, 10(9), 1901; https://doi.org/10.3390/jcm10091901 Available online: https://www.mdpi.com/2077-0383/10/9/1901 |
|
10. “Speckle-Tracking Echocardiography with Novel Imaging Technique of Higher Frame Rate” by Kana Fujikura, Mohammed Makkiya, Muhammad Farooq, Yun Xing, Wayne Humphrey, Mohammad Hashim Mustehsan, Mario J. Garcia and Cynthia C. Taub. J. Clin. Med. 2021, 10(10), 2095; https://doi.org/10.3390/jcm10102095 Available online: https://www.mdpi.com/2077-0383/10/10/2095 |
|
11. “The Non-Coding RNA Landscape in IgA Nephropathy—Where Are We in 2021?” by Izabella Z. A. Pawluczyk, Haresh Selvaskandan and Jonathan Barratt. J. Clin. Med. 2021, 10(11), 2369; https://doi.org/10.3390/jcm10112369 Available online: https://www.mdpi.com/2077-0383/10/11/2369 |
|
12. “Infections as Novel Risk Factors of Atherosclerotic Cardiovascular Diseases: Pathophysiological Links and Therapeutic Implications” by Piotr Szwed, Aleksandra Gąsecka, Mateusz Zawadka, Ceren Eyileten, Marek Postuła, Tomasz Mazurek, Łukasz Szarpak and Krzysztof J. Filipiak. J. Clin. Med. 2021, 10(12), 2539; https://doi.org/10.3390/jcm10122539 Available online: https://www.mdpi.com/2077-0383/10/12/2539 |
|
13. “The Cerebral Effect of Ammonia in Brain Aging: Blood–Brain Barrier Breakdown, Mitochondrial Dysfunction, and Neuroinflammation” by Danbi Jo, Byeong C. Kim, Kyung A. Cho and Juhyun Song. J. Clin. Med. 2021, 10(13), 2773; https://doi.org/10.3390/jcm10132773 Available online: https://www.mdpi.com/2077-0383/10/13/2773 |
|
14. “Genetic Susceptibility to Acute Kidney Injury” by Christian Ortega-Loubon, Pedro Martínez-Paz, Emilio García-Morán, Álvaro Tamayo-Velasco, Francisco J. López-Hernández, Pablo Jorge-Monjas and Eduardo Tamayo. J. Clin. Med. 2021, 10(14), 3039; https://doi.org/10.3390/jcm10143039 Available online: https://www.mdpi.com/2077-0383/10/14/3039 |
|
15. “Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management” by Miguel A. Ortega, Oscar Fraile-Martínez, Cielo García-Montero, Miguel A. Álvarez-Mon, Chen Chaowen, Fernando Ruiz-Grande, Leonel Pekarek, Jorge Monserrat, Angel Asúnsolo and Natalio García-Honduvilla et al. J. Clin. Med. 2021, 10(15), 3239; https://doi.org/10.3390/jcm10153239 Available online: https://www.mdpi.com/2077-0383/10/15/3239 |
|
16. “Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies” by Iosif Papafragkos, Efrosyni Markaki, Christina Kalpadakis and Panayotis Verginis. J. Clin. Med. 2021, 10(16), 3462; https://doi.org/10.3390/jcm10163462 Available online: https://www.mdpi.com/2077-0383/10/16/3462 |
|
17. “Obstructive Sleep Apnea and Cardiac Arrhythmias: A Contemporary Review” by Balint Laczay and Michael D. Faulx. J. Clin. Med. 2021, 10(17), 3785; https://doi.org/10.3390/jcm10173785 Available online: https://www.mdpi.com/2077-0383/10/17/3785 |
|
18. “RBM20-Related Cardiomyopathy: Current Understanding and Future Options” by Jan Koelemen, Michael Gotthardt, Lars M. Steinmetz and Benjamin Meder. J. Clin. Med. 2021, 10(18), 4101; https://doi.org/10.3390/jcm10184101 Available online: https://www.mdpi.com/2077-0383/10/18/4101 |
|
19. “Vaccination for Respiratory Infections in Patients with Heart Failure” by Nicolas Girerd, Nicolas Chapet, Camille Roubille, Jérôme Roncalli, Muriel Salvat, Frédéric Mouquet, Nicolas Lamblin, Jean-Pierre Gueffet, Thibaud Damy and Michel Galinier et al. J. Clin. Med. 2021, 10(19), 4311; https://doi.org/10.3390/jcm10194311 Available online: https://www.mdpi.com/2077-0383/10/19/4311 |
|
20. “The Microbiota-Gut-Brain Axis as a Key to Neuropsychiatric Disorders: A Mini Review” by Katarzyna Stopińska, Maria Radziwoń-Zaleska and Izabela Domitrz. J. Clin. Med. 2021, 10(20), 4640; https://doi.org/10.3390/jcm10204640 Available online: https://www.mdpi.com/2077-0383/10/20/4640 |
|
21. “The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications” by Angelica Varesi, Undine-Sophie Deumer, Sanjana Ananth and Giovanni Ricevuti. J. Clin. Med. 2021, 10(21), 5077; https://doi.org/10.3390/jcm10215077 Available online: https://www.mdpi.com/2077-0383/10/21/5077 |
|
22. “Imaging of Gastric Carcinomatosis” by Raquel Saiz Martínez, Clarisse Dromain and Naik Vietti Violi. J. Clin. Med. 2021, 10(22), 5294; https://doi.org/10.3390/jcm10225294 Available online: https://www.mdpi.com/2077-0383/10/22/5294 |
|
23. “The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure” by Zahi Abu Ghosh, Donna R. Zwas, Andre Keren, Gabby Elbaz-Greener, Vered Israeli, Offer Amir and Israel Gotsman. J. Clin. Med. 2021, 10(23), 5577; https://doi.org/10.3390/jcm10235577 Available online: https://www.mdpi.com/2077-0383/10/23/5577 |
|
24. “Advances in Diagnostic Imaging for Cardiac Sarcoidosis” by Osamu Manabe, Noriko Oyama-Manabe, Tadao Aikawa, Satonori Tsuneta and Nagara Tamaki. J. Clin. Med. 2021, 10(24), 5808; https://doi.org/10.3390/jcm10245808 Available online: https://www.mdpi.com/2077-0383/10/24/5808 |
JCM announces the Best Paper Award each year. If your paper has been highly cited and downloaded, you will have an advantage in applying for this award. Please find more details of the JCM Best Paper Award recipients at the following link: https://www.mdpi.com/journal/jcm/awards/2320.
Journal of Clinical Medicine Editorial Office
25 September 2023
Meet Us at the Gerontological Society of America (GSA) 2023 Annual Scientific Meeting, 8–12 November 2023, Tampa, Florida, USA
MDPI will attend the Gerontological Society of America (GSA) 2023 Annual Scientific Meeting. The Gerontological Society of America is the oldest and largest interdisciplinary organization devoted to research, education, and practice in the field of aging.
The GSA 2023 Annual Scientific Meeting draws professionals in the field of aging on a global scale. Attendees represent specialties including geriatrics, biological sciences, nursing, nutrition, medicine, social work, economics, policy, psychology, and more. The Annual Scientific Meeting offers an extensive amount of stimulating and high-level scholarship, from a diverse variety of aging research disciplines. It is this new, enriching knowledge that will inform policy, practice, and research for years to come.
The following MDPI journals will be represented:
- Healthcare;
- Medicina;
- Epidemiologia;
- Nutrients;
- JCM;
- JPM;
- IJERPH;
- Nursing Reports;
- Geriatrics;
- Life;
- BioMedInformatics;
- Behavioral Sciences;
- Societies;
- JAL.
If you plan on attending this conference, please feel free to stop by our booth #119 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://www.gsa2023.org.
20 September 2023
Meet Us at the 109th Radiological Society of North America Scientific Assembly and Annual Meeting (RSNA 2023), 26–29 November 2023, Chicago, USA
Conference: RSNA 2023
Organization: The Radiological Society of North America
Date: 26–29 November 2023
Place: McCormick Place, 2301 S. Lake Shore Drive, Chicago, IL 60616 USA
Booth: #1103
The Radiological Society of North America (RSNA) is a non-profit organization. RSNA’s annual meeting provides radiology professionals and industry partners with endless opportunities to learn, connect, exchange ideas, and see the latest technology in action. This year’s theme—Leading through Change—focuses on how radiology professionals can be intentional and proactive while leading teams and organizations through change.
The following MDPI journals will be represented as exhibitors:
- Diagnostics;
- JPM;
- Tomography;
- JCM;
- Osteology;
- Radiation;
- Cancers.
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.rsna.org/annual-meeting.
18 September 2023
Meet Us at the 82nd Annual Meeting of the Japan Neurosurgical Society, 25–27 October 2023, Tokyo, Japan
The 82nd Annual Meeting of the Japan Neurosurgical Society will be held from 25 to 27 October 2023 in Tokyo, Japan. The conference is organized by the Department of Neurosurgery, University of Tokyo.
The areas of interest include the following:
- Vascular disorders;
- Brain tumor;
- Spine and the spinal cord;
- Function;
- Pediatric;
- Neurotrauma;
- Education and society.
The following MDPI journals will be represented:
- Clinical Medicine;
- Brain Sciences;
- Neuroglia;
- Neurology International;
- NeuroSci.
If you are attending this conference, please talk to us online. Our delegates look forward to meeting you in person at booth #No. 14 and answering any questions that you may have. For more information about the conference, please visit the following link: http://jns2023.umin.jp/index.html.
14 September 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021–2022 in the Section “Pulmonology”
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. The Section “Pulmonology” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
The Section “Pulmonology” follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2021 and 2022 below:
1. “Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic”
by Shiva Rattan Ambardar, Stephanie L. Hightower, Nikhil A. Huprikar, Kevin K. Chung, Anju Singhal and Jacob F. Collen
J. Clin. Med. 2021, 10(11), 2452; https://doi.org/10.3390/jcm10112452
Available online: https://www.mdpi.com/2077-0383/10/11/2452
2. “Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation”
by Marina Bantulà, Jordi Roca-Ferrer, Ebymar Arismendi and César Picado
J. Clin. Med. 2021, 10(2), 169; https://doi.org/10.3390/jcm10020169
Available online: https://www.mdpi.com/2077-0383/10/2/169
3. “Interstitial Lung Disease at High Resolution CT after SARS-CoV-2-Related Acute Respiratory Distress Syndrome According to Pulmonary Segmental Anatomy”
by Elisa Baratella, Barbara Ruaro, Cristina Marrocchio, Natalia Starvaggi, Francesco Salton, Fabiola Giudici, Emilio Quaia, Marco Confalonieri and Maria Assunta Cova
J. Clin. Med. 2021, 10(17), 3985; https://doi.org/10.3390/jcm10173985
Available online: https://www.mdpi.com/2077-0383/10/17/3985
4. “Management Challenges in Chronic Obstructive Pulmonary Disease in the COVID-19 Pandemic: Telehealth and Virtual Reality”
by Sebastian Rutkowski
J. Clin. Med. 2021, 10(6), 1261; https://doi.org/10.3390/jcm10061261
Available online: https://www.mdpi.com/2077-0383/10/6/1261
5. “Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers and Paving the Way to Lung Cancer”
by Klára Szalontai, Nikolett Gémes, József Furák, Tünde Varga, Patrícia Neuperger, József Á. Balog, László G. Puskás and Gábor J. Szebeni
J. Clin. Med. 2021, 10(13), 2889; https://doi.org/10.3390/jcm10132889
Available online: https://www.mdpi.com/2077-0383/10/13/2889
6. “Electronic Cigarette Aerosol Is Cytotoxic and Increases ACE2 Expression on Human Airway Epithelial Cells: Implications for SARS-CoV-2 (COVID-19)”
by Kielan Darcy McAlinden, Wenying Lu, Parisa Vahidi Ferdowsi, Stephen Myers, James Markos, Josie Larby, Collin Chia, Heinrich C. Weber, Greg Haug, Mathew Suji Eapen et al.
J. Clin. Med. 2021, 10(5), 1028; https://doi.org/10.3390/jcm10051028
Available online: https://www.mdpi.com/2077-0383/10/5/1028
7. “The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis”
by Angelo Zinellu, Claudia Collu, Mouhamad Nasser, Panagiotis Paliogiannis, Sabrina Mellino, Elisabetta Zinellu, Julie Traclet, Kais Ahmad, Arduino Aleksander Mangoni, Ciriaco Carru et al.
J. Clin. Med. 2021, 10(18), 4134; https://doi.org/10.3390/jcm10184134
Available online: https://www.mdpi.com/2077-0383/10/18/4134
8. “The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab”
by Edoardo Lenci, Luca Cantini, Federica Pecci, Valeria Cognigni, Veronica Agostinelli, Giulia Mentrasti, Alessio Lupi, Nicoletta Ranallo, Francesco Paoloni, Silvia Rinaldi et al.
J. Clin. Med. 2021, 10(5), 1005; https://doi.org/10.3390/jcm10051005
Available online: https://www.mdpi.com/2077-0383/10/5/1005
9. “Spontaneous Breathing and Evolving Phenotypes of Lung Damage in Patients with COVID-19: Review of Current Evidence and Forecast of a New Scenario”
by Roberto Tonelli, Alessandro Marchioni, Luca Tabbì, Riccardo Fantini, Stefano Busani, Ivana Castaniere, Dario Andrisani, Filippo Gozzi, Giulia Bruzzi, Linda Manicardi et al.
J. Clin. Med. 2021, 10(5), 975; https://doi.org/10.3390/jcm10050975
Available online: https://www.mdpi.com/2077-0383/10/5/975
10. “Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review”
by Chiara Robba, Denise Battaglini, Lorenzo Ball, Alberto Valbusa, Italo Porto, Roberta Della Bona, Giovanni La Malfa, Nicolò Patroniti, Iole Brunetti, Maurizio Loconte et al.
J. Clin. Med. 2021, 10(1), 140; https://doi.org/10.3390/jcm10010140
Available online: https://www.mdpi.com/2077-0383/10/1/140
11. “Telomeres in Interstitial Lung Disease”
by Carmel J. W. Stock and Elisabetta A. Renzoni
J. Clin. Med. 2021, 10(7), 1384; https://doi.org/10.3390/jcm10071384
Available online: https://www.mdpi.com/2077-0383/10/7/1384
12. “Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study”
by Vincenzo Carnovale, Paola Iacotucci, Vito Terlizzi, Carmela Colangelo, Lorenza Ferrillo, Angela Pepe, Michela Francalanci, Giovanni Taccetti, Serena Buonaurio, Assunta Celardo et al.
J. Clin. Med. 2022, 11(4), 1021; https://doi.org/10.3390/jcm11041021
Available online: https://www.mdpi.com/2077-0383/11/4/1021
13. “COVID-19 Patients Presenting with Post-Intubation Upper Airway Complications: A Parallel Epidemic?”
by Grigoris Stratakos, Nektarios Anagnostopoulos, Rajaa Alsaggaf, Evangelia Koukaki, Katerina Bakiri, Philip Emmanouil, Charalampos Zisis, Konstantinos Vachlas, Christina Vourlakou and Antonia Koutsoukou
J. Clin. Med. 2022, 11(6), 1719; https://doi.org/10.3390/jcm11061719
Available online: https://www.mdpi.com/2077-0383/11/6/1719
14. “Etiologic Classification of Diffuse Parenchymal (Interstitial) Lung Diseases”
by Matthias Griese
J. Clin. Med. 2022, 11(6), 1747; https://doi.org/10.3390/jcm11061747
Available online: https://www.mdpi.com/2077-0383/11/6/1747
15. “Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions”
by Rachel Y. Tam, Josie M. van Dorst, Isabelle McKay, Michael Coffey and Chee Y. Ooi
J. Clin. Med. 2022, 11(3), 649; https://doi.org/10.3390/jcm11030649
Available online: https://www.mdpi.com/2077-0383/11/3/649
16. “Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study”
by Yun Jung Choi, Eun Hee Chung, Eun Lee, Chul-Hong Kim, Yong Ju Lee, Hyo-Bin Kim, Bong-Seong Kim, Hyung Young Kim, Yoojung Cho, Ju-Hee Seo et al.
J. Clin. Med. 2022, 11(2), 306; https://doi.org/10.3390/jcm11020306
Available online: https://www.mdpi.com/2077-0383/11/2/306
17. “Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer”
by Filippo Tommaso Gallina, Riccardo Tajè, Daniele Forcella, Felicita Corzani, Virna Cerasoli, Paolo Visca, Cecilia Coccia, Federico Pierconti, Isabella Sperduti, Fabiana Letizia Cecere et al.
J. Clin. Med. 2022, 11(8), 2173; https://doi.org/10.3390/jcm11082173
Available online: https://www.mdpi.com/2077-0383/11/8/2173
18. “Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management”
by Lin Tong, Shumin Huang, Chen Zheng, Yuanyuan Zhang and Zhimin Chen
J. Clin. Med. 2022, 11(10), 2824; https://doi.org/10.3390/jcm11102824
Available online: https://www.mdpi.com/2077-0383/11/10/2824
19. “A Comprehensive Systematic Review and Meta-Analysis of the Association between the Neutrophil-to-Lymphocyte Ratio and Adverse Outcomes in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease”
by Angelo Zinellu, Elisabetta Zinellu, Maria Carmina Pau, Ciriaco Carru, Pietro Pirina, Alessandro G. Fois and Arduino A. Mangoni
J. Clin. Med. 2022, 11(12), 3365; https://doi.org/10.3390/jcm11123365
Available online: https://www.mdpi.com/2077-0383/11/12/3365
20. “Are Oropharyngeal Dysphagia Screening Tests Effective in Preventing Pneumonia?”
by Ikuko Okuni and Satoru Ebihara
J. Clin. Med. 2022, 11(2), 370; https://doi.org/10.3390/jcm11020370
Available online: https://www.mdpi.com/2077-0383/11/2/370
13 September 2023
Journal of Clinical Medicine Indexed in the Polish Ministry of Education and Science List
We are pleased to inform you that the open access Journal of Clinical Medicine (JCM, ISSN: 2077-0383; IF: 3.9, CiteScore 5.4) has been indexed within the Polish Ministry of Education and Science list of scientific journals and reviewed materials from international conferences. For publishing with JCM, Polish scholars will receive 140 Ministerial Points in the following disciplines related to medicine:
- Biomedical engineering;
- Medical biology;
- Pharmaceutical sciences;
- Medical sciences;
- Science of physical culture;
- Health sciences;
- Family studies;
- Food and nutrition technology;
- Biotechnology;
- Chemical sciences;
- Veterinary medicine.
JCM is an international, peer-reviewed, open access journal of clinical medicine, published semimonthly online by MDPI. We warmly welcome you to consider JCM as the platform for publishing your work. You can contact the JCM Editorial Office at [email protected].
JCM Editorial Office
13 September 2023
Journal of Clinical Medicine | Collection of Papers from the Winners of Best Paper Awards
We invite you to read the best papers published in 2022 below:
1. “Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US”
by Donald J. Alcendor
J. Clin. Med. 2020, 9(8), 2442; https://doi.org/10.3390/jcm9082442
Available online: https://www.mdpi.com/2077-0383/9/8/2442
2. “Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”
by Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella and Gaetano Santulli
J. Clin. Med. 2020, 9(5), 1417; https://doi.org/10.3390/jcm9051417
Available online: https://www.mdpi.com/2077-0383/9/5/1417
3. “Estimation of the Transmission Risk of the 2019-nCoy and Its Implication for Public Health Interventions”
by Biao Tang, Xia Wang, Qian Li, Nicola Luigi Bragazzi, Sanyi Tang, Yanni Xiao and Jianhong Wu
J. Clin. Med. 2020, 9(2), 462; https://doi.org/10.3390/jcm9020462
Available online: https://www.mdpi.com/2077-0383/9/2/462
In addition, we have collected all papers from the Best Paper Award’s authors community from 2019 to 2023, as listed below. You are welcome to read and share them.
1. “BK Polyomavirus Virus Glomerular Tropism: Implications for Virus Reactivation from Latency and Amplification during Immunosuppression”
by Donald J. Alcendor
J. Clin. Med. 2019, 8(9), 1477; https://doi.org/10.3390/jcm8091477
Available online: https://www.mdpi.com/2077-0383/8/9/1477
2. “Inositol 1,4,5-Trisphosphate Receptors in Human Disease: A Comprehensive Update”
by Jessica Gambardella, Angela Lombardi, Marco Bruno Morelli, John Ferrara and Gaetano Santulli
J. Clin. Med. 2020, 9(4), 1096; https://doi.org/10.3390/jcm9041096
Available online: https://www.mdpi.com/2077-0383/9/4/1096
3. “Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study”
by Celestino Sardu, Gaetano Santulli, Germano Guerra, Maria Consiglia Trotta, Matteo Santamaria, Cosimo Sacra, Nicola Testa, Valentino Ducceschi, Gianluca Gatta, Michele D' Amico et al.
J. Clin. Med. 2020, 9(2), 544; https://doi.org/10.3390/jcm9020544
Available online: https://www.mdpi.com/2077-0383/9/2/544
4. “Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure”
by Imma Forzano,Pasquale Mone, Gaetano Mottola, Urna Kansakar, Luigi Salemme, Antonio De Luca, Tullio Tesorio, Fahimeh Varzideh and Gaetano Santulli
J. Clin. Med. 2022, 11(24), 7503; https://doi.org/10.3390/jcm11247503
Available online: https://www.mdpi.com/2077-0383/11/24/7503
5. “Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome”
by Domenico Cozzolino, Ciro Romano, Celestino Sardu, Riccardo Nevola, Giuseppina Rosaria Umano, Luca Rinaldi, Luigi Elio Adinolfi, Christian Catalini, Aldo Marrone and Maurizio Municinò et al.
J. Clin. Med. 2023, 12(17), 5691; https://doi.org/10.3390/jcm12175691
Available online: https://www.mdpi.com/2077-0383/12/17/5691
6. “Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study”
by Raffaele Galiero, Vittorio Simeon, Giuseppe Loffredo, Alfredo Caturano, Luca Rinaldi, Erica Vetrano, Giulia Medicamento, Maria Alfano, Domenico Beccia and Chiara Brin
J. Clin. Med. 2022, 11(20), 6121; https://doi.org/10.3390/jcm11206121
Available online: https://www.mdpi.com/2077-0383/11/20/6121
7. “Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms”
by Celestino Sardu, Raffaele Marfella, Francesco Prattichizzo, Rosalba La Grotta, Giuseppe Paolisso and Antonio Ceriello
J. Clin. Med. 2022, 11(6), 1564; https://doi.org/10.3390/jcm11061564
Available online: https://www.mdpi.com/2077-0383/11/6/1564
8. “Point-of-Care Diagnostic Tests for Detecting SARS-CoV-2 Antibodies: A Systematic Review and Meta-Analysis of Real-World Data”
by Matteo Riccò, Pietro Ferraro, Giovanni Gualerzi, Silvia Ranzieri, Brandon Michael Henry, Younes Ben Said, Natalia Valeryevna Pyatigorskaya, Elena Nevolina, Jianhong Wu, Nicola Luigi Bragazzi et al.
J. Clin. Med. 2020, 9(5), 1515; https://doi.org/10.3390/jcm9051515
Available online: https://www.mdpi.com/2077-0383/9/5/1515
9. “Forecasting COVID-19-Associated Hospitalizations under Different Levels of Social Distancing in Lombardy and Emilia-Romagna, Northern Italy: Results from an Extended SEIR Compartmental Model”
by Chiara Reno, Jacopo Lenzi, Antonio Navarra, Eleonora Barelli, Davide Gori, Alessandro Lanza, Riccardo Valentini, Biao Tang and Maria Pia Fantini
J. Clin. Med. 2020, 9(5), 1492; https://doi.org/10.3390/jcm9051492
Available online: https://www.mdpi.com/2077-0383/9/5/1492
6 September 2023
Recap of Awards Granted to Scholars in 2022
MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.
In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.
The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.
MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:
To explore more MDPI awards, please click here.
30 August 2023
MDPI Insights: The CEO's Letter #3 - Sustainability and Co-opetition
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Our Commitment to Sustainability
As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.
In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.
MDPI and the Sustainable Development Goals (SDGs)
In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.
“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]
As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:
MDPI journals specializing in sustainability-related topics:
- 2009: Sustainability
- 2012: Resources
- 2013: Climate
- 2014: Environments
- 2016: Recycling
- 2019: Clean Technologies
- 2020: Sustainable Chemistry
- 2021: Wind, Biomass, Conservation, Pollutants, Solar
- 2022: Waste, Microplastics
Read more:
Impactful Research
Highly Cited Articles in Sustainability
In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.
We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.
“Sustainability received a 2022 CiteScore of 5.8”
While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.
Highly Cited Papers in Sustainability
Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.
1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?”Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792; https://doi.org/10.3390/su14084792
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)
This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.
2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety”Author: Panu Pihkala
Sustainability 2020, 12(19), 7836; https://doi.org/10.3390/su12197836
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)
This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.
3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review”Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318; https://doi.org/10.3390/su13031318
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)
This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.
4. “Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions”Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963; https://doi.org/10.3390/su13179963
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)
This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.
Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).
Read more:
- Testimonials: See what our editors and authors say about Sustainability.
Inside MDPI
President of Ireland Authors Editorial in MDPI Journal Sustainability
It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:
This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.
The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.
As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.
Read the completed editorial here:
Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683; https://doi.org/10.3390/su15129683
Coming Together for Science
The World Sustainability Forum 2023
The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.
This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:
- The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
- The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
- The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.
MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research
The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:
- The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
- The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.
The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.
2023 World Sustainability Award Winners
Interviews with 2023 Emerging Sustainability Leader Award Finalists
- Dr. Bahareh Kamranzad
- Dr. Youjin Kim
- Dr. Julia Lohmann
As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.
Read more:
Closing Thoughts
“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier
I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.
MDPI’s Interaction with Elsevier
In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.
“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”
Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.
It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.
‘Fully OA’ Organizations Dedicated to Open Access
MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.
This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.
As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”
Chief Executive Officer
MDPI AG
28 August 2023
JCM 2023 Young Investigator Award—Open for Nominations
We are pleased to announce that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is now inviting nominations for the JCM 2023 Young Investigator Award. This prize will be given to one young investigator in recognition of their excellence in the field of clinical medicine.
The prize:
- CHF 2000 (Swiss francs);
- Option to publish one paper free of charge in the JCM after peer review before the end of 2024;
- An electronic certificate.
Eligibility and requirements:
- Must have received their Ph.D. no more than 10 years prior to 31 December 2023;
- Must have produced ground-breaking research and made a significant contribution to the advancement of clinical medicine;
- Candidates must be nominated by senior scientists.
Nomination deadline: 31 December 2023
You can find more information about this award and how to nominate here (https://www.mdpi.com/journal/jcm/awards/2254). To request further information, please contact the JCM Editorial Office ([email protected]).
Journal of Clinical Medicine Editorial Office
25 August 2023
Meet Us at the American Congress of Rehabilitation Medicine (ACRM) 100th Annual Conference, 30 October–2 November 2023, Atlanta, USA
MDPI will attend the American Congress of Rehabilitation Medicine (ACRM) 100th Annual Conference. The 2023 annual meeting of ACRM is the world’s largest interdisciplinary rehabilitation research event. Rehabilitation professionals and community members from around the globe are encouraged to join. With 150+ inter-professional groups at ACRM, including community groups, committees, and task forces, the 100th anniversary conference is planning 4 powerful plenaries, 15+ symposia, 300+ educational sessions, symposia and lectures, and 600+ scientific papers and digital poster presentations, etc.
To enhance patient care, the presentation of science by researchers is required, and to inform and improve research, feedback from the clinicians is required. The aim of the ACRM 100th annual conference is to encourage attendees to join the discussions and collaborations in order to help move the field of physical medicine and rehabilitation forward.
The following MDPI journals will be represented:
If you plan on attending this conference, please feel free to stop by our booth #413 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://conference.acrm.org/.
23 August 2023
Journal of Clinical Medicine | Google Scholar Metrics Released
We are pleased to announce that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) ranked 17th under the subcategory “Health & Medical Sciences (general)” in the latest released 2023 Google Scholar Metrics on 19 July 2023. The latest release covers articles published from 2018 to 2022 and includes citations from all articles that were indexed in Google Scholar as of July 2023 (source: 2023 Google Scholar Metrics).
The h5-index of the Journal of Clinical Medicine is 125, and the h5-median is 178. We express our gratitude to all the editors, reviewers, authors, and readers of the Journal of Clinical Medicine. Thank you for all your support for the journal.
You are welcome to browse the most cited publications over the last 5 years here.
Please feel free to contact us at [email protected] if you have any questions or suggestions for the Journal of Clinical Medicine.
Supplementary explanations:
- Scholar Metrics provide an easy way for authors to quickly gauge the visibility and influence of recent articles in scholarly publications;
- h5-index: the h5-index is the h-index for articles published in the last 5 complete years. H articles published in 2018-2022 have at least h citations each;
- h5-median: the h5-median for a publication is the median number of citations for the articles that make up its h5-index.
18 August 2023
Meet Us at the American Academy of Pediatrics 2023 National Conference & Exhibition, 20–24 October 2023, Washington, USA
MDPI will attend the American Academy of Pediatrics 2023 National Conference & Exhibition. This event will be held in Washington D.C. for five days from Friday, 20 October, to Tuesday, 24 October 2023.
The following MDPI journals will be represented:
- Children;
- JCM;
- Medicina;
- Healthcare;
- IJERPH;
- JPM;
- Clinpract;
- Diagnostics;
- Medicines.
If you plan on attending this conference, please stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://aapexperience.org/.
18 August 2023
MDPI’s 2022 Young Investigator Awards in Medicine and Pharmacology—Winners Announced
MDPI’s Young Investigator Awards recognize promising young researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in medicine and pharmacology. The winners were selected by the journals’ Award Evaluation Committee.
We would like to warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.
- Yuyan Jiang, Stanford University, USA
- Billy Wai-Lung Ng, Chinese University of Hong Kong, China
- Ashleigh Poh, The Olivia Newton-John Cancer Research Institute, Australia
- Miranda Fidler-Benaoudia, University of Calgary, Canada
- Bishal Gyawali, Queen’s University, Canada
- Shahnawaz Anwer, Hong Kong Polytechnic University, Hong Kong
- Jan Bednarsch, Universitätsmedizin Berlin, Germany
- Anda Mihaela Naciu, Fondazione Policlinico Universitario Campus Bio-Medico, Italy
- Jerome Lechien, University of Mons, Belgium
- Daniele Bertoglio, University of Antwerp, Belgium
- Gregor Fuhrmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany
- Haley Adcox, Virginia Commonwealth University, USA
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and a form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to the advancement of their fields.
For more MDPI awards, please click here.
18 August 2023
MDPI’s 2022 Travel Awards in Medicine and Pharmacology—Winners Announced
We are proud to recognize the winners of MDPI’s 2022 Travel Awards in medicine and pharmacology category for their outstanding presentations.
MDPI journals regularly offer Travel Awards to encourage talented junior scientists to present their research at academic conferences in specific fields, which helps to enhance their influence.
The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.
We would like to congratulate the winners of the 2022 Travel Awards and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.
- Filip Jansåker, Lund University, Lund, Sweden
- Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal
- Diego de Miguel Perez, Icahn School of Medicine at Mount Sinai, USA
- Luigi Russo, Italian Institute of Technology (IIT), Italy
- Sneha Sethi, University of Adelaide, Australia
- Xiyin Wang, Indiana University School of Medicine, USA
- Sonia Nath, University of Adelaide, Australia
- Konstantina Kritikou, Carol Davila University of Medicine and Pharmacy, Romania
- Adrien Holzgreve, The University Hospital of Munich, Germany
- Antonella Padella, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Italy
- Susanna Cooper, St. George’s University of London, UK
- Renée Tillie, Maastricht University Medical Center, the Netherlands
- Max Lennart Eckstein, University of Bayreuth, Germany
- Lorenzo Bertani, University of Pisa, Italy
- Yuxue Cao, University of Queensland, Australia
- Flávia Sousa, Italian Institute of Technology, Italy
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form ot recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
See more MDPI awards, please click here.
18 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Medicine and Pharmacology—Winners Announced
In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.
We are proud to recognize the winners for the year 2022 in medicine and pharmacology for their outstanding contributions among the extensive competition by presenting them with an Outstanding Reviewer Award.
We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.
- Maxime Pichon, Centre Hospitalier Universitaire de Poitiers, France
- Violeta Popovici, Ovidius University of Constanta, Romania
- Yosra A. Helmy, University of Kentucky, USA
- Antonio G. Solimando, Aldo Moro University of Bari, Italy
- Linlin Guo, The Ohio State University Medical Center, USA
- Ravindra Deshpande, Wake Forest School of Medicine, USA
- Songli Zhu, Fred Hutchinson Cancer Research Center, USA
- Antonella Argentiero, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Italy
- Camelia Coada, Alma Mater Studiorum-University of Bologna, Italy
- Chenghui Li, University of Arkansas for Medical Sciences, USA
- Laurentiu Pop, University of Texas Southwestern Medical Center, USA
- Muhammad Fazal Ijaz, Dongguk University, Republic of Korea
- Rafał Watrowski, University of Freiburg, Germany
- Ruben C. Petreaca, The Ohio State University, USA
- Ruchi Roy, Rush University Medical Center, USA
- Salvatore Cocuzza, University of Catania, Italy
- Santosh Kumar Singh, Morehouse School of Medicine, USA
- Sergei Boichuk, Kazan State Medical University, Russia
- Simon John Christoph Soerensen, Stanford University, USA
- Takuya Koie, Gifu University, Japan
- Teresa Rubio-Tomás, Foundation for Research and Technology Hellas, Greece
- Teruki Nii, Kyushu University, Japan
- Tomasz Marjanski, Medical University of Gdansk, Poland
- Kristen Haase, The University of British Columbia, Canada
- Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
- Makoto Endo, Kyushu University, Japan
- Tefera Tadesse, Addis Ababa University, Ethiopia
- Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
- Ryuichi Ohta, Unnan City Hospital, Japan
- Henry Sutanto, Cardiovascular Research Institute Maastricht, the Netherlands
- José-María Sánchez-González, University of Seville, Spain
- Emmanouil Kapetanakis, General Hospital of Piraeus “Tzaneio”, Greece
- Eleonora Topino, Libera Università Maria Santissima Assunta (LUMSA), Italy
- Rodolfo Reda, Sapienza University of Rome, Italy
- Giulio Francesco Romiti, Sapienza University of Rome, Italy
- Maria Gabriella Melchiorre, IRCCS INRCA—National Institute of Health and Science on Ageing, Italy
- James Walter, 1Hines VA Hospital, USA; 2 Loyola Medical Center, USA
- Vasiliki Tsigkou, Sotiria Hospital, Greece
- Flavia Zacconi, Pontificia Universidad Católica de Chile, Chile
- Bhupendra Prajapati, Ganpat University, India
- Van-An Duong, Gachon University, Republic of Korea
- Ashish Agrawal, Indian Institute of Technology (BHU), India
- Aydin Eresen, University of California Irvine, USA
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
See more MDPI awards, please click here.
18 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Medicine and Pharmacology—Winners Announced
MDPI’s Best PhD Thesis Awards aim to recognize young scholars who are deemed to have produced the most outstanding PhD thesis in their fields of research and to encourage them to continue their outstanding work and further contributions to their field.
We would like to congratulate the winners of the 2022 Best PhD Thesis Awards in medicine and pharmacology and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.
- “Uncovering Novel Prognostic and Predictive Epigenetic Biomarkers in Malignant Testicular Germ Cell Tumors”
by João Pedro da Silva Machado Lobo, University of Porto, Portugal
- “Metastatic Recurrence in Colorectal Cancer Arises from Residual EMP1+ Cells”
by Adrià Cañellas Socias, University of Barcelona, Spain
- “Investigating Novel Aspects of the Blood–Brain Barrier Using High-Resolution Electron Microscopy”
by Shireen Mentor, University of Cape Town, South Africa
- “An Epidemiological Approach to Study The Interplay between Genome, Epigenome and Exposome in Women”
by Roberta Magnano San Lio, University of Catania, Italy
- “Intravitreal Liposomes as Ocular Drug Delivery Systems: Vitreal Interactions, Retinal Permeation and Drug Release Characteristics”
by Shirin Tavakoli, University of Helsinki, Finland
- “Microbiome-Mediated Colonization Resistance: Defense against Enteropathogens and Multi-Drug Resistant Organisms”
by Quinten Ducarmon, Leiden University Medical Center, the Netherlands
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
For more MDPI awards, please click here.
18 August 2023
MDPI’s Best Paper Awards in Medicine and Pharmacology—Winners Announced in 2022
The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.
The editors of each journal carefully selected review and research papers through a rigorous evaluative process based on criteria such as the scientific merit, overall impact, and quality of presentation of the papers published in the journal.
We are honored to present the winners for the year 2022 in medicine and pharmacology, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.
- “Development and Challenges of Antimicrobial Peptides for Therapeutic Applications”
by Charles H. Chen and Timothy K. Lu
Antibiotics 2020, 9(1), 24; https://doi.org/10.3390/antibiotics9010024
- “Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries”
by Philip Joosten, Daniela Ceccarelli, Evelien Odent, Steven Sarrazin, Haitske Graveland, Liese Van Gompel, Antonio Battisti, Andrea Caprioli, Alessia Franco, Jaap A. Wagenaar et al.
Antibiotics 2020, 9(2), 87; https://doi.org/10.3390/antibiotics9020087
- “Management of Peri-Implantitis Lesions without the Use of Systemic Antibiotics: A Systematic Review”
by Ahsen Khan, Ankit Goyal, Scott D. Currell and Dileep Sharma
Dent. J. 2020, 8(3), 106; https://doi.org/10.3390/dj8030106
- “Associations among Primary Stability, Histomorphometric Findings, and Bone Density: A Prospective Randomized Study after Alveolar Ridge Preservation with a Collagen Cone”
by Sigmar Schnutenhaus, Werner Götz, Jens Dreyhaupt, Heike Rudolph, Ralph G. Luthardt and Cornelia Edelmann
Dent. J. 2020, 8(4), 112; https://doi.org/10.3390/dj8040112
- “Novel Prefrontal Synthesis Intervention Improves Language in Children with Autism”
by Andrey Vyshedskiy, Edward Khokhlovich, Rita Dunn, Alexander Faisman, Jonah Elgart, Lisa Lokshina, Yuriy Gankin, Simone Ostrovsky, Lauren deTorres, Stephen M. Edelson et al.
Healthcare 2020, 8(4), 566; https://doi.org/10.3390/healthcare8040566
- “The Effects of Long-Term 40-Hz Physioacoustic Vibrations on Motor Impairments in Parkinson’s Disease: A Double-Blinded Randomized Control Trial”
by Abdullah Mosabbir, Quincy J. Almeida and Heidi Ahonen
Healthcare 2020, 8(2), 113; https://doi.org/10.3390/healthcare8020113
- “Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US”
by Donald J. Alcendor
J. Clin. Med. 2020, 9(8), 2442; https://doi.org/10.3390/jcm9082442
- “Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”
by Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella and Gaetano Santulli
J. Clin. Med. 2020, 9(5), 1417; https://doi.org/10.3390/jcm9051417
- “Estimation of the Transmission Risk of the 2019-nCoy and Its Implication for Public Health Interventions”
by Biao Tang, Xia Wang, Qian Li, Nicola Luigi Bragazzi, Sanyi Tang, Yanni Xiao and Jianhong Wu
J. Clin. Med. 2020, 9(2), 462; https://doi.org/10.3390/jcm9020462
- “Molecular and Cellular Mechanisms Affected in ALS”
by Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya G. Vijayakumar, William J. Duddy and Stephanie Duguez
J. Pers. Med. 2020, 10(3), 101; https://doi.org/10.3390/jpm10030101
- “Postulated Adjuvant Therapeutic Strategies for COVID-19”
by Anderson O. Ferreira, Hudson C. Polonini and Eli C. F. Dijkers
J. Pers. Med. 2020, 10(3), 80; https://doi.org/10.3390/jpm10030080
- “Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models”
by Vincenzo Quagliariello, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Annamaria Bonelli, Antonietta Caronna, Gerardo Botti, Claudia De Lorenzo and Nicola Maurea
J. Pers. Med. 2020, 10(4), 179; https://doi.org/10.3390/jpm10040179
- "Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics”
by Carla B. Roces, Gustavo Lou, Nikita Jain, Suraj Abraham, Anitha Thomas, Gavin W. Halbert and Yvonne Perrie
Pharmaceutics 2020, 12(11), 1095; https://doi.org/10.3390/pharmaceutics12111095
- “Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing”
by Sawittree Sahakijpijarn, Chaeho Moon, John J. Koleng, Dale J. Christensen and Robert O. Williams III
Pharmaceutics 2020, 12(11), 1002; https://doi.org/10.3390/pharmaceutics12111002
- “Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration”
by Erika Maria Tottoli, Rossella Dorati, Ida Genta, Enrica Chiesa, Silvia Pisani and Bice Conti
Pharmaceutics 2020, 12(8), 735; https://doi.org/10.3390/pharmaceutics12080735
- “The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist”
by Nicola Luigi Bragazzi, Muhammad Mansour, Alessandro Bonsignore and Rosagemma Ciliberti
Pharmacy 2020, 8(3), 140; https://doi.org/10.3390/pharmacy8030140
- “Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly”
by David L. Bankes, Hubert Jin, Stephanie Finnel, Veronique Michaud, Calvin H. Knowlton, Jacques Turgeon and Alan Stein
Pharmacy 2020, 8(2), 87; doi.org/10.3390/pharmacy8020087
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
See more MDPI awards, please click here.
18 August 2023
Journal of Clinical Medicine | Call for Special Issue Proposals and Recruiting Guest Editors
Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal of clinical medicine, published semi-monthly online by MDPI. JCM supports scientific innovations and clinical medicine research within the whole field and its related fields. The journal is indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases. For more details, please see the following link: https://www.mdpi.com/journal/jcm.
The JCM editorial team is pleased to announce this open call for Special Issue proposals, which offers a group of authors the opportunity to work on an interconnected set of papers on an innovative topic. We are soliciting high-quality proposals that will be evaluated in a continuous selection process throughout the year.
If you would like to propose a Special Issue topic for this journal, please visit the following link and then complete and submit the form: https://www.mdpi.com/journalproposal/sendproposalspecialissue/jcm, and contact the JCM Editorial Office ([email protected]). Our editors will respond to you as soon as possible.
The duties of Guest Editors are as follows:
- Refining the Special Issue’s title and scope, as well as providing a short introduction (100–200 words) and 5–10 keywords to set up the Special Issue’s website;
- Inviting contributors with the assistance of the in-house editor to achieve a publication target (e.g., 10 papers);
- Supervising the peer review process of the Special Issue, conducting a pre-review check, making final decisions based on at least two review reports that we have collected, etc.
- You will be offered an opportunity to publish one of your papers free of charge in an open access format, in addition to having the chance to provide the waivers to the papers that you invited for your Special Issue;
- A printed book of the Special Issue can be sent to you if more than 10 papers are published by the end of the Special Issue. See more information at https://www.mdpi.com/books;
- It is an ideal venue for networking and communicating with scholars in the research community, as well as a chance to mark you as influential within your discipline. The relationships you develop will last beyond the publication of your Special Issue, establishing a network for future collaboration;
- You can freely organize or promote your own conferences by using our platform SciForum.
The Editorial Office will set up the Special Issue’s website, arrange the promotional materials, assist with the invitations for paper contributions, and take care of the administrative tasks associated with peer review.
Please do not hesitate to contact the Editorial Office ([email protected]) for further details and clarification.
We look forward to receiving your proposals.
Journal of Clinical Medicine Editorial Office
28 July 2023
Journal of Clinical Medicine | World Hepatitis Day in 2023—“We’re not waiting”
World Hepatitis Day (WHD), held on 28 July every year, aims to raise global awareness of hepatitis—a group of infectious diseases known as hepatitis A, B, C, D, and E—and encourage prevention, diagnosis, and treatment, where we bring the world together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change. In 2023, the theme is “We’re not waiting”, and we call on people around the world to take action because hepatitis can’t wait.
To further explore the related research on the World Hepatitis Day 2023, Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has gathered open access academic research on the topic of hepatitis. We hope to share new scientific knowledge in the field of hepatitis with the world on this special day.
Article Collections:
1. "CD8+ T Cell Responses during HCV Infection and HCC"
by Maike Hofmann, Catrin Tauber, Nina Hensel and Robert Thimme
J. Clin. Med. 2021, 10(5), 991; https://doi.org/10.3390/jcm10050991
2. "Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis"
by Leonardo Frazzoni, Usama Sikandar, Flavio Metelli, Sinan Sadalla, Giuseppe Mazzella, Franco Bazzoli, Lorenzo Fuccio and Francesco Azzaroli
J. Clin. Med. 2021, 10(8), 1694; https://doi.org/10.3390/jcm10081694
3. "Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis"
by Bianca Cerbu, Mirela Loredana Grigoras, Felix Bratosin, Iulia Bogdan, Cosmin Citu, Adrian Vasile Bota, Madalina Timircan, Melania Lavinia Bratu, Mihaela Codrina Levai and Iosif Marincu
J. Clin. Med. 2022, 11(3), 652; https://doi.org/10.3390/jcm11030652
4. "Tracking Down the Epigenetic Footprint of HCV-Induced Hepatocarcinogenesis"
by Tom Domovitz and Meital Gal-Tanamy
J. Clin. Med. 2021, 10(3), 551; https://doi.org/10.3390/jcm10030551
5. "Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection"
by Pil Soo Sung and Eui-Cheol Shin
J. Clin. Med. 2021, 10(2), 221; https://doi.org/10.3390/jcm10020221
6. "Rapid Decline of Serum Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) in Non-Cirrhotic Patients with Chronic Hepatitis C Infection Receiving Direct-Acting Antiviral Therapy"
by Jonathan Grimm, Georg Peschel, Martina Müller, Doris Schacherer, Reiner Wiest, Kilian Weigand and Christa Buechler
J. Clin. Med. 2021, 10(8), 1621; https://doi.org/10.3390/jcm10081621
7. "Day-4 Lille Score Is a Good Prognostic Factor and Early Predictor in Assessing Therapy Response in Patients with Liver Cirrhosis and Severe Alcoholic Hepatitis"
by Camelia Gianina Foncea, Ioan Sporea, Raluca Lupușoru, Tudor Voicu Moga, Felix Bende, Roxana Șirli and Alina Popescu
J. Clin. Med. 2021, 10(11), 2338; https://doi.org/10.3390/jcm10112338
8. "Hepatitis C: A Pharmacological Therapeutic Update"
by Sonia Santander Ballestín, David Gómez Martín, Sara Lorente Pérez and María José Luesma Bartolomé
J. Clin. Med. 2021, 10(8), 1568; https://doi.org/10.3390/jcm10081568
9. "Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis"
by Kei Moriya, Norihisa Nishimura, Tadashi Namisaki, Hiroaki Takaya, Yasuhiko Sawada, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Shinya Sato, Masanori Furukawa et al.
J. Clin. Med. 2021, 10(11), 2465; https://doi.org/10.3390/jcm10112465
10. "Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease"
by Ilkay S. Idilman, Hsien Min Low, Tolga Gidener, Kenneth Philbrick, Taofic Mounajjed, Jiahui Li, Alina M. Allen, Meng Yin and Sudhakar K. Venkatesh
J. Clin. Med. 2021, 10(12), 2565; https://doi.org/10.3390/jcm10122565
11. "Transplantation of Organs from Hepatitis C Virus-Positive Donors under Direct-Acting Antiviral Regimens"
by Muhammad Nauman Zahid
J. Clin. Med. 2022, 11(3), 770; https://doi.org/10.3390/jcm11030770
12. "Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy"
by Cesare Mazzaro, Luigi Elio Adinolfi, Gabriele Pozzato, Riccardo Nevola, Ada Zanier, Diego Serraino, Pietro Andreone, Roberta Fenoglio, Savino Sciascia, Valter Gattei et al.
J. Clin. Med. 2022, 11(21), 6247; https://doi.org/10.3390/jcm11216247
13. "Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients"
by Hiroteru Kamimura, Hirofumi Nonaka, Masaya Mori, Taichi Kobayashi, Toru Setsu, Kenya Kamimura, Atsunori Tsuchiya and Shuji Terai
J. Clin. Med. 2022, 11(2), 387; https://doi.org/10.3390/jcm11020387
14. "Micro-Elimination of Hepatitis C among Patients with Kidney Disease by Using Electronic Reminder System—A Hospital-Based Experience"
by Pei-Yuan Su, Wei-Wen Su, Yu-Chun Hsu, Shu-Yi Wang, Ping-Fang Chiu and Hsu-Heng Yen
J. Clin. Med. 2022, 11(2), 423; https://doi.org/10.3390/jcm11020423
15. "Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients"
by Han Ah Lee, Hyun Woong Lee, Younhee Park, Hyon-Suk Kim and Yeon Seok Seo
J. Clin. Med. 2022, 11(6), 1729; https://doi.org/10.3390/jcm11061729
Access more articles:
https://www.mdpi.com/search?journal=jcm.
Call for Paper:
"Clinical Advances in Viral Hepatitis"
Guest Editor: Prof. Dr. Calvin Q. Pan
Submission Deadline: 30 September 2023
"New Advances in Management of Hepatitis B Virus (HBV) Infection"
Guest Editors: Dr. Maryam Moini and Dr. Scott K. Fung
Submission Deadline: 25 November 2023
Access more Special Issues:
https://www.mdpi.com/journal/jcm/special_issues?section_id=491&search=&sort=deadline&view=open&page_count=100.
Special Issue Book:
“Chronic HCV Infection: Clinical Advances and Eradication Perspectives”
Access more Special Issue books:
https://www.mdpi.com/books/search?type=Reprint%20Book&journal_facet=Journal%20of%20Clinical%20Medicine.
27 July 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Endocrinology & Metabolism”
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. Section “Endocrinology & Metabolism” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
Section "Endocrinology & Metabolism" follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2021 and 2022 below:
1. "Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients"
by Malgorzata Mrugacz, Anna Bryl and Katarzyna Zorena
J. Clin. Med. 2021, 10(3), 458; https://doi.org/10.3390/jcm10030458
Available online: https://www.mdpi.com/2077-0383/10/3/458
2. "The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis"
by Aleksandra Kałużna, Paweł Olczyk and Katarzyna Komosińska-Vassev
J. Clin. Med. 2022, 11(2), 400; https://doi.org/10.3390/jcm11020400
Available online: https://www.mdpi.com/2077-0383/11/2/400
3. "Advances in Osteoporotic Bone Tissue Engineering"
by Cosmin Iulian Codrea, Alexa-Maria Croitoru, Cosmin Constantin Baciu, Alina Melinescu, Denisa Ficai, Victor Fruth and Anton Ficai
J. Clin. Med. 2021, 10(2), 253; https://doi.org/10.3390/jcm10020253
Available online: https://www.mdpi.com/2077-0383/10/2/253
4. "Testosterone and Bone Health in Men: A Narrative Review"
by Kazuyoshi Shigehara, Kouji Izumi, Yoshifumi Kadono and Atsushi Mizokami
J. Clin. Med. 2021, 10(3), 530; https://doi.org/10.3390/jcm10030530
Available online: https://www.mdpi.com/2077-0383/10/3/530
5. "The Role of Extracellular Matrix Components in Inflammatory Bowel Diseases"
by Alicja Derkacz, Paweł Olczyk, Krystyna Olczyk and Katarzyna Komosinska-Vassev
J. Clin. Med. 2021, 10(5), 1122; https://doi.org/10.3390/jcm10051122
Available online: https://www.mdpi.com/2077-0383/10/5/1122
6. "Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis"
by Xiaoling Li, Nina C. Weber, Danny M. Cohn, Markus W. Hollmann, J. Hans DeVries, Jeroen Hermanides and Benedikt Preckel
J. Clin. Med. 2021, 10(11), 2419; https://doi.org/10.3390/jcm10112419
Available online: https://www.mdpi.com/2077-0383/10/11/2419
7. "Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence?"
by Lore Raets, Kaat Beunen and Katrien Benhalima
J. Clin. Med. 2021, 10(6), 1257; https://doi.org/10.3390/jcm10061257
Available online: https://www.mdpi.com/2077-0383/10/6/1257
8. "Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors"
by Agnieszka Jura-Półtorak, Anna Szeremeta, Krystyna Olczyk, Aleksandra Zoń-Giebel and Katarzyna Komosińska-Vassev
J. Clin. Med. 2021, 10(13), 2905; https://doi.org/10.3390/jcm10132905
Available online: https://www.mdpi.com/2077-0383/10/13/2905
9. "Macrophages, Low-Grade Inflammation, Insulin Resistance and Hyperinsulinemia: A Mutual Ambiguous Relationship in the Development of Metabolic Diseases"
by Gerhard Paul Püschel, Julia Klauder and Janin Henkel
J. Clin. Med. 2022, 11(15), 4358; https://doi.org/10.3390/jcm11154358
Available online: https://www.mdpi.com/2077-0383/11/15/4358
10. "The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration—A Narrative Review"
by Laura Rehak, Laura Giurato, Marco Meloni, Andrea Panunzi, Giada Maria Manti and Luigi Uccioli
J. Clin. Med. 2022, 11(3), 889; https://doi.org/10.3390/jcm11030889
Available online: https://www.mdpi.com/2077-0383/11/3/889
11. "Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes"
by Maria Mirabelli, Eusebio Chiefari, Vera Tocci, Patrizia Caroleo, Stefania Giuliano, Emanuela Greco, Raul Miguel Luque, Luigi Puccio, Daniela Patrizia Foti, Antonio Aversa et al.
J. Clin. Med. 2021, 10(5), 985; https://doi.org/10.3390/jcm10050985
Available online: https://www.mdpi.com/2077-0383/10/5/985
12. "Etiology and Diagnosis of Permanent Hypoparathyroidism after Total Thyroidectomy"
by Antonio Sitges-Serra
J. Clin. Med. 2021, 10(3), 543; https://doi.org/10.3390/jcm10030543
Available online: https://www.mdpi.com/2077-0383/10/3/543
13. "The Influence of Multidrug-Resistant Bacteria on Clinical Outcomes of Diabetic Foot Ulcers: A Systematic Review"
by Gianmarco Matta-Gutiérrez, Esther García-Morales, Yolanda García-Álvarez, Francisco Javier Álvaro-Afonso, Raúl Juan Molines-Barroso and José Luis Lázaro-Martínez
J. Clin. Med. 2021, 10(9), 1948; https://doi.org/10.3390/jcm10091948
Available online: https://www.mdpi.com/2077-0383/10/9/1948
14. "Biochemical Markers for the Diagnosis of Mitochondrial Fatty Acid Oxidation Diseases"
by Pedro Ruiz-Sala and Luis Peña-Quintana
J. Clin. Med. 2021, 10(21), 4855; https://doi.org/10.3390/jcm10214855
Available online: https://www.mdpi.com/2077-0383/10/21/4855
15. "Effect of Physical Activity, Smoking, and Sleep on Telomere Length: A Systematic Review of Observational and Intervention Studies"
by Rocío Barragán, Carolina Ortega-Azorín, Jose V. Sorlí, Eva M. Asensio, Oscar Coltell, Marie-Pierre St-Onge, Olga Portolés and Dolores Corella
J. Clin. Med. 2022, 11(1), 76; https://doi.org/10.3390/jcm11010076
Available online: https://www.mdpi.com/2077-0383/11/1/76
16. "Primary Hyperparathyroidism: A Narrative Review of Diagnosis and Medical Management"
by Karel Dandurand, Dalal S. Ali and Aliya A. Khan
J. Clin. Med. 2021, 10(8), 1604; https://doi.org/10.3390/jcm10081604
Available online: https://www.mdpi.com/2077-0383/10/8/1604
17. "MiR-126 Is an Independent Predictor of Long-Term All-Cause Mortality in Patients with Type 2 Diabetes Mellitus"
by Justyna Pordzik, Ceren Eyileten-Postuła, Daniel Jakubik, Pamela Czajka, Anna Nowak, Salvatore De Rosa, Aleksandra Gąsecka, Agnieszka Cieślicka-Kapłon, Piotr Sulikowski, Krzysztof J. Filipiak et al.
J. Clin. Med. 2021, 10(11), 2371; https://doi.org/10.3390/jcm10112371
Available online: https://www.mdpi.com/2077-0383/10/11/2371
18. "Crosstalk between Tryptophan Metabolism via Kynurenine Pathway and Carbohydrate Metabolism in the Context of Cardio-Metabolic Risk—Review"
by Małgorzata Kiluk, Janina Lewkowicz, Dariusz Pawlak and Anna Tankiewicz-Kwedlo
J. Clin. Med. 2021, 10(11), 2484; https://doi.org/10.3390/jcm10112484
Available online: https://www.mdpi.com/2077-0383/10/11/2484
19. "Changes in Body Composition Are Associated with Metabolic Changes and the Risk of Metabolic Syndrome"
by Yun Hwan Oh, Seulggie Choi, Gyeongsil Lee, Joung Sik Son, Kyae Hyung Kim and Sang Min Park
J. Clin. Med. 2021, 10(4), 745; https://doi.org/10.3390/jcm10040745
Available online: https://www.mdpi.com/2077-0383/10/4/745
20. "How to Assess Diabetic Kidney Disease Progression? From Albuminuria to GFR"
by Clara García-Carro, Ander Vergara, Sheila Bermejo, María A. Azancot, Ana I. Sánchez-Fructuoso, M. Dolores Sánchez de la Nieta, Irene Agraz and María José Soler
J. Clin. Med. 2021, 10(11), 2505; https://doi.org/10.3390/jcm10112505
Available online: https://www.mdpi.com/2077-0383/10/11/2505
27 July 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Nephrology & Urology”
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. Section “Nephrology & Urology” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
Section "Nephrology & Urology" follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2021 and 2022 below:
1. “Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients”
by Bilgin Osmanodja, Simon Ronicke, Klemens Budde, Annika Jens, Charlotte Hammett, Nadine Koch, Evelyn Seelow, Johannes Waiser, Bianca Zukunft, Friederike Bachmann et al.
J. Clin. Med. 2022, 11(9), 2565; https://doi.org/10.3390/jcm11092565
Available online: https://www.mdpi.com/2077-0383/11/9/2565
2. “Therapeutic Advances in Diabetic Nephropathy”
by Hanny Sawaf, George Thomas, Jonathan J. Taliercio, Georges Nakhoul, Tushar J. Vachharajani and Ali Mehdi
J. Clin. Med. 2022, 11(2), 378; https://doi.org/10.3390/jcm11020378
Available online: https://www.mdpi.com/2077-0383/11/2/378
3. “Negative Impact of the COVID-19 Pandemic on Kidney Disease Management—A Single-Center Experience in Romania”
by Adrian Vasile Mureșan, Eliza Russu, Emil Marian Arbănași, Réka Kaller, Ioan Hosu, Eliza Mihaela Arbănași and Septimiu Toader Voidăzan
J. Clin. Med. 2022, 11(9), 2452; https://doi.org/10.3390/jcm11092452
Available online: https://www.mdpi.com/2077-0383/11/9/2452
4. “IgA Vasculitis and IgA Nephropathy: Same Disease?”
by Evangeline Pillebout
J. Clin. Med. 2021, 10(11), 2310; https://doi.org/10.3390/jcm10112310
Available online: https://www.mdpi.com/2077-0383/10/11/2310
5. “Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin”
by Susanna Campo, Antonio Lacquaniti, Domenico Trombetta, Antonella Smeriglio and Paolo Monardo
J. Clin. Med. 2022, 11(13), 3759; https://doi.org/10.3390/jcm11133759
Available online: https://www.mdpi.com/2077-0383/11/13/3759
6. “Enhanced Recovery after Surgery: History, Key Advancements and Developments in Transplant Surgery”
by Henry John Golder and Vassilios Papalois
J. Clin. Med. 2021, 10(8), 1634; https://doi.org/10.3390/jcm10081634
Available online: https://www.mdpi.com/2077-0383/10/8/1634
7. “Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know”
by Yukako Ohyama, Matthew B. Renfrow, Jan Novak and Kazuo Takahashi
J. Clin. Med. 2021, 10(16), 3467; https://doi.org/10.3390/jcm10163467
Available online: https://www.mdpi.com/2077-0383/10/16/3467
8. “Perirenal Adipose Tissue—Current Knowledge and Future Opportunities”
by Adriana Grigoraș, Raluca Anca Balan, Irina-Draga Căruntu, Simona Eliza Giușcă, Ludmila Lozneanu, Roxana Elena Avadanei, Andreea Rusu, Laura Adriana Riscanu and Cornelia Amalinei
J. Clin. Med. 2021, 10(6), 1291; https://doi.org/10.3390/jcm10061291
Available online: https://www.mdpi.com/2077-0383/10/6/1291
9. “Targeting Oxidative Stress in Septic Acute Kidney Injury: From Theory to Practice”
by Connie P. C. Ow, Anton Trask-Marino, Ashenafi H. Betrie, Roger G. Evans, Clive N. May and Yugeesh R. Lankadeva
J. Clin. Med. 2021, 10(17), 3798; https://doi.org/10.3390/jcm10173798
Available online: https://www.mdpi.com/2077-0383/10/17/3798
10. “Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study”
by Frank-Peter Tillmann, Lars Figiel, Johannes Ricken, Hermann Still, Christoph Korte, Grete Plassmann and Philipp von Landenberg
J. Clin. Med. 2021, 10(21), 5113; https://doi.org/10.3390/jcm10215113
Available online: https://www.mdpi.com/2077-0383/10/21/5113
11. “Antibody Response to mRNA Vaccines against SARS-CoV-2 with Chronic Kidney Disease, Hemodialysis, and after Kidney Transplantation”
by Lukas Buchwinkler, Claire Anne Solagna, Janosch Messner, Markus Pirklbauer, Michael Rudnicki, Gert Mayer and Julia Kerschbaum
J. Clin. Med. 2022, 11(1), 148; https://doi.org/10.3390/jcm11010148
Available online: https://www.mdpi.com/2077-0383/11/1/148
12. “Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review”
by Adrian Martuszewski, Patrycja Paluszkiewicz, Magdalena Król, Mirosław Banasik and Marta Kepinska
J. Clin. Med. 2021, 10(2), 193; https://doi.org/10.3390/jcm10020193
Available online: https://www.mdpi.com/2077-0383/10/2/193
13. “Urinary Microbiome Characteristics in Female Patients with Acute Uncomplicated Cystitis and Recurrent Cystitis”
by Jeong-Ju Yoo, Hee Bong Shin, Ju Sun Song, Minjung Kim, Jina Yun, Zisun Kim, Yoo Min Lee, Sang Wook Lee, Kwang Woo Lee, Woong bin Kim et al.
J. Clin. Med. 2021, 10(5), 1097; https://doi.org/10.3390/jcm10051097
Available online: https://www.mdpi.com/2077-0383/10/5/1097
14. “Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment”
by Barbora Knoppova, Colin Reily, R. Glenn King, Bruce A. Julian, Jan Novak and Todd J. Green
J. Clin. Med. 2021, 10(19), 4501; https://doi.org/10.3390/jcm10194501
Available online: https://www.mdpi.com/2077-0383/10/19/4501
15. “Drug-Induced Acute Kidney Injury: A Study from the French Medical Administrative and the French National Pharmacovigilance Databases Using Capture-Recapture Method”
by Anne-Lise Rolland, Anne-Sophie Garnier, Katy Meunier, Guillaume Drablier and Marie Briet
J. Clin. Med. 2021, 10(2), 168; https://doi.org/10.3390/jcm10020168
Available online: https://www.mdpi.com/2077-0383/10/2/168
16. “Angiotensin-(1-7)—A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic”
by Samuel N. Heyman, Thomas Walther and Zaid Abassi
J. Clin. Med. 2021, 10(6), 1200; https://doi.org/10.3390/jcm10061200
Available online: https://www.mdpi.com/2077-0383/10/6/1200
17. “Effects of Probiotics, Prebiotics, and Synbiotics on Uremic Toxins, Inflammation, and Oxidative Stress in Hemodialysis Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
by Thi Thuy Uyen Nguyen, Hyeong Wan Kim and Won Kim
J. Clin. Med. 2021, 10(19), 4456; https://doi.org/10.3390/jcm10194456
Available online: https://www.mdpi.com/2077-0383/10/19/4456
18. “A Review of Current and Emerging Trends in Donor Graft-Quality Assessment Techniques”
by Natalia Warmuzińska, Kamil Łuczykowski and Barbara Bojko
J. Clin. Med. 2022, 11(3), 487; https://doi.org/10.3390/jcm11030487
Available online: https://www.mdpi.com/2077-0383/11/3/487
19. “Nomograms in Urologic Oncology: Lights and Shadows”
by Alessandro Morlacco, Daniele Modonutti, Giovanni Motterle, Francesca Martino, Fabrizio Dal Moro and Giacomo Novara
J. Clin. Med. 2021, 10(5), 980; https://doi.org/10.3390/jcm10050980
Available online: https://www.mdpi.com/2077-0383/10/5/980
20. “Podocyte Autophagy in Homeostasis and Disease”
by Qisheng Lin, Khadija Banu, Zhaohui Ni, Jeremy S. Leventhal and Madhav C. Menon
J. Clin. Med. 2021, 10(6), 1184; https://doi.org/10.3390/jcm10061184
Available online: https://www.mdpi.com/2077-0383/10/6/1184
27 July 2023
MDPI Insights: The CEO's Letter #2 - Open Peer-Review and IJERPH
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Peer Review Reports
Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.
MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.
Start and Growth of Open Peer Review at MDPI
The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.
As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.
Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.
Benefits of Open Peer Review
The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.
As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.
Impactful Research
MDPI Papers Cited in the News – IJERPH edition
Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.
During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.
Highly Cited Journal Publications
IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:
- International Journal of Environmental Research and Public Health: 3509 mentions
- Nutrients: 2698 mentions
- International Journal of Molecular Sciences: 1701 mentions
- Journal of Clinical Medicine: 1131 mentions
- Viruses: 1111 mentions
These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.
Example of Recent Mentions
During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:
The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper: “Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments”
Harvard Business Review: “How to Take Better Breaks at Work, According to Research”
IJERPH paper: “Canine-Assisted Therapy Improves Well-Being in Nurses”
National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way”
IJERPH paper: “Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease”
Inside MDPI
MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process
At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.
Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.
To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.
The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.
In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.
Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.
Read more:
Coming Together for Science
The Future of IJERPH
On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.
While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.
Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.
Journal Achievements
In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:
- Founded by Prof. Dr. Paul B. Tchounwou in 2004
- Indexed in PubMed in 2008
- Received its first Impact Factor in 2012
- Published its 5000th paper in 2017
- Over 60,000 papers published as at June 30, 2023
- 131,628,173 paper views in 2018–2022
- Over 28,000 mentions in prominent news outlets
- 17,000 papers cited 10 times or more as at June 30, 2023
- No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
- Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.
These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.
Closing Thoughts
MDPI’s Impact in Spain
During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.
Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.
The Numbers
Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).
Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.
Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.
Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.
Testimonials
I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:
Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)
Chief Executive Officer
MDPI AG
19 July 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Cardiology”
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. Section “Cardiology” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
Section "Cardiology" follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2021 and 2022 below:
1. "Epidemiological Impact of Myocarditis"
by Ainoosh Golpour, Dimitri Patriki, Paul J. Hanson, Bruce McManus and Bettina Heidecker
J. Clin. Med. 2021, 10(4), 603; https://doi.org/10.3390/jcm10040603
Available online: https://www.mdpi.com/2077-0383/10/4/603
2. "Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity"
by Andreea-Luciana Buicu, Simona Cernea, Imre Benedek, Corneliu-Florin Buicu and Theodora Benedek
J. Clin. Med. 2021, 10(8), 1545; https://doi.org/10.3390/jcm10081545
Available online: https://www.mdpi.com/2077-0383/10/8/1545
3. "Predictors and Prognostic Implications of Cardiac Arrhythmias in Patients Hospitalized for COVID-19"
by Maura M. Zylla, Uta Merle, Johannes A. Vey, Grigorios Korosoglou, Eva Hofmann, Michael Müller, Felix Herth, Werner Schmidt, Erwin Blessing, Christoph Göggelmann et al.
J. Clin. Med. 2021, 10(1), 133; https://doi.org/10.3390/jcm10010133
Available online: https://www.mdpi.com/2077-0383/10/1/133
4. "A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation"
by Grażyna Sygitowicz, Agata Maciejak-Jastrzębska and Dariusz Sitkiewicz
J. Clin. Med. 2021, 10(19), 4430; https://doi.org/10.3390/jcm10194430
Available online: https://www.mdpi.com/2077-0383/10/19/4430
5. "Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device"
by Giuseppe Boriani, Pietro Palmisano, Vincenzo Livio Malavasi, Elisa Fantecchi, Marco Vitolo, Niccolo’ Bonini, Jacopo F. Imberti, Anna Chiara Valenti, Renate B. Schnabel and Ben Freedman
J. Clin. Med. 2021, 10(4), 729; https://doi.org/10.3390/jcm10040729
Available online: https://www.mdpi.com/2077-0383/10/4/729
6. "Exercise Training in Post-COVID-19 Patients: The Need for a Multifactorial Protocol for a Multifactorial Pathophysiology"
by Gaia Cattadori, Silvia Di Marco, Massimo Baravelli, Anna Picozzi and Giuseppe Ambrosio
J. Clin. Med. 2022, 11(8), 2228; https://doi.org/10.3390/jcm11082228
Available online: https://www.mdpi.com/2077-0383/11/8/2228
7. "Clinical Characteristics, Exercise Capacity and Pulmonary Function in Post-COVID-19 Competitive Athletes"
by Klara Komici, Antonio Bianco, Fabio Perrotta, Antonio Dello Iacono, Leonardo Bencivenga, Vito D'Agnano, Aldo Rocca, Andrea Bianco, Giuseppe Rengo and Germano Guerra
J. Clin. Med. 2021, 10(14), 3053; https://doi.org/10.3390/jcm10143053
Available online: https://www.mdpi.com/2077-0383/10/14/3053
8. "Impact of COVID-19 Pandemic on Remote Monitoring of Cardiac Implantable Electronic Devices in Italy: Results of a Survey Promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing)"
by Massimiliano Maines, Pietro Palmisano, Maurizio Del Greco, Donato Melissano, Silvana De Bonis, Stella Baccillieri, Gabriele Zanotto, Antonio D’Onofrio, Renato Pietro Ricci, Roberto De Ponti et al.
J. Clin. Med. 2021, 10(18), 4086; https://doi.org/10.3390/jcm10184086
Available online: https://www.mdpi.com/2077-0383/10/18/4086
9. "The Role of Uric Acid in Acute and Chronic Coronary Syndromes"
by Alessandro Maloberti, Marco Biolcati, Giacomo Ruzzenenti, Valentina Giani, Filippo Leidi, Massimiliano Monticelli, Michela Algeri, Sara Scarpellini, Stefano Nava, Francesco Soriano et al.
J. Clin. Med. 2021, 10(20), 4750; https://doi.org/10.3390/jcm10204750
Available online: https://www.mdpi.com/2077-0383/10/20/4750
10. "Frailty in Acute and Chronic Coronary Syndrome Patients Entering Cardiac Rehabilitation"
by Francesco Giallauria, Anna Di Lorenzo, Elio Venturini, Mario Pacileo, Antonello D’Andrea, Umberto Garofalo, Felice De Lucia, Crescenzo Testa, Gianluigi Cuomo, Gabriella Iannuzzo et al.
J. Clin. Med. 2021, 10(8), 1696; https://doi.org/10.3390/jcm10081696
Available online: https://www.mdpi.com/2077-0383/10/8/1696
11. "Clinical Significance of Carotid Intima-Media Complex and Carotid Plaque Assessment by Ultrasound for the Prediction of Adverse Cardiovascular Events in Primary and Secondary Care Patients"
by Anna Kabłak-Ziembicka and Tadeusz Przewłocki
J. Clin. Med. 2021, 10(20), 4628; https://doi.org/10.3390/jcm10204628
Available online: https://www.mdpi.com/2077-0383/10/20/4628
12. "Validation of Noninvasive Remote Dielectric Sensing System to Quantify Lung Fluid Levels"
by Teruhiko Imamura, Wataru Gonoi, Masakazu Hori, Yohei Ueno, Nikhil Narang, Hiroshi Onoda, Shuhei Tanaka, Makiko Nakamura, Naoya Kataoka, Ryuichi Ushijima et al.
J. Clin. Med. 2022, 11(1), 164; https://doi.org/10.3390/jcm11010164
Available online: https://www.mdpi.com/2077-0383/11/1/164
13. "Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes"
by Michał Ząbczyk, Joanna Natorska and Anetta Undas
J. Clin. Med. 2021, 10(13), 2999; https://doi.org/10.3390/jcm10132999
Available online: https://www.mdpi.com/2077-0383/10/13/2999
14. "Diabetes Mellitus and Heart Failure"
by Filippos Triposkiadis, Andrew Xanthopoulos, Alexandra Bargiota, Takeshi Kitai, Niki Katsiki, Dimitrios Farmakis, John Skoularigis, Randall C. Starling and Efstathios Iliodromitis
J. Clin. Med. 2021, 10(16), 3682; https://doi.org/10.3390/jcm10163682
Available online: https://www.mdpi.com/2077-0383/10/16/3682
15. "Acute Coronary Syndrome in the Older Patient"
by Sergio García-Blas, Alberto Cordero, Pablo Diez-Villanueva, Maria Martinez-Avial, Ana Ayesta, Albert Ariza-Solé, Gemma Mateus-Porta, Manuel Martínez-Sellés, David Escribano, Ana Gabaldon-Perez et al.
J. Clin. Med. 2021, 10(18), 4132; https://doi.org/10.3390/jcm10184132
Available online: https://www.mdpi.com/2077-0383/10/18/4132
16. "Association between Lung Fluid Levels Estimated by Remote Dielectric Sensing Values and Invasive Hemodynamic Measurements"
by Teruhiko Imamura, Masakazu Hori, Yohei Ueno, Nikhil Narang, Hiroshi Onoda, Shuhei Tanaka, Makiko Nakamura, Naoya Kataoka, Mitsuo Sobajima, Nobuyuki Fukuda et al.
J. Clin. Med. 2022, 11(5), 1208; https://doi.org/10.3390/jcm11051208
Available online: https://www.mdpi.com/2077-0383/11/5/1208
17. "Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 2—Treatment and Prognosis"
by Francesco Santoro, Adriana Mallardi, Alessandra Leopizzi, Enrica Vitale, Elias Rawish, Thomas Stiermaier, Ingo Eitel and Natale D. Brunetti
J. Clin. Med. 2021, 10(3), 468; https://doi.org/10.3390/jcm10030468
Available online: https://www.mdpi.com/2077-0383/10/3/468
18. "Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1—Pathophysiology and Diagnosis"
by Elias Rawish, Thomas Stiermaier, Francesco Santoro, Natale D. Brunetti and Ingo Eitel
J. Clin. Med. 2021, 10(3), 479; https://doi.org/10.3390/jcm10030479
Available online: https://www.mdpi.com/2077-0383/10/3/479
19. "Coronary Microvascular Dysfunction: PET, CMR and CT Assessment"
by Elisabetta Tonet, Graziella Pompei, Evelina Faragasso, Alberto Cossu, Rita Pavasini, Giulia Passarini, Matteo Tebaldi and Gianluca Campo
J. Clin. Med. 2021, 10(9), 1848; https://doi.org/10.3390/jcm10091848
Available online: https://www.mdpi.com/2077-0383/10/9/1848
20. "Radiological Cardiothoracic Ratio in Evidence-Based Medicine"
by Krystian Truszkiewicz, Rafał Poręba and Paweł Gać
J. Clin. Med. 2021, 10(9), 2016; https://doi.org/10.3390/jcm10092016
Available online: https://www.mdpi.com/2077-0383/10/9/2016
11 July 2023
MDPI’s Newly Launched Journals in June 2023
With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.
The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.
Please feel free to browse and discover more about the new journals below.
Journal | Founding Editor-in-Chief | Journal topics (selected) |
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue | growth and development; diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article |
|
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue | DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article | |
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue | lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article | |
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue | multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article | |
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue | Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee ([email protected]) if you would like to create more new journals.
4 July 2023
Journal of Clinical Medicine Webinar | Geriatric Surgery: State of the Art, Held on 13 July 2023
On 13 July 2023, MDPI and the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) organized the webinar titled Geriatric Surgery: State of the Art.
The webinar provided a comprehensive overview of the current advancements and best practices in the field of geriatric surgery. The webinar was designed to address the unique challenges and considerations involved in surgical interventions for older adults, who are often faced with complex medical conditions and age-related physiological changes, including frailty and futility. Participants gained a deeper understanding of how to implement evidence-based practices to improve outcomes in this vulnerable patient population.
You can watch the recorded webinar at the following link: https://www.youtube.com/watch?v=vKnbDPDMyBw.
Webinar Chairs and Keynote Speakers:
- Prof. Dr. Fausto Catena (Chair), Department of General and Emergency Surgery, “M. Bufalini” Hospital, Cesena, Italy;
- Dr. Belinda De Simone (Co-Chair), 1Department of General minimally invasive surgery, Guastalla Hospital, AUSL Reggio Emilia, Reggio Emilia, Italy; 2Unit of general and bariatric surgery, Clinique St Louis, Poissy, France;
- Dr. Brian Tian, 1Department of General Surgery, Singapore General Hospital, Singapore; 2Division of Surgical Oncology, National Cancer Centre Singapore, Singapore;
- Dr. Carlo Vallicelli, Department of General, Emergency and Trauma Surgery, Maurizio Bufalini Hospital, Cesena, Italy;
- Dr. Raffaele Bova, Department of General, Emergency and Trauma Surgery, Maurizio Bufalini Hospital, Cesena, Italy.
Relevant Special Issue:
“Geriatric Surgery: State of the Art”
Guest Editor: Prof. Dr. Fausto Catena
3 July 2023
MDPI Insights: The CEO's Letter #1 - Open Access and Impactful Research
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
The Future is Open, and MDPI is Leading the Way
I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.
1 Million Published Articles
2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.
Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.
Liberating Science
As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.
In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:
"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”
Impactful Research
MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases
MDPI journals are indexed in every single top database in the world.
As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.
Continued Growth of MDPI Journals
The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.
Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.
Read more
Inside MDPI
Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science
At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.
Increased Visibility for Preprints
I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.
Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.
Read more
What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?
Coming Together for Science
The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications
In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.
Working Together
Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.
Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.
Managing Events With Sciforum
If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!
Read more
Closing Thoughts
Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang
Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team
During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.
I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.
Testimonials
If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:
“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
– Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet
Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection
Chief Executive Officer
MDPI AG
29 June 2023
Meet Us at the ESMO Congress 2023, 20–24 October 2023, Madrid, Spain
MDPI will attend the ESMO Congress 2023 as an exhibitor. This conference will be held in Madrid, Spain, from 20 to 24 October 2023.
The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. They will disseminate the latest cutting-edge data, provide high-quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.
The following MDPI journals will be represented:
- Cancers;
- JCM;
- Cells;
- Diagnostics;
- Medical Sciences;
- Biomedicines;
- Geriatrics;
- Current Oncology;
- Hemato;
- Onco;
- CIMB;
- Healthcare.
If you are attending this conference, please feel free to start a conversation with us at our booth #724. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://www.esmo.org/meeting-calendar/esmo-congress-2023.
28 June 2023
2022 Impact Factors for MDPI Journals
The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:
We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.
Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."
Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.
Journal | Impact Factor | Rank Quartile | Category |
Vaccines | 7.8 | Q1 | Immunology |
Medicine, Research & Experimental | |||
Antioxidants | 7.0 | Q1 | Food Science & Technology |
Biochemistry & Molecular Biology | |||
Chemistry, Medicinal | |||
Cells | 6.0 | Q2 | Cell Biology |
Nutrients | 5.9 | Q1 | Nutrition & Dietetics |
International Journal of Molecular Sciences | 5.6 | Q1 | Biochemistry & Molecular Biology |
Q2 | Chemistry, Multidisciplinary | ||
Journal of Theoretical and Applied Electronic Commerce Research | 5.6 | Q2 | Business |
Biomolecules | 5.5 | Q1 | Biochemistry & Molecular Biology |
Biosensors | 5.4 | Q1 | Chemistry, Analytical |
Instruments & Instrumentation | |||
Q2 | Nanoscience & Nanotechnology | ||
Fractal and Fractional | 5.4 | Q1 | Mathematics, Interdisciplinary Applications |
Marine Drugs | 5.4 | Q1 | Chemistry, Medicinal |
Pharmacology & Pharmacy | |||
Pharmaceutics | 5.4 | Q1 | Pharmacology & Pharmacy |
Nanomaterials | 5.3 | Q1 | Physics, Applied |
Q2 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Nanoscience & Nanotechnology | |||
Cancers | 5.2 | Q2 | Oncology |
Foods | 5.2 | Q1 | Food Science & Technology |
Polymers | 5.0 | Q1 | Polymer Science |
Remote Sensing | 5.0 | Q1 | Geosciences, Multidisciplinary |
Q2 | Remote Sensing | ||
Imaging Science & Photographic Technology | |||
Environmental Sciences | |||
Antibiotics | 4.8 | Q1 | Pharmacology & Pharmacy |
Q2 | Infectious Diseases | ||
Drones | 4.8 | Q2 | Remote Sensing |
Journal of Functional Biomaterials | 4.8 | Q2 | Engineering, Biomedical |
Materials Science, Biomaterials | |||
Biomedicines | 4.7 | Q1 | Pharmacology & Pharmacy |
Q2 | Biochemistry & Molecular Biology | ||
Medicine, Research & Experimental | |||
Journal of Fungi | 4.7 | Q2 | Mycology |
Microbiology | |||
Viruses | 4.7 | Q2 | Virology |
Bioengineering | 4.6 | Q2 | Engineering, Biomedical |
Gels | 4.6 | Q1 | Polymer Science |
Molecules | 4.6 | Q2 | Chemistry, Multidisciplinary |
Biochemistry & Molecular Biology | |||
Pharmaceuticals | 4.6 | Q2 | Pharmacology & Pharmacy |
Chemistry, Medicinal | |||
Toxics | 4.6 | Q1 | Toxicology |
Q2 | Environmental Sciences | ||
Biomimetics | 4.5 | Q1 | Engineering, Multidisciplinary |
Q2 | Materials Science, Biomaterials | ||
Microorganisms | 4.5 | Q2 | Microbiology |
Plants | 4.5 | Q1 | Plant Sciences |
Biology | 4.2 | Q2 | Biology |
Chemosensors | 4.2 | Q2 | Instruments & Instrumentation |
Chemistry, Analytical | |||
Electrochemistry | |||
Membranes | 4.2 | Q2 | Engineering, Chemical |
Materials Science, Multidisciplinary | |||
Chemistry, Physical | |||
Polymer Science | |||
Toxins | 4.2 | Q1 | Toxicology |
Q2 | Food Science & Technology | ||
Metabolites | 4.2 | Q2 | Biochemistry & Molecular Biology |
Batteries | 4.0 | Q2 | Electrochemistry |
Materials Science, Multidisciplinary | |||
Q3 | Energy & Fuels | ||
Catalysts | 3.9 | Q2 | Chemistry, Physical |
Journal of Clinical Medicine | 3.9 | Q2 | Medicine, General & Internal |
Land | 3.9 | Q2 | Environmental Studies |
Sensors | 3.9 | Q2 | Instruments & Instrumentation |
Chemistry, Analytical | |||
Engineering, Electrical & Electronic | |||
Sustainability | 3.9 | Q2 | Environmental Sciences (SCIE) |
Environmental Studies (SSCI) | |||
Q3 | Green & Sustainable Science & Technology (SCIE) | ||
Green & Sustainable Science & Technology (SSCI) | |||
Buildings | 3.8 | Q2 | Construction & Building Technology |
Engineering, Civil | |||
Agronomy | 3.7 | Q1 | Agronomy |
Q2 | Plant Sciences | ||
Fermentation | 3.7 | Q2 | Biotechnology & Applied Microbiology |
Pathogens | 3.7 | Q2 | Microbiology |
Agriculture | 3.6 | Q1 | Agronomy |
Diagnostics | 3.6 | Q2 | Medicine, General & Internal |
Genes | 3.5 | Q2 | Genetics & Heredity |
Journal of Intelligence | 3.5 | Q2 | Psychology, Multidisciplinary |
Lubricants | 3.5 | Q2 | Engineering, Mechanical |
Processes | 3.5 | Q2 | Engineering, Chemical |
Coatings | 3.4 | Q2 | Materials Science, Coatings & Films |
Physics, Applied | |||
Q3 | Materials Science, Multidisciplinary | ||
ISPRS International Journal of Geo-Information | 3.4 | Q2 | Geography, Physical |
Q3 | Computer Science, Information Systems | ||
Remote Sensing | |||
Materials | 3.4 | Q2 | Metallurgy & Metallurgical Engineering |
Physics, Applied | |||
Physics, Condensed Matter | |||
Q3 | Materials Science, Multidisciplinary | ||
Chemistry, Physical | |||
Micromachines | 3.4 | Q2 | Instruments & Instrumentation |
Physics, Applied | |||
Chemistry, Analytical | |||
Q3 | Nanoscience & Nanotechnology | ||
Water | 3.4 | Q2 | Water Resources |
Environmental Sciences | |||
Brain Sciences | 3.3 | Q3 | Neurosciences |
Energies | 3.2 | Q3 | Energy & Fuels |
Fire | 3.2 | Q1 | Forestry |
Q2 | Ecology | ||
Life | 3.2 | Q2 | Biology |
Current Issues in Molecular Biology | 3.1 | Q3 | Biochemistry & Molecular Biology |
Horticulturae | 3.1 | Q1 | Horticulture |
Animals | 3.0 | Q1 | Agriculture, Dairy & Animal Science |
Veterinary Sciences | |||
Insects | 3.0 | Q1 | Entomology |
Atmosphere | 2.9 | Q3 | Meteorology & Atmospheric Sciences |
Environmental Sciences | |||
Electronics | 2.9 | Q2 | Engineering, Electrical & Electronic |
Physics, Applied | |||
Q3 | Computer Science, Information Systems | ||
Forests | 2.9 | Q1 | Forestry |
Inorganics | 2.9 | Q2 | Chemistry, Inorganic & Nuclear |
Journal of Marine Science and Engineering | 2.9 | Q1 | Engineering, Marine |
Q2 | Oceanography | ||
Engineering, Ocean | |||
Metals | 2.9 | Q2 | Metallurgy & Metallurgical Engineering |
Q3 | Materials Science, Multidisciplinary | ||
Tropical Medicine and Infectious Disease | 2.9 | Q2 | Tropical Medicine |
Parasitology | |||
Q3 | Infectious Diseases | ||
Universe | 2.9 | Q2 | Astronomy & Astrophysics |
Physics, Particles & Fields | |||
Healthcare | 2.8 | Q2 | Health Policy & Services (SSCI) |
Q3 | Health Care Sciences & Services (SCIE) | ||
Applied Sciences | 2.7 | Q2 | Engineering, Multidisciplinary |
Physics, Applied | |||
Q3 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Crystals | 2.7 | Q2 | Crystallography |
Q3 | Materials Science, Multidisciplinary | ||
Entropy | 2.7 | Q2 | Physics, Multidisciplinary |
Magnetochemistry | 2.7 | Q2 | Chemistry, Inorganic & Nuclear |
Q3 | Chemistry, Physical | ||
Materials Science, Multidisciplinary | |||
Symmetry | 2.7 | Q2 | Multidisciplinary Sciences |
Actuators | 2.6 | Q2 | Instruments & Instrumentation |
Engineering, Mechanical | |||
Aerospace | 2.6 | Q1 | Engineering, Aerospace |
Behavioral Sciences | 2.6 | Q2 | Psychology, Multidisciplinary |
Current Oncology | 2.6 | Q3 | Oncology |
Machines | 2.6 | Q2 | Engineering, Mechanical |
Q3 | Engineering, Electrical & Electronic | ||
Medicina | 2.6 | Q3 | Medicine, General & Internal |
Separations | 2.6 | Q3 | Chemistry, Analytical |
Minerals | 2.5 | Q2 | Mining & Mineral Processing |
Mineralogy | |||
Geochemistry & Geophysics | |||
Children | 2.4 | Q2 | Pediatrics |
Diversity | 2.4 | Q2 | Biodiversity Conservation |
Q3 | Ecology | ||
Journal of Cardiovascular Development and Disease | 2.4 | Q3 | Cardiac & Cardiovascular Systems |
Mathematics | 2.4 | Q1 | Mathematics |
Photonics | 2.4 | Q3 | Optics |
Veterinary Sciences | 2.4 | Q1 | Veterinary Sciences |
Fishes | 2.3 | Q2 | Marine & Freshwater Biology |
Fisheries | |||
Axioms | 2.0 | Q2 | Mathematics, Applied |
Systems | 1.9 | Q2 | Social Sciences, Interdisciplinary |
Tomography | 1.9 | Q3 | Radiology, Nuclear Medicine & Medical Imaging |
Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.
Source: 2022 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2023)
27 June 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI, where you have free and unlimited access to the full text of all of the published articles. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on article processing charges.
JCM covers all topics related to clinical and pre-clinical practices and is dedicated to publishing high-quality original research, reviews or perspectives on clinical practice. We invite you to read our most cited papers published in 2021:
1. "Volatile Organic Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD"
by Ileana Andreea Ratiu, Tomasz Ligor, Victor Bocos-Bintintan, Chris A Mayhew and Bogusław Buszewski
J. Clin. Med. 2021, 10(1), 32; https://doi.org/10.3390/jcm10010032
Available online: https://www.mdpi.com/2077-0383/10/1/32
2. "Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review"
by Athanasios D. Anastasilakis, Polyzois Makras, Maria P. Yavropoulou, Gaia Tabacco, Anda Mihaela Naciu and Andrea Palermo
J. Clin. Med. 2021, 10(1), 152; https://doi.org/10.3390/jcm10010152
Available online: https://www.mdpi.com/2077-0383/10/1/152
3. "Proposal of the Definition for COVID-19-Associated Coagulopathy"
by Toshiaki Iba, Theodore E. Warkentin, Jecko Thachil, Marcel Levi and Jerrold H. Levy
J. Clin. Med. 2021, 10(2), 191; https://doi.org/10.3390/jcm10020191
Available online: https://www.mdpi.com/2077-0383/10/2/191
4. "Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection"
by Julien Favresse, Constant Gillot, Maxime Oliveira, Julie Cadrobbi, Marc Elsen, Christine Eucher, Kim Laffineur, Catherine Rosseels, Sandrine Van Eeckhoudt, Jean-Baptiste Nicolas et al.
J. Clin. Med. 2021, 10(2), 265; https://doi.org/10.3390/jcm10020265
Available online: https://www.mdpi.com/2077-0383/10/2/265
5. "Oxidative Stress and Inflammation Biomarker Expression in Obstructive Sleep Apnea Patients"
by Antonino Maniaci, Giannicola Iannella, Salvatore Cocuzza, Claudio Vicini, Giuseppe Magliulo, Salvatore Ferlito, Giovanni Cammaroto, Giuseppe Meccariello, Andrea De Vito, Alice Nicolai et al.
J. Clin. Med. 2021, 10(2), 277; https://doi.org/10.3390/jcm10020277
Available online: https://www.mdpi.com/2077-0383/10/2/277
6. "The Impact of COVID-19 Pandemic and Lockdown Measures on Quality of Life among Italian General Population"
by Maria Stella Epifanio, Federica Andrei, Giacomo Mancini, Francesca Agostini, Marco Andrea Piombo, Vittoria Spicuzza, Martina Riolo, Gioacchino Lavanco, Elena Trombini and Sabina La Grutta
J. Clin. Med. 2021, 10(2), 289; https://doi.org/10.3390/jcm10020289
Available online: https://www.mdpi.com/2077-0383/10/2/289
7. "Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity"
by Trinidad Montero-Vilchez, María-Victoria Segura-Fernández-Nogueras, Isabel Pérez-Rodríguez, Miguel Soler-Gongora, Antonio Martinez-Lopez, Ana Fernández-González, Alejandro Molina-Leyva and Salvador Arias-Santiago
J. Clin. Med. 2021, 10(2), 359; https://doi.org/10.3390/jcm10020359
Available online: https://www.mdpi.com/2077-0383/10/2/359
8. "Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study"
by Daniele Roberto Giacobbe, Denise Battaglini, Elisa Martina Enrile, Chiara Dentone, Antonio Vena, Chiara Robba, Lorenzo Ball, Michele Bartoletti, Irene Coloretti, Stefano Di Bella et al.
J. Clin. Med. 2021, 10(4), 555; https://doi.org/10.3390/jcm10040555
Available online: https://www.mdpi.com/2077-0383/10/4/555
9. "Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes"
by Byung-Chul Lee, Insung Kang and Kyung-Rok Yu
J. Clin. Med. 2021, 10(4), 711; https://doi.org/10.3390/jcm10040711
Available online: https://www.mdpi.com/2077-0383/10/4/711
10. "Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic"
by Abanoub Riad, Andrea Pokorná, Sameh Attia, Jitka Klugarová, Michal Koščík and Miloslav Klugar
J. Clin. Med. 2021, 10(7), 1428; https://doi.org/10.3390/jcm10071428
Available online: https://www.mdpi.com/2077-0383/10/7/1428
11. "Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure"
by Marc E. Wolf, Beate Luz, Ludwig Niehaus, Pervinder Bhogal, Hansjörg Bäzner and Hans Henkes
J. Clin. Med. 2021, 10(8), 1599; https://doi.org/10.3390/jcm10081599
Available online: https://www.mdpi.com/2077-0383/10/8/1599
12. "Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey"
by Abanoub Riad, Derya Sağıroğlu, Batuhan Üstün, Andrea Pokorná, Jitka Klugarová, Sameh Attia and Miloslav Klugar
J. Clin. Med. 2021, 10(12), 2629; https://doi.org/10.3390/jcm10122629
Available online: https://www.mdpi.com/2077-0383/10/12/2629
13. "Demographic and Clinical Overview of Hospitalized COVID-19 Patients during the First 17 Months of the Pandemic in Poland"
by Robert Flisiak, Piotr Rzymski, Dorota Zarębska-Michaluk, Magdalena Rogalska, Marta Rorat, Piotr Czupryna, Beata Lorenc, Przemysław Ciechanowski, Dorota Kozielewicz, Anna Piekarska et al.
J. Clin. Med. 2022, 11(1), 117; https://doi.org/10.3390/jcm11010117
Available online: https://www.mdpi.com/2077-0383/11/1/117
14. "Relative Reproduction Number of SARS-CoV-2 Omicron (B.1.1.529) Compared with Delta Variant in South Africa"
by Hiroshi Nishiura, Kimihito Ito, Asami Anzai, Tetsuro Kobayashi, Chayada Piantham and Alfonso J. Rodríguez-Morales
J. Clin. Med. 2022, 11(1), 30; https://doi.org/10.3390/jcm11010030
Available online: https://www.mdpi.com/2077-0383/11/1/30
15. "The Role of Antioxidants on Wound Healing: A Review of the Current Evidence"
by Inés María Comino-Sanz, María Dolores López-Franco, Begoña Castro and Pedro Luis Pancorbo-Hidalgo
J. Clin. Med. 2021, 10(16), 3558; https://doi.org/10.3390/jcm10163558
Available online: https://www.mdpi.com/2077-0383/10/16/3558
16. "Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future"
by Jo Nijs, Astrid Lahousse, Eleni Kapreli, Paraskevi Bilika, İsmail Saraçoğlu, Anneleen Malfliet, Iris Coppieters, Liesbet De Baets, Laurence Leysen, Eva Roose et al.
J. Clin. Med. 2021, 10(15), 3203; https://doi.org/10.3390/jcm10153203
Available online: https://www.mdpi.com/2077-0383/10/15/3203
17. "The Impact of Dental Implant Surface Modifications on Osseointegration and Biofilm Formation"
by Stefanie Kligman, Zhi Ren, Chun-Hsi Chung, Michael Angelo Perillo, Yu-Cheng Chang, Hyun Koo, Zhong Zheng and Chenshuang Li
J. Clin. Med. 2021, 10(8), 1641; https://doi.org/10.3390/jcm10081641
Available online: https://www.mdpi.com/2077-0383/10/8/1641
18. "The Exoscope in Neurosurgery: An Overview of the Current Literature of Intraoperative Use in Brain and Spine Surgery"
by Nicola Montemurro, Alba Scerrati, Luca Ricciardi and Gianluca Trevisi
J. Clin. Med. 2022, 11(1), 223; https://doi.org/10.3390/jcm11010223
Available online: https://www.mdpi.com/2077-0383/11/1/223
19. "Therapeutic Advances in Diabetic Nephropathy"
by Hanny Sawaf, George Thomas, Jonathan J. Taliercio, Georges Nakhoul, Tushar J. Vachharajani and Ali Mehdi
J. Clin. Med. 2022, 11(2), 378; https://doi.org/10.3390/jcm11020378
Available online: https://www.mdpi.com/2077-0383/11/2/378
20. "The Association between Early-Life Gut Microbiota and Long-Term Health and Diseases"
by Anujit Sarkar, Ji Youn Yoo, Samia Valeria Ozorio Dutra, Katherine H. Morgan and Maureen Groer
J. Clin. Med. 2021, 10(3), 459; https://doi.org/10.3390/jcm10030459
Available online: https://www.mdpi.com/2077-0383/10/3/459
21. "Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge"
by Modesto M. Maestre-Muñiz, Ángel Arias, Emilia Mata-Vázquez, María Martín-Toledano, Germán López-Larramona, Ana María Ruiz-Chicote, Bárbara Nieto-Sandoval and Alfredo J. Lucendo
J. Clin. Med. 2021, 10(13), 2945; https://doi.org/10.3390/jcm10132945
Available online: https://www.mdpi.com/2077-0383/10/13/2945
22. "The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro"
by Niko Kohmer, Tuna Toptan, Christiane Pallas, Onur Karaca, Annika Pfeiffer, Sandra Westhaus, Marek Widera, Annemarie Berger, Sebastian Hoehl, Martin Kammel et al.
J. Clin. Med. 2021, 10(2), 328; https://doi.org/10.3390/jcm10020328
Available online: https://www.mdpi.com/2077-0383/10/2/328
23. "Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations"
by Vikram Thakur, Radha Kanta Ratho, Pradeep Kumar, Shashi Kant Bhatia, Ishani Bora, Gursimran Kaur Mohi, Shailendra K Saxena, Manju Devi, Dhananjay Yadav and Sanjeet Mehariya
J. Clin. Med. 2021, 10(3), 446; https://doi.org/10.3390/jcm10030446
Available online: https://www.mdpi.com/2077-0383/10/3/446
27 June 2023
Journal of Clinical Medicine | Highly Cited Papers in 2022
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI, where you have free and unlimited access to the full text of all of the published articles. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on article processing charges.
JCM covers all topics related to clinical and pre-clinical practices and is dedicated to publishing high-quality original research, reviews or perspectives on clinical practice. We invite you to read our most cited papers published in 2022 below:
1. "Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study"
by César Fernández-de-las-Peñas, José D. Martín-Guerrero, Óscar J. Pellicer-Valero, Esperanza Navarro-Pardo, Víctor Gómez-Mayordomo, María L. Cuadrado, José A. Arias-Navalón, Margarita Cigarán-Méndez, Valentín Hernández-Barrera and Lars Arendt-Nielsen
J. Clin. Med. 2022, 11(2), 413; https://doi.org/10.3390/jcm11020413
Available online: https://www.mdpi.com/2077-0383/11/2/413
2. "XR (Extended Reality: Virtual Reality, Augmented Reality, Mixed Reality) Technology in Spine Medicine: Status Quo and Quo Vadis"
by Tadatsugu Morimoto, Takaomi Kobayashi, Hirohito Hirata, Koji Otani, Maki Sugimoto, Masatsugu Tsukamoto, Tomohito Yoshihara, Masaya Ueno and Masaaki Mawatari
J. Clin. Med. 2022, 11(2), 470; https://doi.org/10.3390/jcm11020470
Available online: https://www.mdpi.com/2077-0383/11/2/470
3. "Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices"
by Oksana Volod, Connor M. Bunch, Nuha Zackariya, Ernest E. Moore, Hunter B. Moore, Hau C. Kwaan, Matthew D. Neal, Mahmoud D. Al-Fadhl, Shivani S. Patel, Grant Wiarda et al.
J. Clin. Med. 2022, 11(3), 860; https://doi.org/10.3390/jcm11030860
Available online: https://www.mdpi.com/2077-0383/11/3/860
4. "Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis"
by Giuseppe Maglietta, Francesca Diodati, Matteo Puntoni, Silvia Lazzarelli, Barbara Marcomini, Laura Patrizi and Caterina Caminiti
J. Clin. Med. 2022, 11(6), 1541; https://doi.org/10.3390/jcm11061541
Available online: https://www.mdpi.com/2077-0383/11/6/1541
5. "Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update"
by Paolo Pelosi, Roberto Tonelli, Chiara Torregiani, Elisa Baratella, Marco Confalonieri, Denise Battaglini, Alessandro Marchioni, Paola Confalonieri, Enrico Clini, Francesco Salton et al.
J. Clin. Med. 2022, 11(6), 1704; https://doi.org/10.3390/jcm11061704
Available online: https://www.mdpi.com/2077-0383/11/6/1704
6. "Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients"
by Bilgin Osmanodja, Simon Ronicke, Klemens Budde, Annika Jens, Charlotte Hammett, Nadine Koch, Evelyn Seelow, Johannes Waiser, Bianca Zukunft, Friederike Bachmann et al.
J. Clin. Med. 2022, 11(9), 2565; https://doi.org/10.3390/jcm11092565
Available online: https://www.mdpi.com/2077-0383/11/9/2565
7. "Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS"
by Francesco Salton, Paola Confalonieri, Giuseppina Campisciano, Rossella Cifaldi, Clara Rizzardi, Daniele Generali, Riccardo Pozzan, Stefano Tavano, Chiara Bozzi, Giulia Lapadula et al.
J. Clin. Med. 2022, 11(11), 2951; https://doi.org/10.3390/jcm11112951
Available online: https://www.mdpi.com/2077-0383/11/11/2951
8. "Efficacy of Oxybrasion in the Treatment of Acne Vulgaris: A Preliminary Report"
by Karolina Chilicka, Aleksandra M. Rogowska, Renata Szyguła, Monika Rusztowicz and Danuta Nowicka
J. Clin. Med. 2022, 11(13), 3824; https://doi.org/10.3390/jcm11133824
Available online: https://www.mdpi.com/2077-0383/11/13/3824
9. "Efficacy of Hydrogen Purification and Cosmetic Acids in the Treatment of Acne Vulgaris: A Preliminary Report"
by Karolina Chilicka, Monika Rusztowicz, Aleksandra M. Rogowska, Renata Szyguła, Binnaz Asanova and Danuta Nowicka
J. Clin. Med. 2022, 11(21), 6269; https://doi.org/10.3390/jcm11216269
Available online: https://www.mdpi.com/2077-0383/11/21/6269
10. "The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis"
by Aleksandra Kałużna, Paweł Olczyk and Katarzyna Komosińska-Vassev
J. Clin. Med. 2022, 11(2), 400; https://doi.org/10.3390/jcm11020400
Available online: https://www.mdpi.com/2077-0383/11/2/400
11. "Long-Term Outcomes of Implants Placed in Maxillary Sinus Floor Augmentation with Porous Fluorohydroxyapatite (Algipore® FRIOS®) in Comparison with Anorganic Bovine Bone (Bio-Oss®) and Platelet Rich Plasma (PRP): A Retrospective Study"
by Biagio Rapone, Alessio Danilo Inchingolo, Stefano Trasarti, Elisabetta Ferrara, Erda Qorri, Antonio Mancini, Nicola Montemurro, Antonio Scarano, Angelo Michele Inchingolo, Gianna Dipalma et al.
J. Clin. Med. 2022, 11(9), 2491; https://doi.org/10.3390/jcm11092491
Available online: https://www.mdpi.com/2077-0383/11/9/2491
12. "Exercise Training in Post-COVID-19 Patients: The Need for a Multifactorial Protocol for a Multifactorial Pathophysiology"
by Gaia Cattadori, Silvia Di Marco, Massimo Baravelli, Anna Picozzi and Giuseppe Ambrosio
J. Clin. Med. 2022, 11(8), 2228; https://doi.org/10.3390/jcm11082228
Available online: https://www.mdpi.com/2077-0383/11/8/2228
13. "The Risk of Spontaneous Abortion Does Not Increase Following First Trimester mRNA COVID-19 Vaccination"
by Ioana Mihaela Citu, Cosmin Citu, Florin Gorun, Ioan Sas, Felix Bratosin, Andrei Motoc, Bogdan Burlea, Ovidiu Rosca, Daniel Malita and Oana Maria Gorun
J. Clin. Med. 2022, 11(6), 1698; https://doi.org/10.3390/jcm11061698
Available online: https://www.mdpi.com/2077-0383/11/6/1698
14. "Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis"
by Kin Israel Notarte, Maria Helena Santos de Oliveira, Princess Juneire Peligro, Jacqueline Veronica Velasco, Imee Macaranas, Abbygail Therese Ver, Flos Carmeli Pangilinan, Adriel Pastrana, Nathaniel Goldrich, David Kavteladze et al.
J. Clin. Med. 2022, 11(24), 7314; https://doi.org/10.3390/jcm11247314
Available online: https://www.mdpi.com/2077-0383/11/24/7314
15. "Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems"
by Valeria Visco, Carolina Vitale, Antonella Rispoli, Carmine Izzo, Nicola Virtuoso, Germano Junior Ferruzzi, Mario Santopietro, Americo Melfi, Maria Rosaria Rusciano, Angelantonio Maglio et al.
J. Clin. Med. 2022, 11(3), 524; https://doi.org/10.3390/jcm11030524
Available online: https://www.mdpi.com/2077-0383/11/3/524
16. "The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease"
by Eliza Russu, Adrian Vasile Mureșan, Emil Marian Arbănași, Réka Kaller, Ioan Hosu, Septimiu Voidăzan, Eliza Mihaela Arbănași and Cătălin Mircea Coșarcă
J. Clin. Med. 2022, 11(9), 2620; https://doi.org/10.3390/jcm11092620
Available online: https://www.mdpi.com/2077-0383/11/9/2620
17. "Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients"
by Matteo Regolo, Mauro Vaccaro, Alessandra Sorce, Benedetta Stancanelli, Michele Colaci, Giuseppe Natoli, Mario Russo, Innocenza Alessandria, Massimo Motta, Nicola Santangelo et al.
J. Clin. Med. 2022, 11(8), 2235; https://doi.org/10.3390/jcm11082235
Available online: https://www.mdpi.com/2077-0383/11/8/2235
15 June 2023
Meet Us at the Annual Meeting of American Psychological Association 2023 (APA 2023), 3–5 August 2023, Washington DC, USA
MDPI will attend the Annual Meeting of American Psychological Association 2023 (APA 2023) as an exhibitor. This meeting will be held in Washington DC, USA, from 3 to 5 August 2023.
The Annual Meeting of American Psychological Association is organized by the American Psychological Association annually. The American Psychological Association is the largest scientific and professional organization of psychologists in the United States, with over 146,000 members, including scientists, educators, clinicians, consultants, and students. APA 2023 will provide in-person engagement with psychology professionals (practitioners, researchers, scientists, academicians, students, and others) who seek solutions to the work challenges that they face within the field.
The following MDPI journals will be represented:
- Behavioral Sciences;
- J. Intell.;
- EJIHPE;
- Healthcare;
- JCM;
- Social Sciences;
- Psychoactives;
- Psych;
- Children;
- Psychiatry International.
If you are attending this conference, please feel free to start a conversation with us at our booth #244. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://convention.apa.org/.
13 June 2023
Journal of Clinical Medicine Receives an Increased CiteScore of 5.4
We are pleased to inform you that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has received an updated CiteScore of 5.4, which is an increase of 22% compared with the 2021 metric. The 2022 CiteScore™ was recently released, and it assesses the scientific influence of journals in the 2019 to 2022 period. JCM’s CiteScore ranks Q1 (137 out of 830) in the "General Medicine" category.
To learn more about journal statistics, please visit https://www.mdpi.com/journal/jcm/stats.
Excellent performance is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We would like to take this opportunity to thank all of you who have contributed to the journal.
7 June 2023
Meet Us at the WASOG 2023 Conference, 19–21 June 2023, Stockholm, Sweden
Conference: WASOG 2023
Organization: The World Association of Sarcoidosis and Other Granulomatous Disorders
Date: 19–21 June 2023
Place: Aula Medica, Karolinska Institutet, Stockholm, Sweden
Booth: #7
MDPI will be attending the WASOG 2023 conference, which will be held from 19 to 21 June 2023 at Aula Medica, Karolinska Institutet, Stockholm, Sweden.
WASOG 2023 will offer a creative meeting ground for investigating how novel experimental, theoretical and computational approaches in Sarcoidosis and Interstitial Lung Diseases (ILDs) can improve our understanding of their underlying disease mechanisms. It aims to build an even stronger scientific bridge between different sectors, ultimately closing the knowledge gap and accelerating the development and spread of precision medicine in ILDs.
The following MDPI journals will be represented:
- Biomedicines;
- Clinics and Practice;
- Diagnostics;
- Diseases;
- Genes;
- Healthcare;
- Hematology Reports;
- IJTM;
- JCM;
- Medicines;
- Reports.
Please reach out ([email protected]) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.
For more information about the conference, please visit the following website: https://mkon.nu/wasog2023.
25 May 2023
Meet Us at the 60th European Renal Association (ERA) Congress, 15–17 June 2023, Milan, Italy
Conference: 60th European Renal Association (ERA) Congress
Date: 15–17 June 2023
Location: Milan, Italy
MDPI will be attending the 60th ERA Congress as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference is being organized by the European Renal Association, and it will offer a clearly structured scientific program, combining presentations of cutting-edge research with a broad view of the currently most relevant fields in the prevention, detection, and treatment of kidney disease. At the conference, specialists will share knowledge on the clinical assessment and treatments of renal diseases to improve disease prevention and patients’ quality of life.
The following MDPI journals will be represented:
- JCM;
- JPM;
- Kidney and Dialysis;
- Diagnostics;
- Clinics and Practice;
- Uro;
- Cells;
- BioChem;
- Transplantology.
17 May 2023
Interview with Dr. Jan Bednarsch—Winner of the JCM 2022 Young Investigator Award
We are pleased to announce the winner of the JCM 2022 Young Investigator Award—Dr. Jan Bednarsch.
Name: Dr. Jan Bednarsch
Affiliation: Charité – Universitätsmedizin Berlin, Berlin, Germany
Research Interests: colorectal liver metastases, cholangiocellular carcinoma, hepatocellular carcinoma, liver surgery, pancreatic ductal adenocarcinoma, and pancreas surgery
We would like to thank the award committee for selecting one winner from a large number of exceptional candidates, Dr. Jan Bednarsch. We will continue to reward scholars with the Young Investigator Award to express our acknowledgment of their support for the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). We wish them every success in their careers.
The following is a short interview with Dr. Jan Bednarsch:
- Could you briefly introduce yourself and your current research to our readers?
My name is Jan Bednarsch and I am a consultant surgeon and clinical scientist at RWTH Aachen University in Germany. I studied at Charité University Berlin in Germany, where I also obtained my doctoral degree as a result of clinical research conducted during my time in medical school. Later, I did my surgical training at RWTH Aachen University. Here, I also continued to pursue my research interests in clinical medicine and translational oncology with a focus on surgery. In these terms, I am working on clinical studies (including randomized trials) in hepatobiliary surgery and translational research in cholangiocellular carcinoma, exploring biomarkers and various other topics.
- Why did you choose the current research topic? What attracted you to work on it?
I always had a strong interest in surgery and the theoretical basis of it. Furthermore, I was also very interested in oncology in combination with surgery. Therefore, general surgery with a focus on hepato-biliary-pancreatic surgery seemed like a logical choice for me. As my research interests matched my clinical interests, I enjoy researching topics that have a direct influence on actual clinical work. The thing that most drives me to investigate clinical or translational topics is that the results can immediately be transferred into patient treatment and subsequently improve outcomes or facilitate decision making. Thus, the idea to improve surgical treatment for cancer patients keeps fascinating me and attracts me to continuously work on it.
- How did you overcome difficulties while conducting research?
Being a clinician scientist, time is my most limited resource. One key to success is subsequently developing time efficiency to integrate research time into the “regular” workload as a surgeon working in a large center. It is also essential to work in well-organized interdisciplinary teams as it is not possible to do all the work by oneself. Building an infrastructure that helps to work efficiently, balancing time investment with meaningful scientific output, was therefore most important for me. Additionally, I strongly advise young researchers to collaborate with dedicated scientists from other disciplines, which helps to develop new ideas and approaches. Additionally, organizational support in terms of internal funding, providing opportunities, and off-time is essential to overcoming natural difficulties.
- What is your opinion of the open access model of publishing?
In my mind, open access should be the preferred method of choice when publishing because it gives instant access to publications for researchers all over the world. It is therefore the most democratic and efficient way to distribute research.
- As the winner of this award, is there anything you would like to express?
I, of course, would like to express my gratitude to the Award Committee for their support of my work as well as to the editorial team of the Journal of Clinical Medicine for the excellent and professional handling of research work submitted to them. As such, I can encourage any scientist to consider the Journal of Clinical Medicine for their valuable research.
16 May 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Epidemiology & Public Health”
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on article processing charges. The Section “Epidemiology & Public Health” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing global health and medicine, with the goal of creating a global health information source focused on clinical practice.
The Section "Epidemiology & Public Health" follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full text of all of the published articles. We invite you to read our most cited papers published in 2021 and 2022 below:
- “Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?”
by Viviana Manzulli, Giulia Scioscia, Giulio Giganti, Maria Rosaria Capobianchi, Donato Lacedonia, Lorenzo Pace, Dora Cipolletta, Pasquale Tondo, Rosella De Nittis, Valeria Rondinone et al.
Clin. Med. 2021, 10(2), 309; https://doi.org/10.3390/jcm10020309
Available online: https://www.mdpi.com/2077-0383/10/2/309
- “AI and Big Data in Healthcare: Towards a More Comprehensive Research Framework for Multimorbidity”
by Ljiljana Trtica Majnarić, František Babič, Shane O’Sullivan and Andreas Holzinger
Clin. Med. 2021, 10(4), 766; https://doi.org/10.3390/jcm10040766
Available online: https://www.mdpi.com/2077-0383/10/4/766
- “Acceptance and Intake of COVID-19 Vaccines among Older Germans”
by Marta Malesza and Erich Wittmann
Clin. Med. 2021, 10(7), 1388; https://doi.org/10.3390/jcm10071388
Available online: https://www.mdpi.com/2077-0383/10/7/1388
- “Exercise Ventilatory Inefficiency in Post-COVID-19 Syndrome: Insights from a Prospective Evaluation”
by Álvaro Aparisi, Cristina Ybarra-Falcón, Mario García-Gómez, Javier Tobar, Carolina Iglesias-Echeverría, Sofía Jaurrieta-Largo, Raquel Ladrón, Aitor Uribarri, Pablo Catalá, Williams Hinojosa et al.
Clin. Med. 2021, 10(12), 2591; https://doi.org/10.3390/jcm10122591
Available online: https://www.mdpi.com/2077-0383/10/12/2591
- “Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study”
by Jesús Castilla, Marcela Guevara, Ana Miqueleiz, Fernando Baigorria, Carlos Ibero-Esparza, Ana Navascués, Camino Trobajo-Sanmartín, Iván Martínez-Baz, Itziar Casado and Cristina Burgui
Clin. Med. 2021, 10(12), 2608; https://doi.org/10.3390/jcm10122608
Available online: https://www.mdpi.com/2077-0383/10/12/2608
- “SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence”
by Thi Loi Dao, Van Thuan Hoang, Philippe Colson, Jean Christophe Lagier, Matthieu Million, Didier Raoult, Anthony Levasseur and Philippe Gautret
Clin. Med. 2021, 10(12), 2635; https://doi.org/10.3390/jcm10122635
Available online: https://www.mdpi.com/2077-0383/10/12/2635
- “Diagnostic Accuracy of Rapid Antigen Test Kits for Detecting SARS-CoV-2: A Systematic Review and Meta-Analysis of 17,171 Suspected COVID-19 Patients”
by Shahad Saif Khandker, Nik Haszroel Hysham Nik Hashim, Zakuan Zainy Deris, Rafidah Hanim Shueb and Md Asiful Islam
Clin. Med. 2021, 10(16), 3493; https://doi.org/10.3390/jcm10163493
Available online: https://www.mdpi.com/2077-0383/10/16/3493
- “The Role of Antioxidants on Wound Healing: A Review of the Current Evidence”
by Inés María Comino-Sanz, María Dolores López-Franco, Begoña Castro and Pedro Luis Pancorbo-Hidalgo
Clin. Med. 2021, 10(16), 3558; https://doi.org/10.3390/jcm10163558
Available online: https://www.mdpi.com/2077-0383/10/16/3558
- “Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe”
by Arkadiusz Dziedzic, Abanoub Riad, Sameh Attia, Miloslav Klugar and Marta Tanasiewicz
Clin. Med. 2021, 10(22), 5338; https://doi.org/10.3390/jcm10225338
Available online: https://www.mdpi.com/2077-0383/10/22/5338
- “Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study”
by César Fernández-de-las-Peñas, José D. Martín-Guerrero, Óscar J. Pellicer-Valero, Esperanza Navarro-Pardo, Víctor Gómez-Mayordomo, María L. Cuadrado, José A. Arias-Navalón, Margarita Cigarán-Méndez, Valentín Hernández-Barrera and Lars Arendt-Nielsen
Clin. Med. 2022, 11(2), 413; https://doi.org/10.3390/jcm11020413
Available online: https://www.mdpi.com/2077-0383/11/2/413
- “Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems”
by Valeria Visco, Carolina Vitale, Antonella Rispoli, Carmine Izzo, Nicola Virtuoso, Germano Junior Ferruzzi, Mario Santopietro, Americo Melfi, Maria Rosaria Rusciano, Angelantonio Maglio et al.
Clin. Med. 2022, 11(3), 524; https://doi.org/10.3390/jcm11030524
Available online: https://www.mdpi.com/2077-0383/11/3/524
- “The Interactive Effects of Post-Traumatic Stress Symptoms and Breathlessness on Fatigue Severity in Post-COVID-19 Syndrome”
by Sari Harenwall, Suzanne Heywood-Everett, Rebecca Henderson, Joanne Smith, Rachel McEnery and Amy R. Bland
Clin. Med. 2022, 11(20), 6214; https://doi.org/10.3390/jcm11206214
Available online: https://www.mdpi.com/2077-0383/11/20/6214
- “Psychological and Cognitive Effects of Long COVID: A Narrative Review Focusing on the Assessment and Rehabilitative Approach”
by Rosaria De Luca, Mirjam Bonanno and Rocco Salvatore Calabrò
Clin. Med. 2022, 11(21), 6554; https://doi.org/10.3390/jcm11216554
Available online: https://www.mdpi.com/2077-0383/11/21/6554
- “Practice of Awake Prone Positioning in Critically Ill COVID-19 Patients—Insights from the PRoAcT–COVID Study”
by Willemke Stilma, Christel M. A. Valk, David M. P. van Meenen, Luis Morales, Daantje Remmelzwaal, Sheila N. Myatra, Antonio Artigas, Ary Serpa Neto, Frederique Paulus, Marcus J. Schultz et al.
Clin. Med. 2022, 11(23), 6988; https://doi.org/10.3390/jcm11236988
Available online: https://www.mdpi.com/2077-0383/11/23/6988
- “Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis”
by Kin Israel Notarte, Maria Helena Santos de Oliveira, Princess Juneire Peligro, Jacqueline Veronica Velasco, Imee Macaranas, Abbygail Therese Ver, Flos Carmeli Pangilinan, Adriel Pastrana, Nathaniel Goldrich, David Kavteladze et al.
Clin. Med. 2022, 11(24), 7314; https://doi.org/10.3390/jcm11247314
Available online: https://www.mdpi.com/2077-0383/11/24/7314
16 May 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Infectious Diseases”
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on article processing charges. The Section “Infectious Diseases” of the journal aims to publish articles describing research results on microbiology, immunology, epidemiology, and related disciplines on the pathogenesis, diagnosis, and treatment of infectious diseases, with a particular focus on the role of infections in the pathogenesis of chronic noninfectious conditions as well as on the treatment of infections as comorbidities of chronic conditions.
The Section “Infectious Diseases” follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full text of all of the articles published in our journal. We welcome you to read our most cited papers published in 2021 and 2022, listed below:
- “Proposal of the Definition for COVID-19-Associated Coagulopathy”
by Toshiaki Iba, Theodore E. Warkentin, Jecko Thachil, Marcel Levi and Jerrold H. Levy
Clin. Med. 2021, 10(2), 191; https://doi.org/10.3390/jcm10020191
Avaliable online: https://www.mdpi.com/2077-0383/10/2/191
- “Evidence of Pulmonary Hypertension after SARS-CoV-2 Infection in Subjects without Previous Significant Cardiovascular Pathology”
by Cristina Tudoran, Mariana Tudoran, Voichita Elena Lazureanu, Adelina Raluca Marinescu, Gheorghe Nicusor Pop, Alexandru Silvius Pescariu, Alexandra Enache and Talida Georgiana Cut
Clin. Med. 2021, 10(2), 199; https://doi.org/10.3390/jcm10020199
Avaliable online: https://www.mdpi.com/2077-0383/10/2/199
- “Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection”
by Julien Favresse, Constant Gillot, Maxime Oliveira, Julie Cadrobbi, Marc Elsen, Christine Eucher, Kim Laffineur, Catherine Rosseels, Sandrine Van Eeckhoudt, Jean-Baptiste Nicolas et al.
Clin. Med. 2021, 10(2), 265; https://doi.org/10.3390/jcm10020265
Avaliable online: https://www.mdpi.com/2077-0383/10/2/265
- “Favipiravir in Therapy of Viral Infections”
by Ryta Łagocka, Violetta Dziedziejko, Patrycja Kłos and Andrzej Pawlik
Clin. Med. 2021, 10(2), 273; https://doi.org/10.3390/jcm10020273
Avaliable online: https://www.mdpi.com/2077-0383/10/2/273
- “Severe COVID-19 Lung Infection in Older People and Periodontitis”
by Ruben Aquino-Martinez and Scarlette Hernández-Vigueras
Clin. Med. 2021, 10(2), 279; https://doi.org/10.3390/jcm10020279
Avaliable online: https://www.mdpi.com/2077-0383/10/2/279
- “When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It”
by Stefano Cappanera, Michele Palumbo, Sherman H. Kwan, Giulia Priante, Lucia Assunta Martella, Lavinia Maria Saraca, Francesco Sicari, Carlo Vernelli, Cinzia Di Giuli, Paolo Andreani et al.
Clin. Med. 2021, 10(2), 297; https://doi.org/10.3390/jcm10020297
Avaliable online: https://www.mdpi.com/2077-0383/10/2/297
- “The Prognostic Value of Eosinophil Recovery in COVID-19: A Multicentre, Retrospective Cohort Study on Patients Hospitalised in Spanish Hospitals”
by María Mateos González, Elena Sierra Gonzalo, Irene Casado Lopez, Francisco Arnalich Fernández, José Luis Beato Pérez, Daniel Monge Monge, Juan Antonio Vargas Núñez, Rosa García Fenoll, Carmen Suárez Fernández, Santiago Jesús Freire Castro et al.
Clin. Med. 2021, 10(2), 305; https://doi.org/10.3390/jcm10020305
Avaliable online: https://www.mdpi.com/2077-0383/10/2/305
- “The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro”
by Niko Kohmer, Tuna Toptan, Christiane Pallas, Onur Karaca, Annika Pfeiffer, Sandra Westhaus, Marek Widera, Annemarie Berger, Sebastian Hoehl, Martin Kammel et al.
Clin. Med. 2021, 10(2), 328; https://doi.org/10.3390/jcm10020328
Avaliable online: https://www.mdpi.com/2077-0383/10/2/328
- “’Go To Travel’ Campaign and Travel-Associated Coronavirus Disease 2019 Cases: A Descriptive Analysis, July–August 2020”
by Asami Anzai and Hiroshi Nishiura
Clin. Med. 2021, 10(3), 398; https://doi.org/10.3390/jcm10030398
Avaliable online: https://www.mdpi.com/2077-0383/10/3/398
- “Optimal Allocation of the Limited COVID-19 Vaccine Supply in South Korea”
by Eunha Shim
Clin. Med. 2021, 10(4), 591; https://doi.org/10.3390/jcm10040591
Avaliable online: https://www.mdpi.com/2077-0383/10/4/591
- “Calprotectin, an Emerging Biomarker of Interest in COVID-19: A Systematic Review and Meta-Analysis”
by Raphael Udeh, Shailesh Advani, Luis García de Guadiana Romualdo and Xenia Dolja-Gore
Clin. Med. 2021, 10(4), 775; https://doi.org/10.3390/jcm10040775
Avaliable online: https://www.mdpi.com/2077-0383/10/4/775
- “The Rheumatology Drugs for COVID-19 Management: Which and When?”
by Fabiola Atzeni, Ignazio Francesco Masala, Javier Rodríguez-Carrio, Roberto Ríos-Garcés, Elisabetta Gerratana, Laura La Corte, Manuela Giallanza, Valeria Nucera, Agostino Riva, Gerard Espinosa et al.
Clin. Med. 2021, 10(4), 783; https://doi.org/10.3390/jcm10040783
Avaliable online: https://www.mdpi.com/2077-0383/10/4/783
- “Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6”
by Robert Flisiak, Jerzy Jaroszewicz, Magdalena Rogalska, Tadeusz Łapiński, Aleksandra Berkan-Kawińska, Beata Bolewska, Magdalena Tudrujek-Zdunek, Dorota Kozielewicz, Marta Rorat, Piotr Leszczyński et al.
Clin. Med. 2021, 10(8), 1583; https://doi.org/10.3390/jcm10081583
Avaliable online: https://www.mdpi.com/2077-0383/10/8/1583
- “Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge”
by Domenico Nuzzo, Sonya Vasto, Luca Scalisi, Salvatore Cottone, Gaetano Cambula, Manfredi Rizzo, Daniela Giacomazza and Pasquale Picone
Clin. Med. 2021, 10(9), 1947; https://doi.org/10.3390/jcm10091947
Avaliable online: https://www.mdpi.com/2077-0383/10/9/1947
- “HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients”
by Álvaro Tamayo-Velasco, Pedro Martínez-Paz, María Jesús Peñarrubia-Ponce, Ignacio de la Fuente, Sonia Pérez-González, Itziar Fernández, Carlos Dueñas, Esther Gómez-Sánchez, Mario Lorenzo-López, Estefanía Gómez-Pesquera et al.
Clin. Med. 2021, 10(9), 2017; https://doi.org/10.3390/jcm10092017
Avaliable online: https://www.mdpi.com/2077-0383/10/9/2017
- “Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey”
by Abanoub Riad, Derya Sağıroğlu, Batuhan Üstün, Andrea Pokorná, Jitka Klugarová, Sameh Attia and Miloslav Klugar
Clin. Med. 2021, 10(12), 2629; https://doi.org/10.3390/jcm10122629
Avaliable online: https://www.mdpi.com/2077-0383/10/12/2629
- “Predictive Value of Comorbid Conditions for COVID-19 Mortality”
by Iosif Marincu, Felix Bratosin, Iulia Vidican, Andra-Cristina Bostanaru, Stefan Frent, Bianca Cerbu, Mirela Turaiche, Livius Tirnea and Madalina Timircan
Clin. Med. 2021, 10(12), 2652; https://doi.org/10.3390/jcm10122652
Avaliable online: https://www.mdpi.com/2077-0383/10/12/2652
- “The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review”
by Monika Gudowska-Sawczuk and Barbara Mroczko
Clin. Med. 2021, 10(13), 2772; https://doi.org/10.3390/jcm10132772
Avaliable online: https://www.mdpi.com/2077-0383/10/13/2772
- “COVID-19 and the Endocrine System: A Comprehensive Review on the Theme”
by Giuseppe Lisco, Anna De Tullio, Assunta Stragapede, Antonio Giovanni Solimando, Federica Albanese, Martina Capobianco, Vito Angelo Giagulli, Edoardo Guastamacchia, Giovanni De Pergola, Angelo Vacca et al.
Clin. Med. 2021, 10(13), 2920; https://doi.org/10.3390/jcm10132920
Avaliable online: https://www.mdpi.com/2077-0383/10/13/2920
- “Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge”
by Modesto M. Maestre-Muñiz, Ángel Arias, Emilia Mata-Vázquez, María Martín-Toledano, Germán López-Larramona, Ana María Ruiz-Chicote, Bárbara Nieto-Sandoval and Alfredo J. Lucendo
Clin. Med. 2021, 10(13), 2945; https://doi.org/10.3390/jcm10132945
Avaliable online: https://www.mdpi.com/2077-0383/10/13/2945
- “One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms”
by Andreas Rank, Athanasia Tzortzini, Elisabeth Kling, Christoph Schmid, Rainer Claus, Eva Löll, Roswitha Burger, Christoph Römmele, Christine Dhillon, Katharina Müller et al.
Clin. Med. 2021, 10(15), 3305; https://doi.org/10.3390/jcm10153305
Avaliable online: https://www.mdpi.com/2077-0383/10/15/3305
- “Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study”
by Luigi Rosa, Giovanni Tripepi, Enrico Naldi, Marina Aimati, Stefano Santangeli, Francesco Venditto, Marcello Caldarelli and Piera Valenti
Clin. Med. 2021, 10(18), 4276; https://doi.org/10.3390/jcm10184276
Avaliable online: https://www.mdpi.com/2077-0383/10/18/4276
- “A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome”
by Glenn Jennings, Ann Monaghan, Feng Xue, David Mockler and Román Romero-Ortuño
Clin. Med. 2021, 10(24), 5913; https://doi.org/10.3390/jcm10245913
Avaliable online: https://www.mdpi.com/2077-0383/10/24/5913
- “Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis”
by Giuseppe Maglietta, Francesca Diodati, Matteo Puntoni, Silvia Lazzarelli, Barbara Marcomini, Laura Patrizi and Caterina Caminiti
Clin. Med. 2022, 11(6), 1541; https://doi.org/10.3390/jcm11061541
Avaliable online: https://www.mdpi.com/2077-0383/11/6/1541
- “Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients”
by Matteo Regolo, Mauro Vaccaro, Alessandra Sorce, Benedetta Stancanelli, Michele Colaci, Giuseppe Natoli, Mario Russo, Innocenza Alessandria, Massimo Motta, Nicola Santangelo et al.
Clin. Med. 2022, 11(8), 2235; https://doi.org/10.3390/jcm11082235
Avaliable online: https://www.mdpi.com/2077-0383/11/8/2235
10 May 2023
Meet Us at the ATS (American Thoracic Society) Conference 2023, 21–23 May 2023, Washington DC, USA
Conference: ATS (American Thoracic Society) Conference 2023
Date: 21–23 May 2023
Location: Washington DC, USA
MDPI will be attending ATS 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference has been organized by the American Thoracic Society, and it will showcase the latest advances and discoveries in respiratory science, patient care and global respiratory health. At the conference, specialists will share and discuss the latest research and its applications to clinical, basic, and translational science in pulmonary, critical care, and sleep medicine.
The following MDPI journals will be represented:
- JCM;
- Medicina;
- Clinics and Practice;
- JPM;
- Cancers;
- Medicines;
- Healthcare;
- Metabolites;
- Children;
- Brain Sciences.
If you are planning to attend this conference, please do not hesitate to talk with us online. Our delegates look forward to meeting you in person at booth #2606, and answering any questions that you may have. For more information about the conference, please visit the following website: https://conference.thoracic.org/.
5 May 2023
Meet Us at the 20th International Congress of the European Society for Child and Adolescent Psychiatry (ESCAP 2023), 29 June–1 July 2023, Copenhagen, Denmark
Conference: 20th International Congress of the European Society for Child and Adolescent Psychiatry (ESCAP 2023)
Date: 29 June–1 July 2023
Location: Copenhagen, Denmark
MDPI will be attending ESCAP 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference is organized by the European Society for Child and Adolescent Psychiatry. The theme of the conference is “Mental health of children and adolescents”. At the conference, specialists will share and discuss the latest research and applications of environmental and chemical substances in relation to society.
The following MDPI journals will be represented:
If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.escap2023.eu/.
21 April 2023
Journal of Clinical Medicine Webinar | The Future of COVID-19 mRNA Vaccines: Focus on Innate Immunity, 10 May 2023
COVID-19 mRNA vaccines saved millions of lives during the pandemic crisis by efficiently protecting against the severe forms of the disease. However, they were much less efficient in protecting against the infection itself and viral transmission. Furthermore, the immunity induced by these vaccines proved to wane relatively rapidly. To understand these features and possibly improve the efficacy and safety of mRNA vaccines, it is critical to obtain insight into their action on the innate immune system.
During this webinar, we will first review the current knowledge on adjuvants included in protein-based vaccines and their action on the innate immune system. We will then discuss how lipid nanoparticles and nucleoside-modified mRNA—the two major components of currently approved mRNA vaccines—contribute to the activation of the innate immune system required for the induction of protective immunity. Finally, we will consider the consequences of this activation on the immune defenses against other pathogens through the phenomenon of trained immunity.
Date: 10 May 2023 at 10:00 a.m. CEST | 4:00 a.m. EST | 3:00 a.m. CST Asia
Webinar ID: 871 5675 7294
Register now for free!
Speaker/Presentation |
Time in CEST |
Time in EST |
Prof. Dr. Michel Goldman |
10:00—10:05 a.m. |
4:00—4:05 a.m. |
Dr. Nathalie Garçon |
10:05—10:35 a.m. |
4:05—4:35 a.m. |
Dr. Rein Verbeke |
10:35—11:05 a.m. |
4:35—5:05 a.m. |
Dr. Mihai Netea |
11:05—11:35 a.m. |
5:05—5:35 a.m. |
Q&A Session |
11:35—11:55 a.m. |
5:35—5:55 a.m. |
Prof. Michel Goldman |
11:55—12:00 p.m. |
5:55—6:00 a.m. |
Webinar Chairs and Keynote Speakers:
Prof. Dr. Michel Goldman (Chair), Institute for Interdisciplinary Innovation in healthcare, Université libre de Bruxelles, Brussels, Belgium
Dr. Nathalie Garçon (Co-Chair), N3J Consulting, Belgium
Dr. Rein Verbeke, 1 Ghent Research Group on Nanomedicines, Ghent University, Ghent, Belgium; 2 Cancer Research Institute Ghent (CRIG), Ghent, Belgium
Dr. Mihai Netea, 1 Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboudumc Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands; 2Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany
Relevant Special Issue:
“Learning from COVID-19 Vaccines”
Guest Editor: Prof. Dr. Michel Goldman
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway and we will let you know when the recording is available to watch.
21 April 2023
Journal of Clinical Medicine | Issue Cover Articles in 2022
The articles below have been selected as 2022 Issue Cover Articles by the Editorial Office of the Journal of Clinical Medicine (ISSN: 2077-0383). These articles are from multiple fields within the scope of the Journal of Clinical Medicine, and we hope they can provide insights and references for scholars in related fields.
1. “Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology” by Ridha I. S. Alnuwaysir, Martijn F. Hoes, Dirk J. van Veldhuisen, Peter van der Meer and Niels Grote Beverborg J. Clin. Med. 2022, 11(1), 125; https://doi.org/10.3390/jcm11010125 Available online: https://www.mdpi.com/2077-0383/11/1/125 |
|
2. “Peroral Cholangioscopy-Guided Targeted Biopsy versus Conventional Endoscopic Transpapillary Forceps Biopsy for Biliary Stricture with Suspected Bile Duct Cancer” by Katsunori Sekine, Ichiro Yasuda, Shinpei Doi, Noriyuki Kuniyoshi, Takayuki Tsujikawa, Yuichi Takano, Masatoshi Mabuchi, Kosuke Takahashi, Masashi Kawamoto, Mikiko Takahashi et al. J. Clin. Med. 2022, 11(2), 289; https://doi.org/10.3390/jcm11020289 Available online: https://www.mdpi.com/2077-0383/11/2/289 |
|
3. “Cell Death in AMD: The Rationale for Targeting Fas” by David N. Zacks, Andrew J. Kocab, Joanne J. Choi, Meredith S. Gregory-Ksander, Marisol Cano and James T. Handa J. Clin. Med. 2022, 11(3), 592; https://doi.org/10.3390/jcm11030592 Available online: https://www.mdpi.com/2077-0383/11/3/592 |
|
4. “Comparison of Ultra-Wide Field Photography to Ultra-Wide Field Angiography for the Staging of Sickle Cell Retinopathy” by Héloise Torres-Villaros, Franck Fajnkuchen, Fatima Amari, Lucie Janicot and Audrey Giocanti-Aurégan J. Clin. Med. 2022, 11(4), 936; https://doi.org/10.3390/jcm11040936 Available online: https://www.mdpi.com/2077-0383/11/4/936 |
|
5. “Mitral Paravalvular Leak: Clinical Implications, Diagnosis and Management” by Ignacio Cruz-Gonzalez, Pablo Antunez-Muiños, Sergio Lopez-Tejero and Pedro L. Sanchez J. Clin. Med. 2022, 11(5), 1245; https://doi.org/10.3390/jcm11051245 Available online: https://www.mdpi.com/2077-0383/11/5/1245 |
|
6. “Comparison in Short-Term Safety and Efficacy between New-Generation WATCHMAN FLX and Conventional WATCHMAN 2.5 for Percutaneous Left Atrial Appendage Closure” by Nobuyuki Fukuda, Teruhiko Imamura, Shuhei Tanaka, Naoya Kataoka, Ryuichi Ushijima, Hiroshi Ueno and Koichiro Kinugawa J. Clin. Med. 2022, 11(6), 1618; https://doi.org/10.3390/jcm11061618 Available online: https://www.mdpi.com/2077-0383/11/6/1618 |
|
7. “Ablation Index Predicts Successful Ablation of Focal Atrial Tachycardia: Results of a Multicenter Study” by Paolo Compagnucci, Antonio Dello Russo, Marco Bergonti, Matteo Anselmino, Giulio Zucchelli, Alessio Gasperetti, Laura Cipolletta, Giovanni Volpato, Ciro Ascione, Federico Ferraris et al. J. Clin. Med. 2022, 11(7), 1802; https://doi.org/10.3390/jcm11071802 Available online: https://www.mdpi.com/2077-0383/11/7/1802 |
|
8. “Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges” by Carsten Tschöpe and Ahmed Elsanhoury J. Clin. Med. 2022, 11(8), 2148; https://doi.org/10.3390/jcm11082148 Available online: https://www.mdpi.com/2077-0383/11/8/2148 |
|
9. “Clinical Developmental Cardiology for Understanding Etiology of Congenital Heart Disease” by Hiroyuki Yamagishi J. Clin. Med. 2022, 11(9), 2381; https://doi.org/10.3390/jcm11092381 Available online: https://www.mdpi.com/2077-0383/11/9/2381 |
|
10. “Multimodality Imaging in the Study of the Left Atrium” by Sergio Moral, Marc Abulí, Pau Vilardell, Emilce Trucco, Esther Ballesteros and Ramon Brugada J. Clin. Med. 2022, 11(10), 2854; https://doi.org/10.3390/jcm11102854 Available online: https://www.mdpi.com/2077-0383/11/10/2854 |
|
11. “Pre-Interventional 3D-Printing-Assisted Planning of Flow Disrupter Implantation for the Treatment of an Intracranial Aneurysm” by Guillaume Charbonnier, Panagiotis Primikiris, Benjamin Billottet, Aurélien Louvrier, Sergio Vancheri, Serine Ferhat and Alessandra Biondi J. Clin. Med. 2022, 11(11), 2950; https://doi.org/10.3390/jcm11112950 Available online: https://www.mdpi.com/2077-0383/11/11/2950 |
|
12. “Primary Orbital Reconstruction with Selective Laser Melting (SLM) of Patient-Specific Implants (PSIs): An Overview of 96 Surgically Treated Patients” by Majeed Rana, Henriette L. Moellmann, Lara Schorn, Julian Lommen, Madiha Rana, Max Wilkat and Karsten Hufendiek J. Clin. Med. 2022, 11(12), 3361; https://doi.org/10.3390/jcm11123361 Available online: https://www.mdpi.com/2077-0383/11/12/3361 |
|
13. “Effect of Pneumococcal Vaccine on Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis” by Vikash Jaiswal, Song Peng Ang, Kriti Lnu, Angela Ishak, Nishan Babu Pokhrel, Jia Ee Chia, Adrija Hajra, Monodeep Biswas, Andrija Matetic, Ravinder Dhatt et al. J. Clin. Med. 2022, 11(13), 3799; https://doi.org/10.3390/jcm11133799 Available online: https://www.mdpi.com/2077-0383/11/13/3799 |
|
14. “Impact of COVID-19 on Subclinical Placental Thrombosis and Maternal Thrombotic Factors” by Marie Carbonnel, Camille Daclin, Morgan Tourne, Emmanuel Roux, Mathilde Le-Marchand, Catherine Racowsky, Titouan Kennel, Eric Farfour, Marc Vasse and Jean-Marc Ayoubi J. Clin. Med. 2022, 11(14), 4067; https://doi.org/10.3390/jcm11144067 Available online: https://www.mdpi.com/2077-0383/11/14/4067 |
|
15. “Sex/Gender- and Age-Related Differences in β-Adrenergic Receptor Signaling in Cardiovascular Diseases” by Daniela Liccardo, Beatrice Arosio, Graziamaria Corbi and Alessandro Cannavo J. Clin. Med. 2022, 11(15), 4280; https://doi.org/10.3390/jcm11154280 Available online: https://www.mdpi.com/2077-0383/11/15/4280 |
|
16. “State-of-the-Art Multimodality Imaging in Sudden Cardiac Arrest with Focus on Idiopathic Ventricular Fibrillation: A Review” by Lisa M. Verheul, Sanne A. Groeneveld, Feddo P. Kirkels, Paul G. A. Volders, Arco J. Teske, Maarten J. Cramer, Marco Guglielmo and Rutger J. Hassink J. Clin. Med. 2022, 11(16), 4680; https://doi.org/10.3390/jcm11164680 Available online: https://www.mdpi.com/2077-0383/11/16/4680 |
|
17. “Carbon Fiber Implants in Orthopaedic Oncology” by Caleb M. Yeung, Abhiram R. Bhashyam, Shalin S. Patel, Eduardo Ortiz-Cruz and Santiago A. Lozano-Calderón J. Clin. Med. 2022, 11(17), 4959; https://doi.org/10.3390/jcm11174959 Available online: https://www.mdpi.com/2077-0383/11/17/4959 |
|
18. “Acute Idiopathic Blind Spot Enlargement Syndrome—New Perspectives in the OCT Era” by Julian A. Zimmermann, Nicole Eter and Julia Biermann J. Clin. Med. 2022, 11(18), 5278; https://doi.org/10.3390/jcm11185278 Available online: https://www.mdpi.com/2077-0383/11/18/5278 |
|
19. “Use of Neuronavigation and Augmented Reality in Transsphenoidal Pituitary Adenoma Surgery” by Miriam H. A. Bopp, Benjamin Saß, Mirza Pojskić, Felix Corr, Dustin Grimm, André Kemmling and Christopher Nimsky J. Clin. Med. 2022, 11(19), 5590; https://doi.org/10.3390/jcm11195590 Available online: https://www.mdpi.com/2077-0383/11/19/5590 |
|
20. “Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium” by Fulvia Ceccarelli, Marcello Govoni, Matteo Piga, Giulia Cassone, Francesco Paolo Cantatore, Giulio Olivieri, Alberto Cauli, Ennio Giulio Favalli, Fabiola Atzeni, Elisa Gremese et al. J. Clin. Med. 2022, 11(20), 6016; https://doi.org/10.3390/jcm11206016 Available online: https://www.mdpi.com/2077-0383/11/20/6016 |
|
21. “Endometriosis in Patients with Mayer-Rokitansky-Küster-Hauser-Syndrome—Histological Evaluation of Uterus Remnants and Peritoneal Lesions and Comparison to Samples from Endometriosis Patients without Mullerian Anomaly” by Sahra Steinmacher, Hans Bösmüller, Massimo Granai, André Koch, Sara Yvonne Brucker and Kristin Katharina Rall J. Clin. Med. 2022, 11(21), 6458; https://doi.org/10.3390/jcm11216458 Available online: https://www.mdpi.com/2077-0383/11/21/6458 |
|
22. “Embolization in Pediatric Patients: A Comprehensive Review of Indications, Procedures, and Clinical Outcomes” by Paolo Marra, Barbaro Di Fazio, Ludovico Dulcetta, Francesco Saverio Carbone, Riccardo Muglia, Pietro Andrea Bonaffini, Clarissa Valle, Fabio Corvino, Francesco Giurazza, Giuseppe Muscogiuri et al. J. Clin. Med. 2022, 11(22), 6626; https://doi.org/10.3390/jcm11226626 Available online: https://www.mdpi.com/2077-0383/11/22/6626 |
|
23. “Risk Factors for Rapid Recurrence of Hyperkalemia following Cessation of Sodium Zirconium Cyclosilicate” by Teruhiko Imamura, Nikhil Narang and Koichiro Kinugawa J. Clin. Med. 2022, 11(23), 7096; https://doi.org/10.3390/jcm11237096 Available online: https://www.mdpi.com/2077-0383/11/23/7096 |
|
24. “Impact of Urinary Incontinence on Physical Function and Respiratory Muscle Strength in Incontinent Women: A Comparative Study between Urinary Incontinent and Apparently Healthy Women” by Sirine Abidi, Amine Ghram, Sameh Ghroubi, Said Ahmaidi, Mohamed Habib Elleuch, Olivier Girard, Theodoros Papasavvas, Jari Laukkanen, Helmi Ben Saad, Beat Knechtle et al. J. Clin. Med. 2022, 11(24), 7344; https://doi.org/10.3390/jcm11247344 Available online: https://www.mdpi.com/2077-0383/11/24/7344 |
30 March 2023
Meet Us at the 29th Congress of the European Association for Cancer Research, 12–15 June 2023, Torino, Italy
Conference: 29th Congress of the European Association for Cancer Research
Date: 12–15 June 2023
Place: Torino, Italy
MDPI will be attending the 29th Congress of the European Association for Cancer Research, held in Torino, Italy, from 12 to 15 June 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of cancer research over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest ideas with us.
The following MDPI journals will be represented:
- Cells;
- Cancers;
- Children;
- CIMB;
- Current Oncology;
- Diagnostics;
- Geriatrics;
- Healthcare;
- JCM;
- Medical Sciences.
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.eacr2023.org/.
29 March 2023
Meet Us at the 19th World Congress of Basic & Clinical Pharmacology 2023, 2–7 July 2023, Glasgow, Scotland
This conference organized by the British Pharmacological Society and International Union of Basic and Clinical Pharmacologists (IUPHAR) will be held in Glasgow, Scotland, from 2 July to 7 July 2023. The topic of the conference focuses on pharmacology and drug discovery, research, and development, and the conference will include six days of symposia, keynote lectures, workshops, and debates. Discover the latest in pharmacology research and developments across 10 content themes.
Pharmaceuticals (ISSN: 1424-8247) is a peer-reviewed, open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI. Pharmaceuticals will participate in this event as an exhibitor together with nine other MDPI journals, among which Pharmaceuticals, Journal of Personalized Medicine and Biomedicines will have journal representatives at our booth.
The following MDPI journals will be represented:
- Pharmaceuticals (leading journal);
- Biomedicines;
- JPM;
- JCM;
- Marine Drugs;
- Children;
- Current Oncology;
- BioMedInformatics;
- JoX;
- Rheumato.
If you are attending this conference, please feel free to start a conversation with us at our booth #A22. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://wcp2023.org/ or contact the Pharmaceuticals Editorial Office at [email protected].
16 March 2023
Meet Us at the Chinese Academic Conference on Tumor Biomarker, 7–9 April 2023, Shanghai, China
MDPI will be attending the Chinese Academic Conference on Tumor Biomarker, held in Shanghai, China, from 7 to 9 April 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of tumor markers over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest inspirations with us.
The following MDPI journals will be represented:
- Biomedicines;
- Cancers;
- Cells;
- Diagnostics;
- Current Oncology;
- JPM;
- JCM;
- Onco;
- CIMB;
- BioMedInformatics.
If you plan on attending this conference, feel free to stop by our booth, #B155. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please follow the link below: https://biomarker2022.sciconf.cn/cn/web/index/13496.
13 March 2023
MDPI’s Newly Launched Journals in December 2022
As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.
In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.
Journal |
Founding Editor-in-Chief |
Journal Topics (Selected) |
Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue |
grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article |
|
Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue |
pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article |
|
Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue |
receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article |
|
Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue |
drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article |
|
Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue |
higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article |
If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to [email protected].
7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers
MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page.
We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.
21 February 2023
Meet Us at the 143rd Annual Meeting of the Pharmaceutical Society of Japan, 25–28 March 2023, Sapporo, Japan
Conference: 143rd Annual Meeting of the Pharmaceutical Society of Japan
Date: 25–28 March 2023
Place: Sapporo, Japan
MDPI will be attending the 143rd Annual Meeting of the Pharmaceutical Society of Japan as the exhibitor. This meeting will be held at Hokkaido University, Sapporo, Japan, from 25 to 28 March 2023. The organizing committee comprises the Faculty of Pharmaceutical Sciences, Hokkaido University. The theme of the 143rd annual meeting is "PharmaScience: Integration for Breakthroughs". Through this meeting, we wish to contribute to the progress of research leading to the development of innovative drugs and therapies by bringing together researchers from various research fields.
The following MDPI journals will be represented:
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://confit.atlas.jp/guide/event/pharm143/top.
16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science
On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.
The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.
As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.
MDPI's Preprints Platform – Preprints.org
To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.
During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.
We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.
For more information, please visit Preprints.org.
17 January 2023
Journal of Clinical Medicine | New Section “Clinical Pediatrics” Established
The Journal of Clinical Medicine (ISSN: 2077-0383) editorial team is pleased to announce the launch of a new Section, “Clinical Pediatrics”. The aim of this Section is to offer a platform for pediatric clinicians, physicians, and healthcare professionals to present cutting-edge basic and applied health research and quality clinical services in general and specialty pediatrics. We sincerely welcome your submission to the journal. Our readers are waiting for your contribution in original research on managing health and diagnosing and treating disorders in infants, children, and adolescents. Manuscripts can focus on research, practice, education, administration, or policy.
Topics could include but are not limited to the following:
- Neonatal medicine;
- Genetic and congenital conditions;
- Developmental–behavioral medicine;
- Pediatric surgery;
- Pediatric cardiology;
- Pediatric nephrology;
- Pediatric dermatology;
- Pediatric orthopedics;
- Pediatric stomatology;
- Pediatric infectious diseases;
- Pediatric pulmonary;
- Child and adolescent psychiatry;
- Pediatric neurology;
- Pediatric ophthalmology;
- Childhood cancer;
- Pediatric allergy and immunology;
- Pediatric endocrinology;
- Pediatric gastroenterology.
We are currently recruiting Editorial Board Members (EBMs) for this Section. If you are an active researcher in this field and are passionate about publishing cutting-edge research, please contact us at [email protected]. Alternatively, you may wish to submit your work directly via the following link: https://susy.mdpi.com/user/manuscripts/upload/b407bd95154eb0a526717b8543b30b25?&journal=jcm.
JCM Editorial Office
22 December 2022
Special Issue Mentor Program
We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.
This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.
The mentee’s responsibilities include:
- Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
- Writing a brief promotion plan for the Special Issue;
- Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
- Writing an editorial for the online Special Issue together with the mentor.
The mentor’s responsibilities include:
- Conducting a final check before the Special Issue is published online;
- Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
- Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
- Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
- Making and submitting decisions regarding submissions with the assistance of mentees.
Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.
If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.
In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.
14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals
MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.
This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.
Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.
Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.
Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.
As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.
A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.
MDPI is proud to be the leading agent of the transition to open access.
"Thanks a Million" to all the contributors!
8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open
We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.
The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).
The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.
Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.
29 November 2022
Editorial Board Members from the Journal of Clinical Medicine Featured in the 2022 Highly Cited Researchers List Published by Clarivate
Recently, ClarivateTM revealed its 2022 list of Highly Cited ResearchersTM—individuals at universities, research institutes and commercial organizations.
The scientists who were selected into this year’s list of Highly Cited Researchers have published highly cited papers in the 11-year period from January 2011 to December 2021, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. Based on Web of Science Citation data, 6,938 researchers from across the globe who have demonstrated a disproportionate level of significant and broad influence in their chosen field or fields over the last decade have been awarded Highly Cited Researcher 2022 designations. The list is truly global, spanning 69 countries or regions and spread across a diverse range of research sciences and social sciences.
According to statistics, eight members of the Editorial Board of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) have been selected into the list of Highly Cited Researchers of Clarivate in 2022. They are being recognized for their high-quality scientific research achievements and outstanding contributions to professional fields. The JCM journal office sincerely congratulates all elected Editorial Board Members and hopes that they continue to have an academically productive relationship with the journal.
Name |
Affiliation |
Prof. Dr. Aldo Pietro Maggioni |
Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Italy |
Prof. Dr. Laurent Peyrin-Biroulet |
Universite de Lorraine, France |
Dr. Holger Thiele |
University of Leipzig, Germany |
Dr. Peng Huang |
Shenzhen University, China Mainland |
Dr. Francesco Landi |
Catholic University of the Sacred Heart, Italy |
Dr. Francesc Graus |
University of Barcelona, Spain |
Prof. Dr. Hans-Peter Hartung |
Heinrich Heine University Dusseldorf, Germany |
Prof. Dr. Antonio Vita |
University of Brescia, Italy |
22 November 2022
Journal of Clinical Medicine | Special Issue Mentor Program
We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program.
This program will enable early career researchers (required to hold a Ph.D. in a related field) to gain experience editing a Special Issue in MDPI journals under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to cultivate their ability to edit and process scientific research.
The mentee’s responsibilities include:
- Proposing a Special Issue title and, with the assistance of the mentor, preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
- Writing a brief promotion plan for the Special Issue;
- Preparing a list of scholars who may be interested in the Issue and personally e-mailing the invitations on behalf of Guest Editors;
- Writing an editorial for the online Special Issue together with the mentor.
The mentor’s responsibilities include:
- Conducting a final check before the Special Issue is published online;
- Performing editorial control of the Special issue and quality control of the publications in a timely manner;
- Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
- Organizing video calls with young scholars and the Editorial office regularly to discuss problems and improvement suggestions for the Special Issue.
- Making and submitting decisions for the submissions under the assistance of mentees.
Certificates and Awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.
If you are interested in this opportunity, please send your Special Issue proposal to the Journal of Clinical Medicine Editorial Office ([email protected]), and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.
In addition to the new Special Issue Mentor Program, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) will continue to welcome all Special Issue proposals focusing on hot research topics.
4 November 2022
Meet Us at the 27th Congress of the Chinese Pediatric Society, 15–18 December 2022, Changsha, China
MDPI will be attending the 27th Congress of the Chinese Pediatric Society, held in Changsha, China, from 15–18 December 2022.
The following MDPI journals will be represented:
- Children (leading journal);
- JPM;
- Medicina;
- Audiology Research;
- JCM;
- Healthcare;
- Diagnostics;
- Metabolites;
- Cancers;
- Nutrients.
If you plan on attending this conference, feel free to stop by our booth: #B67. Our delegates look forward to meeting you in person to answer any questions that you may have.
For more information about the conference, please see the following link: https://nccps2022.tiemeeting.com/CN.
21 October 2022
Meet Us at the 15th European Public Health Conference 2022, 9–12 November 2022, Berlin, Germany
MDPI will be attending the 15th European Public Health Conference 2022, held in Berlin, Germany, from 9 to 12 November 2022. The theme of Berlin 2022 is “Strengthening Health Systems: Improving Population Health and Being Prepared for the Unexpected”. This conference will aim to explore ways in which the public health community can rally around the principle of bringing about better population health. Meanwhile, the conference committee wants the discussions at the 15th EPH Conference to contribute to resilient health systems, universal health coverage (UHC), a well-trained and highly qualified clinical and public health workforce, and governance structures that take a stand and shape health systems globally.
During this conference, MDPI (at booth #13) will welcome researchers from different backgrounds to visit and share their latest ideas with us.
The following MDPI journals will be represented:
- IJERPH;
- Medicina;
- JCM;
- EJIHPE;
- Epidemiologia;
- Behavioral Sciences;
- Healthcare;
- Women;
- MPs;
- Nursing Report;
- COVID;
- Diseases;
- Data;
- Adolescents.
If you plan on attending this conference, feel free to stop by our booth at #13. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please see the following link: https://ephconference.eu/index.php.
28 September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research
Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.
To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.
We invite you to view the event recording:
During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:
- Peer Review Week 2022
- Research Integrity
- What We’ve Learned About Peer Review Reports
- 4 Steps to the Perfect Peer Review Report
- How to Write the Perfect Peer Review Report: An Interview
- Inviting Great Peer Reviewers
In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.
You can find the Podcast here.
We hope you enjoy the contents!
21 September 2022
Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) Is Now an Affiliated Society Member of the Journal of Clinical Medicine
In September 2022, the Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) chose the Journal of Clinical Medicine (ISSN: ISSN 2077-0383) as its preferred journal and became an affiliated society member. As part of this collaboration, all members of GÉTICA will benefit from a discount on the article processing charge (APC) when submitting articles to the Journal of Clinical Medicine.
GÉTICA is a Spanish non-profit association that was established in 2014 by and for clinicians as well as scientists in basic and/or translational research who are interested in tumor immunology and immunotherapies for cancer treatment. The overarching aims of GÉTICA are as follows:
1) to advance the research on and development of novel immunotherapies;
2) to promote the education of researchers and clinicians in these fields;
3) to foster public engagement by communicating the latest developments in cancer immunology and immunotherapy.
A further priority is to integrate other scientific societies and cooperative groups with GÉTICA, in order to establish a strong multidisciplinary and collaborative scientific environment that will help us to drive the field of cancer immunology forward and further the development of novel immunotherapies.
The Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) is a professional organization whose functions are highly relevant to the scope of the Journal of Clinical Medicine.
We look forward to collaborating with GÉTICA and publishing state-of-the-art research from its members in this field.
8 September 2022
Meet Us at the 2022 CAGPO ACMOO 19th Annual Conference, 15–18 September 2022, Toronto, Canada
MDPI will be attending the 2022 CAGPO ACMOO Annual Conference, hosted by the 2022 CAGPO Annual Conference Committee, which will be held from 15 to 18 September 2022 in Toronto, Canada.
The CAGPO mission statement is to unify general practitioners in oncology, promote communication amongst general practitioners in oncology in tertiary care and primary care settings, act and speak as the recognized authority on behalf of and for the benefit of general practitioners in oncology and their interests, and promote the role of general practitioners in oncology within cancer centers and within the primary care setting. The conference is to address the learning needs of general practitioners in oncology (GPOs) and oncology-allied health attendees. During this meeting, we will address recent advancements in the standards of oncology care. Our speakers include GPOs, medical and radiation oncologists, as well as speakers from the disciplines of family medicine and clinical trials.
The following MDPI journals will be represented:
- Current Oncology (leading);
- Cancers;
- Medical Sciences;
- Pharmacy;
- Journal of Clinical Medicine;
- Cells;
- Onco.
If you are attending this conference, please feel free to start an on-site conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit the following link: http://cagpo-annual-conference.ca, or contact the Current Oncology Editorial Office at [email protected].
5 August 2022
Meet Us at the European Society of Cardiology (ESC) Congress 2022, 26–29 August 2022, Online or On-Site in Barcelona, Spain
MDPI will be attending the European Society of Cardiology (ESC) Congress 2022, hosted by the European Society of Cardiology and the European Heart House, which will be held from 26 to 29 August 2022 online and on-site in Barcelona, Spain.
The spotlight of the congress is “Global Cardiovascular Health”, focusing on an inclusive approach to cardiovascular health that takes into account the differences in the prevalence, clinical manifestations, prevention strategies, diagnostic modalities, and management of cardiovascular disease around the world. The ESC Congress 2022 is built on a solid foundation that attracts worldwide cardiology leaders to present and exchange their knowledge and most important research results. It focuses on the best and latest science but also emphasizes the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.
The following MDPI journals will be represented:
- Journal of Clinical Medicine (leading);
- Healthcare;
- Journal of Cardiovascular Development and Disease;
- International Journal of Environmental Research and Public Health;
- Cancers;
- Tomography;
- Data;
- Hearts;
- International Journal of Translational Medicine;
- Medicina;
- Medicines;
- Journal of Personalized Medicine.
28 June 2022
2021 Impact Factors - Released
The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:
Journal | Impact Factor | Rank | Category |
Antioxidants | 7.675 | Q1 | Food Science & Technology |
Biochemistry & Molecular Biology | |||
Chemistry, Medicinal | |||
Cells | 7.666 | Q2 | Cell Biology |
Nutrients | 6.706 | Q1 | Nutrition & Dietetics |
Cancers | 6.575 | Q1 | Oncology |
Pharmaceutics | 6.525 | Q1 | Pharmacology & Pharmacy |
International Journal of Molecular Sciences | 6.208 | Q1 | Biochemistry & Molecular Biology |
Q2 | Chemistry, Multidisciplinary | ||
Marine Drugs | 6.085 | Q1 | Chemistry, Medicinal |
Pharmacology & Pharmacy | |||
Biomolecules | 6.064 | Q2 | Biochemistry & Molecular Biology |
Batteries * | 5.938 | Q2 | Electrochemistry |
Energy & Fuels | |||
Materials Science, Multidisciplinary | |||
Viruses | 5.818 | Q2 | Virology |
Biosensors | 5.743 | Q1 | Chemistry, Analytical |
Instruments & Instrumentation | |||
Q2 | Nanoscience & Nanotechnology | ||
Journal of Fungi | 5.724 | Q1 | Mycology |
Q2 | Microbiology | ||
Nanomaterials | 5.719 | Q1 | Physics, Applied |
Q2 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Nanoscience & Nanotechnology | |||
Metabolites | 5.581 | Q2 | Biochemistry & Molecular Biology |
Foods | 5.561 | Q1 | Food Science & Technology |
Drones * | 5.532 | Q2 | Remote Sensing |
Remote Sensing | 5.349 | Q1 | Geosciences, Multidisciplinary |
Imaging Science & Photographic Technology | |||
Q2 | Remote Sensing | ||
Environmental Sciences | |||
Journal of Theoretical and Applied Electronic Commerce Research | 5.318 | Q2 | Business |
Antibiotics | 5.222 | Q1 | Pharmacology & Pharmacy |
Q2 | Infectious Diseases | ||
Pharmaceuticals | 5.215 | Q1 | Pharmacology & Pharmacy |
Q2 | Chemistry, Medicinal | ||
Biology | 5.168 | Q1 | Biology |
Fermentation | 5.123 | Q2 | Biotechnology & Applied Microbiology |
Toxins | 5.075 | Q1 | Toxicology |
Q2 | Food Science & Technology | ||
Bioengineering * | 5.046 | Q2 | Engineering, Biomedical |
Polymers | 4.967 | Q1 | Polymer Science |
Journal of Clinical Medicine | 4.964 | Q2 | Medicine, General & Internal |
Vaccines | 4.961 | Q2 | Immunology |
Medicine, Research & Experimental | |||
Molecules | 4.927 | Q2 | Chemistry, Multidisciplinary |
Biochemistry & Molecular Biology | |||
Microorganisms | 4.926 | Q2 | Microbiology |
Journal of Functional Biomaterials * | 4.901 | Q2 | Engineering, Biomedical |
Materials Science, Biomaterials | |||
Biomedicines | 4.757 | Q2 | Medicine, Research & Experimental |
Pharmacology & Pharmacy | |||
Biochemistry & Molecular Biology | |||
Plants | 4.658 | Q1 | Plant Sciences |
International Journal of Environmental Research and Public Health | 4.614 | Q1 | Public, Environmental & Occupational Health (SSCI) |
Q2 | Public, Environmental & Occupational Health (SCIE) | ||
Environmental Sciences (SCIE) | |||
Membranes | 4.562 | Q1 | Polymer Science |
Q2 | Engineering, Chemical | ||
Materials Science, Multidisciplinary | |||
Chemistry, Physical | |||
Pathogens | 4.531 | Q2 | Microbiology |
Catalysts | 4.501 | Q2 | Chemistry, Physical |
Toxics | 4.472 | Q2 | Toxicology |
Environmental Sciences | |||
Gels | 4.432 | Q1 | Polymer Science |
Journal of Cardiovascular Development and Disease | 4.415 | Q2 | Cardiac & Cardiovascular Systems |
Chemosensors | 4.229 | Q1 | Instruments & Instrumentation |
Q2 | Chemistry, Analytical | ||
Q3 | Electrochemistry | ||
Genes | 4.141 | Q2 | Genetics & Heredity |
Diagnostics | 3.992 | Q2 | Medicine, General & Internal |
Agronomy | 3.949 | Q1 | Agronomy |
Plant Sciences | |||
Land | 3.905 | Q2 | Environmental Studies |
Sustainability | 3.889 | Q2 | Environmental Sciences (SCIE) |
Environmental Studies (SSCI) | |||
Q3 | Green & Sustainable Science & Technology (SCIE) | ||
Q4 | Green & Sustainable Science & Technology (SSCI) | ||
Sensors | 3.847 | Q2 | Instruments & Instrumentation |
Chemistry, Analytical | |||
Engineering, Electrical & Electronic | |||
Materials | 3.748 | Q1 | Metallurgy & Metallurgical Engineering |
Q2 | Physics, Applied | ||
Physics, Condensed Matter | |||
Q3 | Materials Science, Multidisciplinary | ||
Chemistry, Physical | |||
Biomimetics * | 3.743 | Q2 | Engineering, Multidisciplinary |
Q3 | Materials Science, Biomaterials | ||
Tropical Medicine and Infectious Disease * | 3.711 | Q1 | Tropical Medicine |
Q2 | Parasitology | ||
Q3 | Infectious Diseases | ||
Lubricants * | 3.584 | Q2 | Engineering, Mechanical |
Fractal and Fractional | 3.577 | Q1 | Mathematics, Interdisciplinary Applications |
Water | 3.530 | Q2 | Water Resources |
Q3 | Environmental Sciences | ||
Micromachines | 3.523 | Q2 | Instruments & Instrumentation |
Physics, Applied | |||
Chemistry, Analytical | |||
Q3 | Nanoscience & Nanotechnology | ||
Journal of Personalized Medicine | 3.508 | Q2 | Medicine, General & Internal |
Health Care Sciences & Services | |||
Agriculture | 3.408 | Q1 | Agronomy |
Processes | 3.352 | Q2 | Engineering, Chemical |
Separations | 3.344 | Q2 | Chemistry, Analytical |
Magnetochemistry | 3.336 | Q2 | Chemistry, Inorganic & Nuclear |
Q3 | Chemistry, Physical | ||
Materials Science, Multidisciplinary | |||
Brain Sciences | 3.333 | Q3 | Neurosciences |
Buildings | 3.324 | Q2 | Construction & Building Technology |
Engineering, Civil | |||
Forests | 3.282 | Q1 | Forestry |
Energies | 3.252 | Q3 | Energy & Fuels |
Life | 3.251 | Q2 | Biology |
Coatings | 3.236 | Q2 | Materials Science, Coatings & Films |
Physics, Applied | |||
Q3 | Materials Science, Multidisciplinary | ||
Animals | 3.231 | Q1 | Agriculture, Dairy & Animal Science |
Veterinary Sciences | |||
Journal of Intelligence * | 3.176 | Q2 | Psychology, Multidisciplinary |
Fishes | 3.170 | Q1 | Marine & Freshwater Biology |
Q2 | Fisheries | ||
Healthcare | 3.160 | Q2 | Health Policy & Services (SSCI) |
Health Care Sciences & Services (SCIE) | |||
Inorganics * | 3.149 | Q2 | Chemistry, Inorganic & Nuclear |
Insects | 3.139 | Q1 | Entomology |
Atmosphere | 3.110 | Q3 | Meteorology & Atmospheric Sciences |
Environmental Sciences | |||
Current Oncology | 3.109 | Q3 | Oncology |
ISPRS International Journal of Geo-Information | 3.099 | Q2 | Geography, Physical |
Q3 | Computer Science, Information Systems | ||
Remote Sensing | |||
Diversity | 3.029 | Q2 | Biodiversity Conservation |
Ecology | |||
Tomography | 3.000 | Q3 | Radiology, Nuclear Medicine & Medical Imaging |
Current Issues in Molecular Biology | 2.976 | Q3 | Biochemistry & Molecular Biology |
Medicina | 2.948 | Q3 | Medicine, General & Internal |
Symmetry | 2.940 | Q2 | Multidisciplinary Sciences |
Horticulturae | 2.923 | Q1 | Horticulture |
Machines | 2.899 | Q2 | Engineering, Mechanical |
Engineering, Electrical & Electronic | |||
Systems * | 2.895 | Q2 | Social Sciences, Interdisciplinary |
Applied Sciences | 2.838 | Q2 | Engineering, Multidisciplinary |
Physics, Applied | |||
Q3 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Children | 2.835 | Q2 | Pediatrics |
Minerals | 2.818 | Q2 | Mining & Mineral Processing |
Mineralogy | |||
Geochemistry & Geophysics | |||
Universe | 2.813 | Q2 | Astronomy & Astrophysics |
Q3 | Physics, Particles & Fields | ||
Journal of Marine Science and Engineering | 2.744 | Q1 | Engineering, Marine |
Q2 | Oceanography | ||
Engineering, Ocean | |||
Entropy | 2.738 | Q2 | Physics, Multidisciplinary |
Fire * | 2.726 | Q2 | Forestry |
Q3 | Ecology | ||
Metals | 2.695 | Q2 | Metallurgy & Metallurgical Engineering |
Q3 | Materials Science, Multidisciplinary | ||
Electronics | 2.690 | Q3 | Engineering, Electrical & Electronic |
Computer Science, Information Systems | |||
Physics, Applied | |||
Crystals | 2.670 | Q2 | Crystallography |
Q3 | Materials Science, Multidisciplinary | ||
Aerospace | 2.660 | Q1 | Engineering, Aerospace |
Mathematics | 2.592 | Q1 | Mathematics |
Photonics | 2.536 | Q3 | Optics |
Actuators | 2.523 | Q2 | Instruments & Instrumentation |
Q3 | Engineering, Mechanical | ||
Veterinary Sciences | 2.518 | Q2 | Veterinary Sciences |
Behavioral Sciences * | 2.286 | Q3 | Psychology, Multidisciplinary |
Axioms * | 1.824 | Q2 | Mathematics, Applied |
For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.
* Journals given their first Impact Factor in 2022
Source: 2021 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2022)
20 June 2022
MDPI’s 2021 Young Investigator Awards in “Medicine & Pharmacology”—Winners Announced
MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.
We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.
- Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
- Mateusz Maciejczyk, Medical University of Bialystok, Poland
- Matteo Lambertini, University of Genova, Italy
- Helen Rogers, Newcastle University, UK
- Amir Karami, University of South Carolina, USA
- Andrea Palermo, Campus Bio-Medico University, Italy
Journal of Personalized Medicine:
- Simone Di Franco, University of Palermo, Italy
- Catriona Hippman, University of Calgary, Canada
- Veeru Kasivisvanathan, University College London, UK
- Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy
- Qi Zhou, Purdue University, USA
20 June 2022
MDPI’s 2021 Travel Awards in “Medicine & Pharmacology”—Winners Announced
We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.
MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.
The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.
We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.
- Soheil Saeedi, University of Zurich, Switzerland
- Shawn Alexander Hallett, University of Michigan, USA
- Claire Albert, Yale University, USA
- Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
- Patrick Jim Küppers, University Hospital Bonn, Germany
20 June 2022
MDPI’s 2021 Outstanding Reviewer Awards in “Medicine & Pharmacology”—Winners Announced
In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.
We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.
We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.
- Antonio G. Solimando, University of Bari Aldo Moro, Italy
- Chenghui Li, University of Arkansas for Medical Sciences, USA
- Joaquim Carreras, Tokai University, Japan
- Pierfrancesco Franco, University of Turin School of Medicine, Italy
- Laurentiu Pop, University of Texas Southwestern Medical Center, USA
- Margaret Fitch, University of Toronto, Canada
- Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada
- Naser Alsharairi, Griffith University, Australia
- Peter W. Choate, Mount Royal University, Canada
- Qin Xiang Ng, National University of Singapore, Singapore
- Giulio Francesco, Sapienza University of Rome, Italy
- Sebastian Schnaubelt, Medical University of Vienna, Austria
- Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA
Journal of Personalized Medicine:
- Onofrio Laselva, University of Foggia, Italy
- Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
- Vladimir Vladimirov, Virginia Commonwealth University, USA
- Mauro Giuffrè, University of Trieste, Italy
- Erika Palmieri, National Cancer Institute at Frederick, USA
- Anjul Khadria, California Institute of Technology, Pasadena, USA
20 June 2022
MDPI’s 2021 Best Paper Awards in “Medicine & Pharmacology”—Winners Announced
The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.
The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.
We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.
MDPI will continue to provide support and recognition to the academic community.
by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm
Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055
by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado
Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045
by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky
Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029
by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin
Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115
by Chantal Huisman and Helianthe Kort
Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031
by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal
Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037
by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy
Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135
by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya
Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025
by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal
Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019
by Borros Arneth
Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015
by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián
Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356
by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.
Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148
by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu
Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140
9 June 2022
2021 CiteScores - Released
The 2021 citation metrics have been officially released in Scopus!
We are pleased to announce that 182 MDPI journals are included, of which:
● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.
The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:
Journal |
CiteScore |
Quartile |
Category |
10.1 |
Q1 |
Genetics |
|
10.0 |
Q1 |
Biomedical Engineering |
|
8.1 |
Q1 |
Pharmacology, Toxicology and Pharmaceutics (miscellaneous) |
|
7.9 |
Q1 |
Electrical and Electronic Engineering |
|
7.9 |
Q1 |
Nutrition and Dietetics |
|
7.4 |
Q1 |
General Earth and Planetary Sciences |
|
7.2 |
Q1 |
Computer Science Applications |
|
6.9 |
Q1 |
Inorganic Chemistry |
|
6.9 |
Q1 |
Computer Networks and Communications |
|
6.7 |
Q1 |
General Biochemistry, Genetics and Molecular Biology |
|
6.6 |
Q1 |
General Chemical Engineering |
|
6.6 |
Q1 |
Health, Toxicology and Mutagenesis |
|
6.6 |
Q1 |
Infectious Diseases |
|
6.5 |
Q1 |
Food Science |
|
6.5 |
Q1 |
Civil and Structural Engineering |
|
6.4 |
Q1 |
Nature and Landscape Conservation |
|
6.4 |
Q1 |
Instrumentation |
|
6.1 |
Q1 |
Management Information Systems |
|
5.9 |
Q1 |
Chemistry (miscellaneous) |
|
5.7 |
Q1 |
Polymers and Plastics |
|
5.6 |
Q1 |
Engineering (miscellaneous) |
|
5.5 |
Q1 |
General Environmental Science |
|
5.5 |
Q1 |
Urban Studies |
|
5.4 |
Q2 |
Computer Networks and Communications |
|
5.3 |
Q1 |
Food Science |
|
5.3 |
Q1 |
Plant Science |
|
5.2 |
Q1 |
Ecology, Evolution, Behavior and Systematics |
|
5.2 |
Q1 |
General Engineering |
|
Journal of Open Innovation: Technology, Market, and Complexity |
5.1 |
Q1 |
Development |
5.0 |
Q1 |
Chemistry (miscellaneous) |
|
5.0 |
Q1 |
Control and Optimization |
|
5.0 |
Q1 |
Geography, Planning and Development |
|
5.0 |
Q1 |
Geography, Planning and Development |
|
4.9 |
Q1 |
Forestry |
|
4.9 |
Q1 |
Control and Optimization |
|
4.9 |
Q1 |
Soil Science |
|
4.8 |
Q1 |
General Earth and Planetary Sciences |
|
4.8 |
Q1 |
Mechanical Engineering |
|
4.8 |
Q1 |
Public Health, Environmental and Occupational Health |
|
4.8 |
Q1 |
Geography, Planning and Development |
|
International Journal of Environmental Research and Public Health |
4.5 |
Q1 |
Public Health, Environmental and Occupational Health |
4.5 |
Q1 |
Physical Therapy, Sports Therapy and Rehabilitation |
|
4.4 |
Q1 |
Mathematical Physics |
|
4.4 |
Q1 |
General Medicine |
|
4.3 |
Q1 |
General Mathematics |
|
4.2 |
Q1 |
Surgery |
|
4.1 |
Q1 |
Health Professions (miscellaneous) |
|
4.1 |
Q1 |
Plant Science |
|
4.0 |
Q1 |
General Engineering |
|
4.0 |
Q1 |
Forestry |
|
4.0 |
Q1 |
Education |
|
3.9 |
Q1 |
General Pharmacology, Toxicology and Pharmaceutics |
|
3.9 |
Q1 |
Applied Mathematics |
|
3.8 |
Q1 |
Development |
|
3.8 |
Q1 |
Architecture |
|
3.8 |
Q1 |
Metals and Alloys |
|
3.5 |
Q1 |
Communication |
|
3.4 |
Q1 |
General Social Sciences |
|
2.9 |
Q1 |
General Mathematics |
|
2.8 |
Q1 |
Analysis |
|
2.7 |
Q1 |
General Veterinary |
|
2.6 |
Q1 |
Algebra and Number Theory |
|
1.8 |
Q1 |
Conservation |
|
1.0 |
Q1 |
Religious Studies |
|
0.9 |
Q1 |
Philosophy |
Source: 2021 CiteScores™ (Elsevier)
13 May 2022
Journal of Clinical Medicine | Special Issue Development Program
We are pleased to announce a new project of Journal of Clinical Medicine (JCM, ISSN: 2077-0383)—Special Issue Development Program.
The program aims to provide early career scientists with the opportunity to develop a Special Issue and experience the academic editor's role under the mentorship of an experienced scientist.
What you will receive from the Special Issue Development Program:
- A Guest Editor certificate;
- A platform to collect papers on a certain topic;
- Guidance from experienced scientists from JCM;
- More editorial experience and the opportunity to enrich your resume.
If you are interested in this opportunity, please send your Special Issue proposal to the JCM Editorial Office ([email protected]) or submit the proposal at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/jcm. We will then discuss our potential collaboration and how the process works in detail.
In addition to the new Special Issue Development Program, JCM continues to welcome Special Issue proposals based on hot research topics.
22 April 2022
Meet the Editors | Interview with Prof. Marco Sebastiani— Section Editor-in-Chief of the Section “Immunology” in Journal of Clinical Medicine
1. Please briefly introduce yourself.
My name is Marco Sebastiani, professor of rheumatology at the University of Modena and Reggio Emilia. For many years, I’ve been working in some fields of rheumatology, such as rheumatoid arthritis, interstitial lung disease associated to rheumatic diseases, videocapillaroscopy in diagnosis and the management of connective tissue diseases, and cryoglobulinaemic vasculitis.
2. What attracted you to science editing?
Science-editing was a new work opportunity for me. It was a challenge to try to increase my expertise in other scientific fields.
3. The Journal of Clinical Medicine (JCM) is an open access journal. Can you explain your attitude toward open access? How do you think open access affects authors?
Open access is a good opportunity to increase the sharing and the diffusion of scientific progress. The authors can increase the visibility of their work. I frequently publish in open access journals, when I think that my work needs a large and rapid diffusion.
4. What are the current cutting-edge research areas in the field of immunology?
Immunology and rheumatology are experiencing a period of great research activity. The increase of knowledge in innate and acquired immunity, as well as in molecular mechanisms of inflammation, has allowed the discovery of new drugs and a better treatment of immune-mediated and inflammatory diseases. Moreover, in recent years, researchers have shown an increased interest in the lung’s involvement in rheumatic diseases; the development of new opportunities for treatment has induced research to search for new methods of screening and early diagnosis of interstitial lung disease.
5. What motivated you to join the JCM Editorial Board?
Journal of Clinical Medicine is a high-impact open access journal with an eminent Editorial Board. I accepted the opportunity to contribute to the journal and to collaborate with the other members of the Editorial Board with enthusiasm.
To work as a Section Editor-in-Chief of the Section “Immunology” is challenging, but rewarding, and it allows me to contribute to the development of the journal and keep up to date about all the activities of the journal.
6. How do you think COVID-19 affects medical research and publishing? Do you have any suggestions for the development of JCM during the epidemic period?
The appearance of the COVID-19 pandemic has determined a great increase in the research on this topic by researchers of many specialties, not only those with expertise in infectious disease and virology. The main side effect has been the stopping of many research projects in the first months of the pandemic. Now, COVID-19 continues to significantly impact the management of chronic and acute diseases; in this context, the interactions between the management of chronic diseases and the need for treatment and prophylaxis of SARS-CoV-2 infection can represent a topic to be explored in the coming months.
21 March 2022
Welcoming New Editorial Board Members of the Journal of Clinical Medicine
We are pleased to announce that four prominent academics have recently joined the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) Editorial Board. The new Editorial Board Members are as follows:
Name: Prof. Dr. Claudio Tondo
Affiliations: Department of Clinical Electrophysiology & Cardiac Pacing, Heart Rhythm Center, Centro Cardiologico Monzino IRCCS, Milan, Italy;
Department of Biochemical, Surgical and Dentist Sciences, University of Milan, Milan, Italy
Name: Dr. Barbara Bauce
Affiliation: Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, Padua, Italy
Name: Prof. Dr. Chung Cheung Thomas Yau
Affiliation: Department of Medicine, The University of Hong Kong, Hong Kong, China
Name: Prof. Dr. Depei Wu.
Affiliations: National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China;
Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215123, China;
Department of Hematology, the First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215006, China
The commitment of these individuals to JCM is much appreciated, and we look forward to their contributions to the continued success of JCM.
Further details about the JCM Editorial Board can be found via the following link: https://www.mdpi.com/journal/JCM/editors.
27 December 2021
Recruiting Editorial Board Members for Journal of Clinical Medicine
Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm; ISSN 2077-0383) is indexed by Science Citation Index Expanded (SCIE) with the Impact Factor of 4.242 (2020) and accepted for inclusion in Scopus. To secure the high-speed development of our journal in the near future, we are recruiting prestigious scholars from around the world to join our Editorial Board for the Sections that can be accessed at the following link: https://www.mdpi.com/journal/jcm/sections.
The main responsibilities of Editorial Board Members are as follows:
- Prechecking and making decisions for several (12 per year on average) manuscripts based on your area of expertise;
- Acting as, or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
- Promoting JCM and increasing its visibility at related academic social media.
JCM is an international scientific open-access journal, providing a platform for advances in health care and clinical practices, a study of direct observation of patients, and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals, and it is indexed by the SCIE, PubMed, Scopus, and many other databases.
This position is open to experts in clinical medicine. To apply for this position (in one of our sections), recommend potential candidates, or request further information, please contact the JCM Editorial Office ([email protected])
27 December 2021
Welcoming New Editorial Board Members of Journal of Clinical Medicine
We are pleased to announce that three prominent academics have recently joined the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) Editorial Board for the Section “Cardiovascular Medicine”: Prof. Dr. Jeffrey L. Anderson, Prof. Dr. Jiguang Wang and Prof. Dr. Alun Huw Davies.
Name: Prof. Dr. Jeffrey L. Anderson
Affiliation: Intermountain Medical Center Heart Institute, Murray, UT, USA; Department of Internal Medicine, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT, USA
Name: Prof. Dr. Jiguang Wang
Affiliation: Department of Cardiovascular Medicine, National Research Center for Translational Medicine, Centre for Cardiovascular Evaluations, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Shanghai, China; Department of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Name: Prof. Dr. Alun Huw Davies
Affiliation: Academic Section of Vascular Surgery, Division of Surgery, Department of Surgery & Cancer, Imperial College London, Charing Cross Hospital, London W6 8RF, UK.
Their commitment to JCM is much appreciated, and we look forward to their contributions to the continued success of JCM.
Further details about the JCM Editorial Board can be found at the following link: https://www.mdpi.com/journal/JCM/editors.
22 November 2021
722 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction
It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.
Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.
Abate, Antonio Abatzoglou, John T. Abbaszadeh, Mostafa Acharya, U. Rajendra Acharya, Viral V. Agarwal, Ravi P. Ahn, Myung-Ju Airoldi, Laura Ali, Imran Allakhverdiev, Suleyman I. Aluko, Rotimi E. Anasori, Babak Andersson, Dan I. Andes, David Anker, Stefan D. Apergis, Nicholas Ariga, Katsuhiko Arqub, Omar Abu Aschner, Michael Assaraf, Yehuda G. Astruc, Didier Atala, Anthony Atanasov, Atanas G. Atangana, Abdon Bahram, Mohammad Bakris, George L. Balandin, Alexander A. Baleanu, Dumitru Balsamo, Gianpaolo Bando, Yoshio Banks, William A. Bansal-Travers, Maansi Barba, Francisco J. Barros, Lillian Basit, Abdul W. Baskonus, Haci Mehmet Bassetti, Matteo Battino, Maurizio Bell, Jordana T. Bellomo, Nicola Benediktsson, Jon Atli Benelli, Giovanni Benjakul, Soottawat Bhatnagar, Amit Biddle, Stuart J. H. Biondi, Antonio Biondi-Zoccai, Giuseppe Bjarnsholt, Thomas Blaabjerg, Frede Blaschke, Thomas Blay, Jean-Yves Blumwald, Eduardo Blunt, John W. Boffetta, Paolo Bogers, Marcel Bonomo, Robert A. Bowman, David M.J.S. Boyer, Cyrille Brestic, Marian Brevik, Eric C. Buhalis, Dimitrios Burdick, Jason A. Byrd, John C. Cabeza, Luisa F. Cai, Xingjuan Cai, Jianchao Calhoun, Vince D. Calin, George Cao, Jinde Cao, Guozhong Carvalho, Andre F. Castellanos-Gomez, Andres Cerqueira, Miguel Ângelo Parente Ribeiro Chang, Jo-Shu Chang, Chih-Hao Chastin, Sebastien Chau, Kwok-wing Chemat, Farid Chen, Xiaobo Chen, YangQuan Chen, Jianmin Chen, Chaoji Chen, Min Chen, Qi Chen, Jun Chen, Xi Chen, Peng Chen, Yulin Chen, Bo Chen, Chen Chen, Zhi-Gang Chen, Wei-Hsin Chen, Gang Chen, Yongsheng Chen, Xiang Chen, Yimin Chen, Runsheng Chen, Lidong Chen, Shaowei Chen, Qian Chen, Yu Chen, Shuangming Chiclana, Francisco Cho, Sun Young Choi, Wonyong Chowdhary, Anuradha Choyke, Peter L. Cichocki, Andrzej Corella, Dolores Corma, Avelino Cortes, Javier Cortes, Jorge Costanza, Robert Crommie, Michael F. Cui, Yi Cui, Haiying Cui, Qinghua Cummings, Kenneth Michael Dai, Shifeng Dai, Sheng Daiber, Andreas Davis, Steven J. Dawson, Ted M. de la Fuente-Nunez, Cesar Decker, Eric Andrew Dekel, Avishai Demaria, Marco Deng, Yong Deng, Xiangzheng DePinho, Ronald A. Desneux, Nicolas Dimopoulos, Meletios-Athanasios Ding, Aijun Dionysiou, Dionysios D. Dokmeci, Mehmet Remzi Dolgui, Alexandre Dong, Fan Dou, Shi Xue Dou, Letian Du, Qian Du, Bo Dube, Shanta Rishi Dufresne, Alain Dummer, Reinhard Dupont, Didier Edwards, David Elaissari, Abdelhamid Elhoseny, Mohamed Ellahi, Rahmat Ellis, Erle C. ElMasry, Gamal Esteller, Manel Estévez, Mario Fabbro, Doriano Facchetti, Antonio Fan, Zhanxi Fang, Chuanglin Fasano, Alessio Fečkan, Michal Felser, Claudia Feng, Liangzhu Fensholt, Rasmus Ferdinandy, Péter Fernandez-Lafuente, Roberto Ferreira, Isabel C. F. R. Filippi, Massimo Fisher, Helen Fortino, Giancarlo Fosso Wamba, Samuel Franceschi, Claudio Fujita, Hamido Fujita, Masayuki Gai, Francesco Gaisford, Simon Galanakis, Charis M. Galluzzi, Lorenzo Galvano, Fabio Gan, Ren-You Gan, Lihua Gandomi, Amir H. Gao, Bin Gao, Feng Gao, Minrui Gao, Huijun Gao, Wei Gao, Huile Garbe, Claus Garcia, Hermenegildo Gasbarrini, Antonio Gasco, Laura Gautret, Philippe Geng, Yong Gerdts, Gunnar Geschwind, Daniel H. Ghadimi, Noradin Ghaffari, Roozbeh Ghamisi, Pedram Giampieri, Francesca Glick, Bernard R. Gnant, Michael Goel, Ajay Gogotsi, Yury Goldewijk, Kees Klein Gong, Jinlong Gong, Yongji Govindan, Kannan Granato, Daniel Grancini, Giulia Green, Douglas R. Grosso, Giuseppe Gu, Ke Guan, Cao Guastella, Adam J. Guerrero, Josep M. Gui, Guan Guizani, Mohsen Guo, Zaiping Gupta, Rangan Gutzmer, Ralf Haase, Dagmar Habibi-Yangjeh, Aziz Hagemann, Stefan Hagger, Martin Hamblin, Michael R. Hammoudeh, Shawkat Han, Heesup Hanes, Justin Harrison, Roy M. Hartung, Hans-Peter Hasanuzzaman, Mirza He, Jr-Hau He, Hongwen He, Jiaqing He, Debiao Henseler, Jörg Herrera, Francisco Herrera-Viedma, Enrique Hetz, Claudio Ho Kim, Jung Holmes, Elaine Hossain, Ekram Hsueh, Po-Ren Hu, Xiaosong Hu, Wenbin Huang, Jianping Huang, Hongwei Huang, Yu Huang, Jianying Huang, Peng Huang, Baibiao Huang, Shaoming Hubacek, Klaus |
Iqbal, Hafiz M. N. |
Saad, Fred |
The full list of 2021 Highly Cited Researchers can be accessed at the following webpage in the Web of ScienceTM https://recognition.webofscience.com/awards/highly-cited/2021/.
--- Highly Cited Researchers (HCR) is a Clarivate product.
16 November 2021
Topical Advisory Panel Established to Support Editorial Board
Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.
The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.
Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.
To qualify as a Topical Advisory Panel Member, applicants must:
- Have expertise and experience in the field related to the journal;
- Have received a Ph.D. in the last 10 years, approximately;
- Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
- Currently hold an independent research position in academia or a government institute.
If you are interested in this role, please contact the editorial office by email.
We look forward to hearing from you soon.
25 October 2021
Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25–31 October
Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.
The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.
For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.
International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.
Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.
Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.
The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.
Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.
We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.
- 25 October 2021
Energies journal and Institute of Mechanics, Chinese Academy of Sciences
- 28 October 2021
Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University
- 29 October 2021
Processes journal and Beijing Institute of Technology
- 29 October 2021
Coatings journal and Wuhan University of Technology
MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.
23 September 2021
2020 MDPI Top Reviewer Award—Winners Announced
Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:
- Adriana Burlea-Schiopoiu;
- Alban Kuriqi;
- Álvaro González-Vila;
- Alessandro Alaimo;
- Alexey Beskopylny;
- Alexander Yu Churyumov;
- Alberto Fernández-Isabel;
- Andrea Mastinu;
- Antonios N. Papadopoulos;
- Anton Rassõlkin;
- Antonio Humberto Hamad Minervino;
- Arkadiusz Matwijczuk;
- Artur Słomka;
- Baojie He;
- Bartłomiej Potaniec;
- Bojan Đurin;
- Camilo Arturo Rodriguez Diaz;
- Carmelo Maria Musarella;
- Chiachung Chen;
- Chiman Kwan;
- Cristian Busu;
- Danil Pimenov;
- Dan-Cristian Dabija;
- Delfín Ortega-Sánchez;
- Demetrio Antonio Zema;
- Denis Butusov;
- Elena Lucchi;
- Gaurab Dutta;
- Livia Anastasiu;
- M. R. Safaei.
For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.
22 September 2021
MDPI Joins SDG Publishers Compact
UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.
MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.
Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.
The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.
For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
[email protected]
16 September 2021
Journal of Clinical Medicine | New Collaboration with European Independent Foundation in Angiology/Vascular Medicine (VAS)
We are pleased to announce that JCM (ISSN: 2077-0383) has established a new collaboration with the European Independent Foundation in Angiology/Vascular Medicine (VAS). It is a non-profit scientific organization that has been working on vascular diseases and their prevention for 30 years. Members can enjoy discounts for their submissions.
Other affiliated societies of JCM can be found at the following link: https://www.mdpi.com/journal/jcm/societies.
3 August 2021
Announcement on Japanese Consumption Tax (JCT)
This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.
For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").
Contact: Setsuko Nishihara, MDPI Tokyo
16 July 2021
Journal of Clinical Medicine | New Collaboration with Japan Association for Clinical Engineers (JACE)
In July 2021, the Japan Association for Clinical Engineers (JACE) became affiliated with JCM, As part of this collaboration, all members of the JACE enjoy a discount on the article processing charge (APC) when submitting articles to the journal.
JACE was founded as a voluntary organization in February 1990. It has, through its role as an association for professionals specializing in the operation, maintenance, and inspection of life-support systems directly linked to human life, strived constantly to create a system in which patients can receive highly advanced engineering-based medical care safely with the effective use of limited medical resources. In a bid to accomplish its ocial mission, expand the duties, and raise the status of clinical engineers, it was approved as a public-interest corporation by the Ministry of Health, Labor, and Welfare (MHLW) on March 14, 2002.
The objective of this association is to contribute to the promotion and development of the nation’s medical care and welfare through the raising of professional ethics of clinical engineers, enhancement of their professional knowledge and skills, and improvement of reliability of equipment-based medical care and welfare, including life-support systems.
To aim at the global standard, JACE established “World Association for Clinical Engineers” or WACE (tentative name) and organized its first convention in Japan. For more information, please see: https://www.ja-ces.or.jp/.
30 June 2021
2020 Impact Factors - Released
The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!
We are pleased to announce that 85 MDPI journals are included, of which:
- 10 journals received their first impact factor
- 96% of journals increased their impact factor from 2019
- 32 journals (38%) ranked among the top 25% of journals, in at least one category
Journal | Impact Factor | Rank | Category |
Cancers | 6.639 | Q1 | • Oncology |
Cells | 6.600 | Q2 | • Cell Biology |
Pharmaceutics | 6.321 | Q1 | • Pharmacology & Pharmacy |
Antioxidants | 6.313 | Q1 | • Food Science & Technology |
• Biochemistry & Molecular Biology | |||
• Chemistry, Medicinal | |||
Biomedicines | 6.081 | Q1 | • Medicine, Research & Experimental |
• Pharmacology & Pharmacy | |||
• Biochemistry & Molecular Biology | |||
International Journal of Molecular Sciences | 5.924 | Q1 | • Biochemistry & Molecular Biology |
Q2 | • Chemistry, Multidisciplinary | ||
Pharmaceuticals | 5.863 | Q1 | • Pharmacology & Pharmacy |
• Chemistry, Medicinal | |||
Journal of Fungi | 5.816 | Q1 | • Mycology |
• Microbiology | |||
Nutrients | 5.719 | Q1 | • Nutrition & Dietetics |
Biosensors | 5.519 | Q1 | • Chemistry, Analytical |
• Instruments & Instrumentation | |||
Q2 | • Nanoscience & Nanotechnology | ||
Marine Drugs | 5.118 | Q1 | • Chemistry, Medicinal |
• Pharmacology & Pharmacy | |||
Biology | 5.079 | Q1 | • Biology |
Nanomaterials | 5.076 | Q1 | • Physics, Applied |
Q2 | • Chemistry, Multidisciplinary | ||
• Materials Science, Multidisciplinary | |||
• Nanoscience & Nanotechnology | |||
Viruses | 5.048 | Q2 | • Virology |
Journal of Personalized Medicine | 4.945 | Q1 | • Medicine, General & Internal |
• Health Care Sciences & Services | |||
Metabolites | 4.932 | Q2 | • Biochemistry & Molecular Biology |
Biomolecules | 4.879 | Q2 | • Biochemistry & Molecular Biology |
Remote Sensing | 4.848 | Q1 | • Geosciences, Multidisciplinary |
Q2 | • Remote Sensing | ||
• Imaging Science & Photographic Technology | |||
• Environmental Sciences | |||
Gels * | 4.702 | Q1 | • Polymer Science |
Antibiotics | 4.639 | Q2 | • Infectious Diseases |
• Pharmacology & Pharmacy | |||
Toxins | 4.546 | Q1 | • Toxicology |
• Food Science & Technology | |||
Vaccines | 4.422 | Q2 | • Immunology |
• Medicine, Research & Experimental | |||
Molecules | 4.412 | Q2 | • Chemistry, Multidisciplinary |
• Biochemistry & Molecular Biology | |||
Foods | 4.350 | Q2 | • Food Science & Technology |
Polymers | 4.329 | Q1 | • Polymer Science |
Journal of Clinical Medicine | 4.242 | Q1 | • Medicine, General & Internal |
Toxics | 4.146 | Q2 | • Toxicology |
• Environmental Sciences | |||
Catalysts | 4.146 | Q2 | • Chemistry, Physical |
Microorganisms | 4.128 | Q2 | • Microbiology |
Membranes | 4.106 | Q1 | • Polymer Science |
Q2 | • Engineering, Chemical | ||
• Materials Science, Multidisciplinary | |||
• Chemistry, Physical | |||
Genes | 4.096 | Q2 | • Genetics & Heredity |
Fermentation * | 3.975 | Q2 | • Biotechnology & Applied Microbiology |
Journal of Cardiovascular Development and Disease * | 3.948 | Q2 | • Cardiac & Cardiovascular Systems |
Plants | 3.935 | Q1 | • Plant Sciences |
Life | 3.817 | Q2 | • Biology |
Diagnostics | 3.706 | Q2 | • Medicine, General & Internal |
Current Oncology | 3.677 | Q3 | • Oncology |
Materials | 3.623 | Q1 | • Metallurgy & Metallurgical Engineering |
Q2 | • Materials Science, Multidisciplinary | ||
• Chemistry, Physical | |||
• Physics, Applied | |||
• Physics, Condensed Matter | |||
Sensors | 3.576 | Q1 | • Instruments & Instrumentation |
Q2 | • Chemistry, Analytical | ||
• Engineering, Electrical & Electronic | |||
Pathogens | 3.492 | Q2 | • Microbiology |
Agronomy | 3.417 | Q1 | • Agronomy |
• Plant Sciences | |||
Chemosensors | 3.398 | Q2 | • Instruments & Instrumentation |
• Chemistry, Analytical | |||
Q3 | • Electrochemistry | ||
Land | 3.398 | Q2 | • Environmental Studies |
Brain Sciences | 3.394 | Q3 | • Neurosciences |
International Journal of Environmental Research and Public Health | 3.390 | Q1 | • Public, Environmental & Occupational Health (SSCI) |
Q2 | • Public, Environmental & Occupational Health (SCIE) | ||
• Environmental Sciences (SCIE) | |||
Tomography | 3.358 | Q2 | • Radiology, Nuclear Medicine & Medical Imaging |
Fractal and Fractional * | 3.313 | Q1 | • Mathematics, Interdisciplinary Applications |
Sustainability | 3.251 | Q2 | • Environmental Sciences (SCIE) |
• Environmental Studies (SSCI) | |||
Q3 | • Green & Sustainable Science & Technology (SCIE) | ||
• Green & Sustainable Science & Technology (SSCI) | |||
Water | 3.103 | Q2 | • Water Resources |
• Environmental Sciences | |||
Journal of Theoretical and Applied Electronic Commerce Research | 3.049 | Q3 | • Business |
Energies | 3.004 | Q3 | • Energy & Fuels |
Agriculture | 2.925 | Q1 | • Agronomy |
ISPRS International Journal of Geo-Information | 2.899 | Q2 | • Geography, Physical |
• Computer Science, Information Systems | |||
Q3 | • Remote Sensing | ||
Micromachines | 2.891 | Q2 | • Instruments & Instrumentation |
• Physics, Applied | |||
Q3 | • Chemistry, Analytical | ||
• Nanoscience & Nanotechnology | |||
Coatings | 2.881 | Q2 | • Materials Science, Coatings & Films |
• Physics, Applied | |||
Q3 | • Materials Science, Multidisciplinary | ||
Children | 2.863 | Q2 | • Pediatrics |
Processes | 2.847 | Q3 | • Engineering, Chemical |
Separations | 2.777 | Q3 | • Chemistry, Analytical |
Insects | 2.769 | Q1 | • Entomology |
Animals | 2.752 | Q1 | • Agriculture, Dairy & Animal Science |
• Veterinary Sciences | |||
Symmetry | 2.713 | Q2 | • Multidisciplinary Sciences |
Atmosphere | 2.686 | Q3 | • Meteorology & Atmospheric Sciences |
• Environmental Sciences | |||
Applied Sciences | 2.679 | Q2 | • Engineering, Multidisciplinary |
• Physics, Applied | |||
Q3 | • Chemistry, Multidisciplinary | ||
• Materials Science, Multidisciplinary | |||
Photonics | 2.676 | Q2 | • Optics |
Buildings * | 2.648 | Q2 | • Construction & Building Technology |
• Engineering, Civil | |||
Healthcare | 2.645 | Q2 | • Health Policy & Services (SSCI) |
Q3 | • Health Care Sciences & Services (SCIE) | ||
Minerals | 2.644 | Q2 | • Mining & Mineral Processing |
• Mineralogy | |||
• Geochemistry & Geophysics | |||
Forests | 2.634 | Q1 | • Forestry |
Crystals | 2.589 | Q2 | • Crystallography |
Q3 | • Materials Science, Multidisciplinary | ||
Entropy | 2.524 | Q2 | • Physics, Multidisciplinary |
Diversity | 2.465 | Q2 | • Biodiversity Conservation |
Q3 | • Ecology | ||
Journal of Marine Science and Engineering | 2.458 | Q2 | • Oceanography |
• Engineering, Marine | |||
• Engineering, Ocean | |||
Medicina | 2.430 | Q2 | • Medicine, General & Internal |
Machines * | 2.428 | Q2 | • Engineering, Mechanical |
Q3 | • Engineering, Electrical & Electronic | ||
Electronics | 2.397 | Q3 | • Engineering, Electrical & Electronic |
• Computer Science, Information Systems | |||
• Physics, Applied | |||
Fishes * | 2.385 | Q2 | • Fisheries |
• Marine & Freshwater Biology | |||
Metals | 2.351 | Q2 | • Metallurgy & Metallurgical Engineering |
Q3 | • Materials Science, Multidisciplinary | ||
Horticulturae * | 2.331 | Q1 | • Horticulture |
Veterinary Sciences * | 2.304 | Q1 | • Veterinary Sciences |
Universe | 2.278 | Q3 | • Physics, Particles & Fields |
• Astronomy & Astrophysics | |||
Mathematics | 2.258 | Q1 | • Mathematics |
Magnetochemistry | 2.193 | Q3 | • Chemistry, Inorganic & Nuclear |
• Chemistry, Physical | |||
• Materials Science, Multidisciplinary | |||
Current Issues in Molecular Biology | 2.081 | Q4 | • Biochemistry & Molecular Biology |
Actuators | 1.994 | Q3 | • Instruments & Instrumentation |
• Engineering, Mechanical | |||
Aerospace * | 1.659 | Q2 | • Engineering, Aerospace |
* Journals given their first Impact Factor in 2021
Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)
30 June 2021
Welcoming New Editorial Board Members of Journal of Clinical Medicine
We are pleased to announce that, up to now, 116 distinguished scholars have joined the JCM Editorial Board in this quarter, including the well-known Prof. Dr. Aldo Pietro Maggioni from the ANMCO Research Center of the Heart Care Foundation, Prof. Dr. Paolo P. Prandoni from the "Arianna Anticoagulazione" Foundation, Dr. Stefan Evers from the University of Münster, Prof. Dr. Ben Willem Mol from Monash University, Prof. Dr. Tobias Welte from Medizinische Hochaschule Hannover, Prof. Dr. Fabiola Atzeni from the University of Messina, Prof. Dr. Gianluca Aimaretti from Università del Piemonte Orientale, Prof. Dr. Eva Compérat from L’Assistance Publique-Hôpitaux de Paris and various other prominent academics.
You can access more information on our new members on the website: https://www.mdpi.com/journal/jcm/editors.
Their trust in JCM is much appreciated, and we look forward to their contributions to the journal.
28 April 2021
Book Builder—Compile a Customized E-Book from Your Favorite MDPI Open Access Content
MDPI Books recently released Book Builder, a new online tool to conveniently arrange, design and produce an eBook from any content published in MDPI journals. Book Builder offers two functions: on the one hand (1) Selections, available to every registered user of MDPI; on the other hand (2) Special Issue Reprints, which can be used exclusively by Guest Editors of Special Issues.
Selections
In just a matter of a few clicks, all users are now able to assemble books from MDPI articles and receive instantaneous feedback in the form of a fully produced and compiled book (PDF), which can be downloaded or ordered as print copy. Selections can include any paper published with MDPI, picking and combining content from different journals and special issues.
This way, the user may for example choose to compile an ebook focusing around a particular topic, or assemble articles from a group of others.
We invite you to make yourself familiar with the new tool! The Book Builder can be found here: https://www.mdpi.com/books/book_builder.
Special Issue Reprints
The Book Builder allows Guest Editors of MDPI journals to create a reprint from a successfully completed Special Issue or Topical Collection in book format. If you are a Guest Editor for an MDPI journal, you can use the new tool to create an PDF document which includes all articles published in the Special Issue as well as a book cover and table of contents.
For Special Issues containing a minimum of 5 articles, the Guest Editor can request its publication on the MDPI Book platform. Published reprints are assigned an ISBN and DOI.
In addition to the PDF copy of the Reprint Book, as a token of our gratitude, MDPI offers every Guest Editor one (1) complimentary print copy (via print-on-demand). All contributors benefit from a discount on orders of any additional print copies, to share with colleagues or libraries or others.
In line with our organization's values, MDPI Books publishes all content in open access, promoting the exchange of ideas and knowledge in a globalized world. MDPI Books encompasses all the benefits of open access—high availability and visibility, as well as wide and rapid dissemination. MDPI Books are distributed under the terms and conditions of the Creative Commons Attribution License, meaning as an author you retain the copyright for your work. In addition, with MDPI Books you can complement the digital version of your work with a high-quality printed counterpart.
If you are interested in editing a book volume or series, or have a monograph manuscript to be considered for publication, please submit your proposal online and look at our Information for Authors.
Contact: Laura Wagner, MDPI Books Manager (email)
15 April 2021
MDPI Celebrates Company Milestone With 25th Anniversary Page
"We exist to help scientists achieve their own objectives"
In June of this year, MDPI will celebrate the 25th anniversary of its foundation. To mark this significant milestone, we have created a 25th Anniversary page on our website that evokes the development of our company over the past quarter-century.
MDPI has been a pioneer of Open Access publishing ever since the concept was first created.
In a wide-ranging interview, our CEO Delia Mihaila reflects on the company’s 25th anniversary and its contribution to the world of scientific publishing.
Delia considers how MDPI has evolved since starting life in 1996 as a visionary ‘project’ run out of an apartment in Basel, Switzerland, by Dr. Shu-Kun Lin. A chemist who was passionate about the long-term preservation of rare chemical sample, Dr. Lin was determined to help scholars publish their findings as quickly as possible and make their research results available to as wide a readership as possible worldwide. That determination remains unchanged 25 years later.
Today, MDPI is an international organization with over 4,000 employees based on three continents and in ten countries, and ranks among the world's top four academic publishers.
MDPI's mission is to accelerate access to new scientific research, delivering insight faster for researchers worldwide. Read more here about the company's remarkable success story and what the Open Access publishing model can offer the global scientific community.
10 March 2021
Journal Selector: Helping to Find the Right MDPI Journal for Your Article
At MDPI, we strive to make your online publication process seamless and efficient. To achieve this, our team is continuously developing tools and features to make the user experience useful and convenient.
As the number of academic papers continues to grow, so does the need to analyze and work with them on a large scale. This prompted us to design a new feature aimed at helping researchers find journals that are relevant to their publication by matching their abstract topic. In this regard, we designed a similarity model that automatically identifies the most suitable academic journals for your paper.
We are pleased to introduce Journal Selector, a new feature that measures similarity in academic contexts. By simply entering the title and/or abstract into our Journal Selector, the author will see a list of the most related scientific journals published by MDPI. This method helps authors select the correct journals for their papers, highlighting the time of publication and citability.
The methodology is known as representation learning, where words are represented as vectors in hyperspace. Representation helps us differentiate between different concepts within articles, and in turn, helps us identify similarities between them.
We used an advanced machine learning model to better capture the semantic meanings of words. This helps the algorithm make better predictions by leveraging scientific text representation. In turn, this ensures high precision, helping authors decide which journal they should submit their paper to.
The goal is to support authors to publish their work in the most suitable journal for their research, as fast as possible, accelerating their career progress.
Contact: Andrea Perlato, Head of Data Analytics, MDPI (email)
9 February 2021
The First International Electronic Conference on Clinical Medicine
We are pleased to announce that the first International Electronic Conference on Clinical Medicine (ECCM), chaired by Prof. Dr. Emmanuel Andrès, from the University Hospital of Strasbourg, France, and Prof. Dr. Michael G. Hennerici, from the University of Heidelberg, Germany, will be held on 15–30 September 2021 at Sciforum (https://sciforum.net/conference/ECCM).
The conference will cover all the multidisciplinary aspects of clinical medicine. The topics of interest include, but are not limited to, the following:
Cardiology
COVID-19
Gastroenterology and Hepatopancreatobiliary Medicine
Oncology
Infectious Diseases
Pulmonology
Hematology
Neurology and Stroke Neurology
Stomatology
Clinical Psychology
Psychiatry
Obstetrics and Gynecology
Endocrinology and Metabolism
Nephrology and Urology
Epidemiology and Public Health
Orthopedics
Dermatology
Ophthalmology
Otolaryngology
Nuclear Medicine and Radiology
Pharmacology
Anesthesiology
Emergency Medicine
The conference will be completely free of charge, both to attend and, for scholars, to upload and present their latest work on the conference platform. Accepted abstract submissions will be published in the proceedings of the conference, and authors are invited to develop their abstracts into full manuscripts, which will be considered for publication in JCM, with a 10% discount on the APC. JCM is an open access journal, published semimonthly by MDPI, in the field of clinical medicine. The journal is indexed in the Science Citation Index Expanded (SCIE IF = 3.303) and other databases. Full texts are archived in PubMed Central (PMC).
Important Dates
- Abstract Submission: 31 May 2021
- Acceptance Notification: 14 June 2021
- Full Paper Submission: 12 July 2021
- Conference Open: 15–30 September 2021
For more information on ECCM, please visit the conference website (https://sciforum.net/conference/ECCM) or contact us by email ([email protected]).
29 January 2021
The Spanish Society of Hematology and Hemotherapy (SEHH) is Now an Affiliated Society Member of Hemato, JCM and Cells
In November 2020, the Spanish Society of Hematology and Hemotherapy (SEHH) became affiliated with Hemato, JCM and Cells. As part of this collaboration, all members of the SEHH enjoy a discount on the article processing charge (APC) when submitting articles to the journals.
The SEHH is a scientific society purposed with the promotion, development and dissemination of research advances in two specialist areas, Hematology and Hemotherapy. In particular, the SEHH focuses on their medical, scientific, organizational, care, teaching and research aspects. Hematology, as a specialty, covers all aspects related to the physiology of the blood and hematopoietic organs, the diagnosis and treatment of benign and malignant diseases of the blood, the study of the hemostasis and coagulation system, and all aspects related to transfusion medicine, including hematopoietic stem cell transplantation. The professional role of the hematologist covers all aspects of the practice.
With 61 years of history, the SEHH is today an organization that contributes significantly to science. At present, it holds a community of almost 2800 professionals, of which many are internationally recognized figures, who continually contribute to making hematology, globally, one of the most prestigious fields of Spanish medicine. The society considers that, in order to achieve optimal patient care, it is essential to have access to medical advances, promote research and have well-trained and highly qualified specialists in the management of hematological diseases.
The SEHH is a professional organization whose functions and research are highly relevant to the scope of Hemato, JCM and Cells. We look forward to collaborating with the SEHH and to publishing state-of-the-art research from its members.
29 December 2020
Editorial Board Members of JCM Named 2020 Highly Cited Researchers in Web of Science
It is our pleasure to announce that seven JCM Editorial Board Members have been listed as 2020 Highly Cited Researchers by Clarivate. This corresponds to being in the top 1% of the most cited researchers for that publication year.
Prof. Dr. Robert C. Cantu
1. Department of Neurology, Boston University Alzheimer’s Disease and CTE Centers, Boston University School of Medicine, Boston, USA;2. Department of Neurosurgery, Boston University School of Medicine, Boston, USA; Concussion Legacy Foundation, Boston, MA, USA;
3. Department of Neurosurgery, Emerson Hospital, Concord, USA
Interests: Neurosurgery; Spine Surgery; Sports Medicine; Concussion Care
Dr. Michael R. Hamblin
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA
Interests: photodynamic therapy (PDT); low-level light therapy (LLLT); wound healing and infectious disease; atherosclerotic vulnerable plaque; anti-tumor immunity; photochemical mechanisms
Prof. Dr. Hans-Peter Hartung
Department of Neurology, Medical Faculty, Heinrich-Heine-University, Moorenstrasse 5, 40225, Düsseldorf, Germany
Interests: immune mediated neurological disroders; multiple sclerosis; NMOSD; immune encephalitides; immune neuropathies; Guillan Barre syndrome and CIDP
Prof. Dr. Gregory Y. H. Lip
1. Price-Evans Professor of Cardiovascular Medicine, University of Liverpool, United Kingdom2. Distinguished Professor, Aalborg University, Denmark
Interests: atrial fibrillation; hypertension; thrombosis and anticoagulation
Prof. Dr. Russel J. Reiter
Department of Cellular & Structural Biology, The UT Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
Interests: melatonin; free radicals of disease processes and aging; oxygen derivatives
Prof. Fred Saad
Centre Hospitalier de Université de Montréal, Montreal, Canada
Interests: Prostate cancer; biomarkers; novel therapeutics; castration resistant prostate cancer; GU cancers; metastases prevention
Dr. Allan H. Young
Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
Interests: Bipolar disorder; treatment resistant depression; cognition; translational
The 2020 Highly Cited Researchers list has been announced by Web of Science at: https://recognition.webofscience.com/awards/highly-cited/2020/.
15 December 2020
MDPI adopts C4DISC principles to improve diversity and inclusion in scholarly communications
MDPI is proud to adopt the principles of the Coalition for Diversity & Inclusion in Scholarly Communications (C4DISC) to support building equity, inclusion, diversity, and accessibility in scholarly communications.
The C4DISC represents organizations and individuals working in scholarly communications and is focused on addressing issues of diversity and inclusion within the publishing industry.
MDPI’s Managing Editors encourage the Editors-in-Chief and Associate Editors to appoint diverse expert Editorial Boards. This is also reflective in our multi-national and inclusive workplace. We are proud to create equal opportunities without regard to gender, ethnicity, geographic location, sexual orientation, age, disability, political beliefs, religion, or socio-economic status. There is no place for discrimination in our workplace and editors of MDPI journals are to uphold these principles in high regard.
Representatives from C4DISC meet monthly, and have started to implement initiatives to shed light and improve on the lack of diversity in scholarly communications. Some of the initiatives include developing a joint statement of principles; conducting market research; providing training resources, best practices, toolkits, and documentation for our collective memberships; and establishing outreach programs, curricula, events, and publications.
The Coalition is committed to:
- eliminating barriers to participation, extending equitable opportunities across all stakeholders, and ensuring that our practices and policies promote equitable treatment and do not allow, condone, or result in discrimination;
- creating and maintaining an environment that respects diverse traditions, heritages, and experiences;
- promoting diversity in all staff, volunteers, and audiences, including full participation in programs, policy formulation, and decision-making;
- raising awareness about career opportunities in our industries to groups who are currently underrepresented in the workforce;
- supporting our members in achieving diversity and inclusion within their organizations.
14 December 2020
Article Layout and Templates Revised for Future Volumes
At MDPI we have slightly revised the layout for articles to be published in the 2021 Volume, starting at the end of December 2020. As of today, the article templates available for download on ‘Instructions for Authors’ pages have been updated.
The most noticeable change can be found on the first page of the article, where a left-hand column has been created to include the following front matter elements: (i) the recommended citation style for the article, (ii) the publishing history, (iii) as well as the Creative Commons Attribution license used (iv) a standard note regarding affiliations. At the same time, the extra spacing on the left means the authors’ affiliations are now more clearly set apart than before. Other front matter key elements such as journal logo, article type, article title, authors, abstract and keywords remain unchanged.
The blank column on the left runs through all pages in an article; as a result, the main text is slightly more condensed, which improve reader friendliness for smaller screens. Small figures/tables are aligned on the left with standard indenture, while large figures/tables are centered and covering the full width of the page. The revised layout was applied in the article pictured below, to serve as an example:
1) Information is displayed in the left information bar.
2) In the main text, there is a blank column on the left.
3) Small tables/figures are aligned on the left, large tables/figures are centered.
11 December 2020
2020 "Highly Cited Researchers" on MDPI Journal's Editorial Boards
We are pleased to acknowledge that many academic editors who have made an impact on MDPI journals as editorial board members, editors-in-chief, or section editors, are recognized as 2020 Highly Cited Researchers by Clarivate.
Highly Cited Researchers highlights the top 1% of researchers, by citations, in one or more of the 22 fields used in Clarivate Analytics Essential Science Indicators. We offer our congratulations to 279 academic editors of MDPI journals who were recognized as the most influential scholars in their fields in 2020.
Adams, Dave Agarwal, Ravi P. Ahn, Choon Ki Ahn, Myung-Ju Albrecht, Randy A. Andersson, Dan I. Anker, Stefan D. Apergis, Nicholas Ariga, Katsuhiko Artaxo, Paulo Balsamo, Gianpaolo Barba, Francisco J. Benediktsson, Jon Atli Benelli, Giovanni Bhatnagar, Amit Bialystok, Ellen Blaabjerg, Frede Blay, Jean-Yves Bogers, Marcel Bolton, Declan J. Boyer, Cyrille Brocca, Luca Bruix, Jordi Buhalis, Dimitrios Burdick, Jason A. Byrd, John C. Cabeza, Luisa F. Cabrerizo-Lorite, Francisco Javier Cai, Jianchao Calhoun, Vince D. Cantu, Robert C. Cerqueira, Miguel Chang, Jo-Shu Chau, Kwok-wing Chemat, Farid Chen, Jianmin Chen, Jun Chen, Min Chen, Shaowei Chen, Wei Chen, Wei-Hsin Chen, Xiaofeng Chen, Yangkang Chen, Zhi-Gang Chiclana, Francisco Corella, Dolores Cortes, Javier Cortes, Jorge Cummings, Kenneth Michael Dai, Shifeng Decker, Eric A. DePinho, Ronald A. Dimopoulos, Meletios-Athanasios Dincer, Ibrahim Du, Yihong Dupont, Didier Edwards, David Ellahi, Rahmat Ellis, Erle C. ElMasry, Gamal Esteller, Manel Estruch, Ramón Fang, Chuanglin Fasano, Alessio Fernandez-Lafuente, Roberto Ferreira, Isabel Fortino, Giancarlo Galluzzi, Lorenzo Galvano, Fabio Gandomi, Amir H. Gandomi, Amir H. Gao, Bin Gao, Feng Gao, Wei Garbe, Claus García, Hermenegildo Geschwind, Daniel H. Giampieri, Francesca Giralt, Sergio A. Glanz, Karen Goldewijk, Kees Klein Gössling, Stefan Govindan, Kannan Granato, Daniel Grosso, Giuseppe Grosso, Giuseppe Guerrero, Josep M. Haase, Dagmar Hagger, Martin S. Hamblin, Michael R. Han, Heesup Jankovic, Joseph Janotti, Anderson |
Jiang, Hai-Long Kalaji, Hazem M. Kalantar-Zadeh, Kourosh Kaner, Richard B. Karimi, Hamid Reza Kataoka, Kazunori Keesstra, Saskia Kepp, Oliver Kerminen, Veli-Matti Keyzers, Robert A. Khademhosseini, Ali Khan, Nafees A. Kim, Ki-Hyun Klemeš, Jiří Jaromír Klenk, Hans-Peter Konopleva, Marina Y. Krammer, Florian Krebs, Frederik C. Kroemer, Guido Kudo, Masatoshi Kurths, Juergen Kurzrock, Razelle Kuznetsov, Nikolay V. Kyrpides, Nikos C. La Vecchia, Carlo Lai, Yuekun Lam, James Lancellotti, Patrizio Lee, Sangmoon Leung, Victor C. M. Li, Jinghong Li, Yurui Lindahl, José M. Merigó Lip, Gregory Y. H. Loh, Xian Jun Long, Hualou Lund, Henrik Luo, Jingshan Luque, Rafael Lyons, Timothy W. Ma, Jun Ma, Wen-Xiu Ma, Yanming Maeda, Keisuke Makarova, Kira Mantovani, Alberto Martín-Belloso, Olga Martinoia, Enrico Marzband, Mousa Masclaux-Daubresse, Celine Masson, Patrick Mateos, María Victoria Mathiesen, Brian Vad Matyjaszewski, Krzysztof McArthur, Grant A. McCauley, Darren Medlock, Jolyon M. Melero, Ignacio Mezzetti, Bruno Miroshnichenko, Andrey E. Moran, Daniel Mueller, Lukas A. Mueller-Roeber, Bernd Naushad, Mu Nemeroff, Charles B. Nieto, Juan J. O'Donnell, Colm Ogino, Shuji Olabi, Abdul-Ghani O'Regan, Donal Orsini, Nicola Oswald, Isabelle P. Ozcan, Aydogan Pahl-Wostl, Claudia Pang, Huan Payne, James E. Peng, Shushi Perc, Matjaz Perez-Alvarez, Jose Angel Piquero, Alex R. Ploss, Alexander Postolache, Mihai Pradhan, Biswajeet Prinsep, Michele R. Qian, Dong Qu, Xiaogang Reiter, Russel J. Riahi, Keywan Richter, Andreas Rignot, Eric Robert, Caroline Ros, Emilio Rosell, Rafael |
Rosen, Marc A. |
The full list of 2020 Highly Cited Researchers can be accessed on https://recognition.webofsciencegroup.com/awards/highly-cited/2020/
--- Highly Cited Researchers (HCR) is a Clarivate product.
7 December 2020
Recruiting Editorial Board Members for JCM
JCM is recruiting Editorial Board Members for the following sections:
https://www.mdpi.com/journal/jcm/sections.
The main responsibilities of Editorial Board Members are as follows:
1) Making decisions on whether a manuscript can be accepted based on the reports we collect;
2) Reviewing a small number of papers each year;
3) Acting as or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
4) Promoting JCM and increasing its visibility at related academic conferences.
Journal of Clinical Medicine (ISSN 2077-0383) is an international scientific open-access journal, providing a platform for advances in health care/clinical practices, the study of direct observation of patients, and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals. It is abstracted and indexed in the Science Citation Index Expanded in Web of Science and other databases, with citations available in PubMed, and is full-text archived in PubMed Central. The 2019 IF for JCM was 3.303.
This position is open to experts in clinical medicine. To apply for this position (in one of our Sections), recommend potential candidates, or request further information, please contact the JCM Editorial Office ([email protected]) or Lily Pei ([email protected]).
4 December 2020
JCM Free Webinar: Prediction of Preterm Birth in High Risk Pregnancies—06 December 2020
Preterm birth (PTB) remains one of the biggest challenges in contemporary obstetrics as it is associated with an increased risk of mortality as well as short- and long-term morbidity of the offspring. Many risk factors for PTB have been identified, including multiple gestation, placental insufficiency, cervical pathology and uterine factors, among others. As a result, many women are currently classified as at high risk for PTB. Accurate prediction of PTB is crucial as it can assist in selecting the optimal prevention measurements and counseling regarding the suitable antepartum follow up and the need for potential transfer to the appropriate facility in case of very high risk of PTB.
With a distinguished panel of leaders in this field, Professors Liran Hiersch, John Kingdom, Nathan Fox, Tal Biron-Shental and Ido Solt, this webinar will address aspects and perspectives on the prediction of PTB in various clinical scenarios.
Date: 6th December 2020 | 3:00 p.m. CET | 9:00 a.m. EST
Webinar ID: 862 1088 3441
Register for Free Here: https://clincialmed-4.sciforum.net/
Chair:
His main fields of interest include twin pregnancies, fetal growth and preterm birth. |
|
Dr. Liran Hiersch |
Speakers:
Presentation: Placenta Growth Factor: predicting placenta-mediated preterm delivery |
|
Dr. John Kingdom |
|
Presentation: Prediction and Prevention of Preterm Birth in Twins |
|
Dr. Nathan Fox |
|
Presentation: The correlation between telomere homeostasis and gestational length
|
|
Prof. Tal Biron-Shental |
|
Presentation: Is the vaginal microbiome a predictor of preterm birth? |
|
Dr. Ido Solt |
For any questions about the webinar, please contact us at [email protected].
2 November 2020
Current Oncology, Canada's Premier Oncology Journal, Published with MDPI from 2021
MDPI acquired Current Oncology (ISSN 1718-7729) in October 2020 from Multimed Publications Inc., who launched the title in 1994, as Canada’s first peer-reviewed journal in oncology.
Current Oncology features papers in all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. It continues to be a trusted source for all members of the oncology community in Canada and abroad.
Coverage in indexing services includes MEDLINE (PubMed/National Library of Medicine), the Science Citation Index Expanded (Web of Science), Journal Citation Reports, Scopus (Elsevier), EMBASE (Elsevier), and more. Current Oncology's 2019 Impact Factor is 2.257, ranked 185/244 in the 'Oncology' category.
Previously published six times annually, normally with one or two additional supplements, MDPI will continue the schedule of bimonthly publications. The current volume of Current Oncology (v. 27) will be concluded at the end of 2020, at which point MDPI will take over publication of the journal, starting with Volume 28, at the beginning of 2021.
The goal is to greatly expand the journal's global reach, alongside MDPI's flagship Cancers journal, in order to become one of the world’s leading oncology journals.
Website: https://www.mdpi.com/journal/curroncol
Contact: Danica Jevtic, Marko Ristic
Current Oncology Editorial Office
2 November 2020
“JCM 2020 Outstanding Research Award” Winner Announcement
The JCM Outstanding Research Award was initiated to recognize outstanding research by authors of the journal that has had a significant international impact. The novelty and significance of research works were assessed by the JCM Editorial Board and reviewers along with consideration of the citations.
We are very pleased to announce that Dr. Robin Nicholas Thompson will be granted the JCM 2020 Outstanding Research Award for his contribution of using mathematical models to represent the epidemiological or evolutionary behavior of infectious disease outbreaks. The main aims are not only to generate forecasts of specific outbreaks but also to understand how diseases spread such that forecasts can be made, and control interventions can be planned with more precision.
His paper “Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations” published in February 2020 (https://www.mdpi.com/2077-0383/9/2/498) was recognized as recommended reading by the World Health Organization.
Please join us in congratulating Dr. Thompson on receiving this award.
29 October 2020
JCM Free Webinar: Dry Eye 360- Looking at Dry Eye Disease from all Directions—3rd November 2020
Dry Eye Disease (DED) has gained recognition as a public health problem given its prevalence, morbidity, and cost implications. DED can have a variety of symptoms including blurred vision and ocular pain (dryness, burning aching) and a variety of signs including decreased tear production, corneal epithelial disruption, and rapid tear evaporation. However, it is well known that there is often a discrepancy between symptoms and signs of disease.
Date: 1.30pm (CET) | 06.30am (CDT)
Duration: Maximum 2 hours
Webinar ID: 961 1378 0758
Register for Free Here: https://sciforum.net/conference/JCM3
Chair:
Presentation: DED from the outside- a discussion on the interaction between environmental exposures and the ocular surface, and their manifestation as DED. |
|
Associate Professor Anat Galor Guest Editor of “Dry Eye Syndrome: New Insights on Epidemiology and Management” |
Speakers:
Presentation: DED from the inside- a discussion on systemic co-morbidities that may associated and drive disease. |
|
Professor Stephen C. Pflugfelder |
|
Presentation: DED and the local neighborhood- a discussion on effects of the periocular skin and eyelids on the ocular surface and DED. |
|
Associate Professor Jennifer Craig |
For any questions about the webinar, please email [email protected].
20 August 2020
JCM Free Webinar: Advances in Preterm Delivery—24 September 2020
Preterm delivery (PTD; <37 weeks' gestation) complicates 5-13% of deliveries worldwide depending on the geographical and demographical characteristics of the population tested. Based on data from 184 countries, the global average preterm birth rate in 2010 was 11.1% giving a worldwide 14.9 million. It is the leading cause of perinatal morbidity and mortality as well as maternal morbidity. With a distinguished panel of Professors Eyal Sheiner, Gian Carlo Di Renzo, Shali Mazaki-Tovi and Nir Melamed, this webinar will address and share new perspectives on the prevention and monitoring of Preterm Delivery.
Date: 24 September 2020 | 1 pm (CEST) | 7 am (EDT) | 7 am (CST Asia)
Duration: Maximum 2 hours
Webinar ID: 856 8826 9334
Register for Free Here: https://sciforum.net/conference/ClinicalMed-2
Chair:
Presentation: Preterm delivery and other “placental” complications, and long-term maternal morbidity. |
|
Professor Dr. Eyal Sheiner Guest Editor of “Advances in Preterm Delivery” |
Speakers:
Presentation: Prevention of preterm birth: The evidence |
|
Prof. Dr. Gian Carlo Di Renzo |
|
Presentation: Bad rest or bed rest: efficacy and safety of decreased physical activity for the prevention of preterm birth.
|
|
Prof. Dr. Shali Mazaki-Tovi |
|
Presentation: Is there a role for serial monitoring of cervical length in twin pregnancies?
|
|
Prof. Dr. Nir Melamed |
For any questions about the webinar, please send an email to [email protected].
10 July 2020
Meet Us at the Society for Neurosciences’ 50th Annual Meeting (Neuroscience 2020), Washington, USA, 24–28 October 2020
MDPI will be attending the conference Neuroscience 2020, which will be hosted in Washington, USA, 24–28 October 2020.
SfN’s 50th annual meeting is the premier venue for the presentation of emerging science in the field of neurosciences, where one can learn from experts, forge collaborations with peers, explore new tools and technologies, and advance their career.
The following MDPI journals will be represented:
- Brain Sciences (leading journal)
- JCM
- Medicina
- Genes
- Children
- Cancers
- Behavioral Sciences
- Cells
- IJERPH
- Disease
- Biomedicines
- JPM
- Pathogens
- Healthcare
- IJMS
- Psych
- Pharmaceuticals
- Clocks&Sleep
- Jounal of Intelligence
- Pharmaceutics
If you are attending this conference, please feel free to stop by our booth (Booth #208). Our delegates look forward to meeting you in person, to answer any questions you may have. For more information about the conference, please visit:
10 July 2020
JCM: Five Experts in the Editorial Board Named 2019 "Highly Cited Researchers" in Web of Science
It is our pleasure to announce that five JCM Editorial Board Members have been listed as Highly Cited Researchers:
Prof. Fred Saad
Centre Hospitalier de Université de Montréal, Montreal, Canada
Interests: prostate cancer; biomarkers; novel therapeutics; castration resistant prostate cancer; GU cancers; metastases prevention
Prof. Dr. Gregory Y. H. Lip
1. Price-Evans Professor of Cardiovascular Medicine, University of Liverpool, United Kingdom
2. Distinguished Professor, Aalborg University, Denmark
Interests: atrial fibrillation; hypertension; thrombosis and anticoagulation
Prof. Dr. Laxmaiah Manchikanti
Pain Management Center of Paducah Associate Clinical, Anesthesiology and Perioperative Medicine, University of Louisville, 2831 Lone Oak Road, Paducah, KY 42003, USA
Interests: back pain; low back pain; opioids; spinal pain; chronic pain; interventional pain management
Dr. Michael R. Hamblin
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA
Interests: photodynamic therapy (PDT); low-level light therapy (LLLT); wound healing and infectious disease; atherosclerotic vulnerable plaque; anti-tumor immunity; photochemical mechanisms
Prof. Dr. Russel J. Reiter
Department of Cellular & Structural Biology, The UT Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
Interests: melatonin; free radicals of disease processes and aging; oxygen derivatives
The 2019 Highly Cited Researchers list has been announced by Web of Science at:
https://recognition.webofsciencegroup.com/awards/highly-cited/2019/
9 July 2020
Open Access Agreement Between Jisc Collections and MDPI
We are delighted to announce the establishment of our Open Access agreement with Jisc Collections, which will allow UK institutions to benefit from access to article processing charge (APC) discounts and streamlined payment workflows.
All institutions participating in the agreement will also gain access to the MDPI online submission system where they can find full article metadata and pricing information for easy identification and additional transparency.
Eligible authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system.
About Jisc
Jisc's vision is for the UK to be the most digitally advanced education and research nation in the world. At its heart is the super-fast national research and education network, Janet, with built-in cyber security protection. Jisc also provides technology solutions for its members (colleges, universities and research centres) and customers (public sector bodies), helps members save time and money by negotiating sector-wide deals and provides advice and practical assistance on digital technology. Jisc is funded by the UK higher and further education and research funding bodies and member institutions.
For more information, contact [email protected].
About MDPI
MDPI is a publisher of fully peer-reviewed, Open Access journals with a focus on thorough and rapid editorial processing. Its aim is to ensure that high-quality research is verified and made available to the research community as quickly as possible. MDPI stands at the forefront of the Open Access movement, having launched its first online journal Molecules in 1996. Today, MDPI is a leader in Open Access publishing with over 250 journals across all research disciplines, and all content published under a Creative Commons Attribution License (CC BY).
For any questions about this agreement, please contact the MDPI IOAP team at [email protected].
29 June 2020
Updated Impact Factors Released in the Journal Citation Reports (Clarivate)
The updated citation metrics have been released in the Journal Citation Reports (JCR), published by Clarivate. The recent release of the JCR includes seventy-one MDPI titles. Out of these, 18 titles are newcomers, receiving a first Journal Impact Factor which is based on citation activity in 2019: Actuators, Agriculture, Biology, Biomedicines, Biosensors, Chemosensors, Children, Healthcare, Journal of Fungi, Journal of Personalized Medicine (JPM), Land, Life, Magnetochemistry, Membranes, Pharmaceuticals, Photonics, Separations and Toxics.
- Out of the previously listed journals, a total of 72 percent boast an increased Impact Factor.
- 25 journals are ranked among the top 25% of journals in at least one of the categories they are ranked for.
- Articles published in 2019 in MDPI journals account for approximately 17 percent of of articles published in gold Open Access journals covered in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI).
First Impact Factors
Journal | Impact Factor | Rank | Category | Details |
Actuators | 1.957 | 31/64 (Q2) | • Instruments & Instrumentation | Link |
Agriculture | 2.072 | 25/91 (Q2) | • Agronomy | Link |
Biology | 3.796 | 19/93 (Q1) | • Biology | Link |
Biomedicines | 4.717 | 30/138 (Q1) 36/270 (Q1) |
• Medicine, Research & Experimental • Pharmacology & Pharmacy |
Link |
Biosensors | 3.240 | 24/86 (Q2) | • Chemistry, Analytical | Link |
Chemosensors | 3.108 | 16/64 (Q1) 27/86 (Q2) 13/27 (Q2) |
• Instruments & Instrumentation • Chemistry, Analytical • Electrochemistry |
Link |
Children | 2.078 | 50/128 (Q2) | • Pediatrics | Link |
Healthcare | 1.916 | 62/102 (Q3) 45/87 (Q3) |
• Health Care Sciences & Services (SCIE) • Health Policy & Services (SSCI) |
Link |
Journal of Fungi | 4.621 | 5/29 (Q1) 31/135 (Q1) |
• Mycology • Microbiology |
Link |
Journal of Personalized Medicine | 4.433 | 24/165 (Q1) 10/102 (Q1) |
• Medicine, General & Internal • Health Care Sciences & Services |
Link |
Land | 2.429 | 58/123 (Q2) | • Environmental Studies (SSCI) | Link |
Life | 2.991 | 26/93 (Q2) 109/267 (Q2) |
• Biology • Microbiology |
Link |
Magnetochemistry | 1.947 | 22/45 (Q2) 109/159 (Q3) 201/314 (Q3) |
• Chemistry, Inorganic & Nuclear • Chemistry, Physical • Materials Science, Multidisciplinary |
Link |
Membranes | 3.094 | 53/143 (Q2) 129/314 (Q2) 23/89 (Q2) |
• Engineering, Chemical • Materials Science, Multidisciplinary • Polymer Science |
Link |
Pharmaceuticals | 4.286 | 49/270 (Q1) | • Pharmacology & Pharmacy | Link |
Photonics | 2.140 | 48/97 (Q2) | • Optics | Link |
Separations | 1.900 | 53/86 (Q3) | • Chemistry, Analytical | Link |
Toxics | 3.271 | 32/92 (Q2) 92/265 (Q2) |
• Toxicology • Environmental Sciences |
Link |
Updated Impact Factors
Journal | Impact Factor | Rank | Category | Details |
Agronomy | 2.603 | 18/91 (Q1) 65/234 (Q2) |
• Agronomy • Plant Sciences |
Link |
Animals | 2.323 | 10/63 (Q1) 14/142 (Q1) |
• Agriculture, Dairy & Animal Science • Veterinary Sciences |
Link |
Antibiotics | 3.893 | 23/93 (Q1) 64/270 (Q1) |
• Infectious Diseases • Pharmacology & Pharmacy |
Link |
Antioxidants | 5.014 | 10/139 (Q1) 56/297 (Q1) 7/61 (Q1) |
• Food Science & Technology • Biochemistry & Molecular Biology • Chemistry, Medicinal |
Link |
Applied Sciences | 2.474 | 161/314 (Q3) 32/91 (Q2) 88/177 (Q2) 62/154 (Q2) |
• Materials Science, Multidisciplinary • Engineering, Multidisciplinary • Chemistry, Multidisciplinary • Physics, Applied |
Link |
Atmosphere | 2.397 | 48/93 (Q3) | • Meteorology & Atmospheric Sciences | Link |
Biomolecules | 4.082 | 98/297 (Q2) | • Biochemistry & Molecular Biology | Link |
Brain Sciences | 3.332 | 113/271 (Q2) | • Neurosciences | Link |
Cancers | 6.126 | 37/244 (Q1) | • Oncology | Link |
Catalysts | 3.520 | 65/159 (Q2) | • Chemistry, Physical | Link |
Cells | 4.366 | 70/195 (Q2) | • Cell Biology | Link |
Coatings | 2.436 | 10/21 (Q2) | • Materials Science, Coatings & Films | Link |
Crystals | 2.404 | 10/26 (Q2) 165/314 (Q3) |
• Crystallography • Materials Science, Multidisciplinary |
Link |
Diagnostics | 3.110 | 39/165 (Q1) | • Medicine, General & Internal | Link |
Diversity | 1.402 | 119/168 (Q3) | • Ecology | Link |
Electronics | 2.412 | 125/266 (Q2) | • Engineering, Electrical & Electronic | Link |
Energies | 2.702 | 63/112 (Q3) | • Energy & Fuels | Link |
Entropy | 2.494 | 33/85 (Q2) | • Physics, Multidisciplinary | Link |
Foods | 4.092 | 27/139 (Q1) | • Food Science & Technology | Link |
Forests | 2.221 | 17/68 (Q1) | • Forestry | Link |
Genes | 3.759 | 53/177 (Q2) | • Genetics & Heredity | Link |
Insects | 2.220 | 18/101 (Q1) | • Entomology | Link |
International Journal of Environmental Research and Public Health (IJERPH) | 2.849 | 58/193 (Q2) 32/170 (Q1) 105/265 (Q2) |
• Public, Environmental & Occupational Health (SCIE) • Public, Environmental & Occupational Health (SSCI) • Environmental Sciences (SCIE) |
Link |
International Journal of Molecular Sciences (IJMS) | 4.556 | 74/297 (Q1) 48/177 (Q2) |
• Biochemistry & Molecular Biology • Chemistry, Multidisciplinary |
Link |
ISPRS International Journal of Geo-Information (IJGI) | 2.239 | 31/50 (Q3) 18/30 (Q3) |
• Geography, Physical • Remote Sensing |
Link |
Journal of Clinical Medicine | 3.303 | 36/165 (Q1) | • Medicine, General & Internal | Link |
Journal of Marine Science and Engineering | 2.033 | 31/66 (Q2) | • Oceanography | Link |
Marine Drugs | 4.073 | 16/61 (Q2) | • Chemistry, Medicinal | Link |
Materials | 3.057 | 132/314 (Q2) | • Materials Science, Multidisciplinary | Link |
Mathematics | 1.747 | 28/324 (Q1) | • Mathematics | Link |
Medicina | 1.205 | 107/165 (Q3) | • Medicine, General & Internal | Link |
Metabolites | 4.097 | 95/297 (Q2) | • Biochemistry & Molecular Biology | Link |
Metals | 2.117 | 18/79 (Q1) 185/314 (Q3) |
• Metallurgy & Metallurgical Engineering • Materials Science, Multidisciplinary |
Link |
Micromachines | 2.523 | 56/92 (Q3) 23/64 (Q2) |
• Nanoscience & Nanotechnology • Instruments & Instrumentation |
Link |
Microorganisms | 4.152 | 37/135 (Q2) | • Microbiology | Link |
Minerals | 2.380 | 6/21 (Q2) 11/30 (Q2) |
• Mining & Mineral Processing • Mineralogy |
Link |
Molecules | 3.267 | 70/177 (Q2) 141/297 (Q2) |
• Chemistry, Multidisciplinary • Biochemistry & Molecular Biology |
Link |
Nanomaterials | 4.324 | 89/314 (Q2) 42/103 (Q2) |
• Materials Science, Multidisciplinary • Nanoscience & Nanotechnology |
Link |
Nutrients | 4.546 | 17/89 (Q1) | • Nutrition & Dietetics | Link |
Pathogens | 3.018 | 65/135 (Q2) | • Microbiology | Link |
Pharmaceutics | 4.421 | 44/270 (Q1) | • Pharmacology & Pharmacy | Link |
Plants | 2.762 | 58/234 (Q1) | • Plant Sciences | Link |
Polymers | 3.426 | 16/89 (Q1) | • Polymer Science | Link |
Processes | 2.753 | 59/143 (Q2) | • Engineering, Chemical | Link |
Remote Sensing | 4.509 | 9/30 (Q2) | • Remote Sensing | Link |
Sensors | 3.275 | 22/86 (Q2) 77/266 (Q2) 15/64 (Q1) |
• Chemistry, Analytical • Engineering, Electrical & Electronic • Instruments & Instrumentation |
Link |
Sustainability | 2.576 | 120/265 (Q2) 26/41 (Q3) 53/123 (Q2) 6/8 (Q3) |
• Environmental Sciences (SCIE) • Green & Sustainable Science & Technology (SCIE) • Environmental Studies (SSCI) • Green & Sustainable Science & Technology (SSCI) |
Link |
Symmetry | 2.645 | 29/71 (Q2) | • Multidisciplinary Sciences | Link |
Toxins | 3.531 | 21/92 (Q1) 34/139 (Q1) |
• Toxicology • Food Science & Technology |
Link |
Universe | 1.752 | 18/29 (Q3) 42/68 (Q3) |
• Physics, Particles & Fields • Astronomy & Astrophysics |
Link |
Vaccines | 4.086 | 57/158 (Q2) 50/138 (Q2) |
• Immunology • Medicine, Research & Experimental |
Link |
Viruses | 3.816 | 12/37 (Q2) | • Virology | Link |
Water | 2.544 | 31/94 (Q2) | • Water Resources | Link |
Source: Clarivate 2020, InCites Journal Citation Reports®.
5 June 2020
Journal of Clinical Medicine Reaches 5000 Articles Milestone
The Journal of Clinical Medicine (ISSN 2077-0383), an MDPI open access journal on health care, clinical practices, and general medical research, has passed another milestone by publishing its 5000th article since its inception in 2012.
JCM is now covered in the Science Citation Index Expanded in Web of Science and received an impact factor of 5.688 in 2018, which corresponds to a ranking of 15/160 (Q1) under the category ‘Medicine, General & Internal’.
JCM publishes original research covering the following non-exhaustive list of topical areas: Anesthesiology, Cardiology, Clinical Cytology, Clinical Neurology, Clinical Psychology, Dermatology, Emergency Medicine, Endocrinology & Metabolism, Epidemiology & Public Health, Gastroenterology & Hepatopancreatobiliary Medicine, Hematology, Immunology, Infectious Diseases, Molecular Diagnostics, Nuclear Medicine & Radiology, Nephrology & Urology, Obstetrics & Gynecology, Oncology, Ophthalmology, Orthopedics, Otolaryngology, Pharmacology, Psychiatry, Pulmonology, Vascular Medicine, Stomatology.
13 May 2020
COVID-19 Academic Resources Center
Since 1996, MDPI has been committed to supporting the research community by providing the latest research freely available and making relevant and useful research available as quickly as possible. The world is current experiencing a pandemic of COVID-19, and researchers are working extremely hard to understand it and find a cure.
The values MDPI holds strongly are particularly important at the moment, and we will continue to publish relevant, peer-reviewed research as quickly as possible in open access format. This means that it will immediately be available for researchers, health professionals, and the general public to read, distribute, and reuse. We believe that scientific advancements will be crucial to overcoming this pandemic, and will do everything we can to support researchers working looking for solutions.
COVID-19 Academic Resources Center contains a variety of information related to COVID-19 available from MDPI, including journal articles, special issues, and preprints, among others.
For more information, please visit: https://www.mdpi.com/covid-19
30 April 2020
Meet Us at the European Society of Cardiology Congress 2020(ESC Congress 2020) in Amsterdam, The Netherlands, 29 Aug–2 Sep 2020
MDPI will be attending the European Society of Cardiology Congress 2020(ESC Congress 2020) in Amsterdam, The Netherlands, 29 Aug–2 Sep 2020.
ESC Congress 2020 will build on the solid foundations of a congress which attracts worldwide cardiology leaders to present and exchange on their knowledge and most important research results. It will focus on the best and latest science but will also emphasize the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.
The following MDPI journals will be represented:
If you are also attending this conference, please feel free to stop by our booth (Booth N600). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit here.
9 April 2020
Free Open Platforms to Support Academics During the COVID-19 Pandemic
As a leading Open Access publisher, MDPI is committed to fostering open scientific exchange in all forms across all disciplines. Due to the outbreak of COVID-19, many researchers have to stay at home and many academic conferences have been cancelled or postponed. In light of these changes, MDPI has adopted numerous initiatives that may help accelerate scientific exchange and provide support to the academics during this period.
Scholarly Community—Encyclopedia
Encyclopedia is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.
Comprehensive and Free Literature Database—Scilit
Scilit is a comprehensive, free database for scientists that uses a new method to collate data and index scientific material. Our crawlers extract the latest data from CrossRef and PubMed on a daily basis. This means that newly published articles are immediately added to Scilit.
Display Academic Achievements—SciProfiles
SciProfiles is an innovative social network for researchers and scholars that is developed by MDPI. In line with our broad mission, the purpose of SciProfiles is to accelerate discovery and innovation by facilitating immediate access to research results and providing opportunities for academic networking.
Organize and Participate in Conferences Online—Sciforum
Sciforum is an event planning platform that supports open science by offering the opportunity to host and participate in academic conferences. It provides an environment for scholarly exchange, discussion of topics of current interest, building of networks, and establishing collaborations.
Post Early Versions of Research Outputs—Preprints
Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. We post original research articles and comprehensive reviews, and papers can be updated by authors at any time. Content on Preprints is not peer-reviewed, and feedback can be received from readers.
***
MDPI remains committed to open science and open data and has signed a statement, along with more than thirty scholarly publishers, showing our intention to facilitate sharing of new research findings as early on as possible. The initiative sees publishers collectively removing barriers to new research, in the face of a global healthcare crisis.
25 March 2020
MDPI Comment on the COVID-19 Virus
The world is currently suffering from a global pandemic of the corona virus COVID-19. MDPI expresses its sympathies for all of those affected by the virus and stands in solidarity with medical staff and researchers treating patients and searching for scientific solutions.
MDPI has previously published papers covering corona viruses in addition to new papers on the current outbreak, see all papers here. In particular, Viruses has published a number of Special Issues and papers on the topic (see here, here, and here) as well as a forthcoming Special Issue.
Alongside journal articles, MDPI has been a strong supporter of preprints, which are increasingly being used to rapidly disseminate the latest research, and we run the preprint server Preprints.org. Our database of research articles, Scilit, is free to use and covers all publishers including preprint servers. New papers are often in search results within hours of publication and users can set up alerts for new papers.
Our main priority during this period has been the health and safety of staff, and we continue to allow staff to work at home and closely monitor the situation in all locations in which we work. Despite the restrictions, we continue to provide a full publication service and, by close collaboration with our editorial boards and making use our in-house teams, ensure that there are no unnecessary delays in publishing vital research. Fast and open publication has always been at the core of MDPI values and is now more important than ever.
We hope that a solution to the current situation will emerge soon. In the meantime, we will do our best to continue communicating vital research in all fields.
20 March 2020
MDPI Backs Open Pharma Statement on Open Access
MDPI has endorsed Open Pharma’s Position Statement in support of open access publishing with the aim of advancing medical science and ultimately, improving patient care. Open pharma is a group of research funders, healthcare professionals, publishers, academics, and other healthcare stakeholders.
Since its inception in 1996, MDPI’s efforts have aligned with Open Pharma’s vision of more effective and transparent publishing, collaborating internationally with experts to deliver peer-reviewed online research journals to the scientific community and the general public. MDPI publishes 56 journals in the field of Medicine and Pharmacology and is planning to hold the World Pharma Forum in Basel in 2021.
Published under a Creative Commons License, MDPI’s articles can be freely shared and their content re-used, upon proper attribution. In support of the statement, MDPI will continue to uphold its open access policy and provide fast editorial services to ensure that new medical evidence can be read by everyone, without paywall restrictions.
18 March 2020
MDPI Co-Signed Position Statement on Transformative Agreements
The advantages of the open access model of scientific publishing are being increasingly recognized in the scientific community. It allows new scientific evidence to be accessed from the moment of publication for free by anyone around the globe, boosting the impact of new research. In response, many funders, libraries and universities have been adopting new principles to accelerate the transition to open access.
Recently, “transformative agreements” have been negotiated between traditional publishers and various institutions. While increasing the number of open access papers, these agreements lack binding commitments to a full transition to open access, their conditions vary across different regions, and access is still limited for many users.
MDPI is a co-signatory of the recent position statement raising concerns about potential downsides of transformative agreements and how they may delay a full transition to open access. The statement highlights that these models “risk perpetuating current limitations on access, transparency and market competitiveness, while simultaneously facilitating excessive charges on the public purse”.
As a pioneering open access journal publisher, MDPI is the first to promote the importance of science being made available to everyone. Our peer-reviewed journals, covering diverse academic disciplines, are fully accessible to the public free of charge under a Creative Commons Attribution License (CC BY). This is why, along with other open access publishers, MDPI is a proud signatory of the position paper and is committed to contributing to the replacement of weak transitional agreements with “agreements with publishers that are already fully committed to open science and who offer full, immediate and transparent Open Access”.
Read the position paper here
16 March 2020
Encyclopedia Outstanding Contributor Awards 2020 - Open for Application
We are pleased to announce that Encyclopedia will be awarding five Outstanding Contributor Awards for researchers in 2020. The nominations and applications will be assessed by an Evaluation Committee consisting of senior scholars from the Encyclopedia Editorial Board.
Prize for Winners
- An official certificate;
- A cash award of 500 CHF or an MDPI discount voucher of 800 CHF.
Application Deadline
31 December, 2020 (Please send your application email with a list of all entries you contributed to our office before the deadline: [email protected])
Candidate Requirements
- Have a Ph.D. degree;
- Have more than three qualified entries published in Encyclopedia in 2020.
Evaluation Standards
- Number of entries published in Encyclopedia in 2020;
- Quality of entries online (including length, figure quality, and novelty);
- Impact of entries (including the number of likes, discussion contents, views, and downloads).
If you are a researcher and have not yet contribute entries to Encyclopedia, please do not miss this chance to highlight your research results.
21 February 2020
Registered Report: New Article Type Accepted For Submission
We are pleased to announce that our journals Animals, Cancers and Journal of Clinial Medicine (JCM) are starting to accept submissions of Registered Reports, to be considered for publication in one of these journals.
Registered Reports are scientific articles which are peer-reviewed before the research is performed and the data are collected. The ideas that meet high scientific standards, such as rigor, soundness, significant importance and implications for the science community, are then provisionally accepted for publication before data collection starts. This format helps to considerably reduce publication bias and to avoid researchers having to invest much time and effort into questionable research studies, while allowing enough flexibility to perform unregistered experiments and report serendipitous findings.
The detailed guidelines for authors to prepare the manuscript can be accessed on the three journals’ instructions website, i.e., Animals, Cancers, Journal of Clinial Medicine. The guidelines for reviewers can be accessed online at Guidelines for Reviewers for Registered Reports Papers.
Please feel free to contact the respective journal editorial offices for related questions (Animals office; Cancers office; JCM office).
19 February 2020
Meet Us at American Thoracic Society (ATS) 2020 Congress in Philadelphia, PA, USA, 15–20 May 2020
MDPI will be attending the American Thoracic Society (ATS) 2020 Congress in Philadelphia, PA, USA, 15–20 May 2020.
The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. It is truly where today’s science meets tomorrow’s care.
This international conference is also multidisciplinary. Clinicians and researchers in many other fields attend the conference, thereby enriching conversations that lead to insights that ultimately improve patient care.
The following MDPI journals will be represented:
If you are also attending this conference, please feel free to stop by our booth (Booth 1101). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://conference.thoracic.org.
11 December 2019
Meet Us at Precision Medicine World Conference 2020 in Silicon Valley, CA, USA, 21-24 January, 2020
MDPI will be attending Precision Medicine World Conference 2020 in Silicon Valley, CA, USA, 21-24 January, 2020.
PMWC, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization & collaboration in an effort to accelerate the development and spread of precision medicine.
The following MDPI journals will be represented:
- Journal of Personalized Medicine
- Journal of Clinical Medicine
- Medicial Sciences
- Cancers
- Healthcare
- Medicines
- Genes
- Diagnostics
If you are also attending this conference, please feel free to stop by our booth (Booth C1823). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.pmwcintl.com/
11 October 2019
Introducing SciProfiles, an Academic Social Network
MDPI is pleased to announce the release of SciProfiles, its social network platform for researchers and scholars.
The purpose of SciProfiles is aligned with MDPI’s broad mission to accelerate discovery and innovation by facilitating immediate access to research results and to serve scholars and communities by providing opportunities for academic networking.
SciProfiles also ambitions to serve as a sustainable, transparent and community-driven research evaluation system aligned with the DORA principles (https://sfdora.org/). Through their scientific profiles, academics can highlight their contribution to research communities, and measure their impact on their field, beyond publication numbers and impact factors. SciProfiles is currently a beta version and will enrich to give researchers the possibility to highlight all of their contributions to science and their scientific communities as authors, reviewers, editors, conference organizers, conference panelists, conference keynote speakers, or even as lecturers or student mentors at their University.
The classic components of popular community social networks, including follower/following, classical metrics, endorsements and recommendations (https://www.mdpi.com/about/announcements/1690), comments (https://www.mdpi.com/about/announcements/1397) are or will be very soon highlighted in SciProfiles as open science contributions.
To help increase the impact and visibility of articles and their authors to an appropriate audience, the platform offers a NewsFeed that includes recommendations of relevant content based on interests, publication history, saved searches or colleagues’ recommendations.
SciProfiles’ avatars are now being integrated on several MDPI platforms, meaning that you will directly access researchers’ profiles from any of the MDPI platforms:
MDPI's journal publishing website: www.mdpi.com
MDPI's conference hosting and management website: www.sciforum.net
MDPI's pre-print website : www.preprints.org
MDPI's knowledge sharing website : www.encyclopedia.pub
MDPI's books store: www.mdpi.com/books
MDPI's literature database : www.scilit.net
SciProfiles aims to serve scientific communities at large. It can be embedded into third-party websites and also welcomes integration of data from third-parties.
Dr. Shu-Kun Lin: https://sciprofiles.com/profile/2
Dr. Franck Vazquez: https://sciprofiles.com/profile/FranckVazquez
Dr. Martyn Rittman: https://sciprofiles.com/profile/martynrittman
2 October 2019
Winners of the 2019 MDPI Writing Prize
We are delighted to announce the winners of the 2019 MDPI Writing Prize. Entrants were asked to write on the theme "Judging research: How should research and researchers be evaluated and rewarded?" We received a large number of excellent essays from PhD students and postdocs, and the process of shortlisting and choosing winners was not an easy one. The winners demonstrated excellent writing skills alongside interesting and thought-provoking ideas.
As last year, we will begin the process of collating all entries into a book that will be available in open access format. Alongside promoting good writing skills, we see the prize as a way to promote the voices of early career researchers within broader debates and policy discussions.
Congratulations to all of the participants and especially the winners. The winners are:
1st Prize (500 CHF):
Albin Nilsson (National Centre for Nuclear Research, Warsaw, Poland)
[Read here]
2nd Prize (250 CHF):
Qi Zhang (Shandong University, Jinan, China)
[Read here]
Igor Ogashawara (Indiana University, Indianapolis, US)
[Read here]
3rd Prize (100 CHF):
Margaret Sivapragasam (Universiti Teknologi Petronas, Perak, Malaysia)
[Read here]
Arvind Sharma (The University of Queensland, Gatton, Australia)
[Read here]
Jose Flores-Guerrero (University Medical Center Groningen, Groningen, The Netherlands)
[Read here]
The MDPI Writing Prize is an annual award supported by MDPI Author Services, which provides services including language editing, reformatting, plagiarism checks, and image editing.
20 September 2019
MDPI Now Gives Scholars the Possibility to Endorse and Recommend Articles
MDPI is pleased to announce the release of a new functionality giving the possibility for researchers and scholars to endorse, and formally recommend articles to their colleagues.
MDPI was an early signatory of the San Francisco Declaration on Research Assessment (https://sfdora.org/read/) which calls for improvement in how quality and impact of scholarly research outputs are evaluated, especially in moving beyond journal-based citation metrics (journal Impact Factor, Scopus Citescore, etc.).
MDPI supports the establishment of article-level impact metrics, including citations, views, downloads, and Altmetric scores. These measures serve as an impact indicator for research articles on a case–by-case basis, assessing paper on its own merit. However, these metrics are also subjective and can give a biased picture of the article impact: they do not directly reflect the quality or the intrinsic scientific value of the article.
In our view, community engagement with publications based on community-driven metrics can help to overcome this limitation. We have therefore launched an option for scholars to endorse articles, indicating their own assessment of its content and making a recommendation to their community. This follows our implementation of the open source Hypothesis commenting tool, which has been available for all articles published by MDPI for over a year (https://www.mdpi.com/about/announcements/1397). Both endorsement and commenting are available for all previously published and forthcoming MDPI articles.
In addition to potentially serving as a sustainable solution to article assessment, endorsements will help scientific communities to identify the most relevant articles, independently of the journal in which it was published.
The code for the endorsing functionality, which relies on DOIs and ORCIDs, will be made available on GitHub with an open source license.
Dr. Shu-Kun Lin, President and Founder
Dr. Franck Vazquez, Chief Scientific Officer
Dr. Martyn Rittman, Publishing Director
11 September 2019
Create an Entry in Encyclopedia to Get a 100 CHF Voucher in Publishing in MDPI Journals
Encyclopedia is a free online reference created and curated by active scholars. It aims to highlight the latest research results as well as provide a comprehensive record of scientific development. If you have any suggestions or questions, please feel free to contact us via [email protected].
6 August 2019
Preprints Reaches 10,000 Posted Articles Milestone
We are pleased to announce that Preprints has passed the milestone of 10,000 posted preprints. We are delighted to have reached this after just over three years of operation. Our congratulations and thanks go to our authors and advisory board who have supported growth of the platform and been crucial to its operation.
You can find further details at https://www.preprints.org/announcement/show/37.
2 August 2019
DeepGreen Partnering with Publishers and Universities in Distributing Open Access Content to Institutional Repositories
Last week, the DeepGreen initiative in Germany started into an advanced test phase with the publishing partners S. Karger AG, SAGE Publishing, MDPI, Frontiers and De Gruyter, as well as 27 universities from all over Germany, from Hamburg University of Applied Sciences to University of Konstanz.
DeepGreen aims at lowering the barriers for open access publishing by automatically delivering metadata and full text publications from participating publishers to authorized repositories at German universities.
In preparation for a later live operation, the advanced test phase serves to gain experience with extensive data deliveries from publishers and also handling different repository software (including OPUS4, DSpace, EPrints, MyCoRe). DeepGreen thereby acts as a sophisticated platform, receiving articles published by authors affiliated with German universities and depositing these articles to respective university repositories, based on the affiliation metadata. For more information about DeepGreen: https://deepgreen.kobv.de
Karger AG has been a close cooperation partner of the DeepGreen consortium since 2016. S. Karger has more than 80 subscription-based and around 20 open access journals covering a wide spectrum in health science. DeepGreen will assign S. Karger articles to authorized institutions on the legal basis of German alliance and national licenses.
SAGE Publishing was founded by Sara Miller McCune in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE publishes more than 1,000 journals and over 600 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. SAGE Publishing has been a close cooperation partner of DeepGreen since 2016.
MDPI is a scientific open access publisher and has been a partner of DeepGreen since 2017. MDPI comprises 205 peer-reviewed journals of various disciplines. All articles are published under a CC-BY license and are freely available without embargo period.
Frontiers is a scientific open access publisher with 61 journals of over 600 academic disciplines. All articles are peer-reviewed and published freely available under CC-BY license.
De Gruyter is an academic publisher with more than 700 subscription-based and open access journals of 29 disciplines. Articles provided by De Gruyter will be assigned to institutions with German alliance and national licenses.
There is promising communication with other publishers.
DeepGreen is funded by the German Research Foundation (DFG) and the consortium comprises six institutions: the Cooperative Library Network Berlin-Brandenburg, Bavarian State Library, Bavarian Library Network, University Library of the Technische Universität Berlin, University Library of Erlangen-Nuremberg and the Helmholtz Open Science Coordination Office at the GFZ German Research Centre for Geosciences.
If you would like to know in more detail which institutions take part in the advanced test phase of DeepGreen, you can find more information here.
30 July 2019
Meet Us at the 2019 APHA Annual Meeting and Expo
We will be attending the 2019 APHA Annual Meeting and Expo in Philadelphia, PA, USA from 2–6 November 2019. APHA's Annual Meeting and Expo is the largest and most influential annual gathering of public health professionals. Nearly 13,000 attendees join the conference each year to present, learn, and find inspiration. This year, the theme of the conference is “Creating the Healthiest Nation: For science. For action. For health”. Representatives of the following open access journals will attend:
If you are also attending this conference, please feel free to stop by our booth (Booth #1144). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit https://www.apha.org/events-and-meetings/annual.
17 July 2019
First Basel Sustainable Publishing Forum
The University of Basel and the MDPI Sustainability Foundation are organizing the First Basel Sustainable Publishing Forum on 9th September 2019.
The aim of this event is to provide background and perspectives on Plan S to Learned Societies, which have to make well-informed decisions to transition their journals to Open Access (OA).
The BSPF will bring together several representatives of Learned societies, Plan S architects as well as representatives from various publishers and publishing platforms. After getting the big picture from cOAlition S, panel discussions will allow to better understand the diverse challenges that Learned societies are facing to transition their journals to OA as well as to identify sustainable, implementable and scalable solutions for successful Open Access transition.
For program details and registration, please follow the link below:
https://sciforum.net/conference/SustainableSolutionsToOpenAccess
20 June 2019
Journal of Clinical Medicine Receiving 2018 Updated Impact Factor of 5.688
We are pleased to inform that Journal of Clinical Medicine received an updated Journal Impact Factor of 5.688 in the recent release of the Journal Citation Reports®. Journal of Clinical Medicine now ranks 15/160 (Q1) in 'Medicine, General & Internal.'
Source: data according to Journal Citation Reports®, 2018 release, a Clarivate Analytics product.
19 June 2019
Meet Us at Neuroscience 2019 in Chicago, IL, USA, 19–23 October 2019
MDPI will be attending Neuroscience 2019, to be held at McCormick Place in Chicago, IL, USA, 19–23 October 2019.
Join 30,000 colleagues from more than 70 countries at the world’s largest marketplace of ideas and tools for global neuroscience.
The following MDPI journals will be represented:
- Brain Sciences
- Journal of Clinical Medicine
- Genes
- Cancers
- Diagnostics
- Pathogens
- Medicines
- International Journal of Molecular Sciences
- Healthcare
- Journal of Personalized Medicine
- Psych
- Cells
- Children
- Biomedicines
If you are also attending this conference, please feel free to stop by our booth (Booth #405). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.sfn.org/Meetings/Neuroscience-2019.
6 June 2019
Meet Us at European Society of Cardiology Congress 2019 in Paris, France, 31 August – 4 September 2019
MDPI will be attending the European Society of Cardiology Congress 2019 in Paris, France, 31 August – 4 September 2019.
The ESC Congress is the world’s largest conference in cardiovascular medicine. ESC Congress 2019 will take place in one of the world’s most alluring cities, Paris, and will be organised in conjunction with the World Heart Federation emphasizing the global reach of the event.
ESC Congress 2019 will build on the solid foundations of a congress that attracts worldwide cardiology leaders to present and exchange on their knowledge and most important research results. It will focus on the best and latest science but will also emphasize the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.
The following MDPI journals will be represented:
- Journal of Clinical Medicine
- Diagnostics
- Cancers
- Pathogens
- Cells
- Children
- Medicina
- Healthcare
- Journal of Personalized Medicine
- Journal of Cardiovascular Development and Disease
- Biomedicines
If you are also attending this conference, please feel free to stop by our booth (Booth C590). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit the following link: http://www.escexhibition.org/ESC2019/default.aspx.
28 May 2019
Meet US at the 52nd Annual Meeting of ESPGHAN in Glasgow, Scotland, 5–8 June 2019
MDPI will be attending the 52nd Annual Meeting of ESPGHAN, to be held in Glasgow, Scotland, 5–8 June 2019.
Every year the ESPGHAN Annual Meeting attracts the key opinion leaders in the field of Pediatric Gastroenterology, Hepatology and Nutrition from Europe and all around the world, making the congress the largest conference of its kind worldwide.
Attended by 4.600 participants from 100 countries, the previous 51st Annual Meeting in Geneva offered more than 950 abstract presenters a stage to publish their latest research results. Thus, the congress is a great opportunity to meet colleagues in your field from around the world and provides a unique platform to exchange new ideas and discuss the latest developments in these fields. In 2019, the scientific programme will once again include a wide range of sessions and symposia, a clinical track, postgraduate courses as well as the popular hands-on endoscopy learning zone.
The following MDPI journals will be represented:
If you are also attending this conference, please feel free to stop by our booth (Booth #45). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.espghancongress.org/
20 May 2019
Meet Us at the European Human Genetics Conference in Gothenburg, Sweden, 15–18 June 2019
MDPI will be attending the ESHG 2019, to be held in Gothenburg, Sweden, 15th-18th June 2019.
ESHG 2019 - The 53rd European Human Genetics Conference is everything you need in human genetics, whatever your professional background. The Scientific Program Committee (SPC) has worked hard to invite the best speakers from various sectors of human genetics, and to select the best abstracts for platform presentations.
The following MDPI journals will be represented:
- Genes
- Journal of Clinical Medicine
- Cancers
- International Journal of Molecular Sciences
- Cells
- Diagnostics
- Healthcare
- Journal of Personalized Medicine
- Genealogy
- Biomedicines
If you are also attending this conference, please feel free to stop by our booth (Booth #492). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://2019.eshg.org/
8 May 2019
Meet Us at the ESMO Congress 2019
Barcelona, Spain
27 September–1 October 2019
We will be attending the ESMO Congress 2019 in Barcelona, Spain from 27 September to 1 October 2019. The European Society for Medical Oncology (ESMO) is the leading European professional organization for medical oncology. Comprised of 17,000 oncology professionals from over 130 countries, they are the society of reference for oncology education and information. The annual ESMO Congress, which is held every year, is attended by 25,000 participants. The Congress presents the latest scientific developments in basic, translational and clinical cancer research and contextualizes new findings for practical implementation in everyday patient care. Representatives of the following MDPI open access journals will attend:
Cancers (https://www.mdpi.com/journal/cancers)
Diagnostics (https://www.mdpi.com/journal/diagnostics)
Genes (https://www.mdpi.com/journal/genes)
Healthcare (https://www.mdpi.com/journal/healthcare)
IJERPH (https://www.mdpi.com/journal/ijerph)
Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm)
Journal of Personalized Medicine (https://www.mdpi.com/journal/jpm)
Medicina (https://www.mdpi.com/journal/medicina)
Medicines (https://www.mdpi.com/journal/medicines)
Vaccines (https://www.mdpi.com/journal/vaccines)
If you will attend this conference, please stop by our booth (Booth # P433). Our delegates look forward to meeting you in person and to answering any questions you may have concerning open access publishing and our journals.
For more information about the conference, please visit
https://www.esmo.org/Conferences/ESMO-Congress-2019
11 April 2019
Meet Us at the 46th Controlled Release Society Annual Meeting & Exposition
We will be attending the 46th Controlled Release Society Annual Meeting & Exposition. It is one of the biggest events in pharmaceutical field. Representatives of the following open access journals will attend:
Pharmaceutics
JCM
Biomolecules
Materials
IJMS
Molecules
Nanomaterials
Pharmaceuticals
Scientia Pharmaceutica
Vaccines
JPM
Genes
JFB
IJERPH
Biomedicines
Healthcare
If you are also attending this conference, please feel free to stop by our booth (Booth #303). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://2019.controlledreleasesociety.org/
20 March 2019
Fostering Open Access Publishing Worldwide: New IOAP Participants in February and March 2019
We are pleased to welcome more universities from Poland, Italy, Germany, Brazil and other parts of the world to MDPI's Institutional Open Access Program (IOAP). A warm welcome to the institutions listed below, who have joined the Program in February and March this year.
Authors affiliated with these institutions can now enjoy a discount on the APC for papers accepted for publication in any MDPI journal. If you would like to learn more about our program, please visit: https://www.mdpi.com/about/ioap or email us at [email protected].
5 March 2019
MDPI Joins Jisc’s Publications Router Service
We are delighted to announce our participation in Jisc’s Publication Router project, as of March 2019.
Publications Router is a Jisc service that automatically sends notifications about research articles to institutions' systems such as their repositories or CRISs, since May 2015. Through this agreement, MDPI will provide Jisc with daily feeds and information regarding published articles, which will be gathered by their system and delivered to institutions also registered to this service. Nearly all of our articles are published within 15 days of acceptance, so institutions will receive them quite promptly.
The feed will include the full text of the published version of record, with no embargo, so the articles can be exposed immediately for public view. They are accompanied by rich metadata, including confirmation of the immediate CC BY licence, minimising the need for any manual intervention or checking.
For more information about Publications Router, you may contact Jisc’s central helpdesk at [email protected]. For any queries about MDPI’s institutional agreements and collaborations, you may get in touch with MDPI’s Institutional Engagement team at [email protected], which would be very happy to hear from further UK institutions.
1 February 2019
2018 MDPI Top Reviewer Award—Winners Announced
Rigorous peer-review is the cornerstone of high quality academic publishing. Over 97,000 scholars served as reviewers for MDPI journals in 2018. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list all reviewers’ names to express our gratitude. In addition, this year the “MDPI Top Reviewer Awards” are announced, to recognize the very best reviewers for their expertise, dedication, high quality, and timely review reports. We are pleased to announce the following winners of the 2018 MDPI Top Reviewer Awards:
- Ali Behnood
- Andrea Pezzuolo
- Angela Gorgoglione
- Anna D'Auria
- Antonio D'Andrea
- Azhar Abbas
- Bogdan Zagajewski
- Chunhui Chen
- Dominika Głąbska
- Dominika Guzek
- Dragan Pamucar
- Francisco J. G. Silva
- Frank Li
- Gianluca Serafini
- Gyorgy Szekely
- Haozhi Pan
- Helvi Heinonen-Tanski
- José Manuel Gómez-Soberón
- Kathy Lewis
- Klara Kosova
- Luis N. López De Lacalle
- M. Z. Naser
- Malwina Tytła
- Masoume Amirkhani
- Matteo Ghidelli
- Moretti Laura
- Petra Schneider
- Roberto Cerchione
- Spyros Papaefthymiou
- Ştefan Cristian Gherghina
24 January 2019
JAMS Journals: A Low-Cost Publishing Platform
Since 2010, MDPI has run its own online submission system. More recently, we have made the software, with accompanying publishing services, available to other publishers as JAMS (Journal and Article Management System). We are now delighted to announce the launch of JAMS Journals, a standardized platform for operating open access journals at low cost.
JAMS Journals provides a comprehensive service, including a shared submission website, journal websites hosted at a URL provided by the publisher, and a full production service. There is a small setup fee and the cost for each published paper is just a few hundred Swiss francs.
The platform demonstrates that running an open access journal can be straightforward and affordable. The JAMS Journals platform is suitable for
- small publishers or groups of scholars looking to launch their own journal;
- existing publishers or societies seeking to explore open access options;
- publishers looking to convert an existing subscription journal to open access.
JAMS journals launches with two journals from Canadian-based publisher Etcetera Publications:
- Canadian Journal of Pesticides & Pest Management (http://www.cjppm.ca)
- Nanotechnology in Agriculture, Food & Environment (http://www.nanoafe.ca)
Dr AJ Al-Rajab (President of Etcetera Publications) comments:
“In the past few months, we were working on our project to launch new open access scientific journals in the field of agricultural and environmental sciences. We decided to go with JAMS for this venture because of the high quality of their services, reasonable prices, professionalism and easy communication. Our portfolio is expected to grow rapidly during 2019 to include more titles covering different areas in agriculture and environment. MDPI earned already our complete satisfaction and we are looking for a long term cooperation.”
Alongside the new platform, we continue to provide flexible, tailored journal management solutions for existing publishers. For any questions or to request a quotation, contact Dr. Constanze Schelhorn ([email protected]).
24 January 2019
Popularity of Preprints Continues to Grow
2018 was a great year for preprints, with increasing numbers of authors looking to make their papers available online before peer review. Along with other preprint servers, our platform Preprints.org saw an increase in the uptake from authors, and more than double the number of announced papers compared to 2017. In fact, we recently passed two important milestones: 8000 preprints online and 30,000 authors.
We believe that the whole research community has the opportunity to benefit from work being available online as early as possible. We thank and congratulate our authors for supporting us to make this goal a reality.
In 2019, we will be looking carefully at how to provide better value for authors, maintain efficiency while growing in size, and make sure we remain well-connected with the research community.
If you want to participate, you can consider screening preprints or joining our advisory board. And, of course, posting your own work.
9 January 2019
Open Access Agreement between the Austrian Academic Library Consortium (KEMÖ), the Austrian Science Fund (FWF), and MDPI
We are delighted to announce the establishment of our national Open Access agreement with the Austrian Academic Library Consortium (KEMÖ) and the Austrian Science Fund (FWF). Through this national agreement, the Austrian institutions listed below as well as FWF will cover the Article Processing Charges (APC) of manuscripts published by eligible corresponding or funded authors in MDPI journals as long as central funds are available.
All participating institutions have gained access to the MDPI online submission system where they can find full article metadata and pricing information as well as Funder and Grant ID details for easy identification and additional transparency. At the same time eligible authors are benefited from an APC discount which comes at no cost for the institutions.
Eligible corresponding authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email address. To claim their discount, FWF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript. The institutions will then crosscheck the information and confirm the APC funding.
Eligible authors that have their APC covered by their institution or funder are advised to include the following sentence in their acknowledgments: "Open Access Funding by the [name of the institution/funder]".
The full text of the agreement is openly available online at: http://doi.org/10.5281/zenodo.2536007
For any questions about the agreement, please contact the KEMÖ Consortium at [email protected], FWF at [email protected], or the MDPI IOAP team at [email protected].
The Austrian institutions participating in this agreement are:
- Austrian Science Fund (FWF)
- University for Continuing Education Krems
- University of Applied Sciences BFI Vienna
- University of Applied Sciences Upper Austria
- University of Applied Sciences Technikum Wien
- Vorarlberg University of Applied Sciences
- International Institute for Applied Systems Analysis (IIASA)
- Institute of Science and Technology Austria
- MCI Management Center Innsbruck
- University of Graz
- University of Linz
- University of Salzburg
- Graz University of Technology
- TU Wien
- University of Veterinary Medicine Vienna
- University of Vienna
This is our first collective agreement with a national library consortium, while the individual institutions around the world participating in our IOAP are now more than 500 - see details here: https://www.mdpi.com/about/ioap. We would be mostly interested in discussing about possible collaborations with other consortia, funders, and institutions in our mutual efforts to accelerate Open Access.
2 January 2019
Encyclopedia—the Scholarly Community Encyclopedia
We are pleased to announce the new platform Encyclopedia, which is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.
We encourage authors of review articles to quote and adapt the content of their published papers to create Encyclopedia entries. You can create completely new entries on topics in which you have knowledge and expertise. There is no limit on the topics or research fields. All of science and the humanities are included. Each entry will be published directly after submission.
We also have prepared a DOI application function in Encyclopedia. Once a DOI application is approved, the entry website will announce the DOI number and a pdf version with DOI information will be automatically created.
We look forward to your contributions and hope you will make use of this service. Find more about the service at: https://encyclopedia.pub/
30 October 2018
Institutional Open Access Agreement between Bill and Melinda Gates Foundation and MDPI
We are delighted to announce that the Bill and Melinda Gates Foundation (BMGF) is now a participant of our Institutional Open Access Program (IOAP). Authors funded by the BMGF can enjoy discounts on the APC, while the funder covers the costs of eligible articles centrally. BMGF also has access to the MDPI online submission system where they can find full article metadata and pricing information as well as Grant ID details for easy identification and additional transparency.
We hope that funded authors find the programme beneficial and we are happy to offer our IOAP to other funders that need a streamlined workflow of compliance checking and APC coverage.
To claim their discount, BMGF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript.
For any questions about the BMGF agreement, please contact the funder at [email protected] or the MDPI IOAP team at [email protected].
3 October 2018
2018 Nobel Prize in medicine awarded for pioneering research on immune checkpoints
This week, James P. Allison and Tasuku Honjo were awarded the 2018 Nobel prize in physiology or medicine "for their discovery of cancer therapy by inhibition of negative immune regulation." As early as the 1990s, both immunologists discovered proteins that act as brakes on the T cells, ensuring the regulation that keeps autoreactive T cells in check.
Subsequent research found that blocking these so-called immune checkpoints through the use of checkpoint inhibitors shows promising results for cancer treatment, by ramping up the body's immune system and causing a stronger attack against tumor cells. In immunotherapy, doctors now have a viable alternative to chemotherapy and radiotherapy in treating some types of cancer, especially at advanced stages of infestation and including metastasis, even though instances of autoimmune reaction in immunotherapy are not yet fully understood.
Recent research has been looking into the potential of inhibitors blocking PD-1, the T cell protein discovered by Tasuku Honjo in 1992. A group at University of Calgary "investigated the ability for immune checkpoint blockade to enhance the efficacy of oncolytic reovirus (RV) for the treatment of breast cancer" (article published by Ahmed A. Mostafa et al. in Cancers). Simona De Rosa et al. investigated PD-L1/PD-1 expression in gastric cancer cells (article here). One group in Nice, France, studied the characteristics of lung adenocarcinomas in elderly patients in another article published in Cancers.
Diagram depicting the anticancer mechanism of PD-1/PD-L1 inhibitors
(Source: Figure 1 in S.M. Abdin et al., Cancers 2018,
doi:10.3390/cancers10020032).
In an article published in the International Journal of Molecular Sciences (IJMS), Xin Sun et al. give "some structural guidance" for the design of an antibody effective in blocking the PD-L1 immune suppressor. Shifaa M. Abdin et al. provide an overview of checkpoint inhibitors in their review paper entitled "Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors" (Figure 1 to the right).
In order to improve response rates in patients, targeting additional checkpoints such as LAG-3, BTLA or TIM-3 may prove effective, as discussed in an IJMS review paper by Robert J. Torphy et al. Other studies are looking into resistance mechanisms in tumor cells. Once these mechanisms are better understood, adjuvant treatments can help "improve the efficacy of immunotherapy and [...] expand its scope" (review paper by J. Rieth and S. Subramanian: "Mechanisms of Intrinsic Tumor Resistance to Immunotherapy").
One more recent review paper entitled "Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses" (Teresa Nguyen et al.) lays out different strands of use of oncolytic viruses in cancer treatment, one of them being their combined use with checkpoint inhibitors.
A number of papers published in last year's Special Issue on "Targeting Immune Checkpoints and Immunotherapy" (guest-edited by Dr. William Chi-shing Cho) dealt with aspects of immunotherapy as well:
➤ "Targeting Immune Cell Checkpoints during Sepsis" (Naeem K. Patil et al.)
➤ "Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality" (Andreas Pircher et al.)
➤ "PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression"
(Michal Šmahel)
➤ "Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways" (Kai Li et al.)
If you are interested to publish your research on related topics, we welcome your submission to the Special Issue on "Signaling Pathways and Immune Checkpoint Regulation in Cancer" (guest-edited by Prof. Dr. Georgios Rassidakis) in our oncology journal Cancers.
2 October 2018
MDPI Welcomes Plan S
Recently, it was announced that a group of European funders supported 10 principles that will help to expand open access, known as Plan S. MDPI warmly welcomes this move as a step towards achieving more open and accessible communication of research across all disciplines. Some aspects remain to be clarified, however the details given so far match the aims and values that MDPI has held over the past two decades.
We believe that open access publishers should be active participants in discussions around Plan S, particularly regarding potential new business models and practical aspects of implementation. MDPI supports APCs as a transparent unit of payment for article publishing, however we are committed to exploring other measures and recently signed the Jussieu Call. Sustainability is a key value for MDPI, and future funding models should have at their heart the sustainability of knowledge and research dissemination. Plan S provides an opportunity for funders and publishers to directly discuss funding of open access journals in ways that are beneficial to all parties involved.
3 September 2018
Meet Us at the 77th Annual Meeting of the Japanese Cancer Association in Osaka, Japan (27–29 September 2018)
We will be attending the 77th Annual Meeting of the Japanese Cancer Association in Osaka, Japan, 27–29 September 2018. The Japanese Cancer Association (JCA) is the oldest professional association related to cancer research in Japan. It focuses on all aspects of cancer research, including basic, clinical and translational research into the etiology, prevention, diagnosis, and treatment of cancer. More than 5,000 scientists and other cancer professionals attend the JCA Annual Meeting every year.
Representatives of the following MDPI open access journals will attend:
Cancers (https://www.mdpi.com/journal/cancers)
Antibodies (https://www.mdpi.com/journal/antibodies)
Diagnostics (https://www.mdpi.com/journal/diagnostics)
Healthcare (https://www.mdpi.com/journal/healthcare)
Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm)
Vaccines (https://www.mdpi.com/journal/vaccines)
Medicina (https://www.mdpi.com/journal/medicina)
If you are attending this conference, please stop by our booth (Booth # 3-25). Our delegates look forward to meeting you in person and answering any questions you may have concerning open access publishing and our journals.
For more information about the conference, please visit:
https://www.congre.co.jp/jca2018/index_en.php
30 August 2018
MDPI establishes Open Access agreement with Qatar National Library
We are happy to announce the establishment of an Open Access (OA) agreement with Qatar National Library (QNL). QNL is committed to supporting and helping Qatar authors publish OA at no cost. Through this national agreement, QNL will cover the Article Processing Charges (APC) of manuscripts published by Qatar-based corresponding authors in MDPI journals.
Eligible corresponding authors affiliated with Qatar research centers and universities are prompted to choose QNL as part of our Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email and/or a computer registered with the institution’s IP range. QNL will then crosscheck the information and confirm the APC funding.
Qatar authors that have their APC covered by QNL are advised to include the following sentence in their acknowledgments: "The publication of this article was funded by Qatar National Library".
For more information, please visit Open Access at QNL or email the QNL Open Access team at [email protected].
3 July 2018
Meet Us at the ESMO 2018 Congress (19–23 October 2018) in Munich, Germany
We will be attending the ESMO 2018 Congress in Munich, Germany from 19th to 23rd October 2018. The European Society for Medical Oncology (ESMO) is the leading European professional organization for medical oncology. Comprising 18,000 oncology professionals from over 150 countries, they are the society of reference for oncology education and information. The ESMO 2018 Congress will provide a scientific and educational program able to directly impact the daily clinical practice of oncologists. This year, the program also features a dedicated nursing track through a collaboration with the European Oncology Nursing Society (EONS). Representatives of the following MDPI open access journals will attend:
Cancers (https://www.mdpi.com/journal/cancers)
Antibodies (https://www.mdpi.com/journal/antibodies)
Epigenomes (https://www.mdpi.com/journal/epigenomes)
Healthcare (https://www.mdpi.com/journal/healthcare)
High-Throughput (https://www.mdpi.com/journal/high-throughput)
Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm)
Journal of Personalized Medicine (https://www.mdpi.com/journal/jpm)
Medical Sciences (https://www.mdpi.com/journal/medsci)
Medicina (https://www.mdpi.com/journal/medicina)
Medicines (https://www.mdpi.com/journal/medicines)
Vaccines (https://www.mdpi.com/journal/vaccines)
If you are attending this conference, please stop by our booth (Booth # P106). Our delegates look forward to meeting you in person and answering any questions you may have concerning open access publishing and our journals.
For more information about the conference, please visit:
http://www.esmo.org/Conferences/ESMO-2018-Congress
26 June 2018
Journal of Clinical Medicine (ISSN 2077-0383) receives first Journal Impact Factor: 5.583
We are pleased to announce that the Journal of Clinical Medicine (JCM) has received a first Impact Factor in the latest edition of the Journal Citation Reports®, published by Clarivate Analytics in June 2018.
JCM is covered in the Science Citation Index Expanded (SCIE) in Web of Science and received a first Impact Factor of 5.583. The journal ranks 15/154 (Q1) in 'Medicine, General & Internal.'
The Journal Citation Reports®, 2018 release, is a Clarivate Analytics product.
6 June 2018
Meet Us at the 18th World Congress of Basic and Clinical Pharmacology in Kyoto
We will be attending the 18th World Congress of Basic and Clinical Pharmacology, which will be held in Kyoto, Japan, 1–6 July 2018, and representing the following open access journals:
JCM
Pharmaceuticals
Biomedicines
Brain Sciences
Diseases
Pharmacy
Tropical Medicine and Infectious Disease
Cancers
Marine Drugs
Please come along to our booth (#3-6) to chat with our delegates about our journals. We'll gladly answer any questions about our journals and about open access publishing. We look forward to meeting you in person in Edmonton!
For more information on the conference, please visit:
http://www.wcp2018.org/
31 May 2018
Journal of Clinical Medicine 2017 CiteScore™ Announced - 7.07
We are pleased to report the Journal of Clinical Medicine (JCM) received a CiteScore of 7.07 for 2017. The metric reflects citation activity in 2017 in Scopus for papers published in the period 2014‒2016.
JCM ranks 10th out of 841 in the 'General Medicine' category.
For the full details in the current CiteScore release, please see the journal's Source profile. To check the full list of MDPI journals receiving CiteScores, please see here.
31 May 2018
2017 CiteScore™ Metrics Released
The 2017 CiteScore™ data is available now, based on citation data in the Scopus® database. The current CiteScore reflects citation activity in 2017 for articles published in 2014‒2016. Please note that the list below includes journals assigned a CiteScore in this year’s release. For a full list of journals indexed in Scopus, please see our journal list.
Thirteen of our journals received a CiteScore which is in the top 10% of the distribution in at least one of the categories (marked with * in the table below), while a further 32 journals exhibit scores that are in the first quartile of the respective categories.
To access the full data for MDPI journals, please see here. More data can also be found in SJR Scimago Journal & Country Rank.
Unlike CiteScores and the widely used Journal Impact Factors, the Source Normalized Impact per Paper (SNIP) metrics are normalized in order to correct for differences in citation practices between scientific fields. Therefore, the SNIP allows direct comparison between journals specialized in different fields.
According to 2017 data, MDPI publishes six journals with an average citation impact, or SNIP, in excess of 1.500. These journals are Biomolecules, Cancers, Journal of Clinical Medicine (JCM), Marine Drugs, Remote Sensing and Sensors (see the last column in the table below).
CiteScore Data for MDPI Journals
Journal | Rank (Quartile) |
Category | Link | CiteScore 2017 | 2016 |
2015 |
SNIP 2017 |
Aerospace | 43/116 (Q2) | • Aerospace Engineering | Link | 1.23 | - | - | 1.152 |
Agriculture | 69/309 (Q1) 91/398 (Q1) 78/255 (Q2) |
• Agronomy and Crop Science • Plant Science • Food Science |
Link | 1.93 | - | - | 1.133 |
Agronomy | 46/309 (Q1) | • Agronomy and Crop Science | Link | 2.38 | - | - | 1.115 |
Algorithms | 22/46 (Q2) 61/125 (Q2) 60/107 (Q3) 64/114 (Q3) |
• Numerical Analysis • Computational Mathematics • Computational Theory and Mathematics • Theoretical Computer Science |
Link | 1.03 | 1.15 | 1.07 | 0.749 |
Animals | 12/154 (Q1) * 48/367 (Q1) |
• General Veterinary • Animal Science and Zoology |
Link | 2.02 | 1.46 | 1.66 | 1.099 |
Antibiotics | 6/68 (Q1) * 62/263 (Q1) 55/230 (Q1) 31/108 (Q2) 47/134 (Q2) 139/398 (Q2) |
• General Pharmacology, Toxicology and Pharmaceutics • Infectious Diseases • Pharmacology (medical) • Microbiology (medical) • Microbiology • Biochemistry |
Link | 2.85 | 1.65 | - | 0.975 |
Antibodies | 43/143 (Q2) 61/164 (Q2) 85/189 (Q2) |
• Drug Discovery • Immunology and Allergy • Immunology |
Link | 2.85 | - | - | 0.844 |
Antioxidants | 23/119 (Q1) 35/169 (Q2) 100/398 (Q2) 119/367 (Q2) 102/264 (Q2) |
• Clinical Biochemistry • Physiology • Biochemistry • Molecular Biology • Cell Biology |
Link | 3.42 | - | - | 1.361 |
Applied Sciences | 48/270 (Q1) 15/66 (Q1) 31/116 (Q2) 18/53 (Q2) 151/434 (Q2) 186/535 (Q2) |
• General Engineering • Fluid Flow and Transfer Processes • Instrumentation • Process Chemistry and Technology • General Materials Science • Computer Science Applications |
Link | 1.90 | - | - | 0.801 |
Biology | 12/177 (Q1)* 32/186 (Q1) 10/40 (Q1) |
• General Agricultural and Biological Sciences • General Biochemistry, Genetics and Molecular Biology • General Immunology and Microbiology |
Link | 3.48 | 3.02 | 2.78 | 0.961 |
Biomolecules | 31/398 (Q1) * 41/367 (Q1) |
• Biochemistry • Molecular Biology |
Link | 5.72 | 1.67 | 3.08 | 1.542 |
Biosensors | 20/119 (Q1) | • Clinical Biochemistry | Link | 3.59 | 2.83 | 2.37 | 1.122 |
Brain Sciences | 47/111 (Q2) | • General Neuroscience | Link | 2.56 | - | - | 0.695 |
Cancers | 26/323 (Q1) * 23/191 (Q1) |
• Oncology • Cancer Research |
Link | 5.82 | 5.02 | 4.07 | 1.567 |
Catalysts | 32/151 (Q1) 21/46 (Q2) |
• Physical and Theoretical Chemistry • Catalysis |
Link | 3.23 | 3.44 | 3.45 | 0.954 |
Crystals | 76/272 (Q2) 140/434 (Q2) 127/398 (Q2) 26/64 (Q2) |
• General Chemical Engineering • General Materials Science • Condensed Matter Physics • Inorganic Chemistry |
Link | 1.97 | 1.89 | 1.47 | 0.745 |
Diagnostics | 49/119 (Q2) | • Clinical Biochemistry | Link | 2.43 | - | - | 0.788 |
Diversity | 30/124 (Q1) 14/52 (Q2) 83/306 (Q2) 11/29 (Q2) |
• Nature and Landscape Conservation • Agricultural and Biological Sciences (miscellaneous) • Ecology • Ecological Modelling |
Link | 2.15 | 2.03 | 1.96 | 1.300 |
Electronics | 109/644 (Q1) 26/148 (Q1) 42/224 (Q1) 50/259 (Q1) 23/96 (Q1) |
• Electrical and Electronic Engineering • Hardware and Architecture • Control and Systems Engineering • Computer Networks and Communications • Signal Processing |
Link | 2.97 | - | - | 1.227 |
Energies | 6/73 (Q1) * 31/192 (Q1) 103/644 (Q1) 4/16 (Q1) 47/140 (Q2) |
• Control and Optimization • Energy Engineering and Power Technology • Electrical and Electronic Engineering • Energy (miscellaneous) • Renewable Energy, Sustainability and the Environment |
Link | 3.11 | 2.50 | 2.87 | 1.340 |
Entropy | 35/202 (Q1) | • General Physics and Astronomy | Link | 2.41 | 1.87 | 1.99 | 1.189 |
Forests | 17/129 (Q1) | • Forestry | Link | 2.31 | 2.06 | 1.76 | 0.990 |
Future Internet | 132/259 (Q3) | • Computer Networks and Communications | Link | 1.25 | - | - | - |
Games | 132/187 (Q3) 78/110 (Q3) 305/418 (Q3) |
• Statistics and Probability • Statistics, Probability and Uncertainty • Applied Mathematics |
Link | 0.61 | 0.87 | 0.57 | 1.038 |
Genes | 21/91 (Q1) 74/311 (Q1) |
• Genetics (clinical) • Genetics |
Link | 3.49 | 3.62 | 3.18 | 0.374 |
Geosciences | 32/182 (Q1) |
• General Earth and Planetary Sciences | Link | 1.97 | 1.67 | 1.29 | 0.856 |
Information | 143/251 (Q3) | • Information Systems | Link | 1.16 | 0.78 | 0.94 | 1.146 |
Insects | 27/135 (Q1) | • Insect Science | Link | 1.85 | 1.81 | 1.38 | 0.719 |
International Journal of Environmental Research and Public Health (IJERPH) | 80/478 (Q1) 34/106 (Q2) |
• Public Health, Environmental and Occupational Health • Health, Toxicology and Mutagenesis |
Link | 2.41 | 2.38 | 2.42 | 0.931 |
International Journal of Molecular Sciences (IJMS) | 7/69 (Q1) * 61/535 (Q1) 20/163 (Q1) 9/64 (Q1) 26/151 (Q1) 89/367 (Q2) 17/46 (Q2) |
• Spectroscopy • Computer Science Applications • Organic Chemistry • Inorganic Chemistry • Physical and Theoretical Chemistry • Molecular Biology • Catalysis |
Link | 3.86 | 3.73 | 3.37 | 0.998 |
ISPRS International Journal of Geo-Information (IJGI) | 79/605 (Q1) 22/82 (Q2) 13/36 (Q2) |
• Geography, Planning and Development • Earth and Planetary Sciences (miscellaneous) • Computers in Earth Sciences |
Link | 2.10 | 1.62 | 1.52 | 1.062 |
Journal of Clinical Medicine (JCM) | 10/841 (Q1) * | • General Medicine | Link | 7.07 | - | - | 1.535 |
Journal of Functional Biomaterials (JFB) | 43/199 (Q1) 23/77 (Q2) |
• Biomedical Engineering • Biomaterials |
Link | 3.47 | - | - | 1.344 |
Journal of Low Po- wer Electronics and Applications (JLPEA) |
301/644 (Q2) | • Electrical and Electronic Engineering | Link | 1.12 | 0.98 | 0.83 | 0.367 |
Journal of Personalized Medicine (JPM) | 54/189 (Q2) | • Medicine (miscellaneous) | Link | 2.61 | - | - | 0.944 |
Land | 50/124 (Q2) 129/306 (Q2) 36/65 (Q3) |
• Nature and Landscape Conservation • Ecology • Global and Planetary Change |
Link | 1.44 | - | - | 0.658 |
Life | 4/94 (Q1) * 70/561 (Q1) 40/186 (Q1) 20/80 (Q2) |
• Palaeontology • Ecology, Evolution, Behavior and Systematics • General Biochemistry, Genetics and Molecular Biology • Space and Planetary Science |
Link | 3.16 | 2.95 | 1.68 | 0.935 |
Marine Drugs | 17/146 (Q1) | • Drug Discovery | Link | 4.58 | 3.83 | 3.66 | 1.537 |
Materials | 83/434 (Q1) | • General Materials Science | Link | 3.02 | 3.26 | 3.11 | 1.285 |
Membranes | 5/18 (Q2) 15/53 (Q2) 4/10 (Q2) |
• Chemical Engineering (miscellaneous) • Process Chemistry and Technology • Filtration and Separation |
Link | 2.69 | 2.19 | 2.95 | 0.880 |
Metabolites | 47/209 (Q1) 103/398 (Q2) 127/367 (Q2) |
• Endocrinology, Diabetes and Metabolism • Biochemistry • Molecular Biology |
Link | 3.35 | - | - | 0.925 |
Metals | 155/434 (Q2) | • General Materials Science | Link | 1.87 | - | - | 0.955 |
Micromachines | 105/554 (Q1) 154/644 (Q1) 64/224 (Q2) |
• Mechanical Engineering • Electrical and Electronic Engineering • Control and Systems Engineering |
Link | 2.31 | 1.83 | 1.78 | 0.987 |
Minerals | 33/175 (Q1) 45/208 (Q1) |
• Geotechnical Engineering and Engineering Geology • Geology |
Link | 2.21 | 2.13 | 1.77 | 1.149 |
Molecules | 4/25 (Q1) 25/172 (Q1) 18/104 (Q1) 31/163 (Q1) 30/151 (Q1) 31/146 (Q1) 55/160 (Q2) |
• Chemistry (miscellaneous) • Pharmaceutical Science • Analytical Chemistry • Organic Chemistry • Physical and Theoretical Chemistry • Drug Discovery • Molecular Medicine |
Link | 3.27 | 3.09 | 2.65 | 1.146 |
Nutrients | 11/255 (Q1) * 9/112 (Q1) * |
• Food Science • Nutrition and Dietetics |
Link | 4.35 | 4.29 | 4.07 | 1.403 |
Pathogens | 38/263 (Q1) 20/108 (Q1) 9/40 (Q1) 40/164 (Q1) 110/367 (Q2) |
• Infectious Diseases • Microbiology (medical) • General Immunology and Microbiology • Immunology and Allergy • Molecular Biology |
Link | 3.52 | - | - | 1.166 |
Pharmaceuticals | 14/172 (Q1) * 33/160 (Q1) |
• Pharmaceutical Science • Molecular Medicine |
Link | 4.12 | 4.90 | 3.64 | 1.370 |
Pharmaceutics | 21/172 (Q1) | • Pharmaceutical Science | Link | 3.68 | 3.83 | 2.68 | 1.092 |
Photonics | 30/116 (Q1) 80/270 (Q2) 53/160 (Q2) |
• Instrumentation • Radiology Nuclear Medicine and Imaging • Atomic and Molecular Physics, and Optics |
Link | 1.96 | - | - | 0.817 |
Plants | 73/561 (Q1) 48/389 (Q1) 44/306 (Q1) |
• Ecology, Evolution, Behavior and Systematics • Plant Science • Ecology |
Link | 3.13 | - | - | 0.969 |
Polymers | 17/142 (Q1) 63/359 (Q1) |
• Polymers and Plastics • General Chemistry |
Link | 3.30 | 3.74 | 3.37 | 1.213 |
Religions | 26/389 (Q1) * | • Religious Studies | Link | 0.56 | - | - | 0.676 |
Remote Sensing | 13/182 (Q1) * | • General Earth and Planetary Sciences | Link | 4.03 | 3.56 | 3.76 | 1.559 |
Resources | 19/142 (Q1) 39/261 (Q1) |
• Nature and Landscape Conservation • Management, Monitoring, Policy and Law |
Link | 2.69 | - | - | 1.387 |
Scientia Pharmaceutica | 92/172 (Q3) | • Pharmaceutical Science | Link | 0.86 | - | - | 0.513 |
Sensors | 9/116 (Q1) * 25/160 (Q1) 100/644 (Q1) 19/104 (Q1) 113/398 (Q2) |
• Instrumentation • Atomic and Molecular Physics, and Optics • Electrical and Electronic Engineering • Analytical Chemistry • Biochemistry |
Link | 3.23 | 2.78 | 2.21 | 1.550 |
Social Sciences | 81/213 (Q2) | • General Social Sciences | Link | 0.60 | - | - | 0.445 |
Sustainability | 61/605 (Q1) * 55/261 (Q1) 60/140 (Q2) |
• Geography, Planning and Development • Management, Monitoring, Policy and Law • Renewable Energy, Sustainability and the Environment |
Link | 2.37 | 1.96 | 1.78 | 1.030 |
Symmetry | 44/327 (Q1) 17/45 (Q2) 16/40 (Q2) 14/25 (Q2) |
• General Mathematics • Computer Science (miscellaneous) • Physics and Astronomy (miscellaneous) • Chemistry (miscellaneous) |
Link | 1.32 | 1.12 | 0.95 | 0.802 |
Toxins | 18/106 (Q1) 21/111 (Q1) |
• Health, Toxicology and Mutagenesis • Toxicology |
Link | 3.32 | 3.34 | 3.76 | 1.136 |
Vaccines | 5/230 (Q1) * 13/263 (Q1) * 18/302 (Q1) * 11/146 (Q1) * 32/189 (Q1) |
• Pharmacology (medical) • Infectious Diseases • Pharmacology • Drug Discovery • Immunology |
Link | 4.88 | 1.23 | 3.76 | 1.255 |
Viruses | 29/263 (Q1) 16/68 (Q1) |
• Virology • Infectious Diseases |
Link | 3.88 | 3.60 | 3.74 | 1.130 |
Water | 66/605 (Q1) 37/191 (Q1) 43/199 (Q1) 193/398 (Q2) |
• Geography, Planning and Development • Water Science and Technology • Aquatic Science • Biochemistry |
Link | 2.29 | 2.05 | 1.96 | 1.007 |
3 May 2018
Join us at ASM Microbe 2018, Atlanta, GA, USA, 8–10 June 2018
MDPI will be attending ASM Microbe 2018 International Conference during the three day event held from 8–10 June.
ASM Microbe showcases the best microbial sciences in the world and provides a one-of-a-kind forum to explore the complete spectrum of microbiology, from basic science to translation and application. Representatives of the following open access journals will attend:
Toxins
Journal of Clinical Medicine
Viruses
Antibiotics
Diseases
Medicines
Fermentation
Veterinary Sciences
Genes
International Journal of Environmental Research and Public Health (IJERPH)
Pathogens
Tropical Medicine and Infectious Disease
Vaccines
Microorganisms
If you are also attending this conference, please stop by our Booth: #731. Our delegates look forward to meeting you in person, to answer any questions you may have regarding open access publication and our journals. For more information about the conference, please visit: https://www.asm.org/index.php/asm-microbe-2018.
Date: 8–10 June 2018
Location: Georgia World Congress Center, 285 Andrew Young International Blvd NW, Atlanta, GA 30313, USA
30 April 2018
Winners of the First MDPI Writing Prize
We are pleased to announce the results of the first MDPI Writing Prize. We received a large number of entries from across the globe on the theme of “The Global Benefits of Open Research”. It was a pleasure to read so many original, well-researched and well-presented ideas, and the final choice was not an easy one. We are pleased to announce that the winners are as follows:
1st prize (500 CHF, Swiss knife and certificate)
Edmond Sanganyado, Shantou University, China
2nd prizes (250 CHF, Swiss knife and certificate)
Kamala T. Rajahgopal, Asia e University, Malaysia
Yin Zhixuan, Qingdao University of Technology, China
3rd prizes (100 CHF, Swiss knife and certificate)
Alexandra Ticea, Carol Davila University of Medicine and Pharmacy, Romania
Ankur Sarker, University of Virginia, USA
Daniel Attoye, United Arab Emirates University, UAE
Congratulations to all of them! The winning entries can be downloaded by clicking on the names above. A compilation of all entries will soon be available as an open access book.
The writing prize is sponsored by the MDPI English editing service.
23 March 2018
Check for Updates: A New Function in the Article PDF Version
At MDPI, we always want to keep you up to date. Even for already published articles, some corrections or minor changes may occur. To prevent you from missing any updates, from now on you will be able to access the latest version of any manuscript by clicking on the “check for updates” logo that you can find in the PDF file, even if you have saved the file on your computer.
13 March 2018
MDPI Becoming a Member of UKSG
We are proud to announce that MDPI is now a member of UKSG, the UK´s largest scholarly communications community. Through UKSG, different stakeholders share their knowledge and experience in order to improve the knowledge and information environment for researchers. UKSG´s members include universities, publishers, content providers, intermediaries, and other similar organisations. Members participate in discussions and events on issues around scholarly communications.
The UKSG Annual Conference and Exhibition is a flagship initiative from the UKSG and one of the most stimulating events in the scholarly communications calendar. It is held annually and attracts a large number of delegates. More information is available at https://www.uksg.org/events/annualconference
MDPI is delighted to be a part of this active community and we look forward to making our own contribution. We will continue to support organisations and initiatives that boost collaboration and vision within scholarly communication.
More information about UKSG can be found at https://www.uksg.org/. The full membership list is available at: https://www.uksg.org/members.
1 February 2018
MDPI Signed the San Francisco Declaration on Research Assessment (DORA)
The DORA initiative addresses the need for advanced approaches in the evaluation and measurement of the quality of scientific research outputs. It is a worldwide initiative covering all scholarly disciplines. MDPI proudly joins a list of more than 400 organizations around the world which support DORA’s recommendations for improving the way the quality of research results is evaluated.
More info can be found at http://www.ascb.org/dora/
22 January 2018
Meet Us at the Experimental Biology 2018 (21–25 April 2018) in San Diego, CA, USA
MDPI will be attending the Experimental Biology 2018 annual meeting in San Diego, CA, USA from 21 to 25 April 2018, representing the following open access journals:
Antibiotics
Antioxidants
Behavioral Sciences
Bioengineering
Biology
Biomedicines
Brain Sciences
Cancers
Cells
Dentistry Journal
Diagnostics
Diseases
Epigenomes
Fermentation
Genes
High-Throughput
International Journal of Molecular Sciences (IJMS)
International Journal of Environmental Research and Public Health (IJERPH)
Journal of Clinical Medicine (JCM)
Journal of Developmental Biology (JDB)
Journal of Functional Morphology and Kinesiology (JFMK)
Metabolites
Methods and Protocols
Microorganisms
Non-Coding RNA
Nutrients
Pharmaceuticals
Pharmaceutics
Proteomes
Sports
Veterinary Sciences
Viruses
Experimental Biology is the annual meeting of five societies comprised of more than 14,000 scientists and 25 guest societies.
The areas of primary focus include anatomy; biochemistry and molecular biology; investigative pathology; nutrition; pharmacology; physiology. Attendees represent scientists from academic institutions, government agencies, non-profit organizations and industry.
Conference details:
San Diego Convention Center
San Diego CA
USA
21–25 April 2018
Do you want to learn more about MDPI open access journals? Don’t miss this opportunity to discuss them with our editors and MDPI delegates. If you are at Experimental Biology 2018, just come visit our booth for a moment to have a chat. We have some gifts for you to take home and will answer any questions that you have about the open access journal (booth # 1034).
For more information, please visit:
http://experimentalbiology.org/2018/Home.aspx
3 January 2018
Expanding the Coverage in SCIE (Web of Science)
The collection of journals in the Science Citation Index Expanded (SCIE)—the most prestigious part of the Web of Science Core Collection—keeps expanding. Last year, nine MDPI open access journals were added in SCIE; they are due to receive first Journal Impact Factors in June 2018.
Journal |
Current Volume |
Scope |
Oncology | more | submit article |
||
Vol. 8 (2018) | articles |
Animal science; animal welfare | more | submit article |
|
Vol. 7 (2018) | articles |
Cell biology; cell structure; cell function and processes; molecular biology and biophysics | more | submit article |
|
Pharmacokinetics; pharmacodynamics; biopharmaceutics; molecular biology and biotechnology | more | submit article |
||
General and internal medicine; healthcare research and practice | more | submit article |
||
Entomology; physiology and ecology of insects; taxonomy of insects | more | submit article |
||
Chemistry applied to agronomy; agroecology; food science | more | submit article |
||
Vol. 7 (2018) | articles |
Electrical engineering; microelectronics; signal processing | more | submit article |
|
Vol. 6 (2018) | articles |
Chemical engineering and processing; biochemistry | more |
21 December 2017
Meet Us at the AACR Annual Meeting 2018 in Chicago, IL, USA
We will be attending the AACR Annual Meeting 2018, to be held in Chicago, IL, USA, 14-18 April 2018. The American Association for Cancer Research (AACR) is the world's oldest and largest professional association related to cancer research. The AACR gives the opportunity to gain visibility for your organization among more than 21,000 scientists and other cancer professionals who are projected to attend from around the world. Representatives of the following MDPI open access journals will attend:
Antibodies (https://www.mdpi.com/journal/antibodies)
Biomedicines (https://www.mdpi.com/journal/biomedicines)
Cancers (https://www.mdpi.com/journal/cancers)
Cells (https://www.mdpi.com/journal/cells)
Children (https://www.mdpi.com/journal/children)
Diagnostics (https://www.mdpi.com/journal/diagnostics)
Epigenomes (https://www.mdpi.com/journal/epigenomes)
Genes (https://www.mdpi.com/journal/genes)
Healthcare (https://www.mdpi.com/journal/healthcare)
High-Throughput (https://www.mdpi.com/journal/high-throughput)
IJERPH (https://www.mdpi.com/journal/ijerph)
JCM (https://www.mdpi.com/journal/jcm)
IJMS (https://www.mdpi.com/journal/ijms)
JPM (https://www.mdpi.com/journal/jpm)
Medical Sciences (https://www.mdpi.com/journal/medsci)
Medicines (https://www.mdpi.com/journal/medicines)
Metabolites (https://www.mdpi.com/journal/metabolites)
ncRNA (https://www.mdpi.com/journal/ncrna)
Pharmaceuticals (https://www.mdpi.com/journal/pharmaceuticals)
Pharmaceutics (https://www.mdpi.com/journal/pharmaceutics)
Scientia Pharmaceutica (https://www.mdpi.com/journal/scipharm)
Vaccines (https://www.mdpi.com/journal/vaccines)
Please come along to our stand, No.1339, to have a chat with our delegates about the journals, and information on online publishing as well as our editorial procedures. You may also learn more about the various awards offered by the journals, including the Best Paper Awards, the Young Investigator Awards, Travel Awards, etc. Some useful handouts are also available. We look forward to meeting you in person to answer any questions you may have.
Conference address:
AACR Annual Meeting 2018
McCormick Place North/South
Chicago, IL, USA
Conference date:
14-18 April 2018
For more information on the conference, please visit:
http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136
19 December 2017
Announcing the MDPI English Writing Prize
The competition is still open until end of March! Please check out the banner for more details: https://mdpi-res.com/data/english-prize.pdf
15 December 2017
UCL Press Adopts the MDPI Editorial Platform JAMS
We are delighted to announce that UCL Press has adopted MDPI's Journal Article & Management System, JAMS, including production services. JAMS is a modular, integrated editorial platform for academic publishers. It offers flexibility, ease-of-use, and is a fully integrated solution for the end-to-end management of scholarly journals. JAMS is based on the software used to publish MDPI’s portfolio of journals.
Ian Caswell, UCL Press Journals Manager, says he is "excited to see UCL Press and MDPI partner together to implement the JAMS submission system for all UCL Press journals. The system offered a flexible, efficient and straightforward solution for our processes from author submission to ready for publication. I am grateful for the valuable experience and support MDPI have offered and look forward to developing our programme with an effective submission system in place.” Dr Martyn Rittman, MDPI’s Publishing Services Manager, adds, “We are proud to support one of the UK’s premier university presses in their publishing operation. This is an excellent way for us at MDPI to share our experience and knowledge, and benefit the research community beyond our own journals.”
JAMS combines services that are kept separate for many publishers. The entire editorial process, production and invoicing (e.g. for open access article processing charges) are fully integrated into a single platform. This allows for efficient, fast manuscript processing. For further information about JAMS, see https://www.mdpi.com/publishing_services.
23 November 2017
New Participants in the Institutional Open Access Program (IOAP)
We are pleased to welcome new participants to MDPI's Institutional Open Access Program (IOAP), designed to help institutions manage the transition to the Open Access publishing model. Researchers affiliated with participating universites benefit from a 10% discount on the Article Processing Charges (APC) for any paper published in an MDPI journal, while the participating library or university incurs no basic fee for participating in the program.
The IOAP set of free services, provided by MDPI to institutions that sign up, include:- No fee for participants and no obligation to prolong after the initial 12 months. The participants may withdraw from the programme at any time, and we will also keep it free for the library for as long as they continue in the programme.
- Authors affiliated with the university will receive a 10% discount on the APC.
- The institution is granted free access to the MDPI submission system and can receive free alerts of new submissions to our journals.
- By default, authors from the institution will continue to be invoiced directly unless the institution opts for central billing.
- Auto-archiving of papers into the institutions´ repository as long as it supports SWORD 1.3.
More details about the programme and a list of our current participant institutions can be found at: https://www.mdpi.com/about/ioap
Institutions which are interested to participate may do so online at: https://www.mdpi.com/ioap-form
The following North American universities have signed up to the IOAP program recently:
Connecticut College, USA
Emory University, USA
Florida International University, USA
Johns Hopkins University, USA
Mississippi State University, USA
Northeastern University, USA
Rice University, USA
University of Ontario Institute of Technology, Canada
University of Rhode Island, USA
University of Texas Southwestern Medical Center, USA
University of Toronto, Canada
University of Windsor, Canada
University of Wisconsin–Madison, USA
Wellesley College, USA
West Virginia University, USA
Many prestigious institutions from Europe and Asia have joined as well:
Asia Pacific University of Technology & Innovation, Malaysia
Czech Technical University in Prague, Czech Republic
Gdansk University of Technology, Poland
Martin-Luther-Universität Halle-Wittenberg, Germany
National Chung Hsing University, Taiwan
Newcastle University, UK
Northumbria University, UK
Southwest University, China
Technical University of Crete, Greece
University Malaya, Malaysia
University of Antwerp, Belgium
University of Cyprus, Cyprus
University of Manchester, UK
University of Reading, UK
University of Sussex, UK
University of Warwick, UK
West Pomeranian University of Technology Szczecin, Poland
We offer a warm welcome to the new participants!
10 November 2017
Available Journal Awards at MDPI
In order to reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields, for example, Young Investigator Awards, Travel Awards, Best Paper Awards, and Best Poster Awards, etc. The awardees range from PhD students to junior scientists.
Currently, the following 44 awards given by MDPI journals are accepting applications. Please click on the award title below to check whether you are eligible for it and start the application process.
Subject |
Journal |
Award |
Intended Awardee |
Biology & Life Sciences |
Animals |
PhD students or postdoctoral researchers |
|
Antioxidants |
Postdoctoral researchers or PhD students |
||
Biology |
PhD or postdoctoral fellows |
||
Forests |
Postdocs or PhD students |
||
International Journal of Molecular Sciences (IJMS) |
Ground-breaking contribution in the fields of Molecular Biology, and Molecular Pathology |
||
Journal of Fungi (JoF) |
Travel Awards 2018 |
PhD graduate students, and postdoctoral fellows |
|
Life |
Travel Award 2018 |
PhD students or postdoctoral fellows |
|
Metabolites |
PhD students |
||
Pharmaceuticals |
PhD students |
||
Toxins |
Postdoctoral fellows |
||
Viruses |
Viruses 2018 participants |
||
Viruses |
Viruses 2018 participants |
||
Water |
2018 Young Investigator Award |
Young investigators |
|
Chemistry & Materials Science |
Biomimetics
|
Graduate Student or Postdoctoral Trainee / Research Associate |
|
Catalysts |
PhD students |
||
Chemosensors |
PhD or postdoctoral fellows |
||
Entropy |
Young investigators |
||
Fibers |
2018 Travel award |
Postdocs or PhD students |
|
Magnetochemistry |
Postdocs |
||
Materials |
PhD or postdoctoral fellows |
||
Metals |
PhD or postdoctoral fellows |
||
Minerals |
PhD or postdoctoral fellows |
||
Sensors |
Travel Award 2018 |
PhD or postdoctoral fellows |
|
Sensors |
Sensors' reviewers in 2017 |
||
Sensors |
Young investigators |
||
Technologies |
PhD students |
||
Computer Science & Mathematics |
Multimodal Technologies and Interaction (MTI) |
Postdoctoral researchers or PhD students |
|
ISPRS International Journal of Geo-Information(IJGI) |
Postdocs |
||
Journal of Sensor and Actuator Networks (JSAN) |
Postdoctoral fellows and PhD students |
||
Journal of Imaging |
Postdoctoral fellows and PhD students |
||
Engineering |
Actuators |
PhD or postdoctoral fellows |
|
Remote Sensing |
Authors |
||
Machines |
PhD or postdoctoral fellows |
||
Micromachines |
PhD or postdoctoral fellows |
||
Fluids |
Postdoctoral fellows and PhD students |
||
ChemEngineering |
Postdoctoral researchers and PhD students |
||
Environmental & Earth Sciences |
Diversity |
Travel Awards 2018 |
Postdoctoral fellows |
International Journal of Environmental Research and Public Health (IJERPH) |
Authors who submit from 1 Nov 2017 to 31 Oct 2018 |
||
Resources |
Postdocs or PhD students |
||
Geosciences |
Postdoctoral fellows and PhD students |
||
Physical Sciences & Astronomy |
Galaxies |
Ph.D. students, postdoctoral fellows, or lecturers in cosmology or galaxies physics |
|
Applied Science |
Postdocs |
||
Medicine & Pharmacology; Public Health & Healthcare |
Journal of Clinical Medicine (JCM) |
PhD or postdoctoral fellows |
|
Medicines |
Postdocs |
7 November 2017
MDPI has signed the Jussieu Call for Open Science and Bibliodiversity
The Jussieu Call aims to develop and implement alternative models to meet the aims of open science while promoting bibliodiversity. In particular it wishes to promote new business models for funding open access publication. It was drafted on the Jussieu campus in Paris by a group of French researchers and scientific publishing professionals.
MDPI supports scholarly communities and initiatives that innovate and further promote Open Access publishing. There is a need to explore different frameworks to fund open access in ways that ensure that excessive funds are not diverted from research towards publishing. Many fair funding models already exist, and they can be further developed and extended. These include institutional support, library contributions or subsidies, premium services, participatory funding, etc. For this reason, MDPI has signed up to the Jussieu call and welcomes its aims.
More information can be found at http://jussieucall.org/ (archived here)
18 October 2017
Journal of Clinical Medicine, Agronomy and Animals added to SCIE in Web of Science
We are pleased to announce that the Journal of Clinical Medicine (JCM) as well as Agronomy and Animals have been accepted into the Science Citation Index Expanded (SCIE) in the Web of Science Core Collection (Clarivate Analytics). Coverage for the newly added titles starts from first issues in 2015. Agronomy, Animals and JCM are now eligible to be included in next year's Journal Citation Reports (JCR); they are due to receive first Journal Impact Factors in 2018.
6 October 2017
Dr. Franck Vazquez, MDPI CEO, Interviewed by Scholarly Kitchen
The Society for Scholarly Publishing’s popular blog about topics in academic publishing, Scholarly Kitchen, recently interviewed MDPI’s CEO, Dr. Franck Vazquez. He shared some thoughts and information on the past and future of MDPI and open access publishing in general:
“In the long run, we aim to anchor MDPI in research communities. We recently developed and launched the preprint platform Preprints, revamped our free-to-use conference hosting platform Sciforum, and are working on other projects, such as Scilit, our bibliographic database.”
Read the full interview here.
3 October 2017
Meet Us at the 2017 NCRI Cancer Conference in Liverpool
We will be attending the 2017 NCRI Cancer Conference, which will be held in Liverpool, UK, 5–8 November 2017, representing the following open access journals:
Cancers
Genes
Antibodies
Brain Sciences
Journal of Clinical Medicine
Children
Vaccines
Please come along to our stand, No.22, to have a chat with our delegates about the journals, and information on online publishing as well as our editorial procedures. You may also learn more about the various awards offered by the journals, including the Best Reviewer Awards, the Young Investigator Awards, etc. Some useful handouts are also available. We look forward to meeting you in person to answer any questions you may have.
Conference address:
2017 NCRI Cancer Conference
BT Convention Centre, Liverpool, UK
Conference date:
5–8 November 2017
For more information on the conference, please visit:
http://conference.ncri.org.uk/
19 September 2017
A Warm Welcome to the New IOAP Participants
We are delighted to have welcomed 24 new participants to our Institutional Open Access Programme (IOAP) since the beginning of September this year. These are University libraries and Research Institutions located around the world; from the USA and Canada to the UK, and from Norway and Spain to Greece. Well respected Universities, such as the University of Denver, the University of Colorado Boulder, and the University of Arizona in the US, have signed up, while their researchers can now benefit from a 10% discount on the Article Processing Charges (APC) for any papers they publish in MDPI journals, at no cost for the library or the University.
We are more than happy to see the Open Access movement growing stronger and wider every day and we appreciate the vital role which librarians, repository managers, and other scholarly communications professionals play in the field. Our communication with and service to this community is, therefore, one of our principal priorities. The IOAP is our way to support academic and scientific Institutions as well as their scholars in managing, administrating, and publishing research in an Open Access world.
The IOAP set of free services, provided by MDPI to institutions that sign up, include:
- No fee for participants and no obligation to prolong after the initial 12 months. The participants may withdraw from the programme at any time, and we will also keep it free for the library for as long as they continue in the programme.
- Authors affiliated with the university will receive a discount on the article processing charge (APC).
- The institution is granted free access to the MDPI submission system and can receive free alerts of new submissions to our journals.
- By default, authors from the institution will continue to be invoiced directly unless the institution opts for central billing.
- Auto-archiving of papers into the institutions´ repository as long as it supports SWORD 1.3.
More details about the programme and a list of our current participant institutions can be found at: https://www.mdpi.com/about/ioap
Institutions which are interested to participate may do so online at: https://www.mdpi.com/ioap-form
The full list of the Institutions that signed up in September is as follows:
- University of Denver, USA
- University of Colorado Boulder, USA
- University of Arizona, USA
- Institute of Metrology of Bosnia and Herzegovina, Bosnia and Herzegovina
- Middlebury College, USA
- Touro College, USA
- University of New Orleans, USA
- University of Leicester, UK
- Indiana University-Purdue University Indianapolis, USA
- University of Strathclyde, UK
- Cranfield University, UK
- Hope College, USA
- Oregon State University, USA
- Drew University, USA
- Swansea University, UK
- University of South Florida, USA
- University of Georgia, USA
- Arizona State University, USA
- University of Southern Mississippi, USA
- Université du Québec à Chicoutimi, Canada
- Grinnell College, USA
- Norwegian University of Science and Technology, Norway
- University of Patras, Greece
- Public University of Navarre, Spain
23 June 2017
Congratulations for Publishing the 100,000th Peer-Reviewed Article
Congratulations to the authors Javier Monroy and Javier Gonzalez-Jimenez from Universidad de Malaga, Spain, Victor Hernandez-Bennets, Han Fan and Achim Lilienthal from Örebro University, Sweden for publishing the 100,000th peer-reviewed article.
The article is published in the Chemical Sensors section of Sensors.
GADEN: A 3D Gas Dispersion Simulator for Mobile Robot Olfaction in Realistic Environments
Evermore pressing environmental concerns have led global actors and decision-makers to search for stricter emission monitoring approaches. As part of novel monitoring systems, robots with gas and environmental sensors are a promising solution. However, validation of such robotic inspectors is expensive, time consuming, and plagued by repeatability issues. In this article, we present GADEN (the short form for Gas Dispersion Simulator for Mobile Robot Olfaction in Realistic Environments), which combines gas dispersion and robotics simulation in a common framework. Developed under the widely used Robot Operating System (ROS), GADEN enables validation of sensing strategies with gas dispersion being simulated using computational fluid dynamics and filament dispersion theory. GADEN allows simulating complex, realistic, 3D environments for reproducible testing of robotic gas sensing algorithms. Through qualitative and quantitative evaluations, we show that GADEN is a versatile and user-friendly evaluation tool and emphasize its enormous potential for the mobile robot olfaction community.
Read the full article here: https://www.mdpi.com/1424-8220/17/7/1479/htm
6 June 2017
CiteScore™ Metrics Released for Scopus Journals
The CiteScore, the new citation metric for journals covered in the Scopus® database, was released on 1 June 2017, reflecting the citation activity in 2016 for articles published during the three previous years. Please note that the list below does not contain all MDPI journals covered in Scopus. For the CiteScore to serve as a reliable metric at least three volumes of articles need to be indexed in Scopus; journals which have not met this criterion have been omitted here.
Ten MDPI journals received a CiteScore which is in the Top 10% of scores in at least one of the categories, while a further 21 journals exhibit scores that are in the first quartile of the respective categories.
CiteScore Data for MDPI Journals
Journal | Rank | Category | Link | CiteScore 2016 | 2015 |
2014 |
Algorithms | 44/112 (Q2) 49/111 (Q2) 19/42 (Q2) 52/113 (Q2) |
• Numerical Analysis • Computational Mathematics • Computational Theory and Mathematics • Theoretical Computer Science |
Link | 1.15 | 1.07 | 1.06 |
Animals | 69/343 (Q1) 21/146 (Q1) |
• Animal Science and Zoology • General Veterinary |
Link | 1.46 | 1.66 | 0.74 |
Biology | 13/92 (Q1) 34/81 (Q1) 10/75 (Q1) |
• General Agricultural and Biological Sciences • General Biochemistry, Gene- tics and Molecular Biology • General Immunology and Microbiology |
Link | 3.02 | 2.78 | 1.74 |
Biomolecules | 234/382 (Q3) 260/353 (Q3) |
• Biochemistry • Molecular Biology |
Link | 1.67 | 3.08 | 1.00 |
Biosensors | 36/118 (Q2) 209/2156 (Q1) |
• Clinical Biochemistry • General Medicine |
Link | 2.83 | 2.37 | 2.04 |
Cancers | 29/196 (Q1) 27/321 (Q1) |
• Cancer Research • Oncology |
Link | 5.02 | 4.07 | 2.31 |
Catalysts | 18/44 (Q2) 27/144 (Q1) |
• Catalysis • Physical and Theoretical Chemistry |
Link | 3.44 | 3.45 | 2.17 |
Crystals | 70/270 (Q2) 25/64 (Q2) 118/398 (Q2) 131/424 (Q2) |
• General Chemical Engineering • Inorganic Chemistry • Condensed Matter Physics • General Materials Science |
Link | 1.89 | 1.47 | 1.03 |
Diversity | 10/41 (Q1) 9/25 (Q2) 76/291 (Q2) 24/109 (Q1) |
• Agricultural and Biological Sciences (miscellaneous) • Ecological Modelling • Ecology • Nature and Landscape Conservation |
Link | 2.03 | 1.96 | 1.82 |
Energies | - | - | Link | 2.50 | 2.87 | 2.66 |
Entropy | 51/198 (Q2) | • General Physics and Astronomy | Link | 1.87 | 1.99 | 1.69 |
Forests | 17/127 (Q1) | • Forestry | Link | 2.06 | 1.76 | 1.84 |
Games | 204/398 (Q3) 83/181 (Q2) 48/105 (Q2) |
• Applied Mathematics • Statistics and Probability • Statistics, Probability and Uncertainty |
Link | 0.87 | 0.57 | 0.64 |
Genes | 62/300 (Q1) 18/90 (Q1) |
• Genetics • Genetics (clinical) |
Link | 3.62 | 3.18 | 1.33 |
Geosciences | 36/169 (Q1) |
• General Earth and Planetary Sciences | Link | 1.67 | 1.29 | 1.13 |
Information | 156/237 (Q3) | • Information Systems | Link | 0.78 | 0.94 | 0.74 |
Insects | 28/131 (Q1) | • Insect Science | Link | 1.81 | 1.38 | 1.23 |
International Journal of Environmental Research and Public Health (IJERPH) | 67/446 (Q1) 31/102 (Q2) |
• Public Health, Environmental and Occupational Health • Health, Toxicology and Mutagenesis |
Link | 2.38 | 2.42 | 2.47 |
International Journal of Molecular Sciences (IJMS) | 23/157 (Q1) 8/64 (Q1) 90/353 (Q1) 22/144 (Q1) 16/44 (Q1) 8/62 (Q1) |
• Organic Chemistry • Inorganic Chemistry • Molecular Biology • Physical and Theoretical Chemistry • Catalysis • Spectroscopy |
Link | 3.73 | 3.37 | 3.06 |
ISPRS International Journal of Geo-Information | 12/29 (Q2) 28/79 (Q2) 96/587 (Q1) |
• Computers in Earth Sciences • Earth and Planetary Sciences (miscellaneous) • Geography, Planning and Development |
Link | 1.62 | 1.52 | - |
Journal of Low Power Electronic Applications (JLPEA) | 301/645 (Q2) | • Electrical and Electronic Engineering | Link | 0.98 | 0.83 | 0.83 |
Life | 65/525 (Q1) 36/186 (Q1) 5/92 (Q1) 20/80 (Q2) |
• Ecology, Evolution, Behavior and Systematics • General Biochemistry, Gene- tics and Molecular Biology • Palaeontology • Space and Planetary Science |
Link | 2.95 | 1.68 | 1.20 |
Marine Drugs | 18/145 (Q1) | • Drug Discovery | Link | 3.83 | 3.66 | 3.59 |
Materials | 63/424 (Q1) | • General Materials Science | Link | 3.26 | 3.11 | 2.69 |
Membranes | 103/424 (Q1) | • Materials Science | Link | 2.19 | 2.95 | 2.42 |
Micromachines | 173/645 (Q2) 69/211 (Q2) 113/526 (Q1) |
• Electrical and Electronic Engineering • Control and Systems Engineering • Mechanical Engineering |
Link | 1.83 | 1.78 | 2.10 |
Minerals | 45/206 (Q1) 29/167 (Q1) |
• Geology • Geotechnical Engineering and Engineering Geology |
Link | 2.13 | 1.77 | - |
Molecules | 32/157 (Q1) | • Organic Chemistry | Link | 3.09 | 2.65 | 2.62 |
Nutrients | 12/247 (Q1) | • Food Science | Link | 4.29 | 4.07 | 3.78 |
Pharmaceuticals | 8/168 (Q1) 21/158 (Q1) |
• Pharmaceutical Science • Molecular Medicine |
Link | 4.90 | 3.64 | 1.92 |
Pharmaceutics | 19/168 (Q1) | • Pharmaceutical Science | Link | 3.83 | 2.68 | 2.46 |
Polymers | 13/138 (Q1) 44/354 (Q1) |
• Polymers and Plastics • General Chemistry |
Link | 3.74 | 3.37 | 4.10 |
Remote Sensing | 13/169 (Q1) | • General Earth and Planetary Sciences | Link | 3.56 | 3.76 | 3.23 |
Sensors | 25/96 (Q2) 25/159 (Q1) 124/382 (Q2) 103/645 (Q1) |
• Analytical Chemistry • Atomic and Molecular Physics, and Optics • Biochemistry • Electrical and Electronic Engineering |
Link | 2.78 | 2.21 | 2.40 |
Sustainability | 49/129 (Q2) 68/587 (Q1) 56/236 (Q1) |
• Renewable Energy, Sustai-nability and the Environment • Geography, Planning and Development • Management, Monitoring, Policy and Law |
Link | 1.96 | 1.78 | 1.52 |
Symmetry | 17/42 (Q2) 49/111 (Q2) |
• Numerical Analysis • Computational Mathematics |
Link | 1.12 | 0.95 | 1.02 |
Toxins | 16/102 (Q1) 16/108 (Q1) |
• Health, Toxicology and Mutagenesis • Toxicology |
Link | 3.34 | 3.76 | 2.85 |
Vaccines | 146/184 (Q4) 151/250 (Q3) 93/145 (Q3) 186/299 (Q3) 130/232 (Q3) |
• Immunology • Infectious Diseases • Drug Discovery • Pharmacology • Pharmacology (medical) |
Link | 1.23 | 3.76 | 2.85 |
Viruses | 15/68 (Q1) 34/250 (Q1) |
• Virology • Infectious Diseases |
Link | 3.60 | 3.74 | 3.80 |
Water | 33/184 (Q1) 48/195 (Q1) 62/587 (Q1) 198/382 (Q3) |
• Water Science and Technology • Aquatic Science • Geography, Planning and Development • Biochemistry |
Link | 2.05 | 1.96 | 1.45 |
17 May 2017
Three New Institutional Memberships Established
We are pleased to announce that the Goethe University of Frankfurt, the Technical University of Hamburg (TU Hamburg-Harburg), as well as the Humboldt University of Berlin, in Germany, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
4 May 2017
MDPI Supports the Initiative for Open Citations (I4OC)
As an open access publisher, we are keen to support openness and transparency in the research process. Citation data is very important for assessing the value of individual papers and the contribution of researchers. As such, we support the recently launched Initiative for Open Citations (I4OC). The initiative recognizes that citations should be freely available and machine-readable. By doing so, authors gain the maximum benefit from having their work cited.
MDPI now uploads citation data with metadata uploaded to Crossref when registering digital object identifiers (DOIs) for published papers. We are delighted to take this step to support a truly open research environment.
2 May 2017
Publons Peer Review Academy Goes Live
Getting high quality review reports is critical for any journal’s editorial process. At MDPI we have put in place several measures to motivate reviewers and reward them for their work. We are proud of the quality of reviewer reports we receive and grateful for the hours put in by active researchers from across the globe.
Reviewers of MDPI’s largest journals can get recognition via Publons, a website dedicated to rewarding peer reviewers. They have now taken this one step further and launched the Publons Reviewer Academy to help train reviewers to provide useful feedback. Through the academy, researchers can be trained and tutored in various aspects of how to provide structured feedback that will be of genuine help to editors and authors. We support this initiative and recommend it to potential MDPI reviewers, especially early career researchers. See the Publons announcement for further information.
More information on reviewing for MDPI, including how to volunteer as a reviewer, can be found here.
24 April 2017
Two New Institutional Memberships Established
We are pleased to announce that the following universities have joined MDPI's institutional membership program: Trinity University, San Antonio, Texas, USA and the University of New South Wales (UNSW), Sydney, Australia. Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
30 March 2017
Credit for Preprints Comments via Publons
Preprints.org is a platform run by MDPI that allows authors to make early versions of manuscripts available before peer review has been completed.
One of the major benefits of putting a preprint online is to get feedback before journal submission. Until now, however, the feedback has been on a voluntary basis. Preprints is delighted to be the first preprint server to collaborate with Publons to acknowledge substantial comments as reviews and give commentators the opportunity to receive credit for their efforts.
When you add a comment to any article, there is a check box to click for it to appear on Publons. If you have already linked your account it will be passed on automatically. If you don't already have a Publons account, you will be contacted soon afterwards with instructions on how to create one.
We appreciate the enthusiasm and cooperation of Publons in this project and expect it to be of great benefit to authors and commenters alike.
20 March 2017
MDPI 2016 Annual Report Released
We are pleased to announce that our annual report for the year 2016 has now been published.
It contains information regarding company and journal performance, conferences and other publishing services that we provided throughout 2016.
To read the report in full or download a copy, please click here.
15 March 2017
Our 100,000th Article Could be Yours!
After the 20th anniversary of MDPI in 2016, we will reach another milestone this year and will publish the 100,000th peer-reviewed article in one of our 170+ open access journals.
We would like you to be part of this great achievement and so are offering to publish the 100,000th accepted paper free of charge.
To be in with a chance, select a journal in one of our 10 scientific subject areas and submit your paper.
Access the live tracker on published articles here.
3 March 2017
1000 Preprints Online
We are delighted that Preprints now has 1000 papers online since its launch on 3 May 2016.
For more information, see the editorial here.
9 February 2017
Minister and State Secretaries Visit MDPI Office at STP, Belgrade, Serbia
Earlier this week the Science Technology Park in Belgrade, Serbia was visited by Swiss Secretary of State Dr. Mauro Dell’Ambrogio, as well as Serbian Minister of Public Administration and Local Self-Government Ana Brnabic, State Secretary Dr. Vladimir Popovic and Mayor of Belgrade Mr. Siniša Mali.
During the visit to the STP they had a short presentation from MDPI’s CEO Dr. Franck Vazquez and IT Manager Mr. Miloš Čučulović, and further discussed important issues such as Open Access and Open education. Dr. Dell'Ambrogio said he was impressed with the potential for development and ideas for business.
For more information please see:
http://bit.ly/2kpIu7k and http://bit.ly/2kpUQfz
7 February 2017
The 6th World Sustainability Forum: Final Press Release
Basel, 29 January 2017
The 6th World Sustainability Forum #WSF2017SA: African universities critical to achieving the Sustainable Development Goals
Jeffrey and Sonia Sachs win first World Sustainability Award.
Universities need to take the lead in solving the greatest challenges the world faces today, particularly in Africa. They need to do this not only through education – teaching the next generation to think critically and creatively to find sustainable solutions – but also through research that cuts across a range of disciplines. To ensure these solutions are implemented, they need to partner with the private sector and with government.
This was the key message from the 6th World Sustainability Forum (WSF2017), which took place in Cape Town on 27 and 28 January 2017. Sponsored by MDPI and the journal Sustainability under the patronage of the Universities of the Western Cape (UWC), Cape Town (UCT), University of Basel and the National Research Foundation (NRF) of South Africa, the conference was attended by key national and international speakers, including world-leading economist Professor Jeffrey D. Sachs, senior United Nations (UN) advisor and director of the Earth Institute at Columbia University.
The WSF is an annual sustainability conference which addresses research in a range of areas related to sustainable development and sustainability globally. This was the first WSF to take place on the African continent. Discussions at the 2017 conference were driven by the 17 sustainable development goals (SDGs) adopted as part of the 2030 Agenda for Sustainable Development by the UN in September 2015.
Achieving the SDGs “is the moonshot for our generation,” said Sachs. “Like the moonshot [moon landing] of the 1960s, these are tough, bold and achievable objectives.”
“This is a nasty, tough world we live in, and our world agrees on very little. So when 193 governments agree on something, that is important. And when they agree on something as important as sustainable development, that is really something for us to grab hold of – that is a lifeline.”
There was agreement at the WSF that the SDGs are particularly important for Africa, and that African universities in particular have a role to play in achieving them.
Said Professor Tyrone Pretorius, vice-chancellor of UWC: “The quest for sustainable development can only be met through education. Universities today are the oil that fuels the knowledge economy.”
As part of the drive to develop academic capacity to provide the knowledge needed to meet the SDGs, WSF2017 was preceded by the 1st Postgraduate Forum on Sustainability. “A series of workshops for postgraduate education linked to WSF are important, in order to equip postgraduates with the skills necessary to promote sustainability,” said Professor Thandi Mgwebi, director for research at UWC. A second postgraduate forum will take place alongside the WSF2018 in Beijing.
This capacity development is particularly critical to Africa. Said Sachs: “African universities need to do research to find solutions to Africa’s development challenges, because no other university will.”
The UN set a target of achieving the SDGs by 2030: “I regard this as the breakthrough period to end extreme poverty on the continent,” said Sachs, “and for Africa to become one of the most dynamic centres of the world economy.”
It is a critical time for South African universities, said Professor Mamokgethi Phakeng, deputy vice-chancellor for research and internationalisation at UCT: “Higher education is at a crossroads, and there is much polarisation. We need to think carefully about how this sustainable development agenda is owned by all so that it is inclusionary.”
There was also strong emphasis on public–private partnerships – for universities, business and government to work together to achieve the goals.
Said Professor Francis Petersen, deputy vice-chancellor at UCT and vice-chancellor designate at the University of the Free State: “Business sustainability has become critical, because there is increasing demand and complexity of demand on business from the natural, social and economic environment. Sustainability cannot be a standalone issue, divorced from business as usual. Sustainability needs to be embedded into business.”
Environmental crises and climate change was also high on the WSF agenda. In his keynote address, Sachs noted the irreversibility of the climate- and environmental-related challenges.
“If we don’t get our act together, we lose the chance of safety,” he said.
Said Professor Mark New, pro vice-chancellor and director of the African Climate and Development Initiative at UCT: “We have a fundamental challenge in responding to climate change, and we must go further than just putting a plaster on a wound. We need to address the deep structural issues, to move from our current model of development into climate-compatible development.”
“This requires researchers to find the evidence for the correct development pathways to take, and then support the ability of policymakers at all levels to enable the shift to climate-compatible development planning.”
Said Dr. Aldo Stroebel, executive director of international relations and cooperation at the NRF, in closing: “We have seen over the past two days an urgency towards the next step of thinking, that critical type of framework that we all must engage with, not only from an academic perspective, but further up into the policy environment and into rural-based environments where one can clearly see the links and effectiveness of the work.”
World Sustainability Awards
The first World Sustainability Award and the first Emerging Sustainability Leader Awards were presented by Prof. Thandi Mgwebi, Director of Research at UWC, and Dr. Franck Vazquez, CEO of MDPI, during the ceremony on 27 January 2017 as part of the gala dinner of the 6th World Sustainability Forum in South Africa.after day one of proceedings of the 2017 World Sustainability Forum South Africa.
Professor Jeffrey D. Sachs and Dr. Sonia Ehrlich Sachs are the joint recipients of the first World Sustainability Award. Jeffrey Sachs is a world-renowned economist and senior United Nations (UN) advisor and director of the Earth Institute at Columbia University. Sonia Sachs is a paediatrician and public health specialist, and director of the Health Centre at the Centre for Sustainable Development, also at Columbia University.
The joint recipients of the first Emerging Sustainability Leader Award are Dr. Esther Ngumbi and Dr. Xiaosong Hu. Esther Ngumbi is a postdoctoral researcher at Auburn University in Alabama USA and serves as a 2015 Clinton Global University Mentor for agriculture. Xiaosong Hu is a professor at the Chongqing University in China and specialises in automotive control systems and mechanical engineering.
The World Sustainability Award and the Emerging Sustainability Leader Awards are funded to encourage new initiatives and developments in sustainability with the ultimate aim of fostering the transition to sustainable practices and societies.
The World Sustainability Award is funded by the MDPI Sustainability Foundation, and included a monetary prize of USD 100,000 to Jeffrey and Sonia Sachs. The Emerging Sustainability Leader Award is funded by the journal Sustainability, awarded to researchers under 40, and included a monetary prize of USD10,000.
Issued jointly by: UCT Global Strategy and Visibility, Research Office, UWC Communications & Media and MDPI AG
Conference photos are free available at: https://sciforum.net/conference/wsf-6/page/175 Photo credit: Matthias Burkhalter
Carla Bernardo |
Luthando Tyhalibongo |
Matthias Burkhalter |
31 January 2017
Three New Institutional Memberships Established
We are pleased to announce that the Chalmers University of Technology, Sweden, the University of Manitoba, Canada and the Technical University of Cartagena, Spain, have joined MDPI's institutional membership program: Primary authors from these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
27 January 2017
6th World Sustainability Forum under way in South Africa
The 6th World Sustainability Forum is currently being held at the Cape Sun Hotel until 28 January 2017.
The Forum will showcase the work of internationally renowned researchers and include more than 150 presentations. During the conference dinner, the World Sustainability Award, associated with a US$ 100,000 prize, will be announced, as well as the Emerging Sustainability Leader Award, associated with a US$ 10,000 prize. The prizes are sponsored by the MDPI Sustainability Foundation and Sustainability, an academic open access journal by MDPI.
Here are some pictures from the forum so far:
To see the full WSF2017 program and schedule, please see here: https://sciforum.net/conference/wsf-6/page/schedule
19 January 2017
Cape Town to Host the 6th World Sustainability Forum
Cape Town will host the 6th World Sustainability Forum at the Cape Sun Hotel on 27 and 28 January 2017. This prominent event, held for the first time in Africa, will include many illustrious South African and international experts, such as Her Excellency Graça Machel (Sustainable Development Advocate for the United Nations, Mozambique), Joyene Isaacs (HoD Agriculture Western Cape Government), Jeffrey Sachs (Columbia University, USA), Max Bergman (SRaM, University of Basel), Mark New (Pro Vice-Chancellor, University of Cape Town), Frans Swanepoel (FutureAfrica, University of Pretoria) and Francis Petersen (Vice-Chancellor-designate, University of the Free State). The Forum will provide a stage for national and international debates on sustainability in South Africa, the African continent, and about international perspectives on sustainability. It brings together researchers and representatives from government and the business sector to discuss a wide-ranging set of issues associated with sustainability, including food security, water and energy scarcity, mining, poverty reduction, climate change, and urbanisation.
The next few decades will be marked by profound changes in the relationships between global economics, national societies, and the environment. We have entered what some call the Anthropocene, an age in which human activity dominates the climate and the environment. These changes will have numerous consequences on societies around the globe. South Africa and Africa will play a central role, for better or worse, in creating opportunities and risks during these changing times as Africa is profoundly influencing and being influenced by global developments.
The adoption of the 17 United Nations Sustainable Development Goals and the 2030 Agenda for Sustainable Development in September 2015 was accompanied by what insiders considered an optimism they have not experienced in relation to UN resolutions before. The relative efficiency in the drafting, the lack of trenches between East and West, or between North and South, and the unanimity of support of the 193 countries speak volumes. In stark contrast, sustainability seems to go against a changing economic and political tide, where waves of nationalism and protectionism from some of the most powerful countries risk the wellbeing of the rest of the world. The 6th World Sustainability Forum will enable fruitful exchanges, which sensitise South African and international communities to the global urgency and specifics of sustainability.
The Forum will showcase the work of internationally renowned researchers and include more than 150 presentations. During the conference dinner, the World Sustainability Award, associated with a US$ 100 000 prize, will be announced, as well as the Emerging Sustainability Leader Award, associated with a US$ 10 000 prize. The prizes are sponsored by the MDPI Sustainability Foundation and Sustainability, an academic open access journal by MDPI. The World Sustainability Forum is preceded by the Postgraduate Forum on Sustainability, which will introduce more than 100 young scholars from South Africa and the African continent to sustainability research. Both events are organized and sponsored by the University of Cape Town, the University of the Western Cape, the University of Basel, MDPI, and by the National Research Foundation of South Africa.
Contacts:
Scientific Matters: Prof Manfred Max Bergman, Social Research and Methodology Group (SRaM), University of Basel, Switzerland; Email: [email protected]
Press Accreditation and General Enquiries: Mr Matthias Burkhalter, MDPI AG, Basel, Switzerland; Email: [email protected]; Tel. +41 61 683 77 34
Follow us on Twitter
#WSF2017SA
6 January 2017
MDPI Supports the OA2020 Initiative
MDPI is now a proud supporter of the OA2020 Initiative.
Open Access 2020 is an international initiative that aims to induce the swift, smooth and scholarly-oriented transformation of today’s scholarly journals from subscription to open access publishing.
MDPI is participating in the upcoming Berlin13 conference in March 2017, where we are contributing to the initiative by aiding in the design of the roadmap which will make OA the default publishing model.
For more information please see here.
5 January 2017
Three New Institutional Memberships Established
We are pleased to announce that the University of Texas at Arlington, USA, the Harbin Institute of Technology, China and TU Darmstadt, Germany, have joined MDPI's institutional membership program: Primary authors from these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
22 December 2016
Two New Institutional Memberships Established
We are pleased to announce that the Otto-von-Guericke-Universität Magdeburg, Germany and the University of California, Berkeley, USA, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
19 December 2016
MDPI and Wellcome Trust Compliance
The Wellcome Trust has, for a number of years, required that the results of its funded projects are published in open access format. Recently it announced criteria that publishers must fulfil for publication fees to be paid by the Trust. MDPI is pleased to have been added to the list of compliant publishers.
Only publishers who have confirmed their compliance by 16 December 2016 will be eligible to receive payment of APCs by the Wellcome Trust as of 1 April 2017. For more information on the criteria and a full list of publishers that meet them, see here.
13 December 2016
Meet MDPI at the 2016 AGU Fall Meeting
MDPI is currently attending the 2016 AGU Fall Meeting (12–16 December, 2016)
If you are also attending the conference, please feel free to stop by our booth (Booth #1147) and meet the representative editors.
Conference details:
2016 AGU Fall Meeting
12–16 December 2016
Moscone Center
747 Howard St
San Francisco, CA 94103, USA
8 December 2016
Three New Institutional Memberships Established
We are pleased to announce that Purdue University, USA, the Universitat Politécnica de Valencia, Spain and the Queensland University of Technology, Australia, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
16 November 2016
World Sustainability Award - Final Extension
The deadline for the World Sustainability Award has been extended for one last time! You now have one more month to nominate an individual researcher, group or project! The final deadline for nominations will be December 15, 2016.
For full details, please visit here.
11 November 2016
Three New Institutional Memberships Established
We are pleased to announce that the University of Minnesota, USA, the Universidad Politécnica de Madrid, Spain and Shanghai Jiao Tong University, China, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
4 November 2016
MDPI Joins the United Nations Global Compact
MDPI has become a member of the United Nations Global Compact to support corporate sustainability and have committed ourselves to the ten principles associated with the Compact.
Sustainability has always been at the core of MDPI’s values, starting with the collection and preservation of rare chemical samples that started in 1996 and led to the first journal, Molecules. Sustainability has become one of our flagship journals and we have supported and organized several conferences and events based on Sustainability, including the upcoming 6th World Sustainability Forum. As a global enterprise, we see it as our duty to promote responsible practices that will ensure a bright future for our planet. Given this, the choice to join the Global Compact was an easy one and we will do our utmost to fully implement it.
3 November 2016
MDPI Now a Member of SPARC Europe
We are delighted to announce that MDPI has become a member of SPARC Europe, an organization that works for open scholarship in Europe, including support of open access publication.
As one of the few publishers to join SPARC Europe to date, MDPI looks forward to making a contribution that puts open scholarship on a positive and sustainable path. We fully support the goals of open scholarship that allow the largest number of people possible to benefit from work of researchers in all disciplines. We hope that our membership will enable us to work with other stakeholders to find the best possible solution.
2 November 2016
World Sustainability Award Deadline Extension
The deadline for the World Sustainability Award has been extended! You now have until November 15, 2016 to nominate an individual researcher, group or project!
For full details, please visit here.
26 October 2016
Four New Institutional Memberships Established
We are pleased to announce that the Wuppertal Institut, Germany, the University of Girona, Spain and Central South University and Huazhong University of Science and Technology, China, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
24 October 2016
International Open Access Week 2016
Meet us during International Open Access Week 2016! We will be presenting at various locations in Europe and China.
To get involved and for full details see the complete list of events organised by MDPI here.
18 October 2016
Institutional Membership established with Universitat Pompeu Fabra, Spain and Aalto University, Finland
We are pleased to announce that the Universitat Pompeu Fabra, Spain and Aalto University, Finland, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
12 October 2016
Institutional Membership Established with Iowa State University and the University of North Texas, USA
We are pleased to announce that the Iowa State University and the University of North Texas, USA, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
7 October 2016
MDPI at Open Access Days in Munich, 10-11 October 2016
Meet MDPI during the Open Access Days held from 10-11 October 2016 at Ludwig Maximilian University of Munich, Germany.
The two-day event will feature experts from the open access sector, scientists from all disciplines, publishing representatives and supporters of scientific research and communication from libraries as well as research institutes and funding institutions. Join us!
For more information about the event and to see the program, visit the event webpage.
7 October 2016
Institutional Membership Established with the University of Sevilla and the University of Alicante, Spain
We are pleased to announce that the University of Sevilla and the University of Alicante, Spain have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
29 September 2016
Institutional Membership Established with the University of Delaware
We are pleased to announce that the University of Delaware, USA, has joined MDPI's institutional membership program: Primary authors from this university will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
19 September 2016
Peer Review Week 2016
As an open access publisher indebted to the work of our peer reviewers, we are proud to support Peer Review Week 2016. As part of the week's activities and to celebrate this year's theme "Recognition for Review", MDPI will host two webinars that anyone can join.
These webinars will explore the role and value of reviewers and the recognition they receive from a publishers perspective, with examples from MDPI's experience in publishing nearly 80,000 peer reviewed papers, along with evidence from reviewer surveys. It will also touch upon potential changes in how review is carried out and tips for early career researchers who want to be involved in the review process.
Details and links to join can be found below:
Wednesday September 21, 08:00 (CEST)
Friday September 23, 16:00 (CEST)
For more information about all the activites taking place, please visit the Peer Review Week website.
6 September 2016
Institutional Membership established with Kansas State University and Northwestern University, USA
We are pleased to announce that Kansas State University and Northwestern Universty, USE, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
5 September 2016
Institutional Membership Established with University College Cork
We are pleased to announce that University College Cork, Ireland, has joined MDPI's institutional membership program: Primary authors from this university will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
22 August 2016
MDPI New Office Location
We are pleased to announce that MDPI has now moved to a new permanent address:
MDPI AG
St. Alban Anlage 66
CH-4052 Basel
Postfach, CH-4020 Basel
Switzerland
Telephone and fax numbers remain unchanged.
10 August 2016
Institutional Membership established with the University of Texas at Austin, USA, the Wroclaw University of Science and Technology, Poland and the University of Granada and the Compultense University of Madrid, Spain
We are pleased to announce that the following institutions have joined MDPI's institutional membership program in August 2016:
- University of Texas at Austin, USA
- Wroclaw University of Science and Technology, Poland
- University of Granada, Spain
- Compultense University of Madrid, Spain
Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
18 July 2016
Institutional Membership established with Louisiana State University and Florida State University, USA, Royal College of Surgeons, Ireland, University of Rostock, Germany, AGH University of Science and Technology, Poland and Southeast University, China
We are pleased to announce that the following institutions have joined MDPI's institutional membership program in July 2016:
- Louisiana State University, USA
- Florida State University, USA
- Royal College of Surgeons, Ireland
- University of Rostock, Germany
- AGH University of Science and Technology, Poland
- Southeast University, China
Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
12 July 2016
MDPI Moving to New Office Location in Basel (Switzerland) in August 2016
As of 20 August 2016, MDPI's new address in Basel will be:
MDPI AG
St. Alban-Anlage 66
CH-4052 Basel
Switzerland
Telephone and fax numbers remain unchanged.
St. Alban-Anlage 66 was built from 1947 to 1948 and initially the home of the "Bühler AG", a book printing business.
For more information about this building, see: https://www.mdpi.com/about/headquarters
21 June 2016
"Behind the Scenes of Academic Publishing—A Publisher's Perspective" - MDPI's Lecture at the University of Basel
From the 15-16 September, 2016, MDPI will run a course on Academic Publishing at the University of Basel.
In this two day workshop, MDPI will look in detail at the role performed by academic journal publishers and how they interact with academics. Ethical dimensions, what happens when problems occur and how the publisher coordinates all aspects of the submission process will also be covered.
For more detailed information about the program, trainers and registration please visit the course webpage.
14 June 2016
2015 Impact Factors Released
We are pleased to report the 2015 Journal Impact Factors in the latest Journal Citation Reports® Science Edition, published by Thomson Reuters in June 2016. Twenty out of 25 journals have seen an increase in their Impact Factor and two journals (Crystals and IJGI) received a first Impact Factor. Coatings was recently added to SCIE and will receive its first Impact Factor in next year’s JCR.
Updated Impact Factors for Journals in the Science Citation Index Expanded (SCIE)
Journal | 2015 Impact Factor | Details | Category Rank |
Applied Sciences | 1.726 | Link | 83/163 (Q3) in ‘Chemistry, Multidisciplinary’; 129/271 (Q2) in ‘Materials Science, Multidisciplinary’; 64/145 (Q2) in ‘Physics, Applied’ |
Atmosphere | 1.221 | Link | 66/84 (Q4) in ‘Meteorology & Atmospheric Sciences’ |
Catalysts | 2.964 | Link | 53/144 (Q2) in ‘Chemistry, Physical’ |
Energies | 2.077 | Link | 43/88 (Q2) in ‘Energy & Fuels’ |
Entropy | 1.743 | Link | 25/79 (Q2) in ‘Physics, Multidisciplinary’ |
Forests | 1.583 | Link | 19/66 (Q2) in ‘Forestry’ |
Genes | 3.242 | Link | 60/165 (Q2) in ‘Genetics & Heredity’ |
International Journal of Environmental Research and Public Health (IJERPH) | 2.035 | Link | 101/225 (Q2) in ‘Environmental Sciences’ |
International Journal of Molecular Sciences (IJMS) | 3.257 | Link | 110/289 (Q2) in ‘Biochemistry & Molecular Biology’; 51/163 (Q2) in ‘Chemistry, Multidisciplinary’ |
Marine Drugs | 3.345 | Link | 13/59 (Q1) in ‘Chemistry, Medicinal’ |
Materials | 2.728 | Link | 63/271 (Q1) in ‘Materials Science, Multidisciplinary’ |
Metals | 1.574 | Link | 18/73 (Q1) in ‘Metallurgy & Metallurgical Engineering’; 145/271 (Q3) in ‘Materials Science, Multidisciplinary’ |
Micromachines | 1.295 | Link | 30/56 (Q3) in ‘Instruments & Instrumentation’ 63/83 (Q4) in ‘Nanoscience & Nanotechnology’ |
Minerals | 1.468 | Link | 9/21 (Q2) in ‘Mining & Mineral Processing; 14/29 (Q2) in ‘Mineralogy’ |
Molecules | 2.465 | Link | 24/59 (Q2) in ‘Chemistry, Organic’ |
Nanomaterials | 2.690 | Link | 64/271 (Q1) in ‘Materials Science, Multidisciplinary’; 36/83 (Q2) in ‘Nanoscience & Nanotechnology’ |
Nutrients | 3.759 | Link | 16/78 (Q1) in ‘Nutrition & Dietetics’ |
Polymers | 2.944 | Link | 20/85 (Q1) in ‘Polymer Science’ |
Remote Sensing | 3.036 | Link | 5/28 (Q1) in ‘Remote Sensing’ |
Sensors | 2.033 | Link | 36/75 (Q2) in ‘Chemistry, Analytical’; 16/27 (Q3) in ‘Electrochemistry’; 12/56 (Q1) in ‘Instruments & Instrumentation’ |
Sustainability | 1.343 | Link | 146/225 (Q3) in ‘Environmental Sciences’; 22/29 (Q4) in ‘Green & Sustainable Science & Technology’ |
Symmetry | 0.841 | Link | 31/63 (Q2) in ‘Multidisciplinary Sciences’ |
Toxins | 3.571 | Link | 16/89 (Q1) in ‘Toxicology’ |
Viruses | 3.042 | Link | 14/33 (Q2) in ‘Virology’ |
Water | 1.687 | Link | 33/85 (Q2) in ‘Water Resources’ |
Journals with First Impact Factors
Journal | 2015 Impact Factor | Details | Category Rank |
Crystals | 2.075 | Link | 13/26 (Q2) in ‘Crystallography’ |
ISPRS International Journal of Geo-Information | 0.651 | Link | 45/49 (Q4) in ‘Geography, Physical’; 26/28 (Q4) in ‘Remote Sensing’. |
26 May 2016
Institutional Membership established with University of Bremen, Germany, Koç University, Turkey, IIASA, Austria and Jilin University and Kunming Institute of Botany, CAS, China
We are pleased to announce that the following institutions have joined MDPI's institutional membership program in May 2016:
- Unversity of Bremen, Germany
- Koç University, Turkey
- International Institute for Applied Systems Analysis (IIASA), Austria
- Jilin University, China
- Kunming Institute of Botany, Chinese Academy of Sciences, China
Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
23 May 2016
Institutional Membership Established with the KTH Royal Institute of Technology, Sweden and the South China University of Technology, Beijing University of Technology and Southern Medical University, China
We are pleased to announce that the following institutions have joined MDPI's institutional membership program in April and May 2016:
- KTH Royal Institute of Technology, Sweden
- South China University of Technology, China
- Beijing University of Technology, China
- Southern Medical University, China
Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
26 April 2016
New Section on www.mdpi.com - Latest Books
You may have noticed a new section that is now visible on our home page. This section is called "Latest Books" and showcases recent publications from MDPI Books, our book publishing service.
By clicking on the hyperlink "More Books" you will be taken to the MDPI Books Home Page. There you will find more information about the service, as well as the "Recent Publications" list.
Clicking on any of the book images in this list will take you to detailed information about that book (shown below). Here you can also download a PDF version of the book, or order a hardcover printed copy.
For further information about the MDPI Books service, please visit the webpage or contact [email protected].
15 April 2016
Journal of Clinical Medicine 2017 Travel Awards
We are pleased to announce that another MDPI journal is offering an award to encourage junior researchers.
The Journal of clinical Medicine is currently accepting applications and nominations for one Travel Award to sponsor a PhD student/Postdoc to attend a conference in 2017. Find more information about the award and how to apply here.
31 March 2016
Axioms, Behavioral Sciences, Photonics, Separations and Toxics added to the Emerging Sources Citation Index in Web of Science
We are pleased to announce that the journals Axioms, Behavioral Sciences, Photonics, Separations and Toxics were recently accepted for inclusion in the newly launched Emerging Sources Citation Index (ESCI) in Web of Science.
ESCI serves to highlight promising journals which are still under consideration for the Science Citation Index Expanded (SCIE) or the Social Sciences Citation Index (SSCI).
The Emerging Sources Citation Index (ESCI), Science Citation Index Expanded (SCIE), Social Sciences Citation Index
(SSCI), and Web of Science™ (WoS) are Thomson Reuters products.
30 March 2016
Institutional Membership established with the University of Winchester, UK, Silesian University of Technology, Poland and Beijing Jiaotong University and Zhejiang University, China
We are pleased to announce that the University of Winchester, UK, the Silesian University of Technology, Poland and Beijing Jiaotong University and Zhejiang University, China, have joined our Institutional Membership program. Primary authors from these universities will benefit from a 10% discount on article processing charges.
Additional details can be found on our institutional membership page.
24 March 2016
New Editorial Office in Barcelona, Spain
We are excited to announce the opening of our new editorial office in Barcelona, Spain. The launch team is led by a Senior Editor and comprises further staff holding doctoral degrees with several years of research experience. The new editorial team will help us to get closer to European research communities and progress Sciforum, the platform to support the scientific community via conference hosting and other functions. They will also help spread the word about Open Access and meet academics at scientific events.
We are in the process of hiring more doctoral and masters graduates to join the editorial team and welcome applications via [email protected]. For contact details about the office, see our contact page.
22 February 2016
Membership Established with the Max Planck Society
We are pleased to announce that the Max Planck Digital Library (MPDL) has signed an agreement with MDPI to support authors associated with the Max Planck Society (Max-Planck-Gesellschaft). As of 22 February 2016, corresponding authors will receive full funding from the MPDL for articles published in MDPI journals, with a 10% discount applied to the Article Processing Charges. Additional details can be found at our institutional membership page.
Founded in 1948, The Max Planck Society is one of Germany’s leading research organizations, and is currently made up of 83 institutes conducting basic research in natural sciences, life sciences, social sciences and humanities. 18 Nobel laureates have emerged from its ranks of scientists and the society has more than 15,000 publications in scientific journals each year.
5 February 2016
Institutional Membership Extension: Wageningen University, CSIC, University of Zürich, ETH Zürich, University of Tübingen and Osnabrück University
We are pleased to announce that Wageningen University, the Netherlands, the Spanish National Research Council (CSIC), Spain, the University of Zürich and ETH Zürich, Switzerland, and the University of Tübingen and Osnabrück University, Germany, have not only renewed their institutional memberships with MDPI after two years of successful cooperation, but have also increased the reduction of the article processing charges (APCs) for affiliated authors to 25%.
Additional details can be found on our institutional membership page.
5 February 2016
Institutional Membership established with Brock University, Canada and the University of Pisa, Italy
We are pleased to announce that Brock University, Cananda, and the University of Pisa, Italy, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges as of 01 February 2016.
Additional details can be found on our institutional membership page.
25 January 2016
MDPI Sponsors diss:kurs with the University of Basel
MDPI is pleased to announce its newly established sponsorship of diss:kurs, an event coordinated by the University of Basel to support their doctorate program. For more information about the event and how to register, please visit the diss:kurs webpage.
7 January 2016
New Institutional Memberships Established with Tsinghua University, the Chinese Society of Micro-Nano Technology, Ruhr University Bochum and the University of Ulm
We are pleased to announce that the following institutions have joined MDPI's institutional membership program as of 1 January 2016:
- Tsinghua University, China
- Chinese Society of Micro-Nano Technology (CSMNT)
- Ruhr University Bochum, Germany
- University of Ulm, Germany
Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
5 January 2016
Safety, Fermentation, C-Journal of Carbon Research, Magnetochemistry, Batteries and Horticulturae Released Their First Issue in December 2015
We are pleased to announce that MDPI's open access journals Safety, Journal of Imaging, Fermentation, C-Journal of Carbon Research, Magnetochemistry, Batteries and Horticulturae released their first issue at the end of December 2015.
17 December 2015
Institutional Membership Extension: University of Bern, Switzerland
We are pleased to announce that the University of Bern, Switzerland has not only renewed their institutional membership with MDPI after two years of successful cooperation, but also increased the reduction of the article processing charges (APCs) for affiliated authors to 25%.
17 December 2015
Institutional Membership with the University of Ulm and Helmholtz Zentrum Munich
We are pleased to announce that University of Ulm, Germany and Helmholtz Zentrum Munich, Germany has joined MDPI's institutional membership program:
Primary authors from the University of Ulm and Helmholtz Zentrum Munich will benefit from a 10% discount on the article processing charges as of 1 January 2016. Additional details can be found on our institutional membership page.
9 December 2015
Membership Established with the Virginia Polytechnic Institute and State University (Virginia Tech)
We are pleased to announce that Virginia Tech has joined MDPI's institutional membership program. Authors from Virginia Tech will benefit from a 10% discount on the article processing charges as of 1 December 2015. Additional details can be found on our institutional membership page.
1 December 2015
Membership Established with the Technical University of Denmark and the University of North Florida
We are pleased to announce that the following universities have joined MDPI's institutional membership program:
- Technical University of Denmark (as of 1 November 2015)
- University of North Florida, USA (as of 15 November 2015)
Primary authors from the Technical University of Denmark and the University of North Florida will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
16 November 2015
Emerging Sources Citation Index (ESCI) Launched in Web of Science™
The Emerging Sources Citation Index (ESCI) has been launched by Thomson Reuters as a new index in Web of Science™ alongside the established Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI). Web of Science™ thereby continues to reflect the growing importance of Open Access scholarly literature as nearly half of the newly incorporated journals are Open Access journals.
We are pleased to announce that 32 journals published by MDPI were selected for inclusion in the Emerging Sources Citation Index (ESCI). Articles published after 1 January 2015 now appear in ESCI and Web of Science™. This will bring higher visibility to the published research, while they will continue to be under evaluation for SCIE or SSCI.
The following MDPI journals are covered by ESCI:
Journal Title |
Established | About the Journal |
Algorithms | 2008 | Link |
Agriculture | 2011 | Link |
Agronomy | 2011 | Link |
Biomolecules | 2011 | Link |
Brain Sciences | 2011 | Link |
Diagnostics | 2011 | Link |
Membranes | 2011 | Link |
Metabolites | 2011 | Link |
Antibiotics | 2012 | Link |
Antibodies | 2012 | Link |
Antioxidants | 2012 | Link |
Arts | 2012 | Link |
Computers | 2012 | Link |
Electronics | 2012 | Link |
Foods | 2012 | Link |
Journal of Clinical Medicine | 2012 | Link |
Pathogens | 2012 | Link |
Plants | 2012 | Link |
Atoms | 2013 | Link |
Chemosensors | 2013 | Link |
Climate | 2013 | Link |
Computation | 2013 | Link |
Economies | 2013 | Link |
Fibers | 2013 | Link |
International Journal of Financial Studies | 2013 | Link |
Journal of Developmental Biology | 2013 | Link |
Mathematics | 2013 | Link |
Processes | 2013 | Link |
Publications | 2013 | Link |
Risks | 2013 | Link |
Systems | 2013 | Link |
Vaccines | 2013 | Link |
The Emerging Sources Citation Index (ESCI), Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), and Web of Science™ (WoS) are Thomson Reuters products.
2 October 2015
Membership Established with the University of Freiburg and the University of Regensburg
We are pleased to announce that the following universities have joined MDPI's institutional membership program:
University of Freiburg, Germany
University of Regensburg, Germany
Primary authors from the University of Freiburg and the University of Regensburg will benefit from a 10% discount on the article processing charges as of 1 October 2015 and 1 November 2015.
Additional details can be found on our institutional membership page.
5 August 2015
Journal of Clinical Medicine (ISSN 2077-0383) now in PubMed and PubMed Central (PMC)
Citations of papers published in the Journal of Clinical Medicine (ISSN 2079-6374) are now searchable in PubMed. Further, the full-text versions of the papers are archived in PubMed Central.
PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals in PubMed Central, and online books. It is a free resource developed and maintained by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM).